0001193125-21-298813.txt : 20211014 0001193125-21-298813.hdr.sgml : 20211014 20211014163324 ACCESSION NUMBER: 0001193125-21-298813 CONFORMED SUBMISSION TYPE: S-1 PUBLIC DOCUMENT COUNT: 128 FILED AS OF DATE: 20211014 DATE AS OF CHANGE: 20211014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ChargePoint Holdings, Inc. CENTRAL INDEX KEY: 0001777393 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS TRANSPORTATION EQUIPMENT [3790] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-260247 FILM NUMBER: 211323651 BUSINESS ADDRESS: STREET 1: 240 EAST HACIENDA AVENUE CITY: CAMPBELL STATE: CA ZIP: 95008 BUSINESS PHONE: (972) 514-9535 MAIL ADDRESS: STREET 1: 240 EAST HACIENDA AVENUE CITY: CAMPBELL STATE: CA ZIP: 95008 FORMER COMPANY: FORMER CONFORMED NAME: Switchback Energy Acquisition Corp DATE OF NAME CHANGE: 20190521 S-1 1 d233594ds1.htm FORM S-1 Form S-1
false0001777393ChargePoint Holdings, Inc.P10DP10DP20DThe shares of the Company’s common and redeemable convertible preferred stock, prior to the Merger (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.9966 established in the Merger as described in Note 3. The number of Legacy ChargePoint shares was determined from the 217,761,738 shares of Legacy ChargePoint common stock outstanding immediately prior to the closing of the Merger converted at the exchange ratio of 0.9966. All fractional shares were rounded down.This includes 900,000 contingently forfeitable Founder Earn Back Shares pending the occurrence of the Founder Earn Back Triggering Event, which was met on March 12, 2021 0001777393 2021-01-31 0001777393 2021-07-31 0001777393 2020-01-31 0001777393 2018-02-01 2019-01-31 0001777393 2019-02-01 2020-01-31 0001777393 2020-02-01 2021-01-31 0001777393 2020-02-01 2020-07-31 0001777393 2021-02-01 2021-07-31 0001777393 2021-05-01 2021-07-31 0001777393 2020-05-01 2020-07-31 0001777393 2021-02-01 2021-04-30 0001777393 2021-02-26 2021-02-26 0001777393 2020-02-01 2020-04-30 0001777393 2021-02-26 0001777393 2018-01-31 0001777393 2020-07-01 2020-07-31 0001777393 2020-08-01 2020-08-31 0001777393 2019-01-31 0001777393 2019-02-01 0001777393 2020-07-31 0001777393 2021-04-30 0001777393 2020-04-30 0001777393 srt:ChiefExecutiveOfficerMember chpt:CeoAwardsPlanMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember 2021-07-31 0001777393 us-gaap:IPOMember chpt:PrivatePlacementWarrantsMember 2021-07-31 0001777393 us-gaap:IPOMember chpt:PublicWarrantsMember 2021-07-31 0001777393 us-gaap:CommonClassAMember 2021-07-31 0001777393 chpt:CeoAwardsPlanMember 2021-07-31 0001777393 chpt:PublicWarrantsMember 2021-07-31 0001777393 us-gaap:RestrictedStockUnitsRSUMember 2021-07-31 0001777393 chpt:DaimlerMember 2021-07-31 0001777393 us-gaap:LeaseholdImprovementsMember 2021-07-31 0001777393 chpt:OwnedAndOperatedSystemsMember 2021-07-31 0001777393 us-gaap:ConstructionInProgressMember 2021-07-31 0001777393 us-gaap:ToolsDiesAndMoldsMember 2021-07-31 0001777393 us-gaap:MachineryAndEquipmentMember 2021-07-31 0001777393 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-07-31 0001777393 us-gaap:FurnitureAndFixturesMember 2021-07-31 0001777393 us-gaap:CommonStockMember 2021-07-31 0001777393 chpt:EarnoutTriggeringEventMember us-gaap:CommonStockMember chpt:SharePriceGreaterOrEqualFifteenUsdMember 2021-07-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualTwentyUsdMember 2021-07-31 0001777393 chpt:EarnoutTriggeringEventMember us-gaap:CommonStockMember chpt:SharePriceGreaterOrEqualThirtyUsdMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember chpt:MeasurementInputMarketPriceMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-07-31 0001777393 us-gaap:PurchaseCommitmentMember 2021-07-31 0001777393 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001777393 us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001777393 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2021-07-31 0001777393 us-gaap:MoneyMarketFundsMember 2021-07-31 0001777393 us-gaap:FairValueInputsLevel3Member chpt:PrivatePlacementWarrantsMember chpt:AssumedCommonStockWarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember chpt:AssumedCommonStockWarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001777393 chpt:StockOptionsIssuedAndOutstandingMember 2021-07-31 0001777393 chpt:CommonStockReservedForEarnoutMember 2021-07-31 0001777393 chpt:SharesAvailableForGrantUndertwoThousandTwentyOneEquityIncentivePlanMember 2021-07-31 0001777393 chpt:SharesAvailableForGrantUnderTwoThousandTwentyOneEsppMember 2021-07-31 0001777393 chpt:RestrictedStockUnitsAndOutstandingMember 2021-07-31 0001777393 chpt:EquityStockPurchasePlanTwoThousandTwentyOneMember 2021-07-31 0001777393 chpt:EquityIncentivePlanTwoThousandTwentyOneMember 2021-07-31 0001777393 chpt:EquityIncentivePlanTwoThousandSevenMember 2021-07-31 0001777393 chpt:EquityIncentivePlanTwoThousandSeventeenMember 2021-07-31 0001777393 us-gaap:CommonStockMember chpt:LegacyChargepointMember 2021-07-31 0001777393 chpt:LegacyChargepointMember us-gaap:PreferredStockMember 2021-07-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsMember chpt:SeriesBDEPreferredStockMember 2021-07-31 0001777393 us-gaap:IPOMember 2021-07-31 0001777393 chpt:SwitchbackMember 2021-07-31 0001777393 srt:ScenarioPreviouslyReportedMember 2021-01-31 0001777393 chpt:CeoAwardsPlanMember srt:ChiefExecutiveOfficerMember 2021-01-31 0001777393 chpt:CeoAwardsPlanMember 2021-01-31 0001777393 chpt:DaimlerMember 2021-01-31 0001777393 us-gaap:LeaseholdImprovementsMember 2021-01-31 0001777393 chpt:OwnedAndOperatedSystemsMember 2021-01-31 0001777393 us-gaap:ConstructionInProgressMember 2021-01-31 0001777393 us-gaap:FurnitureAndFixturesMember 2021-01-31 0001777393 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-01-31 0001777393 us-gaap:MachineryAndEquipmentMember 2021-01-31 0001777393 us-gaap:ToolsDiesAndMoldsMember 2021-01-31 0001777393 us-gaap:SeriesBPreferredStockMember us-gaap:WarrantMember 2021-01-31 0001777393 us-gaap:SeriesDPreferredStockMember us-gaap:WarrantMember 2021-01-31 0001777393 us-gaap:SeriesEPreferredStockMember us-gaap:WarrantMember 2021-01-31 0001777393 us-gaap:WarrantMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2021-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2021-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2021-01-31 0001777393 chpt:TwoThousandEighteenLoanMember 2021-01-31 0001777393 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2021-01-31 0001777393 us-gaap:MoneyMarketFundsMember 2021-01-31 0001777393 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 us-gaap:FairValueInputsLevel3Member chpt:RedeemableConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 chpt:SwitchbackMember 2021-01-31 0001777393 chpt:ConversionOfRedeemableConvertiblePreferredStockMember 2021-01-31 0001777393 chpt:StockOptionsIssuedAndOutstandingMember 2021-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsOutstandingMember 2021-01-31 0001777393 chpt:CommonStockWarrantsOutstandingMember 2021-01-31 0001777393 chpt:SharesAvailableForGrantUnderTwoThousandSeventeenStockOptionPlanMember 2021-01-31 0001777393 chpt:EquityIncentivePlanTwoThousandSeventeenMember 2021-01-31 0001777393 chpt:EarnoutSharesMember 2021-01-31 0001777393 chpt:CommonStockWarrantsOutstandingAtExercisePriceSixPointZeroTwoMember us-gaap:CommonStockMember 2021-01-31 0001777393 chpt:CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember us-gaap:CommonStockMember 2021-01-31 0001777393 us-gaap:CommonStockMember 2021-01-31 0001777393 chpt:SeriesH1RedeemableConvertiblePreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesGPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesFPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesEPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesDPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesCPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesBPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesAPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesHPreferredStockMember 2021-01-31 0001777393 srt:MaximumMember 2021-01-31 0001777393 us-gaap:SeriesAPreferredStockMember srt:ScenarioPreviouslyReportedMember 2021-01-31 0001777393 us-gaap:SeriesBPreferredStockMember srt:ScenarioPreviouslyReportedMember 2021-01-31 0001777393 us-gaap:SeriesCPreferredStockMember srt:ScenarioPreviouslyReportedMember 2021-01-31 0001777393 us-gaap:SeriesDPreferredStockMember srt:ScenarioPreviouslyReportedMember 2021-01-31 0001777393 us-gaap:SeriesEPreferredStockMember srt:ScenarioPreviouslyReportedMember 2021-01-31 0001777393 us-gaap:SeriesFPreferredStockMember srt:ScenarioPreviouslyReportedMember 2021-01-31 0001777393 us-gaap:SeriesGPreferredStockMember srt:ScenarioPreviouslyReportedMember 2021-01-31 0001777393 us-gaap:SeriesHPreferredStockMember srt:ScenarioPreviouslyReportedMember 2021-01-31 0001777393 chpt:SeriesH1RedeemableConvertiblePreferredStockMember srt:ScenarioPreviouslyReportedMember 2021-01-31 0001777393 country:US 2021-01-31 0001777393 chpt:RestOfWorldMember 2021-01-31 0001777393 chpt:OtherStateMember 2021-01-31 0001777393 stpr:CA 2021-01-31 0001777393 chpt:RestrictedCommonStockMember 2021-01-31 0001777393 us-gaap:LetterOfCreditMember 2021-01-31 0001777393 us-gaap:CashMember us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualFifteenUsdMember 2021-01-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualTwentyUsdMember 2021-01-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualThirtyUsdMember 2021-01-31 0001777393 us-gaap:StateAndLocalJurisdictionMember 2021-01-31 0001777393 us-gaap:CostOfSalesMember 2021-05-01 2021-07-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2021-05-01 2021-07-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2021-05-01 2021-07-31 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2021-05-01 2021-07-31 0001777393 chpt:DaimlerMember 2021-05-01 2021-07-31 0001777393 country:US 2021-05-01 2021-07-31 0001777393 chpt:RestOfTheWorldMember 2021-05-01 2021-07-31 0001777393 chpt:NetworkedChargingSystemsMember 2021-05-01 2021-07-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2021-05-01 2021-07-31 0001777393 chpt:OtherRevenuesMember 2021-05-01 2021-07-31 0001777393 us-gaap:CommonStockMember 2021-05-01 2021-07-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2021-05-01 2021-07-31 0001777393 us-gaap:RetainedEarningsMember 2021-05-01 2021-07-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-01 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember 2021-05-01 2021-07-31 0001777393 chpt:PublicWarrantsMember 2021-05-01 2021-07-31 0001777393 us-gaap:CommonStockMember chpt:LegacyChargepointMember 2021-05-01 2021-07-31 0001777393 us-gaap:CostOfSalesMember 2020-05-01 2020-07-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2020-05-01 2020-07-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2020-05-01 2020-07-31 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2020-05-01 2020-07-31 0001777393 chpt:DaimlerMember 2020-05-01 2020-07-31 0001777393 country:US 2020-05-01 2020-07-31 0001777393 chpt:RestOfTheWorldMember 2020-05-01 2020-07-31 0001777393 chpt:NetworkedChargingSystemsMember 2020-05-01 2020-07-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2020-05-01 2020-07-31 0001777393 chpt:OtherRevenuesMember 2020-05-01 2020-07-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2020-05-01 2020-07-31 0001777393 us-gaap:RetainedEarningsMember 2020-05-01 2020-07-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-05-01 2020-07-31 0001777393 us-gaap:CommonStockMember 2020-05-01 2020-07-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-05-01 2020-07-31 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2021-02-01 2021-07-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2021-02-01 2021-07-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2021-02-01 2021-07-31 0001777393 us-gaap:CostOfSalesMember 2021-02-01 2021-07-31 0001777393 chpt:CeoAwardsPlanMember 2021-02-01 2021-07-31 0001777393 us-gaap:RestrictedStockUnitsRSUMember 2021-02-01 2021-07-31 0001777393 chpt:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2021-02-01 2021-07-31 0001777393 chpt:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2021-02-01 2021-07-31 0001777393 chpt:CommonStockAndPreferredStockWarrantsMember 2021-02-01 2021-07-31 0001777393 us-gaap:RestrictedStockUnitsRSUMember 2021-02-01 2021-07-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2021-02-01 2021-07-31 0001777393 chpt:UnvestedEarlyExercisedCommonStockOptionsMember 2021-02-01 2021-07-31 0001777393 us-gaap:EmployeeStockOptionMember 2021-02-01 2021-07-31 0001777393 chpt:DaimlerMember 2021-02-01 2021-07-31 0001777393 country:US 2021-02-01 2021-07-31 0001777393 chpt:RestOfTheWorldMember 2021-02-01 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember 2021-02-01 2021-07-31 0001777393 chpt:PublicWarrantsMember 2021-02-01 2021-07-31 0001777393 chpt:LegacyCommonAndPreferredStockWarrantsMember 2021-02-01 2021-07-31 0001777393 chpt:TwoThousandEighteenLoanMember 2021-02-01 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-02-01 2021-07-31 0001777393 chpt:EarnOutLiabilityMember us-gaap:FairValueInputsLevel3Member 2021-02-01 2021-07-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2021-02-01 2021-07-31 0001777393 us-gaap:MoneyMarketFundsMember 2021-02-01 2021-07-31 0001777393 chpt:SwitchbackMember 2021-02-01 2021-07-31 0001777393 chpt:PipeFinancingMember 2021-02-01 2021-07-31 0001777393 chpt:NetworkedChargingSystemsMember 2021-02-01 2021-07-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2021-02-01 2021-07-31 0001777393 chpt:OtherRevenuesMember 2021-02-01 2021-07-31 0001777393 chpt:EquityStockPurchasePlanTwoThousandTwentyOneMember 2021-02-01 2021-07-31 0001777393 chpt:EquityIncentivePlanTwoThousandTwentyOneMember 2021-02-01 2021-07-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:TrancheThreeMember chpt:SharePriceGreaterOrEqualThirtyUsdMember 2021-02-01 2021-07-31 0001777393 chpt:SwitchbackPublicStockholdersMember 2021-02-01 2021-07-31 0001777393 chpt:PipeFinancingMember 2021-02-01 2021-07-31 0001777393 us-gaap:CommonStockMember chpt:LegacyChargepointMember 2021-02-01 2021-07-31 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2020-02-01 2020-07-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2020-02-01 2020-07-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2020-02-01 2020-07-31 0001777393 us-gaap:CostOfSalesMember 2020-02-01 2020-07-31 0001777393 chpt:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2020-02-01 2020-07-31 0001777393 chpt:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2020-02-01 2020-07-31 0001777393 chpt:CommonStockAndPreferredStockWarrantsMember 2020-02-01 2020-07-31 0001777393 us-gaap:RestrictedStockUnitsRSUMember 2020-02-01 2020-07-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-02-01 2020-07-31 0001777393 chpt:UnvestedEarlyExercisedCommonStockOptionsMember 2020-02-01 2020-07-31 0001777393 us-gaap:EmployeeStockOptionMember 2020-02-01 2020-07-31 0001777393 chpt:DaimlerMember 2020-02-01 2020-07-31 0001777393 country:US 2020-02-01 2020-07-31 0001777393 chpt:RestOfTheWorldMember 2020-02-01 2020-07-31 0001777393 chpt:TwoThousandEighteenLoanMember 2020-02-01 2020-07-31 0001777393 chpt:NetworkedChargingSystemsMember 2020-02-01 2020-07-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2020-02-01 2020-07-31 0001777393 chpt:OtherRevenuesMember 2020-02-01 2020-07-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2021-02-01 2021-04-30 0001777393 us-gaap:CommonStockMember 2021-02-01 2021-04-30 0001777393 us-gaap:AdditionalPaidInCapitalMember 2021-02-01 2021-04-30 0001777393 chpt:EarnoutSharesMember chpt:GainMember 2021-02-01 2021-04-30 0001777393 us-gaap:RetainedEarningsMember 2021-02-01 2021-04-30 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-02-01 2021-04-30 0001777393 us-gaap:SubsequentEventMember 2021-02-01 2021-04-30 0001777393 us-gaap:AdditionalPaidInCapitalMember 2020-02-01 2020-04-30 0001777393 us-gaap:RetainedEarningsMember 2020-02-01 2020-04-30 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-02-01 2020-04-30 0001777393 us-gaap:CommonStockMember 2020-02-01 2020-04-30 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2020-02-01 2021-01-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2020-02-01 2021-01-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2020-02-01 2021-01-31 0001777393 us-gaap:CostOfSalesMember 2020-02-01 2021-01-31 0001777393 chpt:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2020-02-01 2021-01-31 0001777393 us-gaap:AccountsReceivableMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember chpt:CustomerOneMember 2020-02-01 2021-01-31 0001777393 chpt:CommonStockWarrantsMember 2020-02-01 2021-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantMember 2020-02-01 2021-01-31 0001777393 chpt:UnvestedEarlyExercisedCommonStockOptionsMember 2020-02-01 2021-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:EmployeeStockOptionMember 2020-02-01 2021-01-31 0001777393 chpt:DaimlerMember 2020-02-01 2021-01-31 0001777393 chpt:TwoThousandEighteenLoanMember 2020-02-01 2021-01-31 0001777393 us-gaap:MoneyMarketFundsMember 2020-02-01 2021-01-31 0001777393 chpt:NetworkedChargingSystemsMember 2020-02-01 2021-01-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2020-02-01 2021-01-31 0001777393 chpt:OtherRevenuesMember 2020-02-01 2021-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2020-02-01 2021-01-31 0001777393 us-gaap:RetainedEarningsMember 2020-02-01 2021-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-02-01 2021-01-31 0001777393 us-gaap:CommonStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-02-01 2021-01-31 0001777393 chpt:EquityIncentivePlanTwoThousandSeventeenMember 2020-02-01 2021-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2020-02-01 2021-01-31 0001777393 us-gaap:CommonStockMember chpt:CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember srt:MaximumMember 2020-02-01 2021-01-31 0001777393 us-gaap:CommonStockMember chpt:CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember srt:MinimumMember 2020-02-01 2021-01-31 0001777393 us-gaap:CommonStockMember chpt:CommonStockWarrantsOutstandingAtExercisePriceSixPointZeroTwoMember srt:MaximumMember 2020-02-01 2021-01-31 0001777393 us-gaap:CommonStockMember chpt:CommonStockWarrantsOutstandingAtExercisePriceSixPointZeroTwoMember srt:MinimumMember 2020-02-01 2021-01-31 0001777393 chpt:SeriesH1RedeemableConvertiblePreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesHPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesGPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesFPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesEPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesDPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesCPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesBPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesAPreferredStockMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember us-gaap:ComputerSoftwareIntangibleAssetMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember us-gaap:ComputerSoftwareIntangibleAssetMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember chpt:ToolingMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember chpt:ToolingMember 2020-02-01 2021-01-31 0001777393 chpt:CeoAwardsPlanMember srt:ChiefExecutiveOfficerMember 2020-02-01 2021-01-31 0001777393 country:US 2020-02-01 2021-01-31 0001777393 chpt:RestOfWorldMember 2020-02-01 2021-01-31 0001777393 chpt:RestrictedCommonStockMember 2020-02-01 2021-01-31 0001777393 chpt:CaresActMember 2020-02-01 2021-01-31 0001777393 chpt:CaresActMember srt:MinimumMember 2020-02-01 2021-01-31 0001777393 chpt:CaresActMember srt:MaximumMember 2020-02-01 2021-01-31 0001777393 us-gaap:LeaseholdImprovementsMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesBPreferredStockMember us-gaap:WarrantMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesDPreferredStockMember us-gaap:WarrantMember srt:MinimumMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesDPreferredStockMember us-gaap:WarrantMember srt:MaximumMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesEPreferredStockMember us-gaap:WarrantMember srt:MinimumMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesEPreferredStockMember us-gaap:WarrantMember srt:MaximumMember 2020-02-01 2021-01-31 0001777393 chpt:MergerAgreementMember 2021-02-26 0001777393 chpt:FoundersStockLetterMember chpt:FounderSharesMember 2021-02-26 0001777393 chpt:SponsorMember chpt:PrivatePlacementWarrantsMember 2021-02-26 0001777393 chpt:SponsorMember 2021-02-26 0001777393 us-gaap:CommonStockMember chpt:SwitchbackMember 2021-02-26 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2021-02-26 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-02-26 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2021-02-26 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember chpt:MeasurementInputMarketPriceMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-02-26 0001777393 chpt:ChargePointCommonStockMember chpt:SwitchbackMember chpt:MergerAgreementMember 2021-02-26 0001777393 chpt:ChargePointCommonStockMember chpt:SwitchbackMember 2021-02-26 0001777393 chpt:LegacyChargePointMember 2021-02-26 0001777393 chpt:SwitchbackMember chpt:SubscriptionAgreementMember chpt:PipeFinancingMember 2021-02-26 0001777393 us-gaap:CommonStockMember 2021-02-26 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:EarnoutSharesMember 2021-02-26 0001777393 us-gaap:MeasurementInputSharePriceMember chpt:EarnoutSharesMember 2021-02-26 0001777393 us-gaap:MeasurementInputExpectedTermMember chpt:EarnoutSharesMember 2021-02-26 0001777393 us-gaap:MeasurementInputExpectedDividendRateMember chpt:EarnoutSharesMember 2021-02-26 0001777393 us-gaap:MeasurementInputRiskFreeInterestRateMember chpt:EarnoutSharesMember 2021-02-26 0001777393 us-gaap:MeasurementInputPriceVolatilityMember chpt:EarnoutSharesMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesARedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesBRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesCRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesDRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesERedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesFRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesGRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesHRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesHOneRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 us-gaap:SubsequentEventMember chpt:PipeFinancingMember 2021-02-26 2021-02-26 0001777393 us-gaap:CommonStockMember chpt:ChargePointMember 2021-02-26 2021-02-26 0001777393 chpt:PipeInvestorMember 2021-02-26 2021-02-26 0001777393 chpt:FoundersStockLetterMember chpt:FounderSharesMember 2021-02-26 2021-02-26 0001777393 chpt:SponsorMember chpt:PrivatePlacementWarrantsMember 2021-02-26 2021-02-26 0001777393 chpt:BusinessCombinationAgreementMember us-gaap:CommonStockMember 2021-02-26 2021-02-26 0001777393 us-gaap:CommonStockMember chpt:SwitchbackMember chpt:MergerAgreementMember 2021-02-26 2021-02-26 0001777393 us-gaap:CommonStockMember chpt:SwitchbackMember 2021-02-26 2021-02-26 0001777393 chpt:ChargePointCommonStockMember chpt:SwitchbackMember 2021-02-26 2021-02-26 0001777393 chpt:SwitchbackMember chpt:SubscriptionAgreementMember chpt:PipeFinancingMember 2021-02-26 2021-02-26 0001777393 chpt:FounderSharesMember chpt:SwitchbackMember 2021-02-26 2021-02-26 0001777393 chpt:FounderEarnBackSharesMember chpt:SwitchbackMember 2021-02-26 2021-02-26 0001777393 chpt:FounderEarnBackTriggeringEventMember chpt:SwitchbackMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargepointSharesMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesARedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesBRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesCRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesDRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesERedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesFRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesGRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesHRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesHOneRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 us-gaap:SubsequentEventMember 2021-04-30 0001777393 chpt:TwoThousandEighteenLoanMember 2018-07-31 0001777393 chpt:TwoThousandEighteenLoanMember 2019-06-01 2019-06-30 0001777393 chpt:TwoThousandEighteenLoanMember 2019-06-30 0001777393 chpt:TwoThousandEighteenLoanMember 2021-03-01 2021-03-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualFifteenUsdMember 2021-03-12 0001777393 chpt:SharePriceGreaterOrEqualTwentyUsdMember chpt:EarnoutTriggeringEventMember 2021-03-12 0001777393 chpt:EarnoutTriggeringEventMember chpt:EarnoutSharesMember 2021-03-12 0001777393 chpt:EarnoutTriggeringEventMember us-gaap:CommonStockMember 2021-03-12 0001777393 chpt:EarnoutSharesMember 2021-03-12 0001777393 us-gaap:MeasurementInputSharePriceMember chpt:EarnoutSharesMember 2021-03-12 0001777393 us-gaap:MeasurementInputExpectedTermMember chpt:EarnoutSharesMember 2021-03-12 0001777393 us-gaap:MeasurementInputExpectedDividendRateMember chpt:EarnoutSharesMember 2021-03-12 0001777393 us-gaap:MeasurementInputRiskFreeInterestRateMember chpt:EarnoutSharesMember 2021-03-12 0001777393 us-gaap:MeasurementInputPriceVolatilityMember chpt:EarnoutSharesMember 2021-03-12 0001777393 chpt:EarnoutSharesMember 2021-03-12 2021-03-12 0001777393 chpt:EarnoutSharesMember chpt:MergerAgreementMember 2021-03-12 2021-03-12 0001777393 chpt:TrancheThreeMember 2021-03-12 2021-03-12 0001777393 chpt:EarnoutSharesMember 2021-03-13 2021-03-13 0001777393 chpt:EarnoutSharesMember 2021-03-13 0001777393 chpt:HasToBeMember 2021-07-20 2021-07-20 0001777393 chpt:ViricitiBVMember us-gaap:SubsequentEventMember 2021-08-11 2021-08-11 0001777393 chpt:SharePriceGreaterOrEqualThirtyUsdMember chpt:EarnoutTriggeringEventMember chpt:TrancheThreeMember 2021-07-01 0001777393 chpt:SharePriceGreaterOrEqualThirtyUsdMember chpt:EarnoutTriggeringEventMember chpt:TrancheThreeMember 2021-07-01 2021-07-01 0001777393 chpt:PublicWarrantsMember us-gaap:SubsequentEventMember 2021-07-06 0001777393 chpt:PublicWarrantsMember 2021-07-06 0001777393 chpt:PublicWarrantsMember 2021-06-04 0001777393 chpt:PublicWarrantsMember 2021-07-06 2021-07-06 0001777393 srt:ScenarioPreviouslyReportedMember 2020-01-31 0001777393 chpt:DaimlerMember 2020-01-31 0001777393 us-gaap:FurnitureAndFixturesMember 2020-01-31 0001777393 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-01-31 0001777393 us-gaap:MachineryAndEquipmentMember 2020-01-31 0001777393 us-gaap:ToolsDiesAndMoldsMember 2020-01-31 0001777393 us-gaap:ConstructionInProgressMember 2020-01-31 0001777393 chpt:OwnedAndOperatedSystemsMember 2020-01-31 0001777393 us-gaap:LeaseholdImprovementsMember 2020-01-31 0001777393 us-gaap:WarrantMember us-gaap:SeriesBPreferredStockMember 2020-01-31 0001777393 us-gaap:WarrantMember us-gaap:SeriesDPreferredStockMember 2020-01-31 0001777393 us-gaap:WarrantMember us-gaap:SeriesEPreferredStockMember 2020-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:WarrantMember 2020-01-31 0001777393 us-gaap:MeasurementInputPriceVolatilityMember chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member 2020-01-31 0001777393 us-gaap:MeasurementInputRiskFreeInterestRateMember chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member 2020-01-31 0001777393 us-gaap:MeasurementInputExpectedDividendRateMember chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member 2020-01-31 0001777393 us-gaap:MeasurementInputExpectedTermMember chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member 2020-01-31 0001777393 chpt:TwoThousandEighteenLoanMember 2020-01-31 0001777393 chpt:ConversionOfRedeemableConvertiblePreferredStockMember 2020-01-31 0001777393 chpt:StockOptionsIssuedAndOutstandingMember 2020-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsOutstandingMember 2020-01-31 0001777393 chpt:CommonStockWarrantsOutstandingMember 2020-01-31 0001777393 chpt:SharesAvailableForGrantUnderTwoThousandSeventeenStockOptionPlanMember 2020-01-31 0001777393 chpt:CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember us-gaap:CommonStockMember 2020-01-31 0001777393 us-gaap:CommonStockMember 2020-01-31 0001777393 us-gaap:SeriesHPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesGPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesFPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesEPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesDPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesCPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesBPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesAPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesAPreferredStockMember srt:ScenarioPreviouslyReportedMember 2020-01-31 0001777393 us-gaap:SeriesBPreferredStockMember srt:ScenarioPreviouslyReportedMember 2020-01-31 0001777393 us-gaap:SeriesCPreferredStockMember srt:ScenarioPreviouslyReportedMember 2020-01-31 0001777393 us-gaap:SeriesDPreferredStockMember srt:ScenarioPreviouslyReportedMember 2020-01-31 0001777393 us-gaap:SeriesEPreferredStockMember srt:ScenarioPreviouslyReportedMember 2020-01-31 0001777393 us-gaap:SeriesFPreferredStockMember srt:ScenarioPreviouslyReportedMember 2020-01-31 0001777393 us-gaap:SeriesGPreferredStockMember srt:ScenarioPreviouslyReportedMember 2020-01-31 0001777393 us-gaap:SeriesHPreferredStockMember srt:ScenarioPreviouslyReportedMember 2020-01-31 0001777393 country:US 2020-01-31 0001777393 chpt:RestOfWorldMember 2020-01-31 0001777393 chpt:RestrictedCommonStockMember 2020-01-31 0001777393 us-gaap:LetterOfCreditMember 2020-01-31 0001777393 us-gaap:CashMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-31 0001777393 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-31 0001777393 us-gaap:USTreasuryBillSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-31 0001777393 us-gaap:FairValueMeasurementsRecurringMember 2020-01-31 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2019-02-01 2020-01-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2019-02-01 2020-01-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2019-02-01 2020-01-31 0001777393 us-gaap:CostOfSalesMember 2019-02-01 2020-01-31 0001777393 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SalesRevenueNetMember chpt:CustomerTwoMember 2019-02-01 2020-01-31 0001777393 chpt:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2019-02-01 2020-01-31 0001777393 chpt:CommonStockWarrantsMember 2019-02-01 2020-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantMember 2019-02-01 2020-01-31 0001777393 chpt:UnvestedEarlyExercisedCommonStockOptionsMember 2019-02-01 2020-01-31 0001777393 chpt:UnvestedRestrictedCommonStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:EmployeeStockOptionMember 2019-02-01 2020-01-31 0001777393 chpt:DaimlerMember 2019-02-01 2020-01-31 0001777393 chpt:TwoThousandEighteenLoanMember 2019-02-01 2020-01-31 0001777393 us-gaap:MoneyMarketFundsMember 2019-02-01 2020-01-31 0001777393 chpt:NetworkedChargingSystemsMember 2019-02-01 2020-01-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2019-02-01 2020-01-31 0001777393 chpt:OtherRevenuesMember 2019-02-01 2020-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2019-02-01 2020-01-31 0001777393 us-gaap:RetainedEarningsMember 2019-02-01 2020-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-02-01 2020-01-31 0001777393 us-gaap:CommonStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2019-02-01 2020-01-31 0001777393 us-gaap:CommonStockMember chpt:CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember srt:MaximumMember 2019-02-01 2020-01-31 0001777393 us-gaap:CommonStockMember chpt:CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember srt:MinimumMember 2019-02-01 2020-01-31 0001777393 chpt:SeriesHRedeemableConvertiblePreferredStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:SeriesHPreferredStockMember 2019-02-01 2020-01-31 0001777393 srt:MaximumMember 2019-02-01 2020-01-31 0001777393 srt:MinimumMember 2019-02-01 2020-01-31 0001777393 country:US 2019-02-01 2020-01-31 0001777393 chpt:RestOfWorldMember 2019-02-01 2020-01-31 0001777393 chpt:RestrictedCommonStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:WarrantMember us-gaap:SeriesBPreferredStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:WarrantMember us-gaap:SeriesDPreferredStockMember srt:MinimumMember 2019-02-01 2020-01-31 0001777393 us-gaap:WarrantMember us-gaap:SeriesDPreferredStockMember srt:MaximumMember 2019-02-01 2020-01-31 0001777393 us-gaap:WarrantMember us-gaap:SeriesEPreferredStockMember srt:MinimumMember 2019-02-01 2020-01-31 0001777393 us-gaap:WarrantMember us-gaap:SeriesEPreferredStockMember srt:MaximumMember 2019-02-01 2020-01-31 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2018-02-01 2019-01-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2018-02-01 2019-01-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2018-02-01 2019-01-31 0001777393 us-gaap:CostOfSalesMember 2018-02-01 2019-01-31 0001777393 chpt:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2018-02-01 2019-01-31 0001777393 chpt:CommonStockWarrantsMember 2018-02-01 2019-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantMember 2018-02-01 2019-01-31 0001777393 chpt:UnvestedEarlyExercisedCommonStockOptionsMember 2018-02-01 2019-01-31 0001777393 chpt:UnvestedRestrictedCommonStockMember 2018-02-01 2019-01-31 0001777393 us-gaap:EmployeeStockOptionMember 2018-02-01 2019-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2018-02-01 2019-01-31 0001777393 chpt:DaimlerMember 2018-02-01 2019-01-31 0001777393 chpt:TwoThousandEighteenLoanMember 2018-02-01 2019-01-31 0001777393 chpt:NetworkedChargingSystemsMember 2018-02-01 2019-01-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2018-02-01 2019-01-31 0001777393 chpt:OtherRevenuesMember 2018-02-01 2019-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2018-02-01 2019-01-31 0001777393 us-gaap:RetainedEarningsMember 2018-02-01 2019-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-02-01 2019-01-31 0001777393 us-gaap:CommonStockMember 2018-02-01 2019-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2018-02-01 2019-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2018-02-01 2019-01-31 0001777393 chpt:ElectricFleetMember 2018-02-01 2019-01-31 0001777393 chpt:SeriesHRedeemableConvertiblePreferredStockMember 2018-02-01 2019-01-31 0001777393 us-gaap:SeriesHPreferredStockMember 2018-02-01 2019-01-31 0001777393 srt:MaximumMember 2018-02-01 2019-01-31 0001777393 srt:MinimumMember 2018-02-01 2019-01-31 0001777393 country:US 2018-02-01 2019-01-31 0001777393 chpt:RestOfWorldMember 2018-02-01 2019-01-31 0001777393 chpt:RestrictedCommonStockMember 2018-02-01 2019-01-31 0001777393 chpt:TwoThousandFourteenLoanMember 2014-12-01 2014-12-31 0001777393 chpt:TwoThousandFourteenLoanMember srt:MinimumMember 2014-12-01 2014-12-31 0001777393 chpt:TrancheThreeAndFinalMember us-gaap:SubsequentEventMember 2021-06-29 2021-06-29 0001777393 us-gaap:SubsequentEventMember 2021-03-15 2021-03-15 0001777393 us-gaap:MeasurementInputPriceVolatilityMember chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member 2019-01-31 0001777393 us-gaap:MeasurementInputRiskFreeInterestRateMember chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member 2019-01-31 0001777393 us-gaap:MeasurementInputExpectedDividendRateMember chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member 2019-01-31 0001777393 us-gaap:MeasurementInputExpectedTermMember chpt:RedeemableConvertiblePreferredStockWarrantsMember us-gaap:FairValueInputsLevel3Member 2019-01-31 0001777393 chpt:ElectricFleetMember 2019-01-31 0001777393 us-gaap:SeriesHPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesGPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesFPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesEPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesDPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesCPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesBPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesAPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesAPreferredStockMember srt:ScenarioPreviouslyReportedMember 2019-01-31 0001777393 us-gaap:SeriesBPreferredStockMember srt:ScenarioPreviouslyReportedMember 2019-01-31 0001777393 us-gaap:SeriesCPreferredStockMember srt:ScenarioPreviouslyReportedMember 2019-01-31 0001777393 us-gaap:SeriesDPreferredStockMember srt:ScenarioPreviouslyReportedMember 2019-01-31 0001777393 us-gaap:SeriesEPreferredStockMember srt:ScenarioPreviouslyReportedMember 2019-01-31 0001777393 us-gaap:SeriesFPreferredStockMember srt:ScenarioPreviouslyReportedMember 2019-01-31 0001777393 us-gaap:SeriesGPreferredStockMember srt:ScenarioPreviouslyReportedMember 2019-01-31 0001777393 us-gaap:SeriesHPreferredStockMember srt:ScenarioPreviouslyReportedMember 2019-01-31 0001777393 srt:ScenarioPreviouslyReportedMember 2019-01-31 0001777393 us-gaap:LetterOfCreditMember 2019-01-31 0001777393 chpt:EarnoutSharesMember 2021-03-19 0001777393 chpt:TrancheThreeMember 2021-03-19 2021-03-19 0001777393 chpt:EarnoutSharesMember 2021-03-19 2021-03-19 0001777393 stpr:CA 2020-06-29 2020-06-29 0001777393 chpt:TwoThousandFourteenLoanMember 2014-12-31 0001777393 us-gaap:RetainedEarningsMember 2021-07-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2021-07-31 0001777393 us-gaap:CommonStockMember 2021-07-31 0001777393 us-gaap:CommonStockMember 2020-07-31 0001777393 us-gaap:RetainedEarningsMember 2020-07-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2020-07-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-07-31 0001777393 chpt:LegacyCommonAndPreferredStockWarrantsMember 2021-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2021-01-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-07-31 0001777393 chpt:LegacyCommonAndPreferredStockWarrantsMember 2021-07-31 0001777393 us-gaap:RestrictedStockUnitsRSUMember 2021-01-31 0001777393 us-gaap:RetainedEarningsMember 2021-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2021-01-31 0001777393 us-gaap:CommonStockMember 2021-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2021-04-30 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-30 0001777393 us-gaap:RetainedEarningsMember 2021-04-30 0001777393 us-gaap:CommonStockMember 2021-04-30 0001777393 us-gaap:RetainedEarningsMember 2020-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2020-01-31 0001777393 us-gaap:CommonStockMember 2020-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-01-31 0001777393 us-gaap:RetainedEarningsMember 2020-04-30 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-30 0001777393 us-gaap:AdditionalPaidInCapitalMember 2020-04-30 0001777393 us-gaap:CommonStockMember 2020-04-30 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-04-30 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2020-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2021-01-31 0001777393 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2020-01-31 0001777393 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2019-01-31 0001777393 us-gaap:RetainedEarningsMember 2018-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2018-01-31 0001777393 us-gaap:CommonStockMember 2018-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2018-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2019-01-31 0001777393 us-gaap:CommonStockMember 2019-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2019-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-31 0001777393 us-gaap:RetainedEarningsMember 2019-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2018-01-31 iso4217:USD xbrli:pure xbrli:shares utr:Year utr:Day iso4217:EUR iso4217:USD xbrli:shares chpt:Segment utr:Y
As filed with the Securities and Exchange Commission on October 14, 2021
Registration No.
 333-
          
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
 
 
CHARGEPOINT HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
 
6770
 
84-1747686
(State or other jurisdiction of
incorporation or organization)
 
(Primary Standard Industrial
Classification Code Number)
 
240 East Hacienda Avenue
Campbell, CA 95008 (408)
841-4500
 
(I.R.S. Employer
Identification No.)
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
 
Rex Jackson
Chief Financial Officer
240 East Hacienda Avenue
Campbell, CA 95008
Tel: (408)
841-4500
(Name, address, including zip code, and telephone number, including area code, of agent for service)
 
 
Copies to:
 
Frank R. Adams, Esq.
Weil, Gotshal & Manges LLP
767 Fifth Avenue
New York, NY 10153
Tel: (212)
310-8000
 
Rebecca Chavez, General Counsel
ChargePoint Holdings, Inc.
240 Eeast Hacienda Avenue
Campbell, CA 95008
Tel: (408)
841-4500
 
 
Approximate date of commencement of proposed sale to the public:
From time to time after this Registration Statement becomes effective.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box:  ☒
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:  ☐
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:  ☐
If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer
 
  
Accelerated filer
 
       
Non-accelerated filer
 
  
Smaller reporting company
 
       
 
 
 
  
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act  
 
 
CALCULATION OF REGISTRATION FEE
 
 
 
Title of Securities
to be Registered
 
Amount
to be
Registered
(1)
 
Proposed
Maximum
Aggregate
Offering Price
Per Share
 
Proposed
Maximum
Aggregate
Offering Price
(1)(2)
 
Amount of
Registration Fee
Common Stock, par value $0.0001 per share
 
5,695,176
 
$18.39
 
$104,705,810.76
 
$9,706.23
 
 
(1)
Pursuant to Rule 416(a) under the Securities Act, this Registration Statement shall also cover any additional shares of Registrant’s common stock that become issuable as a result of any stock dividend, stock split, recapitalization, or other similar transaction effected without the receipt of consideration that results in an increase to the number of outstanding shares of Registrant’s common stock, as applicable.
(2)
Estimated solely for the purpose of computing the amount of the registration fee. In accordance with Rule 457(c) under the Securities Act of 1933, as amended, the maximum price per share and maximum aggregate offering price are based on the average of the $18.98 (high) and $17.79 (low) sale price of the registrant’s Common Stock as reported on The New York Stock Exchange on October 7, 2021, which date is within five business days prior to filing this Registration Statement.
 
 
 

The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
 
Registration
No. 333-            
 
 

5,695,176 Shares
ChargePoint Holdings, Inc.
Common Stock
 
 
This prospectus relates to the resale from time to time, by the selling securityholders named in this prospectus or their permitted transferees of up to 5,695,176 shares of our common stock, par value $0.0001 per share (“Common Stock”). The shares of Common Stock offered under this prospectus were initially issued to the selling securityholders in a private placement in connection with our acquisition of the has•to•be gmbh business on October 6, 2021. We are registering the offer and sale of the shares to satisfy certain registration rights we have granted.
The selling securityholders may offer and sell all or a portion of the shares of Common Stock registered hereby publicly or through private transactions at prevailing market prices or at negotiated prices pursuant to the registration statement of which this prospectus is a part by delivering a prospectus with a plan of distribution. We provide more information about how the selling securityholders may sell the securities in the section entitled “Plan of Distribution.” We will not receive any proceeds from the sale of the shares by the selling securityholders, but we have agreed to pay certain offering fees and expenses in connection with the registration of the shares.
Our Common Stock is listed on the New York Stock Exchange (“NYSE”) under the symbol “CHPT.” On October 13, 2021, the last reported sale price of our Common Stock was $20.00 per share.
We are an “emerging growth company” and a “smaller reporting company” under applicable federal securities laws and will be subject to reduced public company reporting requirements.
 
 
Investing in our securities involves risks that are described in the “Risk Factors” section beginning on page 11.
 
 
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities to be issued under this prospectus or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
 
 
Prospectus dated                     , 2021.

TABLE OF CONTENTS
 
     ii  
     iii  
     vi  
     1  
     10  
     11  
     41  
     42  
     43  
     69  
     82  
     89  
     101  
     104  
     106  
     113  
     124  
     129  
     133  
     133  
     133  
    
F-1
 
 
i

ABOUT THE PROSPECTUS
This prospectus is part of a registration statement on Form
S-1
that we filed with the Securities and Exchange Commission (the “SEC”) using the “shelf” registration process. Under this shelf registration process, the selling securityholders may, from time to time, sell the securities offered by them described in this prospectus. We will not receive any proceeds from the sale by such selling securityholders of the securities offered by them described in this prospectus.
We have not, nor have any of the selling securityholders, authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by or on behalf of us or to which we have referred you. None of us or the selling securityholders take responsibility for, or can provide assurance as to the reliability of, any other information that others may give you. Neither we nor the selling securityholders will make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. The information contained in this prospectus or in any applicable free writing prospectus is current only as of its date, regardless of its time of delivery or any sale of shares of our Common Stock. Our business, financial condition, results of operations and prospects may have changed since that date.
For investors outside the United States: We have not, nor have any of the selling securityholders done anything that would permit this offering or possession or distribution of this prospectus or any free writing prospectus we may provide to you in connection with this offering in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus and any such free writing prospectus outside the United States.
 
ii

FREQUENTLY USED TERMS
Unless otherwise stated or unless the context otherwise requires, the terms “we,” “us,” “our,” “Company” and “ChargePoint” refer to ChargePoint Holdings, Inc., a Delaware corporation:
 
   
“Board” or “Board of Directors” means the board of directors of ChargePoint.
 
   
“ChargePoint” means ChargePoint Holdings, Inc., a Delaware corporation.
 
   
“Code” means the Internal Revenue Code of 1986, as amended.
 
   
“Common Stock” means the shares of our common stock, par value $0.0001 per share.
 
   
“DGCL” means the General Corporation Law of the State of Delaware.
 
   
“ESPP” means the ChargePoint Holdings, Inc. 2021 Employee Stock Purchase Plan.
 
   
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
 
   
“Founder Shares” means 6,868,235 shares of Common Stock that were shares of Class B Common Stock, par value $0.0001 per share, of Switchback that automatically converted into shares of Common Stock upon the closing of the Merger.
 
   
“Founders Stock Letter” means the stock letter the Sponsor and Initial Stockholders entered into with Switchback in connection with the execution of the Merger Agreement.
 
   
“Initial Stockholders” means the Sponsor together with Joseph Armes, Zane Arrott and Ray Kubis.
 
   
“IPO” means Switchback’s initial public offering, consummated on July 30, 2019, of 31,411,763 units (including 1,411,763 units that were subsequently issued to the underwriters in connection with their partial exercise of their overallotment option) at $10.00 per unit.
 
   
“Issued Shares” means the number of shares of Common Stock issued to the securityholders pursuant to the terms of the Share Purchase Agreement.
 
   
“leader,” “leading,” “industry leadership,” “industry leading,” and other similar statements included in this prospectus regarding ChargePoint and its services are based on ChargePoint’s beliefs regarding its market position in its sector. ChargePoint bases its beliefs regarding these matters, including its estimates of its market share in its sector, on its collective institutional knowledge and expertise regarding its industries, markets and technology, requests for proposal which are based on, among other things, publicly available information, reports of government agencies, and the results of contract bids and awards, and industry research firms, as well as ChargePoint’s internal research, calculations and assumptions based on its analysis of such information and data. ChargePoint believes these assertions to be reasonable and accurate as of the date of this prospectus.
 
   
“JOBS Act” means the Jumpstart Our Business Startups Act of 2012.
 
   
“Legacy ChargePoint” means ChargePoint, Inc., a Delaware corporation.
 
   
“Legacy ChargePoint Common Stock” means the Common Stock, par value $0.0001 per share, of Legacy ChargePoint.
 
   
“Legacy ChargePoint Options” means all incentive stock options or nonqualified stock options to purchase outstanding shares of Legacy ChargePoint Common Stock, whether or not exercisable and whether or not vested, under the Legacy ChargePoint Stock Plans.
 
   
“Legacy ChargePoint Preferred Stock” means the preferred stock, par value $0.0001 per share, of Legacy ChargePoint.
 
   
“Legacy ChargePoint Stock Plans” means Legacy ChargePoint’s 2007 Stock Incentive Plan and Legacy ChargePoint’s 2017 Stock Plan, in each case, as such may have been amended, supplemented or modified from time to time.
 
iii

   
“Legacy ChargePoint Restricted Stock” means the unvested restricted shares of Legacy ChargePoint Common Stock granted pursuant to the Legacy ChargePoint Stock Plans upon the “early exercise” of Legacy ChargePoint Options.
 
   
“Legacy ChargePoint Warrants” means warrants issued by Legacy ChargePoint that were converted into warrants of ChargePoint in the Merger.
 
   
“Merger” means the transactions described in the Merger Agreement.
 
   
“Merger Agreement” means that certain Merger Agreement and Plan of Reorganization, dated as of September 23, 2020, by and among Switchback, Merger Sub and Legacy ChargePoint.
 
   
“Merger Sub” means Lightning Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Switchback.
 
   
“Non-Reliance
Periods” mean those financial statements which ChargePoint’s audit committee concluded on May 4, 2021 could no longer be relied upon, based on the following facts: (i) the audited consolidated financial statements of Switchback as of December 31, 2020 and 2019, for the year ended December 31, 2020 and for the period from May 10, 2019 (inception) through December 31, 2019 included in the original filing filed with the SEC on March 2, 2021, (ii) certain items on ChargePoint’s previously issued audited balance sheet dated as of July 30, 2019, which was included in ChargePoint’s Current Report on Form
8-K
filed with the SEC on August 5, 2019 (the “IPO Closing
8-K”),
and (iii) the condensed consolidated unaudited financial statements of Switchback included in Switchback’s Quarterly Reports on
Form 10-Q
for (a) the three months ended September 30, 2019 and for the period from May 10, 2019 (inception) through September 30, 2019 (b) the three months ended March 31, 2020, (c) the three and six months ended June 30, 2020, and (d) the three and nine months ended September 30, 2020.
 
   
“NYSE” means the New York Stock Exchange.
 
   
“public shares” means shares of Common Stock included in the public units.
 
   
“public units” means the units sold in the IPO, consisting of one share of Common Stock and
one-third
of one Public Warrant.
 
   
“Public Warrants” means the warrants sold as part of the public units in the IPO (whether they were purchased in the IPO or thereafter in the open market).
 
   
“Private Warrants” means the warrants issued to the Sponsor in a private placement simultaneously with the closing of our IPO.
 
   
“Registrable Securities” means (a) the Issued Shares and (b) any securities issued or issuable with respect to the Issued Shares by way of distribution or in connection with any reorganization or other recapitalization, merger, consolidation or otherwise; provided, however, that a Registrable Security shall cease to be a Registrable Security when (i) such share has been disposed of pursuant to an effective registration statement, (ii) such share has been disposed of pursuant to Rule 144 or any other exemption from the registration requirements of the Securities Act or (iii) such shares are freely tradeable by the holder thereof without volume or other limitations under Rule 144.
 
   
“Registration Rights Holders” refers to the parties listed under holder of the Registration Rights Agreement.
 
   
“Sarbanes-Oxley” means the Sarbanes-Oxley Act of 2002.
 
   
“SEC” means the U.S. Securities and Exchange Commission.
 
   
“Second A&R Bylaws” means our second amended and restated bylaws, dated February 26, 2021.
 
   
“Second A&R Charter” means our second amended and restated certificate of incorporation, dated February 26, 2021.
 
   
“Securities Act” means the Securities Act of 1933, as amended.
 
iv

   
“Sponsor” means NGP Switchback, LLC, a Delaware limited liability company.
 
   
“Switchback” means Switchback Energy Acquisition Corporation, a Delaware corporation, prior to the completion of the Merger.
 
   
“Transfer Agent” means Continental Stock Transfer & Trust Company.
 
   
“Triggering Events” means any time period between the Closing and the five-year anniversary of the Closing Date when eligible former equity holders may receive the Earnout Shares in three equal tranches if the volume-weighted average closing sale price of ChargePoint’s Common Stock is greater than or equal to $15.00, $20.00 and $30.00 for any 10 trading days within any 20 consecutive trading day period.
 
   
“U.S. GAAP” means U.S. generally accepted accounting principles.
 
   
“Warrants” means the Public Warrants, Private Warrants and Legacy ChargePoint Warrants.
 
v

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
ChargePoint makes forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act in this prospectus. All statements, other than statements of present or historical fact included in this prospectus, regarding ChargePoint’s future financial performance, as well as ChargePoint’s strategy, future operations, future operating results, financial position, estimated revenues, and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “continue,” “project” or the negative of such terms and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These statements are based on various assumptions, whether or not identified herein, and on the current expectations of ChargePoint’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of, fact or probability. Actual events and circumstances are difficult or impossible to predict and may differ from assumptions, and such differences may be material. Many actual events and circumstances are beyond the control of ChargePoint. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ChargePoint that may cause the actual results, level of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. If any of these risks materialize or ChargePoint’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that ChargePoint does not presently know or that ChargePoint currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect ChargePoint’s expectations, plans or forecasts of future events and views as of the date hereof. ChargePoint anticipates that subsequent events and developments will cause ChargePoint’s assessments to change. However, while ChargePoint may elect to update these forward-looking statements at some point in the future, except as otherwise required by applicable law, ChargePoint specifically disclaims any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this prospectus. These forward-looking statements should not be relied upon as representing ChargePoint’s assessments as of any date subsequent to the date hereof. Accordingly, undue reliance should not be placed upon the forward-looking statements. ChargePoint cautions you that these forward-looking statements are subject to numerous risk and uncertainties, most of which are all difficult to predict and many of which are beyond the control of ChargePoint.
The following factors, among others, could cause actual results to differ materially from forward-looking statements:
 
   
ChargePoint’s success in retaining or recruiting, or changes in, its officers, key employees or directors;
 
   
changes in applicable laws or regulations;
 
   
the possibility that the coronavirus
(“COVID-19”)
pandemic and its effects on the overall economy may adversely affect the results of operations, financial position and cash flows of ChargePoint;
 
   
ChargePoint’s ability to expand its business in Europe and successfully integrate its acquisitions of ViriCiti B.V. and has•to•be gmbh;
 
   
the Electric Vehicle (“EV”) market may not continue to grow as expected;
 
   
ChargePoint may not attract a sufficient number of fleet owners as customers;
 
   
incentives from governments or utilities may be reduced, which could reduce demand for EVs;
 
   
the impact of competing technologies that could reduce the demand for EVs;
 
   
technological changes;
 
vi

   
data security breaches or other network outages;
 
   
ChargePoint’s ability to remediate its material weaknesses in internal control over financial reporting;
 
   
the possibility that ChargePoint may be adversely affected by other economic, business or competitive factors; and
 
   
any further changes to our financial statements that may be required due to SEC comments, including to our annual report on Form
10-K/A
or quarterly report on Form
10-Q
or further guidance regarding the accounting treatment of the Warrants, and the quantitative effects of the restatement of our financial statements.
The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other risk factors included herein. Forward-looking statements reflect current views about ChargePoint’s plans, strategies and prospects, which are based on information available as of the date of this prospectus. Except to the extent required by applicable law, ChargePoint undertakes no obligation (and expressly disclaims any such obligation) to update or revise the forward-looking statements whether as a result of new information, future events or otherwise.
Forward-looking statements are subject to risks and uncertainties, many of which are outside ChargePoint’s control, which could cause actual results to differ materially from these statements. Therefore, you should not place undue reliance on those statements.
 
vii

PROSPECTUS SUMMARY
This summary highlights selected information from this prospectus and does not contain all of the information that is important to you in making an investment decision. This summary is qualified in its entirety by the more detailed information included in this prospectus. Before making your investment decision with respect to our securities, you should carefully read this entire prospectus, including the information under “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the financial statements included elsewhere in this prospectus.
Unless otherwise indicated or the context otherwise requires, references in this prospectus to “we,” “our,” “us” and other similar terms refer to ChargePoint.
ChargePoint
ChargePoint is a leading EV charging network provider committed to enabling the electrification of mobility for all people and goods. Years before EVs were widely available, ChargePoint envisioned a new way of fueling, conveniently located where drivers live, work and play. By pioneering networked EV charging, ChargePoint has helped make electrified mobility a reality with consumers and fleets rapidly adopting EVs. With 14 years of focused development, over 5,000 existing commercial customers and over $1.1 billion of capital raised from a diversified set of high-profile investors from automotive, energy, manufacturing and venture funding, ChargePoint is driving the shift to electric mobility by providing charging solutions in North America and Europe for all segments, including commercial (e.g., retail, workplace, parking, recreation, education and highway fast charge), fleet (e.g., delivery, logistics, motorpool, transit and shared mobility) and residential (e.g., homes, apartments and condos). As of July 31, 2021, approximately 118,000 ports have been installed and activated on our network of which over 3,500 ports use DC charging. We also provide access to over 200,000 ports through roaming integrations. In addition, we have been focusing on building a sustainable future. Since 2007, we estimate that we have powered approximately 3 billion electric miles driven, resulting in approximately 120 million gallons of gasoline and 462,000 metric tons of greenhouse gas emissions avoided as of July 31, 2021. The avoided amount of greenhouse gas emissions equates to planting of over 11.7 million tree seedlings, capturing carbon from 869,000 acres of U.S. forests and recycling approximately 30 million bags of waste, according to the United States Environmental Protection Agency’s Greenhouse Gas Equivalencies Calculator.
Major auto manufacturers have committed to electrification and large battery EVs are winning the day across vehicle categories. ChargePoint’s networked solutions can charge EV passenger cars or fleet vehicles regardless of manufacturer. ChargePoint believes it should benefit from the broader electrification trend without needing to identify which vehicle brands, traditional or more recent “born electric” entrants, will be successful. ChargePoint believes it will continue to grow proportionally to EV market growth due to the fact that for almost a decade ChargePoint’s charging port (electrified parking space) growth in North America has correlated closely with new passenger EV sales in North America. Passenger EV sales are expected to increase from 2.7% of new vehicles sold in 2019 to 43.1% in 2030 in the United States and Europe according to the Bloomberg New Energy Finance Electric Vehicle Outlook 2021 (the “BNEF Report”). Additional factors propelling this shift to electrification include proposed fossil fuel bans or restrictions, transit electrification mandates and utility incentive programs. Accordingly, the BNEF Report projects that the cumulative EV charging infrastructure investment in North America and Europe is expected to be approximately $121 billion by 2030 and increase to approximately $307 billion by 2040.
The mailing address of ChargePoint’s principal executive office is 240 East Hacienda Avenue, Campbell, CA 95008, and its telephone number is
(408)-841-4500.

 
1

The ChargePoint Model for EV Fueling
Because vehicles spend most of their time parked and electricity is pervasively and safely distributed, fueling can shift to a model where vehicles charge while their drivers are doing something else and the locations where the vehicle is parked will offer fueling with charging speeds matched to the natural parking duration of vehicles at the site. With the exception of occasional drives beyond a vehicle’s battery range, EV charging is primarily a
top-up
model and fueling is transitioning from being a chore commonly performed by having to make a dedicated stop to being conveniently located where drivers live, work and play. ChargePoint offers a platform of products, cloud software subscriptions, support, warranty coverage and professional services enabling
turn-key
development of charging at any location.
ChargePoint’s founders understood that the widespread adoption of electric mobility required a more sustainable, efficient and convenient fueling infrastructure. Fueling with electricity is expected to be less expensive, more sustainable and more convenient than traditional liquid fueling. Further, EV charging does not present all of the same environmental risks of liquid fueling, as it does not involve the storage and potential release of hydrocarbons at the fueling site. ChargePoint believes the development and expanding capacity of renewable energy sources, including wind and solar, can play an increasing and complementary role in electric mobility as the world becomes more electrified and continues to shift to clean energy.
ChargePoint is tackling this growing addressable market one parking lot at a time with a business model it believes is unique in the industry in that it (a) encourages businesses and fleets to directly invest in charging infrastructure, therefore crowdsourcing the buildout of charging infrastructure, (b) is designed to deliver consistent revenue aligned closely to EV sales growth and (c) provides a quality experience for businesses and drivers that yields significant network effects. ChargePoint sells charging solutions in the form of networked hardware and recurring software subscriptions and services primarily sold to commercial and fleet customers. With rare exceptions, ChargePoint does not own charging sites or stations, monetize driver access to stations or monetize the sale of energy. In other words, ChargePoint does not depend on utilization rates and site selections; hence, ChargePoint believes there is limited direct competition with other charging players such as EVgo Services LLC (“Evgo”), Electrify America, Volta and Blink Charging Co. (“Blink”) in the United States. Because customers own the charging infrastructure, ChargePoint can focus its resources on product development, customer acquisition and public policy to drive innovation, competition and customer choice in the market.
For 14 years, ChargePoint has been optimizing its operating model, combining high quality charging hardware and software subscriptions with
turn-key
support and parts and labor warranty services that are among the most comprehensive on the market. ChargePoint believes this approach is unique in the industry, creates significant network effects and, when combined with ChargePoint’s first mover advantage, provides the potential for recurring revenue. ChargePoint’s user experience is designed to generate high driver satisfaction and awareness and to keep site hosts engaged and loyal. This creates a virtuous cycle of brand awareness, recurring software revenue and meaningful charging footprint growth with existing customers (with the opportunity for high land and expand rates), all supported by mass market EV adoption.
The Portfolio
ChargePoint primarily generates revenue through the sale of networked charging hardware, combined with its cloud-based services which enable consumers the ability to locate, reserve, authenticate and transact EV charging sessions (“Cloud” or “Cloud Services”). Cloud Services are billed as an annual subscription. Access to the Cloud Services is available through each charging port. An extended parts and labor warranty (“Assure”) is also offered as an annual subscription. We expect that the revenue contribution for recurring Cloud or Assure sales will equal the revenue contribution from
one-time
CT4000 Dual-Port Station hardware sales after approximately seven years. ChargePoint offers both an upfront sale of the charging stations with subsequent

 
2

payment for Cloud Services and Assure or ChargePoint as a Service (“CPaaS”) in which charging station hardware, Cloud Services and Assure are bundled into an annual subscription payment.
Hardware Portfolio Powered by Software.
While software is at the center of a scaled EV fueling network, ChargePoint believes it offers among the industry’s best in hardware for both Level 2 Alternating Current (“AC”) and Level 3 Direct Current (“DC”) Fast charging. It does not sell these solutions without a Cloud Services subscription. The ChargePoint portfolio includes solutions for many use cases and was designed from the ground up with the software in mind.
Advanced Cloud Services to Scale Charging Infrastructure.
ChargePoint’s network, sold as a Cloud Services subscription, enables commercial and fleet customers to manage charging in their parking lots and depots. Cloud Services capabilities include the following:
 
   
Host pricing and payment remittance capabilities.
 
   
Energy management.
 
   
Driver management tools.
 
   
Integration with route planning systems for fleets.
ChargePoint believes that as EV penetration rises, so does the importance of Cloud Services to help manage charging complexity. Some examples include:
 
   
The ability for commercial customers to adjust the rate at which vehicles charge to match the natural parking duration at the site and to avoid peak or demand charges.
 
   
Charging infrastructure made available to the public during the day can be reserved for private fleets at night.
 
   
Ecosystem integrations enable drivers to access charging functionality via
in-vehicle
infotainment systems, consumer mobile applications, payment systems, mapping tools, home automation assistants, fleet fuel cards, wearables and residential utility programs.
All ChargePoint commercial ports are integrated into one network available to drivers who can use the ChargePoint mobile application to find charging locations, check availability, start sessions, pay for charging, use their ChargePoint account to roam across networks, access preferential pricing and loyalty offers and track the estimated avoidance of CO2 emissions in comparison to the use of liquid fuel, though this does not account for any emissions associated with the generation of the electricity used to charge the EV at the commercial ports.
Parts and Labor Warranty Subscriptions and Customer Support Foster Loyalty.
ChargePoint offers Assure services which include proactive monitoring, fast response times, parts and labor warranty, expert advice and robust reporting. ChargePoint also provides phone support in nine languages to both site hosts and drivers. Rising EV adoption creates more awareness and utilization. ChargePoint believes the quality of the ChargePoint experience generates driver satisfaction and therefore encourages customers to purchase additional networked chargers and software, creating a virtuous cycle of growth from customers expanding their charging capacity.
Go to Market Strategy
ChargePoint sells networked charging solutions in North America and Europe and has over 5,000 existing commercial customers including 76% of the 2021 Fortune 50 companies. It is focused on three key markets: commercial, fleet and residential.
 
   
Commercial:
Commercial businesses already own or lease parking and many wish to electrify some or all of these parking spaces. ChargePoint believes commercial businesses view charging as essential and

 
3

 
invest to attract tenants, employees, customers and visitors, generate direct and indirect income, reduce expenses and achieve sustainability goals. ChargePoint believes commercial businesses choose ChargePoint based on solution completeness (they are not responsible for being the integrator or support agent for drivers) and the quality that comes from designing hardware, software and services together. Customers benefit from drivers typically being familiar with ChargePoint including access to a free,
top-rated
application,
around-the-clock
support, integration to popular mapping platforms, payment systems and wearables. Brand awareness, education and demand marketing programs generate sales opportunities. The commercial market is accessed via a direct sales force (inside and field teams) and by channel partners.
 
   
Fleet:
Fleet customers are organizations that operate vehicle fleets in delivery/logistics, sales/service, motorpool shared transit and ridesharing service operators. ChargePoint believes these customers choose to electrify their fleets for economic reasons, as the comparative total cost of ownership compellingly favors electrification. EV charging solutions can help them design and fuel operations, manage operating costs and achieve sustainability goals. ChargePoint provides a flexible architecture of networked charging stations, software subscriptions, professional services, support, monitoring and parts and labor warranties needed to run electrified depots at scale. The fleet market is accessed via a direct sales force and a curated set of channel partners.
 
   
Residential:
ChargePoint offers residential EV charging solutions for drivers in single family residences who want the convenience of fueling at home with the ability to optimize energy costs and full integration with the same mobile application they use for charging away from home. Residential charging solutions include the capability to manage grid load in conjunction with utility programs and EV fueling rate programs. Single family residential opportunities are accessed by direct marketing to the consumer using proprietary and third party
e-commerce
platforms. For apartments and condominium settings, ChargePoint offers landlords and owner associations the ability to offer charging billed directly to the tenant. ChargePoint also offers customer support
around-the-clock
and in nine languages. This residential aspect is accessed via marketing and direct and channel partners.
With its capital light business model, ChargePoint is able to allocate its capital strategically in research and development, marketing and sales and public policy.
 
   
Research and Development.
With a singular focus on EV charging for 14 years, ChargePoint now offers a complete set of solutions for most EV charging use cases in North America and Europe.
 
   
Go to Market.
ChargePoint has built a global marketing and sales engine, with an established sales channel, digital marketing capability and substantial direct sales. ChargePoint has focused on category awareness, consistent branding and customer acquisition. ChargePoint also has nationwide and local partners who sell, install and maintain ChargePoint solutions.
 
   
Public Policy.
ChargePoint has also supported early and sustained investments in policy and utility relationships. ChargePoint advocates for policies that advance electric mobility and ensure a healthy industry with a focus on competition, innovation and customer choice, including:
 
   
Support for vehicle policy and climate action, such as zero emission vehicle requirements, fossil fuel bans and transit electrification directives;
 
   
Partnership with North America’s leading utilities to scale the new electric fueling network, including enabling the resale of electricity, securing fast charging-friendly tariffs, protecting site host choice, developing make-ready programs, creating rebate programs and informing utility commission decisions and legislation; and
 
   
Reduction in barriers to infrastructure deployment including construction costs, permitting, building codes and right to charge policies for renters and tenants.

 
4

ChargePoint operates in all segments of EV charging stations in North America and Europe, and offers a broad set of solutions for EV applications, including home, multi-family, residential, hospitality, workplace, commercial, fast-charging and fleet. ChargePoint does not compete with charging asset owners and operators and in many cases the asset owners and operators are our actual or potential customers. In addition, ChargePoint does not directly compete with charging asset owners or charging networks that monetize the driver. Rather, it makes solutions available to them for purchase as a platform to enable their services.
Growth Strategies
ChargePoint estimates it had over a 70% market share in publicly available networked Level 2 AC charging in North America as of July 31, 2021. ChargePoint began European operations in late 2017 and currently operates in 16
European countries. It expects significant market opportunities for fleet solutions as fleet EVs begin to arrive in more meaningful volume in coming years. ChargePoint believes that the breadth and quality of its networked EV charging solutions, market share and driver awareness typically leads to customer loyalty, whereby they typically choose to expand their charging footprint with ChargePoint as EV penetration rises and/or charging utilization at their location increases. Over the years, ChargePoint’s customers typically renew their cloud subscriptions and expand the number of charging ports they purchase from ChargePoint. Additional growth results from the breadth of ecosystem integrations ChargePoint has enabled that keep the brand top of mind with drivers, including
in-vehicle
infotainment systems, consumer mobile applications, payment systems, mapping tools, home automation assistants, fleet fuel cards, wearables and residential utility programs.
ChargePoint’s growth strategies to continue to scale networked EV charging are as follows:
 
   
Accelerate new product offerings.
ChargePoint intends to maintain its leadership position with continued efficient investment in product development.
 
   
Invest incrementally in marketing and sales.
In both North America and Europe, ChargePoint intends to continue to attract new customers and pursue a
“land-and-expand”
model which encourages existing customers to increase their charging footprint over time as EV penetration increases. ChargePoint will also fund more CPaaS opportunities for commercial and fleet customers. Our
“land-and-expand”
approach resulted in our top 25 customers to increase their quarterly spending 14x over their first 12 quarters from the initial sale. One Fortune 50 customer’s spend of $2.6 million during fiscal year 2017 was followed by a total cumulative spend of $12.6 million during the five year period through 2021. Another Fortune 50 company’s spend increased from $334,000 in fiscal year 2017 to a cumulative $6.6 million over the five year period from fiscal 2017 to 2021. One major U.S. city’s spend increased from $76,000 in fiscal year 2017 to a cumulative $5.3 million over the five year period from fiscal 2017 to 2021.
 
   
Pursue strategic acquisitions.
On August 11, 2021, ChargePoint acquired ViriCiti B.V. (“ViriCiti”), a Netherlands-based provider of electrification solutions for eBus and commercial fleets. The acquisition of ViriCiti is expected to enhance ChargePoint’s fleet solutions portfolio of hardware, software and services by integrating information sources to optimize electric fleet operations. On October 6, 2021, ChargePoint acquired has•to•be gmbh (“has•to•be”), an Austrian-based
e-mobility
and charging software platform. The acquisition of has•to•be is intended to expand ChargePoint’s access to the European market. ChargePoint will continue to explore potential high-quality acquisition opportunities.
The Merger and Recent Developments
On February 26, 2021 (the “Closing Date”), ChargePoint consummated the previously announced Merger pursuant to the Merger Agreement. As a result of the Merger, Legacy ChargePoint became a wholly-owned subsidiary of ChargePoint.

 
5

Pursuant to the terms of the Merger Agreement, each stockholder of Legacy ChargePoint received 0.9966 shares of Common Stock and the contingent right to receive certain Earnout Shares (as defined below), for each share of Legacy ChargePoint Common Stock, par value $0.0001 per share, owned by such Legacy ChargePoint stockholder that was outstanding immediately prior to the closing of the Merger (other than any shares of Legacy ChargePoint Restricted Stock). In addition, certain investors purchased an aggregate of 22,500,000 shares of Common Stock (such investors, the “PIPE Investors”) concurrently with the closing of the Merger for an aggregate purchase price of $225 million. Additionally, at the closing of the Merger, after giving effect to the forfeiture contemplated by the Founders Stock Letter, each outstanding Founder Share was converted into a share of Common Stock on a
one-for-one
basis and the Founder Shares ceased to exist.
Also at the closing of the Merger, the Sponsor exercised its right to convert a portion of the working capital loans made by the Sponsor to ChargePoint into an additional 1,000,000 Private Warrants at a price of $1.50 per warrant in satisfaction of $1.5 million principal amount of such loans.
In addition, pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the “Effective Time”), (1) warrants to purchase shares of capital stock of Legacy ChargePoint were converted into warrants to purchase an aggregate of 38,761,031 shares of Common Stock and the contingent right to receive certain Earnout Shares, (2) options to purchase shares of Common Stock of Legacy ChargePoint were converted into options to purchase an aggregate of 30,135,695 shares of Common Stock and, with respect to vested options, the contingent right to receive certain Earnout Shares and (3) unvested shares of Legacy ChargePoint Restricted Stock that were outstanding pursuant to the “early exercise” of Legacy ChargePoint Options were converted into an aggregate of 345,689 restricted shares of ChargePoint Common Stock.
During the time period between the Closing Date and the five-year anniversary of the Closing Date, eligible former equityholders of Legacy ChargePoint could receive up to 27,000,000 additional shares of Common Stock (the “Earnout Shares”) in the aggregate in three equal tranches if certain earnout conditions (as further described in the Merger Agreement) are fully satisfied. The first two Triggering Events for up to 18,000,000 of the Earnout Shares occurred on March 12, 2021 and, after the withholding of some of these Earnout Shares for tax withholding, 17,539,657 Earnout Shares were issued on March 19, 2021. The third Triggering Event occurred on June 29, 2021 and, after the withholding of some of these Earnout Shares for tax withholding, 8,773,596 Earnout Shares were issued on July 1, 2021.
On July 6, 2021, ChargePoint redeemed all of its remaining outstanding Public Warrants that had not been exercised as of that date following our issuance of a notice of redemption on June 4, 2021, which resulted in the exercise of 3,517,192 warrants for proceeds to us of $40,447,708 and the redemption of 244,481 Public Warrants at a redemption price of $0.01 per warrant. The Private Warrants were not subject to redemption and, to the extent not exercised, remain outstanding and exercisable through February 26, 2026 or until terminated pursuant to the warrant agreement. As of October 1, 2021, we had no Public Warrants outstanding; Private Warrants were exercisable for 2,173,856 shares of our Common Stock at an exercise price of $11.50 per share outstanding, and Legacy ChargePoint Warrants were exercisable for 35,601,482 shares of our Common Stock with a weighted average exercise price of $7.19 per share outstanding.
Risk Factors
Investing in our securities involves risks. You should carefully consider the risks described in
“Risk Factors”
beginning on page 11 before making a decision to invest in our Common Stock. If any of these risks actually occurs, our business, financial condition and results of operations would likely be materially adversely
affected. In such case, the trading price of our securities would likely decline, and you may lose all or part of your investment. Set forth below is a summary of some of the principal risks we face:
 
   
ChargePoint is an early stage company with a history of losses, and expects to incur significant expenses and continuing losses for the near term.

 
6

   
ChargePoint has experienced rapid growth and expects to invest in growth for the foreseeable future. If it fails to manage growth effectively, its business, operating results and financial condition could be adversely affected.
 
   
ChargePoint currently faces competition from a number of companies, particularly in Europe, and expects to face significant competition in the future as the market for EV charging develops.
 
   
Failure to effectively expand ChargePoint’s sales and marketing capabilities could harm its ability to increase its customer base and achieve broader market acceptance of its solutions.
 
   
ChargePoint faces risks related to health pandemics, including the
COVID-19
pandemic, which could materially and adversely affect its business and results of operations.
 
   
ChargePoint relies on a limited number of suppliers and manufacturers for its charging stations. A loss of or substantial delays in services from any of these partners could negatively affect its business.
 
   
ChargePoint’s business is subject to risks associated with construction, cost overruns and delays, and other contingencies that may arise in the course of completing installations, and such risks may increase in the future as ChargePoint expands the scope of such services with other parties.
 
   
Future acquisitions or strategic investments could be difficult to identify and integrate, including our acquisitions of ViriCiti and has•to•be, divert the attention of key management personnel, disrupt ChargePoint’s business, dilute stockholder value and adversely affect its results of operations and financial condition.
 
   
If ChargePoint is unable to attract and retain key employees and hire qualified management, technical, engineering and sales personnel, its ability to compete and successfully grow its business would be harmed.
 
   
ChargePoint is expanding operations internationally, which will expose it to additional tax, compliance, market and other risks.
 
   
Some members of ChargePoint’s management have limited experience in operating a public company.
 
   
ChargePoint may need to raise additional funds and these funds may not be available when needed.
 
   
ChargePoint’s future revenue growth will depend in significant part on its ability to increase sales of its products and services to fleet operators.
 
   
Computer malware, viruses, ransomware, hacking, phishing attacks and similar disruptions could result in security and privacy breaches and interruption in service, which could harm ChargePoint’s business.
 
   
ChargePoint’s headquarters and other facilities are located in an active earthquake zone; an earthquake or other types of natural disasters or resource shortages, including public safety power shut-offs that have occurred and will continue to occur in California, could disrupt and harm its operations and those of ChargePoint’s customers.
 
   
Seasonality may cause fluctuations in ChargePoint’s revenue.
 
   
ChargePoint’s future growth and success is highly correlated with and thus dependent upon the continuing rapid adoption of EVs for passenger and fleet applications.
 
   
The EV market currently benefits from the availability of rebates, tax credits and other financial incentives from governments, utilities and others to offset the purchase or operating cost of EVs and EV charging stations.
 
   
ChargePoint’s business may be adversely affected if it is unable to protect its technology and intellectual property from unauthorized use by third-parties.

 
7

   
Some of ChargePoint’s products contain open-source software, which may pose particular risks to its proprietary software, products and services in a manner that could harm its business.
 
   
If ChargePoint is unable to remediate the material weaknesses in its internal control over financial reporting, or if ChargePoint identifies additional material weaknesses in the future or otherwise fails to maintain the effective system of internal control over financial reporting, this may result in material misstatements of ChargePoint’s consolidated financial statements or failure to meet its periodic reporting obligations.
 
   
Concentration of ownership among ChargePoint’s existing executive officers, directors and their affiliates may prevent new investors from influencing significant corporate decisions.
 
   
ChargePoint has never paid cash dividends on its capital stock, and does not anticipate paying dividends in the foreseeable future.
 
   
The price of ChargePoint’s Common Stock may be subject to wide fluctuations.
 
   
The coverage of ChargePoint’s business or its securities by securities or industry analysts or the absence thereof could adversely affect the trading price and volume of ChargePoint’s Common Stock, Warrants and other securities.
 
   
Sales of a substantial number of shares of Common Stock by ChargePoint’s existing stockholders could cause the price of the Common Stock to decline.
 
   
ChargePoint’s Warrants are being accounted for as a warrant liability and are being recorded at fair value upon issuance with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of its Common Stock.
Implications of Being an Emerging Growth Company and Smaller Reporting Company
As a company with less than $1.07 billion in revenue during our last fiscal year, we qualify as an “emerging growth company” as defined in the JOBS Act. An emerging growth company may take advantage of reduced reporting requirements that are not otherwise applicable to public companies. These provisions include, but are not limited to:
 
   
being permitted to present only two years of audited financial statements and only two years of related Management’s Discussion and Analysis of Financial Condition and Results of Operations;
 
   
not being required to comply with the auditor attestation requirements on the effectiveness of our internal control over financial reporting;
 
   
not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis);
 
   
reduced disclosure obligations regarding executive compensation arrangements; and
 
   
exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
We may use these provisions until the last day of our fiscal year following the fifth anniversary of our initial public offering. However, if certain events occur prior to the end of such five-year period, including if we become a “large accelerated filer,” our annual gross revenues exceed $1.07 billion or we issue more than $1.0 billion of
non-convertible
debt in any three-year period, we will cease to be an emerging growth company prior to the end of such five-year period.

 
8

We have elected to take advantage of certain of the reduced disclosure obligations in the registration statement of which this prospectus is a part and may elect to take advantage of other reduced reporting requirements in future filings. As a result, the information that we provide to our stockholders may be different than you might receive from other public reporting companies in which you hold equity interests.
The JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards, until those standards apply to private companies. We have elected to take advantage of the benefits of this extended transition period and, therefore, we are not subject to the same new or revised accounting standards as other public companies that are not emerging growth companies; however, we may adopt certain new or revised accounting standards early. Our financial statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards during the period in which we remain an emerging growth company. It is possible that some investors will find our Common Stock less attractive as a result, which may result in a less active trading market for our Common Stock and higher volatility in our stock price.
We are also a “smaller reporting company,” and we will continue to be a “smaller reporting company” if either (i) the market value of our stock held by
non-affiliates
is less than $250.0 million as of the last business day of our second fiscal quarter or (ii) our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our stock held by
non-affiliates
is less than $700.0 million as of the last business day of our second fiscal quarter. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal years of audited financial statements and only two years of management’s discussion and analysis of financial condition and results of operations disclosures and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.

 
9

THE OFFERING
 
Common Stock to be offered by the selling securityholders
5,695,176 shares
 
Use of proceeds
The selling securityholders will receive all of the net proceeds from the sale of Common Stock and we will not receive any proceeds. See the sections entitled “Use of Proceeds,” and “Selling Securityholders”. We will be paying certain costs associated with the sale of shares by the selling securityholders.
 
Risk Factors
You should read the section of this prospectus titled “Risk Factors” and other information included in this prospectus for a discussion of factors you should carefully consider before investing in our Common Stock.
 
NYSE symbol
“CHPT”
As of July 31, 2021, we had 322,170,484 shares of Common Stock outstanding.
The number of shares of our Common Stock to be outstanding after this offering excludes:
 
   
37,075,846 shares of our Common Stock issuable upon exercise of the Legacy ChargePoint Warrants as of July 31, 2021, with a weighted-average exercise price of $7.00 per share;
 
   
2,173,856 shares of our Common Stock issuable upon exercise of outstanding Private Warrants as of July 31, 2021, at an exercise price of $11.50 per share;
 
   
25,401,717 shares of our Common Stock issuable upon the exercise of stock options outstanding as of July 31, 2021, with a weighted-average exercise price of $0.69 per share;
 
   
40,878,653 shares of our Common Stock reserved for future issuance under our 2021 Equity Incentive Plan as of July 31, 2021, plus (i) up to 39,000,000 shares subject to awards that are outstanding under our Predecessor Plans and that are subsequently forfeited, expire or lapse unexercised or unsettled or are reacquired by ChargePoint, plus (ii) the annual increase in shares described below; and
 
   
8,177,683 shares of our Common Stock that may be issued under the ESPP as of July 31, 2021, plus the annual increase in shares that may be issued under the ESPP described below.
2021 Equity Incentive Plan annual increase
. On the first day of each March during the term of the 2021 Equity Incentive Plan, beginning on March 1, 2021 and ending on (and including) March 1, 2030, the number of shares of Common Stock that may be issued under the 2021 Equity Incentive Plan will increase by a number of shares equal to the lesser of (a) 5% of the outstanding shares on the last day of the immediately preceding month or (b) such lesser number of shares (including zero) that the 2021 Plan Administrator (as defined below), determines for purposes of the annual increase for that fiscal year. On March 1, 2021, the number of shares of Common Stock that may be issued under the 2021 Equity Incentive Plan increased by 13,888,417 shares (which shares are included in the reserved shares described in the bullet above).
2021 Employee Stock Purchase Plan
. On the first day of each March during the term of the ESPP, beginning on March 1, 2021 and ending on (and including) March 1, 2040, the number of shares of Common Stock that may be issued under the ESPP will increase by a number of shares equal to the least of (a) 1% of the outstanding shares on the last day of the immediately preceding month, (b) 5,400,000 shares or (c) such lesser number of shares (including zero) that the ESPP Administrator determines for purposes of the annual increase for that fiscal year. On March 1, 2021, the number of shares of Common Stock that may be issued under the ESPP increased by 2,777,683 shares (which shares are included in the shares that may be issued described in the bullet above).

 
10

RISK FACTORS
An investment in our securities involves a high degree of risk. You should carefully consider the risks described below before making an investment decision. Our business, prospects, financial condition, or operating results could be harmed by any of these risks, as well as other risks not known to us or that we consider immaterial as of the date of this prospectus. The trading price of our securities could decline due to any of these risks, and, as a result, you may lose all or part of your investment.
Risks Related to ChargePoint’s Business
ChargePoint is an early-stage company with a history of losses, and expects to incur significant expenses and continuing losses for the near term.
ChargePoint incurred a net loss of $197.0 million for the fiscal year ended January 31, 2021 and had net loss of $2.6 million for the six months ended July 31, 2021. As of July 31, 2021, ChargePoint had an accumulated deficit of $682.1 million. ChargePoint believes it will continue to incur significant operating expenses and net losses in future quarters for the near term. There can be no assurance that it will be able to maintain profitability in the future. ChargePoint’s potential profitability is particularly dependent upon the continued adoption of EVs by consumers and fleet operators, the widespread adoption of electric trucks and other vehicles and other electric transportation modalities, which may not occur.
ChargePoint has experienced rapid growth and expects to invest in growth for the foreseeable future. If it fails to manage growth effectively, its business, operating results and financial condition could be adversely affected
ChargePoint has experienced rapid growth in recent periods. For example, the number of employees has grown from 743 as of January 31, 2020 to 834 as of January 31, 2021 and to 1,045 as of July 31, 2021, including 77 employees in Europe as of January 31, 2020 to 101 as of January 31, 2021 and to 150 as of July 31, 2021. The growth and expansion of its business has placed and continues to place a significant strain on management, operations, financial infrastructure and corporate culture. In the event of further growth, ChargePoint’s information technology systems and ChargePoint’s internal control over financial reporting and procedures may not be adequate to support its operations and may introduce opportunities for data security incidents that may interrupt business operations and permit bad actors to obtain unauthorized access to business information or misappropriate funds. ChargePoint may also face risks to the extent such bad actors infiltrate the information technology infrastructure of its contractors.
To manage growth in operations and personnel, ChargePoint will need to continue to improve its operational, financial and management controls and reporting systems and procedures. Failure to manage growth effectively could result in difficulty or delays in attracting new customers, declines in quality or customer satisfaction, increases in costs, difficulties in introducing new products and services or enhancing existing products and services, loss of customers, information security vulnerabilities or other operational difficulties, any of which could adversely affect its business performance and operating results.
ChargePoint currently faces competition from a number of companies, particularly in Europe, and expects to face significant competition in the future as the market for EV charging develops.
The EV charging market is relatively new and competition is still developing. ChargePoint primarily competes with smaller providers of EV charging station networks for installations, particularly in Europe. Large early-stage markets, such as Europe, require early engagement across verticals and customers to gain market share, and ongoing effort to scale channels, installers, teams and processes. Some European customers require solutions not yet available and ChargePoint’s recent entrance into Europe requires establishing itself against existing competitors. In addition, there are multiple competitors in Europe with limited funding, which could cause poor experiences, hampering overall EV adoption or trust in any particular provider.
 
11

In addition, there are other means for charging EVs, which could affect the level of demand for onsite charging capabilities at businesses. For example, Tesla Inc. (“Tesla”) continues to build out its supercharger network across the United States for its vehicles, which could reduce overall demand for EV charging at other sites. Also, third party contractors can provide basic electric charging capabilities to potential customers seeking to have on premise EV charging capability as well as for home charging. In addition, many EV charging manufacturers, including ChargePoint, are offering home charging equipment, which could reduce demand for on premise charging capabilities of potential customers and reduce the demand for onsite charging capabilities if EV owners find charging at home to be sufficient.
Further, ChargePoint’s current or potential competitors may be acquired by third-parties with greater available resources. In addition, certain of ChargePoint’s competitors are engaging in or have recently completed a process similar to the Merger and may have ready access to the capital markets for additional funding. As a result, competitors may be able to respond more quickly and effectively than ChargePoint to new or changing opportunities, technologies, standards or customer requirements and may have the ability to initiate or withstand substantial price competition. In addition, competitors may in the future establish cooperative relationships with vendors of complementary products, technologies or services to increase the availability of their solutions in the marketplace. This competition may also materialize in the form of costly intellectual property disputes or litigation.
New competitors or alliances may emerge in the future that have greater market share, more widely adopted proprietary technologies, greater marketing expertise and greater financial resources, which could put ChargePoint at a competitive disadvantage. Future competitors could also be better positioned to serve certain segments of ChargePoint’s current or future target markets, which could create price pressure. In light of these factors, even if ChargePoint’s offerings are more effective and higher quality than those of its competitors, current or potential customers may accept competitive solutions. If ChargePoint fails to adapt to changing market conditions or continue to compete successfully with current charging providers or new competitors, its growth will be limited which would adversely affect its business and results of operations.
Failure to effectively expand ChargePoint’s sales and marketing capabilities could harm its ability to increase its customer base and achieve broader market acceptance of its solutions.
ChargePoint’s ability to grow its customer base, achieve broader market acceptance, grow revenue, and achieve and sustain profitability will depend, to a significant extent, on its ability to effectively expand its sales and marketing operations and activities. Sales and marketing expenses represent a significant percentage of its total revenue, and its operating results will suffer if sales and marketing expenditures do not contribute significantly to increasing revenue.
ChargePoint is substantially dependent on its direct sales force to obtain new customers. ChargePoint plans to continue to expand its direct sales force both domestically and internationally but it may not be able to recruit and hire a sufficient number of sales personnel, which may adversely affect its ability to expand its sales capabilities. New hires require significant training and time before they achieve full productivity, particularly in new sales territories. Recent hires and planned hires may not become as productive as quickly as anticipated, and ChargePoint may be unable to hire or retain sufficient numbers of qualified individuals. Furthermore, hiring sales personnel in new countries can be costly, complex and time-consuming, and requires additional set up and upfront costs that may be disproportionate to the initial revenue expected from those countries. There is significant competition for direct sales personnel with strong sales skills and technical knowledge. ChargePoint’s ability to achieve significant revenue growth in the future will depend, in large part, on its success in recruiting, training, incentivizing and retaining a sufficient number of qualified direct sales personnel and on such personnel attaining desired productivity levels within a reasonable amount of time. ChargePoint’s business will be harmed if continuing investment in its sales and marketing capabilities does not generate a significant increase in revenue.
 
12

ChargePoint faces risks related to health pandemics, including the recent coronavirus
(“COVID-19”)
pandemic, which could have a material and adverse effect on its business and results of operations.
The
COVID-19
pandemic, including the actual or contemplated return of stringent restrictions on social gatherings or commerce, has created significant volatility in the global economy. Global trade conditions and consumer trends that have originated during the pandemic continue to persist and may have a long-lasting adverse impact on ChargePoint and its industry.
The pandemic has resulted in government authorities implementing numerous measures to try to contain the virus, such as travel bans and restrictions, quarantines,
stay-at-home
or
shelter-in-place
orders and business shutdowns. These measures may adversely impact ChargePoint’s employees and operations and the operations of its customers, suppliers, vendors and business partners, and may negatively impact demand for EV charging stations, particularly at workplaces. These measures by government authorities may remain in place for a significant period of time and may adversely affect manufacturing and building plans, sales and marketing activities, business and results of operations.
Disruptions in the manufacturing, delivery and overall supply chain of vehicle manufacturers and suppliers, such as exacerbated port congestion and intermittent supplier shutdowns and delays, have resulted in additional costs and, to a lesser extent, component shortages, and have led to fluctuations in EV sales in markets around the world. Increased demand for personal electronics has also created a shortfall of semiconductor chips, which has caused additional supply challenges both within and outside of ChargePoint’s industry. These ongoing challenges and heightened costs have decreased ChargePoint’s gross margins in recent quarters and ChargePoint expects gross margin improvements will continue to be offset by increased freight and logistic expense as a result of ongoing supply chain disruptions caused by
COVID-19
and related measures. Costs incurred to expedite delivery of components used in charging stations or in providing installation or maintenance services or to proactively increase inventory could cause ChargePoint to raise its prices, impose surcharges or other fees or refuse to negotiate discounts. Further, any sustained downturn in demand for EVs would also harm ChargePoint’s business.
During 2020, ChargePoint had modified its business practices by recommending that all
non-essential
personnel work from home and cancelling or reducing physical participation in sales activities, meetings, events and conferences. ChargePoint has also implemented additional safety protocols for workers and cost cutting measures to reduce operating costs. ChargePoint may take further actions as may be required by government authorities or that it determines are in the best interests of its employees, customers, suppliers, vendors and business partners , including acting to lift or
re-impose
initiatives. There is no certainty that such actions will be sufficient to mitigate the risks posed by the pandemic or otherwise be satisfactory to government authorities. If significant portions of ChargePoint’s workforce are unable to work effectively, including due to illness, quarantines, social distancing, government actions or other restrictions in connection with the
COVID-19
pandemic, its operations will be negatively impacted. Furthermore, if significant portions of its customers’ or potential customers’ workforces are subject to
stay-at-home
orders or otherwise have substantial numbers of their employees working remotely for sustained periods of time, user demand for charging stations and services will decline. In addition, measures imposed by governments, may adversely impact ChargePoint’s employees and operations and the operations of its customers, suppliers, vendors and business partners, and may negatively impact demand for EV charging stations, particularly at workplaces.
The effect of the
COVID-19
pandemic on ChargePoint’s business, prospects and results of operations will depend on the direction and duration of current global trends and their sustained impact. Difficult macroeconomic conditions, such as decreases in per capita income and level of disposable income, increased and prolonged unemployment or a decline in consumer confidence as a result of the
COVID-19
pandemic, as well as reduced spending by businesses, could have a material adverse effect on the demand for ChargePoint’s products and services. The effect of the
COVID-19
pandemic can also vary over time and across the geographies in which ChargePoint operates. For example, variations in work-from-home policies can cause fluctuations in revenues,
 
13

and ChargePoint believes that as people are not yet fully back to work ChargePoint has not yet seen the full return of commercial customer demand for ChargePoint products. Even after the
COVID-19
pandemic has subsided, ChargePoint may continue to experience an adverse impact to its business as a result of its global economic impact, including any recession that has occurred or may occur in the future.
ChargePoint relies on a limited number of suppliers and manufacturers for its charging stations. A loss of any of these partners could negatively affect its business.
ChargePoint relies on a limited number of suppliers to manufacture its charging stations, including in some cases only a single supplier for some products and components. This reliance on a limited number of manufacturers increases ChargePoint’s risks, since it does not currently have proven reliable alternatives or replacement manufacturers beyond these key parties. In the event of interruption, including or resulting in a sudden failure by a supplier to meet its obligation, ChargePoint may not be able to increase capacity from other sources or develop alternate or secondary sources without incurring material additional costs and substantial delays. Thus, ChargePoint’s business could be adversely affected if one or more of its suppliers is impacted by any interruption at a particular location.
During the three months ended July 31, 2021, ChargePoint experienced slightly increased demand, which, due to failure by certain suppliers to meet their obligations, prevented it from making an immaterial number of shipments. If ChargePoint experiences a significant increase in demand for its charging stations in future periods, or if it needs to replace an existing supplier, it may not be possible to supplement or replace them on acceptable terms, which may undermine its ability to deliver products to customers in a timely manner. For example, it may take a significant amount of time to identify a manufacturer that has the capability and resources to build charging stations in sufficient volume. Identifying suitable suppliers and manufacturers could be an extensive process that requires ChargePoint to become satisfied with their quality control, technical capabilities, responsiveness and service, financial stability, regulatory compliance, and labor and other ethical practices. Accordingly, a loss of any significant suppliers or manufacturers could have an adverse effect on ChargePoint’s business, financial condition and operating results. In addition, ChargePoint’s suppliers may face supply chain risks and constraints of their own, which may impact the availability and pricing of its products. For example, supply chain challenges related to the
COVID-19
pandemic and the global chip shortages that have impacted companies worldwide both within and outside of ChargePoint’s industry may have adverse effects on its suppliers and, as a result, ChargePoint.
In addition, as a result of the Merger, ChargePoint became subject to requirements under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”) to diligence, disclose, and report whether or not its products contain minerals originating from the Democratic Republic of the Congo and adjoining countries, or conflict minerals. ChargePoint will incur additional costs to comply with these disclosure requirements, including costs related to determining the source of any of the relevant minerals and metals used in ChargePoint’s products. These requirements could adversely affect the sourcing, availability, and pricing of minerals used in the components used in ChargePoint’s products. It is also possible that ChargePoint’s reputation may be adversely affected if it determines that certain of its products contain minerals not determined to be conflict-free or if it is unable to alter its products, processes or sources of supply to avoid use of such materials. ChargePoint may also encounter
end-customers
who require that all of the components of the products be certified as conflict free. If ChargePoint is not able to meet this requirement, such
end-customers
may choose to purchase products from a different company.
ChargePoint’s business is subject to risks associated with construction, cost overruns and delays, and other contingencies that may arise in the course of completing installations, and such risks may increase in the future as ChargePoint expands the scope of such services with other parties.
ChargePoint does not typically install charging stations at customer sites. These installations are typically performed by ChargePoint partners or electrical contractors with an existing relationship with the customer
 
14

and/or knowledge of the site. The installation of charging stations at a particular site is generally subject to oversight and regulation in accordance with state and local laws and ordinances relating to building codes, safety, environmental protection and related matters, and typically requires various local and other governmental approvals and permits that may vary by jurisdiction. In addition, building codes, accessibility requirements or regulations may hinder EV charger installation because they end up costing the developer or installer more in order to meet the code requirements. Meaningful delays or cost overruns may impact ChargePoint’s recognition of revenue in certain cases and/or impact customer relationships, either of which could impact ChargePoint’s business and profitability.
Furthermore, ChargePoint may in the future elect to install charging stations at customer sites or manage contractors, likely as part of offering customers a turnkey solution. Working with contractors may require ChargePoint to obtain licenses or require it or its customers to comply with additional rules, working conditions and other union requirements, which can add costs and complexity to an installation project. In addition, if these contractors are unable to provide timely, thorough and quality installation-related services, customers could fall behind their construction schedules leading to liability to ChargePoint or cause customers to become dissatisfied with the solutions ChargePoint offers and ChargePoint’s overall reputation would be harmed.
Acquisitions or strategic investments could be difficult to identify and integrate, divert the attention of key management personnel, disrupt ChargePoint’s business, dilute stockholder value and adversely affect its results of operations and financial condition.
As part of ChargePoint’s business strategy, ChargePoint has made and continues to consider making acquisitions of, or investments in, businesses, services or technologies that are complementary to its existing business. For example, on August 11, 2021, ChargePoint acquired ViriCiti, a provider of electrification solutions for eBus and commercial fleets, and on October 6, 2021, ChargePoint acquired has•to•be, an
e-mobility
and charging software platform The process of identifying and consummating acquisitions, investments, and the subsequent integration of new assets and businesses into ChargePoint’s own business, requires attention from management and could result in a diversion of resources from its existing business, which in turn could have an adverse effect on its operations. Acquired assets or businesses may not generate the expected financial results. Acquisitions or investments could also result in the use of cash, potentially dilutive issuances of equity securities, the occurrence of goodwill impairment charges, amortization expenses for other intangible assets and exposure to potential unknown liabilities of the acquired business or investment. ChargePoint may also incur costs and management time on transactions that are ultimately not completed. In addition, ChargePoint’s due diligence may fail to identify all of the problems, liabilities or other shortcomings or challenges of an acquired business, product, technology or investment, including issues related to intellectual property, product quality or product architecture, regulatory compliance practices, revenue recognition or other accounting practices or issues with employees or customers.
ChargePoint’s future acquisitions or investments may not ultimately strengthen its competitive position or achieve its goals and business strategy; ChargePoint may be subject to claims or liabilities assumed from an acquired company, product, or technology; acquisitions or investments ChargePoint completes could be viewed negatively by its customers, investors, and securities analysts; and ChargePoint may incur costs and expenses necessary to address an acquired company’s failure to comply with laws and governmental rules and regulations. Additionally, ChargePoint may be subject to litigation or other claims in connection with the acquired company, including claims from terminated employees, former stockholders or other third parties, which may differ from or be more significant than the risks ChargePoint’s business faces. An acquired company may also need to implement or improve its controls, procedures and policies, and ChargePoint may face risks associated if any of those controls, procedures or policies are insufficiently effective. ChargePoint may also face retention or cultural challenges associated with integrating employees from the acquired company into its organization. If ChargePoint is unsuccessful at integrating acquisitions or investments, in a timely manner, the revenue and operating results of the combined company could be adversely affected. Any integration process may require significant time and resources, which may disrupt ChargePoint’s ongoing business and divert management’s
 
15

attention, and ChargePoint may not be able to manage the integration process successfully or in a timely manner. ChargePoint may not successfully evaluate or utilize the acquired technology or personnel, realize anticipated synergies from the acquisition or investment, or accurately forecast the financial impact of an acquisition or investment transaction or the related integration of such acquisition or investment, including accounting charges and any potential impairment of goodwill and intangible assets recognized in connection with such transaction. ChargePoint may have to pay cash, incur debt, or issue equity or equity-linked securities to pay for any acquisitions or investments, each of which could adversely affect its financial condition or the market price of its Common Stock. Furthermore, the sale of equity or issuance of equity-linked debt to finance any such transaction could result in dilution to ChargePoint’s stockholders. The occurrence of any of these risks could harm ChargePoint’s business, operating results, and financial condition.
If ChargePoint is unable to attract and retain key employees and hire qualified management, technical, engineering and sales personnel, its ability to compete and successfully grow its business would be harmed.
ChargePoint’s success depends, in part, on its continuing ability to identify, hire, attract, train and develop and retain highly qualified personnel. The inability to do so effectively would adversely affect its business. ChargePoint’s future performance also depends on the continued services and continuing contributions of its senior management to execute on its business plan and to identify and pursue new opportunities and product innovations. The loss of services of senior management, or the ineffective management of any leadership transitions, especially within ChargePoint’s sales organization, could significantly delay or prevent the achievement of its development and strategic objectives, which could adversely affect its business, financial condition, and operating results.
Competition for employees can be intense, particularly in Silicon Valley where ChargePoint is headquartered, and the ability to attract, hire and retain them depends on ChargePoint’s ability to provide competitive compensation. ChargePoint may not be able to attract, assimilate, develop or retain qualified personnel in the future, and failure to do so could adversely affect its business, including the execution of its global business strategy.
ChargePoint is expanding operations internationally, which will expose it to additional tax, compliance, market and other risks.
ChargePoint’s primary operations are in the United States and it maintains contractual relationships with parts and manufacturing suppliers in Asia, Mexico and other locations. Also, ChargePoint is continuing to invest to increase its presence in Europe, including its acquisitions of ViriCiti and has•to•be, and to expand a primarily research and development teams in India and Reading, England. Managing this expansion requires additional resources and controls, and could subject ChargePoint to risks associated with international operations, including:
 
   
conformity with applicable business customs, including translation into foreign languages and associated expenses;
 
   
lack of availability of government incentives and subsidies;
 
   
challenges in arranging, and availability of, financing for customers;
 
   
potential changes to its established business model;
 
   
cost of alternative power sources, which could vary meaningfully outside the United States;
 
   
difficulties in staffing and managing foreign operations in an environment of diverse culture, laws, and customers, and the increased travel, infrastructure, and legal and compliance costs associated with international operations;
 
   
installation challenges;
 
16

   
differing driving habits and transportation modalities in other markets;
 
   
different levels of demand among commercial, fleet and residential customers;
 
   
compliance with multiple, potentially conflicting and changing governmental laws, regulations, certifications, and permitting processes including environmental, banking, employment, tax, information security, privacy, and data protection laws and regulations such as the California Consumer Privacy Act (“CCPA”) and newer state privacy laws in the U.S. including in Virginia and Colorado, the European Union (the “EU”) General Data Protection Regulation (“GDPR”), national legislation implementing the same and changing requirements for legally transferring data out of the European Economic Area;
 
   
compliance with U.S. and foreign anti-bribery laws including the Foreign Corrupt Practices Act (“FCPA”) and the United Kingdom Anti-Bribery Act of 2020 (the “Anti-Bribery Act”);
 
   
conforming products to various international regulatory and safety requirements as well as charging and other electric infrastructures;
 
   
difficulty in establishing, staffing and managing foreign operations;
 
   
difficulties in collecting payments in foreign currencies and associated foreign currency exposure;
 
   
restrictions on repatriation of earnings;
 
   
compliance with potentially conflicting and changing laws of taxing jurisdictions and compliance with applicable U.S. tax laws as they relate to international operations, the complexity and adverse consequences of such tax laws, and potentially adverse tax consequences due to changes in such tax laws; and
 
   
regional economic and political conditions.
As a result of these risks, ChargePoint’s current expansion efforts and any potential future international expansion efforts may not be successful.
Some members of ChargePoint’s management have limited experience in operating a public company.
Some of ChargePoint’s executive officers have limited experience in the management of a publicly-traded company. The management team may not successfully or effectively manage the transition to a public company that will be subject to significant regulatory oversight and reporting obligations under federal securities laws.
Their limited experience in dealing with the increasingly complex laws pertaining to public companies could be a significant disadvantage in that it is likely that an increasing amount of their time may be devoted to these activities, which will result in less time being devoted to the management and growth of ChargePoint. ChargePoint may not have adequate personnel with the appropriate level of knowledge, experience and training in the accounting policies, practices or internal control over financial reporting required of public companies. The development and implementation of the standards and controls and the hiring of experienced personnel necessary to achieve the level of accounting standards required of a public company may require costs greater than expected.
ChargePoint may need to raise additional funds and these funds may not be available when needed.
ChargePoint may need to raise additional capital in the future to further scale its business and expand to additional markets. ChargePoint may raise additional funds through the issuance of equity, equity-related or debt securities, or through obtaining credit from government or financial institutions. ChargePoint cannot be certain that additional funds will be available on favorable terms when required, or at all. If ChargePoint cannot raise additional funds when needed, its financial condition, results of operations, business and prospects could be
 
17

materially and adversely affected. If ChargePoint raises funds through the issuance of debt securities or through loan arrangements, the terms of which could require significant interest payments, contain covenants that restrict ChargePoint’s business, or other unfavorable terms. In addition, to the extent ChargePoint raises funds through the sale of additional equity securities, ChargePoint stockholders would experience additional dilution.
ChargePoint’s future revenue growth will depend in significant part on its ability to increase sales of its products and services to fleet operators.
ChargePoint’s future revenue growth will depend in significant part on its ability to increase sales of its products and services to fleet operators. The electrification of fleets is an emerging market, and fleet operators may not adopt EVs on a widespread basis and on the timelines ChargePoint anticipates. In addition to the factors affecting the growth of the EV market generally, transitioning to an EV fleet can be costly and capital intensive, which could result in slower than anticipated adoption. The sales cycle could also be longer for sales to fleet operators, as they are often larger organizations, with more formal procurement processes than smaller commercial site hosts. Fleet operators may also require significant additional services and support, and if ChargePoint is unable to provide such services and support, it may adversely affect its ability to attract additional fleet operators as customers. Any failure to attract and retain fleet operators as customers in the future would adversely affect ChargePoint’s business and results of operations.
Computer malware, viruses, ransomware, hacking, phishing attacks and similar disruptions could result in security and privacy breaches and interruption in service, which could harm ChargePoint’s business.
Computer malware, viruses, physical or electronic
break-ins
and similar disruptions could lead to interruption and delays in ChargePoint’s services and operations and loss, misuse or theft of data. Computer malware, viruses, ransomware, hacking and phishing attacks against online networks have become more prevalent and may occur on ChargePoint’s systems in the future. Any attempts by cyber attackers to disrupt ChargePoint’s services or systems, if successful, could harm its business, introduce liability to data subjects, result in the misappropriation of funds, be expensive to remedy, subject ChargePoint to substantial fines, penalties, damages and other liabilities under applicable laws and regulations, lead to a loss of protection of its intellectual property or trade secrets and damage its reputation or brand. Insurance may not be sufficient to cover significant expenses and losses related to cyber-attacks. Efforts to prevent cyber attackers from entering computer systems are expensive to implement, and ChargePoint may not be able to cause the implementation or enforcement of such preventions with respect to its third party vendors. Though it is difficult to determine what, if any, harm may directly result from any specific interruption or attack, any failure to maintain performance, reliability, security and availability of systems and technical infrastructure may, in addition to other losses, harm ChargePoint’s reputation, brand and ability to attract customers.
ChargePoint has previously experienced, and may in the future experience, service disruptions, outages and other performance problems due to a variety of factors, including infrastructure changes, third party service providers, human or software errors and capacity constraints. If ChargePoint’s services are unavailable when users attempt to access them, they may seek other services, which could reduce demand for its solutions from target customers.
ChargePoint has processes and procedures in place designed to enable it to quickly recover from a disaster or catastrophe and continue business operations and has tested this capability under controlled circumstances. However, there are several factors ranging from human error to data corruption that could materially impact the efficacy of such processes and procedures, including by lengthening the time services are partially or fully unavailable to customers and users. It may be difficult or impossible to perform some or all recovery steps and continue normal business operations due to the nature of a particular disaster or catastrophe, especially during peak periods, which could cause additional reputational damages, or loss of revenue, any of which could adversely affect its business and financial results.
 
18

ChargePoint’s headquarters and other facilities are located in an active earthquake zone; an earthquake or other types of natural disasters or resource shortages, including public safety power shut-offs that have occurred and will continue to occur in California, could disrupt and harm its operations and those of ChargePoint’s customers.
ChargePoint conducts a majority of its operations in the San Francisco Bay area in an active earthquake zone. The occurrence of a natural disaster such as an earthquake, drought, flood, fire (such as the recent extensive wildfires in California), localized extended outages of critical utilities (such as California’s public safety power shut-offs) or transportation systems, or any critical resource shortages could cause a significant interruption in its business, damage or destroy its facilities or inventories, and cause it to incur significant costs, any of which could harm its business, financial condition and results of operations. The insurance ChargePoint maintains against fires, earthquakes and other natural disasters may not be adequate to cover losses in any particular case.
In addition, rolling public safety power shut offs in California or other states can affect user acceptance of EVs, as charging may be unavailable at the desired times, or at all during these events. These shut offs could also affect the ability of fleet operators to charge their EVs, which, for example, could adversely affect transportation schedules or any service level agreements to which either ChargePoint or the fleet operator may be a party. If these events persist, the demand for EVs could decline, which would result in reduced demand for charging solutions.
Seasonality may cause fluctuations in ChargePoint’s revenue.
ChargePoint believes there are seasonal factors that may cause ChargePoint to record higher revenue in some quarters compared with others. A significant share of ChargePoint’s annual revenues are typically generated in the fourth fiscal quarter, which coincides with customers with a December 31
year-end
choosing to spend remaining unused portions of their budgets and its sales commission plans which provide
year-end
accelerators. ChargePoint’s revenues are typically lower in its fiscal first quarter than its preceding fourth quarter, due to unfavorable weather conditions which result in a decrease in construction activity during the winter months, periods of wet weather and times when other weather and climate conditions would impair construction activity. While ChargePoint believes it has visibility into the seasonality of its business, various factors, including difficult weather conditions (such as flooding, hurricanes, prolonged rain or periods of unseasonably cold or snow storms) in any quarter, may materially and adversely affect its business, financial condition and results of operations.
Risks Related to the EV Market
Changes to fuel economy standards or the success of alternative fuels may negatively impact the EV market and thus the demand for ChargePoint’s products and services.
As regulatory initiatives have required an increase in the mileage capabilities of cars, consumption of renewable transportation fuels, such as ethanol and biodiesel, and consumer acceptance of EVs and other alternative vehicles has been increasing. If fuel efficiency of
non-electric
vehicles continues to rise, whether as the result of regulations or otherwise, and affordability of vehicles using renewable transportation fuels improves, the demand for electric and high energy vehicles could diminish. In addition, the EV fueling model is different than gas or other fuel models, requiring behavior change and education of influencers, consumers and others such as regulatory bodies. Developments in alternative technologies, such as advanced diesel, ethanol, fuel cells or compressed natural gas, or improvements in the fuel economy of the internal combustion engine, may materially and adversely affect demand for EVs and EV charging stations. For example, fuel which is abundant and relatively inexpensive in the United States, such as compressed natural gas, may emerge as a preferred alternative to petroleum-based propulsion. Regulatory bodies may also adopt rules that substantially favor certain alternatives to petroleum-based propulsion over others, which may not necessarily be EVs. This may impose additional obstacles to the purchase of EVs or the development of a more ubiquitous EV market. Finally, the current litigation between the state of California and the National Highway Traffic Safety Administration
 
19

(“NHTSA”) could impact California’s ability to set fuel economy standards that encourage the adoption of EVs, and could be followed by many other states. If any of the above cause or contribute to consumers or businesses to no longer purchase EVs or purchase them at a lower rate, it would materially and adversely affect ChargePoint’s business, operating results, financial condition and prospects.
ChargePoint’s future growth and success is highly correlated with and thus dependent upon the continuing rapid adoption of EVs for passenger and fleet applications.
ChargePoint’s future growth is highly dependent upon the adoption of EVs by businesses and consumers. The market for EVs is still rapidly evolving, characterized by rapidly changing technologies, competitive pricing and competitive factors, evolving government regulation and industry standards and changing consumer demands and behaviors, changing levels of concern related to environmental issues and governmental initiatives related to climate change and the environment generally. Although demand for EVs has grown in recent years, there is no guarantee of continuing future demand. If the market for EVs develops more slowly than expected, or if demand for EVs decreases, ChargePoint’s business, prospects, financial condition and operating results would be harmed. The market for EVs could be affected by numerous factors, such as:
 
   
perceptions about EV features, quality, safety, performance and cost;
 
   
perceptions about the limited range over which EVs may be driven on a single battery charge;
 
   
competition, including from other types of alternative fuel vehicles,
plug-in
hybrid electric vehicles and high fuel-economy internal combustion engine vehicles;
 
   
volatility in the cost of oil and gasoline;
 
   
concerns regarding the stability of the electrical grid;
 
   
the decline of an EV battery’s ability to hold a charge over time;
 
   
availability of service for EVs;
 
   
consumers’ perception about the convenience and cost of charging EVs;
 
   
increases in fuel efficiency;
 
   
government regulations and economic incentives, including adverse changes in, or expiration of, favorable tax incentives related to EVs, EV charging stations or decarbonization generally;
 
   
relaxation of government mandates or quotas regarding the sale of EVs; and
 
   
concerns about the future viability of EV manufacturers.
In addition, sales of vehicles in the automotive industry can be cyclical, which may affect growth in acceptance of EVs. It is uncertain how macroeconomic factors will impact demand for EVs, particularly since they can be more expensive than traditional gasoline-powered vehicles, when the automotive industry globally has been experiencing a recent decline in sales. Furthermore, because fleet operators often make large purchases of EVs, this cyclicality and volatility in the automotive industry may be more pronounced with commercial purchasers, and any significant decline in demand from these customers could reduce demand for EV charging and ChargePoint’s products and services in particular.
Demand for EVs may also be affected by factors directly impacting automobile prices or the cost of purchasing and operating automobiles, such as sales and financing incentives, prices of raw materials and parts and components, cost of fuel and governmental regulations, including tariffs, import regulation and other taxes. Volatility in demand may lead to lower vehicle unit sales, which may result in reduced demand for EV charging solutions and therefore adversely affect ChargePoint’s business, financial condition and operating results.
 
20

The EV market currently benefits from the availability of rebates, tax credits and other financial incentives from governments, utilities and others to offset the purchase or operating cost of EVs and EV charging stations. In particular, ChargePoint’s marketing efforts have heavily relied upon federal tax credits available to purchasers of its EV charging stations that effectively provide purchasers with a significantly discounted purchase price. The reduction, modification, or elimination of such benefits could cause reduced demand for EVs and EV charging stations, which would adversely affect ChargePoint’s financial results.
The U.S. federal government, foreign governments and some state and local governments provide incentives to end users and purchasers of EVs and EV charging stations in the form of rebates, tax credits and other financial incentives, such as payments for regulatory credits. The EV market relies on these governmental rebates, tax credits and other financial incentives to significantly lower the effective price of EVs and EV charging stations to customers. However, these incentives may expire on a particular date, end when the allocated funding is exhausted, or be reduced or terminated as a matter of regulatory or legislative policy. In particular, ChargePoint has heavily relied upon the availability of federal tax credits to purchasers under Section 30C of the Code to market its EV charging stations, which can effectively provide such purchasers with up to a 30% discount off the purchase price of ChargePoint’s EV charging stations. The credits under Section 30C of the Code are set to expire on December 31, 2021 and thus would not be available to ChargePoint’s customers unless extended. There can be no assurance that the credits under Section 30C of the Code will be extended, or if extended, will not be otherwise reduced. Any reduction in rebates, tax credits or other financial incentives, including the credit under Section 30C of the Code, could materially reduce the demand for EVs and ChargePoint’s solutions and, as a result, may adversely impact ChargePoint’s business and expansion potential.
ChargePoint also derives other revenue from regulatory credits. If government support of these credits declines, ChargePoint’s ability to generate this other revenue in the future would be adversely affected. In years prior to fiscal year 2021, ChargePoint has derived a slight majority of its other revenue from regulatory credits. However, revenue from this source as a percentage of other and total revenue has declined in recent quarters and it may continue to decline over time. Further, the availability of such credits may decline even with general governmental support of the transition to EV infrastructure. For example, in September 2020, California Governor Gavin Newsom issued Executive Order
N-79-20
(the “EO”), announcing a target for all
in-state
sales of new passenger cars and trucks to be
zero-emission
by 2035. While the EO calls for the support of EV infrastructure, the form of this support is unclear. If California or other jurisdictions choose to adopt regulatory mandates instead of establishing or continuing green energy credit regimes for EV infrastructure, ChargePoint’s revenue from these credits would be adversely impacted.
The EV charging market is characterized by rapid technological change, which requires ChargePoint to continue to develop new products and product innovations. Any delays in such development could adversely affect market adoption of its products and ChargePoint’s financial results.
Continuing technological changes in battery and other EV technologies could adversely affect adoption of current EV charging technology and/or ChargePoint’s products. ChargePoint’s future success will depend upon its ability to develop and introduce a variety of new capabilities and innovations to its existing product offerings, as well as introduce a variety of new product offerings, to address the changing needs of the EV charging market. As new products are introduced, gross margins tend to decline in the near term and improves as the product become more mature and with a more efficient manufacturing process.
As EV technologies change, ChargePoint may need to upgrade or adapt its charging station technology and introduce new products and services in order to serve vehicles that have the latest technology, in particular battery cell technology, which could involve substantial costs. Even if ChargePoint is able to keep pace with changes in technology and develop new products and services, its research and development expenses could increase, its gross margins could be adversely affected in some periods and its prior products could become obsolete more quickly than expected.
 
21

ChargePoint cannot guarantee that any new products will be released in a timely manner, or at all, or achieve market acceptance. Delays in delivering new products that meet customer requirements could damage ChargePoint’s relationships with customers and lead them to seek alternative providers. Delays in introducing products and innovations or the failure to offer innovative products or services at competitive prices may cause existing and potential customers to purchase ChargePoint’s competitors’ products or services.
If ChargePoint is unable to devote adequate resources to develop products or cannot otherwise successfully develop products or services that meet customer requirements on a timely basis or that remain competitive with technological alternatives, its products and services could lose market share, its revenue will decline, it may experience higher operating losses and its business and prospects will be adversely affected.
Certain statements ChargePoint makes about estimates of market opportunity and forecasts of market growth included in this prospectus may prove to be inaccurate.
This prospectus includes estimates of the addressable market for ChargePoint’s solutions and the EV market in general. Market opportunity estimates and growth forecasts, whether obtained from third-party sources or developed internally, are subject to significant uncertainty and are based on assumptions and estimates that may prove to be inaccurate. This is especially so at the present time due to the uncertain and rapidly changing projections of the severity, magnitude and duration of the
COVID-19
pandemic. The estimates and forecasts in this prospectus relating to the size and expected growth of the target market, market demand and adoption, capacity to address this demand and pricing may also prove to be inaccurate. In particular, estimates regarding the current and projected market opportunity are difficult to predict. The estimated addressable market may not materialize for many years, if ever, and even if the markets meet the size estimates and growth forecasted in this prospectus, ChargePoint’s business could fail to grow at similar rates.
Risks Related to ChargePoint’s Technology, Intellectual Property and Infrastructure
ChargePoint expects to incur research and development costs and devote significant resources to developing new products, which could significantly reduce its profitability and may never result in revenue to ChargePoint.
ChargePoint’s future growth depends on penetrating new markets, adapting existing products to new applications and customer requirements, and introducing new products that achieve market acceptance. ChargePoint plans to incur significant research and development costs in the future as part of its efforts to design, develop, manufacture and introduce new products and enhance existing products. ChargePoint’s research and development expenses were $65.8 million, $75.0 million, $69.5 million and $50.5 million during the six months ended July 31, 2021, and during the fiscal years ended January 31, 2021, 2020 and 2019, respectively, and are likely to grow in the future. Further, ChargePoint’s research and development program may not produce successful results, and its new products may not achieve market acceptance, create additional revenue or become profitable.
ChargePoint may need to defend against intellectual property infringement or misappropriation claims, which may be time-consuming and expensive.
From time to time, the holders of intellectual property rights may assert their rights and urge ChargePoint to take licenses, and/or may bring suits alleging infringement, misappropriation or other violation of such rights. There can be no assurance that ChargePoint will be able to mitigate the risk of potential suits or other legal demands by competitors or other third-parties. Accordingly, ChargePoint may consider entering into licensing agreements with respect to such rights, although no assurance can be given that such licenses can be obtained on acceptable terms or that litigation will not occur, and such licenses and associated litigation could significantly increase ChargePoint’s operating expenses. In addition, if ChargePoint is determined to have or believes there is a high likelihood that it has infringed upon, misappropriated or otherwise violated a third party’s intellectual
 
22

property rights, it may be required to cease making, selling or incorporating certain key components or intellectual property into the products and services it offers, to pay substantial damages and/or royalties, to redesign its products and services, and/or to establish and maintain alternative branding. In addition, to the extent that ChargePoint’s customers and business partners become the subject of any allegation or claim regarding the infringement, misappropriation or other violation of intellectual property rights related to ChargePoint’s products and services, ChargePoint may be required to indemnify such customers and business partners. If ChargePoint were required to take one or more such actions, its business, prospects, operating results and financial condition could be materially and adversely affected. In addition, any litigation or claims, whether or not valid, could result in substantial costs, negative publicity and diversion of resources and management attention.
ChargePoint’s business may be adversely affected if it is unable to protect its technology and intellectual property from unauthorized use by third parties.
ChargePoint’s success depends, at least in part, on ChargePoint’s ability to obtain, maintain, enforce and protect its core technology and intellectual property. To accomplish this, ChargePoint relies on, and plans to continue relying on, a combination of patents, trade secrets (including
know-how),
employee and third party nondisclosure agreements, copyright, trademarks, intellectual property licenses and other contractual rights to retain ownership of, and protect, its technology. Despite ChargePoint’s efforts to obtain, maintain, enforce and protect intellectual property rights, there can be no assurance that these steps will be available in all cases or will be adequate to prevent ChargePoint’s competitors or other third-parties from copying, reverse engineering, or otherwise obtaining and using its technology or products or seeking court declarations that they do not infringe, misappropriate or otherwise violate its intellectual property. Failure to adequately protect its technology and intellectual property could result in competitors offering similar products, potentially resulting in the loss of some of ChargePoint’s competitive advantage and a decrease in revenue which would adversely affect its business, prospects, financial condition and operating results.
The measures ChargePoint takes to protect its technology intellectual property from unauthorized use by others may not be effective for various reasons, including the following:
 
   
any patent applications ChargePoint submits may not result in the issuance of patents;
 
   
the scope of issued patents may not be broad enough to protect its inventions and proprietary rights;
 
   
any issued patents may be challenged by competitors and/or invalidated by courts or governmental authorities;
 
   
ChargePoint may not be the first inventor of the subject matter to which it has filed a particular patent application, and it may not be the first party to file such a patent application;
 
   
Patents have a finite term, and competitors and other third-parties may offer identical or similar products after the expiration of ChargePoint’s patents that cover such products;
 
   
the costs associated with enforcing patents, confidentiality and invention agreements or other intellectual property rights may make aggressive enforcement impracticable;
 
   
current and future competitors may circumvent patents or independently develop similar trade secrets or works of authorship, such as software;
 
   
know-how
and other proprietary information ChargePoint purports to hold as a trade secret may not qualify as a trade secret under applicable laws;
 
   
ChargePoint’s employees, contractors or business partners may breach their confidentiality,
non-disclosure,
and nonuse obligations; and
 
   
proprietary designs and technology embodied in ChargePoint’s products may be discoverable by third-parties through means that do not constitute violations of applicable laws.
 
23

Patent, trademark, and trade secret laws vary significantly throughout the world. Some foreign countries do not protect intellectual property rights to the same extent as do the laws of the United States. Further, policing the unauthorized use of its intellectual property in foreign jurisdictions may be difficult or impossible. Therefore, ChargePoint’s intellectual property rights may not be as strong or as easily enforced outside of the United States.
Certain patents in the EV space may come to be considered “standards essential.” If this is the case with respect to any of ChargePoint’s patents, it may be required to license certain technology on “fair, reasonable and
non-discriminatory”
terms, decreasing revenue. Further, competitors, vendors, or customers may, in certain instances, be free to create variations or derivative works of ChargePoint technology and intellectual property, and those derivative works may become directly competitive with ChargePoint’s offerings. Finally, ChargePoint may not be able to leverage, or obtain ownership of, all technology and intellectual property developed by ChargePoint’s vendors in connection with design and manufacture of ChargePoint’s products, thereby jeopardizing ChargePoint’s ability to obtain a competitive advantage over its competitors.
It is ChargePoint’s policy to enter into confidentiality and invention assignment agreements with its employees and contractors that have developed material intellectual property for ChargePoint, but these agreements may not be self-executing and may not otherwise adequately protect ChargePoint’s intellectual property, particularly with respect to conflicts of ownership relating to work product generated by employees and contractors. Furthermore, ChargePoint cannot be certain that these agreements will not be breached and that third-parties will not gain access to its trade secrets,
know-how
and other proprietary technology. Third-parties may also independently develop the same or substantially similar proprietary technology. Monitoring unauthorized use of ChargePoint’s intellectual property is difficult and costly, as are the steps ChargePoint has taken or will take to prevent misappropriation.
To prevent unauthorized use of ChargePoint’s intellectual property, it may be necessary to prosecute actions for infringement, misappropriation or other violation of ChargePoint’s intellectual property against third-parties. Any such action could result in significant costs and diversion of ChargePoint’s resources and management’s attention, and there can be no assurance that ChargePoint will be successful in any such action. Furthermore, many of ChargePoint’s current and potential competitors have the ability to dedicate substantially greater resources to enforce their intellectual property rights than ChargePoint does. Accordingly, despite its efforts, ChargePoint may not be able to prevent third-parties from infringing, misappropriating or otherwise violating its intellectual property. Any of the foregoing may adversely affect ChargePoint’s revenues or results of operations.
The current lack of international standards may lead to uncertainty, additional competition and further unexpected costs.
Lack of industry standards for EV station management, coupled with utilities and other large organizations mandating their own adoption of specifications that have not become widely adopted in the industry, may hinder innovation or slow new product or new feature introduction.
In addition, automobile manufacturers may choose to utilize their own proprietary systems, which could lock out competition for EV charging stations, or to use their size and market position to influence the market, which could limit ChargePoint’s market and reach to customers, negatively impacting its business.
Further, should regulatory bodies later impose a standard that is not compatible with ChargePoint’s infrastructure, it may incur significant costs to adapt its business model to the new regulatory standard, which may require significant time and, as a result, may have a material and adverse effect on its revenue or results of operations.
 
24

ChargePoint’s technology could have undetected defects, errors or bugs in hardware or software which could reduce market adoption, damage its reputation with current or prospective customers, and/or expose it to product liability and other claims that could materially and adversely affect its business.
ChargePoint may be subject to claims that charging stations have malfunctioned and persons were injured or purported to be injured. Any insurance that ChargePoint carries may not be sufficient or it may not apply to all situations. Similarly, to the extent that such malfunctions are related to components obtained from third party vendors, such vendors may not assume responsibility for such malfunctions. In addition, ChargePoint’s customers could be subjected to claims as a result of such incidents and may bring legal claims against ChargePoint to attempt to hold it liable. Any of these events could adversely affect ChargePoint’s brand, relationships with customers, operating results or financial condition.
Across ChargePoint’s product line, ChargePoint develops equipment solutions based on preferred second source or common
off-the-shelf
vendors. However, due to its designs, ChargePoint does rely on some single source vendors, the unavailability or failure of which can pose risks to supply chain or product shipping situations.
Furthermore, ChargePoint’s software platform is complex, developed for over a decade by many developers, and includes a number of licensed third party commercial and open-source software libraries. ChargePoint’s software has contained defects and errors and may in the future contain undetected defects or errors. ChargePoint is continuing to evolve the features and functionality of its platform through updates and enhancements, and as it does, it may introduce additional defects or errors that may not be detected until after deployment to customers. In addition, if ChargePoint’s products and services, including any updates or patches, are not implemented or used correctly or as intended, inadequate performance and disruptions in service may result.
Any defects or errors in product or services offerings, or the perception of such defects or errors, or other performance problems could result in any of the following, each of which could adversely affect ChargePoint’s business and results of its operations:
 
   
expenditure of significant financial and product development resources, including recalls, in efforts to analyze, correct, eliminate or work around errors or defects;
 
   
loss of existing or potential customers or partners;
 
   
interruptions or delays in sales;
 
   
delayed or lost revenue;
 
   
delay or failure to attain market acceptance;
 
   
delay in the development or release of new functionality or improvements;
 
   
negative publicity and reputational harm;
 
   
sales credits or refunds;
 
   
exposure of confidential or proprietary information;
 
   
diversion of development and customer service resources;
 
   
breach of warranty claims;
 
   
legal claims under applicable laws, rules and regulations; and
 
   
an increase in collection cycles for accounts receivable or the expense and risk of litigation.
Although ChargePoint has contractual protections, such as warranty disclaimers and limitation of liability provisions, in many of its agreements with customers, resellers and other business partners, such protections may
 
25

not be uniformly implemented in all contracts and, where implemented, may not fully or effectively protect from claims by customers, resellers, business partners or other third-parties. Any insurance coverage or indemnification obligations of suppliers may not adequately cover all such claims, or cover only a portion of such claims. A successful product liability, warranty, or other similar claim could have an adverse effect on ChargePoint’s business, operating results and financial condition. In addition, even claims that ultimately are unsuccessful could result in expenditure of funds in litigation, divert management’s time and other resources and cause reputational harm.
In addition, ChargePoint relies on some open-source software and libraries issued under the General Public License (or similar “copyleft” licenses) for development of its products and may continue to rely on similar copyleft licenses. Third-parties may assert a copyright claim against ChargePoint regarding its use of such software or libraries, which could lead to the adverse results listed above. Use of such software or libraries may also force ChargePoint to provide third-parties, at no cost, the source code to its proprietary software, which may decrease revenue and lessen any competitive advantage ChargePoint has due to the secrecy of its source code.
Some of ChargePoint’s products contain open-source software, which may pose particular risks to its proprietary software, products and services in a manner that could harm its business.
ChargePoint uses open-source software in its products and anticipates using open-source software in the future. Some open-source software licenses require those who distribute open-source software as part of their own software product to publicly disclose all or part of the source code to such software product or to make available any derivative works of the open-source code on unfavorable terms or at no cost, and ChargePoint may be subject to such terms. The terms of many open-source licenses have not been interpreted by U.S. or foreign courts, and there is a risk that open source software licenses could be construed in a manner that imposes unanticipated conditions or restrictions on ChargePoint’s ability to provide or distribute ChargePoint’s products or services.
In addition, ChargePoint relies on some open-source software and libraries issued under the General Public License (or similar “copyleft” licenses) for development of its products and may continue to rely on similar copyleft licenses. Third-parties may assert a copyright claim against ChargePoint regarding its use of such software or libraries, which could lead to the adverse results listed above. Use of such software or libraries may also force ChargePoint to provide third-parties, at no cost, the source code to its proprietary software, which may decrease revenue and lessen any competitive advantage ChargePoint has due to the secrecy of its source code.
ChargePoint could face claims from third-parties claiming ownership of, or demanding release of, the open-source software or derivative works that ChargePoint developed using such software, which could include ChargePoint’s proprietary source code, or otherwise seeking to enforce the terms of the applicable open-source license. These claims could result in litigation and could require ChargePoint to make its software source code freely available, purchase a costly license or cease offering the implicated products or services unless and until ChargePoint can
re-engineer
them to avoid infringement, which may be a costly and time-consuming process, and ChargePoint may not be able to complete the
re-engineering
process successfully.
Additionally, the use of certain open-source software can lead to greater risks than use of third party commercial software, as open-source licensors generally do not provide warranties or controls on the origin of software. There is typically no support available for open-source software, and ChargePoint cannot ensure that the authors of such open-source software will implement or push updates to address security risks or will not abandon further development and maintenance. Many of the risks associated with the use of open-source software, such as the lack of warranties or assurances of title or performance, cannot be eliminated, and could, if not properly addressed, could have an adverse effect on ChargePoint’s business and results.
 
26

Interruptions, delays in service or inability to increase capacity, including internationally, at third party data center facilities could impair the use or functionality of ChargePoint’s subscription services, harm its business and subject it to liability.
ChargePoint currently serves customers from third party data center facilities operated by Amazon Web Services (“AWS”) located in the United States, Europe and Canada. In addition to AWS, some ChargePoint services are housed in third party data centers operated by Rackspace Technology in the United States. Any outage or failure of such data centers could negatively affect ChargePoint’s product connectivity and performance. ChargePoint’s primary environments are behind the Content Delivery Network operated by Cloudflare, Inc. (“Cloudflare”), and any interruptions of Cloudflare’s services could negatively affect ChargePoint’s product connectivity and performance. Furthermore, ChargePoint depends on connectivity from its charging stations to its data centers through cellular service providers, such as Verizon. Any incident affecting a data center facility’s or a cellular service provider’s infrastructure or operations, whether caused by fire, flood, severe storm, earthquake, power loss, telecommunications failures, breach of security protocols, computer viruses and disabling devices, failure of access control mechanisms, natural disasters, war, criminal act, military actions, terrorist attacks and other similar events could negatively affect the use, functionality or availability of ChargePoint’s services.
Any damage to, or failure of, ChargePoint’s systems, or those of its third party providers, could interrupt or hinder the use or functionality of its services. Impairment of or interruptions in ChargePoint’s services may reduce revenue, subject it to claims and litigation, cause customers to terminate their subscriptions, and adversely affect renewal rates and its ability to attract new customers. ChargePoint’s business will also be harmed if customers and potential customers believe its products and services are unreliable.
Customer-Related Risks
ChargePoint may be unable to leverage customer data in all geographic locations, and this limitation may impact research and development operations.
ChargePoint relies on data collected through charging stations or its mobile application, including usage data and geolocation data. ChargePoint uses this data in connection with the research, development and analysis of its technologies. ChargePoint’s inability to obtain necessary rights to use this data or freely transfer this data out of, for example, the European Economic Area, could result in delays or otherwise negatively impact ChargePoint’s research and development efforts.
If ChargePoint fails to offer high-quality support to station owners and drivers, its business and reputation will suffer.
Once a customer has installed ChargePoint charging stations and subscribed to ChargePoint’s services, station owners and drivers will rely on ChargePoint to provide support services to resolve any issues that might arise in the future. Rapid and high-quality customer support is important so station owners can provide charging services and drivers can receive reliable charging for their EVs. The importance of high-quality customer support will increase as ChargePoint seeks to expand its business and pursue new customers and geographies. If ChargePoint does not quickly resolve issues and provide effective support, its ability to retain customers or sell additional products and services to existing customers could suffer and its brand and reputation could be harmed.
ChargePoint’s business will depend on customers renewing their services subscriptions. If customers do not continue to use its subscription offerings or if they fail to add more stations, its business and operating results will be adversely affected.
In addition to selling charging station hardware, ChargePoint also depends on customers continuing to subscribe to its EV charging services and extended warranty coverages. Therefore, it is important that customers renew their subscriptions when the contract term expires and add additional charging stations and services to
 
27

their subscriptions. Customers may decide not to renew their subscriptions with a similar contract period, at the same prices or terms or with the same or a greater number of users, stations or level of functionality. Customer retention may decline or fluctuate as a result of a number of factors, including satisfaction with software and features, functionality of the charging stations, prices, features and pricing of competing products, reductions in spending levels, mergers and acquisitions involving customers and deteriorating general economic conditions.
If customers do not renew their subscriptions, if they renew on less favorable terms or if they fail to add products or services, ChargePoint’s business and operating results will be adversely affected.
Changes in subscriptions or pricing models may not be reflected in near-term operating results.
ChargePoint generally recognizes subscription revenue from customers ratably over the terms of their contracts. As a result, most of the subscription revenue reported in each quarter is derived from the recognition of deferred revenue relating to subscriptions entered into during previous quarters. Consequently, a decline in new or renewed subscriptions in any single quarter will likely have only a small impact on revenue for that quarter. However, such a decline will negatively affect revenue in future quarters. In addition, the severity and duration of events may not be predictable and their effects could extend beyond a single quarter. Accordingly, the effect of significant downturns in sales and market acceptance of subscription services, and potential changes in pricing policies or rate of renewals, may not be fully apparent until future periods.
Financial, Tax and Accounting-Related Risks
ChargePoint’s financial condition and results of operations are likely to fluctuate on a quarterly basis in future periods, which could cause its results for a particular period to fall below expectations, resulting in a decline in the price of its Common Stock.
ChargePoint’s financial condition and results of operations have fluctuated in the past and may continue to fluctuate in the future due to a variety of factors, many of which are beyond its control.
In addition to the other risks described herein, the following factors could also cause ChargePoint’s financial condition and results of operations to fluctuate on a quarterly basis:
 
   
the timing and volume of new sales;
 
   
fluctuations in service costs, particularly due to unexpected costs of servicing and maintaining charging stations;
 
   
the timing of new product introductions, which can initially have lower gross margins;
 
   
the introduction of new products by competitors, changes in pricing or other factors impacting competition;
 
   
weaker than anticipated demand for charging stations, whether due to changes in government incentives and policies or due to other conditions;
 
   
fluctuations in sales and marketing or research and development expenses;
 
   
supply chain interruptions and manufacturing or delivery delays;
 
   
the timing and availability of new
products relative to customers’ and investors’ expectations;
 
   
the length of the sales and installation cycle for a particular customer;
 
   
the impact of
COVID-19
on ChargePoint’s workforce, or those of its customers, suppliers, vendors or business partners;
 
   
disruptions in sales, production, service or other business activities or ChargePoint’s inability to attract and retain qualified personnel; and
 
28

   
unanticipated changes in federal, state, local or foreign government incentive programs, which can affect demand for EVs.
Fluctuations in operating results and cash flow could, among other things, give rise to short-term liquidity issues. In addition, revenue, and other operating results in future quarters may fall short of the expectations of investors and financial analysts, which could have an adverse effect on the price of the Common Stock.
Changes to applicable U.S. tax laws and regulations or exposure to additional income tax liabilities could affect ChargePoint’s business and future profitability.
ChargePoint is a U.S. corporation and thus subject to U.S. corporate income tax on its worldwide operations. Moreover, the majority of ChargePoint’s operations and customers are located in the United States, and as a result, ChargePoint is subject to various U.S. federal, state and local taxes. New U.S. laws and policy relating to taxes may have an adverse effect on ChargePoint’s business and future profitability. Further, existing U.S. tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to ChargePoint.
For example, on December 22, 2017, the Tax Cuts and Jobs Act of 2017 (“Tax Act”), was signed into law making significant changes to the Internal Revenue Code of 1986, as amended, or the Code, and certain provisions of the Tax Act may adversely affect ChargePoint. In particular, sweeping changes were made to the U.S. taxation of foreign operations. Changes include, but are not limited to, a permanent reduction to the corporate income tax rate, limiting interest deductions, a reduction to the maximum deduction allowed for net operating losses generated in tax years after December 31, 2017, the elimination of carrybacks of net operating losses, adopting elements of a territorial tax system, assessing a repatriation tax or “toll-charge” on undistributed earnings and profits of U.S.-owned foreign corporations, and introducing certain anti-base erosion provisions, including a new minimum tax on global intangible
low-taxed
income and base erosion and anti-abuse tax. The Tax Act could be subject to potential amendments and technical corrections, and is subject to interpretations and implementing regulations by the U.S. Treasury and Internal Revenue Service (“IRS”), any of which could mitigate or increase certain adverse effects of the legislation.
In addition, the Tax Act may impact taxation in other jurisdictions, including with respect to state income taxes as state legislatures respond to the Tax Act. Additionally, other foreign governing bodies have and may enact changes to their tax laws in reaction to the Tax Act that could result in changes to ChargePoint’s global tax position and materially adversely affect its business and future profitability.
As a result of ChargePoint’s plans to expand operations, including to jurisdictions in which the tax laws may not be favorable, ChargePoint’s tax rate may fluctuate, ChargePoint’s tax obligations may become significantly more complex and subject to greater risk of examination by taxing authorities or ChargePoint may be subject to future changes in tax law, the impacts of which could adversely affect ChargePoint’s
after-tax
profitability and financial results.
Because ChargePoint does not have a long history of operating at its present scale and it has significant expansion plans, ChargePoint’s effective tax rate may fluctuate in the future. Future effective tax rates could be affected by operating losses in jurisdictions where no tax benefit can be recorded under U.S. GAAP, changes in the composition of earnings in countries with differing tax rates, changes in deferred tax assets and liabilities, or changes in tax laws. Factors that could materially affect ChargePoint’s future effective tax rates include, but are not limited to: (a) changes in tax laws or the regulatory environment, (b) changes in accounting and tax standards or practices, (c) changes in the composition of operating income by tax jurisdiction and (d) ChargePoint’s operating results before taxes.
Additionally, ChargePoint’s operations are subject to significant income, withholding and other tax obligations in the United States and may become subject to taxes in numerous additional state, local and
 
29

non-U.S.
jurisdictions with respect to its income, operations and subsidiaries related to those jurisdictions. ChargePoint’s
after-tax
profitability and financial results could be subject to volatility or be affected by numerous factors, including (a) the availability of tax deductions, credits, exemptions, refunds (including refunds of value added taxes) and other benefits to reduce ChargePoint’s tax liabilities, (b) changes in the valuation of ChargePoint’s deferred tax assets and liabilities, (c) expected timing and amount of the release of any tax valuation allowances, (d) tax treatment of stock-based compensation, (e) changes in the relative amount of ChargePoint’s earnings subject to tax in the various jurisdictions in which ChargePoint operates or has subsidiaries, (f) the potential expansion of ChargePoint’s business into or otherwise becoming subject to tax in additional jurisdictions, (g) changes to ChargePoint’s existing intercompany structure (and any costs related thereto) and business operations, (h) the extent of ChargePoint’s intercompany transactions and the extent to which taxing authorities in the relevant jurisdictions respect those intercompany transactions and (i) ChargePoint’s ability to structure ChargePoint’s operations in an efficient and competitive manner. Due to the complexity of multinational tax obligations and filings, ChargePoint may have a heightened risk related to audits or examinations by U.S. federal, state, local and
non-U.S.
taxing authorities. Outcomes from these audits or examinations could have an adverse effect on ChargePoint’s
after-tax
profitability and financial condition. Additionally, the IRS and several foreign tax authorities have increasingly focused attention on intercompany transfer pricing with respect to sales of products and services and the use of intangibles. Tax authorities could disagree with ChargePoint’s intercompany charges, cross-jurisdictional transfer pricing or other matters and assess additional taxes. If ChargePoint does not prevail in any such disagreements, its profitability may be affected.
ChargePoint’s
after-tax
profitability and financial results may also be adversely impacted by changes in the relevant tax laws and tax rates, treaties, regulations, administrative practices and principles, judicial decisions and interpretations thereof, in each case, possibly with retroactive effect. For example, the Multilateral Convention to Implement Tax Treaty Related Measures to Prevent Base Erosion and Profit Shifting recently entered into force among the jurisdictions that have ratified it, although the United States has not yet entered into this convention. These recent changes could negatively impact ChargePoint’s taxation, especially as ChargePoint expands its relationships and operations internationally.
The ability of ChargePoint to utilize net operating loss and tax credit carryforwards is conditioned upon ChargePoint attaining profitability and generating taxable income. ChargePoint has incurred significant net losses since inception and it is anticipated that ChargePoint will continue to incur significant losses. Additionally, ChargePoint’s ability to utilize net operating loss and tax credit carryforwards to offset future taxable income may be limited.
As of January 31, 2021, ChargePoint had $434.7 million of U.S. federal and $229.7 million of California net operating loss carryforwards available to reduce future taxable income, of which $281.9 million of the U.S. federal net operating loss carryforwards can be carried forward indefinitely. The U.S. federal and California state net operating loss carryforwards begin to expire in 2028. In addition, ChargePoint had net operating loss carryforwards for other states of $134.7 million, which begin to expire in 2022. The Tax Act included a reduction to the maximum deduction allowed for net operating losses generated in tax years after December 31, 2017 and the elimination of carrybacks of net operating losses. Under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, which modified the Tax Act, U.S. federal net operating loss carryforwards generated in taxable periods beginning after December 31, 2017, may be carried forward indefinitely, but the deductibility of such net operating loss carryforwards in taxable years beginning after December 31, 2020, is limited to 80% of taxable income. It is possible that ChargePoint will not generate taxable income in time to utilize the net operating loss carryforwards.
In addition, net operating loss carryforwards and certain tax credits may be subject to significant limitations under Section 382 and Section 383 of the Code, respectively, and similar provisions of state law. Under those sections of the Code, if a corporation undergoes an “ownership change,” the corporation’s ability to use its
pre-change
net operating loss carryforwards and other
pre-change
attributes, such as research tax credits, to offset
 
30

its post-change income or tax may be limited. In general, an “ownership change” will occur if there is a cumulative change in ownership by “5% stockholders” that exceeds 50 percentage points over a rolling
three-year
period. If ChargePoint has experienced an ownership change at any time since its incorporation, ChargePoint may already be subject to limitations on its ability to utilize its existing net operating loss carryforwards and other tax attributes to offset taxable income or tax liability. In addition, future changes in ChargePoint’s stock ownership, which may be outside of ChargePoint’s control, may trigger an ownership change. Similar provisions of state tax law may also apply to limit ChargePoint’s use of accumulated state tax attributes. As a result, even if ChargePoint earns net taxable income in the future, its ability to use its
pre-change
net operating loss carryforwards and other tax attributes to offset such taxable income or tax liability may be subject to limitations, which could potentially result in increased future income tax liability to ChargePoint.
ChargePoint performed an analysis to assess whether an “ownership change,” as defined by Section 382 of the Code, has occurred from its inception through January 31, 2021 and expects to complete this Section 382 analysis during the fiscal year ending January 31, 2022. Based on this analysis, ChargePoint has experienced “ownership changes,” limiting the utilization of the net operating loss carryforwards or research and development tax credit carryforwards under Section 382 of the Code by first multiplying the value of the ChargePoint’s stock at the time of the ownership change by the applicable long-term
tax-exempt
rate, and then applying additional adjustments, as required. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization. In addition, the Merger may constitute an ownership change under Sections 382 and 383 of the Code. ChargePoint’s net operating losses or credits may also be impaired under state law. Accordingly, ChargePoint may not be able to utilize a material portion of the net operating losses or credits. The ability of ChargePoint to utilize ChargePoint’s net operating losses or credits is conditioned upon ChargePoint attaining profitability and generating U.S. federal and state taxable income. ChargePoint has incurred significant net losses since inception and will continue to incur significant losses; and therefore, ChargePoint does not know whether or when the combined carryforwards may be or may become subject to limitation by Sections 382 and 383 of the Code.
ChargePoint’s reported financial results may be negatively impacted by changes in U.S. GAAP.
U.S. GAAP is subject to interpretation by the Financial Accounting Standards Board’s Accounting Standards Codification, the SEC and various bodies formed to promulgate and interpret appropriate accounting principles. A change in these principles or interpretations could have a significant effect on reported financial results, and may even affect the reporting of transactions completed before the announcement or effectiveness of a change.
ChargePoint is an “emerging growth company” and it cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make its Common Stock less attractive to investors and may make it more difficult to compare performance with other public companies.
ChargePoint is currently an emerging growth company as defined in the U.S. legislation Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), but as of January 31, 2022, it expects to be a large accelerated filer and, as a result, will no longer be an emerging growth company as of that date. Until then, ChargePoint intends to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley”), reduced disclosure obligations regarding executive compensation in periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Investors may find the Common Stock less attractive because ChargePoint will continue to rely on these exemptions. If some investors find the Common Stock less attractive as a result, there may be a less active trading market for their Common Stock, and the stock price may be more volatile.
 
31

An emerging growth company may elect to delay the adoption of new or revised accounting standards. With Switchback making this election, Section 102(b)(2) of the JOBS Act allows ChargePoint to delay adoption of new or revised accounting standards until those standards apply to
non-public
business entities. As a result, the financial statements contained in this prospectus and those that ChargePoint will file in the future may not be comparable to companies that comply with public business entities revised accounting standards effective dates.
ChargePoint incurs significant increased expenses and administrative burdens as a public company, which could have an adverse effect on its business, financial condition and results of operations.
ChargePoint faces increased legal, accounting, administrative and other costs and expenses as a public company that it did not incur as a private company. Sarbanes-Oxley, including the requirements of Section 404, as well as rules and regulations subsequently implemented by the SEC, the Dodd-Frank Act and the rules and regulations promulgated and to be promulgated thereunder, the Public Company Accounting Oversight Board and the securities exchanges, impose additional reporting and other obligations on public companies. Compliance with public company requirements increases costs and make certain activities more time-consuming. A number of those requirements require it to carry out activities ChargePoint has not done previously. In addition, expenses associated with SEC reporting requirements will be incurred. Furthermore, if any issues in complying with those requirements are identified, such as the restatement of ChargePoint’s previously issued consolidated financial statements, and related material weakness as described in this prospectus, ChargePoint may be subject additional costs and expenses to come into compliance (see also “Risks Related to Legal Matters and Regulations—ChargePoint may face litigation and other risks as a result of the material weakness in its internal control over financial reporting and the restatement of its financial statements,” and “—ChargePoint has identified material weaknesses in its internal control over financial reporting.” If ChargePoint is unable to remediate these material weaknesses, or if ChargePoint identifies additional material weaknesses in the future or otherwise fails to maintain an effective system of internal control over financial reporting, this may result in material misstatements of ChargePoint’s consolidated financial statements or cause ChargePoint to fail to meet its periodic reporting obligations,” for more detail), ChargePoint has incurred and could incur additional costs to rectify those or new issues, and the existence of these issues could adversely affect its reputation or investor perceptions. In addition, as a public company, ChargePoint maintains director and officer liability insurance, for which it must pay substantial premiums. The additional reporting and other obligations imposed by these rules and regulations increase legal and financial compliance costs and the costs of related legal, accounting and administrative activities. Advocacy efforts by stockholders and third-parties may also prompt additional changes in governance and reporting requirements, which could further increase costs.
ChargePoint has identified material weaknesses in its internal control over financial reporting. If ChargePoint is unable to remediate these material weaknesses, or if ChargePoint identifies additional material weaknesses in the future or otherwise fails to maintain an effective internal control over financial reporting, this may result in material misstatements of ChargePoint’s consolidated financial statements or cause ChargePoint to fail to meet its periodic reporting obligations.
As a public company, ChargePoint is required to provide management’s attestation on controls pursuant to Section 404 of Sarbanes-Oxley. The standards required for a public company under Section 404(a) of Sarbanes-Oxley are significantly more stringent than those previously required of ChargePoint as a privately-held company. When ChargePoint ceases to be an emerging growth company, it will also be subject to auditor attestation requirements of Section 404(b) of Sarbanes-Oxley and the relevant increased disclosure obligations. Management may not be able to effectively and timely implement controls and procedures that adequately respond to the increased regulatory compliance and reporting requirements of Section 404(a) and/or Section 404(b) of Sarbanes-Oxley. If ChargePoint is not able to implement these additional requirements in a timely manner or with adequate compliance, it may not be able to assess whether its internal control over financial reporting is effective, which may subject it to adverse regulatory consequences and could harm investor confidence.
 
32

In connection with the preparation and audit of ChargePoint’s consolidated financial statements, material weaknesses were identified in its internal control over financial reporting as of January 31, 2021. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of ChargePoint’s annual or interim financial statements will not be prevented or detected on a timely basis.
ChargePoint did not design and maintain an effective control environment commensurate with its financial reporting requirements. Specifically, ChargePoint did not maintain a sufficient complement of personnel with an appropriate degree of accounting knowledge, experience and training to appropriately analyze, record and disclose accounting matters commensurate with its accounting and reporting requirements. This material weakness contributed to the following additional material weaknesses:
 
   
ChargePoint did not design and maintain formal accounting policies, procedures and controls over significant accounts and disclosures to achieve complete, accurate and timely financial accounting, reporting and disclosures, including accounting for complex features associated with warrants, segregation of duties and adequate controls related to the preparation and review of journal entries; and
 
   
ChargePoint did not design and maintain effective controls over certain information technology (“IT”) general controls for information systems that are relevant to the preparation of its consolidated financial statements. Specifically, ChargePoint did not design and maintain (a) program change management controls to ensure that information technology program and data changes affecting financial IT applications and underlying accounting records are identified, tested, authorized and implemented appropriately and (b) user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to its financial applications and data to appropriate company personnel.
The material weaknesses related to the control environment and lack of formal accounting policies, procedures and controls resulted in material adjustments to warrant liabilities, stockholders’ equity and related accounts and disclosures and immaterial adjustments to a number of other account balances and disclosures in the historical consolidated financial statements.
The IT deficiencies did not result in a misstatement to the consolidated financial statements, however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of
IT-dependent
controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would not be prevented or detected. Additionally, each of these material weaknesses could result in a misstatement of account balances or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.
ChargePoint has continued implementation of a plan to remediate these material weaknesses. These remediation measures are ongoing and include the following:
 
   
hiring additional finance and accounting personnel to bolster the accounting capabilities and capacity and to establish and maintain internal control over financial reporting;
 
   
designing and implementing controls to formalize roles and review responsibilities to align with the staff’s skills and experience and designing and implementing controls over segregation of duties;
 
   
providing ongoing training for personnel on accounting, financial reporting and internal control over financial reporting;
 
   
engaging an external advisor to assist with evaluating and documenting the design and operating effectiveness of internal control over financial reporting and assist with the remediation of deficiencies, as necessary;
 
33

   
designing and implementing controls over the preparation and review of journal entries and account reconciliations, including controls over the segregation of duties; and
 
   
designing and implementing IT general controls, including controls over the provisioning and monitoring of user access rights and privileges and change management processes and procedures.
ChargePoint’s remediation efforts could continue beyond the fiscal year ending January 31, 2023. At this time, ChargePoint cannot provide an estimate of costs expected to be incurred in connection with implementing this remediation plan; however, these remediation measures will be time consuming, will result in it incurring significant costs, and will place significant demands on its financial and operational resources.
In order to maintain and improve the effectiveness of its internal control over financial reporting, ChargePoint has expended, and anticipates that ChargePoint will continue to expend, significant resources, including accounting-related costs and significant management oversight. At such time, ChargePoint’s independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which its internal control over financial reporting is documented, designed or operating. Any failure to maintain effective disclosure controls and internal control over financial reporting could adversely affect the business and operating results and could cause a decline in the price of ChargePoint’s Common Stock.
Risks Related to Legal Matters and Regulations
Privacy concerns and laws, or other domestic or foreign regulations, may adversely affect ChargePoint’s business.
ChargePoint relies on data collected through charging stations or its mobile application, including usage data and geolocation data. ChargePoint uses this data in connection with the research, development and analysis of its technologies. Accordingly, ChargePoint may be subject to or affected by a number of federal, state, local and international laws and regulations, as well as contractual obligations and industry standards, that impose certain obligations and restrictions with respect to data privacy and security and govern its collection, storage, retention, protection, use, processing, transmission, sharing and disclosure of personal information including that of ChargePoint’s employees, customers and other third-parties with whom ChargePoint conducts business. National and local governments and agencies in the countries in which ChargePoint operates and in which customers operate have adopted, are considering adopting, or may adopt laws and regulations regarding the collection, use, storage, processing and disclosure of information regarding consumers and other individuals, which could impact its ability to offer services in certain jurisdictions. Laws and regulations relating to the collection, use, storage, disclosure, security and other processing of individuals’ information can vary significantly from jurisdiction to jurisdiction and are particularly stringent in Europe. The costs of compliance with, and other burdens imposed by, laws, regulations, standards and other obligations relating to privacy, data protection and information security are significant. In addition, some companies, particularly larger enterprises, often will not contract with vendors that do not meet these rigorous standards. Accordingly, the failure, or perceived inability, to comply with these laws, regulations, standards and other obligations may limit the use and adoption of ChargePoint’s solutions, reduce overall demand, lead to regulatory investigations, litigation and significant fines, penalties or liabilities for actual or alleged noncompliance, or slow the pace at which it closes sales transactions, any of which could harm its business. Moreover, if ChargePoint or any of its employees or contractors fail or are believed to fail to adhere to appropriate practices regarding customers’ data, it may damage its reputation and brand.
Additionally, existing laws, regulations, standards and other obligations may be interpreted in new and differing manners in the future, and may be inconsistent among jurisdictions. Future laws, regulations, standards and other obligations, and changes in the interpretation of existing laws, regulations, standards and other obligations could result in increased regulation, increased costs of compliance and penalties for
non-compliance,
and limitations on data collection, use, disclosure and transfer for ChargePoint and its customers.
 
34

Additionally, the EU adopted the GDPR in 2016, and it became effective in May 2018. The GDPR establishes requirements applicable to the handling of personal data and imposes penalties for
non-compliance
of up to the greater of €20 million or 4% of worldwide revenue. The costs of compliance with, and other burdens imposed by, the GDPR may limit the use and adoption of ChargePoint’s products and services and could have an adverse impact on its business. Further, California adopted the CCPA and the California State Attorney General has begun enforcement actions. Although ChargePoint initiated a compliance program designed to ensure CCPA compliance after consulting with outside privacy counsel, ChargePoint may remain exposed to ongoing legal risks and compliance costs related to CCPA and the new California Privacy Rights Act (“CPRA”), which will become effective in most material respects starting on January 1, 2023.
The costs of compliance with, and other burdens imposed by, laws and regulations relating to privacy, data protection and information security that are applicable to the businesses of customers may adversely affect ability and willingness to process, handle, store, use and transmit certain types of information, such as demographic and other personal information. The EU and the United States agreed in 2016 to the
EU-US
Privacy Shield Framework, which provided one mechanism for lawful cross-border transfers of personal data between the EU and the United States. However, the Court of Justice of the EU issued a decision on July 16, 2020 invalidating the
EU-US
Privacy Shield Framework, thereby creating additional legal risk for ChargePoint. In addition, the other bases on which ChargePoint and its customers rely for the transfer of personal data across national borders, such as the Standard Contractual Clauses promulgated by the EU Commission Decision 2010/87/EU, commonly referred to as the Model Clauses, continue to be subjected to regulatory and judicial scrutiny. If ChargePoint or its customers are unable to transfer data between and among countries and regions in which it operates, it could decrease demand for its products and services or require it to modify or restrict some of its products or services.
In addition to government activity, privacy advocacy groups, the technology industry and other industries have established or may establish various new, additional or different self-regulatory standards that may place additional burdens on technology companies. Customers may expect that ChargePoint will meet voluntary certifications or adhere to other standards established by them or third-parties. If ChargePoint is unable to maintain these certifications or meet these standards, it could reduce demand for its solutions and adversely affect its business.
Failure to comply with anticorruption and anti-money laundering laws, including the FCPA and similar laws associated with activities outside of the United States, could subject ChargePoint to penalties and other adverse consequences.
ChargePoint is subject to the FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. § 201, the U.S. Travel Act, the USA PATRIOT Act, the Anti-Bribery Act and possibly other anti-bribery and anti-money laundering laws in countries in which it conducts activities. It faces significant risks if it fails to comply with the FCPA and other anti-corruption laws that prohibit companies and their employees and third party intermediaries from promising, authorizing, offering or providing, directly or indirectly, improper payments or benefits to foreign government officials, political parties and private-sector recipients for the purpose of obtaining or retaining business, directing business to any person or securing any advantage. Any violation of the FCPA, other applicable anti-corruption laws, and anti-money laundering laws could result in whistleblower complaints, adverse media coverage, investigations, loss of export privileges, or severe criminal or civil sanctions, which could have a materially adverse effect on ChargePoint’s reputation, business, operating results and prospects. In addition, responding to any enforcement action may result in a significant diversion of management’s attention and resources, significant defense costs and other professional fees.
Failure to comply with laws relating to employment could subject ChargePoint to penalties and other adverse consequences.
ChargePoint is subject to various employment-related laws in the jurisdictions in which its employees are based. It faces risks if it fails to comply with applicable U.S. federal or state wage laws, or wage laws applicable
 
35

to its employees outside of the United States. In addition, ChargePoint implemented a reduction in force and furloughed employees in 2020, and the attendant layoffs and/or furloughs could create an additional risk of claims being made on behalf of affected employees. Any violation of applicable wage laws or other
labor-or
employment-related laws could result in complaints by current or former employees, adverse media coverage, investigations and damages or penalties which could have a materially adverse effect on ChargePoint’s reputation, business, operating results and prospects. In addition, responding to any such proceeding may result in a significant diversion of management’s attention and resources, significant defense costs and other professional fees.
Existing and future environmental health and safety laws and regulations could result in increased compliance costs or additional operating costs or construction costs and restrictions. Failure to comply with such laws and regulations may result in substantial fines or other limitations that may adversely impact ChargePoint’s financial results or results of operation.
ChargePoint and its operations, as well as those of ChargePoint’s contractors, suppliers and customers, are subject to certain environmental laws and regulations, including laws related to the use, handling, storage, transportation and disposal of hazardous substances and wastes as well as electronic wastes and hardware, whether hazardous or not. These laws may require ChargePoint or others in ChargePoint’s value chain to obtain permits and comply with procedures that impose various restrictions and obligations that may have material effects on ChargePoint’s operations. If key permits and approvals cannot be obtained on acceptable terms, or if other operational requirements cannot be met in a manner satisfactory for ChargePoint’s operations or on a timeline that meets ChargePoint’s commercial obligations, it may adversely impact ChargePoint’s business.
Environmental and health and safety laws and regulations can be complex and may be subject to change, such as through new requirements enacted at the supranational, national,
sub-national
and/or local level or new or modified regulations that may be implemented under existing law. The nature and extent of any changes in these laws, rules, regulations and permits may be unpredictable and may have material effects on ChargePoint’s business. Future legislation and regulations or changes in existing legislation and regulations, or interpretations thereof, including those relating to hardware manufacturing, electronic waste or batteries, could cause additional expenditures, restrictions and delays in connection with ChargePoint’s operations as well as other future projects, the extent of which cannot be predicted.
Further, ChargePoint currently relies on third-parties to ensure compliance with certain environmental laws, including those related to the disposal of hazardous and
non-hazardous
wastes. Any failure to properly handle or dispose of such wastes, regardless of whether such failure is ChargePoint’s or its contractors, may result in liability under environmental laws, including, but not limited to, the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”), under which liability may be imposed without regard to fault or degree of contribution for the investigation and
clean-up
of contaminated sites, as well as impacts to human health and damages to natural resources. Additionally, ChargePoint may not be able to secure contracts with third-parties to continue their key supply chain and disposal services for ChargePoint’s business, which may result in increased costs for compliance with environmental laws and regulations.
ChargePoint may face litigation and other risks as a result of the material weakness in its internal control over financial reporting and the restatement of its financial statements.
Following the issuance of the SEC’s Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies on April 12, 2021, the audit committee of the Board, after considering the recommendations of management, determined that it was appropriate to restate ChargePoint’s previously filed financial statements for the
Non-Reliance
Periods. See “—Risks Related to Legal Matters and Regulations—The Warrants are being accounted for as a warrant liability and are being recorded at fair value upon issuance with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of ChargePoint’s Common Stock.” As part of this restatement, ChargePoint identified a material weakness in its internal control over financial reporting.
 
36

As a result of such material weakness, such restatement, the change in accounting for the Warrants, and other matters raised or that may in the future be raised by the SEC, ChargePoint faces potential for litigation or other disputes which may include, among others, claims invoking the federal and state securities laws, contractual claims or other claims arising from the restatement and material weaknesses in its internal control over financial reporting and the preparation of its financial statements. As of the date of this prospectus, ChargePoint has no knowledge of any such litigation or dispute. However, ChargePoint can provide no assurance that such litigation or dispute will not arise in the future. Any such litigation or dispute, whether successful or not, could have a material adverse effect on its business, results of operations and financial condition.
Risks Related to Ownership of ChargePoint’s Securities and this Offering
Concentration of ownership among ChargePoint’s existing executive officers, directors and their affiliates may prevent new investors from influencing significant corporate decisions.
As of October 1, 2021, ChargePoint’s directors, executive officers and their affiliates in the aggregate beneficially own approximately 27.3% of the outstanding Common Stock. As a result, these stockholders are able to exercise a significant level of control over all matters requiring stockholder approval, including the election of directors, any amendment of the certificate of incorporation and approval of significant corporate transactions. This control could have the effect of delaying or preventing a change of control or changes in management and will make the approval of certain transactions difficult or impossible without the support of these stockholders.
ChargePoint has never paid cash dividends on its capital stock, and does not anticipate paying dividends in the foreseeable future.
ChargePoint has never paid cash dividends on its capital stock and currently intends to retain any future earnings to fund the growth of its business. Any determination to pay dividends in the future will be at the discretion of the Board and will depend on financial condition, operating results, capital requirements, general business conditions and other factors that the Board may deem relevant. As a result, capital appreciation, if any, of Common Stock will be the sole source of gain for the foreseeable future.
The price of ChargePoint’s Common Stock may be subject to wide fluctuations.
The trading price of the Common Stock will be volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond ChargePoint’s control. These factors include:
 
   
actual or anticipated fluctuations in operating results;
 
   
failure to meet or exceed financial estimates and projections of the investment community or that ChargePoint provides to the public;
 
   
issuance of new or updated research or reports by securities analysts or changed recommendations for the industry in general;
 
   
announcements of significant acquisitions, strategic partnerships, joint ventures, collaborations or capital commitments;
 
   
changes in competitive factors;
 
   
operating and share price performance of other companies in the industry or related markets;
 
   
sales of shares of ChargePoint’s Common Stock into the market pursuant to the exercise of registration rights described elsewhere in this prospectus;
 
   
the timing and magnitude of investments in the growth of the business;
 
37

   
actual or anticipated changes in laws and regulations;
 
   
additions or departures of key management or other personnel;
 
   
increased labor costs;
 
   
disputes or other developments related to intellectual property or other proprietary rights, including litigation;
 
   
the ability to market new
and enhanced solutions on a timely basis;
 
   
sales of substantial amounts of the Common Stock by the Board, executive officers or significant stockholders or the perception that such sales could occur;
 
   
changes in capital structure, including future issuances of securities or the incurrence of debt; and
 
   
general economic, political and market conditions.
In addition, the stock market in general, and the stock prices of technology companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Broad market and industry factors may seriously affect the market price of ChargePoint’s Common Stock, regardless of actual operating performance. In addition, in the past, following periods of volatility in the overall market and the market price of a particular company’s securities, securities class action litigation has often been instituted against these companies. This litigation, if instituted, could result in substantial costs and a diversion of management’s attention and resources.
The coverage of ChargePoint’s business or its securities by securities or industry analysts or the absence thereof could adversely affect the trading price and volume of ChargePoint’s Common Stock, Warrants and other securities.
The trading market for ChargePoint’s securities is influenced in part by the research and other reports that industry or securities analysts publish about ChargePoint or its business or industry from time to time. ChargePoint does not control these analysts or the content and opinions included in their reports. As a former shell company, ChargePoint may be slow to attract equity research coverage, and the analysts who publish information about ChargePoint’s securities will have had relatively little experience with ChargePoint, which could affect their ability to accurately forecast ChargePoint’s results and make it more likely that ChargePoint fails to meet their estimates. If no or few analysts commence equity research coverage of ChargePoint, the trading price and volume of ChargePoint’s securities would likely be negatively impacted. If analysts do cover ChargePoint and one or more of them downgrade its securities, or if they issue other unfavorable commentary about ChargePoint or its industry or inaccurate research, the trading price of ChargePoint’s Common Stock, Warrants and other securities would likely decline. Furthermore, if one or more of these analysts cease coverage or fail to regularly publish reports on ChargePoint, it could lose visibility in the financial markets. Any of the foregoing would likely cause the trading price and volume of ChargePoint’s Common Stock, Warrants and other securities to decline.
Anti-takeover provisions contained in ChargePoint’s governing documents and applicable laws could impair a takeover attempt.
ChargePoint’s Second A&R Charter and Second A&R Bylaws afford certain rights and powers to the Board that could contribute to the delay or prevention of an acquisition that it deems undesirable. ChargePoint is also subject to Section 203 of the DGCL and other provisions of Delaware law that limit the ability of stockholders in certain situations to effect certain mergers. Any of the foregoing provisions and terms that has the effect of delaying or deterring a change in control could limit the opportunity for stockholders to receive a premium for their shares of their Common Stock, and could also affect the price that some investors are willing to pay for the Common Stock.
 
38

ChargePoint’s Second A&R Charter provides, subject to limited exceptions, that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for certain stockholder litigation matters, which could limit stockholders’ ability to obtain a more favorable judicial forum for disputes with us or its directors, officers, employees or stockholders.
The Second A&R Charter requires, to the fullest extent permitted by law, that derivative actions brought on behalf of ChargePoint, actions against current or former directors, officers, stockholders or, subject to certain exceptions, employees for breach of fiduciary duty and certain other actions may be brought in the Court of Chancery in the State of Delaware or, if that court lacks subject matter jurisdiction, another federal or state court situated in the State of Delaware. Any person or entity purchasing or otherwise acquiring or holding any interest in shares of capital stock of ChargePoint shall be deemed to have notice of and consented to the forum provisions in the certificate of incorporation. In addition, the Second A&R Charter and Second A&R Bylaws provide that, unless ChargePoint consents in writing to another forum, the federal district courts of the United States shall, to the fullest extent of the law, be the exclusive forum for the resolution of any complaint asserting a cause of action under the Securities Act or the Exchange Act.
In March 2020, the Delaware Supreme Court issued a decision in Salzburg et al. v. Sciabacucchi, which found that an exclusive forum provision providing for claims under the Securities Act to be brought in federal court is facially valid under Delaware law. It is unclear whether this decision will be appealed, or what the final outcome of this case will be. ChargePoint intends to enforce this provision, but it does not know whether courts in other jurisdictions will agree with this decision or enforce it.
This choice of forum provision may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with ChargePoint or any of its directors, officers, other employees or stockholders, which may discourage lawsuits with respect to such claims. Alternatively, if a court were to find the choice of forum provision contained in the certificate of incorporation to be inapplicable or unenforceable in an action, ChargePoint may incur additional costs associated with resolving such action in other jurisdictions, which could harm its business, operating results and financial condition.
Sales of a substantial number of shares of Common Stock by ChargePoint’s existing stockholders could cause the price of the Common Stock to decline.
Sales of a substantial number of shares of ChargePoint’s Common Stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of ChargePoint’s Common Stock.
For example, on July 12, 2021, ChargePoint filed a resale registration statement on Form
S-1
(No. 333-257855)
that relates to the offer and sale from time to time by the selling security holders named in that prospectus of up to 12,000,000 shares of ChargePoint’s Common Stock (the “Secondary Offering”). ChargePoint’s directors, executive officers and certain stockholders entered into
lock-up
agreements with the representatives of the several underwriters, in connection with the Secondary Offering, which expired on September 28, 2021.
As of July 9, 2021, 224,656,707 shares of ChargePoint’s Common Stock or 69.9% of all outstanding shares of its Common Stock were prohibited or otherwise restricted from being sold in the public market under securities laws or
lock-up
agreements entered into in connection with the Merger (which subsequently expired August 26, 2021) or Secondary Offering. Shares issued upon the exercise of stock options outstanding under ChargePoint’s equity incentive plans or pursuant to future awards granted under those plans will become available for sale in the public market to the extent permitted by the provisions of applicable vesting schedules, any applicable market standoff and
lock-up
agreements, a registration statement on Form
S-8
and Rule 144 and Rule 701 under the Securities Act.
 
39

Moreover, as of July 9, 2021, holders of 218,988,521 shares of Common Stock and 38,314,712 Public Warrants and Private Warrants have rights, subject to conditions, to require ChargePoint to file registration statements with the SEC covering such shares, Public Warrants and Private Warrants or the shares underlying the Public Warrants and Private Warrants or to include their shares in registration statements that ChargePoint may file. 246,020,583 shares of Common Stock and 6,521,568 Private Warrants are included on a resale registration statement filed with the SEC on March 2, 2021 and that was declared effective by the SEC. During the six months ended July 31, 2021, 10,226,081 Public Warrants and 4,347,712 Private Warrants were exercised and the remaining 244,481 Public Warrants outstanding on July 6, 2021 were redeemed for cash and none remain outstanding.
Warrants are exercisable for ChargePoint’s Common Stock, which would increase the number of shares eligible for future resale in the public market and result in dilution to ChargePoint’s stockholders.
As of July 31, 2021, the Private Warrants were exercisable for 2,173,856 shares of Common Stock at a weighted average exercise price of $11.50 per share and the Legacy ChargePoint Warrants were exercisable for 37,075,846 shares of Common Stock at a weighted-average exercise price of $7.00 per share. Any shares of ChargePoint’s Common Stock issued upon exercise of the Private Warrants and the Legacy ChargePoint Warrants will result in dilution to the then existing holders of Common Stock and increase the number of shares eligible for resale in the public market. Sales of substantial numbers of such shares in the public market could adversely affect the market price of ChargePoint’s Common Stock.
The Private Warrants are accounted for as a warrant liability and recorded at fair value with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of ChargePoint’s Common Stock.
Under U.S. GAAP, ChargePoint is required to evaluate the Private Warrants to determine whether they should be accounted for as a warrant liability or as equity. ChargePoint has concluded that the Private Warrants contain provisions requiring liability classification as of July 31, 2021. Therefore, ChargePoint is accounting for the Private Warrants as a warrant liability at fair value upon issuance. ChargePoint records any subsequent changes in fair value as of the end of each reporting period. The impact of changes in fair value on earnings may have an adverse effect on its results of operations based on factors that are outside of its control.
 
40

USE OF PROCEEDS
All of the shares of Common Stock offered by the selling securityholders pursuant to this prospectus will be sold by the selling securityholders for their account. We will not receive any of the proceeds from these sales. We will, however, bear certain costs associated with the sale of shares by the selling securityholders.
 
41

MARKET INFORMATION FOR SECURITIES AND DIVIDEND POLICY
Market Information
Our Common Stock is currently listed on the NYSE under the symbols “CHPT.” Prior to the consummation of the Merger, our Common Stock was listed on the NYSE under the symbol “SBE.” Prior to the closing of the Merger, there was no established public trading market for Legacy ChargePoint’s Common Stock. As of October 1, 2021, we had 324,904,565 shares of Common Stock issued and outstanding held of record by approximately 360 holders, and warrants to purchase an aggregate of 37,775,338 shares of Common Stock outstanding held of record by approximately 20 holders.
Dividends
We have not paid any cash dividends on the Common Stock to date. We expect to retain future earnings, if any, for future operations, expansion and debt repayment and have no current plans to pay cash dividends for the foreseeable future. Any decision to declare and pay dividends in the future will be made at the discretion of the Board and will depend on, among other things, our results of operations, financial condition, cash requirements, contractual restrictions and other factors that the Board may deem relevant. In addition, our ability to pay dividends may in the future be limited by covenants of our then existing outstanding indebtedness.
 
42

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
The following discussion and analysis provides information which ChargePoint’s management believes is relevant to an assessment and understanding of ChargePoint’s consolidated results of operations and financial condition. The discussion should be read together with the audited consolidated financial statements and related notes and the unaudited condensed consolidated financial statements and related notes that are included elsewhere in this prospectus. This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. ChargePoint’s actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under “Risk Factors” or in other parts of this prospectus.
Overview
ChargePoint designs, develops and markets networked EV charging system infrastructure and its Cloud Services enable consumers the ability to locate, reserve, authenticate and transact EV charging sessions. As part of ChargePoint’s networked charging systems, subscriptions and other offerings, it provides an open platform that integrates with system hardware from ChargePoint and other manufacturers, connecting systems over an intelligent network that provides real-time information about charging sessions and control, support and management of the networked charging systems. This network provides multiple
web-based
portals for charging system owners, fleet managers, drivers and utilities.
ChargePoint generates revenue primarily through the sale of networked charging systems, Cloud Services and Assure, which are typically paid for upfront. Assure also includes proactive monitoring, fast response times, parts and labor warranty, expert advice and robust reporting. The CPaaS program combines the customer’s use of ChargePoint’s owned and operated systems with Cloud Services, Assure and other benefits available to subscribers into one subscription. ChargePoint targets three key customer markets: commercial, fleet and residential. Commercial customers have parking places largely within their workplaces. Fleet includes municipal buses, delivery and work vehicles, port/airport/warehouse and other industrial applications, ridesharing services, and is expected to eventually include, autonomous transportation. Residential includes single family homes and multifamily residences.
Since ChargePoint’s inception in 2007, it has been engaged in developing and marketing its networked charging systems, subscriptions and other offerings, raising capital and recruiting personnel. ChargePoint has incurred net operating losses and negative cash flows from operations every year since its inception. As of July 31, 2021, ChargePoint had an accumulated deficit of $682.1 million. ChargePoint has funded its operations primarily from sales of its solutions, with proceeds from the issuance of redeemable convertible preferred stock and common stock and borrowings under its loan facilities.
Recent Developments
Acquisitions
On October 6, 2021, ChargePoint acquired all the outstanding shares of has•to•be gmbh (“has•to•be” or “HTB”) for approximately Euro 250.0 million in cash and Company common stock subject to adjustments. After the completion of its acquisition of has•to•be gmbh, ChargePoint Europe paid to the former stockholders of has•to•be gmbh an aggregate of 5,695,176 shares of ChargePoint’s common stock pursuant to the terms of the Share Purchase Agreement. has•to•be is an Austria-based e-mobility provider with a European charging software platform. The acquisition is intended to expand ChargePoint’s access to the European market. See “Selling Securityholders—ChargePoint’s Issuance of Shares to former stockholders of has•to•be gmbh” for more information.
On August 11, 2021, ChargePoint acquired all of the outstanding shares of ViriCiti B.V. (“ViriCiti”) for approximately Euro 75.0 million in cash, subject to adjustments. ViriCiti is a Netherlands-based provider of electrification solutions for eBus and commercial fleets with offices in the Netherlands and the United States.
 
43

The acquisition is expected to enhance ChargePoint’s fleet solutions portfolio of hardware, software and services by integrating information sources to optimize electric fleet operations.
Completion of Merger
On February 26, 2021 (“Closing Date”), Switchback Energy Acquisition Corporation (“Switchback”) consummated the previously announced transactions pursuant to which Lightning Merger Sub Inc., a wholly owned subsidiary of Switchback incorporated in the State of Delaware (“Merger Sub”), merged with ChargePoint, Inc., a Delaware corporation (“Legacy ChargePoint”); Legacy ChargePoint survived as a wholly-owned subsidiary of Switchback (“Merger,” and, collectively with the other transactions described in the Merger Agreement (as defined below), the “Reverse Recapitalization”). Further, as a result of the Merger, Switchback was renamed “ChargePoint Holdings, Inc.”.
Pursuant to the terms of the Merger Agreement, each stockholder of Legacy ChargePoint received 0.9966 shares of ChargePoint’s common stock, par value $0.0001 per share (“Common Stock”) and the contingent right to receive as additional merger consideration certain Earnout Shares (as defined below), for each share of Legacy ChargePoint common stock, par value $0.0001 per share, owned by such Legacy ChargePoint stockholder that was outstanding immediately prior to the Closing (other than any shares of Legacy ChargePoint restricted stock). In addition, certain investors purchased an aggregate of 22,500,000 shares of Common Stock (such investors, the “PIPE Investors”) concurrently with the Closing for an aggregate purchase price of $225,000,000.
In addition, pursuant to the terms of the Merger Agreement, at the effective time of the Merger (“Effective Time”), (1) warrants to purchase shares of capital stock of Legacy ChargePoint were converted into warrants to purchase an aggregate of 38,761,031 shares of Common Stock and the contingent right to receive certain Earnout Shares, (2) options to purchase shares of common stock of Legacy ChargePoint were converted into options to purchase an aggregate of 30,135,695 shares of Common Stock and, with respect to vested options, the contingent right to receive certain Earnout Shares and (3) unvested restricted shares of common stock of Legacy ChargePoint that were outstanding pursuant to the “early exercise” of Legacy ChargePoint options were converted into an aggregate of 345,689 restricted shares of ChargePoint (“Restricted Shares”).
During the time period between the Closing and the five-year anniversary of the Closing Date, eligible former equity holders could receive up to 27,000,000 additional shares of ChargePoint’s common stock (“Earnout Shares”) in the aggregate in three equal tranches if the volume-weighted average closing sale price of ChargePoint’s common stock is greater than or equal to $15.00, $20.00 and $30.00 for any 10 trading days within any 20 consecutive trading day period (“Trigger Events”). On March 19, 2021, a total of approximately 18,000,000 shares of Common Stock were released to eligible former equity holders of Legacy ChargePoint pursuant to the Earnout Shares provisions of the Merger Agreement, as the first two Trigger Events had been met. The Trigger Events were met by virtue of the volume-weighted average closing sale price of Common Stock having been greater than or equal to $15.00 and $20.00 for ten (10) trading days out of twenty (20) consecutive trading days following the closing of the Merger. The holders of Legacy ChargePoint common stock (other than restricted stock), warrants and vested options as of the closing of the Merger received their pro rata portion of the Earnout Shares. On July 1, 2021, a total of approximately 9,000,000 shares of Common Stock were released to eligible former equity holders of Legacy ChargePoint pursuant to the Earnout Shares provision of the Merger Agreement, as the third Trigger Event had been met. The Trigger Event was met by virtue of the volume-weighted average closing sale price of Common Stock having been greater than or equal to $30.00 for ten (10) trading days out of twenty (20) consecutive trading days following the closing of the Merger.
Key Factors Affecting Operating Results
ChargePoint believes its performance and future success depend on several factors that present significant opportunities for it but also pose risks and challenges, including those discussed below and in the section of this prospectus titled “Risk Factors.”
 
44

Growth in EV Adoption
ChargePoint’s revenue growth is directly tied to the number of passenger and commercial EVs sold, which it believes drives the demand for charging infrastructure. The market for EVs is still rapidly evolving and although demand for EVs has grown in recent years, there is no guarantee of such future demand. Factors impacting the adoption of EVs include but are not limited to: perceptions about EV features, quality, safety, performance and cost; perceptions about the limited range over which EVs may be driven on a single battery charge; volatility in the cost of oil and gasoline; availability of services for EVs; consumers’ perception about the convenience and cost of charging EVs; and increases in fuel efficiency. In addition, macroeconomic factors, including government mandates and incentives could impact demand for EVs, particularly since they can be more expensive than traditional gasoline-powered vehicles when the automotive industry globally has been experiencing a recent decline in sales. If the market for EVs does not develop as expected or if there is any slow-down or delay in overall EV adoption rates, this would impact ChargePoint’s ability to increase its revenue or grow its business.
Competition
ChargePoint is currently a market leader in North America in commercial Level 2 Alternating Current (“AC”) charging. ChargePoint also offers chargers for use at home or multifamily settings, and high-power Level 3 Direct Current (“DC”) chargers for fast urban charging, corridor or long-trip charging and fleet applications. ChargePoint intends to expand its market share over time in its product categories, leveraging the network effect of its products and Cloud Services software. Existing competitors may expand their product offerings and sales strategies, and new competitors may enter the market. Furthermore, ChargePoint’s competition includes other types of alternative fuel vehicles and high fuel-economy gasoline powered vehicles. If ChargePoint’s market share decreases due to increased competition, its financial condition and results of operations in the future may be impacted.
Europe Expansion
ChargePoint operates in North America and selected countries in Europe. Europe is expected to be a significant contributor to ChargePoint’s revenue in future years. ChargePoint is using a portion of the proceeds from the Merger to increase its sales and marketing activities in Europe. ChargePoint is also positioned to grow its European business through existing partnerships with car leasing companies and its recently closed acquisitions of ViriCiti and has•to•be. In Europe, ChargePoint primarily competes with smaller providers of EV charging station networks. Many of these competitors have limited funding, which could cause poor experiences and have a negative impact on overall EV adoption in Europe. ChargePoint’s growth in Europe requires differentiating itself as compared to these existing competitors. If ChargePoint is unable to continue penetrating the market in Europe, its financial condition and results of operations may be impacted.
Fleet Expansion
ChargePoint’s future growth is highly dependent upon fleet applications. Because fleet operators often make large purchases of EVs volatility may be more pronounced, and any significant decline from these customers reduces ChargePoint’s potential for future growth.
Impact of New Product Releases and Investments in Growth
As ChargePoint introduces new products, its gross margins may be initially impacted by launch costs and lower volumes until its supply chain achieves targeted cost reductions, such as the market introduction of its Level 3 DC fast charger in fiscal year 2020. In addition, ChargePoint may accelerate its operating expenditures where it sees growth opportunities which may impact gross margin until upfront costs and inefficiencies are absorbed and normalized operations are achieved. ChargePoint also continuously evaluates and may adjust its operating expenditures based on its launch plans for its new products, as well as other factors including the pace and prioritization of current projects under development and the addition of new projects. As ChargePoint attains
 
45

higher revenue, it expects operating expenses as a percentage of total revenue to decrease as it scales and focuses on increasing operational efficiency and process automation.
Government Mandates, Incentives and Programs
The U.S. federal government, certain foreign governments and some state and local governments provide incentives to end users and purchasers of EVs and EV infrastructure in the form of rebates, tax credits and other financial incentives. These governmental rebates, tax credits and other financial incentives significantly lower the effective price of EVs and EV infrastructure to customers. However, these incentives may expire on specified dates, end when the allocated funding is no longer available, or be reduced or terminated as a matter of regulatory or legislative policy. In particular, the credits under Section 30C of the Code which benefit investments in EV infrastructure may be reduced or become unavailable if not extended in future years. Any reduction in rebates, tax credits or other financial incentives could reduce the demand for EVs and for charging infrastructure, including infrastructure ChargePoint offers.
ChargePoint also derives other revenue from fees received for regulatory credits earned for participating in low carbon fuel programs in approved U.S. states. ChargePoint claims these regulatory credits only if they are not claimed by purchasers of its EV charging stations; only a small percentage of its customers currently elect to claim such credits. If a material percentage of its customers were to claim these regulatory credits, ChargePoint’s revenue from this source could decline significantly, which could have an adverse effect on its revenue and overall gross margin. Prior to fiscal year 2021, ChargePoint derived a slight majority of its other revenue from these regulatory credits. However, revenue from this source as a percentage of total revenue has declined in recent quarters and it may continue to decline over time. Further, the availability of such credits depends on continued governmental support for these programs. If these programs are modified, reduced or eliminated, ChargePoint’s ability to generate this revenue in the future would be adversely impacted.
Impact of
COVID-19
In March 2020, the World Health Organization (the “WHO”) characterized
COVID-19
as a pandemic. The impact of
COVID-19,
including changes in consumer and business behavior, pandemic fears and market downturns, and restrictions on business and individual activities, has created significant volatility in the global economy and led to reduced economic activity. The spread of
COVID-19
has disrupted ChargePoint’s supply chain and heightened its freight and logistic costs, and has similarly disrupted manufacturing, delivery and overall supply chain of vehicle manufacturers and suppliers, which has led to fluctuations in EV sales in markets around the world. These ongoing supply chain challenges and heightened logistic costs decreased gross margins in the three and six months ended July 31, 2021 and ChargePoint expects gross margins will continue to be adversely affected by increased component, freight and logistic expenses through the remainder of the fiscal year.
As a result of the
COVID-19
pandemic, ChargePoint initially modified its business practices (including reducing employee travel, recommending that all
non-essential
personnel work from home and canceling or reducing physical participation in sales activities, meetings, events and conferences), implemented additional safety protocols for essential workers, and implemented temporary cost cutting measures in order to reduce its operating costs. ChargePoint may take further actions as may be required by government authorities or that it determines are in the best interests of its employees, customers, suppliers, vendors and business partners.
While the ultimate duration and extent of the
COVID-19
pandemic depends on current and future developments that cannot be accurately predicted, such as the extent and effectiveness of containment actions and vaccinations, it has already had an adverse effect on the global economy, the ultimate societal and economic impact of the
COVID-19
pandemic remains unknown. The effect of the
COVID-19
pandemic can also vary over time and across the geographies in which ChargePoint operates. For example, variations in work-from-home policies can cause fluctuations in ChargePoint’s revenues, and ChargePoint believes that since people are not yet fully back to work it has not yet seen the full return of commercial customer demand for its products. The
 
46

conditions caused by the
COVID-19
pandemic, such as more permanent work-from-home policies, are likely to continue affecting the rate of global infrastructure spending, and thus to continue to adversely impact ChargePoint’s gross margins as ChargePoint’s commercial business contributes higher margins than its residential and fleet businesses. Further, the
COVID-19
pandemic could continue to heighten supply chain pricing and logistics expenses, and could, for example, adversely impact ChargePoint’s gross margins through heightened supply chain expenses, and could adversely affect demand for ChargePoint’s platforms, lengthen its sales cycles, reduce the value, renewal rate or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from new customers, cause some of its paying customers to go out of business and limit the ability of its direct sales force to travel to customers and potential customers, all of which could adversely affect its business, results of operations and financial condition.
Components of Results of Operations
Revenue
Networked Charging Systems
Networked charging systems revenue includes revenue related to the deliveries of EV charging system infrastructure, which include lower priced Level 1 home chargers typically sold to drivers, Level 2 AC chargers for commercial use and Level 3 DC fast charging systems for urban/corridor charging and for fleet operators. A majority of ChargePoint’s networked charging systems revenue is presently derived from the sale of Level 2 AC chargers. ChargePoint recognizes revenue from sales of networked charging systems upon shipment to the customer, which is when the performance obligation has been satisfied.
Subscriptions
Subscriptions revenue consists of services related to Cloud, as well as extended maintenance service plans under Assure. Subscriptions revenue also consists of CPaaS revenue which combines the customer’s use of ChargePoint’s owned and operated systems with Cloud and Assure programs into a single subscription. CPaaS subscriptions are considered to contain a lease for the customer’s use of ChargePoint’s owned and operated systems unless the location allows the customer to receive incremental economic benefit from regulatory credits earned on that EV charging system. Lessor revenue relates to operating leases and historically has not been material. Subscriptions revenue is recognized over time on a straight-line basis as ChargePoint has a stand-ready obligation to deliver such services to the customer.
Other
Other revenue consists of fees received for transferring regulatory credits earned for participating in low carbon fuel programs in approved states, charging related fees received from drivers using charging sites owned and operated by ChargePoint, net transaction fees earned for processing payments collected on driver charging sessions at charging sites owned by its customers, and other professional services. Revenue from regulatory credits is recognized at the point in time the regulatory credits are transferred. Revenue from fees for owned and operated sites is recognized over time on a straight-line basis over the performance period of the service contract as ChargePoint has a stand-ready obligation to deliver such services. Revenue from driver charging sessions and charging transaction fees is recognized at the point in time the charging session or transaction is completed. Revenue from professional services is recognized as the services are rendered.
For the remainder of fiscal year 2022, ChargePoint expects revenue to grow in both networked charging systems and subscriptions due to increased demand in EV and its related charging infrastructure market.
Cost of Revenue
Networked Charging Systems
ChargePoint uses contract manufacturers to manufacture the majority of its networked charging systems. ChargePoint conducts the remainder of its manufacturing
in-house.
ChargePoint’s cost of revenue for the sale of
 
47

networked charging systems includes the contract manufacturer costs of finished goods. For ChargePoint’s limited
in-house
production, cost of revenue for the sale of networked charging systems also includes parts, labor, manufacturing costs, and allocated facilities and information technology expenses. Cost of revenue for the sale of networked charging systems also consists of salaries and related personnel expenses, including stock-based compensation, warranty provisions, depreciation of manufacturing related equipment and facilities, amortization of capitalized
internal-use
software, and allocated facilities and information technology expenses. As revenue is recognized, ChargePoint accounts for estimated warranty cost as a charge to cost of revenue. The estimated warranty cost is based on historical and predicted product failure rates and repair expenses. Costs incurred for shipping and handling are recorded in cost of revenue.
Subscriptions
Cost of subscriptions revenue includes salaries and related personnel expenses, including stock-based compensation and third party support costs to manage the systems and helpdesk services for drivers and site hosts, network and wireless connectivity costs for subscription services, field maintenance costs for Assure to support ChargePoint’s network of systems, depreciation of owned and operated systems used in CPaaS arrangements, amortization of capitalized
internal-use
software development costs, allocated facilities and information technology expenses.
Other
Cost of other revenue includes depreciation and other costs for ChargePoint’s owned and operated charging sites, salaries and related personnel expenses, including stock-based compensation, as well as costs of environmental and professional services.
Gross Profit and Gross Margin
Gross profit is revenue less cost of revenue and gross margin is gross profit as a percentage of revenue. ChargePoint offers a range of networked charging systems products which vary widely in selling price and associated margin. Accordingly, ChargePoint’s gross profit and gross margin have varied and are expected to continue to vary from period to period due to revenue levels; geographic, vertical and product mix; new product introductions, and its efforts to optimize its operations and supply chain.
In the long term, improvements in ChargePoint’s gross profit and gross margin will depend on its ability to increase its revenue and continue to optimize its operations and supply chain. However, at least in the short term, as ChargePoint launches new Networked Charging Systems products, grows its presence in Europe where it has not yet achieved economies of scale, and expands its solutions for its fleet customers, it expects gross margin to experience variability from period to period. In addition, ChargePoint expects gross margins will continue to be adversely affected by increased freight and logistic expense as a result of ongoing supply chain disruptions caused by
COVID-19
and related measures.
Research and Development Expenses
Research and development expenses consist primarily of salaries and related personnel expenses, including stock-based compensation, for personnel related to the development of improvements and expanded features for ChargePoint’s services, as well as quality assurance, testing, product management, amortization of capitalized
internal-use
software, and allocated facilities and information technology expenses. Research and development costs are expensed as incurred.
ChargePoint expects its research and development expenses to increase on an absolute basis and they may increase as a percentage of total revenue for the foreseeable future as ChargePoint continues to invest in research and development activities to achieve its technology and product roadmap.
 
48

Sales and Marketing Expenses
Sales and marketing expenses consist primarily of salaries and related personnel expenses, including stock-based compensation, sales commissions, professional services fees, travel, marketing and promotional expenses amortization of capitalized
internal-use
software and allocated facilities and information technology expenses.
ChargePoint expects its sales and marketing expenses to increase on an absolute basis and they may increase as a percentage of total revenue for the foreseeable future while it continues to add sales and marketing personnel, expand its sales channels and expand in Europe.
General and Administrative Expenses
General and administrative expenses consist primarily of salaries and related personnel expenses, including stock-based compensation, related to finance, legal and human resource functions, contractor and professional services fees, audit and compliance expenses, insurance costs, bad debt expenses, amortization of capitalized
internal-use
software and general corporate expenses, including allocated facilities and information technology expenses.
ChargePoint expects its general and administrative expenses to increase in absolute dollars as it continues to grow its business. ChargePoint also expects to incur additional expenses as a result of operating as a public company, including expenses necessary to comply with the rules and regulations applicable to companies listed on a national securities exchange and related to compliance and reporting obligations pursuant to the rules and regulations of the SEC, as well as higher expenses for director and officer insurance, investor relations and legal, accounting and other professional services.
Interest Income
Interest income consists primarily of interest earned on ChargePoint’s cash, cash equivalents and short-term investments.
Interest Expense
Interest expense consists primarily of the interest on ChargePoint’s term loan which was paid off in March 2021.
Change in Fair Value of Redeemable Convertible Preferred Stock Warrant Liability
Redeemable convertible preferred stock warrant liability is subject to remeasurement to fair value at each balance sheet date. Changes in fair value of redeemable convertible preferred stock warrant liability are recognized in the condensed consolidated statements of operations. ChargePoint adjusts the liability for changes in fair value until the earlier of the exercise or expiration of the warrants and conversion of redeemable convertible preferred stock into Common Stock.
Change in Fair Value of Common Stock Warrant Liabilities
Common stock warrant liabilities consist of publicly-traded warrants (“Public Warrants”) and private placement warrants issued to NGP Switchback, LLC (“Private Warrants”) which ChargePoint assumed in connection with the Merger and are subject to remeasurement to fair value at each balance sheet date. ChargePoint expects to incur an incremental income (expense) in the condensed consolidated statements of operations for the fair value adjustments for the outstanding common stock warrant liabilities at the end of each reporting period or through the exercise of such warrants.
 
49

Change in Fair Value of Contingent Earnout Liability
Contingent earnout liability was accounted for as a liability as of the date of the Merger and remeasured to fair value until the Earnout Triggering Event was met for the first two tranches in March 2021 and the Earnout Shares issued. In March 2021, the remaining earnout liability for the third tranche converted to be accounted for as equity. The Earnout Triggering Event was met for the third and final tranche in June 2021 and in July 2021 the Earnout Shares were issued. As of July 31, 2021, there are no remaining Earnout Shares.
Transaction Costs Expensed
Transaction costs consist of legal, accounting, banking fees and other costs that were directly related to the consummation of the Merger. Transaction costs related to the issuance of shares were recognized in stockholders’ equity (deficit) while costs associated with the warrant liabilities and
non-capitalized
amounts were expensed in the condensed consolidated statements of operations upon the completion of the Merger on February 26, 2021.
Other Income (Expense), Net
Other income (expense), net consists primarily of foreign currency transaction gains and losses.
Provision for Income Taxes
ChargePoint’s provision for income taxes consists of an estimate of federal, state and foreign income taxes based on enacted federal, state and foreign tax rates, as adjusted for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities and changes in tax law. Due to the level of historical losses, ChargePoint maintains a valuation allowance against U.S. federal and state deferred tax assets as it has concluded it is more likely than not that these deferred tax assets will not be realized.
 
50

Results of Operations
Comparison of the Six Months Ended July 31, 2021 to the Six Months Ended July 31, 2020
The following table summarizes ChargePoint’s results of operations for the periods indicated:
 
    
Six Months Ended
July 31,
   
Period-over-Period
Change Six Months Ended
July 31, 2021 to 2020
 
    
2021
   
2020
 
    
(in thousands, except
percentages)
   
Change
($)
    
Change
(%)
 
Revenue
         
Networked charging systems
   $ 67,674     $ 41,025     $ 26,649        65.0
Subscriptions
     22,906       18,815       4,091        21.7
Other
     6,051       7,893       (1,842      (23.3 )% 
  
 
 
   
 
 
   
 
 
    
Total revenue
     96,631       67,733       21,164        60
Cost of revenue
         
Networked charging systems
     59,126       39,024       20,102        51.5
Subscriptions
     13,470       9,225       4,245        46.0
Other
     4,041       2,692       1,349        50.1
  
 
 
   
 
 
   
 
 
    
Total cost of revenue
     76,637       50,941       19,415        75
  
 
 
   
 
 
   
 
 
    
Gross profit
  
 
19,994
 
 
 
16,792
 
 
 
1,749
 
  
 
19
  
 
 
   
 
 
   
 
 
    
Gross margin
     20.7     24.8     
Operating expenses
         
Research and development
     65,784       35,152       30,632        87.1
Sales and marketing
     37,897       25,167       12,730        50.6
General and administrative
     37,199       9,555       27,644        289.3
  
 
 
   
 
 
   
 
 
    
Total operating expenses
     140,880       69,874       52,507        161
  
 
 
   
 
 
   
 
 
    
Loss from operations
  
 
(120,886
 
 
(53,082
 
 
(50,758
  
 
216
Interest income
     47       280       (233      (83.2 )% 
Interest expense
     (1,499     (1,628     129        (7.9 )% 
Change in fair value of redeemable convertible preferred stock warrant liability
     9,237       (10,981     20,218        (184.1 )% 
Change in fair value of common stock warrant liabilities
     33,340       —         33,340        *  
Change in fair value of contingent earnout liability
     84,420       —         84,420        *  
Transaction costs expensed
     (7,031     —         (7,031      *  
Other income (expense), net
     (174     131       (305      (232.8 %) 
  
 
 
   
 
 
   
 
 
    
Net income (loss) before income taxes
     (2,546     (65,280     (49,634      *  
Provision for income taxes
     103       105       2        (1.9 )% 
Net income (loss)
   $ (2,649   $ (65,835   $ (49,697      (141 )% 
  
 
 
   
 
 
   
 
 
    
 
*
Not Meaningful
Revenue
Networked Charging Systems
Networked Charging Systems revenue increased during the six months ended July 31, 2021, compared to the six months ended July 31, 2020, primarily due to higher demand from customers resulting in higher volumes of systems delivered across all of ChargePoint’s major product families.
 
51

Subscriptions
Subscriptions revenue increased during the six months ended July 31, 2021, compared to the six months ended July 31, 2020, primarily due to growth in the number of charging systems connected to ChargePoint’s network.
Other
Other revenue decreased during the six months ended July 31, 2021, compared to the six months ended July 31, 2020 mainly due to fewer regulatory credits transferred.
For the remainder of fiscal year 2022, ChargePoint expects revenue to grow in both networked charging systems and subscriptions due to increased demand in EV and its related charging infrastructure market.
Cost of Revenue
Networked Charging Systems
Cost of Networked Charging Systems revenue increased during the six months ended July 31, 2021, compared to the six months ended July 31, 2020, primarily due to an increase in the number of Networked Charging Systems delivered
Subscriptions
Cost of subscriptions revenue increased during the six months ended July 31, 2021, compared to the six months ended July 31, 2020, primarily resulting from an increase in stock-based compensation and ChargePoint expanding its network of charging systems.
Other
Other cost of revenue increased during the six months ended July 31, 2021, compared to the six months ended July 31, 2020, primarily related to higher depreciation on owned and operated charging sites.
Gross Profit and Gross Margin
Gross profit increased during the six months ended July 31, 2021, compared to the six months ended July 31, 2020, primarily due to an increase in Networked Charging Systems sales resulting from a larger number of charging systems delivered.
Gross margin decreased during the six months ended July 31, 2021, compared to the six months ended July 31, 2020, primarily due to an increase in stock-based compensation expense and a decrease in other revenue in the form of regulatory credits transferred.
Research and Development Expenses
Research and development expenses increased during the six months ended July 31, 2021, compared to the six months ended July 31, 2020, primarily attributable to a $23.0 million increase in personnel costs related to a $13.6 million increase in stock-based compensation expense from RSU grants and a $9.4 million increase in salary and bonus expenses due to headcount growth.
Sales and Marketing Expenses
Sales and marketing expenses increased during the six months ended July 31, 2021, compared to the six months ended July 31, 2020, primarily attributable to a $10.1 million increase in personnel costs related to a $6.0 million increase in salary, bonus and commissions due to headcount growth as well as revenue growth and a $4.1 million increase in stock-based compensation expense resulting from RSU grants.
 
52

General and Administrative Expenses
General and administrative expenses increased during the six months ended July 31, 2021, compared to the six months ended July 31, 2020, primarily attributable to a $15.7 million increase in personnel costs related to a $13.9 million increase in stock-based compensation expense resulting from RSU grants and stock option grants, a $1.8 million increase in salary expense due to headcount growth, a $5.2 million increase in consulting expenses as well as a $5.4 million increase in professional services fees related to acquisitions and the Secondary Offering.
Interest Income
Interest income decreased during the six months ended July 31, 2021 as compared to the six months ended July 31, 2020 due to lower returns on investments.
Interest Expense
Interest expense decreased during the six months ended July 31, 2021, compared to the six months ended July 31, 2020, primarily due to repayment of the term loan in March 2021. As of July 31, 2021, ChargePoint had no outstanding loans.
Change in Fair Value of Redeemable Convertible Preferred Stock Warrant Liability
The change in fair value of redeemable convertible preferred stock warrant liability during the six months ended July 31, 2021 compared to the six months ended July 31, 2020 was primarily due to changes in the fair value of Legacy ChargePoint’s redeemable convertible preferred stock through the date of the Merger. As of July 31, 2021, ChargePoint had no outstanding redeemable convertible preferred stock warrant liabilities.
Change in Fair Value of Common Stock Warrant Liabilities
ChargePoint recognized a $33.3 million gain during the six months ended July 31, 2021 due to the change in the fair value of common stock warrants during the respective period the warrants were outstanding.
Change in Fair Value of Contingent Earnout Liability
ChargePoint recognized a change in fair value of contingent earnout liability of $84.4 million for the six months ended July 31, 2021, due to the decrease in the fair value of ChargePoint’s common stock after consummation of the Merger.
Transaction Costs Expensed
During the six months ended July 31, 2021 ChargePoint expensed $7.0 million out of $36.5 million total transaction costs, that related to the warrant liabilities assumed as part of the Merger.
Other Income (Expense), Net
Other income (expense) decreased during the six months ended July 31, 2021 as compared to the six months ended July 31, 2020 due to unfavorable changes in foreign exchange rates.
Provision for income taxes
The provision for income taxes did not significantly fluctuate during the six months ended July 31, 2021 as compared to the six months ended July 31, 2020.
 
53

Comparison of the Fiscal Year Ended January 31, 2021 to the Fiscal Year Ended January 31, 2020 and the Fiscal Year Ended January 31, 2020 to the Fiscal Year Ended January 31, 2019
The following table summarizes ChargePoint’s results of operations for the periods indicated:
 
   
Year Ended January 31,
   
Year-over-Year Change
 
 
2021
   
2020
   
2019
   
2021 to 2020
   
Change
(%)
   
2020 to 2019
   
Change
(%)
 
 
(in thousands, except percentages)
   
Change
($)
   
Change
($)
 
Revenue
             
Networked charging systems
  $ 91,893     $ 101,012     $ 61,338     $ (9,119     (9 )%    $ 39,674       65
Subscriptions
    40,563       28,930       22,504       11,633       40     6,426       29
Other
  $ 14,034     $ 14,573     $ 8,188     $ (539     (4 )%    $ 6,385       78
 
 
 
   
 
 
   
 
 
   
 
 
     
 
 
   
Total revenue
    146,490       144,515       92,030       1,975       1     52,485       57
Cost of revenue
             
Networked charging systems
    87,083       105,940       59,928       (18,857     (18 )%      46,012       77
Subscriptions
    20,385       16,244       10,441       4,141       25     5,803       56
Other
    6,073       4,289       2,157       1,784       42     2,132       99
 
 
 
   
 
 
   
 
 
   
 
 
     
 
 
   
Total cost of revenue
    113,541       126,473       72,526       (12,932     (10 )%      53,947       74
 
 
 
   
 
 
   
 
 
   
 
 
     
 
 
   
Gross profit
    32,949       18,042       19,504       14,907       83     (1,462     (7 )% 
 
 
 
   
 
 
   
 
 
   
 
 
     
 
 
   
Gross margin
    22     12     21        
Operating expenses
             
Research and development
    75,017       69,464       50,510       5,553       8     18,954       38
Sales and marketing
    53,002       56,997       56,411       (3,995     (7 )%      586       1
General and administrative
    25,922       23,945       17,870       1,977       8     6,075       34
 
 
 
   
 
 
   
 
 
   
 
 
     
 
 
   
Total operating expenses
    153,941       150,406       124,791       3,535       2     25,615       21
 
 
 
   
 
 
   
 
 
   
 
 
     
 
 
   
Loss from operations
    (120,992     (132,364     (105,287     11,372       (9 )%      (27,077     26
Interest income
    315       3,245       1,402       (2,930     (90 )%      1,843       *  
Interest expense
    (3,253     (3,544     (3,690     291       *       146       (4 )% 
Change in fair value of redeemable convertible preferred stock warrant liability
    (73,125     (875     (388     (72,250     8,257     (487     *  
Other income (expense), net
    229       (565     (5     794       *       (560     *  
 
 
 
   
 
 
   
 
 
   
 
 
     
 
 
   
Net loss before income taxes
    (196,826     (134,103     (107,968     (62,723     47     (26,135     24
Provision for income taxes
    198       224       119       (26     *       105       *  
 
 
 
   
 
 
   
 
 
   
 
 
     
 
 
   
Net loss
 
$
(197,024
 
$
(134,327
 
$
(108,087
 
$
(62,697
 
 
47
 
$
(26,240
 
 
24
 
 
 
   
 
 
   
 
 
   
 
 
     
 
 
   
 
*
Not Meaningful
Revenue
Revenue increased by $2.0 million or 1% from $144.5 million during the fiscal year ended January 31, 2020 to $146.5 million during the fiscal year ended January 31, 2021, primarily due to a $11.6 million increase in subscriptions revenue due to growth in the number of charging systems connected to ChargePoint’s network, while other revenue remained relatively unchanged. This increase was partially offset by a $9.1 million decrease
 
54

in networked charging systems revenue. This decrease was attributable to a shift in product mix primarily due to the effects of the
COVID-19
pandemic on ChargePoint’s business as fewer Level 2 AC and Level 3 DC chargers were sold while more Level 1 chargers were sold which have lower average selling prices. While product mix shifted, overall sales volume remained consistent between the fiscal years ended January 31, 2021 and 2020.
Revenue increased by $52.5 million or 57% from $92.0 million during the fiscal year ended January 31, 2019 to $144.5 million during the fiscal year ended January 31, 2020, primarily due to a $39.7 million increase in networked charging systems revenue. This increase was primarily attributable to higher volumes of systems delivered across both ChargePoint’s Level 2 AC and Level 3 DC chargers as well as an increase in its overall average selling prices due to increased volumes of its higher priced DC chargers. ChargePoint’s subscriptions revenue increased by $6.4 million primarily due to growth in the number of charging systems connected to its network while pricing remained relatively consistent. Other revenue increased by $6.4 million primarily due to increased number of regulatory credits transferred.
Cost of Revenue
Cost of revenue decreased by $12.9 million or 10% from $126.5 million during the fiscal year ended January 31, 2020 to $113.5 million during the fiscal year ended January 31, 2021, primarily due to a decrease of $18.9 million in networked charging systems cost of revenue resulting from cost optimization initiatives related to the Level 3 DC charger and from a shift in product mix primarily due to the effects of the
COVID-19
pandemic as more Level 1 chargers were sold at lower average cost while fewer Level 2 AC and Level 3 DC chargers were sold. This decrease was partially offset by a $4.1 million increase in subscriptions cost of revenue as ChargePoint expanded its network and support capabilities, and a $1.8 million increase in other cost of revenue primarily related to higher depreciation on owned and operated charging sites.
Cost of revenue increased by $53.9 million or 74% from $72.5 million during the fiscal year ended January 31, 2019 to $126.5 million during the fiscal year ended January 31, 2020, primarily due to an increase of $46.0 million in networked charging systems cost of revenue resulting from growth in the number of systems delivered and the launch costs associated with the market introduction of its Level 3 DC charging systems, a $5.8 million increase in subscriptions cost of revenue as it expanded its network and support capabilities, and a $2.1 million increase in other cost of revenue primarily due to higher depreciation on owned and operated charging sites.
Gross Profit and Gross Margin
Gross profit increased by $14.9 million, or 83% from $18.0 million during the fiscal year ended January 31, 2020 to $32.9 million during the fiscal year ended January 31, 2021. Gross margin increased to 22% during the fiscal year ended January 31, 2021 compared to 12% during the fiscal year ended January 31, 2020. The increase was primarily due to cost optimization initiatives related to the Level 3 DC charger and an increase in subscriptions revenue due to growth in the number of charging systems connected to ChargePoint’s network, which have higher margin compared to other product offerings.
Gross profit decreased by $1.5 million, or 7% from $19.5 million during the fiscal year ended January 31, 2019 to $18.0 million during the fiscal year ended January 31, 2020. Gross margin decreased to 12% during the fiscal year ended January 31, 2020 compared to 21% during the fiscal year ended January 31, 2019. The decreases were primarily due to the launch costs associated with the continued market introduction of ChargePoint’s new Level 3 DC charger, which have lower margins compared to other products.
Research and Development Expenses
Research and development expenses increased by $5.6 million or 8% from $69.5 million during the fiscal year ended January 31, 2020 to $75.0 million during the fiscal year ended January 31, 2021. The increase was
 
55

primarily attributable to a $2.3 million increase in engineering personnel costs from due to headcount growth as well as a $3.8 million increase in allocated facilities and information technology expenses, partially offset by a $1.2 million decrease in travel costs in response to the
COVID-19
pandemic.
Research and development expenses increased by $19.0 million or 38% from $50.5 million during the fiscal year ended January 31, 2019 to $69.5 million during the fiscal year ended January 31, 2020, primarily due to a $14.4 million increase in engineering personnel costs from due to headcount growth as ChargePoint expanded its product portfolio and the features of its Cloud Services software and a $4.3 million increase in allocated facilities and information technology expenses.
Sales and Marketing Expenses
Sales and marketing expenses decreased by $4.0 million or 7% from $57.0 million during the fiscal year ended January 31, 2020 to $53.0 million during the fiscal year ended January 31, 2021, primarily attributable to reduced personnel costs and travel expenses in response to the
COVID-19
pandemic.
Sales and marketing expenses increased by $0.6 million or 1% from $56.4 million during the fiscal year ended January 31, 2019 to $57.0 million during the fiscal year ended January 31, 2020, primarily due to an increase in personnel costs, including sales commissions, due to headcount growth, partially offset by a decrease in marketing and consulting expenses.
General and Administrative Expenses
General and administrative expenses increased by $2.0 million or 8% from $23.9 million during the fiscal year ended January 31, 2020 to $25.9 million during the fiscal year ended January 31, 2021. The increase was primarily attributable to a $3.7 million increase in audit, legal and advisory fees in connection with the Merger, and an increase in personnel costs partially offset by a $3.0 million legal provision incurred in the fiscal year ended January 31, 2020 which did not recur in the fiscal year ended January 31, 2021.
General and administrative expenses increased by $6.1 million or 34% from $17.9 million during the fiscal year ended January 31, 2019 to $23.9 million during the fiscal year ended January 31, 2020, primarily due to a $3.9 million increase in personnel costs due to headcount growth as ChargePoint expanded its corporate functions, and a $3.0 million increase in reserves for legal matters.
Interest Income
Interest income decreased by $2.9 million or 90% from $3.2 million during the fiscal year ended January 31, 2020 to $0.3 million during the fiscal year ended January 31, 2021. The decrease in interest income was attributable to a decline in market interest rates and a decline in the balance of short-term investments during the fiscal year ended January 31, 2021.
Interest income increased by $1.8 million from $1.4 million during the fiscal year ended January 31, 2019 to $3.2 million during the fiscal year ended January 31, 2020. The increase was primarily due to increased balances and market interest rates on ChargePoint’s interest-bearing investments.
Interest Expense
Interest expense did not significantly change during the fiscal year ended January 31, 2021 as compared to the fiscal year ended January 31, 2020, or during the fiscal year ended January 31, 2020 as compared to the fiscal year ended January 31, 2019.
 
56

Change in Fair Value of Redeemable Convertible Preferred Stock Warrant Liability
Change in fair value of redeemable convertible preferred stock warrant liability changed from $0.9 million during the fiscal year ended January 31, 2020 to $73.1 million during the fiscal year ended January 31, 2021 due to the increase in the fair value of ChargePoint’s Common Stock and redeemable convertible preferred stock after ChargePoint announced the Merger.
Change in fair value of redeemable convertible preferred stock warrant liability changed from $0.4 million during the fiscal year ended January 31, 2019 to $0.9 million during the fiscal year ended January 31, 2020, due to increased fair value of the redeemable convertible preferred stock warrant liability.
Other Income (Expense), Net
Other income (expense), net changed from $(0.6) million during the fiscal year ended January 31, 2020 to $0.2 million during the fiscal year ended January 31, 2021, and from $(5) thousand during the fiscal year ended January 31, 2019 to $(0.6) million during the fiscal year ended January 31, 2020, primarily due to the effects of foreign currency transactions.
Provision for income taxes
The provision for income taxes did not significantly fluctuate during the fiscal year ended January 31, 2021 as compared to the fiscal year ended January 31, 2020, or during the fiscal year ended January 31, 2020 as compared to the fiscal year ended January 31, 2019.
Liquidity and Capital Resources
Sources of Liquidity
ChargePoint has incurred net losses and negative cash flows from operations since its inception which it anticipates will continue for the foreseeable future. To date, ChargePoint has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock, proceeds from warrant and option exercises for cash, borrowings under its loan facilities, customer payments and proceeds from the Merger. As of July 31, 2021, ChargePoint had cash, cash equivalents and restricted cash of $618.5 million. ChargePoint believes that its cash on hand, together with cash generated from sales to customers will satisfy its working capital and capital requirements for at least the next twelve months.
From inception to July 31, 2021, ChargePoint has raised aggregate net cash proceeds of $615.7 million from the sale of shares of redeemable convertible preferred stock and $477.5 million from the Merger and the concurrent purchase by certain investors of shares of Common Stock pursuant to separate subscription agreements (the “PIPE financing”). During the six months ended July 31, 2021, ChargePoint received $117.6 million in proceeds from the Public Warrants.
In March 2021, ChargePoint repaid the entire loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million.
Long-Term Liquidity Requirements
Until ChargePoint can generate sufficient revenue to cover its cost of sales, operating expenses, working capital and capital expenditures, it expects to primarily fund cash needs through a combination of equity and debt financing. If ChargePoint raises funds by issuing equity securities, dilution to existing stockholders may result. Any equity securities issued may also provide for rights, preferences or privileges senior to those of holders of Common Stock. If ChargePoint raises funds by issuing debt securities, these debt securities would have rights, preferences and privileges senior to those of holders of Common Stock. The terms of debt securities or
 
57

borrowings could impose significant restrictions on ChargePoint’s operations. The capital markets have in the past, and may in the future, experience periods of upheaval that could impact the availability and cost of equity and debt financing.
ChargePoint’s principal use of cash in recent periods has been funding its operations and investing in capital expenditures. ChargePoint’s future capital requirements will depend on many factors, including its revenue growth rate, the timing and the amount of cash received from customers, the expansion of sales and marketing activities, the timing and extent of spending to support development efforts, expenses associated with its international expansion, the introduction of network enhancements and the continuing market adoption of its network. ChargePoint has and may in the future enter into arrangements to acquire or invest in complementary businesses, products and technologies. ChargePoint may be required to seek additional equity or debt financing. In the event that ChargePoint requires additional financing, it may not be able to raise such financing on acceptable terms or at all. If ChargePoint is unable to raise additional capital or generate cash flows necessary to expand its operations and invest in continued innovation, it may not be able to compete successfully, which would harm its business, results of operations and financial condition. If adequate funds are not available, ChargePoint may need to reconsider its expansion plans or limit its research and development activities, which could have a material adverse impact on its business prospects and results of operations.
Cash Flows
For the Six Months Ended July 31, 2021 and 2020
The following table sets forth a summary of ChargePoint’s cash flows for the periods indicated:
 
    
Six Months Ended July 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Net cash (used in) provided by:
     
Operating activities
   $ (61,198    $ (50,069
Investing activities
     (7,788      41,052  
Financing activities
     541,590        125,365  
Effects of exchange rates on cash, cash equivalents, and restricted cash
     (6      36  
  
 
 
    
 
 
 
Net increase (decrease) in cash, cash equivalents, and restricted cash
   $ 472,598      $ 116,384  
  
 
 
    
 
 
 
Net Cash Used in Operating Activities
During the six months ended July 31, 2021, net cash used in operating activities was $61.2 million, consisting primarily of a net loss of $2.6 million and
non-cash
charges of $74.5 million, partially offset by a decrease in net operating assets of $15.9 million. The decrease in net operating assets was primarily due to a $3.0 million increase in accrued and other liabilities, a $9.3 million increase in accounts payable, a $5.6 million decrease in inventories and a $15.9 million increase in deferred revenue, partially offset by a $9.3 million increase in prepaid expenses and other assets, a $7.7 million increase in accounts receivable and a $1.0 million decrease in operating lease liabilities. The
non-cash
charges primarily consisted of $84.4 million change in fair value of contingent earnout liability, $33.3 million change in fair value of common stock warrant liability and $9.2 million change in fair value of redeemable convertible preferred stock warrant liability, partially offset by $35.9 million of stock-based compensation expense, $7.0 million of transaction costs expensed, $5.6 million of depreciation and amortization expense, and $2.0 million of
non-cash
operating lease cost.
During the six months ended July 31, 2020, net cash used in operating activities was $50.1 million, consisting primarily of a net loss of $65.4 million and an increase in net operating assets of $5.4 million, partially
 
58

offset by
non-cash
charges of $20.7 million. The increase in net operating assets was primarily attributable to a $9.3 million decrease in accounts payable, a $7.4 million increase in inventories, a $2.0 million decrease in operating lease liabilities, a $4.1 million decrease in accrued and other liabilities and a $3.3 million increase in prepaid expenses and other assets, partially offset by a $16.2 million decrease in accounts receivable and $4.6 million increase in deferred revenue. The
non-cash
charges primarily consisted of $4.7 million of depreciation and amortization expense, $2.1 million of stock-based compensation expense and $1.7 million of
non-cash
operating lease cost and $11.0 million change in fair value of common stock warrant liability.
Net Cash (Used In) Provided By Investing Activities
During the six months ended July 31, 2021, net cash used in investing activities was $7.8 million for purchases of property and equipment.
During the six months ended July 31, 2020, net cash provided by investing activities was $41.1 million, consisting of maturities of investments of $47.0 million, partially offset by purchases of property and equipment of $6.0 million.
Net Cash Provided by Financing Activities
During the six months ended July 31, 2021, net cash provided by financing activities was $541.6 million, consisting of net proceeds from the Merger and PIPE financing of $511.6 million, proceeds from the exercise of warrants of $117.6 million and proceeds from exercises of vested and unvested stock options of $1.8 million, partially offset by payment of transaction costs related to the Merger of $32.5 million, issuance of earnout shares, payment of tax withholding obligations on settlement of earnout shares of $20.9 million and repayment of borrowings of $36.1 million.
During the six months ended July 31, 2020, net cash provided by financing activities was $125.4 million consisting of proceeds from issuance of redeemable convertible preferred stock of $92.4 million, proceeds from the exercise of public warrants of $31.4 million and proceeds from exercises of vested and unvested stock options of $1.5 million.
For the Fiscal Years Ended January 31, 2021, 2020, and 2019
The following table sets forth a summary of ChargePoint’s cash flows for the periods indicated:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Net cash (used in) provided by:
        
Operating activities
   $ (91,846    $ (87,936    $ (100,546
Investing activities
     35,530        (61,899      (16,297
Financing activities
     128,913        17,158        233,798  
Effects of exchange rates on cash, cash equivalents, and restricted cash
     141        132        (101
  
 
 
    
 
 
    
 
 
 
Net increase (decrease) in cash, cash equivalents and restricted cash
   $ 72,738      $ (132,545    $ 116,854  
  
 
 
    
 
 
    
 
 
 
Net Cash Used in Operating Activities
During the fiscal year ended January 31, 2021, net cash used in operating activities was $91.8 million, consisting primarily of a net loss of $197.0 million, partially offset by a decrease in net operating assets of
 
59

$10.2 million and
non-cash
charges of $95.0 million. The decrease in net operating assets was due to a $17.2 million increase in deferred revenue, a $11.6 million increase in accrued and other liabilities and a $3.3 million decrease in accounts receivable, net due to increased collections, largely offset by a $8.9 million increase in prepaid expenses and other assets, a $9.6 million increase in inventories, a $2.8 million decrease in operating lease liabilities and a $0.5 million decrease in accounts payable. The
non-cash
charges primarily consisted of a $73.1 million change in the fair value of redeemable convertible preferred stock warrant liability, $10.1 million of depreciation and amortization expense, $4.9 million of stock-based compensation expense and $3.8 million of
non-cash
operating lease cost.
During the fiscal year ended January 31, 2020, net cash used in operating activities was $87.9 million, consisting primarily of a net loss of $134.3 million, partially offset by a decrease in net operating assets of $29.1 million and
non-cash
charges of $17.3 million. The decrease in net operating assets was primarily attributable to a $27.6 million increase in deferred revenue from customer prepayments for subscriptions as ChargePoint’s business expanded and a $15.7 million increase in accounts payable, partially offset by a $8.7 million increase in accounts receivable, net, a $3.0 million increase in prepaid expenses and other assets, a $1.5 million increase in inventories and a $1.2 million decrease in operating lease liabilities. The
non-cash
charges primarily consisted of $7.7 million of depreciation and amortization expense, $3.1 million of
non-cash
operating lease costs, as well as $2.9 million of stock-based compensation expense.
During the fiscal year ended January 31, 2019, net cash used in operating activities was $100.5 million, consisting primarily of a net loss of $108.1 million and an increase in net operating assets of $1.6 million, partially offset by
non-cash
charges of $9.1 million. In net operating assets, a $2.7 million increase in accounts receivable, net, a $19.5 million increase in inventories, a $1.8 million increase in prepaid expenses and other assets and a $1.1 million decrease in accounts payable were primarily offset by a $10.8 million increase in accrued and other liabilities and a $12.7 million increase in deferred revenue as ChargePoint’s business expanded. The
non-cash
charges primarily consisted of $4.1 million of depreciation and amortization expense, $1.7 million of stock-based compensation expense and $1.1 million of inventory reserves.
Net Cash Provided By (Used In) Investing Activities
During the fiscal year ended January 31, 2021, net cash provided by investing activities was $35.5 million, consisting of maturities of investments of $47.0 million, partially offset by purchases of property and equipment of $11.5 million.
During the fiscal year ended January 31, 2020, net cash used in investing activities was $61.9 million, consisting of purchases and maturities of investments of $47.0 million and purchases of property and equipment of $14.9 million.
During the fiscal year ended January 31, 2019, net cash used in investing activities was $16.3 million, consisting of purchases of property and equipment of $14.8 million and cash paid for an acquisition, net of cash acquired of $1.5 million.
Net Cash Provided by Financing Activities
During the fiscal year ended January 31, 2021, net cash provided by financing activities was $128.9 million, consisting of net proceeds from the issuance of ChargePoint redeemable convertible preferred stock of $95.5 million, proceeds from the issuance of common stock warrants of $31.5 million and proceeds from exercises of vested and unvested stock options of $5.9 million, partially offset by $4.0 million of payment of deferred transaction costs.
During the fiscal year ended January 31, 2020, net cash provided by financing activities was $17.2 million, consisting of net proceeds from the issuance of ChargePoint redeemable convertible preferred stock of
 
60

$14.8 million, proceeds from the issuance of common stock warrants of $0.2 million and proceeds from exercises of vested and unvested stock options of $2.2 million.
During the fiscal year ended January 31, 2019, net cash provided by financing activities was $233.8 million, consisting of net proceeds from the issuance of redeemable convertible preferred stock of $215.2 million, proceeds from the issuance of common stock warrants of $1.5 million, net proceeds from issuance of debt of $34.0 million and proceeds from exercises of vested and unvested stock options of $1.4 million, partially offset by repayment of debt of $18.2 million.
Off-Balance
Sheet Arrangements
ChargePoint is not a party to any
off-balance
sheet arrangements.
Contractual Obligations and Commitments
The following table summarizes ChargePoint’s contractual obligations and commitments as of January 31, 2021:
 
    
Less
Than
1 Year
    
1-3 Years
    
3-5 Years
    
More
Than
5 Years
    
Total
 
    
(in thousands)
 
Net cash (used in) provided by:
              
Operating lease obligations
   $ 4,719      $ 9,457      $ 7,985      $ 13,855      $ 36,016  
Term Loan
     11,667        23,333        —          —          35,000  
Purchase commitments
     61,691        2,422        —          —          64,113  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
  
$
78,077
 
  
$
35,212
 
  
$
7,985
 
  
$
13,855
 
  
$
135,129
 
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
ChargePoint enters into purchase commitments that include purchase orders and agreements in the normal course of business with contract manufacturers, parts manufacturers, vendors for research and development services and outsourced services.
In March 2021, ChargePoint repaid the entire loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million. The purchase commitments as of April 30, 2021 were $100.5 million. ChargePoint’s contractual obligations have not otherwise changed significantly since January 31, 2021.
Critical Accounting Policies and Estimates
ChargePoint’s discussion and analysis of its financial condition and results of operations are based upon its consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these condensed consolidated financial statements requires ChargePoint to make estimates and assumptions that affect the reported amounts of assets, liabilities, net sales and expenses. ChargePoint evaluates its estimates and assumptions on an ongoing basis, and base its estimates on historical experience and on various other assumptions that ChargePoint believes to be reasonable under the circumstances, the results of which form the basis for the judgments ChargePoint makes about the carrying value of assets and liabilities that are not readily apparent from other sources. Because these estimates can vary depending on the situation, actual results may differ from these estimates. Making estimates and judgments about future events is inherently unpredictable and is subject to significant uncertainties, some of which are beyond ChargePoint’s control. Should any of these estimates and assumptions change or prove to have been incorrect, it could have a material impact on ChargePoint’s results of operations, financial position and statement of cash flows.
 
61

Other than the policies noted in Note 2, “Summary of Significant Accounting Policies,” in ChargePoint’s notes to condensed consolidated financial statements in this prospectus, there have been no material changes to its critical accounting policies and estimates as compared to those disclosed in its audited consolidated financial statements.
Revenue Recognition
On February 1, 2019, ChargePoint adopted ASU
No. 2014-09
Revenue from Contracts with Customers (Topic 606), as amended, using the modified retrospective method applied to contracts which were not completed as of that date. ChargePoint recognizes revenue using the five-step model in determining revenue recognition: (a) identification of the contract, or contracts, with a customer; (b) identification of the performance obligations in the contract; (c) determination of the transaction price; (d) allocation of the transaction price to the performance obligations in the contract; and (e) recognition of revenue when, or as, it satisfies a performance obligation.
ChargePoint enters into contracts with customers that regularly include promises to transfer multiple products and services, such as charging systems, software subscriptions, extended maintenance, and professional services. For arrangements with multiple products and services, ChargePoint evaluates whether the individual products and services qualify as distinct performance obligations. In ChargePoint’s assessment of whether products and services are a distinct performance obligation, it determines whether the customer can benefit from the product or service on its own or with other readily available resources and whether the service is separately identifiable from other products or services in the contract. This evaluation requires ChargePoint to assess the nature of each of its networked charging systems, subscriptions and other offerings and how they are provided in the context of the contract, including whether they are significantly integrated which may require judgment based on the facts and circumstances of the contract.
The transaction price for each contract is determined based on the amount ChargePoint expects to be entitled to receive in exchange for transferring the promised products or services to the customer. Collectability of revenue is reasonably assured based on historical evidence of collectability of fees ChargePoint charges its customers. The transaction price in the contract is allocated to each distinct performance obligation in an amount that represents the relative amount of consideration expected to be received in exchange for satisfying each performance obligation. Revenue is recognized when performance obligations are satisfied. Revenue is recorded based on the transaction price excluding amounts collected on behalf of third-parties such as sales taxes, which are collected on behalf of and remitted to governmental authorities, or driver fees, collected on behalf of customers who offer public charging for a fee.
When agreements involve multiple distinct performance obligations, ChargePoint accounts for individual performance obligations separately if they are distinct. ChargePoint applies significant judgment in identifying and accounting for each performance obligation, as a result of evaluating terms and conditions in contracts. The transaction price is allocated to the separate performance obligations on a relative standalone selling price (“SSP”) basis. ChargePoint determines SSP based on observable standalone selling price when it is available, as well as other factors, including the price charged to its customers, its discounting practices and its overall pricing objectives, while maximizing observable inputs. In situations where pricing is highly variable, or a product is never sold on a stand-alone basis, ChargePoint estimates the SSP using the residual approach.
Areas of Judgment and Estimates
Determining whether the networked charging systems, Cloud, Assure and professional services are considered distinct performance obligations that should be accounted for separately or as a single performance obligation requires significant judgment. In reaching its conclusion, ChargePoint assesses the nature of each individual service offering and how the services are provided in the context of the contract, including whether the services are significantly integrated which may require judgment based on the facts and circumstances of the contract.
 
62

Determining the relative SSP for contracts that contain multiple performance obligations requires significant judgment. ChargePoint determines SSP using observable pricing when available, which takes into consideration market conditions and customer specific factors while maximizing observable inputs. When observable pricing is not available, ChargePoint first allocates to the performance obligations with established SSPs and then applies the residual approach to allocate the remaining transaction price.
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost, on a
first-in,
first-out
basis. Inventory levels are analyzed periodically and written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value or are in excess of expected demand. ChargePoint analyzes current and future product demand relative to the remaining product life to identify potential excess inventories. These forecasts of future demand are based upon historical trends and analysis as adjusted for overall market conditions. Inventory write-downs are measured as the difference between the cost of the inventory and its net realizable value, and charged to inventory reserves, which is a component of cost of revenue. At the point of the loss recognition, a new, lower cost basis for those inventories is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
Stock-based Compensation
Determining the grant date fair value of options using the Black-Scholes option-pricing model requires management to make certain assumptions and judgments. These estimates involve inherent uncertainties, and, if different assumptions had been used, stock-based compensation expense could have been materially different from the amounts recorded. Stock-based compensation is measured at the grant date, based on the fair value of the award and is recognized as an expense, net of estimated forfeitures, on a straight-line basis over the requisite service period. ChargePoint estimates the forfeiture rate based on the historical experience at the date of grant and revises it, if necessary, in subsequent periods if actual forfeitures differ from those estimates. For performance-based stock options issued, the value of the award is measured at the grant date as the fair value of the award and is expensed over the requisite service period, using the accelerated attribution method, once the performance condition becomes probable of being achieved. These inputs are subjective and generally required significant analysis and judgment to develop.
The determination of the grant date fair value of stock option awards issued is affected by a number of variables, including the fair value of ChargePoint’s underlying Common Stock, its expected Common Stock price volatility over the term of the option award, the expected term of the award, risk-free interest rates, and the expected dividend yield of ChargePoint Common Stock.
The following table summarizes the weighted-average assumptions used in estimating the fair value of stock options granted during each of the periods presented:
 
    
Year Ended January 31,
  
2021
  
2020
  
2019
Expected volatility
   49.1% – 51.6%    40.3% – 40.9%    40.9% – 41.6%
Risk-free interest rate
   0.3% – 1.6%    1.4% – 2.4%    2.7% – 2.9%
Dividend rate
   0.0%    0.0%    0.0%
Expected term (in years)
   5.6 – 5.8    5.0 – 5.9    6.1 – 6.4
Expected Volatility.
The volatility rate was determined by using an average of historical volatilities of selected industry peers deemed to be comparable to the ChargePoint’s business corresponding to the expected term of the awards.
 
63

ChargePoint also grants stock-based awards to
non-employees.
Therefore, ChargePoint estimates the fair value of
non-employee
stock options using a Black-Scholes valuation model with appropriate assumptions.
Dividend Yield.
The expected dividend yield is zero as ChargePoint has never declared or paid cash dividends and have no current plans to do so in the foreseeable future.
Risk Free Interest Rate.
The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for
zero-coupon
U.S. Treasury notes with maturities corresponding to the expected term of the awards.
Expected Term.
The expected term represents the period that ChargePoint’s stock-based awards are expected to be outstanding and is based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior.
Common Stock Valuation
The fair value of ChargePoint Common Stock has historically been determined by the Board with the assistance of management.
In the absence of a public trading market for ChargePoint Common Stock, on each grant date, ChargePoint has developed an estimate of the fair value of ChargePoint Common Stock based on the information known on the date of grant, upon a review of any recent events and their potential impact on the estimated fair value per share of ChargePoint Common Stock, and in part on input from contemporaneous third party valuations.
ChargePoint’s valuations of ChargePoint Common Stock was determined in accordance with the guidelines outlined in the American Institute of Certified Public Accountants Practice Aid,
Valuation of Privately-Held-Company Equity Securities Issued as Compensation
.
The assumptions used to determine the estimated fair value of ChargePoint Common Stock are based on numerous objective and subjective factors, combined with management’s judgment, including:
 
   
contemporaneous third party valuations of its common stock;
 
   
external market conditions affecting the EV industry and trends within the industry;
 
   
the rights, preferences and privileges of ChargePoint redeemable convertible preferred stock relative to those of ChargePoint Common Stock;
 
   
the prices at which it sold shares of ChargePoint redeemable convertible preferred stock and ChargePoint Common Stock;
 
   
the prices paid in secondary transactions involving its capital stock and the facts and circumstances of each transaction to determine the extent to which they represented a fair value exchange, such as transaction volume, timing, whether the transactions occurred among willing and unrelated parties, and whether the transactions involved investors with access to its financial information;
 
   
its financial condition and operating results, including its levels of available capital resources;
 
   
the progress of its research and development efforts, its stage of development and business strategy;
 
   
the likelihood of achieving a liquidity event, such as an initial public offering or a sale of ChargePoint given prevailing market conditions;
 
   
the history and nature of its business, industry trends and competitive environment;
 
   
the lack of marketability of ChargePoint Common Stock;
 
   
equity market conditions affecting comparable public companies; and
 
   
general U.S. and global market conditions.
 
64

In determining the fair value of ChargePoint Common Stock, ChargePoint established the enterprise value of its business using the market approach and the income approach. ChargePoint also estimated the enterprise value by reference to the closest round of equity financing preceding the date of the valuation if such financing took place around the valuation date. Under the income approach, forecasted cash flows are discounted to the present value at a risk-adjusted discount rate. The valuation analyses determine discrete free cash flows over multiple years based on forecasted financial information provided by ChargePoint’s management and a terminal value for the residual period beyond the discrete forecast, which are discounted at its estimated weighted-average cost of capital to estimate its enterprise value. Under the market approach, a group of guideline publicly-traded companies with similar financial and operating characteristics to ChargePoint are selected, and valuation multiples based on the guideline public companies’ financial information and market data are calculated. Based on the observed valuation multiples, an appropriate multiple was selected to apply to ChargePoint’s historical and forecasted revenue results.
In allocating the equity value of ChargePoint’s business among the various classes of equity securities prior to July 2020, it used the option pricing model (“OPM”) method, which models each class of equity securities as a call option with a unique claim on its assets. The OPM treats ChargePoint Common Stock and redeemable convertible preferred stock as call options on an equity value with exercise prices based on the liquidation preference of its redeemable convertible preferred stock. The Common Stock is modeled as a call option with a claim on the equity value at an exercise price equal to the remaining value immediately after its redeemable convertible preferred stock is liquidated. The exclusive reliance on the OPM until July 2020 was appropriate when the range of possible future outcomes was difficult to predict and resulted in a highly speculative forecast.
Since July 2020, ChargePoint used a hybrid method utilizing a combination of the OPM and the probability weighted expected return method (“PWERM”). The PWERM is a scenario-based methodology that estimates the fair value of common stock based upon an analysis of future values for ChargePoint, assuming various outcomes. The common stock value is based on the probability-weighted present value of expected future investment returns considering each of the possible outcomes available as well as the rights of each class of shares. The future value of the Common Stock under each outcome is discounted back to the valuation date at an appropriate risk-adjusted discount rate and probability weighted to arrive at an indication of value for the Common Stock. ChargePoint considered three different scenarios: (a) a transaction with a special purpose acquisition company, (b) remaining a private company and (c) an acquisition by another company. Under the hybrid method, ChargePoint used the OPM, the
if-converted
method, and the liquidation method to allocate the equity value of its business among the various classes of stock. The
if-converted
method presumes that all shares of ChargePoint redeemable convertible preferred stock convert into ChargePoint Common Stock based upon their conversion terms and differences in the rights and preferences of the share of ChargePoint redeemable convertible preferred stock are ignored. The liquidation method presumes payment of proceeds in accordance with the liquidation terms of each class of stock.
After the allocation to the various classes of equity securities, a discount for lack of marketability (“DLOM”) was applied to arrive at a fair value of common stock. A DLOM was meant to account for the lack of marketability of a stock that was not publicly-traded. In making the final determination of Common Stock value, consideration was also given to recent sales of Common Stock.
Application of these approaches and methodologies involves the use of estimates, judgments and assumptions that are highly complex and subjective, such as those regarding ChargePoint’s expected future revenue, expenses and future cash flows, discount rates, market multiples, the selection of comparable public companies and the probability of and timing associated with possible future events. Changes in any or all of these estimates and assumptions or the relationships between those assumptions impact ChargePoint’s valuations as of each valuation date and may have a material impact on the valuation of ChargePoint Common Stock.
 
65

Redeemable Convertible Preferred Stock Warrant Liability
Warrants to purchase shares of Series B, D and E redeemable convertible preferred stock are classified as a liability as the underlying ChargePoint redeemable convertible preferred stock is considered redeemable and may require ChargePoint to transfer assets upon exercise. The Warrants are recorded at fair value upon issuance and are subject to remeasurement to fair value at each balance sheet date. Changes in the fair value of the ChargePoint redeemable convertible preferred stock warrant liability are recognized in ChargePoint’s consolidated statements of operations. ChargePoint will continue to adjust the liability for changes in fair value until the exercise or expiration of the warrants, conversion of ChargePoint redeemable convertible preferred stock into ChargePoint Common Stock or until the ChargePoint redeemable convertible preferred stock is otherwise no longer redeemable. At that time, the ChargePoint redeemable convertible preferred stock warrant liability will be reclassified to ChargePoint redeemable convertible preferred stock or additional
paid-in
capital, as applicable.
Income Taxes
ChargePoint utilizes the asset and liability method in accounting for income taxes. Deferred tax assets and liabilities reflect the estimated future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax asset and liability. Valuation allowances are established when necessary to reduce deferred tax assets where it is more likely than not that the deferred tax assets will not be realized. ChargePoint makes estimates, assumptions and judgments to determine its provision for its income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. ChargePoint assesses the likelihood that its deferred tax assets will be recovered from future taxable income, and to the extent it believes that recovery is not likely, it establishes a valuation allowance.
ChargePoint recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits which, as of the date of this prospectus, have not been material, are recognized within provision for income taxes.
Recent Accounting Pronouncements
For a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on ChargePoint’s condensed consolidated financial statements, see Note 2, “Summary of Significant Accounting Policies” of ChargePoint’s consolidated financial statements, included elsewhere in this prospectus.
Quantitative and Qualitative Disclosures About Market Risk
Interest Rate Risk
ChargePoint is exposed to market risk for changes in interest rates applicable to its short-term investments. ChargePoint had cash, cash equivalents and restricted cash totaling $618.5 million as of July 31, 2021. Cash equivalents and short-term investments were invested primarily in money market funds and U.S. treasury bills. ChargePoint’s investment policy is focused on the preservation of capital and supporting its liquidity needs. Under the policy, ChargePoint invests in highly rated securities, issued by the U.S. government or liquid money market funds. ChargePoint does not invest in financial instruments for trading or speculative purposes, nor does it use leveraged financial instruments. ChargePoint utilizes external investment managers who adhere to the
 
66

guidelines of its investment policy. A hypothetical 10% change in interest rates would not have a material impact on the value of ChargePoint’s cash, cash equivalents or short-term investments.
Foreign Currency Risk
ChargePoint has foreign currency risks related to its revenue and operating expenses denominated in currencies other than the U.S. dollar, primarily the euro, causing both its revenue and its operating results to be impacted by fluctuations in the exchange rates.
Gains or losses from the revaluation of certain cash balances, accounts receivable balances and intercompany balances that are denominated in these currencies impact ChargePoint’s net loss. A hypothetical decrease in all foreign currencies against the U.S. dollar of 10% would not result in a material foreign currency loss on foreign-denominated balances, as of July 31, 2021. As ChargePoint’s foreign operations expand, its results may be more materially impacted by fluctuations in the exchange rates of the currencies in which it does business.
At this time, ChargePoint does not enter into financial instruments to hedge its foreign currency exchange risk, but it may in the future.
Internal Control Over Financial Reporting
In connection with the preparation and audit of ChargePoint’s consolidated financial statements as of January 31, 2021 and 2020 and for the fiscal years ended January 31, 2021, 2020 and 2019, material weaknesses were identified in its internal control over financial reporting. See the subsection titled “Risk Factors—Financial, Tax and Accounting-Related Risks—ChargePoint has identified material weaknesses in its internal control over financial reporting.”
Emerging Growth Company Accounting Election
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can choose not to take advantage of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies, and any such election to not take advantage of the extended transition period is irrevocable. ChargePoint is an “emerging growth company” as defined in Section 2(A) of the Securities Act, as amended, and has elected to take advantage of the benefits of this extended transition period.
ChargePoint has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public business entities and
non-public
business entities until the earlier of the date it (a) is no longer an emerging growth company or (b) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. This may make it difficult or impossible to compare ChargePoint financial results with the financial results of another public company that is either not an emerging growth company or is an emerging growth company that has chosen not to take advantage of the extended transition period exemptions because of the potential differences in accounting standards used. See Note 2 of the accompanying audited consolidated financial statements and unaudited condensed consolidated financial statements of ChargePoint included elsewhere in this prospectus for the recent accounting pronouncements adopted and the recent accounting pronouncements not yet adopted for the fiscal years ended January 31, 2021, 2020 and 2019 and for the six months ended July 31, 2021.
In addition, ChargePoint intends to continue to rely on the other exemptions and reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an emerging growth company, ChargePoint intends to rely on such exemptions, it is not required to, among other
 
67

things: (a) provide an auditor’s attestation report on its system of internal control over financial reporting pursuant to Section 404(b) of Sarbanes-Oxley: (b) provide all of the compensation disclosure that may be required of
non-emerging
growth public companies under the Dodd-Frank Act; (c) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the consolidated financial statements (auditor discussion and analysis); and (d) disclose certain executive compensation-related items such as the correlation between executive compensation and performance and comparisons of the Chief Executive Officer’s compensation to median employee compensation.
ChargePoint will remain an emerging growth company under the JOBS Act until the earliest of (a) January 31, 2026, the last day of our fiscal year following the fifth anniversary of ChargePoint’s initial public offering, (b) the last date of its fiscal year in which it has a total annual gross revenue of at least $1.07 billion, (c) the date on which it is deemed to be a “large accelerated filer” under the rules of the SEC with at least $700.0 million of outstanding securities held by
non-affiliates
or (d) the date on which it has issued more than $1.0 billion in
non-convertible
debt securities during the previous three years.
 
68

BUSINESS
ChargePoint is a leading EV charging network provider committed to enabling the electrification of mobility for all people and goods. Years before EVs were widely available, ChargePoint envisioned a new way of fueling, conveniently located where drivers live, work and play. By pioneering networked EV charging, ChargePoint has helped make electrified mobility a reality with consumers and fleets rapidly adopting EVs. With 14 years of focused development, over 5,000 existing commercial customers and over $1.1 billion of capital raised from a diversified set of high-profile investors from automotive, energy, manufacturing and venture funding, ChargePoint is driving the shift to electric mobility by providing charging solutions in North America and Europe for all segments, including commercial (e.g., retail, workplace, parking, recreation, education and highway fast charge), fleet (e.g., delivery, logistics, motorpool, transit and shared mobility) and residential (e.g., homes, apartments and condos). As of July 31, 2021, approximately 118,000 ports have been installed and activated on our network of which over 3,500 ports use DC charging. We also provide access to over 200,000 ports through roaming integrations. In addition, we have been focusing on building a sustainable future. Since 2007, we estimate that we have powered approximately 3 billion electric miles driven, resulting in 120 million gallons of gasoline and 462,000 metric tons of greenhouse gas emissions avoided as of July 31, 2021. The avoided amount of greenhouse gas emissions equate to planting 11.7 million tree seedlings, capturing carbon from 869,000 acres of U.S. forests and recycling 30 million bags of waste, according to the United States Environmental Protection Agency’s Greenhouse Gas Equivalencies Calculator.
 
 

Major auto manufacturers have committed to electrification and large battery EVs are winning the day across vehicle categories. ChargePoint’s networked solutions can charge EV passenger cars or fleet vehicles regardless of manufacturer. ChargePoint believes it should benefit from the broader electrification trend without needing to identify which vehicle brands, traditional or more recent “born electric” entrants, will be successful. ChargePoint believes it will continue to grow proportionally to EV market growth due to the fact that for almost a decade ChargePoint charging port (electrified parking space) growth in North America has correlated closely with new passenger EV sales in North America (as illustrated below). Passenger EV sales are expected to increase from 2.7% of new vehicles sold in 2019 to 43.1% in 2030 in the United States and Europe according to the BNEF Report. Additional factors propelling this shift to electrification include proposed fossil fuel bans or restrictions, transit electrification mandates and utility incentive programs. Accordingly, the BNEF Report
 
69

projects that the cumulative EV charging infrastructure investment in North America and Europe is expected to be approximately $121 billion by 2030 and increase to approximately $307 billion by 2040.
ChargePoint Growth Directly Proportional to EV Penetration
 
 
Source: Historical EV sales from InsideEVs, Baum and BNEF. Future EV sales projections from BNEF. Note: ChargePoint FY runs 2/1 – 1/31. Passenger EV sales reflect CY for simplicity
The ChargePoint Model for EV Fueling
Because vehicles spend most of their time parked and electricity is pervasively and safely distributed, fueling can shift to a model where vehicles charge while their drivers are doing something else and the locations where the vehicle is parked will offer fueling with charging speeds matched to the natural parking duration of vehicles at the site. With the exception of occasional drives beyond a vehicle’s battery range, EV charging is primarily a
top-up
model and fueling is transitioning from being a chore commonly performed by having to make a dedicated stop to being conveniently located where drivers live, work and play. For example, EV drivers might
top-up
with Level 2 AC charging while parked at a shopping center for a few hours, but choose Level 3 DC charging for occasional road trips. ChargePoint offers a platform of products, cloud software subscriptions, support, warranty coverage and professional services enabling
turn-key
development of charging at any location.
ChargePoint’s founders understood that the widespread adoption of electric mobility required a more sustainable, efficient and convenient fueling infrastructure. Fueling with electricity is expected to be less expensive, more sustainable and more convenient than traditional liquid fueling. Further, EV charging does not present all of the same environmental risks of liquid fueling, as it does not involve the storage and potential release of hydrocarbons at the fueling site. ChargePoint believes the development and expanding capacity of renewable energy sources, including wind and solar, can play an increasing and complementary role in electric mobility as the world becomes more electrified and continues to shift to clean energy.
ChargePoint is tackling this growing addressable market one parking lot at a time with a business model it believes is unique in the industry in that it (a) encourages businesses and fleets to directly invest in charging infrastructure, therefore crowdsourcing the buildout of charging infrastructure, (b) is designed to deliver consistent revenue aligned closely to EV sales growth and (c) provides a quality experience for businesses and
 
70

drivers that yields significant network effects. ChargePoint sells charging solutions in the form of networked hardware and recurring software subscriptions and services primarily sold to commercial and fleet customers. With rare exceptions, ChargePoint does not own charging sites or stations, monetize driver access to stations or monetize the sale of energy. In other words, ChargePoint does not depend on utilization rates and site selections; hence, ChargePoint believes there is limited direct competition with other charging players such as EVgo, Electrify America, Volta and Blink in the United States. Because customers own the charging infrastructure, ChargePoint can focus its resources on product development, customer acquisition and public policy to drive innovation, competition and customer choice in the market.
For 14 years, ChargePoint has been optimizing its operating model, combining high quality charging hardware and software subscriptions with
turn-key
support and parts and labor warranty services that are among the most comprehensive on the market. ChargePoint believes this approach is unique in the industry, creates significant network effects and, when combined with ChargePoint’s first mover advantage, provides the potential for recurring revenue. ChargePoint’s user experience is designed to generate high driver satisfaction and awareness and to keep site hosts engaged and loyal. This creates a virtuous cycle of brand awareness, recurring software revenue and meaningful charging footprint growth with existing customers (with the opportunity for high land and expand rates), all supported by mass market EV adoption.
 
 

The Portfolio
ChargePoint primarily generates revenue through the sale of networked charging hardware, combined with its Cloud Services billed as an annual subscription. Access to the Cloud Services is available through each charging port. Its extended parts and labor warranty, Assure, is also offered as an annual subscription. We expect that the revenue contribution for recurring Cloud or Assure sales will equal the revenue contribution from
one-time
CT4000 Dual-Port Station hardware sales after approximately seven years. ChargePoint offers both an upfront sale of the charging stations with subsequent payment for Cloud Services and Assure or CPaaS in which charging station hardware, Cloud Services and Assure are bundled into an annual subscription payment.
 
   
Hardware Portfolio Powered by Software
. While software is at the center of a scaled EV fueling network, ChargePoint believes it offers among the industry’s best in hardware for both Level 2 AC and
 
71

 
Level 3 DC charging. It does not sell these solutions without a Cloud Services subscription. The ChargePoint portfolio includes solutions for many use cases and was designed from the ground up with the software in mind. ChargePoint’s solutions deliver differentiated features and high efficiency in power and footprint, with a modular and scalable architecture that is created for high availability, easy expansion and serviceability. ChargePoint thoroughly tests its products, including compatibility checks for different types of EVs, for a range of functional, climate and environmental conditions and for high, long-term reliability. ChargePoint’s stations are available with customizable video and signage options for customers who want to promote their brand.
 
 
 
 
   
Advanced Cloud Services to Scale Charging Infrastructure
. ChargePoint’s network, sold as a Cloud Services subscription, enables commercial and fleet customers to manage charging in their parking lots and depots. Features are tuned for a variety of settings. Retailers can optimize for foot traffic and loyalty, employers can make fueling an efficient benefit to attract talent and parking operators can vary pricing to reflect market conditions. Cloud Services capabilities include the following:
 
   
Station and site host management,
making charging accessible to the public or select users, simplifying management of multiple charging sites and their parking policies, enabling
sub-hosts,
delivery of analytics, utilization reporting, remote diagnosis and updates with the latest software features.
 
   
Host pricing and payment remittance capabilities,
enabling site hosts to set pricing, including support for pricing scenarios (by driver group, time of day, idle status, energy dispensed, by session, etc.). Remittance is possible to one or many accounts.
 
   
Energy management,
enabling stations to share circuits, oversubscribe electrical panels to add more ports beyond the peak electrical capacity and support the creation of advanced groups and rules, which enable energy use policies. Energy management can be integrated with support for building load management and integration with utility load management programs.
 
   
Driver management tools,
enabling convenience features including specific user access via the ChargePoint connections system, the creation of driver groups to support a site host policy and the waitlist feature for drivers to reserve a place in line, among other features.
 
72

   
Integration with route planning systems for fleets,
enabling
on-budget
deadline scheduling in accordance with energy rate structures and
on-site
energy storage.
On-site
and
on-route
charging are supported and fueling payment is facilitated by integration with leading fuel cards.
 
 
ChargePoint believes that as EV penetration rises, so does the importance of Cloud Services to help manage charging complexity. Some examples include:
 
   
The ability for commercial customers to adjust the rate at which vehicles charge to match the natural parking duration at the site and to avoid peak or demand charges.
 
   
Charging infrastructure made available to the public during the day can be reserved for private fleets at night. Fleet software integrations also offer load control, charging scheduling and alerts to reduce cost and improve reliability. The software is designed to integrate with fuel management systems, fleet operations software and vehicle telematics to enable seamless integration into fleet processes.
 
   
Ecosystem integrations enable drivers to access charging functionality via
in-vehicle
infotainment systems, consumer mobile applications, payment systems, mapping tools, home automation assistants, fleet fuel cards, wearables and residential utility
programs.
All ChargePoint commercial ports are integrated into one network available to drivers who can use the ChargePoint mobile application to find charging locations, check availability, start sessions, pay for charging, use their ChargePoint account to roam across networks, access preferential pricing and loyalty offers and track the
 
73

estimated avoidance of CO2 emissions in comparison to the use of liquid fuel, though this does not account for any emissions associated with the generation of the electricity used to charge the EV at the commercial ports.
 
 
 
   
Parts and Labor Warranty Subscriptions and Customer Support Foster Loyalty.
ChargePoint offers Assure services which include proactive monitoring, fast response times, parts and labor warranty, expert advice and robust reporting. ChargePoint also provides phone support in nine languages to both site hosts and drivers. Rising EV adoption creates more awareness and utilization. ChargePoint believes the quality of the ChargePoint experience generates driver satisfaction and therefore encourages customers to purchase additional networked chargers and software, creating a virtuous cycle of growth from customers expanding their charging capacity.
 
 
 
74

Go to Market Strategy
ChargePoint sells networked charging solutions in North America and Europe and has over 5,000 existing commercial customers including 76% of the 2021 Fortune 50 list of companies. It is focused on three key markets: commercial, fleet and residential.
 
 
 
   
Commercial:
Commercial businesses already own or lease parking and many wish to electrify some or all of these parking spaces. These include retail centers, offices, medical complexes, schools, airports, convenience stores, recreation centers and fast fueling sites, among others. ChargePoint believes commercial businesses view charging as essential and invest to attract tenants, employees, customers and visitors, generate direct and indirect income, reduce expenses and achieve sustainability goals. ChargePoint believes commercial businesses choose ChargePoint based on solution completeness (they are not responsible for being the integrator or support agent for drivers) and the quality that comes from designing hardware, software and services together. Customers benefit from drivers typically being familiar with ChargePoint including access to a free,
top-rated
application,
around-the-clock
support, integration to popular mapping platforms, payment systems and wearables. Brand awareness, education and demand marketing programs generate sales opportunities. The commercial market is accessed via a direct sales force (inside and field teams) and by channel partners.
 
   
Fleet:
Fleet customers are organizations that operate vehicle fleets in delivery/logistics, sales/service/ motorpool shared transit and ridesharing service operators. ChargePoint believes these customers choose to electrify their fleets for economic reasons, as the comparative total cost of ownership compellingly favors electrification. EV charging solutions can help them design and fuel operations, manage operating costs and achieve sustainability goals. ChargePoint provides a flexible architecture of networked charging stations, software subscriptions, professional services, support, monitoring and parts and labor warranties needed to run electrified depots at scale. The fleet market is accessed via a direct sales force and a curated set of channel partners.
 
   
Residential:
ChargePoint offers residential EV charging solutions for drivers in single-family residences who want the convenience of fueling at home with the ability to optimize energy costs and full integration with the same mobile application they use for charging away from home. Residential charging solutions include the capability to manage grid load in conjunction with utility programs and EV fueling rate programs. Single family residential opportunities are accessed by direct marketing to the consumer using proprietary and third party
e-commerce
platforms. For apartments and condominium settings, ChargePoint offers landlords and owner associations the ability to offer charging billed directly to the tenant. ChargePoint also offers customer support
around-the-clock
and in nine languages. This residential aspect is accessed via marketing and direct and channel partners.
 
75

With its capital light business model, ChargePoint is able to allocate its capital strategically in research and development, marketing and sales and public policy.
 
   
Research and Development.
With a singular focus on EV charging for 14 years, ChargePoint now offers a complete set of solutions for most EV charging use cases in North America and Europe.
 
   
Go to Market.
ChargePoint has built a global marketing and sales engine, with an established sales channel, digital marketing capability and substantial direct sales. ChargePoint has focused on category awareness, consistent branding and customer acquisition. ChargePoint also has nationwide and local partners who sell, install and maintain ChargePoint solutions.
 
   
Public Policy.
ChargePoint has also supported early and sustained investments in policy and utility relationships. ChargePoint advocates for policies that advance electric mobility and ensure a healthy industry with a focus on competition, innovation and customer choice, including:
 
   
Support for vehicle policy and climate action, such as zero emission vehicle requirements, fossil fuel bans and transit electrification directives;
 
   
Partnership with North America’s leading utilities to scale the new electric fueling network, including enabling the resale of electricity, securing fast charging-friendly tariffs, protecting site host choice, developing make-ready programs, creating rebate programs and informing utility commission decisions and legislation; and
 
   
Reduction in barriers to infrastructure deployment including construction costs, permitting, building codes and right to charge policies for renters and tenants.
ChargePoint operates in all segments of EV charging in North America and Europe and offers a broad set of solutions for EV applications, including home, multi-family, residential, hospitality, workplace, commercial, fast charging and fleet. However, there are “point solutions” that ChargePoint may compete with at a category level or in a given geography (e.g. Level 2 AC workplace charging in the United States). ChargePoint does not directly compete with charging asset owners or charging networks that monetize the driver. Rather, it makes solutions available to them for purchase as a platform to enable their services.
Growth Strategies
ChargePoint estimates it had over a 70% market share in publicly available networked Level 2 AC charging in North America as of July 31, 2021. ChargePoint began European operations in late 2017 and currently operates in 16 European countries. It expects significant market opportunities for fleet solutions as fleet EVs begin to arrive in more meaningful volume in coming years. ChargePoint believes that the breadth and quality of its networked EV charging solutions, market share and driver awareness typically leads to customer loyalty, whereby they typically choose to expand their charging footprint with ChargePoint as EV penetration rises and/or charging utilization at their location increases. Over the years, ChargePoint’s customers typically renew their cloud subscriptions and expand the number of charging ports they purchase from ChargePoint. Additional growth results from the breadth of ecosystem integrations ChargePoint has enabled that keep the brand top of mind with drivers, including
in-vehicle
infotainment systems, consumer mobile applications, payment systems, mapping tools, home automation assistants, fleet fuel cards, wearables and residential utility programs.
ChargePoint’s growth strategies to continue to scale networked EV charging are as follows:
 
   
Accelerate new product offerings.
ChargePoint intends to maintain its leadership position with continued efficient investment in product development.
 
   
Invest incrementally in marketing and sales.
In both North America and Europe, ChargePoint intends to continue to attract new customers and pursue a
“land-and-expand”
model which encourages existing customers to increase their charging footprint over time as EV penetration increases. ChargePoint will also fund more CPaaS opportunities for commercial and fleet customers. Our
“land-and-expand”
 
76

 
approach resulted in our top 25 customers to increase their quarterly spending 14x over their first 12 quarters from the initial sale. One Fortune 50 customer’s spend of $2.6 million during fiscal year 2017 was followed by a total cumulative spend of $12.6 million during the five year period through 2021. Another Fortune 50 company’s spend increased from $334,000 in fiscal year 2017 to a cumulative $6.6 million over the five year period from fiscal 2017 to 2021. One major U.S. city’s spend increased from $76,000 in fiscal year 2017 to a cumulative $5.3 million over the five year period from fiscal 2017 to 2021.
ChargePoint Top 25 Customers’ Cumulative Spending
 
 
 
 
   
Pursue strategic acquisitions.
On August 11, 2021, ChargePoint acquired ViriCiti, a Netherlands-based provider of electrification solutions for eBus and commercial fleets. The acquisition of ViriCiti is expected to enhance ChargePoint’s fleet solutions portfolio of hardware, software and services by integrating information sources to optimize electric fleet operations. On October 6, 2021, ChargePoint acquired has•to•be, an Austrian-based
e-mobility
and charging software platform. The acquisition of has•to•be is intended to expand ChargePoint’s access to the European market. ChargePoint will continue to explore potential high-quality acquisition opportunities.
Manufacturing
ChargePoint designs its products
in-house
and outsources production to an assortment of contract manufacturers based in the United States, Mexico and Europe. The majority of its hardware products are manufactured in Mexico. Components are sourced from a number of global suppliers, with concentrations in the United States and Asia. ChargePoint deploys a global supply chain management team that works proactively with piece part and final assembly supply partners. That supply management team readies factories for new products, puts in place and monitors quality control points, plans ongoing production, issues purchase orders and coordinates deliveries to distribution hubs that ChargePoint manages in North America and Europe.
Government Regulation and Incentives
State, regional and local regulations for installation of EV charging stations vary from jurisdiction to jurisdiction and may include permitting requirements, inspection requirements, licensing of contractors and certifications as examples. Compliance with such regulation(s) may cause installation delays.
 
77

OSHA
ChargePoint is subject to the Occupational Safety and Health Act of 1970, as amended (“OSHA”). OSHA establishes certain employer responsibilities, including maintenance of a workplace free of recognized hazards likely to cause death or serious injury, compliance with standards promulgated by OSHA and various record keeping, disclosure and procedural requirements. Various standards, including standards for notices of hazards, safety in excavation and demolition work and the handling of asbestos, may apply to ChargePoint’s operations. ChargePoint is in full compliance with OSHA regulations.
NEMA
The National Electrical Manufacturers Association (“NEMA”) is the association of electrical equipment and medical imaging manufacturers. NEMA provides a forum for the development of technical standards that are in the best interests of the industry and users, advocacy of industry policies on legislative and regulatory matters, and collection, analysis, and dissemination of industry data. All of ChargePoint’s products comply with the NEMA standards that are applicable to such products.
CAFE Standards
The regulations mandated by the Corporate Average Fuel Economy (“CAFE”) standards set the average new vehicle fuel economy, as weighted by sales, that a manufacturer’s fleet must achieve. Although ChargePoint is not a car manufacturer and are thus not directly subject to the CAFE standards, ChargePoint believes such standards may have a material effect on its business. The Energy Independence and Security Act of 2007 raised the fuel economy standards of America’s cars, light trucks and sport utility vehicles to a combined average of at least 35 miles per gallon by 2020—a 10 miles per gallon increase over 2007 levels—and required standards to be met at maximum feasible levels through 2030. Building on the success of the first phase of the National Program, the second phase of fuel economy and global warming pollution standards for light duty vehicles covers model years 2017–2025. These standards were finalized by the U.S. Environmental Protection Agency (“EPA”) and NHTSA in August 2012. These standards would have required a reduction in average carbon dioxide emissions of new passenger cars and light trucks to 163 grams per mile (g/mi) in model year 2025. Manufacturers may choose to comply with these standards by manufacturing more EVs which would mean that more charging stations of the type ChargePoint manufactures will be needed.
However, in April 2020, EPA and NHTSA finalized the Safer Affordable Fuel-Efficient Vehicles Rule, which reformulated the required reductions, establishing average carbon dioxide emissions of new passenger cars and light trucks of 240 g/mi in model year 2026. Several states and groups have announced intentions to sue the U.S. government over this reformulation, so the final CAFE standards cannot currently be predicted with any certainty. However, to the extent fuel-efficiency standards are decreased, this may result in less demand for EVs and, in turn, charging stations of the type ChargePoint manufactures.
Waste Handling and Disposal
ChargePoint is subject to laws and regulations regarding the handling and disposal of hazardous substances and solid wastes, including electronic wastes and batteries. These laws generally regulate the generation, storage, treatment, transportation and disposal of solid and hazardous waste, and may impose strict, joint and several liability for the investigation and remediation of areas where hazardous substances may have been released or disposed. For instance, CERCLA, also known as the Superfund law, in the United States and comparable state laws impose liability, without regard to fault or the legality of the original conduct, on certain classes of persons that contributed to the release of a hazardous substance into the environment. These persons include current and prior owners or operators of the site where the release occurred as well as companies that disposed or arranged for the disposal of hazardous substances found at the site. Under CERCLA, these persons may be subject to joint and several strict liability for the costs of cleaning up the hazardous substances that have been released into the
 
78

environment, for damages to natural resources and for the costs of certain health studies. CERCLA also authorizes the EPA and, in some instances, third-parties to act in response to threats to the public health or the environmental and to seek to recover from the responsible classes of persons the costs they incur. ChargePoint may handle hazardous substances within the meaning of CERCLA, or similar state statutes, in the course of ordinary operations and, as a result, may be jointly and severally liable under CERCLA for all or part of the costs required to clean up sites at which these hazardous substances have been released into the environment.
ChargePoint also generates solid wastes, which may include hazardous wastes that are subject to the requirements of the Resource Conservation and Recovery Act (“RCRA”) and comparable state statutes. While RCRA regulates both solid and hazardous wastes, it imposes strict requirements on the generation, storage, treatment, transportation and disposal of hazardous wastes. Certain components of ChargePoint’s products are excluded from RCRA’s hazardous waste regulations, provided certain requirements are met. However, if these components do not meet all of the established requirements for the exclusion, or if the requirements for the exclusion change, ChargePoint may be required to treat such products as hazardous waste, which are subject to more rigorous and costly disposal requirements. Any such changes in the laws and regulations, or ChargePoint’s ability to qualify the materials it uses for exclusions under such laws and regulations, could adversely affect ChargePoint’s operating expenses.
Similar laws exist in other jurisdictions where ChargePoint operates. Additionally, in the EU, ChargePoint is subject to the Waste Electrical and Electronic Equipment Directive (“WEEE Directive”). The WEEE Directive provides for the creation of collection scheme where consumers return waste electrical and electronic equipment to merchants, such as ChargePoint. If ChargePoint fails to properly manage such waste electrical and electronic equipment, it may be subject to fines, sanctions, or other actions that may adversely affect ChargePoint’s financial operations.
Research and Development
ChargePoint has invested a significant amount of time and expense into research and development of its networked charging platform technologies. ChargePoint’s ability to maintain its leadership position depends in part on its ongoing research and development activities. ChargePoint’s research and development team is responsible for the design, development, manufacturing and testing of its products. ChargePoint focuses its efforts on developing its charging hardware and developing the technology to support ChargePoint’s software subscriptions and support services.
ChargePoint’s hardware research and development is principally conducted at its headquarters in Campbell, California. As of July 31, 2021, ChargePoint had over 500 full-time employees in total engaged in its research and development activities.
Intellectual Property
ChargePoint relies on a combination of patent, trademark, copyright, unfair competition and trade secret laws, as well as confidentiality procedures and contractual restrictions, to establish, maintain and protect its proprietary rights. ChargePoint’s success depends in part upon its ability to obtain and maintain proprietary protection for ChargePoint’s products, technology and
know-how,
to operate without infringing the proprietary rights of others, and to prevent others from infringing ChargePoint’s proprietary rights.
As of July 31, 2021, ChargePoint had 80 U.S. patents issued and 22 U.S. pending
non-provisional
patent. Additionally, ChargePoint had 17 issued foreign patents (Canada, Japan, Australia, New Zealand, China, Taiwan and Korea) and 12 foreign patent applications currently pending in various foreign jurisdictions. In addition, as of July 31, 2021, there were three pending Patent Cooperation Treaty applications. These patents relate to various EV charging station designs and/or EV charging functionality. Such issued patents and any patents derived from such applications or applications that claim priority from such applications, if granted, would be expected to
 
79

expire between 2024 and 2039, excluding any additional term for patent term adjustments. ChargePoint cannot be assured that any of its patent applications will result in the issuance of a patent or whether the examination process will require ChargePoint to narrow the scope of the claims sought. ChargePoint’s issued patents, and any future patents issued to ChargePoint, may be challenged, invalidated or circumvented, may not provide sufficiently broad protection and may not prove to be enforceable inactions against alleged infringers.
ChargePoint enters into agreements with its employees, contractors, customers, partners and other parties with which it does business to limit access to and disclosure of its technology and other proprietary information. ChargePoint cannot be certain that the steps it has taken will be sufficient or effective to prevent the unauthorized access, use, copying or the reverse engineering of ChargePoint’s technology and other proprietary information, including by third-parties who may use its technology or other proprietary information to develop products and services that compete with ChargePoint’s. Moreover, others may independently develop technologies that are competitive with ChargePoint or that infringe on, misappropriate or otherwise violate its intellectual property and proprietary rights, and policing the unauthorized use of ChargePoint’s intellectual property and proprietary rights can be difficult. The enforcement of ChargePoint’s intellectual property and proprietary rights also depends on any legal actions ChargePoint may bring against any such parties being successful, but these actions are costly, time-consuming and may not be successful, even when ChargePoint’s rights have been infringed, misappropriated or otherwise violated.
ChargePoint intends to continue to regularly assess opportunities for seeking patent protection for those aspects of its technology, designs and methodologies that ChargePoint believes provide a meaningful competitive advantage. However, ChargePoint’s ability to do so may be limited until such time as it is able to generate cash flow from operations or otherwise raise sufficient capital to continue to invest in ChargePoint’s intellectual property. For example, maintaining patents in the United States and other countries requires the payment of maintenance fees which, if ChargePoint is unable to pay, may result in loss of its patent rights. If ChargePoint is unable to do so, its ability to protect its intellectual property or prevent others from infringing its proprietary rights may be impaired.
Competition
North America
ChargePoint is currently a market leader in North America in the commercial Level 2 AC chargers. ChargePoint also offers Level 1 power chargers for use at home or multifamily settings and high-power Level 3 DC chargers for urban fast charging, corridor or long-trip charging and fleet applications. Furthermore, ChargePoint’s competition includes other types of alternative fuel vehicles,
plug-in
hybrid electric vehicles and high fuel-economy gasoline powered vehicles.
In addition, there are other means for charging EVs, which could affect the level of demand for onsite charging capabilities at businesses. For example, Tesla continues to build out its supercharger network across the United States for its vehicles, which could reduce overall demand for EV charging at other sites. Also, third party contractors can provide basic electric charging capabilities to potential customers seeking to have on premise EV charging capability as well as for home charging. In addition, many EV manufacturers are offering home charging equipment which could reduce the demand for onsite charging capabilities if EV owners find charging at home to be sufficient.
Europe
ChargePoint primarily competes with smaller providers of EV charging station networks for installations, particularly in Europe. Large early stage markets, such as Europe, require early engagement across verticals and customers to gain market share, requires ongoing efforts to scale channels, installers, teams and processes. Some
 
80

European customers require solutions not yet available and ChargePoint’s recent entrance into Europe requires establishing itself as compared to existing competitors, many of which have been in the market for a substantial amount of time. In addition, there are multiple competitors in Europe with limited funding, which could cause poor experiences, hampering overall EV adoption or trust in any particular provider.
ChargePoint believes the primary factors on which it competes include:
 
   
variety and quality of product offerings;
 
   
product performance;
 
   
software functionality for its network;
 
   
ease of use;
 
   
brand awareness;
 
   
quality of support;
 
   
size and scale of network; and
 
   
scale of operations.
ChargePoint believes it competes favorably with respect to each of these factors.
Facilities
ChargePoint’s headquarters are located in Campbell, California where it currently leases approximately 72,000 square feet of office space under a lease that expires on August 31, 2029. ChargePoint believes this space is sufficient to meet its needs for the foreseeable future and that any additional space ChargePoint may require will be available on commercially reasonable terms. ChargePoint also maintains facilities in Amsterdam, the Netherlands; Gurgaon, India; Scottsdale, Arizona; Radstadt, Austria and Reading, United Kingdom, as well as smaller sales offices in the United States and Europe.
Employees
ChargePoint strives to offer competitive employee compensation and benefits in order to attract and retain a skilled and diverse work force. As of July 31, 2021, ChargePoint had 1,045 employees, over 500 of whom were engaged in research and development activity. Most of ChargePoint’s employees are located in the United States, although it has additional employees in Europe and India. As a result of the
COVID-19
pandemic, most of ChargePoint’s employees are currently working remotely, although ChargePoint expects that when the
COVID-19
pandemic subsides, its employees will return to work at its facilities noted above. None of ChargePoint’s employees are represented by a labor union and ChargePoint believes it maintains good relations with its employees.
Legal Proceedings
ChargePoint is not party to any material legal proceedings. From time to time, ChargePoint may be involved in legal proceedings or subject to claims incident to the ordinary course of business. Regardless of the outcome, such proceedings or claims can have an adverse impact on ChargePoint because of defense and settlement costs, diversion of resources and other factors, and there can be no assurances that favorable outcomes will be obtained.
 
81

Management
Executive Officers and Directors
The table below lists our directors and executive officers along with each person’s age as of the date of this prospectus and any other position that such person holds.
 
Name
  
Age
    
Position(s)
Executive Officers
     
Pasquale Romano
     56      President, Chief Executive Officer and Director
Christopher Burghardt
     47      Managing Director, Europe
Rebecca Chavez
     44      General Counsel and Secretary
Henrik Gerdes
     45      Chief Accounting Officer
Michael Hughes
     54      Chief Commercial and Revenue Officer
Rex Jackson
     61      Chief Financial Officer
Colleen Jansen
     50      Chief Marketing Officer
Lawrence Lee
     47      Senior Vice President, Operations and Support
Bill Loewenthal
     59      Senior Vice President, Product
Eric Sidle
     47      Senior Vice President, Engineering
Non-Employee
Directors
     
Roxanne Bowman
     55      Director
(3)
Bruce Chizen
     66      Director
(2)(3)
Axel Harries
     57      Director
Jeffrey Harris
     65      Director
(1)
Susan Heystee
     59      Director
(1)
Mark Leschly
     53      Director
(2)(3)
Michael Linse
     47      Director
(2)
G. Richard Wagoner Jr
     68      Director
(1)
 
(1)
Member of the audit committee.
(2)
Member of the compensation and organizational development committee.
(3)
Member of the nominating and corporate governance committee.
Executive Officers
Pasquale Romano.
Mr. Romano has served as ChargePoint’s President and Chief Executive Officer and a member of the Board since the closing of the Merger and has held the same positions at Legacy ChargePoint since February 2011. Prior to ChargePoint, Mr. Romano
co-founded
2Wire, Inc., a provider of broadband service delivery platforms, where he served as its President and Chief Executive Officer from October 2006 until July 2010 when 2Wire, Inc. was acquired by Pace plc. In 1989, he
co-founded
Fluent, Inc., a digital video networking company and served as its Chief Architect until the company was sold to Novell Corporation in 1993. Mr. Romano holds an A.B. in Computer Science from Harvard University and an M.S. from Massachusetts Institute of Technology. We believe Mr. Romano is qualified to serve as a member of our Board due to his extensive executive management and technology industry leadership experience.
Christopher Burghardt.
Mr. Burghardt has served as ChargePoint’s Managing Director for Europe since the closing of the Merger and has held the same position at Legacy ChargePoint since November 2017. Prior to ChargePoint, Mr. Burghardt served as Head of Policy and Communications, EMEA for Uber Technologies, Inc., from September 2016 to November 2017. Mr. Burghardt served in senior management positions at First Solar, Inc., a provider of solar panels and utility-scale photovoltaic power plants in Europe, from September 2009 to September 2016, most recently as Managing Director and Vice President of Business Development and Sales from May 2014 to September 2016. He also served as Vice President of Corporate Affairs for Western Europe, among other roles, at Anheuser-Busch InBev. Mr. Burghardt has served as a founding board member for
 
82

ChargeUp Europe, an EV charging industry alliance, since its inception in March 2020. He holds a B.A. from the University of Sussex and the Institut d’Etudes Politiques of
Aix-en-Provence,
an M.B.A. from the Wharton School of the University of Pennsylvania and an M.A. from the College of Europe.
Rebecca Chavez.
Ms. Chavez has served as ChargePoint’s General Counsel and Secretary since the closing of the Merger and has held the same position at Legacy ChargePoint since February 2021. Prior to ChargePoint, Ms. Chavez served in various legal leadership roles at Palo Alto Networks, Inc., a global cybersecurity company, including serving as the Vice President, Deputy General Counsel, Corporate, Securities and M&A, from November 2018 to February 2021, Associate General Counsel and Senior Director, Corporate and Securities, from November 2016 to November 2018 and Director, Corporate and Securities, from August 2015 to November 2016. Prior to joining Palo Alto Networks, Inc., she served as Associate General Counsel, Finance & Governance at Levi Strauss & Co., an American clothing company, from April 2013 to July 2015. Ms. Chavez began her legal career working at Morrison & Foerster LLP followed by Sidley Austin LLP. Ms. Chavez holds a B.A. in Latin American Studies and M.A. in Education from Stanford University and a J.D. from the University of California, Davis School of Law.
Henrik Gerdes.
Mr. Gerdes has served as ChargePoint’s Chief Accounting Officer since April 2019. Prior to ChargePoint, Mr. Gerdes served as Chief Accounting Officer of 8x8, Inc., a provider of voice over IP products, from April 2017 to March 2019. Before 8x8, Inc., Mr. Gerdes served as Vice President, Corporate Controller and Treasurer for Rocket Fuel, Inc., a marketing and advertising platform, from September 2014 to March 2017. Prior to Rocket Fuel, Inc., Mr. Gerdes has held a variety of senior accounting positions as well as spending more than seven years with PricewaterhouseCoopers LLP as a senior associate and audit manager. He holds a Master in Finance, from the University of Göttingen.
Michael Hughes.
Mr. Hughes has served as ChargePoint’s Chief Revenue Officer since the closing of the Merger and has held the same position at Legacy ChargePoint since August 2019. Prior to ChargePoint, Mr. Hughes served as Senior Vice President of Worldwide Sales and Services for Barracuda Networks, Inc., a provider of security, networking and storage products, from June 2009 to August 2019. Before Barracuda Networks, Inc., Mr. Hughes served as Vice President of Sales for Asempra Technologies, a provider of one click, instant recovery solutions for Microsoft
®
Exchange, SQL and Windows File Servers. Mr. Hughes also serves as a board advisor for technology
start-ups
in the areas of data residency and security, threat intelligence and multi-cloud container data management. He holds a B.S. in Marketing from Miami University and an M.B.A. from the University of Michigan.
Rex Jackson.
Mr. Jackson has served as ChargePoint’s Chief Financial Officer since the closing of the Merger and has held the same position at Legacy ChargePoint since May 2018. Prior to ChargePoint, Mr. Jackson served as chief financial officer of Gigamon, Inc., a developer of network and security visibility solutions, from October 2016 to April 2018 through its
go-private
transaction. Mr. Jackson served as Chief Financial Officer of Rocket Fuel Inc., an advertising technology company, from March 2016 to October 2016. Prior, Mr. Jackson served as Chief Financial Officer of JDS Uniphase Corporation (“JDSU”), a provider of network and service enablement solutions and optical products for service providers, cable operators and network equipment manufacturers, from January 2013 to September 2015, where he drove the separation of JDSU into two independent public companies (Lumentum Holdings Inc./Viavi Solutions) in August 2015. Mr. Jackson joined JDSU in January 2011 as Senior Vice President, Business Services, with responsibility for corporate development, legal, corporate marketing and information technology. Prior to JDSU, Mr. Jackson served as Chief Financial Officer of Symyx Technologies from 2007 to 2010, where he led the company’s acquisition of MDL Information Systems and subsequent merger of equals with another public company. Previously, Mr. Jackson also served as acting Chief Financial Officer for Synopsys, Inc. and General Counsel at Avago, AdForce and Read-Rite. Mr. Jackson holds a B.A. from Duke University and a J.D. from Stanford Law School.
Colleen Jansen.
Ms. Jansen has served as ChargePoint’s Chief Marketing Officer since the closing of the Merger and has held the same position at Legacy ChargePoint since July 2016. Prior to ChargePoint, she served
 
83

as Vice President of Marketing at Jive Software, a provider of enterprise collaboration solutions, from April 2014 to September 2015. Prior, Ms. Jansen served as Senior Director of Global Consumer Marketing, among other roles, at LinkedIn, the world’s leading professional network, from 2011 to 2014. Previously, she served as Vice President Marketing at Yahoo, a consumer internet company as well as in leadership roles in public companies and privately-funded
start-ups
focused on software. Ms. Jansen has served as a member of the board of directors of CALSTART since February 2020. She holds a B.S. in Business Administration from California State University, Fresno.
Lawrence Lee.
Mr. Lee has served as ChargePoint’s Senior Vice President of Operations and Services since the closing of the Merger and has held the same position at Legacy ChargePoint since November 2018. Prior to ChargePoint, Mr. Lee served in several roles over nine years at Apple, Inc., a multinational technology company that designs, develops and sells consumer electronics, computer software and online services, including as Director of New Product Introduction, from June 2015 to October 2018. Prior to Apple, Mr. Lee served as Senior Operations Manager for Brooks Automation, a worldwide provider of semiconductor manufacturing solutions and life science sample-based services and solutions. Mr. Lee holds a B.S. in Mechanical Engineering from Texas A&M University, an M.S. in Mechanical Engineering and an M.B.A. from the University of California, Berkeley.
Bill Loewenthal.
Mr. Loewenthal has served as ChargePoint’s Senior Vice President, Product since the closing of the Merger and has held the same position at Legacy ChargePoint since July 2018. Prior to ChargePoint, Mr. Loewenthal served as Vice President of Product Portfolio Management at Avaya, a provider of business communication solutions, from July 2017 until February 2018. Since 2010, Mr. Loewenthal held various roles at audio communications leader Poly (formerly Plantronics), including from February 2012 to February 2016 when he served as Vice President Enterprise Solutions. His career includes leadership roles in public and startup companies with an emphasis on hardware and software solutions. Mr. Loewenthal holds a B.S. from San Jose State University.
Eric Sidle.
Mr. Sidle has served as ChargePoint’s Senior Vice President of Engineering since the closing of the Merger and has held the same position at Legacy ChargePoint since September 2018. Prior to ChargePoint, Mr. Sidle served in several leadership roles at NIO, a manufacturer of electric vehicles, including Senior Director of Autonomous Driving Hardware, from December 2017 to August 2018 and as Director of Hardware and Advanced Technologies from December 2016 to December 2017. Before NIO, Mr. Sidle led multiple teams in special projects as well as Mac development at Apple, Inc., a multinational technology company that designs, develops and sells consumer electronics, computer software, and online services, from September 2011 to December 2016. He holds a B.S. in Electrical Engineering from the University of Illinois at Urbana-Champaign.
Non-Employee
Directors
Roxanne Bowman.
Ms. Bowman has served as a member of the Board since the closing of the Merger and previously served as a director of Legacy ChargePoint since August 2019. Ms. Bowman has served as Operating Executive at NMS Capital, a private investment firm, since March 2019. From September 2013 to November 2018, Ms. Bowman served as Chief Executive Officer of PowerTeam Services, LLC, a gas and electric utility service provider. Ms. Bowman holds a B.S. in Electrical Engineering from Clemson University and an M.B.A. from the Pamplin College of Business at Virginia Polytechnic Institute and State University. We believe Ms. Bowman is qualified to serve as a member of our Board based on her wide-ranging experience in management, sales, marketing and strategic planning within the utilities industry.
Bruce Chizen.
Mr. Chizen has served as a member of the Board since the closing of the Merger and previously served as a director of Legacy ChargePoint since December 2014. Mr. Chizen is currently an independent consultant and has served as Senior Adviser to Permira Advisers LLP, a private equity fund, since July 2008, and as a Venture Partner at Voyager Capital, a venture capital firm, since August 2009. He has also served as an Operating Partner for Permira Growth Opportunities, a private equity fund since June 2018. From
 
84

1994 until 2008, Mr. Chizen served in a number of positions at Adobe Systems Incorporated, a provider of design, imaging and publishing software, including as its Chief Executive Officer from 2000 until 2007, President from 2000 until 2005, acting Chief Financial Officer from 2006 until 2007 and Strategic Advisor from 2007 until 2008. Mr. Chizen currently serves as a director of Synopsys, Inc. and Oracle Corporation. Mr. Chizen holds a bachelor’s degree from Brooklyn College, City University of New York. We believe Mr. Chizen is qualified to serve as a member of our Board based on his extensive leadership experience in digital media and software.
Axel Harries.
Mr. Harries has served as a member of the Board since the closing of the Merger and previously served as a director of Legacy ChargePoint since October 2016. Mr. Harries has served as Vice President of Product Management and Sales for
Mercedes-Benz
AG since June 2017. Prior to this, from June 1993 to June 2017, Mr. Harries held several roles at Daimler AG, including leading the Connected, Autonomous, Shared & Services and Electric Drive unit, which is responsible for
all-electric
vehicle architecture from July 2016 to June 2017 and Quality Management of
Mercedez-Benz
Cars from July 2014 until July 2016 and Head of the
G-Wagon
Business Unit at
Mercedes-Benz
Cars from July 2008 until June 2014. Mr. Harries has served as a member of the board of Carwow and
Mercedes-Benz
USA since July 2019 and June 2017, respectively. Mr. Harries studied product engineering with finance and management accounting at Furtwangen University, Germany. We believe Mr. Harries is qualified to serve as a member of our Board based on his extensive management experience in the automotive industry and knowledge of Europe’s auto charging market.
Jeffrey Harris.
Mr. Harris has served as a member of the Board since the closing of the Merger and previously served as a director of Legacy ChargePoint since December 2018. In 2012, Mr. Harris founded Global Reserve Group LLC, a financial advisory and investment firm focused primarily on the energy and technology industries. In addition, he has been a Venture Partner of Quantum Energy Partners since 2012. Previously, Mr. Harris was a managing director of Warburg Pincus LLC, a private equity firm, from 1983 until 2011. Mr. Harris currently serves as a director of Knoll, Inc., InterPrivate Acquisition Corp. and several private companies. Mr. Harris holds a B.S. in Economics from the Wharton School of the University of Pennsylvania and an M.B.A. from Harvard Business School. We believe Mr. Harris is qualified to serve as a member of our Board based on his extensive financial expertise and knowledge of the energy industry and clean technology.
Susan Heystee
.
Ms. Heystee has served as a member of the Board since May 2021. Since September 2018, Ms. Heystee has served as a member of the Ouster, Inc. board of directors, and she currently also serves as a strategic advisor to the company. Previously, Ms. Heystee was Senior Vice President of Global Automotive Business at Verizon Connect from January 2017 to June 2018. Previously, Ms. Heystee served as Executive Vice President of Global Sales and OEM Business at Telogis, which was acquired by Verizon in July 2016, from February 2010 to December 2016. Ms. Heystee holds Bachelor’s degrees in mathematics and business from the University of Waterloo and an executive M.B.A. from Harvard Business School. We believe that Ms. Heystee is qualified to serve as a member of our Board due to her extensive experience in the technology sector and knowledge of market driven strategies.
Mark Leschly.
Mr. Leschly has served as a member of the Board since the closing of the Merger and previously served as a director of Legacy ChargePoint since December 2009. Since July 1999, Mr. Leschly has served as a managing partner of Rho Capital Partners, Inc., an investment and venture capital management company. Since 2017, Mr. Leschly has been the chairman and chief executive officer of Universal Tennis, LLC, which is the developer of a software platform for tennis analytics and tournament management. Since 2014, Mr. Leschly has also been the owner and managing member of Iconica LLC, which primarily focuses on investments at the intersection of sports, media and technology. Mr. Leschly has served as a director of NGM Biopharmaceuticals, Inc. since January 2008. From 2002 until June 2016, Mr. Leschly served as a director of Anacor Pharmaceuticals, Inc. Mr. Leschly holds an M.B.A. from Stanford Graduate School of Business and a B.A. from Harvard University. We believe Mr. Leschly is qualified to serve as a member of our Board based on his extensive experience in corporate finance and investing in energy companies.
 
85

Michael Linse.
Mr. Linse has served as a member of the Board since the closing of the Merger and previously served as a director of Legacy ChargePoint since April 2012. Mr. Linse has served as the founder and managing director of Linse Capital LLC since October 2015, a growth equity firm investing in late-stage technology companies, and Levitate Capital, a venture capital firm, since March 2017. Prior to founding Linse Capital, Mr. Linse served as a partner at Kleiner Perkins Caufield & Byers (“KPCB”) from 2008 until March 2016. Prior to joining KPCB, Mr. Linse worked at Goldman Sachs for over a decade, most recently as Managing Director of the alternative energy investing team. Mr. Linse holds a B.A. in Economics from Harvard University and an M.B.A. from Harvard Business School. We believe Mr. Linse is qualified to serve as a member of our Board based on his extensive experience in corporate finance and investing in alternative energy space.
G. Richard Wagoner, Jr.
Mr. Wagoner has served as a member of the Board since the closing of the Merger and previously served as a director of Legacy ChargePoint since February 2017. From 1977 to 2009, Mr. Wagoner held numerous senior positions at General Motors Corporation, including Chairman and Chief Executive Officer from 2003 to 2009. Mr. Wagoner currently serves as a director of Invesco Ltd., where he has served since October 2013, and Graham Holdings Inc., where he has served since June 2010. Mr. Wagoner previously served as a director of Aleris Corporation from August 2010 until April 2020. Mr. Wagoner holds a bachelor’s degree from Duke University and an M.B.A. from Harvard Business School. We believe Mr. Wagoner is qualified to serve as a member of our Board based on his extensive experience in the automobile industry, general management and public company board service.
Family Relationships
There are no familial relationships among the ChargePoint directors and executive officers.
Board Composition
Our Board is comprised of 9 directors and is divided into three classes with staggered three-year terms. Our directors are divided among the three classes as follows:
 
   
the Class I directors are Roxanne Bowman, Axel Harries and Mark Leschly and their terms will expire at the annual meeting of stockholders to be held in 2024;
 
   
the Class II directors are Jeffrey Harris, Susan Heystee and G. Richard Wagoner, Jr. and their terms will expire at the annual meeting of stockholders to be held in 2022; and
 
   
the Class III directors are Bruce Chizen, Michael Linse and Pasquale Romano and their terms will expire at the annual meeting of stockholders to be held in 2023.
Directors in a particular class will be elected for three-year terms at the annual meeting of stockholders in the year in which their terms expire. As a result, only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. Each director’s term continues until the election and qualification of his or her successor, or the earlier of his or her death, resignation or removal.
Director Independence
The Board has determined that each member, other than Pasquale Romano, will qualify as independent, as defined under the listing rules of the NYSE. In addition, we will be subject to the rules of the SEC and NYSE relating to the memberships, qualifications and operations of the audit committee, as discussed below.
Board Oversight of Risk
One of the key functions of the Board is to be informed oversight of our risk management process. We do not anticipate having a standing risk management committee, but rather anticipate administering this oversight
 
86

function directly through the Board as a whole, as well as through various standing committees of the Board that address risks inherent in their respective areas of oversight.
Board Committees
Audit Committee
The members of the audit committee are Messrs. Harrisand Wagoner and Ms. Heystee, each of whom can read and understand fundamental financial statements. Each of Messrs. Harrisand Wagoner and Ms. Heystee is independent under the rules and regulations of the SEC and the listing standards of the NYSE applicable to audit committee members. Mr. Harris is the chair of the audit committee. Mr. Harris qualifies as an audit committee financial expert within the meaning of SEC regulations and meets the financial sophistication requirements of the NYSE. The audit committee assists the Board with its oversight of the following: the integrity of ChargePoint’s financial statements; ChargePoint’s compliance with legal and regulatory requirements; the qualifications, independence and performance of the independent registered public accounting firm; and the design and implementation of our internal audit function and risk assessment and risk management. Among other things, the audit committee is responsible for reviewing and discussing with management the adequacy and effectiveness of our disclosure controls and procedures. The audit committee also discusses with ChargePoint’s management and independent registered public accounting firm the annual audit plan and scope of audit activities, scope and timing of the annual audit of ChargePoint’s financial statements, and the results of the audit, quarterly reviews of our financial statements and, as appropriate, initiates inquiries into certain aspects of ChargePoint’s financial affairs. The audit committee is be responsible for establishing and overseeing procedures for the receipt, retention and treatment of any complaints regarding accounting, internal accounting controls or auditing matters, as well as for the confidential and anonymous submissions by ChargePoint’s employees of concerns regarding questionable accounting or auditing matters. In addition, the audit committee has direct responsibility for the appointment, compensation, retention and oversight of the work of ChargePoint’s independent registered public accounting firm. The audit committee has sole authority to approve the hiring and discharging of ChargePoint’s independent registered public accounting firm, all audit engagement terms and fees and all permissible
non-audit
engagements with the independent auditor. The audit committee reviews and oversees all related person transactions in accordance with ChargePoint’s policies and procedures.
Compensation and Organizational Development Committee
The members of the compensation and organizational development committee are Messrs. Chizen, Leschly and Linse. Mr. Linse is the chair of the compensation and organizational development committee. Each member of the compensation and organizational development committee is considered independent under the rules and regulations of the SEC and the listing standards of the NYSE applicable to compensation and organizational development committee members. The compensation and organizational development committee assists the Board in discharging certain of the responsibilities with respect to compensating our executive officers, and the administration and review of the incentive plans for employees and other service providers, including our equity incentive plans, and certain other matters related to our compensation programs.
Nominating and Corporate Governance Committee
The members of the nominating and corporate governance committee are Ms. Bowman and Messrs. Chizen and Leschly. Mr. Leschly is the chair of the nominating and corporate governance committee. The nominating and corporate governance committee assists the Board with its oversight of and identification of individuals qualified to become members of the Board, consistent with criteria approved by the Board, and selects, or recommends that the Board selects, director nominees, develops and recommends to the Board a set of corporate governance guidelines, and oversees the evaluation of the Board.
 
87

Code of Conduct
The Board has adopted a Code of Conduct. The Code of Conduct applies to all of our employees, officers and directors, as well as all of our contractors, consultants, suppliers and agents in connection with their work for ChargePoint. The full text of the Code of Conduct is on our website at
https://investors.chargepoint.com
under the Governance section. We intend to disclose future amendments to, or waivers of, the Code of Conduct, as and to the extent required by SEC regulations, at the same location on the website identified above or in public filings. Information contained on the website is not incorporated by reference into this prospectus, and you should not consider information contained on our website to be part of this prospectus.
Compensation and Organizational Development Committee Interlocks and Insider Participation
None of the intended members of the compensation and organizational development committee has ever been a member of the Board or compensation committee of any other entity that has or has had one or more executive officers serving as a member of the Board or compensation and organizational development committee.
 
88

EXECUTIVE COMPENSATION
For the fiscal year ended January 31, 2021, ChargePoint’s named executive officers were:
 
   
Pasquale Romano, Chief Executive Officer
 
   
Christopher Burghardt, Managing Director, Europe
 
   
Michael Hughes, Chief Revenue Officer
Fiscal Year 2021 Summary Compensation Table
The following table shows information regarding the compensation of ChargePoint’s named executive officers for services performed during the fiscal years ended January 31, 2021 and January 31, 2020.
 
Name and Principal Position
  
Year
    
Salary
($)
    
Bonus
($)
    
Option
Awards)
($)
(1)
   
Non-Equity

Incentive Plan
Compensation
($)
   
Total
($)
 
Pasquale Romano,
               
Chief Executive Officer
     2021        454,167        405,000        —  
(2)
 
    —         859,167  
     2020        500,000        375,000        960,294       —         1,835,294  
Christopher Burghardt,
(3),(4)
               
Managing Director, Europe
     2021        402,500        130,410        —         —         532,910  
Michael Hughes,
(4)
               
Chief Revenue Officer
     2021        272,500        97,200        —         294,000
(5)
 
    663,700  
 
(1)
The amounts in this column represent the aggregate grant date fair value of option awards granted to the officer in the applicable fiscal year computed in accordance with FASB ASC Topic 718. See Note 12 of the notes to ChargePoint’s consolidated financial statements included elsewhere in this prospectus for a discussion of the assumptions made by ChargePoint in determining the grant date fair value of its equity awards. In accordance with SEC rules, the grant date fair value of an award subject to a performance condition is based on the probable outcome of the performance condition.
(2)
Mr. Romano was granted an option to purchase 1,500,000 shares of ChargePoint’s Common Stock on June 2, 2020. As originally granted, the option would have vested if ChargePoint achieved positive operating income for the fiscal year ending January 31, 2024. At the time the option was granted it was not probable that the performance condition would be achieved, and therefore no amount is included in the “Option Awards” column for fiscal year 2021. The grant date fair value of the option granted to Mr. Romano, assuming maximum achievement of the performance condition, was $783,991.
(3)
Mr. Burghardt’s salary is paid in Euros and has been converted to U.S. dollars using the average exchange rate during the fiscal year of 1.15.
(4)
Messrs. Burghardt and Hughes were employed by us, but were not named executive officers, in the fiscal year ended January 31, 2020. Accordingly, compensation information is only provided for the fiscal year ending January 31, 2021.
(5)
Reflects sales commissions.
Narrative Disclosure to Summary Compensation Table
The compensation of ChargePoint’s named executive officers generally consists of base salary, annual incentive compensation and equity compensation. In making executive compensation decisions, the Board and ChargePoint’s compensation and organizational development committee consider such factors as they deem appropriate in their exercise of discretion and business judgment, including a subjective assessment of the named executive officer’s performance, the amount of vested and unvested equity held by the officer, amounts paid to ChargePoint’s other executive officers and competitive market conditions.
 
89

The salaries and target bonus opportunities of ChargePoint’s named executive officers are typically reviewed annually and adjusted when the Board or compensation and organizational development committee determines it is appropriate. For the fiscal year ended January 31, 2021, Mr. Romano’s base salary was $500,000 per year, Mr. Burghardt’s base salary was €350,000 per year and Mr. Hughes’ base salary was $300,000 per year. However, as part of a COVID-related expense reduction program, the base salaries of ChargePoint’s U.S. employees (including Messrs. Romano and Hughes) were reduced by 20% from April 16, 2020 to September 30, 2020.
As part of the same
COVID-19-related
expense reduction program, ChargePoint did not adopt a formal executive bonus program for the fiscal year ended January 31, 2021. Any bonuses for the fiscal year ended January 31, 2021, were discretionary. In light of the successful completion of the Merger and overachievement of ChargePoint’s billings target, the Board approved fiscal 2021 bonuses for our named executive officers at 108% of target. The fiscal 2021 bonuses earned by our named executive officers are included in the “Bonus” column of the Fiscal Year 2021 Summary Compensation Table above. Mr. Hughes was eligible to earn sales commissions based on ChargePoint’s billings. For the fiscal year ended January 31, 2021, his target commission opportunity was 70% of his base salary. The commissions earned by Mr. Hughes are included in the
“Non-Equity
Incentive Plan” column of the Fiscal Year 2021 Summary Compensation Table above.
Effective as of the closing of the Merger, the Board approved the following changes in the base salaries and target bonuses of ChargePoint’s named executive officers: Mr. Romano’s target bonus was increased to 100% of base salary and his base salary remains unchanged, Mr. Burghardt’s target bonus was increased to 40% of his base salary and his base salary remains unchanged and Mr. Hughes’ base salary was increased to $350,000 per year and his target bonus remains unchanged.
Historically, the equity compensation granted to ChargePoint’s named executive officers has consisted of stock options. For a description of the stock options granted to ChargePoint’s named executive officers in fiscal year 2021, please see the “Outstanding Equity Award at Fiscal Year 2021
Year-End”
table below.
During the fiscal year ended January 31, 2021, Mr. Romano was granted an option to purchase 1,500,000 shares of ChargePoint’s Common Stock. As originally granted, the option was eligible to vest if ChargePoint achieved positive operating income for the fiscal year ending January 31, 2024. Effective upon consummation of the Merger, in order to provide an additional retention incentive as ChargePoint transitions to becoming a publicly-traded company, this option was amended so that it will fully vest in a single installment on January 31, 2024 subject to Mr. Romano’s service through the vesting date. The incremental fair value associated with the modification of Mr. Romano’s option will appear in our Fiscal Year 2022 Summary Compensation Table.
ChargePoint granted 100,000 restricted stock units (“RSUs”) to Mr. Burghardt and 150,000 RSUs to Mr. Hughes on June 2, 2021. These RSU awards will vest in quarterly installments over four years of service subject to the officer’s continuous service through each vesting date.
ChargePoint’s named executive officers were eligible to participate in ChargePoint’s health and welfare plans to the same extent as other full-time employees generally. ChargePoint generally did not provide ChargePoint’s named executive officers with perquisites or other personal benefits. However, ChargePoint did reimburse ChargePoint’s named executive officers for their necessary and reasonable business and travel expenses incurred in connection with their services. For all named executive officers, any reimbursed amounts considered to be a prerequisite did not exceed $10,000 in fiscal year 2021.
Employment Arrangements with ChargePoint’s Named Executive Officers
ChargePoint has entered into offer letters or employment agreements with each of its named executive officers setting forth the initial terms of the officer’s employment. Offer letters with our U.S. named executive officers provide that the officer’s employment will be “at will” and may be terminated at any time. The
 
90

employment agreement with Mr. Burghardt, who is a resident of Europe, includes statutory notice provisions required under European law. The severance benefits that ChargePoint’s named executive officers are entitled to are described in “Severance and Change in Control Benefits” below.
Severance and Change in Control Benefits
Messrs. Romano and Hughes are entitled to severance payments in the event the named executive officer’s employment is terminated by ChargePoint without Cause (as defined below) or if the officer resigns for Good Reason (as defined below) (either of which, a “Qualifying Termination”). In the case of a Qualifying Termination, the named executive officer is eligible to receive a lump sum payment equal to six months’ worth of his then current base salary and a lump sum payment equal to six months of premiums under ChargePoint’s group health plans pursuant to the Consolidated Omnibus Budget Reconciliation Action of 1985 (in the case of Mr. Romano) or benefits premiums (in the case of Mr. Hughes). As a condition to the receipt of severance benefits, the officer must execute a release of claims, resign from all positions with ChargePoint and return all company property.
Each of our named executive officers is entitled to severance payments pursuant to their severance and change in control agreements. These agreements have a three year term from the closing of the Merger and supersede any severance provisions in the officer’s offer letter or employment agreement. Pursuant to these agreements, if a named executive officer’s employment is terminated by ChargePoint without Cause (as defined below) or if the officer resigns for Good Reason (as defined below) (either of which, an “Involuntary Termination”), the officer is eligible to receive a lump sum payment equal to six months of the officer’s then current base salary and COBRA premiums. If an Involuntary Termination occurs within 3 months prior to, or within 12 months after, a Change in Control, then the cash severance payment the officer is eligible to receive is increased to 12 months of the officer’s base salary and COBRA premiums, 100% of the officer’s time-based equity awards outstanding at the time the officer’s employment terminates will vest and any outstanding performance-based equity awards will vest at the greater of the target level of achievement or based on actual performance. As a condition to the receipt of severance benefits, the officer must execute a release of claims, resign from all positions with ChargePoint and return all company property.
For purposes of the severance and acceleration benefits described above, the terms “Cause,” “Corporate Transaction,” “Change in Control” and “Good Reason” have the following meanings:
“Cause” means a named executive officer’s unauthorized use or disclosure of our confidential information or trade secrets which causes material harm, material breach of any agreement with us, material failure to comply with our written policies or rules, conviction of (or plea of guilty or “no contest” to) a felony, gross negligence or willful misconduct in the performance of the officer’s duties, continuing failure to perform assigned duties or failure to cooperate in good faith with a governmental or internal investigation.
“Corporate Transaction” means any of the following transactions whether accomplished through one or a series of related transactions: (a) a merger or acquisition in which ChargePoint is not the surviving entity, except for a transaction the principal purpose of which is to change the state in which ChargePoint is incorporated, (b) the sale, transfer or other disposition of all or substantially all of the assets of ChargePoint whether through a single transaction or a series of transactions, (c) any reverse merger in which ChargePoint is the surviving entity but in which 50% or more of ChargePoint’s outstanding voting stock is transferred to holders different from those who held the stock immediately prior to such merger or (d) a transaction or series of related transactions in which any “person” or “group” (as defined in the Exchange Act) becomes the “beneficial owner” (as defined in Rule
13d-3
under the Exchange Act) directly or indirectly of securities representing more than 50% of the voting power of ChargePoint then outstanding.
“Change in control” means any person acquires ownership of more than 50% of our voting stock, a sale of all or substantially all of our assets, consummation of a merger of the company with or into another entity if our
 
91

capital stock represents less than 50% of the voting power of the surviving entity or its parent or certain changes in the composition of the Board. The Merger is not a change in control for purposes of the severance arrangements with our named executive officers.
“Good Reason” means a material diminution in the named executive officer’s responsibilities, authority, power, functions or duties (other than a change of title), a material reduction in the officer’s base salary or benefits or the named executive officer’s office is relocated more than 50 miles from its then current location. In order to resign for Good Reason, the named executive officer must provide written notice to ChargePoint of the existence of one or more of the above conditions within 90 days of its initial existence and ChargePoint must be provided with 30 days to cure the condition. If the condition is not cured within such 30 day period, the named executive officer must terminate employment within 30 days of the end of such cure period.
In addition, Mr. Romano was granted an option to purchase 1,500,000 shares of our Common Stock in June 2020 that will accelerate with respect to 6/48th of the total option shares if Mr. Romano is subject to a termination without cause or a resignation for good reason prior to January 31, 2024. As a condition to such acceleration, Mr. Romano must execute a release of claims.
Pursuant to his employment agreement, Mr. Burghardt is entitled to a lump sum severance payment equal to six months of his base salary if his employment is terminated by ChargePoint other than as a result of Mr. Burghardt’s death, conviction of a felony or certain other statutory grounds. In addition, if Mr. Burghardt’s employment is terminated by ChargePoint other than as a result of his death, conviction of a felony or certain statutory grounds and such termination occurs within 12 months after certain transactions that result in a change in control of ChargePoint, 50% of the unvested options granted to Mr. Burghardt by ChargePoint will vest subject to Mr. Burghardt’s execution of a release of claims.
Outstanding Equity Awards at Fiscal Year 2021
Year-End
The following table provides information regarding outstanding equity awards held by ChargePoint’s named executive officers as of January 31, 2021.
The number of shares subject to each option set forth below and the applicable exercise price are as of January 31, 2021, but have been adjusted to reflect adjustments made on the Closing Date when ChargePoint options were converted into options to purchase ChargePoint’s Common Stock.
The vesting schedule applicable to each outstanding award is described in the footnotes to the table below. For information regarding the vesting acceleration provisions applicable to ChargePoint’s named executive officers’ equity awards, see “—Severance and Change in Control Benefits” above.
 
Name
  
Option Awards
 
  
Grant Date
    
Vesting
Commencement
Date
    
Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
   
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
    
Option
Exercise
Price
    
Option
Expiration
Date
 
Pasquale Romano
     3/1/2011        —          16,623       —          60.21        2/28/2021  
     6/11/2012        —          815,802       —          0.27        6/10/2022  
     11/6/2014        —          1,364,712       —          0.27        11/5/2024  
     1/26/2018        11/1/2017        2,130,232
(1)
 
    560,587        0.84        1/25/2028  
     10/23/2019        2/1/2020        342,581
(1)
 
    1,152,318        0.76        10/22/2029  
     6/2/2020        2/1/2020        —  
(2)
 
    1,494,900        0.76        6/1/2030  
Christopher Burghardt
     12/22/17        11/6/2017        89,611
(3)
 
    158,124        0.84        12/26/2027  
Michael Hughes
     8/27/2018        08/16/2018        861,469
(4)
 
    629,705        0.56        8/26/2028  
 
92

 
(1)
Option vests in 48 equal monthly installments beginning with the vesting commencement date set forth above, subject to the named executive officer’s continued employment through the applicable vesting date.
(2)
As of January 31, 2021, the option was subject to a performance condition which had not yet been achieved. Effective as of closing of the Merger, option vests in a single installment on January 31, 2024 subject to the named executive officer’s continuous service through the applicable vesting date.
(3)
Represents the unexercised portion of an option to purchase a total of 758,990 shares. 25% of the option vests on the
one-year
anniversary of the vesting commencement date set forth above and 1/48th of the option vests per month thereafter, subject to the named executive officer’s continued employment through the applicable vesting date.
(4)
Represents the unexercised portion of an option to purchase a total of 1,590,834 shares. 25% of the option vests on the
one-year
anniversary of the vesting commencement date set forth above and 1/48th of the option vests per month thereafter, subject to the named executive officer’s continued employment through the applicable vesting date.
401(k) Plan
ChargePoint maintains a 401(k) plan for employees. The 401(k) plan is intended to qualify under Section 401(a) of the Code, so that contributions to the 401(k) plan by employees or by ChargePoint, and the investment earnings thereon, are not taxable to the employees until withdrawn, and so that contributions made by ChargePoint, if any, will be deductible by ChargePoint when made. Employees may elect to reduce their current compensation by up to the statutorily prescribed annual limits and to have the amount of such reduction contributed to their 401(k) plans. The 401(k) plan permits us to make contributions up to the limits allowed by law on behalf of all eligible employees. ChargePoint currently does not make matching contributions under its 401(k) plan.
Equity Plans
2017 Stock Plan
General.
The Legacy ChargePoint Board of Directors adopted Legacy ChargePoint’s 2017 Stock Plan on December 21, 2017, and it was approved by Legacy ChargePoint’s stockholders on December 21, 2017. No further awards will be made under ChargePoint’s 2017 Stock Plan; however, awards outstanding under Legacy ChargePoint’s 2017 Stock Plan will continue to be governed by their existing terms.
Share Reserve.
As of January 31, 2021, ChargePoint has reserved 37,326,944 shares of ChargePoint Common Stock for issuance under ChargePoint’s 2017 Stock Plan plus up to 11,735,265 shares of ChargePoint Common Stock that recycle from ChargePoint’s 2007 Stock Incentive Plan, all of which may be issued as incentive stock options. As of January 31, 2021, options to purchase 24,981,124 shares of Common Stock, at exercise prices ranging from $0.56 to $0.84 per share, or a weighted-average exercise price of $0.73 per share were outstanding under ChargePoint’s 2017 Stock Plan, and 4,528,390 shares of Common Stock remained available for future issuance. Shares subject to awards granted under ChargePoint’s 2017 Stock Plan that expire or are cancelled or lapse unexercised, shares forfeited to or reacquired by us will again become available for issuance under the 2021 Plan.
2007 Stock Incentive Plan
The Legacy ChargePoint Board adopted ChargePoint’s 2007 Stock Incentive Plan on September 13, 2007, and it was approved by ChargePoint’s stockholders on November 15, 2007. ChargePoint ceased making awards under the 2007 Stock Incentive Plan after the 2017 Stock Plan was adopted and, as of January 31, 2021, there were options to purchase 5,186,053 shares of Common Stock, at exercise prices ranging from $0.27 to $65.23 per share, or a weighted-average exercise price of $0.58 per share outstanding under ChargePoint’s 2007 Stock Incentive Plan.
 
93

2021 Equity Incentive Plan
The material terms of the 2021 Equity Incentive Plan are summarized below. This summary, however, is not intended to be a complete description of the 2021 Equity Incentive Plan and is qualified in its entirety by reference to the complete text of the 2021 Equity Incentive Plan, which is filed as an exhibit to the registration statement of which this prospectus is a part. To the extent there is a conflict between the terms of this summary and the 2021 Equity Incentive Plan, the terms of the 2021 Equity Incentive Plan will control.
Types of Awards.
The 2021 Equity Incentive Plan provides for the grant stock options, which may be ISOs or nonstatutory stock options (“NSOs”), stock appreciation rights (“SARs”), restricted shares and restricted stock units (“RSUs”), or collectively, awards.
Administration.
The 2021 Equity Incentive Plan will be administered by the Board or by one or more committees to which the Board delegates such administration (as applicable, the “2021 Plan Administrator”). Subject to the terms of the 2021 Equity Incentive Plan, the 2021 Plan Administrator will have the complete discretion to determine the eligible individuals who are to receive awards under the plan, to determine the terms and conditions of awards granted under the 2021 Equity Incentive Plan and to make all decisions related to the 2021 Equity Incentive Plan and awards granted thereunder.
Share Reserve.
The number of shares of Common Stock that may be issued under the 2021 Equity Incentive Plan is equal to the sum of (x) 27,200,000 shares, plus (y) up to 39,000,000 shares subject to awards granted under Legacy ChargePoint’s 2017 Stock Plan and 2007 Stock Incentive Plan (the “Predecessor Plans”) that are outstanding on September 30, 2020 (the “Merger Date”) and that are subsequently forfeited, expire or lapse unexercised or unsettled or are reacquired by ChargePoint, plus (z) the annual increase in shares described below. While a maximum of 39,000,000 shares could have been added to the 2021 Equity Incentive Plan from the Predecessor Plans, only 30,135,695 shares were issuable upon awards outstanding awards under the Predecessor Plans on the Merger Date. In addition since we do not expect all awards outstanding under the Predecessor Plans on the Merger Date will be forfeited, ChargePoint expects the actual number of shares added to the 2021 Equity Incentive Plan to be less.
On the first day of each March during the term of the 2021 Equity Incentive Plan, beginning on March 1, 2021 and ending on (and including) March 1, 2030, the number of shares of Common Stock that may be issued under the 2021 Equity Incentive Plan will increase by a number of shares equal to the lesser of (a) 5% of the outstanding shares on the last day of the immediately preceding month or (b) such lesser number of shares (including zero) that the 2021 Plan Administrator determines for purposes of the annual increase for that fiscal year. On March 1, 2021, the number of shares of Common Stock that may be issued under the 2021 Equity Incentive Plan increased by 13,888,417 shares.
If options, stock appreciation rights, restricted stock units or any other awards are forfeited, cancelled or expire, the shares subject to such awards will again be available for issuance under the 2021 Equity Incentive Plan. If stock appreciation rights are exercised or restricted stock units are settled, only the number of shares actually issued upon exercise or settlement of such awards will reduce the number of shares available under the 2021 Equity Incentive Plan. If restricted shares or shares issued upon exercise of an option are reacquired by the ChargePoint pursuant to a forfeiture provision, repurchase right or for any other reason, then such shares will again be available for issuance under the 2021 Equity Incentive Plan. Shares applied to pay the exercise price of an option or satisfy withholding taxes related to any award will again become available for issuance under the 2021 Equity Incentive Plan. To the extent an award is settled in cash, the cash settlement will not reduce the number of shares available for issuance under the 2021 Equity Incentive Plan.
Shares issued under the 2021 Equity Incentive Plan may be authorized but unissued shares or treasury shares. As of July 31, 2021, 4,679,586 awards have been granted under the 2021 Equity Incentive Plan.
 
94

Incentive Stock Option Limit.
No more than 75,000,000 shares of Common Stock may be issued under the 2021 Equity Incentive Plan upon the exercise of ISOs.
Annual Limitation on Compensation of
Non-Employee
Directors.
The grant date fair value of awards granted to each
non-employee
director during any fiscal year of ChargePoint, together with the value of any cash compensation paid to the
non-employee
director during such fiscal year, may not exceed $750,000. This limit is increased to $1,000,000 in the fiscal year a
non-employee
director is initially appointed or elected to the Board. Compensation paid to an individual for services as an employee or consultant will not count towards these limitations.
Eligibility.
Employees (including officers),
non-employee
directors and consultants who render services to ChargePoint or a parent, subsidiary or affiliate thereof (whether now existing or subsequently established) are eligible to receive awards under the 2021 Equity Incentive Plan. ISOs may only be granted to employees of ChargePoint or a parent or subsidiary thereof (whether now existing or subsequently established).
International Participation.
The 2021 Plan Administrator has the authority to implement
sub-plans
(or otherwise modify applicable grant terms) for purposes of satisfying applicable foreign laws, conforming to applicable market practices or for qualifying for favorable tax treatment under applicable foreign laws, and the terms and conditions applicable to awards granted under any such
sub-plan
or modified award may differ from the terms of the 2021 Equity Incentive Plan. Any shares issued in satisfaction of awards granted under a
sub-plan
will come from the 2021 Equity Incentive Plan share reserve.
Repricing.
The 2021 Plan Administrator has full authority to reprice (reduce the exercise price of) options and stock appreciation rights or to approve programs in which options and stock appreciation rights are exchanged for cash or other equity awards on terms the 2021 Plan Administrator determines.
Stock Options.
A stock option is the right to purchase a certain number of shares of stock at a fixed exercise price which, pursuant to the 2021 Equity Incentive Plan, may not be less than 100% of the fair market value of ChargePoint’s Common Stock on the date of grant. Subject to limited exceptions, an option may have a term of up to 10 years and will generally expire sooner if the optionee’s service terminates. Options will vest at the rate determined by the 2021 Plan Administrator. An optionee may pay the exercise price of an option in cash, or, with the administrator’s consent, with shares of Common Stock the optionee already owns, with proceeds from an immediate sale of the option shares through a broker approved by us, through a net exercise procedure or by any other method permitted by applicable law.
Stock Appreciation Rights (SAR).
A stock appreciation right provides the recipient with the right to the appreciation in a specified number of shares of stock. The 2021 Plan Administrator determines the exercise price of stock appreciation rights granted under the 2021 Equity Incentive Plan, which may not be less than 100% of the fair market value of Common Stock on the date of grant. Subject to limited exceptions, a stock appreciation right may have a term of up to 10 years and will generally expire sooner if the recipient’s service terminates. SARs will vest at the rate determined by the 2021 Plan Administrator. Upon exercise of a SAR, the recipient will receive an amount in cash, stock, or a combination of stock and cash determined by the 2021 Plan Administrator, equal to the excess of the fair market value of the shares being exercised over their exercise price.
Tax Limitations on Incentive Stock Options (ISO).
The aggregate fair market value, determined at the time of grant, of Common Stock with respect to ISOs that are exercisable for the first time by an optionholder during any calendar year under all of ChargePoint’s stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of ChargePoint’s total combined voting power or that of any of ChargePoint’s affiliates unless (a) the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant and (b) the term of the ISO does not exceed five years from the date of grant.
 
95

Restricted Stock Awards.
Shares of restricted stock may be issued under the 2021 Equity Incentive Plan for such consideration as the 2021 Plan Administrator may determine, including cash, services rendered or to be rendered to ChargePoint, promissory notes or such other forms of consideration permitted under applicable law. Restricted shares may be subject to vesting, as determined by the 2021 Plan Administrator. Recipients of restricted shares generally have all of the rights of a stockholder with respect to those shares, including voting rights, however any dividends and other distributions on restricted shares will generally be subject to the same restrictions and conditions as the underlying shares.
Restricted Stock Units (RSU).
A restricted stock unit is a right to receive a share, at no cost to the recipient, upon satisfaction of certain conditions, including vesting conditions, established by the 2021 Plan Administrator. RSUs vest at the rate determined by the 2021 Plan Administrator and any unvested RSUs will generally be forfeited upon termination of the recipient’s service. Settlement of restricted stock units may be made in the form of cash, Common Stock or a combination of cash and Common Stock, as determined by the 2021 Plan Administrator. Recipients of restricted stock units generally will have no voting or dividend rights prior to the time the vesting conditions are satisfied and the award is settled. At the 2021 Plan Administrator’s discretion and as set forth in the applicable restricted stock unit agreement, restricted stock units may provide for the right to dividend equivalents which will generally be subject to the same conditions and restrictions as the restricted stock units to which they pertain.
Other Awards.
The 2021 Plan Administrator may grant other awards based in whole or in part by reference to Common Stock and may grant awards under other plans and programs that will be settled with shares issued under the 2021 Equity Incentive Plan. The 2021 Plan Administrator will determine the terms and conditions of any such awards.
Changes to Capital Structure.
In the event of certain changes in capitalization, including a stock split, reverse stock split or stock dividend, proportionate adjustments will be made in the number and kind of shares available for issuance under the 2021 Equity Incentive Plan, the number of shares that may be added to the 2021 Equity Incentive Plan from the Predecessor Plans, the limit on the number of shares that may be issued under the 2021 Equity Incentive Plan as ISOs, the number and kind of shares subject to each outstanding award and/or the exercise price of each outstanding award.
Corporate Transactions.
If ChargePoint is party to a merger, consolidation or certain change in control transactions, each outstanding award will be treated as described in the definitive transaction agreement or as the 2021 Plan Administrator determines, which may include the continuation, assumption or substitution of an outstanding award, the cancellation of an outstanding award after an opportunity to exercise or the cancellation of an outstanding award in exchange for a payment equal to the value of the shares subject to such award less any applicable exercise price. In general, if an award held by a participant who remains in service at the effective time of a change in control transaction is not continued, assumed or substituted, then the award will vest in full.
Change of Control.
The 2021 Plan Administrator may provide, in an individual award agreement or in any other written agreement with a participant that the award will be subject to acceleration of vesting and exercisability in the event of a change of control or in connection with a termination of employment in connection with or following a change in control.
Transferability of Awards.
Unless the 2021 Plan Administrator determines otherwise, an award generally will not be transferable other than by beneficiary designation, a will or the laws of descent and distribution. The 2021 Plan Administrator may permit transfer of an award in a manner consistent with applicable law.
Amendment and Termination.
The 2021 Plan Administrator may amend or terminate the 2021 Equity Incentive Plan at any time. Any such amendment or termination will not affect outstanding awards. If not sooner terminated, the 2021 Equity Incentive Plan will terminate automatically in 2031, 10 years after its adoption by the Board. Shareholder approval is not required for any amendment of the 2021 Equity Incentive Plan, unless required by applicable law or exchange listing standards.
 
96

2021 Employee Stock Purchase Plan
The following summary of the principal provisions of the ESPP is qualified in its entirety by reference to the full text of the ESPP. A copy of the ESPP is filed as an exhibit to the registration statement of which this prospectus is a part. To the extent there is a conflict between this summary and the ESPP, the terms of the ESPP will govern.
General.
The ESPP is intended to qualify as an “employee stock purchase plan” under Section 423 of the Code; however, the ESPP also allows ChargePoint to conduct offerings for
non-U.S.
employees that do not qualify under Section 423 of the Code as described in “International Participation” below. During regularly scheduled “offering periods” under the ESPP, participants will be able to request payroll deductions which will be applied periodically to purchase a number of shares of Common Stock at a discount to the market price and in an amount determined in accordance with the ESPP’s terms.
Administration.
The ESPP will be administered by the Board or by one or more committees to which the Board delegates such administration (as applicable, the “ESPP Administrator”). Subject to the terms of the ESPP, the ESPP Administrator will have the complete discretion to establish the terms and conditions of offering periods under the ESPP, to interpret the ESPP and to make all decisions related to the operation of the ESPP.
Shares Available for Issuance.
Up to a maximum of 5,400,000 shares of Common Stock may be issued under the ESPP, plus an annual increase in shares described below.
On the first day of each March during the term of the ESPP, beginning on March 1, 2021 and ending on (and including) March 1, 2040, the number of shares of Common Stock that may be issued under the ESPP will increase by a number of shares equal to the least of (a) 1% of the outstanding shares on the last day of the immediately preceding month, (b) 5,400,000 shares or (c) such lesser number of shares (including zero) that the ESPP Administrator determines for purposes of the annual increase for that fiscal year. On March 1, 2021, the number of shares of Common Stock that may be issued under the ESPP increased by 2,777,683 shares.
Shares issued under the ESPP may be authorized but unissued shares or treasury shares. As of the date hereof, no shares have been granted under the ESPP.
Eligibility and Participation.
All employees (including officers and employee directors) who are employed by ChargePoint or a designated subsidiary or, solely in the case of an offering period that is not intended to qualify under Section 423 of the Code, a designated affiliate (whether currently existing or subsequently established) are eligible to participate in the ESPP. The ESPP Administrator may exclude certain categories of employees from participating in any offering period to the extent permitted by Section 423 of the Code, including part-time employees, seasonal employees, employees who have not completed a minimum period of service with us and/or highly compensated employees. No employee will be allowed to participate in the ESPP if his or her participation in the ESPP is prohibited by local law or if complying with local law would cause the ESPP or an offering period that is intended to qualify under Section 423 of the Code to violate the requirements of Section 423 of the Code. In the case of an offering period that is not intended to qualify under Section 423 of the Code, the ESPP Administrator may exclude any individual(s) from participation if the ESPP Administrator determines that the participation of such individual(s) is not advisable or practicable. Also, in accordance with Section 423 of the Code, no employee may be granted an option under the ESPP, if immediately, after the grant such employee would own stock and/or hold outstanding options to purchase stock possessing more than 5% of the total combined voting power or value of all classes of the stock of ChargePoint or any parent or subsidiary.
The ESPP will permit an eligible employee to purchase Common Stock through payroll deductions, which may not exceed 15% of the employee’s eligible compensation (or such lower limit as may be determined by the ESPP Administrator for an offering period). Employees will be able to withdraw their accumulated payroll deductions prior to the end of the offering period in accordance with the terms of the offering period. Participation
 
97

in the ESPP will end automatically upon termination of employment. In the event of withdrawal or termination of participation in the ESPP, a participant’s accumulated payroll contributions will be refunded without interest.
Certain limitations on the number of shares that a participant may purchase apply. For example, the option granted to an employee may not permit him or her to purchase stock under the ESPP at a rate which exceeds $25,000 in fair market value of such stock (determined as of the start of the applicable offering period) for each calendar year in which the option is outstanding. The ESPP Administrator may also establish one or more limits on the number of shares that may be purchased during any offering period and/or purchase period. Unless the ESPP Administrator provides otherwise with respect to an offering period, no participant may purchase more than 10,000 shares during any purchase period within an offering period.
International Participation.
To provide ChargePoint with greater flexibility in structuring its equity compensation programs for
non-U.S.
employees, the ESPP also permits ChargePoint to grant employees of ChargePoint’s
non-U.S.
subsidiaries and affiliates rights to purchase shares of Common Stock pursuant to other offering periods and/or
sub-plans
adopted by the ESPP Administrator in order to achieve tax, securities law or other compliance objectives. While the ESPP is intended to be a qualified “employee stock purchase plan” within the meaning of Section 423 of the Code, any such international
sub-plans
or offerings are not required to satisfy those U.S. tax code requirements and therefore may have terms that differ from the ESPP terms applicable in the United States.
Offering Periods and Purchase Price.
The ESPP will be implemented through a series of offerings periods of up to 27 months, which may consist of one or more purchase periods. During each purchase period, payroll contributions will accumulate without interest. On the last trading day of the purchase period, accumulated payroll deductions will be used to purchase Common Stock.
The purchase price for each offering period will be established by the ESPP Administrator and may not be less than 85% of the fair market value per share of Common Stock on either the first trading day in an offering period or on the purchase date, whichever is less.
Changes in Capital Structure. In the event that there is a specified type of change in ChargePoint’s capital structure, such as a stock split, appropriate adjustments will be made to (a) the number of shares reserved under the ESPP and the maximum size of the annual increase in shares, (b) the individual participant share limitations described in the ESPP and (c) the purchase price per share and the number and class of stock covered by each outstanding option which has not yet been exercised.
Corporate Reorganization.
In the event of certain corporate reorganizations, any offering period then in progress will terminate unless the ESPP is continued, assumed or substituted by ChargePoint or its parent. In the event an offering period is terminated, a new purchase date will be set for such offering period prior the effective time of the reorganization and each outstanding purchase right will be exercised on such date.
Amendment and Termination.
The ESPP Administrator will have the right to amend, suspend or terminate the ESPP at any time. Any increase in the aggregate number of shares of stock to be issued under the ESPP is subject to stockholder approval. Any other amendment is subject to stockholder approval only to the extent required under applicable law or regulation. If not sooner terminated, the ESPP will terminate in 2041 on the twentieth anniversary of the date the Board adopted the ESPP.
Fiscal Year 2021 Director Compensation
In fiscal year 2021, ChargePoint paid certain of its directors an annual retainer in connection with their service on the Board. ChargePoint also had a policy of reimbursing all of its
non-employee
directors for their reasonable
out-of-pocket
expenses in connection with attending Board and committee meetings. From time to time, ChargePoint has granted stock options to certain of its
non-employee
directors, typically in connection with a
non-employee
director’s initial appointment to the Board.
 
98

The following table sets forth information regarding the compensation of ChargePoint’s
non-employee
directors during the fiscal year ended January 31, 2021:
 
Name
  
Fees Earned or
Paid in Cash
($)
    
Option
Awards
($)
(1)
   
Total
($)
 
Bruce Chizen
     40,000        2,485,949
(2)
 
    2,525,949  
Roxanne Bowman
     40,000        —  
(3)
 
    40,000  
Axel Harries
     —          —         —    
Jeffrey Harris
     —          —         —    
Mark Leschly
     —          —         —    
Michael Linse
     —          —         —    
Richard Lowenthal
     —          —  
(4)
 
    —    
Neil S. Suslak
     —          —         —    
G. Richard Wagoner Jr.
     40,000        —  
(5)
 
    40,000  
 
(1)
The amounts in this column represent the aggregate grant date fair value of option awards granted to the
non-employee
director in the applicable fiscal year computed in accordance with FASB ASC Topic 718. See Note 13 of the notes to ChargePoint’s consolidated financial statements included elsewhere in this prospectus for a discussion of the assumptions made by ChargePoint in determining the grant date fair value of its equity awards.
(2)
As of January 31, 2021, Mr. Chizen held options to purchase 398,640 shares of ChargePoint Common Stock in the aggregate.
(3)
As of January 31, 2021, Ms. Bowman held options to purchase 348,810 shares of ChargePoint Common Stock in the aggregate.
(4)
As of January 31, 2021, Mr. Lowenthal held options to purchase 235,963 shares of ChargePoint Common Stock in the aggregate.
(5)
As of January 31, 2021, Mr. Wagoner held options to purchase 379,717 shares of ChargePoint Common Stock in the aggregate.
ChargePoint has implemented a compensation program for its
non-employee
directors. Pursuant to this program,
non-employee
directors will receive the following cash compensation, paid quarterly in arrears:
 
Position
  
Annual
Retainer
 
Board service plus (as applicable):
   $ 40,000  
Board Chair
   $ 30,000  
Audit Committee Chair
   $ 20,000  
Compensation and Organizational Development Committee Chair
   $ 15,000  
Nominating/Governance Committee Chair
   $ 8,000  
ChargePoint will reimburse
non-employee
directors for their reasonable
out-of-pocket
expenses incurred in connection with attending Board and committee meetings.
In addition,
non-employee
directors will receive automatic grants of equity awards under the 2021 Plan. Upon joining the Board, a new
non-employee
director will receive RSUs with an approximate grant date value of $350,000. This new director equity award will vest in three annual installments on each anniversary of the date of grant subject to the director’s continued service on the board through each such anniversary. In connection with each annual meeting of stockholders, each
non-employee
director who will continue to serve on ChargePoint’s Board (other than a director who joined the board within three months prior to the annual meeting) will receive RSUs with an approximate grant date value of $185,000 ($92,500 in the case of a
non-employee
director who joined the board at least three, but less than six, months prior to the date of the annual meeting). These annual equity awards will vest in full on the earlier of the
one-year
anniversary of the date of grant or the date of the
 
99

next annual meeting of stockholders subject to the director’s continued service on the board through such date. Both new director equity awards and annual equity awards will vest in full in the event of a change in control while the
non-employee
director remains in service.
Non-employee
directors who served on the Legacy ChargePoint Board prior to the Merger are not eligible for new director equity awards in connection with joining the Board. Instead, following the closing of the Merger, certain of ChargePoint’s directors, Messrs. Harries, Harris, Leschly, Linse and Wagoner received
one-time
equity awards consisting of 18,500 RSUs that will vest in full on the earlier of the
one-year
anniversary of closing of the Merger or a change in control subject to the director’s continued service on the board through such date.
 
100

BENEFICIAL OWNERSHIP OF SECURITIES
The following table sets forth information known to ChargePoint regarding the beneficial ownership of ChargePoint’s Common Stock as of October 1, 2021 by:
 
   
each person who is known by ChargePoint to be the beneficial owner of more than five percent (5%) of the outstanding shares of Common Stock;
 
   
each current named executive officer and director of ChargePoint; and
 
   
all current executive officers and directors of ChargePoint, as a group.
Beneficial ownership for the purposes of the following table is determined in accordance with the rules and regulations of the SEC. A person is a “beneficial owner” of a security if that person has or shares “voting power,” which includes the power to vote or to direct the voting of the security, or “investment power,” which includes the power to dispose of or to direct the disposition of the security or has the right to acquire such powers within 60 days.
The beneficial ownership percentages set forth in the table below are based on 324,904,565 shares of Common Stock issued and outstanding as of October 1, 2021.
Unless otherwise noted in the footnotes to the following table, and subject to applicable community property laws, the persons and entities named in the table have sole voting and investment power with respect to their beneficially owned Common Stock and preferred stock.
Unless otherwise noted in the footnotes to the following table, the business address of each executive officer and director is 240 East Hacienda Avenue, Campbell, California 95008.
 
Name of Beneficial Owners
  
Number of
Shares of
Common Stock
Beneficially
Owned
    
Percentage
of
Outstanding
Common
Stock
 
5% Stockholders:
     
Entities affiliated with Linse Capital, LLC
(1)
     73,455,084        21.8 %
Q-GRG VII (CP) Investment Partners, LLC
(2)
     34,444,824        10.3 %
Rho Ventures VI, L.P.
(3)
     25,073,877        7.7 %
Entities affiliated with Braemar Energy Ventures III, LP
(4)
     19,786,711        6.1 %
CPP Investment Board (USRE) Inc.
(5)
     20,165,208        6.1 %
Named Executive Officers and Directors:
     
Pasquale Romano
(6)
     7,526,213        2.3 %
Christopher Burghardt
(7)
     545,471        *  
Michael Hughes
(8)
     1,261,017        *  
Roxanne Bowman
(9)
     201,179        *  
Bruce Chizen
(10)
     1,064,245        *  
Axel Harries
            *  
Jeffrey Harris
            *  
Susan Heystee
            *  
Mark Leschly
(11)
     420,946        *  
Michael Linse
(12)
     73,455,084        21.8 %
G. Richard Wagoner, Jr.
(13)
     462,859        *  
All directors and executive officers as a group (17 individuals)
(14)
    
88,774,206
      
27.3
 
 
*
Less than one percent
 
101

(1)
Includes (a) 25,156,256 shares of Common Stock held directly by Linse Capital CP LLC (“Linse I”), (b) 7,284,087 shares of Common Stock held directly by Linse Capital CP II LLC (“Linse II”), (c) 8,195,682 shares of Common Stock held directly by Linse Capital CP III, LLC (“Linse III”), (d) 5,672,261 shares of Common Stock held directly by Linse Capital CP IV, LLC (“Linse IV”), (e) 6,008,549 shares of Common Stock and 2,166,266 shares of Common Stock subject to a warrant exercisable within 60 days of October 1, 2021, all of which is held directly by Linse Capital CP V, LLC (“Linse V”) and (f) 9,573,040 shares of Common Stock and 9,389,424 shares of Common Stock subject to a warrant exercisable within 60 days of October 1, 2021, all of which is held directly by Linse Capital CP VI, LLC (“Linse VI,” and collectively, the “Linse Funds”), and (g) 9,519 shares of Common Stock held directly by Linse Capital CP VI GP LP (“Linse GP VI”). Linse Capital CP VI GP LP (“Linse GP VI”) is the manager of Linse VI, and Linse Capital Management PR LLC (“LCMPR”) is the general partner of Linse GP VI. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of LCMPR and the managing member of Linse I, Linse II, Linse III, Linse IV and Linse V. Mr. Linse has sole voting and investment power over the shares held by each of the Linse Funds. The principal address of Linse I, Linse II, Linse III, Linse IV and Linse V is 53 Calle Palmeras, Suite 601, San Juan, Puerto Rico 00901. The principal address of Linse VI is 985 Damonte Ranch Parkway, Suite 240, Reno, NV 89521.
(2)
Includes 23,320,751 shares of Common Stock and 11,124,073 shares of Common Stock subject to a warrant exercisable within 60 days of October 1, 2021, all of which is held directly by Q-GRG VII (CP) Investment Partners, LLC (“Q-GRG”). QEM VII, LLC (“QEM VII”) is the managing member of Q-GRG. Therefore, QEM VII may be deemed to share voting and dispositive power over the securities held by Q-GRG and may also be deemed to be the beneficial owner of these securities. QEM VII disclaims beneficial ownership of such securities in excess of its pecuniary interest in the securities. Any decision taken by QEM VII to vote, or to direct to vote, and to dispose, or to direct the disposition of, the securities held by Q-GRG has to be approved by a majority of the members of its investment committee, which majority must include S. Wil VanLoh, Jr. and Dheeraj Verma. Therefore, Messrs. VanLoh, Jr. and Verma may be deemed to share voting and dispositive power over the securities held by Q-GRG and may also be deemed to be the beneficial owner of these securities. Messrs. VanLoh, Jr. and Verma disclaim beneficial ownership of such securities in excess of their pecuniary interests in the securities. The principal address of Q-GRG is 800 Capitol Street, Suite 3600, Houston, TX 77002.
(3)
Includes 25,073,877 shares of Common Stock which is held directly by Rho Ventures VI, L.P. (“RV VI”). RMV VI, L.L.C. (“RMV VI”) is the General Partner of RV VI, and Rho Capital Partners LLC (“RCP LLC”) is the Managing Member of RMV VI, and as such each of RCP LLC and RMV VI has the power to direct the voting and disposition of the shares owned by RV VI and may be deemed to have indirect beneficial ownership of the shares held by RV VI. As managing members of RCP LLC, Joshua Ruch and Habib Kairouz possess the power to direct the voting and disposition of the shares owned by RV VI and may be deemed to have indirect beneficial ownership of the shares held by RV VI. The principal address of each of RV VI is 152 West 57th St., 23rd Floor, New York, NY 10019.
(4)
Includes (a) 313,356 shares of Common Stock held directly by Braemar CP Investments 2019 LLC, (b) 2,411,765 shares of Common Stock held directly by Braemar CP Investments II 2020, LLC, (c) 10,346,019 shares of Common Stock and 29,273 shares of Common Stock subject to a warrant exercisable within 60 days of October 1, 2021, all of which is held directly by Braemar Energy Ventures III, L.P., (d) 2,742,388 shares of Common Stock and 53,773 shares of Common Stock subject to a warrant exercisable within 60 days of October 1, 2021, all of which is held directly by ChargePoint Investments LLC, (e) 790,755 shares of Common Stock held directly by ChargePoint Investments II, LLC and (f) 1,633,331 shares of Common Stock and 1,466,051 shares of Common Stock subject to a warrant exercisable within 60 days of October 1, 2021, all of which is held directly by Braemar ChargePoint Investments III, LLC (collectively, the “Braemar Funds”). Mr. Suslak is the Managing Partner of Braemar Energy Ventures, which is the General Partner of each of the Braemar Funds. Mr. Suslak shares voting and investment power over the shares held by each of the Braemar Funds with William D. Lese and Donald F. Tappan, III. Each of Messrs. Suslak, Lese and Tappan disclaim beneficial ownership of the securities held by the Braemar Funds. The principal address of each of the funds is c/o Braemar Energy Ventures, 350 Madison Avenue, 23rd Floor, New York, NY 10017.
 
102

(5)
Canada Pension Plan Investment Board (“CPPIB”), through its wholly-owned subsidiary CPP Investment Board (USRE) Inc. (“USRE”), beneficially owns (a) 14,720,268 shares of Common Stock and (b) 5,444,940 shares of Common Stock subject to a warrant exercisable within 60 days of October 1, 2021. CPPIB is managed by a board of directors and because the board of directors acts by consensus/majority approval, none of the members of the CPPIB board of directors has sole voting or dispositive power with respect to the securities of ChargePoint held by USRE. The principal address of USRE is c/o Canada Pension Plan Investment Board, One Queen St., E Suite 2600, Toronto, ON M5C 2W5, Canada.
(6)
Includes (a) 2,284,712 shares of Common Stock and (b) 5,241,501 shares of Common Stock subject to options exercisable within 60 days of October 1, 2021 held directly by Mr. Romano. 436,364 shares of Common Stock held by Mr. Romano are pledged to collateralize a personal loan entered into in May 10, 2021.
(7)
Includes (a) 513,737 shares of Common Stock and (b) 31,734 shares of Common Stock subject to options exercisable within 60 days of October 1, 2021, all of which is held directly by Mr. Burghardt.
(8)
Includes (a) 168,120 shares of Common Stock and (b) 1,092,897 shares of Common Stock subject to options exercisable within 60 days of October 1, 2021, all of which is held directly by Mr. Hughes.
(9)
Includes (a) 12,240 shares of Common Stock and (b) 188,939 shares of Common Stock subject to options exercisable within 60 days of October 1, 2021 held by Ms. Bowman.
(10)
Includes (a) 7,407 shares of Common Stock and (b) 157,795 shares of Common Stock subject to options exercisable within 60 days of October 1, 2021 held directly by Mr. Chizen, (b) 767,237 shares of Common Stock and (c) 87,821 shares of Common Stock subject to a warrant exercisable within 60 days of October 1, 2021, all of which is held directly by the Bruce Chizen 2009 Irrevocable Trust, dated January 24, 2009 (the “Chizen Trust”) and (c) 43,985 shares of Common Stock held directly by the Gail Chizen 2009 Irrevocable Trust (the “Gail Chizen Trust”). Mr. Chizen is the co-trustee of each the Chizen Trust and the Gail Chizen Trust and has shared voting and investment power over the shares held by each of the Chizen Trust and the Gail Chizen Trust.
(11)
Includes 420,946 shares of Common Stock held directly by Iconica LLC. As the managing member of Iconica LLC, Mr. Leschly possesses sole power to direct the voting and disposition of the shares owned by Iconica LLC. The principal address of Iconica LLC is c/o Iconica Partners, 525 University Avenue, Suite 1350, Palo Alto, CA 94301.
(12)
See footnote 1.
(13)
Includes (a) 4,156 shares of Common Stock and (b) 379,717 shares of Common Stock subject to options exercisable within 60 days of October 1, 2021 held by Mr. Wagoner and (b) 43,857 shares of Common Stock and 35,129 shares of Common Stock subject to a warrant exercisable within 60 days of October 1, 2021, all of which is held directly by the G. Richard Wagoner, Jr. Trust dated July 13, 1989, as amended and restated October 19, 2018 (the “Wagoner Trust”). Mr. Wagoner is the trustee of the Wagoner Trust and has sole voting and investment power over the shares held by the Wagoner Trust.
(14)
Includes (a) 9,749,315 shares of Common Stock subject to options exercisable within 60 days of October 1, 2021, (b) 11,827,935 shares of Common Stock subject to a warrant exercisable within 60 days of October 1, 2021.
 
103

SELLING SECURITYHOLDERS
ChargePoint’s Issuance of Shares to former stockholders of has•to•be gmbh
On July 20, 2021, ChargePoint and its wholly owned subsidiary ChargePoint European Holdings B.V. (“ChargePoint Europe”) entered into a Share Purchase and Transfer Agreement (the “Share Purchase Agreement”) pursuant to which ChargePoint Europe agreed to acquire has•to•be gmbh for aggregate consideration of Euro 250.0 million payable in cash and ChargePoint common stock, subject to adjustments. On October 6, 2021, ChargePoint Europe completed its acquisition of has•to•be gmbh (the “Closing”) and paid to the former stockholders of has•to•be gmbh an aggregate of 5,695,176 shares of ChargePoint’s common stock (the “Shares”) pursuant to the terms of the Share Purchase Agreement, of which 885,692 Shares are subject to escrow to secure potential future indemnification claims. The Shares were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act because such issuance did not involve a public offering.
Registration Rights Agreement
In accordance with the terms of the Share Purchase Agreement, on October 6, 2021, ChargePoint also entered into a registration rights agreement (the “Registration Rights Agreement”) with the Registration Rights Holders. The Registration Rights Agreement requires ChargePoint, as promptly as practicable and in any event on or prior to the Required Shelf Filing Date, to prepare and file a “shelf” registration statement under the Securities Act to permit the resale of the Registrable Securities from time to time as permitted by Rule 415 under the Securities Act (or any similar provision adopted by the Commission then in effect) (the “Shelf Registration Statement”). ChargePoint agreed to use its commercially reasonable efforts to cause such Shelf Registration Statement to become or be declared effective as soon as practicable after the filing thereof and, in any event, 90 days after the date of filing.
ChargePoint is required to use its commercially reasonable efforts to cause the Shelf Registration Statement to remain effective, and to be supplemented and amended as promptly as practicable to the extent necessary to ensure that the Shelf Registration Statement is available or that another registration statement is available, for the resale of all the Registrable Securities until the earliest of (i) two years after October 6, 2021, (ii) all of the Issued Shares and any securities issued or issuable with respect to the Issued Shares by way of distribution or in connection with any reorganization or other recapitalization, merger, consolidation or otherwise have ceased to be Registrable Securities, and (iii) the earlier termination of the Registration Rights Agreement (as to all holders).
The Selling Securityholders
The selling securityholders may from time to time offer and sell any or all of the Common Stock set forth below pursuant to this prospectus and any accompanying prospectus supplement The selling securityholders will pay any underwriting discounts and commissions and expenses incurred by the selling securityholders for brokerage, accounting, tax or legal services or any other expenses incurred by the selling securityholders in disposing of the securities, except that we have agreed to pay certain expenses for legal counsel to the selling securityholders. We will bear the costs, fees and expenses incurred in effecting the registration of the securities covered by this prospectus, including all registration and filing fees, listing fees and fees and expenses of our counsel and our independent registered public accounting firm.
The following table sets forth, as of the date of this prospectus, the names of the selling securityholders, the aggregate number of shares of Common Stock held by the selling securityholders, the number of shares of our Common Stock by the selling securityholders that may be sold and the number of shares of Common Stock that
the selling securityholders will beneficially own after this offering. For purposes of the table below, we have assumed that (i) after this offering none of the shares of Common Stock covered by this prospectus will be beneficially owned by the selling securityholders and (ii) the selling securityholders will not acquire beneficial ownership of any additional securities. See also “Certain Relationships and Related Parties Transactions” and
 
104

“Management” for additional information regarding relationships between the selling securityholders and ChargePoint. In addition, we assume that the selling securityholders have not sold, transferred or otherwise disposed of, our securities in transactions exempt from the registration requirements of the Securities Act.
Beneficial ownership for the purposes of the following table is determined in accordance with the rules and regulations of the SEC. A person is a “beneficial owner” of a security if that person has or shares “voting power,” which includes the power to vote or to direct the voting of the security, or “investment power,” which includes the power to dispose of or to direct the disposition of the security or has the right to acquire such powers within 60 days.
The beneficial ownership percentages set forth in the table below are based on 324,904,565 shares of Common Stock issued and outstanding as of October 1, 2021.
Unless otherwise noted in the footnotes to the following table, the business address of each executive officer and director of ChargePoint is 240 East Hacienda Avenue, Campbell, California 95008.
The selling securityholders may sell or otherwise transfer some or none of such shares in this offering.
 
    
Number of Shares
Beneficially Owned
Before this Offering
    
Number of
Shares of
Common
Stock
Offered
Hereby
    
Number of Shares
Beneficially Owned
After Sale of All Shares
of Common Stock
Offered Hereby
 
    
Number
   
Percent
    
Number
    
Number
    
Percent
 
Selling Securityholders
             
Miross Management AG
(1)
     1,632,841
(3)
 
    *        1,632,841        —          *  
Martin Klässner
     1,031,191
(4)
 
    *        1,031,191        —          *  
Other selling securityholders
(2)
     3,031,144
(5)
 
    *        3,031,144        —          *  
 
*
Less than one percent.
(1)
Dr. Gerhard Roiss, Dr. Michael Roiss, Dr. Michaela Roiss and Thomas Roiss exercise shared voting and dispositive power over Miross Management AG and as such may be deemed to beneficially own the shares held by Miross Management AG. The principal address of Miross Management AG is Höh-Rohnenweg 27, CH-8832 Willen, Switzerland.
(2)
Represents shares held by nine selling securityholders not listed above who, as a group, owned less than one percent of our outstanding shares of our Common Stock prior to this offering.
(3)
Includes 236,568 shares which are held in escrow, to secure certain indemnification claims and may thereafter be released to the holder.
(4)
Includes 203,709 shares which are held in escrow, to secure certain indemnification claims and may thereafter be released to the holder.
(5)
Includes 445,415 shares which are held in escrow, to secure certain indemnification claims and may thereafter be released to the holders.
 
105

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
Switchback Related Party Transactions
Founder Shares
On May 16, 2019, Switchback issued an aggregate of 8,625,000 Founder Shares to the Sponsor for an aggregate purchase price of $25,000 in cash, or approximately $0.003 per share. In July 2019, the Sponsor transferred 40,000 Founder Shares to each of our independent director nominees at their original purchase price. In September 2019, the Sponsor forfeited an aggregate of 772,059 Founder Shares. On July 31, 2020, the Sponsor transferred an aggregate of 40,000 Founder Shares to our third independent director at their original purchase price.
Pursuant to the Founders Stock Letter, the Initial Stockholders, (a) subject to the satisfaction of the conditions to the closing of the Merger set forth in the Merger Agreement, immediately prior to the closing, surrendered to Switchback, for no consideration and as a capital contribution to Switchback, 984,706 Founder Shares held by them (on a pro rata basis), whereupon such Founder Shares were immediately cancelled and (b) upon and subject to the closing, subjected the 900,000 Founder Earn Back Shares (including any Common Stock issued in exchange therefor in the Merger) held by them (on a pro rata basis) to potential forfeiture if the closing volume-weighted average closing sale price of one share of Common Stock quoted on the NYSE does not satisfy the price target set forth in the Founders Stock Letter for any ten trading days within any 20 consecutive trading day period within the five-year period following the closing.
Private Warrants
The Sponsor purchased an aggregate of 5,521,568 Private Warrants for a purchase price of $1.50 per warrant in private placements that occurred simultaneously with the closing of the IPO and the sale of the over-allotment units. As such, the Sponsor’s interest in this transaction was valued at approximately $8.3 million. Each Private Warrant entitles the holder to purchase one share of our Common Stock at $11.50 per share. In addition, prior to the closing of the Merger, the Sponsor advanced to Switchback approximately $2.0 million in working capital loans. At the closing of the Merger, the Sponsor converted $1.5 million of these working capital loans into 1,000,000 Private Warrants. As such, the Sponsor’s interest in this transaction was valued at approximately $1.5 million.
Administrative Services Agreement
On July 25, 2019, Switchback entered into an administrative services agreement pursuant to which Switchback paid the Sponsor a total of $10,000 per month for office space, utilities, secretarial support and administrative services. Upon completion of the Merger, we ceased paying these monthly fees.
Other than these monthly fees, no compensation of any kind, including finder’s and consulting fees, was paid by us to the Sponsor, officers and directors, or any of their respective affiliates, for services rendered prior to or in connection with the completion of the Merger. However, these individuals were reimbursed for any
out-of-pocket
expenses incurred in connection with activities on our behalf. There was no cap or ceiling on the reimbursement of
out-of-pocket
expenses incurred by such persons in connection with activities on our behalf.
Related Party Loans and Advances
Until the consummation of the IPO, Switchback’s only source of liquidity was an initial sale of Founder Shares to the Sponsor, and the proceeds of loans and advances from the Sponsor in the amount of $251,000. In August 2019, we repaid the Sponsor $251,000 in settlement of the outstanding loan and advances.
In addition, prior to the closing of the Merger, the Sponsor advanced to Switchback approximately $2.0 million in working capital loans. At the closing of the Merger, the Sponsor converted $1.5 million of these
 
106

working capital loans into 1,000,000 Private Warrants. As such, the Sponsor’s interest in this transaction was valued at approximately $1.5 million. $1.5 million of such loans were convertible into warrants at a price of $1.50 per warrant at the option of the Sponsor. The warrants are identical to the Private Warrants, including as to exercise price, exercisability and exercise period. The remainder of the loans were repaid in connection with the closing of the Merger.
Registration Rights
In connection with the closing of the Merger, ChargePoint and the holders of registration rights in Switchback and Legacy ChargePoint entered into an amended and restated Registration Rights Agreement (the “A&R Registration Rights Agreement”). Pursuant to the A&R Registration Rights Agreement, we filed a resale registration statement with the SEC that has been declared effective. In certain circumstances, the Registration Rights Holders can demand up to four underwritten offerings and will be entitled to customary piggyback registration rights. The A&R Registration Rights Agreement does not provide for the payment of any cash penalties by Switchback if it fails to satisfy any of its obligations under the A&R Registration Rights Agreement.
Related Party Transactions with Respect to ChargePoint
In addition to the compensation arrangements, including employment, termination of employment, and change in control arrangements and indemnification arrangements, discussed, when required, in the sections titled “Management” and “Executive Compensation” and the registration rights described in the section titled “Description of Securities,” the following is a description of each transaction since February 1, 2017 and each currently proposed transaction in which:
 
   
ChargePoint has been or is to be a participant;
 
   
the amount involved exceeded or exceeds $120,000; and
 
   
any of ChargePoint’s directors, executive officers or holders of more than 5% of its capital stock prior to the Merger, or any immediate family member of, or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest.
Equity Financings
Sales of Series G Preferred Stock
In February 2017, Legacy ChargePoint sold an aggregate of 28,630,981 shares of its Series G Preferred Stock at a purchase price of $4.3659 per share to accredited investors for an aggregate purchase price of approximately $125.0 million. Each share of Legacy ChargePoint’s Series G Preferred Stock converted automatically into shares of Common Stock of ChargePoint in connection with the conversion, as provided in the Merger Agreement.
The following table summarizes purchases of shares of Legacy ChargePoint’s Series G Preferred Stock by its executive officers, directors and holders of more than 5% of its capital stock.
 
Purchaser
  
Affiliated
Director(s) or
Officer(s)
    
Shares of Series G Preferred
Stock
 
  
Number of
Shares
    
Aggregate Gross
Consideration
($)
 
Braemar Energy Ventures
(1)
     Neil S. Suslak        687,144      $ 3,000,001.99  
Entities affiliated with Linse Capital LLC
(2)
     Michael Linse        9,161,913      $ 39,999,996  
Rho Ventures VI, L.P.
(3)
     Mark Leschly        1,145,239      $ 4,999,998.96  
 
107

 
(1)
Entities affiliated with Braemar Energy holding shares of Legacy ChargePoint’s Series C preferred stock which are aggregated for purposes of reporting share ownership information include Braemar CP Investments 2019 LLC, Braemar ChargePoint Investments II, LLC and Braemar ChargePoint Investments III, LLC.
(2)
Entities affiliated with Linse Capital, LLC held more than 5% of Legacy ChargePoint’s capital stock prior to the Merger.
(3)
Entities affiliated with Rho Ventures VI, L.P. held more than 5% of Legacy ChargePoint’s capital stock prior to the Merger, which, at the time of purchase, were affiliated with Mark Leschly.
Sales of Series H Preferred Stock and Warrants
From November 2018 to February 2019, Legacy ChargePoint sold an aggregate of 42,298,202 shares of its Series H Preferred Stock and warrants to purchase up to an aggregate of 14,099,400 shares of Legacy ChargePoint Common Stock at a purchase price of $5.674 per unit consisting of (a) one share of Series H Preferred Stock and (b) a warrant to purchase
one-third
of a share of Legacy ChargePoint Common Stock to accredited investors for an aggregate purchase price of approximately $240.0 million. Each share of Legacy ChargePoint’s Series H Preferred Stock converted automatically into shares of Common Stock of Legacy ChargePoint in connection with the conversion, as provided in the Merger Agreement. As of January 31, 2021, the warrants remained outstanding and exercisable.
The following table summarizes purchases of shares of Legacy ChargePoint’s Series H Preferred Stock by its executive officers, directors and holders of more than 5% of its capital stock.
 
Purchaser
  
Affiliated
Director(s) or
Officer(s)
    
Shares of Series H Preferred Stock
 
  
Shares
Purchased
    
Warrants
Purchased
    
Aggregate
Purchase Price
 
Entities affiliated with Braemar Energy Ventures III, L.P.
(1)
     Neil S. Suslak        88,121        29,373      $ 499,998.56  
Canada Pension Plan Investment Board
        11,103,278        3,701,093      $ 62,999,999.38  
Entities affiliated with Linse Capital LLC
(2)
     Michael Linse        6,520,973        2,173,658      $ 37,000,000.81  
Next47 Services GmbH
        352,485        117,495      $ 1,999,999.89  
Q-GRG
VII (CP) Investment Partners, LLC
(3)
     Jeffrey Harris        17,624,251        5,874,750      $ 100,000,000.18  
 
(1)
Entities affiliated with Braemar Energy Ventures III, L.P. held more than 5% of Legacy ChargePoint’s capital stock prior to the Merger.
(2)
Entities affiliated with Linse Capital, LLC held more than 5% of Legacy ChargePoint’s capital stock prior to the Merger.
(3)
Entities affiliated with
Q-GRG
VII (CP) Investment Partners, LLC held more than 5% of Legacy ChargePoint’s capital stock prior to the Merger.
Sales of Series
H-1
Preferred Stock
In July 2020, Legacy ChargePoint sold an aggregate of 22,427,306 shares of its Series
H-1
Preferred Stock and warrants to purchase up to an aggregate of 22,427,306 shares of Legacy ChargePoint Common Stock at a purchase price of $5.674 per unit consisting of (a) one share of Series H Preferred Stock and (b) a warrant to purchase one share of Legacy ChargePoint Common Stock to accredited investors for an aggregate purchase price of approximately $127.3 million. Each share of Legacy ChargePoint’s Series
H-1
Preferred Stock converted automatically into shares of Common Stock of ChargePoint in connection with the conversion, as provided in the Merger Agreement. As of January 31, 2021, the warrants remained outstanding and exercisable.
 
108

The following table summarizes purchases of shares of Legacy ChargePoint’s Series
H-1
Preferred Stock by its executive officers, directors and holders of more than 5% of its capital stock.
 
Purchaser
  
Affiliated

Director(s)
or Officer(s)
  
Shares of Series
H-1

Preferred Stock
 
  
Shares
Purchased
    
Warrants
Purchased
    
Aggregate
Purchase Price
 
Braemar ChargePoint Investments III, LLC
(1)
   Neil S. Suslak      1,471,053        1,471,053      $ 8,346,754.73  
Bruce Chizen 2009 Irrevocable Trust, dated January 24, 2009
   Bruce Chizen      88,121        88,121      $ 499,998.56  
CPP Investment Board (USRE) Inc.
(2)
        1,762,425        1,762,425      $ 9,999,999.45  
G. Richard Wagoner, Jr. Trust, dated July 13, 1989, as amended and restated October 19, 2018
   G. Richard
Wagoner, Jr.
     35,249        35,249      $ 200,002.83  
Jackson 1997 Trust, dated, November 6, 1997
   Rex Jackson      88,121        88,121      $ 499,998.56  
Five Plus Nine LLC
   Lawrence Lee      61,684        61,684      $ 349,995.02  
Entities affiliated with Linse Capital, LLC
(3)
   Michael Linse      9,421,458        9,421,458      $ 53,457,352.70  
Richard Lowenthal
   Richard Lowenthal      176,243        176,243      $ 1,000,002.79  
Q-GRG
VII (CP) Investment Partners, LLC
(4)
   Jeffrey Harris      5,287,275        5,287,275      $ 29,999,998.35  
 
(1)
Entities affiliated with Braemar ChargePoint Investments III, LLC held more than 5% of Legacy ChargePoint’s capital stock prior to the Merger.
(2)
CPP Investment (USRE) Inc. is affiliated with Canada Pension Plan Investment Board, which held more than 5% of Legacy ChargePoint’s capital stock prior to the Merger.
(3)
Entities affiliated with Linse Capital, LLC held more than 5% of Legacy ChargePoint’s capital stock prior to the Merger.
(4)
Entities affiliated with
Q-GRG
VII (CP) Investment Partners, LLC held more than 5% of Legacy ChargePoint’s capital stock prior to the Merger.
Indemnification Agreements
The Second A&R Charter contains provisions limiting the liability of directors, and our Second A&R Bylaws provide that we will indemnify each of our directors to the fullest extent permitted under Delaware law. The Second A&R Charter and our Second A&R Bylaws also provide us with discretion to indemnify officers and employees when determined appropriate by the Board.
We entered into indemnification agreements with each of our directors and executive officers and certain other key employees. The indemnification agreements provide that we indemnify each of our directors, executive officers and such other key employees against any and all expenses incurred by that director, executive officer or other key employee because of his or her status as one of our directors, executive officers or other key employees, to the fullest extent permitted by Delaware law, the Second A&R Charter and our Second A&R Bylaws. In addition, the indemnification agreements provide that, to the fullest extent permitted by Delaware law, we will advance all expenses incurred by our directors, executive officers, and other key employees in connection with a legal proceeding involving his or her status as a director, executive officer or key employee.
Customer Agreements
ChargePoint has entered into certain business relationships with Daimler AG and its affiliated entities (“Daimler”). Daimler is an affiliate of Axel Harries, a director of Legacy ChargePoint and current director of ChargePoint. Revenue from Daimler was $3.4 million, $3.1 million and $1.1 million for the fiscal years ended January 31, 2021, 2020 and 2019, respectively.
 
109

Amended and Restated Investors’ Rights Agreement
In connection with the issuances of shares of its Series
H-1
Preferred Stock in July 2020, Legacy ChargePoint entered into an amended and restated investors’ rights agreement (the “Investors’ Rights Agreement”) with certain holders of Legacy ChargePoint’s capital stock. The Investors’ Rights Agreement provides for, among other things, certain demand, piggy-back and
S-3
registration rights. The following directors, executive officers and holders of more than 5% of Legacy ChargePoint capital stock and their affiliates were parties to the Investors’ Rights Agreement:
 
   
Entities affiliated with Braemar ChargePoint Investments III, LLC;
 
   
An entity affiliated with Bruce Chizen;
 
   
Canada Pension Plan Investment Board;
 
   
An entity affiliated with Rex Jackson;
 
   
An entity affiliated with Lawrence Lee;
 
   
Entities affiliated with Mark Leschly;
 
   
Entities affiliated with Linse Capital CP VI, LLC;
 
   
Next47 Services GmbH;
 
   
Richard Lowenthal;
 
   
Q-GRG
VII (CP) Investment Partners, LLC;
 
   
Rho Ventures VI L.P.; and
 
   
An entity affiliated with G. Richard Wagoner, Jr.
The Investors’ Rights Agreement terminated upon the closing of the Merger.
Amended and Restated Voting Agreement
In connection with the issuances of shares of its Series
H-1
Preferred Stock in July 2020, Legacy ChargePoint entered into an amended and restated voting agreement (the “Voting Agreement”) with certain holders of Legacy ChargePoint’s capital stock. The Voting Agreement provided for, among other things, such holders to vote in accordance with its terms, including in matters related to the composition of the Legacy ChargePoint Board, and provides for drag-along rights with respect to proposed sales of Legacy ChargePoint securities. The following directors, executive officers and holders of more than 5% of Legacy ChargePoint capital stock and their affiliates were parties to the Voting Agreement:
 
   
Entities affiliated with Braemar ChargePoint Investments III, LLC;
 
   
An entity affiliated with Bruce Chizen;
 
   
Canada Pension Plan Investment Board;
 
   
An entity affiliated with Rex Jackson;
 
   
An entity affiliated with Lawrence Lee;
 
   
Entities affiliated with Mark Leschly;
 
   
Entities affiliated with Linse Capital CP VI, LLC;
 
   
Richard Lowenthal;
 
   
Next47 Services GmbH;
 
   
Q-GRG
VII (CP) Investment Partners, LLC;
 
110

 
Rho Ventures VI L.P.; and
 
   
An entity affiliated with G. Richard Wagoner, Jr.
The Voting Agreement terminated upon the closing of the Merger.
Amended and Restated Right of First Refusal and
Co-Sale
Agreement
In connection with the issuances of shares of its Series
H-1
Preferred Stock in July 2020, Legacy ChargePoint entered into an amended and restated right of first refusal and
co-sale
agreement (the
“Co-Sale
Agreement”) with certain holders of Legacy ChargePoint’s capital stock. The following directors, executive officers and holders of more than 5% of Legacy ChargePoint capital stock and their affiliates were parties to the
Co-Sale
Agreement:
 
   
Entities affiliated with Braemar ChargePoint Investments III, LLC;
 
   
An entity affiliated with Bruce Chizen;
 
   
Canada Pension Plan Investment Board;
 
   
An entity affiliated with Rex Jackson;
 
   
An entity affiliated with Lawrence Lee;
 
   
Entities affiliated with Mark Leschly;
 
   
Entities affiliated with Linse Capital CP VI, LLC;
 
   
Richard Lowenthal;
 
   
Next47 Services GmbH;
 
   
Q-GRG
VII (CP) Investment Partners, LLC;
 
   
Rho Ventures VI L.P.;
 
   
Pasquale Romano; and
 
   
An entity affiliated with G. Richard Wagoner, Jr.
The
Co-Sale
Agreement terminated upon the closing of the Merger.
Policies and Procedures for Related Party Transactions
The Board reviews and considers the interests of its directors, executive officers and principal stockholders in its review and consideration of transactions and forms committees of
non-interested
directors when it determines that the formation of such committees is appropriate under the circumstances.
We have a related party transaction policy. The policy provides that officers, directors, holders of more than 5% of any class of our voting securities, and any member of the immediate family of and any entity affiliated with any of the foregoing persons, will not be permitted to enter into a related-party transaction with ChargePoint without the prior consent of the audit committee, or other independent members of our Board in the event it is inappropriate for the audit committee to review such transaction due to a conflict of interest. Any request for us to enter into a transaction with an executive officer, director, principal stockholder, or any of their immediate family members or affiliates, in which the amount involved exceeds $120,000, must first be presented to the audit committee for review, consideration and approval. In approving or rejecting the proposed transactions, the audit committee will take into account all of the relevant facts and circumstances available.
All of the transactions with respect to Legacy ChargePoint described in this section were entered into prior to the adoption of this policy. Although Legacy ChargePoint has not had a written policy for the review and
 
111

approval of transactions with related persons, the Legacy ChargePoint Board has historically reviewed and approved any transaction where a director or officer had a financial interest, including the transactions described above. Prior to approving such a transaction, the material facts as to a director’s or officer’s relationship or interest in the agreement or transaction were disclosed to the Legacy ChargePoint Board. The Legacy ChargePoint Board took this information into account when evaluating the transaction and in determining whether such transaction was fair to Legacy ChargePoint and in the best interest of all Legacy ChargePoint stockholders.
 
112

DESCRIPTION OF SECURITIES
The following summary of the material terms of our securities is not intended to be a complete summary of the rights and preferences of such securities. We urge you to read our Second A&R Charter in its entirety for a complete description of the rights and preferences of our Common Stock and the warrant agreement and form of warrant for a description of the terms of the Warrants.
Authorized and Outstanding Stock
The Second A&R Charter authorizes the issuance of 1,000,000,000 shares of Common Stock and 10,000,000 shares of preferred stock, each with a par value of $0.0001 per share. As of October 1, 2021, we had 324,904,565 shares of Common Stock outstanding.
Common Stock
Dividend Rights
Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of our Common Stock are entitled to receive dividends out of funds legally available if the Board, in its discretion, determines to issue dividends and only then at the times and in the amounts that the Board may determine. See “Market Information for Securities and Dividend Policy” for more information.
Voting Rights
The holders of our Common Stock are entitled to one vote per share. Stockholders do not have the ability to cumulate votes for the election of directors. Our Second A&R Charter and Second A&R Bylaws provide for a classified board of directors consisting of three classes of approximately equal size, each serving staggered
three-year
terms. Only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms.
No Preemptive or Similar Rights
Our Common Stock is not entitled to preemptive rights and is not subject to conversion, redemption or sinking fund provisions.
Right to Receive Liquidation Distributions
Upon our dissolution, liquidation or
winding-up,
the assets legally available for distribution to our stockholders are distributable ratably among the holders of our Common Stock, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights and payment of liquidation preferences, if any, on any outstanding shares of preferred stock.
Preferred Stock
We are authorized, subject to limitations prescribed by Delaware law, to issue preferred stock in one or more series, to establish from time to time the number of shares to be included in each series and to fix the designation, powers, preferences and rights of the shares of each series and any associated qualifications, limitations or restrictions. The Board also can increase or decrease the number of shares of any series, but not below the number of shares of that series then outstanding, without any further vote or action by our stockholders. The Board may authorize the issuance of preferred stock with voting or conversion rights that could
 
113

adversely affect the voting power or other rights of the holders of the Common Stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and may adversely affect the market price of our Common Stock and the voting and other rights of the holders of Common Stock. We have no current plan to issue any shares of preferred stock.
Options
As of October 1, 2021, there were options to purchase 25,265,603 shares of our Common Stock outstanding, with a weighted average exercise price of $0.69.
Registration Rights
Certain holders of Common Stock are entitled to registration rights as described in the “Registration Rights” in this prospectus below.
Certificate of Incorporation and Bylaw Provisions
The Second A&R Charter and Second A&R Bylaws include a number of provisions that may have the effect of deterring hostile takeovers or delaying or preventing changes in control of the management team, including the following:
 
   
Board of Directors Vacancies.
The Second A&R Charter and Second A&R Bylaws authorizes the Board to fill vacant directorships, including newly-created seats. In addition, the number of directors constituting the Board will be set only by resolution adopted by a majority vote of the entire Board. These provisions will prevent a stockholder from increasing the size of the Board and gaining control of the Board by filling the resulting vacancies with its own nominees.
 
   
Classified Board.
The Second A&R Charter and Second A&R Bylaws provide that the Board is classified into three classes of directors, each of which will hold office for a three-year term. In addition, directors may only be removed from the Board for cause and only by the approval of 66 2/3% of the then-outstanding shares of Common Stock. A third party may be discouraged from making a tender offer or otherwise attempting to obtain control of us as it is more difficult and time consuming for stockholders to replace a majority of the directors on a classified board of directors.
 
   
Stockholder Action; Special Meeting of Stockholders.
The Second A&R Charter provides that stockholders will not be able to take action by written consent, and will only be able to take action at annual or special meetings of the stockholders. Stockholders will not be permitted to cumulate their votes for the election of directors. The Second A&R Bylaws further provides that special meetings of the stockholders may be called only by a majority vote of the entire Board, the chairman of the Board or the chief executive officer.
 
   
Advance Notice Requirements for Stockholder Proposals and Director Nominations.
The Second A&R Bylaws provide advance notice procedures for stockholders seeking to bring business before the annual meeting of stockholders, or to nominate candidates for election as directors at any meeting of stockholders. The Second A&R Bylaws also specifies certain requirements regarding the form and content of a stockholder’s notice. These provisions may preclude the stockholders from bringing matters before the annual meeting of stockholders or from making nominations for directors at the meetings of stockholders.
 
   
Issuance of Undesignated Preferred Stock.
The Board has the authority, without further action by the holders of Common Stock, to issue up to 10,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by the Board. The existence of
 
114

 
authorized but unissued shares of preferred stock will enable the Board to render more difficult or discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise.
Transfer Agent
The Transfer Agent for our Common Stock is Continental Stock Transfer & Trust Company. We have agreed to indemnify the Transfer Agent in its role as transfer agent, its agents and each of its stockholders, directors, officers and employees against all liabilities, including judgments, costs and reasonable counsel fees that may arise out of acts performed or omitted for its activities in that capacity, except for any liability due to any gross negligence, willful misconduct or bad faith of the indemnified person or entity.
Anti-Takeover Provisions
Delaware Law
ChargePoint is governed by the provisions of Section 203 of the DGCL regulating corporate takeovers. This section prevents some Delaware corporations from engaging, under some circumstances, in a Merger, which includes a merger or sale of at least 10% of the corporation’s assets with any interested stockholder, meaning a stockholder who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, did own 15% or more of the corporation’s outstanding voting stock, unless:
 
   
the transaction is approved by the board of directors prior to the time that the interested stockholder became an interested stockholder;
 
   
upon closing of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding those shares owned (i) by persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or
 
   
subsequent to such time that the stockholder became an interested stockholder the Merger is approved by the board of directors and authorized at an annual or special meeting of stockholders by at least
two-thirds
of the outstanding voting stock which is not owned by the interested stockholder.
A Delaware corporation may “opt out” of these provisions with an express provision in its original certificate of incorporation or an express provision in its certificate of incorporation or amended and restated bylaws resulting from a stockholders’ amendment approved by at least a majority of the outstanding voting shares. We have not opted out of these provisions. As a result, mergers or other takeover or change in control attempts of us may be discouraged or prevented.
Forum Selection Clause
The Second A&R Charter provides that unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if and only if the Court of Chancery of the State of Delaware lacks subject matter jurisdiction, any state court located within the State of Delaware or, if and only if all such state courts lack subject matter jurisdiction, the federal district court for the District of Delaware) shall be the sole and exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: (a) any derivative action brought on behalf of ChargePoint; (b) any action or proceeding asserting a claim of breach of a fiduciary duty owed by any current or former directors, officers, stockholders or, subject to certain exceptions, employees; (c) any action or proceeding asserting a claim arising out of or arising pursuant to any provision of the DGCL, the Second A&R Charter or our Second A&R Bylaws (as each may be amended from
 
115

time to time) against ChargePoint or any current or former directors, officers, stockholders or, subject to certain exceptions, employees; (d) any action or proceeding asserting a claim governed by the internal affairs doctrine against ChargePoint, any current or former directors, officers or, subject to certain exceptions, employees except for, as to each of (a) through (d) above, (i) any action as to which the Court of Chancery determines that there is an indispensable party not subject to the personal jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten (10) days following such determination) and (ii) any action asserted to enforce any liability or duty created by the Securities Act, the Exchange Act or, in each case, rules and regulations promulgated thereunder, for which there is exclusive federal or concurrent federal and state jurisdiction. In addition, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act.
Any person or entity purchasing or otherwise acquiring or holding any interest in any shares of Common Stock shall be deemed to have notice of and consented to these exclusive forum provisions and will not be deemed to have waived ChargePoint’s compliance with the federal securities laws and the regulations promulgated thereunder.
Warrants
Public Warrants
Each whole Public Warrant entitles the registered holder to purchase one whole share of our Common Stock at a price of $11.50 per share, subject to adjustment as discussed below, provided that we have an effective registration statement under the Securities Act covering the shares of Common Stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or we permit holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. Pursuant to the warrant agreement, a warrantholder may exercise its warrants only for a whole number of shares of Common Stock. This means that only a whole warrant may be exercised at any given time by a warrantholder. The warrants will expire five years after the completion of our Merger, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
On July 6, 2021, we redeemed all of our outstanding Public Warrants that had not been exercised as of that date, which resulted in the exercise of 3,517,192 warrants for proceeds to us of $40,447,708 and the redemption of 244,481 Public Warrants at a redemption price of $0.01 per warrant. The Private Warrants were not subject to redemption and, to the extent not exercised, remain outstanding and exercisable. As of October 1, 2021, we had no Public Warrants outstanding, Private Warrants exercisable for 2,173,856 shares of our Common Stock at an exercise price of $11.50 per share, and Legacy ChargePoint Warrants exercisable for 35,601,482 shares of our Common Stock with a weighted average exercise price of $7.19 per share.
We will not be obligated to deliver any shares of Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Common Stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration. No warrant will be exercisable and we will not be obligated to issue shares of Common Stock upon exercise of a warrant unless the Common Stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any warrant. In the event that a registration
 
116

statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of Common Stock underlying such unit.
After the closing of our Merger, we filed with the SEC a registration statement for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the warrants. This registration statement was declared effective on March 11, 2021. We will use our best efforts to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in an accordance with the provisions of the warrant agreement.
Notwithstanding the above, if our Common Stock is, at the time of any exercise of a warrant, not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, but we will be required to use our best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Once the warrants become exercisable, we may call the warrants for redemption for cash:
 
   
in whole and not in part;
 
   
at a price of $0.01 per warrant;
 
   
upon not less than 30 days’ prior written notice of redemption to each warrantholder; and
 
   
if, and only if, the reported last sale price of the Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a
30-trading
day period ending three business days before we send the notice of redemption to the warrantholders.
If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws.
We have established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrantholder will be entitled to exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the Common Stock may fall below the $18.00 redemption trigger price (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.
Following the completion of the redemption of our Public Warrants, there were no Public Warrants outstanding. Accordingly, the provisions relating to cash redemption would only become applicable in the event of certain transfers of our Private Warrants such that they were not held by the Sponsor or its permitted transferees.
Commencing 90 days after the warrants become exercisable, we may redeem the outstanding warrants for shares of Common Stock:
 
   
in whole and not in part;
 
   
at a price equal to a number of shares of Common Stock to be determined by reference to the table below, based on the redemption date and the “fair market value” of our Common Stock except as otherwise described below;
 
   
upon a minimum of 30 days’ prior written notice; and
 
117

   
if, and only if, the last sale price of our Common Stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which we send the notice of redemption to the warrantholders.
The numbers in the table below represent the “redemption prices,” or the number of shares of Common Stock that a warrantholder will receive upon redemption by us pursuant to this redemption feature, based on the “fair market value” of our Common Stock on the corresponding redemption date, and the number of months that the corresponding redemption date precedes the expiration date of the warrants, each as set forth in the table below.
 
Redemption Date
  
Fair Market Value of Common Stock
 
(period to expiration of warrants)
  
$10.00
    
$11.00
    
$12.00
    
$13.00
    
$14.00
    
$15.00
    
$16.00
    
$17.00
    
$18.00
 
57 months
     0.257        0.277        0.294        0.310        0.324        0.337        0.348        0.358        0.365  
54 months
     0.252        0.272        0.291        0.307        0.322        0.335        0.347        0.357        0.365  
51 months
     0.246        0.268        0.287        0.304        0.320        0.333        0.346        0.357        0.365  
48 months
     0.241        0.263        0.283        0.301        0.317        0.332        0.344        0.356        0.365  
45 months
     0.235        0.258        0.279        0.298        0.315        0.330        0.343        0.356        0.365  
42 months
     0.228        0.252        0.274        0.294        0.312        0.328        0.342        0.355        0.364  
39 months
     0.221        0.246        0.269        0.290        0.309        0.325        0.340        0.354        0.364  
36 months
     0.213        0.239        0.263        0.285        0.305        0.323        0.339        0.353        0.364  
33 months
     0.205        0.232        0.257        0.280        0.301        0.320        0.337        0.352        0.364  
30 months
     0.196        0.224        0.250        0.274        0.297        0.316        0.335        0.351        0.364  
27 months
     0.185        0.214        0.242        0.268        0.291        0.313        0.332        0.350        0.364  
24 months
     0.173        0.204        0.233        0.260        0.285        0.308        0.329        0.348        0.364  
21 months
     0.161        0.193        0.223        0.252        0.279        0.304        0.326        0.347        0.364  
18 months
     0.146        0.179        0.211        0.242        0.271        0.298        0.322        0.345        0.363  
15 months
     0.130        0.164        0.197        0.230        0.262        0.291        0.317        0.342        0.363  
12 months
     0.111        0.146        0.181        0.216        0.250        0.282        0.312        0.339        0.363  
9 months
     0.090        0.125        0.162        0.199        0.237        0.272        0.305        0.336        0.362  
6 months
     0.065        0.099        0.137        0.178        0.219        0.259        0.296        0.331        0.362  
3 months
     0.034        0.065        0.104        0.150        0.197        0.243        0.286        0.326        0.361  
0 months
     —          —          0.042        0.115        0.179        0.233        0.281        0.323        0.361  
The “fair market value” of our Common Stock shall mean the average reported last sale price of our Common Stock for the ten trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.
The exact fair market value and redemption date may not be set forth in the table above, in which case, if the fair market value is between two values in the table or the redemption date is between two redemption dates in the table, the number of shares of Common Stock to be issued for each warrant redeemed will be determined by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values and the earlier and later redemption dates, as applicable, based on a
365-day
year.
No fractional shares of Common Stock will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, we will round down to the nearest whole number of the number of shares of Common Stock to be issued to the holder.
If we call the warrants for redemption for cash as described above, our management will have the option to require any holder that wishes to exercise his, her or its warrant to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” our management will consider, among other factors, our cash position, the number of warrants that are outstanding and the dilutive effect on our stockholders of issuing the maximum number of shares of Common Stock issuable upon the exercise of our
 
118

warrants. If our management takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined above) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the Common Stock for the ten trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. If our management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares of Common Stock to be received upon exercise of the warrants, including the “fair market value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. We believe this feature is an attractive option to us if we do not need the cash from the exercise of the warrants after our Merger. If we call our warrants for redemption and our management does not take advantage of this option, the Sponsor and its permitted transferees would still be entitled to exercise their Private Warrants for cash or on a cashless basis using the same formula described above that other warrantholders would have been required to use had all warrantholders been required to exercise their warrants on a cashless basis, as described in more detail below.
A holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 9.8% (or such other amount as a holder may specify) of the shares of Common Stock outstanding immediately after giving effect to such exercise.
The stock prices set forth in the column headings of the table above shall be adjusted as of any date on which the number of shares issuable upon exercise of a warrant is adjusted pursuant to the following three paragraphs. The adjusted stock prices in the column headings shall equal the stock prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a warrant as so adjusted. The number of shares in the table above shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise of a warrant.
If the number of outstanding shares of Common Stock is increased by a stock dividend payable in shares of Common Stock, or by a
split-up
of shares of Common Stock or other similar event, then, on the effective date of such stock dividend,
split-up
or similar event, the number of shares of Common Stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding shares of Common Stock. A rights offering to holders of Common Stock entitling holders to purchase shares of Common Stock at a price less than the fair market value will be deemed a stock dividend of a number of shares of Common Stock equal to the product of (a) the number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Common Stock) multiplied by (b) one (1) minus the quotient of (x) the price per share of Common Stock paid in such rights offering divided by (y) the fair market value. For these purposes (a) if the rights offering is for securities convertible into or exercisable for Common Stock, in determining the price payable for Common Stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (b) fair market value means the volume-weighted average price of Common Stock as reported during the ten trading day period ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.
In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of Common Stock on account of such shares of Common Stock (or other shares of our capital stock into which the warrants are convertible), other than (a) as described above, (b) certain ordinary cash dividends (initially defined as up to $0.10 per share in a 365 day
 
119

period), (c) to satisfy the redemption rights of the holders of Common Stock in connection with a proposed Initial Merger, (d) to satisfy the redemption rights of the holders of Common Stock in connection with a stockholder vote to approve an amendment to our current certificate of incorporation that would affect the substance or timing of our obligation to redeem 100% of our Common Stock if we have not consummated an Merger within the time period set forth in the current certificate of incorporation or (e) in connection with the redemption of our public shares upon our failure to complete our Merger, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each share of Common Stock in respect of such event.
If the number of outstanding shares of our Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of Common Stock issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding shares of Common Stock.
Whenever the number of shares of Common Stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of shares of Common Stock purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y) the denominator of which will be the number of shares of Common Stock so purchasable immediately thereafter.
In case of any reclassification or reorganization of the outstanding shares of Common Stock (other than those described above or that solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization of our outstanding shares of Common Stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the shares of our Common Stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised his, her or its warrants immediately prior to such event. If less than 70% of the consideration receivable by the holders of Common Stock in such a transaction is payable in the form of Common Stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established
over-the-counter
market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within 30 days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes value (as defined in the warrant agreement) of the warrant. The warrant exercise price will not be adjusted for other events.
The warrants have been issued in registered form under a warrant agreement between the Transfer Agent, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 50% of the then outstanding Public Warrants to make any change that adversely affects the interests of the registered holders of Public Warrants. If an amendment adversely affects the Private Warrants in a different manner than the Public Warrants or vice versa, then approval of holders of at least 65% of the then-outstanding Public Warrants and 65% of the then-outstanding Private Warrants, voting as separate classes, will be required.
The warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if
 
120

applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrantholders do not have the rights or privileges of holders of Common Stock or any voting rights until they exercise their warrants and receive shares of Common Stock. After the issuance of shares of Common Stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders.
No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number of shares of Common Stock to be issued to the warrantholder.
Private Warrants
The Private Warrants (including the shares of Common Stock issuable upon exercise of the Private Warrants) are not transferable, assignable or salable until 30 days after the completion of our Merger (except, among other limited exceptions, to our officers and directors and other persons or entities affiliated with the Sponsor), and they will not be redeemable by us for cash so long as they are held by the Sponsor or its permitted transferees. The Sponsor, or its permitted transferees, has the option to exercise the Private Warrants on a cashless basis. Except as described below, the Private Warrants have terms and provisions that are identical to those of the warrants sold as part of the units in the IPO, including as to exercise price, exercisability and exercise period. If the Private Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Warrants will be redeemable by us and exercisable by the holders on the same basis as the warrants included in the units sold in the IPO.
If holders of the Private Warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering his, her or its warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the Common Stock for the ten trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent.
Legacy ChargePoint Warrants
Legacy ChargePoint had outstanding warrants to purchase shares of Legacy ChargePoint Common Stock and Legacy ChargePoint Preferred Stock, which now represent warrants to purchase ChargePoint Common Stock as follows:
 
Holder
  
Number of
ChargePoint
Warrant
Shares
    
Exercise
Price per
Share
    
Expiration Date
 
Q-GRG
VII (CP) Investment Partners, LLC
     5,854,775      $ 9.04        Nov. 16, 2028  
Canada Pension Plan Investment Board
     2,927,387      $ 9.04        Nov. 16, 2028  
Linse Capital CP V, LLC
     1,346,598      $ 9.04        Nov. 16, 2028  
Next47 Services GmbH
     117,095      $ 9.04        Nov. 16, 2028  
Clearvision Ventures Ecosystem Fund, LP
     117,095      $ 9.04        Nov. 16, 2028  
Braemar Energy Ventures III L.P.
     29,273      $ 9.04        Nov. 16, 2028  
BMW i Ventures SCS SIVAC-RAIF
     5,854      $ 9.04        Nov. 16, 2028  
AEP Investments, Inc.
     234,191      $ 9.04        Nov. 30, 2028  
CTTV Investments, LLC
     292,739      $ 9.04        Dec. 5, 2028  
Purple Green Investments Pte Ltd.
     1,516,386      $ 9.04        Dec. 20, 2028  
Linse Capital CP V, LLC
     702,573      $ 9.04        Dec. 21, 2028  
 
121

Holder
  
Number of
ChargePoint
Warrant
Shares
    
Exercise
Price per
Share
    
Expiration Date
 
Daimler Trucks & Buses Holding Inc.
     29,274      $ 9.04        Jan. 11, 2029  
Linse Capital CP V, LLC
     117,095      $ 9.04        Feb. 14, 2029  
Canada Pension Plan Investment Board
     761,121      $ 9.04        Feb. 14, 2029  
Linse Capital CP VI, LLC
     8,909,527      $ 6.03        Jul. 31, 2030  
Q-GRG
VII (CP) Investments Partners, LLC
     5,269,298      $ 6.03        Jul. 31, 2030  
Purple Green Investments Pte Ltd.
     2,775,164      $ 6.03        Jul. 31, 2030  
Canada Pension Plan Investment Board
     1,756,432      $ 6.03        Jul. 31, 2030  
AEP Investments, Inc.
     702,573      $ 6.03        Jul. 31, 2030  
Bruce Chizen 2009 Irrevocable Trust, dated January 24, 2009
     87,821      $ 6.03        Jul. 31, 2030  
CTTV Investments, LLC
     105,110      $ 6.03        Jul. 31, 2030  
G. Richard Wagoner, Jr. Trust, dated July 13, 1989, as amended and restated October 19, 2018
     35,129      $ 6.03        Jul. 31, 2030  
Braemar ChargePoint Investments III, LLC
     1,466,051      $ 6.03        Jul. 31, 2030  
Clearvision Ventures Ecosystem Fund, LP
     87,821      $ 6.03        Jul. 31, 2030  
Clearvision Ventures Ecosystem Fund 2, LP
     351,286      $ 6.03        Jul. 31, 2030  
Five Plus Nine, LLC
     61,474      $ 6.03        Jul. 31, 2030  
Linse Capital CP VI, LLC
     479,897      $ 6.03        Aug. 3, 2030  
Jackson 1997 Trust, dated November 6, 1997
     87,821      $ 6.03        Aug. 6, 2030  
Rho Ventures VI L.P.
     115,872      $ 1.25        Sep. 12, 2021  
Rho Ventures VI L.P.
     115,872      $ 1.25        Oct. 28, 2021  
Rho Ventures VI L.P.
     103,520      $ 1.25        Jan. 5, 2022  
Rho Ventures VI L.P.
     78,211      $ 1.25        Mar. 5, 2022  
Richard Lowenthal
     120,956      $ 1.25        Jan. 5, 2022  
Richard Lowenthal
     28,222      $ 1.25        Mar. 4, 2022  
Silicon Valley Bank
     205,626      $ 1.25        Dec. 12, 2022  
Silicon Valley Bank
     96,765      $ 1.25        Dec. 12, 2022  
Silicon Valley Bank
     40,318      $ 1.25        Dec. 12, 2022  
ChargePoint Investments LLC
     454      $ 1.25        Sep. 12, 2021  
ChargePoint Investments LLC
     454      $ 1.25        Oct. 28, 2021  
ChargePoint Investments LLC
     2,058      $ 1.25        Jan. 5, 2022  
ChargePoint Investments LLC
     1,368      $ 1.25        Mar. 4, 2022  
ChargePoint Investments LLC
     16,425      $ 1.25        Sep. 12, 2021  
ChargePoint Investments LLC
     16,425      $ 1.25        Oct. 28, 2021  
ChargePoint Investments LLC
     20,268      $ 1.25        Jan. 5, 2022  
ChargePoint Investments LLC
     13,200      $ 1.25        Mar. 4, 2022  
Next47 Services GmbH
     57,964      $ 1.25        Oct 12, 2021  
Next47 Services GmbH
     57,964      $ 1.25        Oct. 28, 2021  
Next47 Services GmbH
     58,220      $ 1.25        Jan. 30, 2022  
Next47 Services GmbH
     29,193      $ 1.25        Mar. 27, 2022  
Ares Capital Corporation
     806,374      $ 1.25        Dec. 24, 2024  
Rule 144 and Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies
Rule 144 is not available for the resale of securities initially issued by shell companies or issuers that have been at any time previously a shell company. However, Rule 144 also includes an important exception to this prohibition if the following conditions are met:
 
   
the issuer of the securities that was formerly a shell company has ceased to be a shell company;
 
   
the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;
 
122

   
the issuer of the securities has filed all Exchange Act reports and materials required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Current Reports on Form
8-K;
and
 
   
at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.
As a result, our Initial Stockholders will be able to sell their Founder Shares pursuant to Rule 144 without registration one year after we have completed Merger, although these shares may be sold sooner to the extent they have been registered on a registration statement that has been declared effective by the SEC.
Registration Rights
Switchback and Legacy ChargePoint Stockholders’ Registration Rights
Pursuant to the A&R Registration Rights Agreement, we filed with the SEC the registration statement that was declared effective on May 28, 2021. In certain circumstances, the Registration Rights Holders can demand up to four underwritten offerings and will be entitled to customary piggyback registration rights. The A&R Registration Rights Agreement does not provide for the payment of any cash penalties by Switchback if it fails to satisfy any of its obligations under the A&R Registration Rights Agreement.
PIPE Shares
Pursuant to the Subscription Agreements, we filed with the SEC the registration statement that was declared effective on March 11, 2021, registering the resale of 22,500,000 shares of Common Stock at a purchase price of $10.00 per share (the “PIPE Shares”).
Lock-Up
Agreements
Concurrently with the Merger, certain stockholders of Legacy ChargePoint agreed, subject to certain customary exceptions, not to effect any (a) direct or indirect sale, assignment, encumbrance, pledge, hypothecation, disposition, loan or other transfer, or entry into any agreement with respect to any sale, assignment, encumbrance, pledge, hypothecation, disposition, loan or other transfer, with respect to any shares of Common Stock held by them immediately after the closing of the Merger, including any shares of Common Stock issuable upon the exercise of options or warrants to purchase shares of Common Stock held by them immediately following the closing of the Merger or (b) publicly announce any intention to effect any transaction specified in clause (a), in each case, for six months after the closing of the Merger. The lock-up with respect to these shares expired on August 26, 2021. The Earnout Shares were not subject to these lock-up restrictions and could be sold publicly following receipt.
Listing of Securities
Our Common Stock is listed on the NYSE under the symbol “CHPT”.
 
123

MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR
NON-U.S.
HOLDERS
The following is a discussion of material U.S. federal income tax consequences to
Non-U.S.
Holders (as defined below) of the purchase, ownership and disposition of shares of our Common Stock. This discussion is limited to material U.S. federal income tax considerations to beneficial owners of our Common Stock who are purchasers of such Common Stock pursuant to this offering and hold the Common Stock as a capital asset within the meaning of Section 1221 of the U.S. Internal Revenue Code of 1986, as amended (the “Code”).
This summary is based upon the Code and existing and proposed U.S. Treasury regulations promulgated thereunder, administrative pronouncements, judicial decisions, and interpretations of the foregoing, all as of the date of this prospectus and all of which are subject to change or differing interpretations, possibly with retroactive effect. This discussion is a summary only and does not describe all of the tax consequences that may be relevant to a
Non-U.S.
Holder in light of a
Non-U.S.
Holder’s particular circumstances, including but not limited to the alternative minimum tax, the Medicare tax on certain net investment income and the different consequences that may apply if you are subject to special rules that apply to certain types of investors, including but not limited to:
 
   
financial institutions or financial services entities;
 
   
broker-dealers;
 
   
governments or agencies or instrumentalities thereof;
 
   
regulated investment companies;
 
   
real estate investment trusts;
 
   
expatriates or former long-term residents of the United States;
 
   
persons that actually or constructively own five percent or more (by vote or value) of our shares;
 
   
persons that acquired our Common Stock pursuant to an exercise of employee share options, in connection with employee share incentive plans or otherwise as compensation;
 
   
insurance companies;
 
   
dealers or traders subject to a
mark-to-market
method of accounting with respect to our Common Stock;
 
   
persons holding our Common Stock as part of a “straddle,” constructive sale, hedge, conversion or other integrated or similar transaction;
 
   
partnerships (or entities or arrangements classified as partnerships or other pass-through entities for U.S. federal income tax purposes) and any beneficial owners of such partnerships;
 
   
tax-exempt
entities;
 
   
controlled foreign corporations; and
 
   
passive foreign investment companies.
In addition, this discussion does not address any aspect of state, local or
non-U.S.
taxation, or any U.S. federal taxes other than income taxes (such as gift and estate taxes).
Non-U.S.
Holders are urged to consult their own tax advisors concerning the U.S. federal income tax consequences of purchasing, owning and disposing of our Common Stock, as well as the application of any other U.S. federal, state, local,
non-U.S.
tax laws and income tax treaties. As used in this section, a
“Non-U.S.
Holder”
 
124

is a beneficial owner of our Common Stock (other than a partnership or any other entity treated as a pass-through entity for U.S. federal income tax purposes) that is not, for U.S. federal income tax purposes:
 
   
an individual who is a citizen or resident of the United States;
 
   
a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) that is created or organized in or under the laws of the United States, any state thereof or the District of Columbia;
 
   
an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or
 
   
a trust if (i) a court within the United States is able to exercise primary supervision over the administration of the trust and one or more “United States persons” (within the meaning of Section 7701(a)(30) of the Code) have the authority to control all substantial decisions of the trust or (ii) it has a valid election in effect under applicable U.S. Treasury regulations to be treated as a domestic trust.
If you are an individual, you are a resident alien if you are a lawful permanent resident of the United States (e.g., a green card holder) and you may, in many cases, be deemed to be a resident alien, as opposed to a nonresident alien, by virtue of being present in the United States for at least 31 days in the relevant calendar year and for an aggregate of at least 183 days during a three-year period ending in and including the relevant calendar year, subject to certain exceptions. For these purposes, all the days present in the United States in the relevant year,
one-third
of the days present in the immediately preceding year, and
one-sixth
of the days present in the second preceding year are counted. Resident aliens are subject to U.S. federal income tax as if they are U.S. citizens. Such an individual is urged to consult his or her own tax advisor regarding the U.S. federal income tax consequences of the purchase, ownership or disposition of our common stock.
If a partnership (including an entity or arrangement treated as a partnership or other pass-through entity for U.S. federal income tax purposes) holds our Common Stock, the tax treatment of a partner or owner of the other pass-through entity will generally depend upon the status of the partner or owner and the activities of the partnership or other pass-through entity. Any partnership, partner in such a partnership or owner of another pass-through entity holding our Common Stock should consult its own tax advisor as to the particular U.S. federal income tax consequences applicable to it.
THIS DISCUSSION IS ONLY A SUMMARY OF CERTAIN U.S. FEDERAL INCOME TAX CONSIDERATIONS ASSOCIATED WITH THE ACQUISITION, OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK. EACH PROSPECTIVE INVESTOR IN OUR COMMON STOCK IS URGED TO CONSULT ITS OWN TAX ADVISOR WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCES TO SUCH INVESTOR OF THE ACQUISITION, OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK, INCLUDING THE APPLICABILITY AND EFFECT OF ANY U.S. FEDERAL
NON-INCOME,
STATE, LOCAL, AND
NON-U.S.
TAX LAWS.
Distributions on Common Stock
Although we do not currently anticipate doing so in the foreseeable future (as discussed in “Market Information for Securities and Dividend Policy—Dividends”), any distributions we make to a
Non-U.S.
Holder on shares of our Common Stock, to the extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles), will constitute dividends for U.S. federal income tax purposes. Distributions in excess of our current and accumulated earnings and profits will constitute a return of capital that is first applied against and reduces (but not below zero) a
Non-U.S.
Holder’s adjusted tax basis in its shares of our Common Stock. Any remaining excess will be treated as gain realized from the sale or other taxable disposition of our Common Stock, which will be treated as described under “Dispositions of Common Stock” below.
 
125

Subject to the discussion below regarding effectively connected income, any dividend paid to a
Non-U.S.
Holder on our Common Stock will generally be subject to U.S. federal withholding tax at a 30% rate of the gross amount of the dividend. The withholding tax might not apply, however, or might apply at a reduced rate, under the terms of an applicable income tax treaty. A
Non-U.S.
Holder is urged to consult its own tax advisor regarding its entitlement to benefits under a relevant income tax treaty. Generally, to obtain the benefit of such right, a
Non-U.S.
Holder must certify its entitlement to treaty benefits. A
Non-U.S.
Holder generally can meet this certification requirement by providing a valid IRS Form
W-8BEN
or IRS Form
W-8BEN-E
(or other applicable form or documentation), as applicable, to the applicable withholding agent. If the
Non-U.S.
Holder holds our Common Stock through a financial institution or other agent acting on the
Non-U.S.
Holder’s behalf, the
Non-U.S.
Holder will be required to provide appropriate documentation to such agent. Even if our current and accumulated earnings and profits are less than the amount of the distribution, the applicable withholding agent may elect to treat the entire distribution as a dividend for U.S. federal withholding tax purposes. A
Non-U.S.
Holder that does not timely furnish the required documentation, but that qualifies for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS.
Dividends received by a
Non-U.S.
Holder that are effectively connected with a U.S. trade or business conducted by the
Non-U.S.
Holder and, if required by an applicable income tax treaty, are attributable to a permanent establishment (or, in certain cases involving individual holders, a fixed base) maintained by the
Non-U.S.
Holder in the United States, are generally exempt from the U.S. federal withholding tax described above. To obtain this exemption, a
Non-U.S.
Holder must provide a valid IRS Form
W-8ECI
properly certifying such exemption. Such effectively connected dividends, although not subject to U.S. federal withholding tax (provided certain certification and disclosure requirements are satisfied), are taxed at the same rates applicable to U.S. persons, net of certain deductions and credits. In addition to a
Non-U.S.
Holder being subject to taxation at the regular rates on effectively connected dividends as described above, such effectively connected dividends, as adjusted for certain items, received by corporate
Non-U.S.
Holders may also be subject to a branch profits tax at a rate of 30% or such lower rate as may be specified by an applicable income tax treaty.
Dispositions of Common Stock
Subject to the discussions below on backup withholding and other withholding tax requirements, a
Non-U.S.
Holder generally will not be subject to U.S. federal income or withholding tax in respect of gain recognized on a sale, taxable exchange or other taxable disposition of our Common Stock unless:
 
   
the gain is effectively connected with the conduct by the
Non-U.S.
Holder of a trade or business within the United States (and, under certain income tax treaties, is attributable to a United States permanent establishment or fixed base maintained by the
Non-U.S.
Holder);
 
   
the
Non-U.S.
Holder is an individual who is present in the United States for 183 or more days in the taxable year of such disposition and certain other conditions are met (in which case the gain would be subject to U.S. federal income tax at a rate of 30%, or such reduced rate as may be specified by an applicable income tax treaty, which may be offset by certain U.S. source capital losses of the
Non-U.S.
Holder, provided the
Non-U.S.
Holder has timely filed U.S. federal income tax returns with respect to such losses); or
 
   
we are, or become, a “United States real property holding corporation” (a “USRPHC”) for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on the date of disposition or the period that the
Non-U.S.
Holder held our Common Stock.
Unless an applicable treaty provides otherwise, gain described in the first bullet point above will be subject to tax at generally applicable U.S. federal income tax rates as if the
Non-U.S.
Holder were a U.S. resident. Any gains described in the first bullet point above of a
Non-U.S.
Holder that is a foreign corporation may also be subject to an additional “branch profits tax” imposed at a 30% rate (or lower treaty rate).
 
126

Generally, a corporation is a USRPHC if the fair market value of its “United States real property interests” equals 50% or more of the sum of the fair market value of (a) its worldwide real property interests and (b) its other assets used or held for use in a trade or business. Gain recognized by a
Non-U.S.
Holder on the sale, exchange or other disposition of our Common Stock if we are a USRPHC will be subject to tax at generally applicable U.S. federal income tax rates. In addition, a buyer of our Common Stock from such holder may be required to withhold U.S. federal income tax at a rate of 15% of the amount realized upon such disposition. The tax relating to dispositions of stock in a USRPHC does not apply to a
Non-U.S.
Holder whose holdings, actual and constructive, amount to 5% or less of our Common Stock at all times during the shorter of the five-year period ending on the date of disposition of our Common Stock and the
Non-U.S.
Holder’s holding period for our Common Stock, provided that our Common Stock is regularly traded on an established securities market. No assurance can be provided that our Common Stock will be regularly traded on an established securities market at all times for purposes of the rules described above. Although there can be no assurances in this regard, we believe we have not been and are not currently a USRPHC and do not anticipate being a USRPHC in the future.
Non-U.S.
Holders are urged to consult their own tax advisor about the consequences that could result if we are, or become, a USRPHC.
Information Reporting and Backup Withholding
Any dividends or other distributions that are paid to a
Non-U.S.
Holder must be reported annually to the IRS and to the
Non-U.S.
Holder. Copies of these information returns also may be made available to the tax authorities of the country in which the
Non-U.S.
Holder resides or is established under the provisions of various treaties or agreements for the exchange of information. Dividends paid on our Common Stock and the gross proceeds from a taxable disposition of our Common Stock may be subject to additional information reporting and may also be subject to U.S. federal backup withholding if such
Non-U.S.
Holder fails to comply with applicable U.S. information reporting and backup withholding certification requirements. Provision of an IRS Form
W-8
appropriate to the
Non-U.S.
Holder’s circumstances will generally satisfy the certification requirements necessary to avoid the additional information reporting and backup withholding.
Backup withholding is not an additional tax. Any amounts so withheld under the backup withholding rules may be refunded by the IRS or credited against the
Non-U.S.
Holder’s U.S. federal income tax liability, provided that the required information is timely furnished to the IRS.
FATCA Withholding Taxes
Provisions commonly referred to as “FATCA” impose a withholding tax (separate and apart from, but without duplication of, the withholding tax described above) at a rate of 30% on payments of U.S.-source dividends (including our dividends) paid to “foreign financial institutions” (which is broadly defined for this purpose and in general includes investment vehicles) and certain other
non-U.S.
entities unless various U.S. information reporting and due diligence requirements (generally relating to ownership by U.S. persons of interests in or accounts with those entities) have been satisfied, or an exemption applies. Withholding imposed by FATCA may also apply to gross proceeds from the sale or other taxable disposition of U.S. corporate stock (including our Common Stock); however, under proposed U.S. Treasury regulations, no withholding would apply to such gross proceeds. The preamble to the proposed U.S. Treasury regulations specifies that taxpayers (including withholding agents) are permitted to rely on the proposed U.S. Treasury regulations pending finalization. An intergovernmental agreement between the United States and an applicable
non-U.S.
country may modify these requirements. Accordingly, the entity through which our Common Stock is held will affect the determination of whether such withholding is required. If FATCA withholding is imposed, a beneficial owner that is not a foreign financial institution generally will be entitled to a refund of any amounts withheld by filing a U.S. federal income tax return containing the required information (which may entail a significant administrative burden).
Non-U.S.
Holders are urged to consult their own tax advisors regarding the effects of FATCA on their investment in our Common Stock.
 
127

THE PRECEDING DISCUSSION OF U.S. FEDERAL INCOME TAX CONSIDERATIONS IS FOR GENERAL INFORMATION ONLY. IT IS NOT TAX ADVICE. EACH PROSPECTIVE INVESTOR IS URGED TO CONSULT ITS OWN TAX ADVISOR REGARDING THE PARTICULAR U.S. FEDERAL, STATE, LOCAL AND
NON-U.S.
TAX CONSEQUENCES OF PURCHASING, OWNING AND DISPOSING OF OUR COMMON STOCK, INCLUDING THE CONSEQUENCES OF ANY PROPOSED CHANGE IN APPLICABLE LAWS AND INCOME TAX TREATIES.
 
128

PLAN OF DISTRIBUTION
We are registering the offer and sale, from time to time, by the selling securityholders of up to 5,695,176 shares of Common Stock.
We will not receive any of the proceeds from the sale of the securities by the selling securityholders. The aggregate proceeds to the selling securityholders will be the purchase price of the securities less any discounts and commissions borne by the selling securityholders.
Once issued and upon effectiveness of the registration statement of which this prospectus forms a part, the securities beneficially owned by the selling securityholders covered by this prospectus may be offered and sold from time to time by the selling securityholders. The term “selling securityholders” includes donees, pledgees, transferees or other
successors-in-interest
selling Common Stock or interests in stock received after the date of this prospectus from a registered stockholder as a gift, pledge, partnership, limited liability company or other entity distribution or other transfer, and may, or may not, elect to sell or transfer their shares of Common Stock or interests in stock covered by this prospectus, as and to the extent they may determine. The selling securityholders will act independently of us in making decisions with respect to the timing, manner and size of each sale. Such sales may be made on one or more exchanges or in the
over-the-counter
market or otherwise, at prices and under terms then prevailing or at prices related to the then current market price or in negotiated transactions. The selling securityholders reserve the right to accept and, together with its respective agents, to reject, any proposed purchase of securities to be made directly or through agents. The selling securityholders and any permitted transferees may sell or transfer their securities offered by this prospectus on any stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at a fixed price or varying prices, which may be changed, or at market prices prevailing at the time of sale, at prices relating to prevailing market prices or at negotiated prices. The securities may be offered to the public through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate. The obligations of the underwriters to purchase the securities will be subject to certain conditions. The underwriters will be obligated to purchase all the securities offered if any of the securities are purchased.
Subject to the limitations set forth in any applicable registration rights agreement, the selling securityholders may use any one or more of the following methods when selling the securities offered by this prospectus:
 
   
purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus;
 
   
ordinary brokerage transactions and transactions in which the broker solicits purchasers;
 
   
block trades in which the broker-dealer so engaged will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;
 
   
an
over-the-counter
distribution in accordance with the rules of the applicable exchange;
 
   
through trading plans entered into by a selling securityholder pursuant to Rule
10b5-1
under the Exchange Act that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans;
 
   
through one or more underwritten offerings on a firm commitment or best efforts basis;
 
   
settlement of short sales entered into after the date of this prospectus;
 
   
agreements with broker-dealers to sell a specified number of the securities at a stipulated price per share;
 
   
in “at the market” offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales
 
129

 
made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents;
 
   
directly to purchasers, including through a specific bidding, auction or other process or in privately negotiated transactions;
 
   
through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
 
   
through a combination of any of the above methods of sale; or
 
   
any other method permitted pursuant to applicable law.
In addition, a selling securityholder that is an entity may elect to make an
in-kind
distribution of securities to its members, partners or stockholders pursuant to the registration statement of which this prospectus is a part by delivering a prospectus with a plan of distribution. Such members, partners or stockholders would thereby receive freely tradeable securities pursuant to the distribution through a registration statement. To the extent a distributee is an affiliate of ours (or to the extent otherwise required by law), we may file a prospectus supplement in order to permit the distributees to use the prospectus to resell the securities acquired in the distribution.
The selling securityholders also may transfer the securities in other circumstances, in which case the transferees, pledgees or other
successors-in-interest
will be the selling beneficial owners for purposes of this prospectus. Upon being notified by the selling securityholders that a donee, pledgee, transferee, other successor-
in-interest
intends to sell our securities, we will, to the extent required, promptly file a supplement to this prospectus to name specifically such person as a selling securityholders.
There can be no assurance that the selling securityholders will sell all or any of the securities offered by this prospectus. In addition, the selling securityholders may also sell securities under Rule 144 under the Securities Act, if available, or in other transactions exempt from registration, rather than under this prospectus. The selling securityholders have the sole and absolute discretion not to accept any purchase offer or make any sale of securities if they deem the purchase price to be unsatisfactory at any particular time.
To the extent required, the shares of our Common Stock to be sold, the name of the selling securityholders, the respective purchase prices and public offering prices, the proceeds to be received from the sale, if any, and other material terms of the offering, the settlement of short sales entered into after the date of this prospectus, the names of any agents, dealer or underwriter, any applicable commissions or discounts or any other items constituting compensation from the selling securityholders with respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus.
In connection with the sale of shares of our Common Stock, the selling securityholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the shares of our Common Stock in the course of hedging the positions they assume. The selling securityholders may also sell shares of our Common Stock short and deliver these securities to close out their short positions, or loan or pledge the Common Stock to broker-dealers that in turn may sell these shares. The selling securityholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).
In order to facilitate the offering of the securities, any underwriters or agents, as the case may be, involved in the offering of such securities may engage in transactions that stabilize, maintain or otherwise affect the price of our securities. Specifically, the underwriters or agents, as the case may be, may overallot in connection with the
 
130

offering, creating a short position in our securities for their own account. In addition, to cover overallotments or to stabilize the price of our securities, the underwriters or agents, as the case may be, may bid for, and purchase, such securities in the open market. Finally, in any offering of securities through a syndicate of underwriters, the underwriting syndicate may reclaim selling concessions allotted to an underwriter or a broker-dealer for distributing such securities in the offering if the syndicate repurchases previously distributed securities in transactions to cover syndicate short positions, in stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the securities above independent market levels. The underwriters or agents, as the case may be, are not required to engage in these activities, and may end any of these activities at any time.
In offering the securities covered by this prospectus, the selling securityholders and any underwriters, broker-dealers or agents who execute sales for the selling securityholders may be deemed to be “underwriters” within the meaning of the Securities Act in connection with such sales. Any discounts, commissions, concessions or profit they earn on any resale of those securities may be underwriting discounts and commissions under the Securities Act.
The selling securityholders may solicit offers to purchase the securities directly from, and it may sell such securities directly to, institutional investors or others. In this case, no underwriters or agents would be involved. The terms of any of those sales, including the terms of any bidding or auction process, if utilized, will be described in the applicable prospectus supplement.
It is possible that one or more underwriters may make a market in our securities, but such underwriters will not be obligated to do so and may discontinue any market making at any time without notice. We cannot give any assurance as to the liquidity of the trading market for our securities. Our shares of Common Stock are currently listed on the NYSE under the symbol “CHPT”.
The selling securityholders may authorize underwriters, broker-dealers or agents to solicit offers by certain purchasers to purchase the securities at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. The contracts will be subject only to those conditions set forth in the prospectus supplement, and the prospectus supplement will set forth any commissions we or the selling securityholders pay for solicitation of these contracts.
A selling securityholder may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by any selling securityholder or borrowed from any selling securityholder or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from any selling securityholder in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter and will be identified in the applicable prospectus supplement (or a post-effective amendment). In addition, any selling securityholder may otherwise loan or pledge securities to a financial institution or other third party that in turn may sell the securities short using this prospectus. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities.
In effecting sales, broker-dealers or agents engaged by the selling securityholders may arrange for other broker-dealers to participate. Broker-dealers or agents may receive commissions, discounts or concessions from the selling securityholders in amounts to be negotiated immediately prior to the sale.
In compliance with the guidelines of the Financial Industry Regulatory Authority (“FINRA”), the aggregate maximum discount, commission, fees or other items constituting underwriting compensation to be received by any FINRA member or independent broker-dealer will not exceed 8% of the gross proceeds of any offering pursuant to this prospectus and any applicable prospectus supplement.
 
131

If at the time of any offering made under this prospectus a member of FINRA participating in the offering has a “conflict of interest” as defined in FINRA Rule 5121 (“Rule 5121”), that offering will be conducted in accordance with the relevant provisions of Rule 5121.
To our knowledge, there are currently no plans, arrangements or understandings between the selling securityholders and any broker-dealer or agent regarding the sale of the securities by the selling securityholders. Upon our notification by a selling securityholder that any material arrangement has been entered into with an underwriter or broker-dealer for the sale of securities through a block trade, special offering, exchange distribution, secondary distribution or a purchase by an underwriter or broker-dealer, we will file, if required by applicable law or regulation, a supplement to this prospectus pursuant to Rule 424(b) under the Securities Act disclosing certain material information relating to such underwriter or broker-dealer and such offering.
Underwriters, broker-dealers or agents may facilitate the marketing of an offering online directly or through one of their affiliates. In those cases, prospective investors may view offering terms and a prospectus online and, depending upon the particular underwriter, broker-dealer or agent, place orders online or through their financial advisors.
The underwriters, broker-dealers and agents may engage in transactions with us or the selling securityholders, or perform services for us or the selling securityholders, in the ordinary course of business.
In order to comply with the securities laws of certain states, if applicable, the securities must be sold in such jurisdictions only through registered or licensed brokers or dealers. In addition, in certain states the securities may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.
We have advised the selling securityholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities of the selling securityholders and their affiliates. In addition, to the extent applicable we will make copies of this prospectus (as it may be supplemented or amended from time to time) available to the selling securityholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling securityholders may indemnify any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act.
We will make copies of this prospectus available to the selling securityholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling securityholders may indemnify any agent, broker-dealer or underwriter that participates in transactions involving the sale of the securities against certain liabilities, including liabilities arising under the Securities Act.
We have agreed to indemnify certain of the selling securityholders against certain liabilities, including certain liabilities under the Securities Act, the Exchange Act or other federal or state law. Agents, broker-dealers and underwriters may be entitled to indemnification by us and the selling securityholders against certain civil liabilities, including liabilities under the Securities Act, or to contribution with respect to payments which the agents, broker-dealers or underwriters may be required to make in respect thereof.
We are required to use our commercially reasonable efforts to cause the Shelf Registration Statement to remain effective, and to be supplemented and amended as promptly as practicable to the extent necessary to ensure that the Shelf Registration Statement is available or that another registration statement is available, for the resale of all the Registrable Securities until the earliest of (i) two years after October 6, 2021, (ii) all of the Issued Shares and any securities issued or issuable with respect to the Issued Shares by way of distribution or in connection with any reorganization or other recapitalization, merger, consolidation or otherwise have ceased to be Registrable Securities, and (iii) the earlier termination of the Registration Rights Agreement (as to all holders).
 
132

LEGAL MATTERS
Weil, Gotshal & Manges LLP, New York, New York has passed upon the validity of the Common Stock of ChargePoint offered by this prospectus.
EXPERTS
The financial statements of Legacy ChargePoint as of January 31, 2021 and 2020 and for each of the three years in the period ended January 31, 2021 included in this prospectus have been so included in reliance on the report of PricewaterhouseCoopers LLP (“PwC”), an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.
WHERE YOU CAN FIND MORE INFORMATION
We have filed a registration statement on Form
S-1,
including exhibits, under the Securities Act, as amended, with respect to the securities offered by this prospectus. This prospectus does not contain all of the information included in the registration statement. For further information pertaining to us and our securities, you should refer to the registration statement and the exhibits.
In addition, we file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public on a website maintained by the SEC located at ww.sec.gov. We also maintain a website at
https://investors.chargepoint.com/governance/governance-documents.
Through our website, we make available, free of charge, annual, quarterly and current reports, proxy statements and other information as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. The information contained on, or that may be accessed through, our website is not part of, and is not incorporated into, this prospectus.
 
133

INDEX TO FINANCIAL STATEMENTS
 
    
Page
No.
 
ChargePoint Holdings, Inc. Unaudited Condensed Consolidated Financial Statements
  
    
F-2
 
    
F-3
 
    
F-4
 
    
F-5
 
    
F-7
 
    
F-9
 
ChargePoint, Inc. Audited Consolidated Financial Statements
  
    
F-32
 
    
F-33
 
    
F-34
 
    
F-35
 
    
F-36
 
    
F-38
 
    
F-39
 
 
F-1

ChargePoint Holdings, Inc.
Condensed Consolidated Balance Sheets
(unaudited)
 
 
  
July 31,

2021
 
 
January 31,

2021
 
 
  
(in thousands, except
share and per share data)
 
Assets
  
     
 
     
Current assets:
  
     
 
     
Cash and cash equivalents
  
$
618,089
 
 
$
145,491
 
Restricted cash
  
 
400
 
 
 
400
 
Accounts receivable, net of allowance of $2,000
as of July 31, 2021 and January 31, 2021
  
 
42,708
 
 
 
35,075
 
Inventories
  
 
27,916
 
 
 
33,592
 
Prepaid expenses and other current assets
  
 
22,138
 
 
 
12,074
 
 
  
 
 
 
 
 
 
 
Total current assets
  
 
711,251
 
 
 
226,632
 
Property and equipment, net
  
 
32,265
 
 
 
29,988
 
Operating lease
right-of-use
assets
  
 
20,834
 
 
 
21,817
 
Goodwill
  
 
1,215
 
 
 
1,215
 
Other assets
  
 
5,023
 
 
 
10,468
 
 
  
 
 
 
 
 
 
 
Total assets
  
$
770,588
 
 
$
290,120
 
 
  
 
 
 
 
 
 
 
Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit)
  
 
 
 
 
 
 
 
Current liabilities:
  
 
 
 
 
 
 
 
Accounts payable
  
$
28,416
 
 
$
19,784
 
Accrued and other current liabilities
  
 
51,980
 
 
 
47,162
 
Deferred revenue
  
 
47,769
 
 
 
40,934
 
Debt, current
  
 
—  
 
 
 
10,208
 
Total current liabilities
  
 
128,165
 
 
 
118,088
 
Deferred revenue, noncurrent
  
 
58,000
 
 
 
48,896
 
Debt, noncurrent
  
 
 
 
 
24,686
 
Operating lease liabilities
  
 
21,582
 
 
 
22,459
 
Common stock warrant liabilities
  
 
26,868
 
 
 
 
Redeemable convertible preferred stock warrant liability
  
 
 
 
 
75,843
 
Other long-term liabilities
  
 
961
 
 
 
972
 
 
  
 
 
 
 
 
 
 
Total liabilities
  
 
235,576
 
 
 
290,944
 
 
  
 
 
 
 
 
 
 
Commitments and contingencies (Note 7)
  
 
 
 
 
 
Redeemable convertible preferred stock: $0.0001 par value; 0
and 185,180,248
shares authorized as of July 31, 2021 and January 31, 2021, respectively; 0
and 182,934,257
shares issued and outstanding as of July 31, 2021 and January 31, 2021, respectively (liquidation value: $0
and $17,492,964
as of July 31, 2021 and January 31, 2021, respectively)
  
 
—  
 
 
 
615,697
 
Stockholders’ equity (deficit):
  
 
 
 
 
 
 
 
Common stock: $0.0001 par value; 1,000,000,000
and 299,771,284
shares authorized as of July 31, 2021 and January 31, 2021, respectively; 322,170,484
and 22,961,032
shares issued and outstanding as of July 31, 2021 and January 31, 2021,
respectively
  
 
32
 
 
 
2
 
Preferred stock, $0.0001 par value; 10,000,000 and 0 shares
authorized as of July 31, 2021 and January 31, 2021, respectively; 0
issued and outstanding as of July 31, 2021 and January 31, 2021
  
 
  
 
 
 
  
 
Additional
paid-in
capital
  
 
1,216,893
 
 
 
62,736
 
Accumulated other comprehensive income
  
 
150
 
 
 
155
 
Accumulated deficit
  
 
(682,063
 
 
(679,414
 
  
 
 
 
 
 
 
 
Total stockholders’ equity (deficit)
  
 
535,012
 
 
 
(616,521
 
  
 
 
 
 
 
 
 
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit)
  
$
770,588
 
 
$
290,120  
    
 
 
   
 
 
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
F-2

ChargePoint Holdings, Inc.
Condensed Consolidated Statements of Operations
(unaudited)
 
 
 
Three Months Ended

July 31,
 
 
Six Months Ended

July 31,
 
 
 
2021
 
 
2020
 
 
2021
 
 
2020
 
 
 
(in thousands, except share
and per share data)
 
 
(in thousands, except share
and per share data)
 
Revenue
 
     
 
     
 
     
 
     
Networked charging systems
 
$
40,874
 
 
$
21,368
 
 
$
67,674
 
 
$
41,025
 
Subscriptions
 
 
12,082
 
 
 
9,811
 
 
 
22,906
 
 
 
18,815
 
Other
 
 
3,165
 
 
 
3,778
 
 
 
6,051
 
 
 
7,893
 
Total revenue
 
 
56,121
 
 
 
34,957
 
 
 
96,631
 
 
 
67,733
 
Cost of revenue
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Networked charging systems
 
 
35,384
 
 
 
20,408
 
 
 
59,126
 
 
 
39,024
 
Subscriptions
 
 
7,830
 
 
 
4,452
 
 
 
13,470
 
 
 
9,225
 
Other
 
 
2,130
 
 
 
1,069
 
 
 
4,041
 
 
 
2,692
 
Total cost of revenue
 
 
45,344
 
 
 
25,929
 
 
 
76,637
 
 
 
50,941
 
Gross profit
 
 
10,777
 
 
 
9,028
 
 
 
19,994
 
 
 
16,792
 
Operating expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Research and development
 
 
40,410
 
 
 
17,126
 
 
 
65,784
 
 
 
35,152
 
Sales and marketing
 
 
21,923
 
 
 
10,966
 
 
 
37,897
 
 
 
25,167
 
General and administrative
 
 
22,732
 
 
 
4,466
 
 
 
37,199
 
 
 
9,555
 
Total operating expenses
 
 
85,065
 
 
 
32,558
 
 
 
140,880
 
 
 
69,874
 
Loss from operations
 
 
(74,288
 
 
(23,530
 
 
(120,886
 
 
(53,082
Interest income
 
 
25
 
 
 
37
 
 
 
47
 
 
 
280
 
Interest expense
 
 
—  
 
 
 
(793
 
 
(1,499
 
 
(1,628
Change in fair value of redeemable convertible preferred stock warrant liability
 
 
—  
 
 
 
(11,516
 
 
9,237
 
 
 
(10,981
Change in fair value of common stock warrant liabilities
 
 
(10,421
 
 
—  
 
 
 
33,340
 
 
 
—  
 
Change in fair value of contingent earnout liability
 
 
—  
 
 
 
—  
 
 
 
84,420
 
 
 
—  
 
Transaction costs expensed
 
 
—  
 
 
 
—  
 
 
 
(7,031
 
 
—  
 
Other (expense) income, net
 
 
(189
 
 
563
 
 
 
(174
 
 
131
 
Net loss before income taxes
 
 
(84,873
 
 
(35,239
 
 
(2,546
 
 
(65,280
Provision for income taxes
 
 
65
 
 
 
48
 
 
 
103
 
 
 
105
 
Net loss
 
$
(84,938
 
$
(35,287
 
$
(2,649
 
$
(65,385
Accretion of beneficial conversion feature of redeemable convertible preferred stock
 
 
—  
 
 
 
(58,625
 
 
—  
 
 
 
(58,625
Cumulative dividends on redeemable convertible preferred stock
 
 
  
 
 
 
—  
 
 
 
(4,292
 
 
—  
 
Deemed dividends attributable to vested option holders
 
 
  
 
 
 
—  
 
 
 
(51,855
 
 
—  
 
Deemed dividends attributable to common stock warrant holders
 
 
  
 
 
 
—  
 
 
 
(110,635
 
 
—  
 
Net loss attributable to common stockholders - Basic
 
$
(84,938
 
$
(93,912
 
$
(169,431
 
$
(124,010
Gain attributable to earnout shares issued
 
 
  
 
 
 
—  
 
 
 
(84,420
 
 
—  
 
Change in fair value of dilutive warrants
 
 
(7,427
 
 
—  
 
 
 
(53,540
 
 
—  
 
Net loss attributable to common stockholders - Diluted
 
$
(92,365
 
$
(93,912
 
$
(307,391
 
$
(124,010
Weighted average shares outstanding - Basic
 
 
312,227,526
 
 
 
13,468,677
 
 
 
266,197,482
 
 
 
12,822,481
 
Weighted average shares outstanding - Diluted
 
 
313,602,100
 
 
 
13,468,677
 
 
 
275,577,000
 
 
 
12,822,481
 
Net loss per share - Basic
 
$
(0.27
 
$
(6.97
 
$
(0.64
 
$
(9.67
Net loss per share - Diluted
 
$
(0.29
 
$
(6.97
 
$
(1.12
 
$
(9.67
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
F-3

ChargePoint Holdings, Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(unaudited)
 
 
  
Three Months Ended

July 31,
 
 
Six Months Ended

July 31,
 
 
  
2021
 
 
2020
 
 
2021
 
 
2020
 
 
  
(in thousands)
 
 
(in thousands)
 
Net loss
  
$
(84,938
 
$
(35,287
 
$
(2,649
 
$
(65,385
Other comprehensive income (loss):
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustment
  
 
(12
 
 
92
 
 
 
(5
 
 
36  
Unrealized loss on short-term investments, net of t
a
x
     —         (23     —         (23
Other comprehensive (loss) income
  
 
(12
 
 
69
 
 
 
(5
 
 
13  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comprehensive loss
  
$
(84,950
 
$
(35,218
 
$
(2,654
 
$
(65,372
    
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
F-4

ChargePoint Holdings, Inc.
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit)
(unaudited)
 
 
 
Redeemable
Convertible Preferred
Stock
 
 
Common Stock
 
 
Additional
Paid-In

Capital
 
 
Accumulated
Other
Comprehensive
Income
 
 
Accumulated
Deficit
 
 
Total
Stockholders’
(Deficit)
Equity
 
 
 
Shares
(1)
 
 
Amount
 
 
Shares
(1)
 
 
Amount
 
 
 
(in thousands, except share data)
 
Balances as of January 31, 2021
 
 
182,934,257
 
 
$
615,697
 
 
 
22,961,032
 
 
$
2
 
 
$
62,736
 
 
$
155
 
 
$
(679,414
 
$
(616,521
Conversion of redeemable conv
e
rtible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series
H-1
paid in kind dividend
 
 
(182,934,257
 
 
(615,697
 
 
194,060,336
 
 
 
20
 
 
 
615,677
 
 
 
—  
 
 
 
—  
 
 
 
615,697
 
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse recapitalization
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
66,606
 
 
 
—  
 
 
 
—  
 
 
 
66,606
 
Issuance of common stock upon the reverse recapitalization, net of issuance costs
 
 
—  
 
 
 
—  
 
 
 
60,746,989
 
 
 
6
 
 
 
200,460
 
 
 
—  
 
 
 
—  
 
 
 
200,466
 
Issuance of common stock upon exercise of warrants
 
 
—  
 
 
 
—  
 
 
 
9,766,774
 
 
 
1
 
 
 
225,375
 
 
 
—  
 
 
 
—  
 
 
 
225,376
 
Contingent earnout liability recognized upon the closing of the reverse recapitalization
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
(828,180
 
 
—  
 
 
 
—  
 
 
 
(828,180
Issuance of earnout shares upon triggering events, net of tax withholding
 
 
—  
 
 
 
—  
 
 
 
17,539,657
 
 
 
2
 
 
 
488,303
 
 
 
—  
 
 
 
—  
 
 
 
488,305
 
Reclassification of remaining contingent
earnout liability upon triggering even
t
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
242,640
 
 
 
—  
 
 
 
—  
 
 
 
242,640
 
Vesting of early exercised stock options
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
78
 
 
 
—  
 
 
 
—  
 
 
 
78
 
Repurchase of early exercised common stock
 
 
—  
 
 
 
—  
 
 
 
(1,588
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
Stock-based compensation
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
7,577
 
 
 
—  
 
 
 
—  
 
 
 
7,577
 
Net income
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
82,289
 
 
 
82,289
 
Other comprehensive income
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
7
 
 
 
—  
 
 
 
7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balances as of April 30, 2021
 
 
—  
 
 
 
—  
 
 
 
305,073,200
 
 
 
31
 
 
 
1,081,272
 
 
 
162
 
 
 
(597,125
 
 
484,340
 
Issuance of common stock upon release of restricted stock units
 
 
—  
 
 
 
—  
 
 
 
652,901
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
Issuance of common stock upon exercise of warrants
 
 
—  
 
 
 
—  
 
 
 
4,378,568
 
 
 
  
 
 
 
113,608
 
 
 
—  
 
 
 
—  
 
 
 
113,608
 
Issuance of common stock upon exercise of vested stock options
 
 
—  
 
 
 
—  
 
 
 
3,292,219
 
 
 
—  
 
 
 
1,761
 
 
 
—  
 
 
 
—  
 
 
 
1,761
 
Issuance of earnout shares upon triggering events, net of tax withholding
 
 
—  
 
 
 
—  
 
 
 
8,773,596
 
 
 
1
 
 
 
(8,081
 
 
—  
 
 
 
—  
 
 
 
(8,080
Vesting of early exercised stock options
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
40
 
 
 
—  
 
 
 
—  
 
 
 
40
 
Stock-based compensation
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
28,293
 
 
 
—  
 
 
 
—  
 
 
 
28,293
 
Net loss
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
(84,938
 
 
(84,938
Other comprehensive loss
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
(12
 
 
—  
 
 
 
(12
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balances as of July 31, 2021
 
 
—  
 
 
$
—  
 
 
 
322,170,484
 
 
$
32
 
 
$
1,216,893
 
 
$
150
 
 
$
(682,063
 
$
535,012
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
F-5

 
 
Redeemable
Convertible
Preferred Stock
 
 
Common Stock
 
 
Additional
Paid-In

Capital
 
 
Accumulated
Other
Comprehensive
Income (Loss)
 
 
Accumulated
Deficit
 
 
Total
Stockholders’
Deficit
 
 
 
Shares
(1)
 
 
Amount
 
 
Shares
(1)
 
 
Amount
 
 
 
 
 
 
 
 
 
(in thousands, except share data)
 
Balances as of January 31, 2020
 
 
160,583,203
 
 
$
520,241
 
 
 
11,918,418
 
 
$
1
 
 
$
20,331
 
 
$
37
 
 
 
(482,390
 
$
(462,021
Issuance of common stock upon exercise of vested stock options
 
 
—  
 
 
 
—  
 
 
 
1,071,203
 
 
 
—  
 
 
 
436
 
 
 
—  
 
 
 
—  
 
 
 
436
 
Vesting of early exercised stock options
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
10
 
 
 
—  
 
 
 
—  
 
 
 
10
 
Stock-based compensation
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
910
 
 
 
—  
 
 
 
—  
 
 
 
910
 
Net loss
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
(30,098
 
 
(30,098
Other comprehensive loss
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
(56
 
 
—  
 
 
 
(56
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balances as of April 30, 2020
 
 
160,583,203
 
 
 
520,241
 
 
 
12,989,621
 
 
 
1
 
 
 
21,687
 
 
 
(19
 
 
(512,488
 
 
(490,819
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs
 
 
21,783,334
 
 
 
92,433
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
Issuance of common stock warrants in connection with Series
H-1
redeemable convertible preferred stock
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
31,390
 
 
 
—  
 
 
 
—  
 
 
 
31,390
 
Beneficial conversion feature in connection with Series
H-1
redeemable preferred stock
 
 
—  
 
 
 
(58,625
 
 
—  
 
 
 
—  
 
 
 
58,625
 
 
 
—  
 
 
 
—  
 
 
 
58,625
 
Accretion of beneficial conversion feature in connection with Series
H-1
redeemable preferred stock
 
 
—  
 
 
 
58,625
 
 
 
—  
 
 
 
—  
 
 
 
(58,625
 
 
—  
 
 
 
—  
 
 
 
(58,625
Issuance of common stock upon exercise of vested stock options
 
 
—  
 
 
 
—  
 
 
 
1,523,641
 
 
 
—  
 
 
 
1,095
 
 
 
—  
 
 
 
—  
 
 
 
1,095
 
Issuance of common stock related to early exercise of stock options
 
 
—  
 
 
 
—  
 
 
 
66,440
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
Vesting of early exercised stock options
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
1
 
 
 
—  
 
 
 
—  
 
 
 
1
 
Stock-based compensation
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
1,190
 
 
 
—  
 
 
 
—  
 
 
 
1,190
 
Net loss
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
(35,287
 
 
(35,287
Other comprehensive income
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
69
 
 
 
—  
 
 
 
69
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balances as of July 31, 2020
 
 
182,366,537
 
 
$
612,674
 
 
 
14,579,702
 
 
$
1
 
 
$
55,363
 
 
$
50
 
 
$
(547,775
 
$
(492,361
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
The shares of the Company’s common and redeemable convertible preferred stock, prior to the Merger (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.9966 established in the Merger as described in Note 3.
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
F-6
ChargePoint Holdings, Inc.
Condensed Consolidated Statements of Cash Flows
(unaudited)
 
    
Six Months Ended

July 31,
 
    
2021
   
2020
 
    
(in thousands)
 
Cash flows from operating activities
                
Net loss
   $ (2,649   $ (65,385
Adjustments to reconcile net loss to net cash used in operating activities:
                
Depreciation and amortization
     5,576       4,684  
Non-cash
operating lease cost
     1,963       1,749  
Stock-based compensation
     35,870       2,100  
Amortization of deferred contract acquisition costs
     829       538  
Change in fair value of redeemable convertible preferred stock warrant liability
     (9,237     —    
Change in fair value of common stock warrant liabilities
     (33,340     10,981  
Change in fair value of contingent earnout liability
     (84,420     —    
Transaction costs expensed
     7,031       —    
Other
     1,236       683  
Changes in operating assets and liabilities, net of effect of acquisitions:
                
Accounts receivable, net
     (7,657     16,188  
Inventories
     5,620       (7,427
Prepaid expenses and other assets
     (9,325     (3,335
Operating lease liabilities
     (953     (2,031
Accounts payable
     9,293       (9,324
Accrued and other liabilities
     3,027       (4,054
Deferred revenue
     15,938       4,564  
    
 
 
   
 
 
 
Net cash used in operating activities
     (61,198     (50,069
    
 
 
   
 
 
 
Cash flows from investing activities
                
Purchases of property and equipment
     (7,788     (5,962
Maturities of investments
     —         47,014  
    
 
 
   
 
 
 
Net cash (used in) provided by investing activities
     (7,788     41,052  
    
 
 
   
 
 
 
Cash flows from financing activities
                
Proceeds from issuance of redeemable convertible preferred stock
     —         92,433  
Proceeds from the exercise of public warrants
     117,598       31,390  
Merger and PIPE financing
     511,646       —    
Payments of transaction costs related to Merger
     (32,468     —    
Payment of tax withholding obligations on settlement of earnout shares
     (20,894     —    
Repayment of borrowings
     (36,051     —    
Proceeds from exercises of vested and unvested stock options
     1,759       1,542  
    
 
 
   
 
 
 
Net cash provided by financing activities
     541,590       125,365  
    
 
 
   
 
 
 
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
     (6     36  
Net increase in cash, cash equivalents, and restricted cash
     472,598       116,384  
Cash, cash equivalents, and restricted cash at beginning of period
     145,891       73,153  
    
 
 
   
 
 
 
Cash, cash equivalents, and restricted cash at end of period
   $ 618,489     $ 189,537  
    
 
 
   
 
 
 
 
F-7

ChargePoint Holdings, Inc.
Condensed Consolidated Statements of Cash Flows - (continued)
Six Months Ended July 31, 2021 and 2020 (Unaudited)
 
    
Six Months Ended

July 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Supplementary cash flow information
                 
Cash paid for interest
   $ 344      $ 1,402  
Cash paid for taxes
   $ 115      $ 105  
Supplementary cash flow information on noncash investing and financing activities
                 
Accretion of beneficial conversion feature of redeemable convertible preferred stock
   $ —        $ 58,625  
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization
   $ 615,697      $ —    
Reclassification of Legacy ChargePoint redeemable convertible preferred stock warrant liability upon the reverse
capitalization
   $ 66,606      $ —    
Contingent earnout liability recognized upon the closing of the reverse recapitalization
   $ 828,180      $ —    
Reclassification of remaining contingent earnout liability upon triggering event
   $ 242,640      $ —    
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
F-8

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
1.
Description of Business
 
and Basis of Presentation
ChargePoint Holdings, Inc. (“ChargePoint” or the “Company,” “it,” “its”) designs, develops, and markets networked electric vehicle (“EV”) charging system infrastructure (“Networked Charging Systems”) and cloud-based services which enable consumers the ability to locate, reserve, authenticate and transact EV charging sessions (“Cloud” or “Cloud Services”). As part of ChargePoint’s Networked Charging Systems, subscriptions and other offerings, it provides an open platform that integrates with system hardware from ChargePoint and other manufacturers, connecting systems over an intelligent network that provides real-time information about charging sessions and full control, support and m
a
nagement of the Networked Charging Systems. This network provides multiple
web-based portals
for charging system owners, fleet managers, drivers, and utilities.
In addition, the Company offers extended parts and labor warranty (“Assure”) that includes proactive monitoring, fast response times, expert advice and robust reporting. The ChargePoint as a Service (“CPaaS”) program combines the customer’s use of ChargePoint’s owned and operated systems with Cloud Services, Assure and other benefits available to subscribers into one subscription.
The Company’s fiscal year ends on January 31. References to fiscal year 2021 relate to the fiscal year ended January 31, 2021 and to fiscal year 2022 refer to the fiscal year ending January 31, 2022.
Basis of Presentation
The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting. The Company’s condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended January 31, 2021 and the related notes included in the Company’s Registration Statement on Form S-1 filed with the SEC on July 12, 2021, which provides a more complete discussion of the Company’s accounting policies and certain other information. The information as of January 31, 2021 included on the condensed consolidated balance sheets was derived from the Company’s audited consolidated financial statements. The condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company’s financial position as of July 31, 2021 and the results of operations for the three and six months ended July 31, 2021 and 2020, and cash flows for the six months ended July 31, 2021 and 2020. The results of operations for the three and six months ended July 31, 2021 are not necessarily indicative of the results that may be expected for the year ending January 31, 2022.
The Company’s condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its product offerings, raising capital, and recruiting personnel. The Company’s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial
 
F-9

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
efforts, or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company’s stockholders. The Company has incurred net operating losses and negative cash flows from operations in every year since inception and expects this to continue for the foreseeable future. As of July 31, 2021, the Company had an accumulated deficit of $682.1 million.
The Company has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock, borrowings under its loan facilities, customer payments and proceeds from the Reverse Recapitalization (as defined below). The Company had cash, cash equivalents, and restricted cash of $618.5 million as of July 31, 2021. As of September 10, 2021, the date on which these condensed consolidated financial statements were available to be issued, the Company believes that its cash on hand, together with cash generated from sales to customers, will satisfy its working capital and capital requirements for at least the next twelve months.
The Company’s assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties. The Company’s actual results could vary as a result of, and its near- and long-term future capital requirements will depend on, many factors, including its growth rate, subscription renewal activity, the timing and extent of spending to support its acquisitions, infrastructure and research and development efforts, the expansion of sales and marketing activities, the timing of new introductions of products or features, the continuing market adoption of its Networked Charging Systems platform, and the overall market acceptance of EVs. The Company has and may in the future enter into arrangements to acquire or invest in complementary businesses, services, and technologies, including intellectual property rights. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may be required to seek additional equity or debt financing. Future liquidity and cash requirements will depend on numerous factors, including market penetration, the introduction of new products, and potential acquisitions of related businesses or technology. In the event that additional financing is required from outside sources, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected.
On February 26, 2021 (“Closing Date”), Switchback Energy Acquisition Corporation (“Switchback”) consummated the previously announced transactions pursuant to which Lightning Merger Sub Inc., a wholly owned subsidiary of Switchback incorporated in the State of Delaware (“Lightning Merger Sub”), merged with ChargePoint, Inc., a Delaware corporation (“Legacy ChargePoint”); Legacy ChargePoint survived as a wholly-owned subsidiary of Switchback (such transactions, the “Merger,” and, collectively with the other transactions described in the Merger Agreement (as defined below), the “Reverse Recapitalization”). Further, as a result of the Merger, Switchback was renamed “ChargePoint Holdings,
Inc.
Please refer to Note 3 “Reverse Recapitalization” for further details of the Merger.
 
2.
Summary of Significant Accounting Policies
Other than policies noted below, there have been no significant changes to the significant accounting policies disclosed in Note 2 of the
audited
consolidated financial statements as of January 31, 2021 and 2020 and for the years ended January 31, 2021, 2020, and 2019.
Common Stock Warrants Liabilities
The Company assumed 10,470,562 publicly-traded warrants (“Public Warrants”) and 6,521,568 private placement warrants issued to NGP Switchback, LLC (“Private Placement Warrants” and, together with the
 
F-10

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
Public Warrants, the “Common Stock Warrants”) upon the Merger, all of which were issued in
connection
with
Switch
back’s initial public offering and subsequent overallotment (other than 1,000,000 Private Placement Warrants
which
were issued in connection with the closing of the Merger) and entitle the holder to purchase one share of the Company’s Common stock, par value $0.0001 (“Common Stock”) at an exercise price of $11.50 per share. During the six months ended July 31, 2021, 10,226,081 Public Warrants and 4,347,712
 
Private Placement Warrants were exercised and the remaining 244,481 Public Warrants outstanding as of the July 6, 2021 redemption date were redeemed for cash. The Public Warrants, prior to their redemption, were publicly traded and were exercisable for cash unless certain conditions occurred, such as the failure to have an effective registration statement related to the shares issuable upon exercise or redemption by the Company under certain conditions, at which time the warrants could be cashlessly exercised. The Private Placement Warrants are not redeemable for cash so long as they are held by the initial purchasers or their permitted transferees but may be redeemable for common stock if certain other conditions are met. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
The Company evaluated the Common Stock Warrants and concluded
that t
hey do not meet the criteria to be classified within stockholders’ equity. The agreement governing the Common Stock Warrants includes a provision (“Replacement of Securities Upon Reorganization”), the application of which could result in a different settlement value for the Common Stock Warrants depending on their holder. Because the holder of an instrument is not an input into the pricing of a
fixed-for-fixed
option on the Company’s ordinary shares, the Private Placement Warrants are not considered to be “indexed to the Company’s own stock.” In addition, the provision provides that in the event of a tender or exchange offer accepted by holders of more than 50% of the outstanding shares of the Company’s ordinary shares, all holders of the Common Stock Warrants (both the Public Warrants and the Private Placement Warrants) would be entitled to receive cash for all of their Common Stock Warrants. Specifically, in the event of a qualifying cash tender offer (which could be outside of the Company’s control), all Common Stock Warrant holders would be entitled to cash, while only certain of the holders of the Company’s ordinary shares may be entitled to cash. These provisions preclude the Company from classifying the Common Stock Warrants in stockholders’ equity. As the Common Stock Warrants meet the definition of a derivative, the Company recorded these warrants as liabilities on the consolidated balance sheet at fair value, with subsequent changes in their respective fair values recognized in the condensed consolidated statements of operations and comprehensive loss at each reporting date.
Contingent Earnout
 
Liability
In connection with the Reverse Recapitalization and pursuant to the Merger Agreement and Plan of Merger dated as of September 23, 2020 by and among the Company, Lightning Merger Sub Inc., and Switchback (“Merger Agreement”), eligible ChargePoint equity holders were entitled to receive as additional merger consideration shares of the Comp
a
ny’s Common Stock upon the Company achieving certain Earnout Triggering Events (as described in the Merger Agreement and Note 9). In accordance with ASC
815-40,
the earnout shares were not indexed to the Common Stock and therefore were accounted for as a liability at the Reverse Recapitalization date and subsequently remeasured at each reporting date with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statements of operations.
The estimated fair value of the contingent consideration was determined using a Monte Carlo simulation using a distribution of potential outcomes on a monthly basis over the Earnout Period (as defined in Note 9) prioritizing the most reliable information available. The assumptions utilized in the calculation were based on the achievement of certain stock price milestones, including the current Company Common Stock price, expected volatility, risk-free rate, expected term and dividend rate.
 
F-11

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
Until its settlement the contingent earnout liability was categorized as a Level 3 fair val
ue measurem
ent (see Fair Value of Financial Instruments accounting policy as described above) because the Company estimated projections during the Earnout Period utilizing unobservable inputs. Contingent earnout payments involve certain assumptions requiring significant judgment and actual results can differ from assumed and estimated amounts.
Use of Estimates
The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for doubtful accounts, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of redeemable convertible preferred stock warrants and common stock warrants, including Common Stock Warrants as a result of the Merger, contingent earnout liability, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Concentration of Credit Risk and Other Risks and Uncertainties
Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts with large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. 
Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.
Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of July 31, 2021 and January 31, 2021, one customer individually accounted for 9% and 16% of accounts receivable, net, respectively. For the six months ended July 31, 2021 and 2020, there were no customers that represented 10% or more of total revenue.
The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s operating results.
 
F-12

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
Impact of
COVID-19
In March 2020, the World Health Organization characterized
COVID-19
as a pandemic. The impact of
COVID-19,
including changes in consumer and business behavior, pandemic fears and market downturns, and restrictions on business and individual activities, has created significant volatility in the global economy and led to reduced economic activity. The spread of
COVID-19
has disrupted ChargePoint’s supply chain and heightened its freight and logistic costs, and has similarly disrupted manufacturing, delivery and overall supply chain of vehicle manufacturers and suppliers, which has led to fluctuations in EV sales around the world.
As a result of the
COVID-19
pandemic, ChargePoint initially modified its business practices (including reducing employee travel, recommending that all
non-essential
personnel work from home and cancelling or reducing physical participation in sales activities, meetings, events and conferences), implemented additional safety protocols for essential workers, and implemented temporary cost cutting measures in order to reduce its operating costs. The Company may take further actions as may be required by government authorities or that it determines are in the best interests of its employees, customers, suppliers, vendors and business partners.
While the ultimate duration and extent of the
COVID-19
pandemic depends on current and future developments that cannot be accurately predicted, such as the extent and effectiveness of containment actions and vaccinations, it has already had an adverse effect on the global economy, the ultimate societal and economic impact of the
COVID-19
pandemic remains unknown. The effect of the COVID-19 pandemic can also vary over time and across the geographies in which ChargePoint operates. For example, variations in work-from-home policies can cause fluctuations in ChargePoint’s revenues, and the Company believes that since people are not yet fully back to work it has not yet seen the full return of commercial customer demand for its products. The conditions caused by the COVID-19 pandemic, such as more permanent work-from-home policies, are likely to continue affecting the rate of global infrastructure spending, and thus to continue to adversely impact ChargePoint’s gross margins as the Company’s commercial business contributes higher margins than its residential and fleet businesses. Further, the COVID-19 pandemic could continue to heighten supply chain pricing and logistics expenses, and could, for example, adversely impact ChargePoint’s gross margins through heightened supply chain expenses, and could adversely affect demand for ChargePoint’s platforms, lengthen its sales cycles, reduce the value, renewal rate or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from new customers, cause some of its paying customers to go out of business and limit the ability of its direct sales force to travel to customers and potential customers, all of which could adversely affect its business, results of operations and financial condition
.
Segment Reporting
The Company operates as one operating segment because its
 
Chief Executive Officer, as the Company’s chief operating decision maker reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance.
Fair Value of Financial Instruments
Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value:
 
 
(Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
 
F-13

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
 
(Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and
 
 
(Level 3) — Inputs that are unobservable for the asset or liability.
The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material
non-financial assets
valued on a
non-recurring basis
that resulted in an impairment in any period presented.
The carrying values of the Company’s cash eq
uivalents, account
s receivable,
net
, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments.
Remaining Performance Obligations
Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and
non-cancellable contracted
amounts that will be invoiced and recognized as revenue in future periods. The Company’s Assure, Cloud, and CPaaS subscription terms typically range from one to five years
 
and are paid up-front
. Revenue expected to be recognized from remaining performance obligations was $118.2 million as of July 31, 2021, of which 42 % is expected to be recognized over the next twelve months
.
Deferred Revenue
Deferred revenue represents billings or payments received in advance of revenue recognition and is recognized in revenue upon transfer of control. Balances consist primarily of Cloud Services and Assure services not yet provided as of the balance sheet date. Contract assets, which represent services provided or products transferred to customers in advance of the date the Company has a right to invoice, are netted against deferred revenue on a
customer-by-customer basis.
Deferred revenue that will be recognized during the succeeding
twelve-month
period is recorded as current deferred revenue with the remainder recorded as deferred revenue,
non-current
on the condensed consolidated balance sheets.
Total current and non-current deferred revenue was
$105.8 million and $89.8 
million as of July 31, 2021 and January 31, 2021, respectively. The Company recognized $7.7 million and $4.6 million of revenue during the three months ended July 31, 2021 and July 31, 2020, and
$22.9 million and $21.0 
million of revenue during the six months ended July 31, 2021 and July 31, 2020, respectively, that was included in the deferred revenue balance
at the beginning of the period.
Accounting Pronouncements
The Company can adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as
non-public business
entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt
 
F-14

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
when permissible, the Company has elected to adopt new or revised accounting guidance within t
he
same time period as
non-public business
entities, as indicated below. Based on the Company’s public float as of July 31, 2021, it will become a large accelerated filer, and lose emerging growth company status, as of January 31, 2022. As of January 31, 2022, the Company will be required to adopt new or revised accounting standards when they are applicable to public companies that are not emerging growth companies.
Recently Issued Accounting Standards Not Yet Adopted
In June 2016, the FASB issued
ASU 2016-13,
Financial Instruments
 — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,
and has since released various amendments including ASU
No. 2019-04.
The guidance modifies the measurement of expected credit losses on certain financial instruments. The Company will become a large accelerated filer effective January 31, 2022, at which point the Company will follow the timeline for adoption of new accounting pronouncements for public companies. As a result, the Company will adopt ASU 2016-13 for the January 31, 2022 annual period, with a modified retrospective application to all outstanding instruments and a cumulative effect adjustment recorded to opening retained earnings as of February 1, 2021 and is currently assessing the impact the guidance will have on its condensed consolidated financial statements.
In December 2019, the FASB issued ASU
2019-12,
Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,
which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis
step-up in
goodwill obtained in a transaction that is not a business combination. The guidance will be effective for annual reporting periods beginning after December 15, 2020, including interim periods therein. As a result, the Company will adopt ASU 2019-12 for the January 31, 2022 annual
period
and
is
currently assessing the impact the guidance will have on its condensed consolidated financial statements.
In August 2020, the FASB issued ASU
 
2020-06,
 
Debt — Debt with Conversion and Other Options (Subtopic
 
470-20)
 
and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic
 
815-40),
 
which modifies and simplifies accounting for convertible instruments. The new guidance eliminates certain separation models that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance will be effective for annual reporting periods beginning after December 15, 2020. As a result, the Company will adopt ASU 2020-06 for the January 31, 2022 annual period and is currently assessing the impact the guidance will have on its condensed consolidated financial statements.
 
3.
Reverse Recapitalization
On February 26, 2021, Lightning Merger Sub, a wholly-owned subsidiary of Switchback, merged with Legacy ChargePoint, with Legacy ChargePoint surviving as a wholly-owned subsidiary of Switchback. As a result of the Merger, Switchback was renamed “ChargePoint Holdings, Inc.” Immediately prior to the closing of the Merger:
 
   
all 22,427,306 shares of Legacy ChargePoint’s outstanding Series
H-1
redeemable convertible preferred stock
were
converted into an equivalent number of shares of Legacy ChargePoint common stock on a
one-to-one
basis
and an additional 1,026,084 shares of Common Stock were issued to settle the accumulated dividend to the Series
H-1
redeemable convertible preferred stockholders of $21.1 million;
 
F-15

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
   
all 160,925,957 shares of Legacy ChargePoint’s outstanding Series H, Series G, Series F, Series E, and Series D redeemable convertible preferred stock
were
converted into an equivalent number of shares of Legacy ChargePoint common stock on a
one-to-one
basis
;
 
   
all 45,376 shares of Legacy ChargePoint’s outstanding Series C redeemable convertible preferred stock
were
converted into an equivalent number of shares of Legacy ChargePoint common stock on a 1:73.4403 basis;
 
   
all 130,590 shares of Legacy ChargePoint’s outstanding Series B redeemable convertible preferred stock
were
converted into an equivalent number of shares of Legacy ChargePoint common stock on a 1:42.9220 basis; and
 
   
all 29,126 shares of Legacy ChargePoint’s outstanding Series A redeemable convertible preferred stock
were
converted into an equivalent number of shares of Legacy ChargePoint common stock on a 1:48.2529 basis.
At the Merger, eligible ChargePoint equity holders received or
had
the right to receive shares of Common Stock at a deemed value of $10.00 per share after giving effect to the exchange ratio of 0.9966 as defined in the Merger Agreement (“Exchange Ratio”). Accordingly, immediately following the consummation of the Merger, Legacy ChargePoint common stock exchanged into 217,021,368 shares of Common Stock
,
68,896,516 shares were reserved for the issuance of Common Stock upon the potential future exercise of Legacy ChargePoint stock options and warrants that were exchanged into ChargePoint stock options and warrants, and 27,000,000 shares of Common Stock were reserved for the potential future issuance of the earnout shares.
In connection with the execution of the Merger Agreement, Switchback entered into separate subscription agreements (each a “Subscription Agreement”) with a number of investors (each a “New PIPE Investor”), pursuant to which the New PIPE Investors agreed to purchase, and Switchback agreed to sell to the New PIPE Investors, an aggregate of 22,500,000 shares of Common Stock (“PIPE Shares”), for a purchase price of $10.00 per share and an aggregate purchase price of $225.0 million, in a private placement pursuant to the subscription agreements (“PIPE Financing”). The PIPE Financing closed simultaneously with the consummation of the Merger.
Pursuant to the terms of a letter agreement the initial Switchback stockholders entered into in connection with the execution of the Merger Agreement (“Founders Stock Letter”), the initial stockholders surrendered 984,706 of Switchback Class B common stock shares purchased by NGP Switchback, LLC, a Delaware limited liability company (“Sponsor”) prior to Switchback Public Offering on May 16, 2019 ( “Founder Shares”) for no consideration, whereupon such Founder Shares were immediately cancelled. Additionally, 900,000 Founder Earn Back Shares, which were previously subjected to potential forfeiture until the closing volume weighted average price per share of Common Stock
achieved
 $12.00 for any ten trading days within any twenty consecutive trading day period during the five-year period following the Closing (“Founder Earn Back Triggering Event”), met the Earn Back Triggering Event on March 12, 2021.
At the Closing, the Sponsor exercised its right to convert a portion of the working capital loans made by the Sponsor to Switchback into an additional 1,000,000 Private Placement Warrants at a price of $1.50 per warrant in satisfaction of $1.5 million principal amount of such loans.
 
F-16

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
The number of shares of Common Stock issued immediately following the consummation of the Merger was
 
as follows:
 
    
Shares
 
Common stock of Switchback, outstanding prior to Merger
     39,264,704  
Less redemption of Switchback shares
     (33,009
Less surrender of Switchback Founder Shares
     (984,706
    
 
 
 
Common stock of Switchback
     38,246,989  
Shares issued in PIPE
     22,500,000  
    
 
 
 
Merger and PIPE financing shares (1)
     60,746,989  
Legacy ChargePoint shares (2)
     217,021,368  
    
 
 
 
Total shares of common stock immediately after Merger
     277,768,357  
    
 
 
 
The
 
Merger is accounted for as a reverse recapitalization under U.S. GAAP. This determination is primarily based on Legacy ChargePoint stockholders comprising a relative majority of the voting power of ChargePoint and having the ability to nominate the members of the Board, Legacy ChargePoint’s operations prior to the acquisition comprising the only ongoing operations of ChargePoint, and Legacy ChargePoint’s senior management comprising a majority of the senior management of ChargePoint. Under this method of accounting, Switchback is treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of ChargePoint represent a continuation of the financial statements of Legacy ChargePoint with the Merger being treated as the equivalent of ChargePoint issuing stock for the net assets of Switchback, accompanied by a recapitalization. The net assets of Switchback are stated at historical costs, with no goodwill or other intangible assets recorded. Operations prior to the Merger are presented as those of ChargePoint. All periods prior to the Merger have been retrospectively adjusted using the Exchange Ratio for the equivalent number of shares outstanding immediately after the Merger to effect the reverse recapitalization. Additionally, upon the consummation of the Merger, the Company gave effect to the issuance of 60,746,989 shares of Common Stock for the previously issued Switchback common stock and PIPE Shares that were outstanding at the Closing Date.
In connection with the Merger, the Company raised $511.6 million of proceeds including the contribution of $286.6 million of cash held in Switchback’s trust account from its initial public offering, net of redemptions of Switchback public stockholders of $0.3 million, and $225.0 million of cash in connection with the PIPE financing. The Company incurred $36.5 million of transaction costs, consisting of banking, legal, and other professional fees, of which $29.5 million was recorded as a reduction to additional
paid-in
capital of proceeds and the remaining $7.0 million was expensed in the condensed consolidated statements of operations.
 
(1)
This includes 900,000 contingently forfeitable Founder Earn Back Shares pending the occurrence of the Founder Earn Back Triggering Event, which was met on March 12, 2021
(2)
The number of Legacy ChargePoint shares was determined from the 217,761,738 shares of Legacy ChargePoint common stock outstanding immediately prior to the closing of the Merger converted at the exchange ratio of 0.9966. All fractional shares were rounded down.
 
F-17

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
4.
Fair Value Measurements
The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
 
    
Fair Value Measured as of July 31, 2021
        
    
Level 1
    
Level 2
    
Level 3
    
Total
 
    
(in thousands)
 
Assets
                                   
Money market funds
   $ 454,713      $ —        $ —        $ 454,713  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial assets
  
$
454,713
 
  
$
—  
 
  
$
—  
 
  
$
454,713  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Common stock warrant liabilities (Private Placement)
  
$
—  
 
  
$
—  
 
  
$
26,868
 
  
$
26,868  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial liabilities
  
$
  
 
  
$
—  
 
  
$
26,868
 
  
$
26,868  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
Fair Value Measured as of January 31, 2021
        
    
Level 1
    
Level 2
    
Level 3
    
Total
 
    
(in thousands)
 
Assets
                                   
Money market funds
   $ 109,703      $ —        $ —        $ 109,703  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial assets
  
$
109,703
 
  
$
—  
 
  
$
—  
 
  
$
109,703  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Redeemable convertible preferred stock warrant liability
  
$
—  
 
  
$
—  
 
  
$
75,843
 
  
$
75,843  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial liabilities
  
$
—  
 
  
$
—  
 
  
$
75,843
 
  
$
75,843  
    
 
 
    
 
 
    
 
 
    
 
 
 
The money market funds were classified as cash and cash equivalents on the condensed consolidated balance sheets. The aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains or losses on money market funds as of July 31, 2021 and January 31, 2021. Realized gains and losses, net of tax, were not material for any of the periods presented.
As of July 31, 2021 and January 31, 2021, the Company had no investments with a contractual maturity of greater than one year.
 
F-18

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments:
 
    
Redeemable
convertible
preferred stock
warrant liability
    
Private
placement
warrant
liability
    
Earnout
liability
 
    
(in thousands)
 
Fair value as of January 31, 2021
   $ (75,843    $      $  
Private placement warrant liability acquired as part of the merger
            (127,888       
Contingent earnout liability recognized upon the closing of the reverse recapitalization
                   (828,180
Change in fair value included in other income (expense), net
     9,237        49,264        84,420  
Reclassification of warrants to stockholders’ equity (deficit) due to exercise
            51,756         
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization
     66,606                
Issuance of earnout shares upon triggering events
                   501,120  
Reclassification of remaining contingent earnout liability upon triggering event
                   242,640  
    
 
 
    
 
 
    
 
 
 
Fair value as of July 31, 2021
  
$
    
$
(26,868
  
$
 
    
 
 
    
 
 
    
 
 
 
The fair
values
of the private placement warrant liability, redeemable convertible preferred stock warrant liability and earnout liability are based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy. The significant unobservable inputs used in the fair value measurements of the private placement warrant liability, the redeemable convertible preferred stock warrant liability and the earnout liability include the expected volatility and dividend yield. In determining the fair value of the private placement warrant liability, the Company used the Binomial Lattice Model (“BLM”) that assumes optimal exercise of the Company’s redemption option at the earliest possible date (Note 9). In determining the fair value of the redeemable convertible preferred stock warrant liability, the Company used
the
Black-Scholes Option Pricing Model (“Black-Scholes”) to estimate the fair value using unobservable inputs including the expected term, expected volatility, risk-free interest rate and dividend yield (see Note 9). In determining the fair value of the earnout liability, the Company used the Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the Earnout Period using the most reliable information available (see Note 9).
 
F-19

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
5.
Composition of
 
Certain Financial Statement Items
Inventories
Inventories consisted of the following:
 
    
July 31,

2021
    
January 31,

2021
 
    
(in thousands)
 
Raw materials
   $ 8,421      $ 13,029  
Work
-in-progress
            68  
Finished
goods
     19,495        20,495  
    
 
 
    
 
 
 
Total Inventories
  
$
27,916
    
$
33,592
 
    
 
 
    
 
 
 
Property and equipment, net
Property and equipment, net consisted of the following:
 
    
July 31,

2021
    
January 31,

2021
 
    
(in thousands)
 
Furniture and fixtures
   $ 899      $ 1,594  
Computers and software
     5,843        5,384  
Machinery and equipment
     12,140        10,605  
Tooling
     9,666        7,705  
Leasehold improvements
     9,680        9,398  
Owned and operated systems
     20,582        17,703  
Construction in progress
     2,760        2,462  
    
 
 
    
 
 
 
       61,570        54,851  
    
 
 
    
 
 
 
Less: Accumulated depreciation
     (29,305      (24,863
    
 
 
    
 
 
 
Total Property and Equipment, Net
   $ 32,265      $ 29,988  
    
 
 
    
 
 
 
Depreciation expense for the three months ended July 31, 2021 and 2020 was $2.9 million and $2.4 million, respectively.
Depreciation expense for the six months ended July 31, 2021 and 2020 was $5.6 million and $4.7 million, respectively.
 
F-20

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
Accrued and other current liabilities
Accrued and other current liabilities consisted of the following:
 
    
July 31,

2021
    
January 31,

2021
 
    
(in thousands)
 
Accrued expenses
   $ 19,113      $ 18,404  
Refundable customer deposits
     7,488        6,482  
Taxes payable
     6,495        5,213  
Payroll and related expenses
     7,372        7,547  
Warranty accruals
     3,100        3,000  
Operating lease liabilities, current
     3,130        2,393  
Other liabilities
     5,282        4,123  
    
 
 
    
 
 
 
Total Accrued and Other Current Liabilities
   $ 51,980      $ 47,162  
    
 
 
    
 
 
 
Revenue
Revenue consisted of the following:
 
    
Three Months Ended July 31,
    
Six Months Ended July 31,
 
    
2021
    
2020
    
2021
    
2020
 
    
(in thousands)
    
(in thousands)
 
United States
   $ 51,109      $ 32,347      $ 86,219      $ 62,638  
Rest of World
     5,012        2,610        10,412        5,095  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 56,121      $ 34,957      $ 96,631      $ 67,733  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
6.
Debt
In July 2018, the Company entered into a term loan facility with certain lenders (“2018 Loan”) with a borrowing capacity of $45.0 million to finance working capital and repay all outstanding amounts owed under
 
previous loans. The Company borrowed $35.0 million, with issuance costs of $1.1 million and net proceeds of $33.9 million. The 2018 Loan was secured by substantially all of the Company’s assets, contained customary affirmative and negative covenants, and required the Company to maintain minimum cash balances and attain certain customer billing targets. The 2018 Loan had a
five
-year
maturity and interest was calculated at LIBOR plus 6.55%. The 2018 Loan agreement was amended on March 20, 2019 to extend the interest only monthly payments through June 30, 2021 to be followed by equal monthly payments of principal and interest. As of January 31, 2021, the Company was in compliance with all financial and
non-financial
debt covenants.
Transaction costs upon entering into the 2018 Loan were recorded as debt discount and were amortized over the term of the 2018 Loan.
There was no interest expense incurred during the three months ending July 31, 2021; the interest expense incurred during the three months ended July 31, 2020 was $0.8 million. 
Total interest expense incurred during the six months ended
July 31, 2021 and 2020 was $1.5 million and $1.6 million, respectively. There was no accrued interest as of July 31, 2021 and January 31, 2021.
 
F-21

ChargePoint
Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
In March 2021, the Company repaid the
entire
loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million.
 
7.
Commitments
 
and Contingencies
Purchase Commitments
Open purchase
commitments
are for the purchase of
goods
and services related to, but not limited to, manufacturing, facilities, and professional services under
non-cancellable
contracts. As of July 31, 2021, the Company had open purchase commitments for goods and services of $133.7 million, all of which are
expected
to be received by June 30, 2024.
Legal Proceedings
The Company may be involved in various lawsuits, claims, and proceedings, including intellectual property, commercial, securities, and employment matters that arise in the normal course of business. The Company accrues a liability when management believes information available prior to the issuance of the condensed consolidated financial statements indicates it is probable a loss has been incurred as of the date of the condensed consolidated financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred.

The Company believes it has recorded adequate provisions for any such
lawsuits
, claims, and proceedings and, as of July 31, 2021, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in the condensed consolidated financial statements. Based on its experience, the Company believes that damage amounts claimed in these matters are not meaningful indicators of potential liability. Given the inherent uncertainties of litigation, the ultimate outcome of the ongoing matters described herein cannot be predicted with certainty. While litigation is inherently unpredictable, the Company believes it has valid defenses with respect to the legal matters pending against it. Nevertheless, the condensed consolidated financial statements could be materially adversely affected in a particular period by the resolution of one or more of these contingencies. Liabilities established to provide for contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved; and such changes are recorded in the accompanying condensed consolidated statements of operations during the period of the change and reflected in accrued and other current liabilities on the accompanying condensed consolidated balance sheets.
Guarantees
 
and Indemnifications
The Company has service level commitments to its customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits if the Company fails to meet those levels. To date, the Company has not incurred any material costs as a
result
of such commitments.
The Company’s arrangements generally include certain provisions for indemnifying customers against liabilities if its products or services infringe a third-party’s intellectual property rights. Additionally, the Company may be required to indemnify for claims caused by its negligence or willful misconduct. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. To date, the Company has not incurred any material costs as a result of such obligations and has not accrued any liabilities related to such obligations in the condensed consolidated financial statements.
 
F-22

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company also may be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions.
Leases
The Company leases its office facilities under
non-cancelable
operating leases with various lease terms. The Company also leases certain office equipment under operating lease agreements.

The following table presents future payments of lease liabilities under the Company’s
non-cancelable
operating leases as of July 31, 2021 (in thousands):
 
    
(in
 
thousands)
 
2022 (remaining six months)
  
$
2,759  
2023
  
 
5,111  
2024
  
 
4,329  
2025
  
 
4,153  
2026
  
 
3,837  
Thereafter
  
 
13,871  
    
 
 
 
Total undiscounted operating lease payments
     34,060  
Less: imputed interest
     (9,348
    
 
 
 
Total operating lease liabilities
     24,712  
Less: current portion of operating lease liabilities
     (3,130
    
 
 
 
Operating lease liabilities, noncurrent
   $ 21,582  
    
 
 
 
8. Common Stock
On February 26, 2021, the Merger was consummated and the Company issued 60,746,989 shares for an aggregate purchase price of $200.5 million, net of issuance costs of $29.4 million. Immediately following the Merger, there were 277,768,357 shares of Common Stock outstanding with a par value of $0.0001. The holder of each share of Common Stock is entitled to one vote.
The Company has retroactively adjusted the shares issued and outstanding prior to February 26, 2021 to give effect to the
Exchange
 
Ratio
established in the Merger Agreement to determine the number of shares of Common Stock into which they were converted. Immediately prior to the Merger, 484,951,532 shares were authorized to issue at $0.0001 par value, with 299,771,284 shares designated as Common Stock and 185,180,248 shares of redeemable convertible preferred stock.
 
F-23

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
Common Stock Reserved for Future Issuance
Shares of Common Stock reserved for future issuance, on an
as-if converted
basis, were as follows:
 
    
July 31,

2021
 
Stock options issued and outstanding
     26,401,717  
Restricted stock units outstanding
     4,017,149  
Common stock warrants outstanding
     39,249,702  
Shares available for grant under 2021 Equity Incentive Plan
     40,878,653  
Shares available for grant under 2021 ESPP
     8,177,683  
    
 
 
 
Total shares of common stock reserved
     118,724,904  
    
 
 
 
On February 26, 2021, upon the closing of the Merger (Note 3), all of the outstanding redeemable convertible preferred stock was converted to Common Stock pursuant to the conversion rate effective immediately prior to the Merger and the remaining amount was reclassified to additional
paid-in
capital.
 
9.
Stock Warrants and
 
Earnout
Redeemable Convertible Preferred Stock Warrants
Warrants to purchase a total of 2,358,528
shares of Series B, D and E redeemable convertible preferred stock were initially recognized as a liability recorded at fair value upon issuance and were subject to remeasurement to fair value at each balance sheet date. As part of the Merger, Legacy ChargePoint redeemable convertible preferred stock was converted into Legacy ChargePoint common stock pursuant to the conversion rate effective immediately prior to the Merger while all related Legacy ChargePoint preferred stock warrants were converted into warrants exercisable for shares of Common Stock with terms consistent with the Legacy ChargePoint preferred stock warrants except for the number of shares exercisable therefor and the exercise price, each of which was adjusted using the Exchange Ratio. At that time, the redeemable convertible preferred stock warrant liability was remeasured and reclassified to
additional paid-in capital.
The liability associated with these warrants was subject to remeasurement at each balance sheet date using the Level 3 fair value inputs. See Note 4 for further details.
The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows:
 
    
February 26,
2021

(Merger Date)
   
January 31,

2021
 
Expected volatility
     84.3     80.5
Risk-free interest rate
     0.0     0.1
Dividend rate
     0.0     0.0
Expected term (years)
     0.0       1.4  
Common Stock Warrants
In addition to the warrants to purchase 2,358,528 shares of Legacy ChargePoint preferred stock described above, Legacy ChargePoint had outstanding warrants to purchase 36,402,503 shares of Legacy ChargePoint
 
F-24

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
common stock (collectively, “Legacy Warrants”), which now represent warrants to purchase Common Stock. During the three months ended July 31, 2021, 587,880 Legacy Warrants were net exercised resulting in the issuance of 558,100 shares of Common Stock. During the six months ended July 31, 2021, 1,685,185 Legacy Warrants were net exercised resulting in the issuance of 1,480,080 shares of Common Stock. As of July 31, 2021, there were 37,075,846 Legacy Warrants outstanding which are classified as equity.
Private Placement Warrants
The Private Placement Warrants were initially recognized as a liability on February 26, 2021, at a fair value of $127.9 million and the Private Placement Warrant liability was remeasured to fair value as of any respective exercise dates and as of July 31, 2021. The Company recorded a gain of $3.8 million and $49.2 million for the three and six months ended July 31, 2021, respectively, classified within change in fair value of warrant liabilities in the condensed consolidated statements of operations.
The Private Placement Warrants were valued using the following assumptions under
the
BLM that assumes optimal exercise of the Company’s redemption option at the earliest possible date:
 
    
July 31,

2021
   
February 26,

2021
 
Market price of public stock
   $ 23.65       $30.83  
Exercise price
   $ 11.50       $11.50  
Expected term (years)
     4.6       5.0  
Volatility
     70.2     73.5
Risk-free interest rate
     0.6     0.8
Dividend rate
     0.0     0.0
Public Warrants
The Public Warrants may only be exercised for a whole number of shares. The Public Warrants became exercisable 30 days after the completion of the Merger.
The Public Warrants were initially recognized as a liability on February 26, 2021 at a fair value of $153.7 million and the public warrant liability was remeasured to fair value based upon the market price as warrants were exercised.
On June 4, 2021 the Company issued a redemption notice pursuant to which all but 244,481 Public Warrants were exercised by the Public Warrant holders. At the conclusion of the redemption notice period on
July 6, 2021, the Company redeemed the remaining
 
244,481
Public Warrants
 outstanding
 for $0.01 per warrant. The Company recognized a loss of $14.3 million for the three months ended July 31, 2021 and a loss of $15.9 million for the six months ended July 31, 2021, classified within change in fair value of warrant liabilities in the condensed consolidated statements of operations.
During the six months ended July 31, 2021, proceeds received for the exercise of Public Warrants were $117.6 million. As of July 31, 2021, no Public Warrants remained outstanding.
 
F-25

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
Activity of warrants is set forth below:
 
    
Legacy Common
and Preferred Stock
Warrants
(1)
    
Private
Placement
Warrants
    
Public
Warrants
    
Total

Common Stock
Warrants
(1)
 
Outstanding as of January 31, 2021
     38,761,031        —          —          38,761,031  
Common Stock Warrants as Part of the Merger
     —          6,521,568        10,470,562        16,992,130  
Warrants Exercised
     (1,685,185      (4,347,712      (10,226,081      (16,258,978
Warrants Redeemed
     —          —          (244,481      (244,481
    
 
 
    
 
 
    
 
 
    
 
 
 
Outstanding as of July 31, 2021
     37,075,846        2,173,856                  39,249,702  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
(1)
The shares (and the warrants’ exercise prices) subject to the Company’s Legacy common and preferred stock warrants were restated to reflect the exchange ratio of approximately 0.9966 established in the Merger Agreement as discussed in Note 3.
Contingent Earnout Liability
During the five year period starting at the closing of the Merger (“Earnout Period”), eligible former equity holders of Legacy ChargePoint
 
could

receive up to 27,000,000 additional shares of Common Stock (“Earnout Shares”) in the aggregate in three equal tranches if certain Earnout Triggering Events (as described in the Merger Agreement) are fully satisfied. An “Earnout Triggering Event” means the date on which the closing volume weighted-average price (“VWAP”) per share of common stock quoted on the NYSE (or the exchange on which the shares of common stock are then listed) is greater or equal to $15.00, $20.00 and $30.00 for any ten trading days within any 20 consecutive trading day period within the Earnout Period.
Upon the closing of the Merger, the contingent obligation to issue Earnout Shares was accounted for as a liability because the Earnout Triggering Events that determine the number of Earnout Shares required to be issued include events that are not solely indexed to the common stock of ChargePoint. The estimated fair value of the total Earnout Shares at the closing of the Merger on February 26, 2021, was $828.2 million based on a Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the Earnout Period using the most reliable information available. Assumptions used in the valuation are described below.
 
    
March 12,

2021
   
February 26,

2021
 
Current stock price
   $ 27.84     $ 30.83  
Expected volatility
     72.00     71.60
Risk-free interest rate
     0.85     0.75
Dividend rate
     0.00     0.00
Expected term (years)
     4.96       5.00  
The first two Earnout Triggering Events for up to 18,000,000 of the Earnout Shares occurred on March 12, 2021, and, after withholding some of these Earnout Shares
 to cover 
tax
withholding obligations,
 17,539,657 Earnout Shares were issued on March 19, 2021, and the estimated fair value of the earnout liability was remeasured to $743.7 million, including (i) $501.1 million related to the Earnout Shares issuable upon the occurrence of the Earnout Triggering Event associated with the $15.00 and $20.00 VWAP per share thresholds
 
F-26

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
based on the Common Stock price as of March 12, 2021, and (ii) $242.6 million related to the estimated fair value of earnout liability related to the remaining 9,000,000 Earnout Shares issuable upon the occurrence of the Earnout Triggering Event associated with the $30.00 VWAP per share threshold based on a Monte Carlo simulation valuation model as of March 12, 2021, as described above. The change in fair value resulted in a gain of $84.4 million recognized in the condensed consolidated statement of operations for the three months ended April 30, 2021. Upon settlement of the first two tranches, the classification of the remaining 9,000,000 Earnout Shares of the third tranche was changed to equity on March 12, 2021, because the Earnout Shares became an instrument contingently issuable upon the occurrence of the Earnout Triggering Event into a fixed number of Common Shares that is not based on an observable market price or index other than the Company’s own stock price.
The third and final
 
Earnout Triggering Event for up to 9,000,000 of the Earnout Shares associated with the $30.00 VWAP per share threshold occurred on June 29, 2021, and, after the withholding of some of these Earnout Shares
to cover
 tax
withholding obligations,
8,773,596 Earnout Shares were issued on July 1, 2021
.
 
No
further Earnout Shares remained contingently issuable as of July 31, 2021.
 
10.
Equity Plans and Stock-based Compensation
On February 25, 2021, the stockholders of the Company approved the 2021 Equity Incentive Plan (“2021 EIP”) and the 2021 Employee Stock Purchase Plan (“2021 ESPP”). As of July 31, 2021, 40,878,653 and 8,177,683 shares of Common Stock were available under the 2021 EIP and 2021 ESPP, respectively. On the first day of each March, beginning on March 1, 2021 and continuing through March 1, 2030, the 2021 EIP reserve will automatically increase by a number of shares equal to the lesser of (a) 5% of the total number of shares actually issued and outstanding on the last day of the preceding month and (b) a number determined by the Company’s Board of Directors. Further, on the first day of each March during the term of the 2021 ESPP, commencing on March 1, 2021 and ending on (and including) March 1, 2040, the aggregate number of shares of stock that may be issued under the 2021 ESPP shall automatically increase by a number equal to the lesser of (i) one percent (1%) of the total number of shares of stock issued and outstanding on the last day of the preceding month, (ii) 5,400,000 shares of stock (subject to standard anti-dilution adjustments), or (iii) a number of shares of stock determined by the Company’s Board of Directors.
Under the 2021 EIP, the Company can grant stock options, stock appreciation rights, restricted stock, restricted stock units (“RSU”) and certain other awards which are
s
ettled in the form of common shares issued under this 2021 EIP. Under the 2021 ESPP, eligible employees are permitted to purchase shares of the Company’s Common Stock at 85% of the lower of fair market value the Company’s Common Stock on the first trading day of an offering period or on the purchase date.
No further awards will be granted under Legacy ChargePoint’s 2017 Stock Plan (“2017 Plan”) and 24,259,238 shares of Common Stock remain reserved for outstanding awards issued under the 2017 Plan at the time of adoption of the 2021 EIP and the 2021 ESPP. Additionally, no other awards can be granted under Legacy ChargePoint’s 2007 Stock Incentive Plan (“2007 Plan”) and 5,143,849 shares of Common Stock remained reserved for outstanding awards issued under the 2007 Plan at the time of the adoption of the 2021 EIP and the 2021 ESPP.
 
F-27

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
The Company’s stock option awards activity is set forth below:
 
    
Number of
Stock Option
Awards
    
Weighted
Average
Exercise Price
    
Weighted
Average
Remaining
Contractual
term (in years)
    
Aggregate
Intrinsic Value
(in thousands)
 
Outstanding as of January 31, 2021
     30,166,792      $ 0.71        7.3      $ 1,064,539  
Options exercised
     (3,292,219    $ 0.53                    
Options forfeited
     (452,893    $ 0.73                    
Options expired
     (19,963    $ 53.22                    
    
 
 
                            
Outstanding as of July 31, 2021
     26,401,717      $ 0.69        7.0      $ 606,280  
    
 
 
                            
Options vested and expected to vest as of July 31, 2021
     25,667,621      $ 0.69        7.0      $ 589,470  
    
 
 
                            
Exercisable as of July 31, 2021
     16,457,228      $ 0.66        6.3      $ 378,402  
    
 
 
                            
The options outstanding as of July 31, 2021, include the June 2020 grant of a stock option to purchase a total of 1.5 million shares of Common Stock subject to both service and performance-based vesting conditions to the Chief Executive Officer under the 2017 Plan (“CEO Award”). No stock-based compensation expense had been recorded as the CEO awards were improbable of vesting before and after two modifications in each of September 2020 and December 2020, because the performance-based vesting condition was contingent upon the closing of the Merger. Accordingly, the Company commenced recognition of stock-based compensation expense for such CEO Award following the Merger in February 2021. As of July 31, 2021, the total unrecognized compensation expense related to these unvested CEO Award was $35.3 million, which is expected to be recognized over a period of 2.5 years
.
The Company’s RSU activity is set forth below:
 
    
Number of
Shares
    
Weighted
Average Grant
Date Fair Value
per Share
 
Outstanding as of January 31, 2021
             $     
RSU granted
     4,680,439      $ 27.38  
RSU vested
     (652,901    $ 27.30  
RSU forfeited
     (10,389    $ 27.30  
    
 
 
          
Outstanding as of July 31, 2021
     4,017,149      $ 27.40  
    
 
 
          
As of July 31, 2021, total unrecognized stock-based compensation expense related to stock options was $41.0 million, including the CEO Award, and is expected to be recognized over a weighted-average period of 1.9 years. As of July 31, 2021, total unrecognized stock-based compensation expense related to RSU was $86.3 million and is expected to be recognized over a weighted-average period of 3.1 years.
 
F-28

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
The following sets forth the total stock-based compensation expense for the Company’s stock options (including the CEO Award) and RSU included in the Company’s condensed consolidated statements of operations:
 
    
Three Months Ended

July 31,
    
Six Months Ended

July 31,
 
    
2021
    
2020
    
2021
    
2020
 
    
(in thousands)
    
(in thousands)
 
Cost of revenue
   $ 2,164      $ 41      $ 2,188      $ 64  
Research and development
     13,682        454        14,357        757  
Sales and marketing
     4,169        356        4,767        655  
General and administrative
     8,278        339        14,558        624  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation expense
   $ 28,293      $ 1,190      $ 35,870      $ 2,100  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
11.
Income
 
Taxes
The income tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate as adjusted for discrete items arising in that quarter. The effective income tax rate was nil for the three and six months ended July 31, 2021 and 2020. The effective tax rate differs from the U.S. statutory rate primarily due to the full valuation allowances on the Company’s net domestic deferred tax assets as it is more likely than not that all of the deferred tax assets will not be realized.
On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) was enacted and signed into law in the United States. The CARES Act includes measures to assist companies, including temporary changes to income and
non-income-based tax
laws. The Company did not receive a stimulus payment related to the CARES Act.
 
12.
Related Party Transactions
Daimler AG and its affiliated entities (“Daimler”) are investors in the Company and one of its employees is a member of the Company’s Board of Directors. The following revenue transactions took place between the Company and Daimler during the periods presented:
 
    
Three Months Ended

July 31,
    
Six Months Ended

July 31,
 
    
2021
    
2020
    
2021
    
2020
 
    
(in thousands)
    
(in thousands)
 
Daimler
   $ 2,071      $ 850      $ 3,406      $ 1,576  
    
 
 
    
 
 
    
 
 
    
 
 
 
Revenue from related parties
   $ 2,071      $ 850      $ 3,406      $ 1,576  
    
 
 
    
 
 
    
 
 
    
 
 
 
Related party accounts receivable as of July 31, 2021 and January 31, 2021 from Daimler was $2.5 million and $1.2 million, respectively.
 
F-29

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
13. Basic and Diluted Net Loss per Share
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and six months ended July 31, 2021 and 2020:
 
 
  
Three Months Ended

July 31,
 
 
Six Months Ended

July 31,
 
 
  
2021
 
 
2020
 
 
2021
 
 
2020
 
 
  
(in thousands, except share and
per share data)
 
 
(in thousands, except share and
per share data)
 
Numerator:
  
     
 
     
 
     
 
     
Net income (loss)
  
$
(84,938
 
$
(35,287
 
$
(2,649
 
$
(65,385
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjust:
Accretion of beneficial conversion feature of redeemable convertible preferred stock
  
 
  
 
 
 
(58,625
 
 
  
 
 
 
(58,625
Adjust:
Cumulative dividends on redeemable convertible preferred stock
  
 
  
 
 
 
—  
 
 
 
(4,292
 
 
—  
 
Adjust:
Deemed dividends attributable to vested option holders
  
 
  
 
 
 
—  
 
 
 
(51,855
 
 
—  
 
Adjust:
Deemed dividends attributable to common stock warrant holders
  
 
  
 
 
 
—  
 
 
 
(110,635
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to common stockholders - Basic
  
 
(84,938
 
 
(93,912
 
 
(169,431
 
 
(124,010
Less:
Gain attributable to earnout shares issued
  
 
  
 
 
 
—  
 
 
 
(84,420
 
 
—  
 
Less:
Change in fair value of dilutive warrants
  
 
(7,427
 
 
—  
 
 
 
(53,540
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to common stockholders - Diluted
  
$
(92,365
 
$
(93,912
 
$
(307,391
 
$
(124,010
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator:
  
     
 
     
 
     
 
     
Weighted average common shares outstanding
  
 
312,465,016
 
 
 
13,537,501
 
 
 
266,473,703
 
 
 
12,822,481
 
Less:
Weighted-average unvested restricted shares and shares subject to repurchase
  
 
(237,490
 
 
(68,824
 
 
(276,221
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares outstanding - Basic
  
 
312,227,526
 
 
 
13,468,677
 
 
 
266,197,482
 
 
 
12,822,481
 
Add:
Earnout Shares under the treasury stock method
  
 
  
 
 
 
  
 
 
 
7,464,203
 
 
 
  
 
Add:
Public and Private Placement Warrants under the treasury stock method
  
 
1,374,574
 
 
 
  
 
 
 
1,915,315
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares outstanding - Diluted
  
 
313,602,100
 
 
 
13,468,677
 
 
 
275,577,000
 
 
 
12,822,481
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss per share - Basic
  
$
(0.27
 
$
(6.97
 
$
(0.64
 
$
(9.67
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss per share - Diluted
  
$
(0.29
 
$
(6.97
 
$
(1.12
 
$
(9.67
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F-30

ChargePoint Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
 
As a result of the Merger, the Company has retroactively adjusted the weighted-average number of shares of Common Stock outstanding prior to
the
Closing Date by multiplying them by the
Exchange Ratio
 of 0.9966 used to determine the number of shares of Common Stock into which they converted. The Common Stock issued as a result of the redeemable convertible preferred stock conversion on the Closing Date was included in the basic net loss per share calculation on a prospective basis.
Redeemable convertible preferred stock and preferred stock warrants outstanding prior to the Merger Closing Date were excluded from the diluted net loss per share calculation for the
six-months
period ended July 31, 2021, because including them would have had an antidilutive effect
.
The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows:
 
    
July 31,
2021
 
  
July 31,
2020
 
Redeemable convertible preferred stock (on an
as-converted
basis)
               192,469,995  
Options to purchase common stock
     26,401,717        39,463,877  
Restricted stock units
     4,017,149     
 
  
 
Unvested early exercised common stock options
     211,464        102,781  
Common stock and preferred stock warrants
     37,075,846        38,193,342  
    
 
 
    
 
 
 
Total potentially dilutive common share equivalents
  
 
67,706,176
    
 
270,229,995
 
    
 
 
    
 
 
 
14. Acquisitions
 
and Subsequent Events
On July 20, 2021, the Company entered into a definitive agreement to acquire all of the outstanding shares of has•to•be gmbh (“has•to•be” or “HTB”) for approximately
 
Euro 250.0 million
in cash and Company common stock subject to adjustments.
has•to•be
 
is an Austria-based
e-mobility
provider with a European charging software platform. The acquisition is intended to expand the Company’s access to the European market. The Company currently expects the transaction to close as early as October 2021.
On August 11, 2021, the Company acquired all of the outstanding shares of ViriCiti B.V. (“ViriCiti”) for approximately
 
Euro
75.0
 million in cash,

subject to adjustments. ViriCiti is a Netherlands-based provider of electrification solutions for eBus and commercial fleets with offices in the Netherlands and the United States. The acquisition is expected to enhance ChargePoint’s fleet solutions portfolio of hardware, software and services by integrating information sources to optimize electric fleet operations.
As permitted by ASU
805-10-50,
the Company is not able to include certain required disclosures in its quarterly report on Form
10-Q
for the three and six months ended July 31, 2021, because the information necessary to complete the preliminary purchase price allocation related to the acquisition was not yet available.
 
F-31

Report of Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of ChargePoint Holdings, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of ChargePoint, Inc. and its subsidiaries (the “Company”) as of January 31, 2021 and 2020, and the related consolidated statements of operations, of comprehensive loss, of redeemable convertible preferred stock and stockholder’s deficit and of cash flows for each of the three years in the period ended January 31, 2021, including the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of January 31, 2021 and January 31, 2020, and the results of its operations and its cash flows for each of the three years in the period ended January 31, 2021 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 31, 2021, except for the effects of the reverse recapitalization described in Note 1 to the consolidated financial statements, as to which the date is July 2, 2021
We have served as the Company’s auditor since 2016.
 
F-32

ChargePoint, Inc.
Consolidated Balance Sheets
January 31, 2021 and 2020
(in thousands, except share and per share data)
 
    
January 31,
 
    
2021
   
2020
 
Assets
    
Current assets:
    
Cash and cash equivalents
   $ 145,491     $ 72,753  
Restricted cash
     400       400  
Short-term investments
              47,037  
Accounts receivable, net of allowance of $2,000 as of January 31, 2021 and 2020
     35,075       38,488  
Inventories
     33,592       25,419  
Prepaid expenses and other current assets
     12,074       7,221  
  
 
 
   
 
 
 
Total current assets
     226,632       191,318  
Property and equipment, net
     29,988       27,941  
Operating lease
right-of-use
assets
     21,817       10,269  
Goodwill
     1,215       1,215  
Other assets
     10,468       3,448  
  
 
 
   
 
 
 
Total assets
   $ 290,120     $ 234,191  
  
 
 
   
 
 
 
Liabilities, Redeemable Convertible Preferred Stock, and Stockholders’ Deficit
    
Current liabilities:
    
Accounts payable
   $ 19,784     $ 19,631  
Accrued and other current liabilities
     47,162       37,659  
Deferred revenue
     40,934       39,408  
Debt, current
     10,208           
  
 
 
   
 
 
 
Total current liabilities
     118,088       96,698  
Deferred revenue, noncurrent
     48,896       33,266  
Debt, noncurrent
     24,686       34,261  
Operating lease liabilities
     22,459       8,230  
Redeemable convertible preferred stock warrant liability
     75,843       2,718  
Other long-term liabilities
     972       798  
  
 
 
   
 
 
 
Total liabilities
     290,944       175,971  
  
 
 
   
 
 
 
Commitments and contingencies (Note 8)
    
Redeemable convertible preferred stock: $0.0001 par value; 185,180,248 and 162,829,195 shares authorized as of January 31, 2021 and 2020, respectively; 182,934,257 and 160,583,203 shares issued and outstanding as of January 31, 2021 and 2020, respectively (liquidation value: $693,548 and $563,753 as of January 31, 2021 and 2020, respectively)
     615,697       520,241  
Stockholders’ deficit:
    
Common stock: $0.0001 par value; 299,771,284 and 240,180,600 shares authorized as of January 31, 2021 and 2020, respectively; 22,961,032 and 11,918,418 shares issued and outstanding as of January 31, 2021 and 2020, respectively
     2       1  
Additional
paid-in
capital
     62,736       20,331  
Accumulated other comprehensive income
     155       37  
Accumulated deficit
     (679,414     (482,390
  
 
 
   
 
 
 
Total stockholders’ deficit
     (616,521     (462,021
  
 
 
   
 
 
 
Total liabilities, redeemable convertible preferred stock, and stockholders’ deficit
   $ 290,120     $ 234,191  
  
 
 
   
 
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 
F-33

ChargePoint, Inc. Consolidated
Statements of Operations
Years Ended January 31, 2021, 2020, and 2019
(in thousands, except share and per share data)
 
    
Year Ended January 31,
 
    
2021
   
2020
   
2019
 
Revenue
      
Networked charging systems
   $ 91,893     $ 101,012     $ 61,338  
Subscriptions
     40,563       28,930       22,504  
Other
     14,034       14,573       8,188  
  
 
 
   
 
 
   
 
 
 
Total revenue
     146,490       144,515       92,030  
Cost of revenue
      
Networked charging systems
     87,083       105,940       59,928  
Subscriptions
     20,385       16,244       10,441  
Other
     6,073       4,289       2,157  
  
 
 
   
 
 
   
 
 
 
Total cost of revenue
     113,541       126,473       72,526  
  
 
 
   
 
 
   
 
 
 
Gross profit
     32,949       18,042       19,504  
  
 
 
   
 
 
   
 
 
 
Operating expenses
      
Research and development
     75,017       69,464       50,510  
Sales and marketing
     53,002       56,997       56,411  
General and administrative
     25,922       23,945       17,870  
  
 
 
   
 
 
   
 
 
 
Total operating expenses
     153,941       150,406       124,791  
  
 
 
   
 
 
   
 
 
 
Loss from operations
     (120,992     (132,364     (105,287
Interest income
     315       3,245       1,402  
Interest expense
     (3,253     (3,544     (3,690
Change in fair value of redeemable convertible preferred stock warrant liability
     (73,125     (875     (388
Other income (expense), net
     229       (565     (5
  
 
 
   
 
 
   
 
 
 
Net loss before income taxes
   $ (196,826   $ (134,103   $ (107,968
  
 
 
   
 
 
   
 
 
 
Provision for income taxes
     198       224       119  
  
 
 
   
 
 
   
 
 
 
Net loss
   $ (197,024   $ (134,327   $ (108,087
  
 
 
   
 
 
   
 
 
 
Accretion of beneficial conversion feature of redeemable convertible preferred stock
     (60,377                  
Cumulative undeclared dividends on redeemable convertible preferred stock
     (16,799                  
  
 
 
   
 
 
   
 
 
 
Net loss attributable to common stockholders
   $ (274,200   $ (134,327   $ (108,087
  
 
 
   
 
 
   
 
 
 
Net loss per share attributable to common stockholders, basic and diluted
   $ (18.14)     $ (15.10   $ (24.89
  
 
 
   
 
 
   
 
 
 
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted
     15,116,763       8,893,787       4,342,517  
  
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 
F-34

ChargePoint, Inc.
Consolidated Statements of Comprehensive Loss
Years Ended January 31, 2021, 2020, and 2019
(in thousands)
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
Net loss
   $ (197,024    $ (134,327    $ (108,087
Other comprehensive income (loss):
        
Foreign currency translation adjustment
     141        131        (106
Available-for-sale
short-term investments:
        
Unrealized gain, net of tax
               23            
Reclassification to net income, net of tax
     (23                    
  
 
 
    
 
 
    
 
 
 
Other comprehensive income (loss)
     118        154        (106
  
 
 
    
 
 
    
 
 
 
Comprehensive loss
   $ (196,906    $ (134,173    $ (108,193
  
 
 
    
 
 
    
 
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 
F-35

ChargePoint, Inc.
Consolidated Statements of Redeemable Convertible Preferred Stock and
Stockholders’ Deficit
Years Ended January 31, 2021, 2020, and 2019
(in thousands, except share data)
 
   
Redeemable

Convertible

Preferred Stock
   
Common Stock
   
Additional

Paid-In

Capital
   
Accumulated

Other
Comprehensive
Income (Loss)
   
Accumulated
Deficit
   
Total

Stockholders’

Deficit
 
   
Shares
   
Amount
   
Shares
   
Amount
 
Balances as of January 31, 2018
    118,428,814     $ 290,316       2,436,734     $        $ 10,463     $ (11   $ (242,165   $ (231,713
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Issuance of Series H redeemable convertible preferred stock, net of issuance costs of $8.4 million
    39,519,739       215,169       —         —         —         —         —         —    
Issuance of common stock warrants issued in connection with Series H redeemable convertible preferred stock
    —         —         —         —         1,454       —         —         1,454  
Issuance of common stock upon exercise of vested stock options
    —         —         3,794,964    
 
1
 
    1,366       —         —         1,367  
Issuance of common stock upon early exercise of stock options
    —         —         58,971       —         —         —         —         —    
Issuance of restricted common stock
    —         —         797,280       —         —         —         —         —    
Vesting of early exercised stock options
    —         —         —         —         4       —         —         4  
Stock-based compensation
    —         —         —         —         1,706       —         —         1,706  
Net loss
    —         —         —         —         —         —         (108,087     (108,087
Other comprehensive loss
    —         —         —         —         —         (106     —         (106
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balances as of January 31, 2019
    157,948,553     $ 505,485       7,087,949    
$
1
 
  $ 14,993     $ (117   $ (350,252   $ (335,375
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Effect of adoption of ASC 340
    —         —         —         —         —         —         2,189       2,189  
Issuance of Series H redeemable convertible preferred stock, net of issuance costs of $0.1 million
    2,634,650       14,756       —         —         —         —         —         —    
Issuance of common stock warrants issued in connection with
                 
Series H redeemable convertible preferred stock
    —         —         —         —         185       —         —         185  
Issuance of common stock upon exercise of vested stock options
    —         —         4,795,588       —         2,201       —         —         2,201  
 
The accompanying notes are an integral part of these consolidated financial statements.
 
F-36

   
Redeemable

Convertible

Preferred Stock
   
Common Stock
   
Additional

Paid-In

Capital
   
Accumulated

Other
Comprehensive
Income (Loss)
   
Accumulated
Deficit
   
Total

Stockholders’

Deficit
 
   
Shares
   
Amount
   
Shares
   
Amount
 
Issuance of common stock related to early exercise of stock options
    —       $ —         34,881     $ —       $ —       $ —       $ —       $ —    
Vesting of early exercised stock options
    —         —         —         —         15       —         —         15  
Stock-based compensation
    —         —         —         —         2,937       —         —         2,937  
Net loss
    —         —         —         —         —         —         (134,327     (134,327
Other comprehensive income
    —         —         —         —         —         154       —         154  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balances as of January 31, 2020
    160,583,203     $ 520,241       11,918,418    
$
1
 
  $ 20,331     $ 37     $ (482,390   $ (462,021
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs of $0.2 million
    22,351,054       95,456       —         —         —         —         —         —    
Issuance of common stock warrants in connection with Series
H-1
redeemable convertible preferred stock
    —         —         —         —         31,547       —         —         31,547  
Beneficial conversion feature in connection with Series
H-1
redeemable preferred stock
    —         (60,377     —         —         60,377       —         —         60,377  
Accretion of beneficial conversion feature in connection with Series
H-1
redeemable preferred stock
    —         60,377       —         —         (60,377     —         —         (60,377
Issuance of common stock upon exercise of vested stock options
    —         —         10,363,603       1       5,643       —         —         5,644  
Issuance of common stock related to early exercise of stock options
    —         —         679,011       —         —         —         —         —    
Vesting of early exercised stock options
    —         —         —         —         268       —         —         268  
Stock-based compensation
    —         —         —         —         4,947       —         —         4,947  
Net loss
    —         —         —         —         —         —         (197,024     (197,024
Other comprehensive income
    —         —         —         —         —         118       —         118  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balances as of January 31, 2021
 
 
182,934,257
 
 
$
615,697
 
 
 
22,961,032
 
 
$
2
 
 
$
62,736
 
 
$
155
 
 
$
(679,414
 
$
(616,521
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 
F-37

ChargePoint, Inc. Consolidated
Statements of Cash Flows
Years Ended January 31, 2021, 2020, and 2019
(in thousands)
 
   
Year Ended January 31,
 
   
2021
   
2020
   
2019
 
Cash flows from operating activities
     
Net loss
  $ (197,024   $ (134,327   $ (108,087
Adjustments to reconcile net loss to net cash used in operating activities:
     
Depreciation and amortization
    10,083       7,698       4,086  
Non-cash
operating lease cost
    3,762       3,121           
Stock-based compensation
    4,947       2,937       1,706  
Amortization of deferred contract acquisition costs
    1,206       675           
Change in fair value of redeemable convertible preferred stock warrant liability
    73,125       875       388  
Inventory reserves
    1,412       1,425       1,089  
Other
    446       589       1,822  
Changes in operating assets and liabilities, net of effect of acquisitions:
     
Accounts receivable, net
    3,292       (8,702     (2,735
Inventories
    (9,585     (1,472     (19,457
Prepaid expenses and other assets
    (8,914     (2,961     (1,760
Operating lease liabilities
    (2,815     (1,181         
Accounts payable
    (493     15,704       (1,120
Accrued and other liabilities
    11,556       93       10,802  
Deferred revenue
    17,156       27,590       12,720  
 
 
 
   
 
 
   
 
 
 
Net cash used in operating activities
    (91,846     (87,936     (100,546
 
 
 
   
 
 
   
 
 
 
Cash flows from investing activities
     
Purchases of property and equipment
    (11,484     (14,885     (14,822
Purchases of investments
             (179,514         
Maturities of investments
    47,014       132,500           
Cash paid for acquisition, net of cash acquired
                      (1,475
 
 
 
   
 
 
   
 
 
 
Net cash provided by (used in) investing activities
    35,530       (61,899     (16,297
 
 
 
   
 
 
   
 
 
 
Cash flows from financing activities
     
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
    95,456       14,756       215,168  
Proceeds from issuance of common stock warrants
    31,547       185       1,454  
Proceeds from issuance of debt, net of issuance costs
                      33,988  
Payments of deferred offering costs
    (4,003                  
Repayment of debt
                      (18,182
Proceeds from exercises of vested and unvested stock options
    5,913       2,217       1,370  
 
 
 
   
 
 
   
 
 
 
Net cash provided by financing activities
    128,913       17,158       233,798  
 
 
 
   
 
 
   
 
 
 
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
    141       132       (101
Net increase (decrease) in cash, cash equivalents, and restricted cash
    72,738       (132,545     116,854  
Cash, cash equivalents, and restricted cash at beginning of period
    73,153       205,698       88,844  
 
 
 
   
 
 
   
 
 
 
Cash, cash equivalents, and restricted cash at end of period
  $ 145,891     $ 73,153     $ 205,698  
 
 
 
   
 
 
   
 
 
 
Supplementary cash flow information
     
Cash paid for interest
  $ 2,801     $ 3,414     $ 2,583  
Cash paid for taxes
  $ 172     $ 153     $ 117  
Supplementary cash flow information on
non-cash
investing and financing activities
     
Accretion of beneficial conversion feature of redeemable convertible preferred stock
  $ 60,377     $        $     
Deferred transaction costs not yet paid
  $ 1,685     $        $     
Right-of-use
assets obtained in exchange for lease liabilities
  $ 2,118     $ 2,906     $     
Right-of-use
asset remeasurement subsequent to lease extension
  $ 12,867     $        $     
Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities
  $ 647     $ 1,287     $     
Vesting of early exercised stock options
  $ 268     $ 15     $ 4  
The accompanying notes are an integral part of these consolidated financial statements.
 
F-38

ChargePoint, Inc.
Notes to Consolidated Financial Statements
1.    Description of Business and Basis of Presentation
ChargePoint, Inc. (“ChargePoint” or the “Company,” “it,” “its”) designs, develops, and markets networked electric vehicle (“EV”) charging system infrastructure and cloud-based services which enable consumers the ability to locate, reserve, authenticate, and transact charging sessions for EVs. As part of its networked charging systems, subscriptions, and other offerings, the Company provides an open platform that integrates with system hardware from multiple manufacturers, connecting systems over an intelligent network that provides real-time information about charging systems. This network provides multiple
web-based
portals for charging system owners, fleet managers, drivers, and utilities.
On September 23, 2020, the Company entered into a merger agreement (the “Merger Agreement”) with Switchback Energy Acquisition Corporation (“Switchback”), where a subsidiary of Switchback was to merge with the Company (collectively with the other transactions described in the Merger Agreement, the “Merger”). As a result of the proposed Merger, Switchback was to be renamed to ChargePoint Holdings, Inc.
On February 26, 2021 (the “Closing Date”), ChargePoint Holdings, Inc. consummated the Merger by and among Switchback, Lightning Merger Sub Inc., a subsidiary of the Company (“Merger Sub”), and ChargePoint. At the Closing, Merger Sub merged with and into ChargePoint, with ChargePoint surviving the Merger as a wholly owned subsidiary of ChargePoint Holdings, Inc.
In addition, as part of the Merger, certain investors purchased an aggregate of 22,500,000 shares of Common Stock (“PIPE Investors”) concurrently with the Closing for an aggregate purchase price of $225,000,000.
On February 26, 2021, upon consummation of the Merger, eligible ChargePoint equity holders, including holders of ChargePoint’s redeemable convertible preferred stock which converted into shares of common stock immediately prior to the closing of the Merger, received or have the right to receive shares of common stock at a deemed value of $10.00 per share after giving effect to the exchange ratio of 0.9966 as defined in the Merger Agreement (“Exchange Ratio”). The Merger is accounted for as a reverse recapitalization under U.S. GAAP. For accounting purposes, the financial statements of the Company will represent a continuation of the financial statements of ChargePoint with the Merger treated as the equivalent of ChargePoint issuing stock for the net assets of Switchback, accompanied by a recapitalization. Accordingly, all periods prior to the Merger for the reported share and per share amounts have been retrospectively adjusted using the Exchange Ratio to effect the reverse recapitalization. See Note 18 for more information.
The Company’s fiscal year ends on January 31. References to fiscal years 2021, 2020, and 2019 relate to the fiscal years ended January 31, 2021, January 31, 2020, and January 31, 2019, respectively.
Basis of Presentation
The consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Company’s consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
The Company’s consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its product offerings, raising capital, and recruiting personnel. The Company’s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial efforts, or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company’s stockholders. The Company has incurred net operating losses and negative cash flows from
 
F-39

operations in every year since inception and expects this to continue for the foreseeable future. As of January 31, 2021, the Company had an accumulated deficit of $679.4 million.
The Company has funded its operations primarily with proceeds from the issuance of redeemable cash proceeds of $127.0 million, net of issuance costs of $0.2 million in July and August 2020 through the issuance of 22.4 million shares of Series
H-1
redeemable convertible preferred stock and 22.4 million common stock warrants. The Company had cash, cash equivalents, and restricted cash of $145.9 million as of January 31,
2021. In February 2021, the Company received cash proceeds of $484.1 million from the Merger. As of March 31, 2021, the date on which these consolidated financial statements were available to be issued, the Company believes that its cash on hand as of January 31, 2021 and the proceeds from the Merger, together with cash generated from sales to customers will satisfy its working capital and capital requirements for at least the next twelve months following the issuance of the consolidated financial statements.
The Company’s assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties. The Company’s actual results could vary as a result of, and its near- and long-term future capital requirements will depend on, many factors, including its growth rate, subscription renewal activity, the timing and extent of spending to support its infrastructure and research and development efforts, the expansion of sales and marketing activities, the timing of new introductions of products or features, the continuing market adoption of its networked charging systems platform, and the overall market acceptance of EVs. The Company may in the future enter into arrangements to acquire or invest in complementary businesses, services, and technologies, including intellectual property rights, although it has no agreements or commitments to complete any material transactions as of March 31, 2021, the date on which these consolidated financial statements were available to be issued. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may seek additional equity or debt financing. Future liquidity and cash requirements will depend on numerous factors, including market penetration, the introduction of new products, and potential acquisitions of related businesses or technology. In the event that additional financing is required from outside sources, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected.
2.    Summary of Significant Accounting Policies
Use of Estimates
The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for doubtful accounts, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of redeemable convertible preferred stock warrants and common stock warrants, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic
 
F-40

environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Concentration of Credit Risk and Other Risks and
Uncertainties
Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts with large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. Short-term investments consist of U.S. treasury bills that carry high-credit ratings and accordingly, minimal credit risk exists with respect to these balances.
Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.
Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of January 31, 2021, one customer individually accounted for 16% of accounts receivable, net. As of January 31, 2020, there were no customers that accounted for 10% or more of accounts receivable, net. For the years ended January 31, 2021, 2020, and 2019 there were no customers that represented 10% or more of total revenue.
The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s operating results.
In December 2019,
COVID-19
was first reported to the World Health Organization (“WHO”), and in January 2020, the WHO declared the outbreak to be a public health emergency. In March 2020, the WHO characterized
COVID-19
as a pandemic. Since then, the
COVID-19
pandemic and efforts to control its spread have significantly curtailed the movement of people, goods, and services worldwide. As a result, the Company has temporarily closed its headquarters and most of its other offices, enabled its employees and contractors to work remotely, implemented travel restrictions, implemented cost cutting measures, and shifted Company events and meetings to virtual-only experiences, all of which may continue for an indefinite amount of time and represent a significant disruption in how it operates its business. The operations of the Company’s partners, vendors, and customers have likewise been disrupted.
While the duration and extent of the
COVID-19
pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment and mitigation actions, it has already had an adverse effect on the global economy, and the ultimate societal and economic impact of the
COVID-19
pandemic remains unknown. In particular, the conditions caused by this pandemic may affect the rate of global infrastructure spending, which could adversely affect demand for the Company’s platform. Further, the
COVID-19
pandemic has caused the Company to experience, in some cases, longer sales cycles and an increase in certain prospective and current customers seeking lower prices or other more favorable contract terms, and has limited the ability of its direct sales force to travel to customers and potential customers. In addition, the
COVID-19
pandemic could reduce the value or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from the Company’s paying customers, cause some of its paying customers to go out of business, and affect contraction or attrition rates of its paying customers, all of which could adversely affect the Company’s business, results of operations, and financial condition. Additionally, concerns over the economic impact of
COVID-19
have caused extreme volatility in financial and other capital markets, which may adversely affect the Company’s ability to access capital markets in the future.
While the Company has developed and continues to develop plans to help mitigate the potential negative impact of
COVID-19,
these efforts may not be effective, and any protracted economic downturn will likely limit the
 
F-41

effectiveness of its efforts. Accordingly, it is not possible for the Company to predict the duration and ultimate extent to which this will affect its business, future results of operations, and financial condition at this time.
Segment Reporting
Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company operates as one operating segment because its CODM, who is its Chief Executive Officer, reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance. The Company has no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels of components below the consolidated unit level.
Cash, Cash Equivalents, and Restricted Cash
The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. Cash equivalents may be invested in money market funds. Cash and cash equivalents are carried at cost, which approximates their fair value.
Restricted cash of $0.4 million as of January 31, 2021 and 2020 and $0.5 million as of January 31, 2019 relates to cash deposits restricted under letters of credit issued in support of customer agreements.
The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated statements of cash flows were as follows:
 
    
January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Cash and cash equivalents
   $ 145,491      $ 72,753      $ 205,238  
Restricted cash
     400        400        460  
  
 
 
    
 
 
    
 
 
 
Total cash, cash equivalents, and restricted cash
  
$
145,891
 
  
$
73,153
 
  
$
205,698
 
  
 
 
    
 
 
    
 
 
 
Short-term Investments
The Company considers investments with original maturities greater than three months and remaining maturities less than one year to be short-term investments. The Company’s short-term investments consist of U.S. treasury bills and are classified as available for sale and reported at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For short-term investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of short-term investments are recorded in other income (expense), net in the consolidated statements of operations.
Other-than-temporary Impairment
The Company evaluates its short-term investments with unrealized losses for other-than-temporary impairment. When assessing short-term investments for other-than-temporary declines in value, the Company considers factors such as, among other things, the extent and length of time the investment’s fair value has been lower than its cost basis, the financial condition and near-term prospects of the investee, the Company’s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value, and the expected cash flows from the security. If any adjustment to fair value reflects a decline in the value of the investment that the Company considers to be “other than temporary,” the Company reduces the investment to fair value through a charge to the consolidated statements of operations and consolidated statements of comprehensive loss. No such adjustments were necessary during the periods presented.
 
F-42

Accounts Receivable, net
Accounts receivable are recorded at the invoiced amount and are
non-interest
bearing. The Company performs ongoing credit evaluations of its customers and maintains an allowance for doubtful accounts to ensure trade receivables are not overstated due to uncollectibility. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results, or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables are further adjusted. The Company also considers broader factors in evaluating the sufficiency of its allowances for doubtful accounts, including the length of time receivables are past due, macroeconomic conditions, significant
one-time
events, and historical experience. When the Company determines that there are accounts receivable that are uncollectible, they are written off against the allowance for doubtful accounts. The change in the allowance for doubtful accounts for the years ended January 31, 2021, 2020, and 2019 was as follows:
 
    
Beginning
Balance
    
Additions
Charged To
Expense
    
Write-offs
    
Ending
Balance
 
    
(in thousands)
 
Year ended January 31, 2021
           
Allowance for doubtful accounts
   $ 2,000      $ 121      $ (121    $ 2,000  
Year ended January 31, 2020
           
Allowance for doubtful accounts
   $ 3,124      $ 339      $ (1,463    $ 2,000  
Year ended January 31, 2019
           
Allowance for doubtful accounts
   $ 1,316      $ 1,812      $ (4    $ 3,124  
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost, on a
first-in,
first-out
basis. Inventory levels are analyzed periodically and written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value or are in excess of expected demand. The Company analyzes current and future product demand relative to the remaining product life to identify potential excess inventories. The write-down is measured as the difference between the cost of the inventories and net realizable value and charged to inventory reserves, which is a component of cost of revenue. At the point of the loss recognition, a new, lower cost basis for those inventories is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
Property and Equipment, net
Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets, as follows:
 
    
Useful Lives
Furniture and fixtures
   3 to 5 years
Computers and software
   3 to 5 years
Machinery and equipment
   3 to 5 years
Tooling
   3 to 5 years
Leasehold improvements
   Shorter of the estimated
lease term or useful life
Owned and operated systems
   5 to 7 years
Leasehold improvements are amortized over the shorter of estimated useful lives of the assets or the lease term. Expenditures for repairs and maintenance are charged to expense as incurred. Upon disposition, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is reflected in the consolidated statements of operations.
 
F-43

ChargePoint-as-a-Service
(“CPaaS”) combines the customer’s use of the Company’s owned and operated systems with Cloud subscription software (“Cloud”) and the Company’s Assure program (“Assure”) into a single subscription. When CPaaS contracts contain a lease, the underlying asset is carried at its carrying value within property and equipment, net on the consolidated balance sheets.
Internal-Use
Software Development Costs
The Company capitalizes qualifying
internal-use
software development costs incurred during the application development stage for internal tools and cloud-based applications used to deliver its services, provided that management with the relevant authority authorizes and commits to the funding of the project, it is probable the project will be completed, and the software will be used to perform the function intended. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Capitalized
internal-use
software development costs are included in property and equipment and are amortized on a straight- line basis over their estimated useful lives once it is ready for its intended use. Amortization of capitalized
internal-use
software development costs is included within cost of revenue for networked charging systems and subscriptions, research and development expense, sales and marketing expense, and general and administrative expense based on the use of the software. Costs incurred for enhancements that are expected to result in additional material functionality are capitalized. As of January 31, 2021 and 2020, capitalized costs have not been material.
Leases
On February 1, 2019, the Company early adopted the requirements of Accounting Standards Update (“ASU”)
2016-02,
Leases (Topic 842) (“ASC 842”), using the modified retrospective approach with no adjustment to comparative periods.
Lessee
The Company determines if a contract is a lease or contains a lease at the inception of the contract and reassesses that conclusion if the contract is modified. All leases are assessed for classification as an operating lease or a finance lease. Operating lease
right-of-use
(“ROU”) assets are presented separately on the Company’s consolidated balance sheets. Operating lease liabilities are separated into a current portion, included within accrued and other current liabilities on the Company’s consolidated balance sheets, and a noncurrent portion included within operating lease liabilities on the Company’s consolidated balance sheets. The Company does not have material finance leases. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. The Company does not obtain and control its right to use the asset until the lease commencement date.
The Company’s lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s ROU assets are also recognized at the applicable lease commencement date. The ROU asset equals the carrying amount of the related lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable ROU asset or lease liability.
The term of the Company’s leases equals the
non-cancellable
period of the lease, including any rent-free periods provided by the lessor, and also includes options to renew or extend the lease (including by not terminating the lease) that the Company is reasonably certain to exercise. The Company establishes the term of each lease at lease commencement and reassesses that term in subsequent periods when one of the triggering events outlined in ASC 842 occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term.
 
F-44

The Company’s lease contracts often include lease and
non-lease
components. The Company has elected the practical expedient offered by the standard to not separate the lease from
non-lease
components and accounts for them as a single lease component.
The Company elected the package of practical expedients permitted under the transition guidance, which allows the Company to carry forward its historical lease classification, its assessment on whether a contract is or contains a lease, and its initial direct costs for any leases that existed prior to adoption of the new standard. The Company has elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.
Lessor
The Company leases networked charging systems to customers within certain CPaaS contracts. The leasing arrangements the Company enters into with lessees are operating leases, and as a result, the underlying asset is carried at its carrying value as owned and operated systems within property and equipment, net on the consolidated balance sheets. Adoption of ASC 842 did not have a material impact on the Company’s accounting as a lessor.
Impairment of Long-Lived Assets
The Company evaluates long-lived assets or asset groups for impairment whenever events indicate that the carrying amount of an asset or asset group may not be recoverable based on expected future cash flows attributable to that asset or asset group. Recoverability of assets held and used is measured by comparison of the carrying amounts of an asset or an asset group to the estimated future undiscounted cash flows which the asset or asset group is expected to generate. If the carrying amount of an asset or asset group exceeds estimated undiscounted future cash flows, then an impairment charge would be recognized based on the excess of the carrying amount of the asset or asset group over its fair value. Assets to be disposed of are reported at the lower of their carrying amount or fair value less costs to sell. There were no impairments of long-lived assets for the years ended January 31, 2021, 2020, and 2019.
Business Combinations
The total purchase consideration for an acquisition is measured as the fair value of the assets transferred, equity instruments issued, and liabilities assumed at the acquisition date. Costs that are directly attributable to the acquisition are expensed as incurred and included in general and administrative expense in the Company’s consolidated statements of operations. Identifiable assets (including intangible assets), liabilities assumed (including contingent liabilities), and noncontrolling interests in an acquisition are measured initially at their fair values at the acquisition date. The Company recognizes goodwill if the fair value of the total purchase consideration and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, cost of capital, future cash flows, and discount rates. The Company’s estimates of fair value are based on assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. The Company includes the results of operations of the acquired business in the consolidated financial statements beginning on the acquisition date.
Goodwill
Goodwill represents the excess of the purchase price of an acquired busines
s over
the fair value of the net tangible and identifiable intangible assets acquired. The carrying amount of goodwill is reviewed for impairment
 
F-45

at least annually, in the second quarter, or whenever events or changes in circumstances
indicate
that the carrying value may not be recoverable. As of January 31, 2021 and 2020, the Company had a single operating segment and reporting unit structure. As part of the annual goodwill impairment test performed in the second quarter, the Company first performs a qualitative assessment to determine whether further impairment testing is necessary. If, as a result of the qualitative assessment, it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the quantitative impairment test will be required. If the Company has determined it necessary to perform a quantitative impairment assessment, the Company will compare the fair value of the reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the total amount of goodwill of the reporting unit. The carrying value of goodwill was $1.2 million as of January 31, 2021 and 2020, and no goodwill impairment has been recognized to date.
Fair Value of Financial Instruments
Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value:
 
   
(Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
 
   
(Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and
 
   
(Level 3) — Inputs that are unobservable for the asset or liability.
The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material
non-financial
assets valued on a
non-recurring
basis that resulted in an impairment in any period presented.
The carrying values of the Company’s cash equivalents, short-term investments, accounts receivable, net, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments.
Redeemable Convertible Preferred Stock Warrants
Warrants to purchase shares of the Company’s Series B, D, and E redeemable convertible preferred stock are classified as liabilities as the underlying redeemable convertible preferred stock is considered redeemable and may require the Company to transfer assets upon exercise. Redeemable convertible preferred stock warrants are recorded within noncurrent liabilities on the consolidated balance sheets. The warrants were recorded at fair value upon issuance and are subject to remeasurement to fair value at each balance sheet date. Changes in fair value of the redeemable convertible preferred stock warrant liability are recorded in the consolidated statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the warrants, conversion of redeemable convertible preferred stock into common stock, or until the redeemable convertible preferred stock is otherwise no longer redeemable. At that time, the redeemable convertible preferred stock warrant liability will be reclassified to redeemable convertible preferred stock or additional
paid-in
capital, as applicable.
 
F-46

Common Stock Warrants
Warrants to purchase shares of the Company’s common stock are equity classified and recognized within additional
paid-in
capital with no subsequent remeasurement. The amount recognized within additional
paid-in
capital is determined by allocating proceeds received and issuance costs incurred between the instruments issued based on their relative fair value.
Revenue Recognition
On February 1, 2019, the Company early adopted ASU
No. 2014-09.
Revenue from Contracts with Customers (Topic 606), as amended (“ASC 606”), using the modified retrospective method applied to contracts which were not completed as of that date. During the fiscal years ended January 31, 2021 and January 31, 2020, the Company recognized revenue using the following five-step model as prescribed by ASC 606:
 
   
Identification of the contract, or contracts, with a customer;
 
   
Identification of the performance obligations in the contract;
 
   
Determination of the transaction price;
 
   
Allocation of the transaction price to the performance obligations in the contract; and
 
   
Recognition of revenue when, or as, the Company satisfies a performance obligation.
Significant judgment and estimates are necessary for the allocation of the proceeds received from an arrangement to the multiple performance obligations and the appropriate timing of revenue recognition. The Company enters into contracts with customers that regularly include promises to transfer multiple products and services, such as charging systems, software subscriptions, extended maintenance, and professional services. For arrangements with multiple products or services, the Company evaluates whether the individual products or services qualify as distinct performance obligations. In its assessment of whether products or services are a distinct performance obligation, the Company determines whether the customer can benefit from the product or service on its own or with other readily available resources and whether the service is separately identifiable from other products or services in the contract. This evaluation requires the Company to assess the nature of each of its networked charging systems, subscriptions, and other offerings and how each is provided in the context of the contract, including whether they are significantly integrated which may require judgment based on the facts and circumstances of the contract.
The transaction price for each contract is determined based on the amount the Company expects to be entitled to receive in exchange for transferring the promised products or services to the customer. Collectability of revenue is reasonably assured based on historical evidence of collectability of fees the Company charges its customers. The transaction price in the contract is allocated to each distinct performance obligation in an amount that represents the relative amount of consideration expected to be received in exchange for satisfying each performance obligation. Revenue is recognized when performance obligations are satisfied. Revenue is recorded based on the transaction price excluding amounts collected on behalf of third-parties such as sales taxes, which are collected on behalf of and remitted to governmental authorities, or driver fees, collected on behalf of customers who offer public charging for a fee.
When agreements involve multiple distinct performance obligations, the Company accounts for individual performance obligations separately if they are distinct. The Company applies significant judgment in identifying and accounting for each performance obligation, as a result of evaluating terms and conditions in contracts. The transaction price is allocated to the separate performance obligations on a relative standalone selling price (“SSP”) basis. The Company determines SSP based on observable standalone selling price when it is available, as well as other factors, including the price charged to its customers, its discounting practices, and its overall pricing objectives, while maximizing observable inputs. In situations where pricing is highly variable, or a product is never sold on a stand-alone basis, the Company estimates the SSP using the residual approach.
 
F-47

The Company usually bills its customers at the onset of the arrangement for both the products and a predetermined period of time for services. Contracts for services typically range from annual to multi-year agreements with typical payment terms of 30 to 90 days.
Networked charging systems revenue
Networked charging systems revenue includes revenue related to the deliveries of EV charging system infrastructure. The Company recognizes revenue from sales of networked charging systems upon shipment to the customer, which is when the performance obligation has been satisfied.
Subscriptions revenue
Subscriptions revenue consists of services related to Cloud, as well as extended maintenance service plans under Assure. Subscriptions revenue also consists of CPaaS revenue, which combines the customer’s use of the Company’s owned and operated systems with Cloud and Assure programs into a single subscription. CPaaS subscriptions contain a lease for the customer’s use of the Company’s owned and operated systems unless the location allows the Company to receive incremental economic benefit from regulatory credits earned on that owned and operated system. Lessor revenue relates to operating leases and historically has not been material. Subscriptions revenue is recognized over time on a straight-line basis as the Company has a stand-ready obligation to deliver such services to the customer.
Other revenue
Other revenue consists of fees received for transferring regulatory credits earned for participating in low carbon fuel programs in approved states, charging related fees received from drivers using charging sites owned and operated by the Company, net transaction fees earned for processing payments collected on driver charging sessions at charging sites owned by ChargePoint customers, and other professional services. Revenue from regulatory credits is recognized at the point in time the regulatory credits are transferred. Revenue from fees for owned and operated sites is recognized over time on a straight-line basis over the performance period of the service contract as the Company has a stand-ready obligation to deliver such services. Revenue from driver charging sessions and charging transaction fees is recognized at the point in time the charging session or transaction is completed. Revenue from professional services is recognized as the services are rendered.
Revenue Recognition (ASC 605)
During the fiscal year ended January 31, 2019, the Company recognized revenue under ASC Topic 605, Revenue Recognition (“ASC 605”) when persuasive evidence of an arrangement existed, delivery had occurred, the fee was fixed or determinable, and collectability was probable. Revenue for this period was generally recognized net of allowances for returns and any taxes collected from customers and subsequently remitted to governmental authorities.
When a sales arrangement contained multiple elements, the Company first determined whether the delivered items qualify as separate units of accounting. A delivered item qualified as a separate unit of accounting when it had value to the customer on a standalone basis and when an arrangement included a general right of return relative to the delivered item, delivery, or performance of any undelivered items was considered probable or substantially in control of the Company. The Company then allocated revenue to each separate unit of accounting based on the relative selling price method and using the established selling price hierarchy. The selling price for a unit of accounting was based on its vendor specific objective evidence (“VSOE”), if available, third-party evidence (“TPE”) if VSOE was not available, or best estimate of selling price (“ESP”) if neither VSOE nor TPE was available. The Company generally utilized ESP.
 
F-48

The objective of ESP was to determine the price at which the Company would transact a sale if the product or service were sold on a standalone basis. ESP was generally used for new or highly customized offerings and solutions or offerings not priced within a narrow range, and it applied to a large proportion of the Company’s arrangements with multiple deliverables.
The process for determining ESP requires judgment and considers multiple factors that may vary over time depending upon the unique facts and circumstances related to each deliverable.
Lessor Revenue
The leasing arrangements the Company enters into with lessees are operating leases. The Company recognizes operating lease revenue on a straight-line basis over the lease term and expenses deferred initial direct costs on the same basis.
Operating lease revenue is classified as subscriptions revenue in the Company’s consolidated statements of operations. Operating lease revenue and the future maturities of lease payments from lessees was not material to the consolidated financial statements for all periods presented.
Remaining Performance Obligations
Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and
non-cancelable
contracted amounts that will be invoiced and recognized as revenue in future periods. The Company’s Assure, Cloud, and CPaaS subscription terms typically range from one to five years. Revenue expected to be recognized from remaining performance obligations was $101.8 million as of January 31, 2021, of which 43% is expected to be recognized over the next twelve months and the remainder thereafter.
Deferred Revenue
Deferred revenue represents billings or payments received in advance of revenue recognition and is recognized in revenue upon transfer of control. Balances consist primarily of software subscription services and extended Assure maintenance services not yet provided as of the balance sheet date. Contract assets, which represent services provided or products transferred to customers in advance of the date the Company has a right to invoice, are netted against deferred revenue on a
customer-by-customer
basis. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as deferred revenue with the remainder recorded as deferred revenue, noncurrent on the consolidated balance sheets. Total deferred revenue was $89.8 million and $72.7 million as of January 31, 2021 and 2020, respectively. The Company recognized $39.4 million, $25.5 million, and $16.0 million of revenue during the years ended January 31, 2021, 2020, and 2019, respectively, that was included in the deferred revenue balance at the beginning of the respective period.
Cost of Revenue
Cost of networked charging systems revenue includes the material costs for parts and manufacturing costs for the hardware products, compensation, including salaries and related personnel expenses, including stock-based compensation, warranty provisions, depreciation of manufacturing related equipment and facilities, amortization of capitalized
internal-use
software development costs, and allocated overhead costs. Costs for shipping and handling are recorded in cost of revenue as incurred.
Cost of subscriptions revenue includes network and wireless connectivity costs for subscription services, field maintenance costs for Assure to support the Company’s network of systems, depreciation of owned and operated systems used in CPaaS arrangements, amortization of capitalized
internal-use
software development costs, allocated overhead costs, and support costs to manage the systems and helpdesk services for drivers and site hosts.
 
F-49

Cost of other revenue includes costs for the Company’s owned and operated charging sites, as well as costs of environmental and professional services.
Costs to Obtain a Customer Contract
Sales commissions are considered incremental and recoverable costs of acquiring customer contracts. Beginning at the Company’s adoption of ASC 606 on February 1, 2019, incremental and recoverable costs for the sale of cloud enabled software and extended maintenance service plans are capitalized as deferred contract acquisition costs within prepaid expenses and other current assets and other assets on the consolidated balance sheets and amortized on a straight-line basis over the anticipated benefit period of five years. The benefit period was estimated by taking into consideration the length of customer contracts, renewals, technology lifecycle, and other factors. This amortization is recorded within sales and marketing expense in the Company’s consolidated statements of operations. The sales commissions paid related to the sale of networked charging systems are expensed as incurred.
The Company elected the practical expedient that permits the Company to apply ASC Subtopic
340-40,
“Other Assets and Deferred Costs- Contracts with Customers,” (“ASC 340”) to a portfolio containing multiple contracts, as they are similar in their characteristics, and the financial statement effects of applying ASC Subtopic
340-40
to that portfolio would not differ materially from applying it to the individual contracts within that portfolio.
Changes in the deferred contract acquisition costs during the years ended January 31, 2021 and 2020 were as follows:
 
   
(in thousands)
 
Balance upon adoption of ASC 340 on February 1, 2019
  $ 2,189  
Capitalization of deferred contract acquisition costs
    2,318  
Amortization of deferred contract acquisition costs
    (675
 
 
 
 
Balance as of January 31, 2020
 
$
3,832
 
 
 
 
 
Capitalization of deferred contract acquisition costs
    2,908  
Amortization of deferred contract acquisition costs
    (1,206
 
 
 
 
Balance as of January 31, 2021
 
$
5,534
 
 
 
 
 
Deferred acquisition costs capitalized on the consolidated balance sheets were as follows:
 
    
January 31
 
    
2021
    
2020
 
    
(in thousands)
 
Deferred contract acquisition costs, current
   $ 1,550      $ 1,013  
Deferred contract acquisition costs, noncurrent
     3,984        2,819  
  
 
 
    
 
 
 
Total deferred contract acquisition costs
  
$
5,534
 
  
$
3,832
 
  
 
 
    
 
 
 
Research and Development
Research and development expenses consist primarily of salary and related expenses, including stock-based compensation, for personnel related to the development of improvements and expanded features for the Company’s products and services, as well as quality assurance, testing, product management, amortization of capitalized
internal-use
software, and allocated overhead. Research and development costs are expensed as incurred.
 
F-50

Stock-based Compensation
The Company measures and recognizes compensation expense for all stock-based awards, including stock options and restricted common stock, granted to employees and directors based on the estimated fair value of the awards on the date of grant. The fair value of each stock option award is estimated on the grant date using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock, the expected term of the option, the expected volatility of the price of the Company’s common stock, risk-free interest rates, and the expected dividend yield of the Company’s common stock. The assumptions used to determine the fair value of the awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.
The Company amortizes the fair value of each stock award on a straight-line basis over the requisite service period of the awards. Stock-based compensation expense is based on the value of the portion of stock-based awards that is ultimately expected to vest. As such, the Company’s stock-based compensation is reduced for the estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
Advertising
The Company expenses the costs of advertising, including promotional expenses, as incurred. Advertising expenses for the years ended January 31, 2021, 2020, and 2019 were not material.
Warranty
The Company provides standard warranty coverage on its products for twelve months, providing parts necessary to repair the systems during the warranty period. The Company accounts for the estimated warranty cost as a charge to networked charging systems cost of revenue when revenue is recognized. The estimated warranty cost is based on historical and predicted product failure rates and repair expenses. Warranty expense for the years ended January 31, 2021, 2020, and 2019 was $3.4 million, $2.8 million, and $2.0 million, respectively.
In addition, the Company offers
paid-for
subscriptions to extended maintenance service plans under Assure. Assure provides both the labor and parts to maintain the products over the subscription terms of typically one to five years. The costs related to the Assure program are expensed as incurred and charged to subscriptions cost of revenue.
Foreign Currency
The functional currency of the Company’s foreign subsidiaries is generally the local currency. The translation of foreign currencies into U.S. dollars is performed for monetary assets and liabilities at the end of each reporting period based on the then current exchange rates.
Non-monetary
items are translated using historical exchange rates. For revenue and expense accounts, an average foreign currency rate during the period is applied. Adjustments resulting from translating foreign functional currency financial statements into U.S. dollars are recorded as part of a separate component of stockholders’ deficit and reported in the consolidated statements of comprehensive loss. Foreign currency transaction gains and losses are included in other income (expense), net for the period.
Income Taxes
The Company uses the asset and liability method in accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the
 
F-51

financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax asset and liability. Valuation allowances are established when necessary to reduce deferred tax assets where it is more likely than not that the deferred tax assets will not be realized. In evaluating the Company’s ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including historical operating results, ongoing tax planning, and forecasts of future taxable income on a
jurisdiction-by-jurisdiction
basis. Based on the level of historical losses, the Company has established a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized.
A tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination by the taxing authorities, including resolutions of any related appeals or litigation processes, based on the technical merits of the position.
Net Loss per Share Attributable to Common Stockholders
Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the
two-class
method required for participating securities. The Company considers all series of its redeemable convertible preferred stock to be participating securities. The Company also considers any shares issued on the early exercise of stock options subject to repurchase to be participating securities because holders of such shares have nonforfeitable dividend rights in the event a dividend is paid on common stock. Under the
two-class
method, net income is attributed to common stockholders and participating securities based on their participation rights. The holders of the redeemable convertible preferred stock, as well as the holders of early exercised shares subject to repurchase, do not have a contractual obligation to share in the losses of the Company. As such, the Company’s net losses for the years ended January 31, 2021, 2020, and 2019 were not allocated to these participating securities. Under the
two-class
method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. Diluted net loss per share attributable to common stockholders adjusts basic net loss per share for the effect of dilutive securities, including stock options. As the Company has reported losses for all periods presented, all potentially dilutive securities are antidilutive and accordingly, basic net loss per share equals diluted net loss per share.
Accounting Pronouncements
The Company is provided the option to adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as
non-public
business entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt, when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as
non-public
business entities, as indicated below.
Recently Adopted Accounting Standards
In June 2018, the FASB issued ASU
No. 2018-13,
“Fair Value Measurement (Topic 820): Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurements,” which expands the disclosure requirements for Level 3 fair value measurements and expands disclosures for measurement uncertainty. This guidance became effective for annual reporting periods beginning after December 15, 2019. The Company adopted the guidance at the beginning of fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures.
In August 2018, the FASB issued
2018-15,
“Intangibles-Goodwill and Other-Internal Use Software (Subtopic
350-40):
Customer’s Accounting for Implementation Costs Incurred In a Cloud Computing
 
F-52

Arrangement That Is a Service Contract,” which reduces complexity of the accounting for costs of implementing a cloud computing service arrangement. The guidance is effective for annual reporting periods beginning after December 15, 2020. The Company early adopted this guidance at the beginning of fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures.
In March 2020, the FASB issued ASU
2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which provides optional expedients and exceptions for applying U.S. GAAP to contract modifications, hedging relationships, and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The guidance is effective for the Company beginning on March 12, 2020 and it will apply the amendments prospectively through December 31, 2022. The Company adopted this guidance during fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures.
In May 2014, the FASB issued ASC 606 with several subsequent amendments. ASC 606 amends the existing accounting standards for revenue recognition. The new guidance provides a new model to determine when and over what period revenue is recognized. Revenue is recognized for the transfer of promised goods or services to customers in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company early adopted the new revenue standard as of February 1, 2019 using the modified retrospective approach. The impact of the adoption was not material to the Company’s consolidated financial statements and disclosures. Comparative information prior to the date of adoption has not been restated and continues to be reported under the accounting standards in effect for those periods.
With the adoption of ASC 606 the Company also early adopted ASC 340 which requires the deferral of incremental costs of obtaining a customer contract which, under the old guidance, were expensed as incurred. The guidance requires the deferral of incremental contract acquisition costs and subsequent amortization over the expected period of benefit. The benefit period was estimated by taking into consideration the length of customer contracts, renewals, technology lifecycle, and other factors. The amortization of these costs is charged to sales and marketing expenses in the consolidated statements of operations. The cumulative impact of ASC 340 adoption on February 1, 2019 resulted in an increase of $2.2 million in total assets related to costs to obtain customer contracts that were previously expensed as incurred but would have been capitalized under ASC 340. Upon adoption, the Company recorded the cumulative impact of adoption as an adjustment to the Company’s accumulated deficit on February 1, 2019. Prior periods were not retroactively adjusted.
The adoption of ASC 340 resulted in a net decrease in sales and marketing expenses due to the capitalization and related amortization of deferred contract acquisition costs that would have been expensed as incurred prior to adoption. During the year ended January 31, 2020, the adoption of ASC 340 resulted in offsetting changes within operating assets and liabilities and had no net impact on the consolidated statements of cash flows.
In February 2016, the FASB issued ASC 842. The guidance is effective for annual reporting periods for
non-public
business entities beginning after December 15, 2021 and early adoption is permitted. The new standard requires lessees to recognize operating and finance lease liabilities on the balance sheet, as well as corresponding ROU assets. This standard also made some changes to lessor accounting and aligns key aspects of the lessor accounting model with the revenue recognition standard. In addition, disclosures are required to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. ASC 842 requires adoption using the modified retrospective approach, with the option of applying the requirements of the standard either (a) retrospectively to each prior comparative reporting period presented, or (b) retrospectively at the beginning of the period of adoption.
The Company has early adopted ASC 842 as of February 1, 2019 on a modified retrospective basis. Prior period amounts were not adjusted and continue to be reported in accordance with our historic accounting under
 
F-53

previous lease guidance, ASC 840, Leases. Upon adopting ASC 842 at the beginning of the fiscal year ended January 31, 2020, as a lessee, the Company recognized operating lease
right-of-use
assets of $11.3 million and operating lease liabilities of $12.5 million and corresponding reductions of $1.6 million to deferred rent and $0.4 million to prepaid rent. The adoption of the standard did not result in any adjustments to accumulated deficit. See Note 6, Leases, for more information.
For lessor accounting, the impact was not material to the Company’s consolidated financial statements and disclosures.
In January 2017, the FASB issued ASU
No. 2017-04,
“Intangibles — Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” The new standard simplifies the measurement of goodwill by eliminating step two of the
two-step
impairment test. Step two measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. The new guidance requires an entity to compare the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any
tax-deductible
goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. The guidance is effective for annual reporting periods beginning after December 15, 2021. The Company early adopted this guidance at the beginning of fiscal year 2020. The impact of the adoption had no impact on the Company’s consolidated financial statements and disclosures.
In July 2017, the FASB issued ASU
No. 2017-11,
“Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception.” The new guidance reduces the complexity associated with an issuer’s accounting for certain financial instruments with characteristics of liability and equity. Specifically, the FASB determined that a down round feature would no longer cause a freestanding equity-linked financial instrument (or an embedded conversion option) to be accounted for as a derivative liability at fair value with changes in fair value recognized in current earnings. This guidance is effective for annual reporting periods beginning after December 15, 2019. The Company early adopted this guidance at the beginning of fiscal year 2020. The adoption of this guidance did not have a material impact to the Company’s consolidated financial statements and disclosures.
In February 2018, the FASB issued ASU
No. 2018-02,
“Income Statement- Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” The new guidance permits, but does not require, companies to reclassify the stranded tax effects of the Tax Cuts and Jobs Act (the “Act”) on items within accumulated other comprehensive income to retained earnings. This guidance became effective for annual reporting periods beginning after December 15, 2018. The Company did not elect to reclassify the stranded tax effects of the Act on items within accumulated other comprehensive income to retained earnings.
In June 2018, the FASB issued ASU
No. 2018-07,
“Compensation — Stock Compensation (Topic 718): Improvements to
Non-Employee
Share-Based Payment Accounting.” The new guidance expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from
non-employees
and to account for awards to
non-employees
using the grant date fair value without subsequent periodic measurement. The guidance is effective for annual reporting periods beginning after December 15, 2019. The Company early adopted this guidance in fiscal year 2020 using a modified retrospective transition method. Adoption of this guidance did not have a material impact to the Company’s consolidated financial statements and disclosures.
 
F-54

Recently Issued Accounting Standards Not Yet Adopted
In June 2016, the FASB issued ASU
No. 2016-13,
“Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” and has since released various amendments including ASU
No. 2019-04.
The guidance modifies the measurement of expected credit losses on certain financial instruments. This guidance is effective for the Company’s annual reporting periods beginning after December 15, 2022. Early adoption is permitted. The Company is currently assessing the impact of the guidance on its consolidated financial statements and disclosures.
In November 2018, the FASB issued ASU
No. 2018-18,
“Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606”, which clarifies when certain transactions between collaborative arrangement participants should be accounted for under ASC 606 and incorporates
unit-of-account
guidance consistent with ASC 606 to aid in this determination. The guidance is effective for the Company’s annual reporting periods beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures.
In December 2019, the FASB issued ASU
2019-12,
“Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis
step-up
in goodwill obtained in a transaction that is not a business combination. The guidance will be effective for the Company’s annual reporting periods beginning after December 15, 2021. Early adoption is permitted. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures.
In August 2020, the FASB issued ASU
2020-06,
“Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic
815-40),”
which modifies and simplifies accounting for convertible instruments. The new guidance eliminates certain separation models that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance will be effective for annual reporting periods beginning after December 15, 2023. Early adoption is permitted, but no earlier than for fiscal years beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures.
In October 2020, the FASB issued ASU
2020-08,
“Codification Improvements to Subtopic
310-20
— Receivables-Nonrefundable Fees and Other Costs,” which clarifies the accounting for the amortization period for certain purchased callable debt securities held at a premium by giving consideration to securities which have multiple call dates. The guidance will be effective for annual reporting periods beginning after December 15, 2021. Early adoption is permitted for annual reporting periods beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures.
3. Fair Value Measurements
The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
 
           
Gross Unrealized
           
Reported as:
 
January 31, 2021
  
Amortized
Cost
    
Gains
    
Losses
    
Fair Value
    
Cash and cash
equivalents
    
Short-term
investments
 
                         
(in thousands)
               
Cash
   $ 35,788      $         $         $ 35,788      $ 35,788      $ —    
Level 1
                 
Money market funds
     109,703                            109,703        109,703        —    
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total assets measured at fair value on a recurring basis
  
$
145,491
 
  
$
  
 
  
$
  
 
  
$
145,491
 
  
$
145,491
 
  
$
—  
 
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
F-55


           
Gross Unrealized
           
Reported as:
 
January 31, 2020
  
Amortized
Cost
    
Gains
    
Losses
    
Fair Value
    
Cash and cash
equivalents
    
Short-term
investments
 
                         
(in thousands)
               
Cash
   $ 33,266      $         $         $ 33,266      $ 33,266      $ —    
Level 1
                 
Money market funds
     39,487                            39,487        39,487        —    
Level 2
                 
U.S. treasury bills
     47,014        23                  47,037                  47,037  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total assets measured at fair value on a recurring basis
  
$
119,767
 
  
$
23
 
  
$
  
 
  
$
119,790
 
  
$
72,753
 
  
$
47,037
 
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
The money market funds were classified as cash and cash equivalents on the consolidated balance sheets and were within Level 1 of the fair value hierarchy. The aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains or losses on money market funds as of January 31, 2021 and 2020. Realized gains and losses, net of tax, were not material for any of the periods presented.
All of the Company’s U.S. treasury bills were classified as short-term investments on the consolidated balance sheets and were within Level 2 of the fair value hierarchy because they were valued using inputs other than quoted prices in active markets that were observable either directly or indirectly that may include benchmark yields, reported trades, broker/dealer quotes,
two-sided
markets, benchmark securities, bids, offers, and reference data including market research publications. Realized gains and losses, net of tax, were not material for any of the periods presented.
As of January 31, 2021 and 2020, the Company had no investments with a contractual maturity of greater than one year.
The Company’s only Level 3 financial instruments were its redeemable convertible preferred stock warrants. See Note 11 for information on the valuation of the redeemable convertible preferred stock warrant liability.
4. Acquisitions
In fiscal year 2019, the Company acquired an electric fleet and energy management business for a total purchase consideration of $1.5 million in cash. The Company recognized intangible assets related to customer relationships of $0.3 million and goodwill of $1.2 million. The goodwill amount represented synergies related to the Company’s existing platform expected to be realized from this business combination and assembled workforce. The associated goodwill and intangible assets are not deductible for tax purposes. Acquisition costs were not material and were charged to general and administrative expenses in the consolidated statements of operations as incurred. The intangible assets were recorded at fair value and were fully amortized as of January 31, 2020.
Unaudited pro forma results of operations for fiscal years 2019 was not provided because the historical operating results of the acquired business was not material and pro forma results would not be materially different from reported results for the periods presented.
In addition to the purchase consideration, the Company provided an additional $1.0 million of cash compensation awards and 797,280 shares of restricted common stock to employees for future services that vest over two years from the date of the acquisition. Total grant date fair value for the restricted common stock was $0.6 million. The Company recognizes expenses related to the cash compensation awards and restricted common stock on a straight-line basis over the requisite service period of two years. See Note 10 for further information on the restricted common stock.
 
F-56

5. Balance Sheet Components
Inventories
Inventories consisted of the following:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Raw materials
   $ 13,029      $ 11,335  
Work-in-progress
     68            
Finished goods
     20,495        14,084  
  
 
 
    
 
 
 
Total Inventories
  
$
33,592
 
  
$
25,419
 
  
 
 
    
 
 
 
Property and equipment, net
Property and equipment, net consisted of the following:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Furniture and fixtures
   $ 1,594      $ 1,347  
Computers and software
     5,384        4,350  
Machinery and equipment
     10,605        7,614  
Tooling
     7,705        6,299  
Leasehold improvements
     9,398        8,869  
Owned and operated systems
     17,703        8,422  
Construction in progress
     2,462        5,796  
  
 
 
    
 
 
 
     54,851        42,697  
  
 
 
    
 
 
 
Less: Accumulated depreciation
     (24,863      (14,756
  
 
 
    
 
 
 
Total Property and Equipment, Net
  
$
29,988
 
  
$
27,941
 
  
 
 
    
 
 
 
Depreciation expense for the years ended January 31, 2021, 2020, and 2019 was $10.1 million, $7.1 million, and $3.9 million, respectively.
Amortization expense for intangible assets for the years ended January 31, 2020 and 2019 was $0.6 million and $0.2 million, respectively. There was no amortization expense for the year ended January 31, 2021.
Accrued and other current liabilities
Accrued and other current liabilities consisted of the following:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Accrued expenses
   $ 18,404      $ 11,335  
Refundable customer deposits
     6,482        5,241  
Payroll and related expenses
     7,547        6,727  
Taxes payable
     5,213        5,348  
Operating lease liabilities, current
     2,393        3,979  
Warranty accruals
     3,000        2,000  
Other liabilities
     4,123        3,029  
  
 
 
    
 
 
 
Total Accrued and Other Current Liabilities
  
$
47,162
 
  
$
37,659
 
  
 
 
    
 
 
 
 
F-57

6. Leases
The Company leases its office facilities under
non-cancellable
operating leases with various lease terms. The Company also leases certain office equipment under operating lease agreements. As of January 31, 2021,
non-cancellable
leases expire on various dates between fiscal years 2022 and 2030.
Generally, the Company’s
non-cancellable
leases include renewal options to extend the lease term from one to five years. The Company has not included any renewal options in its lease terms as these options are not reasonably certain of being exercised. The lease agreements do not contain any material residual value guarantees or material restrictive covenants.
As of January 31, 2021 and 2020, lease balances were as follows:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Operating leases
     
Operating lease
right-of-use
assets
  
$
21,817
 
  
$
10,269
 
  
 
 
    
 
 
 
Operating lease liabilities, current
     2,286        3,979  
Operating lease liabilities, noncurrent
     22,459        8,230  
  
 
 
    
 
 
 
Total operating lease liabilities
  
$
24,745
 
  
$
12,209
 
  
 
 
    
 
 
 
The Company recognizes operating lease costs on a straight-line basis over the lease period. Lease expense for the years ended January 31, 2021, 2020, and 2019 was $5.1 million, $4.5 million, and $3.1 million, respectively. Operating lease costs for short-term leases and variable lease costs were not material during the years ended January 31, 2021 and January 31, 2020.
Maturities of the operating lease liabilities as of January 31, 2021 were as follows:
 
    
(in thousands)
 
Years Ending January 31,
  
2022
   $ 4,719  
2023
     5,123  
2024
     4,334  
2025
     4,152  
2026
     3,833  
Thereafter
     13,855  
  
 
 
 
Total undiscounted operating lease payments
  
$
36,016
 
  
 
 
 
Less: imputed interest
     (11,271
  
 
 
 
Total operating lease liabilities
  
$
24,745
 
  
 
 
 
 
F-58

Maturities of the operating lease liabilities as of January 31, 2020 were as follows:
 
    
(in thousands)
 
Years Ending January 31,
  
2021
   $ 4,849  
2022
     4,809  
2023
     2,671  
2024
     268  
2025
     292  
Thereafter
     1,341  
  
 
 
 
Total undiscounted operating lease payments
  
$
14,230
 
Less: imputed interest
     (2,021
  
 
 
 
Total operating lease liabilities
  
$
12,209
 
  
 
 
 
Other supplemental information as of January 31, 2021 and 2020 was as follows:
 
    
January 31,
 
    
2021
   
2020
 
Lease Term and Discount Rate
    
Weighted-average remaining operating lease term (years)
     7.5       3.7  
Weighted-average operating lease discount rate
     7.9     8.7
Other supplemental cash flow information for the years ended January 31, 2021 and January 31, 2020 was as follows:
 
    
Year ended January 31,
 
    
    2021    
    
    2020    
 
    
(in thousands)
 
Supplemental Cash Flow Information
     
Cash paid for amounts in the measurement of operating lease liabilities
   $ 4,226      $ 4,527  
As of January 31, 2021, the Company has additional operating leases of approximately $1.0 million that have not yet commenced and as such, have not yet been recognized on the Company’s Consolidated Balance Sheet. These operating leases are expected to commence on February 1, 2021 with lease terms of up to 4.5 years.
7. Debt
In December 2014, the Company entered into a $20.0 million term loan agreement to finance working capital requirements and repay certain indebtedness of the Company’s original credit facility (the “2014 Loan”). The 2014 Loan was to be repaid in forty-eight monthly installments commencing on September 1, 2016; the first fifteen payments were interest only, followed by thirty-three equal monthly payments of principal and interest. Interest was calculated at 8.75% plus LIBOR, provided that the interest rate could not be less than 9.75%. The borrowings were secured by substantially all of the Company’s assets.
In July 2018, the Company entered into a term loan facility with certain lenders (the “2018 Loan”) with a borrowing capacity of $45.0 million to finance working capital and repay all outstanding amounts owed under the 2014 Loan, of which $10.0 million expired unused in June 2019. The Company borrowed $35.0 million, with issuance costs of $1.1 million and net proceeds of $33.9 million. The 2018 Loan is secured by substantially all of the Company’s assets, contains customary affirmative and negative covenants, and requires the Company to maintain minimum cash balances and attain certain customer billing targets. The 2018 Loan has a five-year
 
F-59

maturity and interest is calculated at LIBOR plus 6.55%. The 2018 Loan agreement was amended on March 20, 2019 to extend the interest only monthly payments through June 30, 2021 to be followed by equal monthly payments of principal and interest. The Company believes that the fair value of the term loan approximates the recorded amount as of January 31, 2021, as the interest rates on the long-term debt are variable and the rates are based on market interest rates after consideration of default and credit risk (using Level 2 inputs). As of January 31, 2021 and 2020 the Company was in compliance with all financial and
non-financial
debt covenants.
Transaction costs upon entering into the 2018 Loan were recorded as debt discount and are amortized over the term of the 2018 Loan.
Total interest expense incurred during the years ended January 31, 2021, 2020, and 2019 was $3.3 million, $3.5 million, and $3.7 million, respectively. There was no accrued interest as of January 31, 2021 and 2020.
Total future principal payments under all borrowings as of January 31, 2021 were as follows:
 
    
(in thousands)
 
Years Ending January 31,
  
2022
     11,667  
2023
     17,500  
2024
     5,833  
  
 
 
 
Total payments
  
$
35,000
 
  
 
 
 
In March 2021, the Company repaid the entire loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million.
8. Commitments and Contingencies
Purchase Commitments
Open purchase commitments are for the purchase of goods and services related to, but not limited to, manufacturing, facilities, and professional services under
non-cancellable
contracts. They were not recorded as liabilities on the consolidated balance sheets as of January 31, 2021 and 2020 as the Company had not yet received the related goods or services. The Company had open purchase commitments for goods and services of $64.1 million as of January 31, 2021. All of them are expected to be received by January 31, 2024.
Legal Proceedings
The Company may be involved in various lawsuits, claims, and proceedings, including intellectual property, commercial, securities, and employment matters that arise in the normal course of business. The Company accrues a liability when management believes information available prior to the issuance of the consolidated financial statements indicates it is probable a loss has been incurred as of the date of the consolidated financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred.
The Company believes it has recorded adequate provisions for any such lawsuits, claims, and proceedings as of January 31, 2021. Based on its experience, the Company believes that damage amounts claimed in these matters are not meaningful indicators of potential liability. Given the inherent uncertainties of litigation, the ultimate outcome of the ongoing matters described herein cannot be predicted with certainty. While litigation is inherently unpredictable, the Company believes it has valid defenses with respect to the legal matters pending against it. Nevertheless, the consolidated financial statements could be materially adversely affected in a particular period by the resolution of one or more of these contingencies. Liabilities established to provide for
 
F-60

contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved; and such changes are recorded in the accompanying consolidated statements of operations during the period of the change and reflected in accrued and other current liabilities on the accompanying consolidated balance sheets.
Guarantees and Indemnifications
The Company has service level commitments to its customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits in the event that the Company fails to meet those levels. To date, the Company has not incurred any material costs as a result of such commitments.
The Company’s arrangements generally include certain provisions for indemnifying customers against liabilities if its products or services infringe a third-party’s intellectual property rights. Additionally, the Company may be required to indemnify for claims caused by its negligence or willful misconduct. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. To date, the Company has not incurred any material costs as a result of such obligations and has not accrued any liabilities related to such obligations in the consolidated financial statements.
The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company also may be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions.
Letters of Credit
The Company had $0.4 million of secured letters of credit outstanding as of January 31, 2021 and 2020. These primarily relate to support of customer agreements and are fully collateralized by cash deposits which the Company recorded in restricted cash on its consolidated balance sheets based on the term of the remaining restriction.
9. Redeemable Convertible Preferred Stock
In fiscal year 2021, the Company issued 22.4 million shares of Series
H-1
redeemable convertible preferred stock and 22.4 million common stock warrants for total cash proceeds of $127.0 million, net of issuance costs of $0.2 million. On issuance, the Company’s redeemable convertible preferred stock and common stock warrants were recorded at fair value of the amount of allocated proceeds, net of issuance costs. The Company performed a valuation of the Series
H-1
redeemable convertible preferred stock as well as the common stock warrants. The common stock warrants were valued using a Black-Scholes Option pricing model. Based upon that valuation, the Company allocated the net proceeds between the Series
H-1
redeemable convertible preferred stock and common stock warrants of $95.5 million and $31.5 million, respectively, based on their relative fair values. In addition, the Company evaluated the conversion feature of the Series
H-1
redeemable convertible preferred stock to assess whether it met the definition of a beneficial conversion feature (“BCF”). As the fair value of a share of common stock exceeded the effective conversion price at the issuance date, the Series
H-1
redeemable convertible preferred stock contained a BCF. The intrinsic value of $60.4 million was recorded as a discount to the Series
H-1
redeemable convertible preferred stock and a credit to additional
paid-in
capital. As a result of the shares being readily convertible into shares of the Company’s common stock at the option of the holders, the full value of the BCF was immediately recorded as a deemed dividend through additional
paid-in
capital to reflect the accretion of the discount resulting from the
at-issuance
BCF embedded within the redeemable convertible preferred stock.
 
F-61

In fiscal year 2020, the Company issued 2.6 million shares of Series H redeemable convertible preferred stock and 0.9 million common stock warrants for total cash proceeds of $14.9 million, net of $0.1 million of issuance costs. Of the total cash proceeds, $14.8 million, net of $0.1 million of issuance costs, was allocated to the Series H redeemable convertible preferred stock, based on the estimated fair value of the redeemable convertible preferred stock relative to the estimated fair value of the common stock warrants.
In fiscal year 2019, the Company issued 39.5 million shares of Series H redeemable convertible preferred stock and 13.2 million common stock warrants for total cash proceeds of $216.6 million, net of $8.4 million of issuance costs. Of the total cash proceeds, $215.2 million, net of $8.4 million of issuance costs was allocated to the Series H redeemable convertible preferred stock, based on the estimated fair value of the redeemable convertible preferred stock relative to the estimated fair value of the common stock warrants.
Redeemable convertible preferred stock as of January 31, 2021, 2020, and 2019, respectively, consisted of the following:
 
    
January 31, 2021
 
    
Shares
    
Liquidation

Preference
    
Carrying

Value
 
    
Authorized
    
Outstanding
 
Series A
     29,027        29,027      $ 3,746      $ 3,697  
Series B
     132,831        130,146        13,993        13,947  
Series C
     45,222        45,222        13,068        13,039  
Series D
     45,744,194        44,307,263        54,946        49,469  
Series E
     22,578,525        21,772,150        54,000        26,795  
Series F
     23,611,372        23,611,372        59,000        58,624  
Series G
     28,533,636        28,533,636        125,000        124,745  
Series H
     42,154,388        42,154,388        240,000        229,925  
Series H-1
     22,351,053        22,351,053        129,795        95,456  
  
 
 
    
 
 
    
 
 
    
 
 
 
  
 
185,180,248
 
  
 
182,934,257
 
  
$
693,548
 
  
$
615,697
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
January 31, 2020
 
    
Shares
    
Liquidation

Preference
    
Carrying

Value
 
    
Authorized
    
Outstanding
 
Series A
     29,027        29,027      $ 3,746      $ 3,697  
Series B
     132,831        130,146        13,993        13,947  
Series C
     45,222        45,222        13,068        13,039  
Series D
     45,744,194        44,307,262        54,946        49,469  
Series E
     22,578,525        21,772,150        54,000        26,795  
Series F
     23,611,372        23,611,372        59,000        58,624  
Series G
     28,533,636        28,533,636        125,000        124,745  
Series H
     42,154,388        42,154,388        240,000        229,925  
  
 
 
    
 
 
    
 
 
    
 
 
 
  
 
162,829,195
 
  
 
160,583,203
 
  
$
563,753
 
  
$
520,241
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
F-62

    
January 31, 2019
 
    
Shares
    
Liquidation

Preference
    
Carrying

Value
 
    
Authorized
    
Outstanding
 
Series A
     29,027        29,027      $ 3,746      $ 3,697  
Series B
     132,831        130,146        13,993        13,947  
Series C
     45,222        45,222        13,068        13,039  
Series D
     45,744,194        44,307,263        54,946        49,469  
Series E
     22,578,525        21,772,150        54,000        26,795  
Series F
     23,611,372        23,611,372        59,000        58,624  
Series G
     28,533,636        28,533,636        125,000        124,745  
Series H
     42,154,388        39,519,737        225,000        215,169  
  
 
 
    
 
 
    
 
 
    
 
 
 
    
162,829,195
      
157,948,553
    
$
548,753
    
$
505,485
 
  
 
 
    
 
 
    
 
 
    
 
 
 
The significant features of the Company’s redeemable convertible preferred stock are as follows:
Dividend provisions
— The holders of the outstanding shares of Series A, Series B, Series C, Series D, Series E, Series F, Series G, and Series H redeemable convertible preferred stock are entitled to receive, when and if declared by the Company’s Board of Directors, a noncumulative dividend at the annual rate per share of $10.3251, $8.5792, $23.1286, $0.0992, $0.0992, $0.1999, $0.3505, $0.4554 respectively, per annum, adjustable for certain events, such as stock splits and combinations. The holders of the outstanding shares of Series
H-1
redeemable convertible preferred stock are entitled to receive a cumulative dividend accrued at the annual rate of $0.4554 per share, accruing on a daily basis through the second anniversary of the issuance of the Series
H-1
redeemable convertible preferred stock. In addition, holders of redeemable convertible preferred stock participate in any distribution in excess of preferred dividends on an as converted basis. The Company has declared no dividends as of January 31, 2021. As of January 31, 2021, total unpaid accumulated dividends due to the
Series H-1
redeemable convertible preferred stockholders were $16.8 million.
Liquidation preference
— In the event of any liquidation, dissolution, winding up or change of control of the Company, whether voluntary or involuntary, the holders of Series H-1 redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $5.6934 per share for each share of Series H-1 redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series
H-1
redeemable convertible preferred stock, the holders of Series H redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $5.6934 per share for each share of Series H redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series H redeemable convertible preferred stock, holders of Series G redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $4.3808 per share for each share of Series G redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series G redeemable convertible preferred stock, holders of Series F redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $2.4988 per share for each share of Series F redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
 
F-63

After payments to the holders of Series F redeemable convertible preferred stock, holders of Series E redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $2.4802 per share for each share of Series E redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series E redeemable convertible preferred stock, holders of Series D redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $1.2401 per share for each share of Series D redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series D redeemable convertible preferred stock, the holders of the Series C and Series B redeemable convertible preferred stock are entitled to receive the amount of $288.9825 and $107.5156 per share, respectively, for each share of Series C and Series B redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series C and Series B redeemable convertible preferred stock, the holders of the Series A redeemable convertible preferred stock are entitled to receive the amount of $129.0387 per share, respectively, for each share of Series A redeemable convertible preferred stock share then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series A redeemable convertible preferred stock, the entire remaining assets and surplus funds of the Company legally available for distribution, if any, shall be distributed pro rata among the holders of the then outstanding common stock and redeemable convertible preferred stock on an
as-converted
basis, rounded down to the next whole number of shares on a pari passu basis according to the number of shares of common stock held by such holders, until such time as each holder of then outstanding Series A, Series B, Series C, Series D, Series E, Series F, Series G, Series H, and Series
H-1
redeemable convertible preferred stock have received an aggregate amount equal to 2, 4, 4, 4, 2.5, 4, 2, 2, and 2 times the preference amount, respectively, of each share of redeemable convertible preferred stock held by each holder. After these distributions have been paid to all holders of redeemable convertible preferred stock, then the holders of then outstanding common stock will be entitled to receive all remaining assets of the Company legally available for distribution pro rata according to the number of outstanding shares of common stock then held by each holder. The redeemable convertible preferred stock will be deemed to have been automatically converted into common stock if the redemption amount per share on an
as-converted
basis would be greater than such holder would otherwise be entitled to.
Conversion rights
— Each share of Series A, Series B, Series C, Series D, Series E, Series F, Series G, Series H, and Series
H-1
redeemable convertible preferred stock are convertible, at the option of the holder thereof, at any time after the date of issuance of such share, into such number of fully paid and
non-assessable
shares of common stock as is determined by dividing, $91.7319, $81.5974, $139.6147, $1.2401, $1.2401, $2.4988, $4.3808, $5.6934, and $5.6934, respectively, by the conversion price $1.9011, $1.9011, $1.9011, $1.2401, $1.2401, $2.4988, $4.3808, $5.6934, and $5.6934, respectively, in effect on the date the certificate is surrendered for conversion.
The holders of each series of redeemable convertible preferred stock shall benefit from certain anti-dilution adjustments in the event the Company issues shares at a per share price lower than the respective issuance price of each series of redeemable convertible preferred stock.
The redeemable convertible preferred stock will automatically convert into shares of common stock at the then effective conversion price for each such share immediately upon the Company’s sale of its common stock in a firm commitment of an underwritten initial public offering pursuant to a registration statement under the
 
F-64

Securities Act of 1933, as amended, that has a public offering price of not less than $11.3867 per share, adjusted for any stock dividends, combinations, splits, or recapitalizations, and which results in aggregate gross proceeds to the Company of not less than $100.0 million, net of underwriting discounts, commissions, and expenses.
Redemption and Balance Sheet Classification
— While the redeemable convertible preferred stock does not have mandatory redemption provisions, the deemed liquidation preference provisions of the redeemable convertible preferred stock are considered contingent redemption provisions that are not solely within the Company’s control. These elements primarily relate to deemed liquidation events such as a change of control. Accordingly, the Company’s redeemable convertible preferred stock has been presented outside of permanent equity in the mezzanine section of the consolidated balance sheets.
Voting rights
— The holders of each share of redeemable convertible preferred stock are entitled to the number of votes equal to the number of shares of common stock into which such shares of redeemable convertible preferred stock could be converted. The holder of each share of common stock shall have the right to one vote for each such share and shall be entitled to notice of any stockholders’ meeting in accordance with the bylaws of the Company. Holders of Series A, Series B, Series D, Series, F, and Series H redeemable convertible preferred stock have the right to appoint one, two, three, two, and two directors to the Company’s board of directors, respectively.
10. Common Stock
As of January 31, 2021 and 2020, the Company was authorized to issue 299,771,284 and 240,180,600 shares of common stock, respectively, with a par value of $0.0001 per share. There were 22,961,032 and 11,918,418 shares issued and outstanding as of January 31, 2021 and 2020, respectively.
The holders of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders. The holders of common stock are not entitled to cumulative voting rights with respect to the election of directors, and as a consequence, minority stockholders are not able to elect directors on the basis of their votes alone. Subject to preferences that may be applicable to any shares of redeemable convertible preferred stock currently outstanding or issued in the future, holders of common stock are entitled to receive ratably such dividends as may be declared by the Company’s board of directors out of funds legally available therefor. In the event of the Company’s liquidation, dissolution, or winding up, holders of the Company’s common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preference of any then outstanding redeemable convertible preferred stock. Holders of common stock have no preemptive rights and no right to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock.
Restricted Common Stock
In connection with a business combination in fiscal year 2019 as referenced in Note 4, the Company granted 797,280 shares of restricted common stock to employees for future services that vest over two years from the date of the acquisition. During the years ended January 31, 2021, 2020 and 2019, 166,100, 398,640 and 232,540 shares of restricted common stock vested, respectively. As of January 31, 2021, no shares of restricted common stock remained unvested.
 
F-65

Common Stock Reserved for Future Issuance
Shares of common stock reserved for future issuance on an
as-if
converted basis, were as follows:
 
    
January 31,
 
    
2021
    
2020
 
Conversion of redeemable convertible preferred stock
     193,037,715        170,686,661  
Stock options issued and outstanding
     30,167,178        34,883,465  
Redeemable convertible preferred stock warrants outstanding
     2,358,546        2,358,546  
Common stock warrants outstanding
     36,402,515        14,051,462  
Shares available for grant under 2017 Stock Option Plan
     4,528,391        5,844,909  
  
 
 
    
 
 
 
Total shares of common stock reserved
  
 
266,494,345
 
  
 
227,825,043
 
  
 
 
    
 
 
 
 
11.
Stock Warrants
In connection with its issuance of Series
H-1
redeemable convertible preferred stock in the fiscal year 2021, the Company issued 22.4 million common stock warrants which were recorded at fair value within additional
paid-in
capital in stockholders’ deficit.
In connection with its issuance of Series H redeemable convertible preferred stock in fiscal years 2020 and 2019, the Company issued 0.9 million and 13.2 million common stock warrants, respectively, which were recorded at fair value within additional
paid-in
capital in stockholders’ deficit.
Warrants issued and outstanding as of January 31, 2021 and 2020 consisted of the following:
Common Stock Warrants
 
    
January 31, 2021
 
    
Outstanding Warrants
        
    
Number of
Warrants
    
Exercise
Price
    
Expiration Date
 
Common Stock
     22,351,053      $ 6.02        7/31/2030 – 8/6/2030  
Common Stock
     14,051,462      $ 9.03        11/16/2028 – 2/14/2029  
  
 
 
       
Total outstanding common stock warrants
  
 
36,402,515
 
     
  
 
 
       
 
    
January 31, 2020
 
    
Outstanding Warrants
        
    
Number of
Warrants
    
Exercise
Price
    
Expiration Date
 
Common Stock
     14,051,462      $ 9.03        11/16/2028 – 2/14/2029  
  
 
 
       
Total outstanding common stock warrants
  
 
14,051,462
 
     
  
 
 
       
 
F-66

Redeemable Convertible Preferred Stock Warrants
 
    
January 31, 2021 and 2020
 
    
Outstanding Warrants
    
Expiration Date
 
    
Number of
Warrants
    
Exercise
Price
 
Series B Preferred Stock
     2,685      $ 107.52        4/30/2021  
Series D Preferred Stock
     1,436,932      $ 1.24        4/20/2022 – 1/24/2024  
Series E Preferred Stock
     806,375      $ 1.24        12/24/2024 – 7/15/2025  
  
 
 
       
Total outstanding redeemable convertible preferred stock warrants
  
 
2,245,992
 
     
  
 
 
       
The liability associated with these warrants was subject to remeasurement at each balance sheet date using the Level 3 fair value inputs and was as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Fair value at beginning of period
   $ 2,718      $ 1,843      $ 1,455  
Change in fair value
     73,125        875        388  
  
 
 
    
 
 
    
 
 
 
Fair value at end of period
  
$
75,843
 
  
$
2,718
 
  
$
1,843
 
  
 
 
    
 
 
    
 
 
 
The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows:
 
    
January 31,
 
    
2021
   
2020
   
2019
 
Expected volatility
     80.5     58.4     65.0
Risk-free interest rate
     0.1     1.6     2.8
Dividend rate
     0.0     0.0     0.0
Expected term (years)
     1.4       2.0       2.0  
Historically, value was assigned to each class of equity securities using an option pricing model method (“OPM”). In July 2020, the Company began allocating the equity value using a hybrid method that utilizes a combination of the OPM and the probability weighted expected return method (“PWERM”). The PWERM is a scenario-based methodology that estimates the fair value of equity securities based upon an analysis of future values for the Company, assuming various outcomes. As the probability of a transaction with a special purpose acquisition company (“SPAC”) increased, the fair value of the redeemable convertible preferred stock warrant liability increased as of January 31, 2021.
 
12.
Stock Option Plan and Stock-based Compensation
In 2007, the Company adopted its 2007 Stock Option Plan (the “2007 Plan”) which provides for the granting of stock options to employees, directors, and consultants of the Company. In 2017, the Company adopted its 2017 Stock Option Plan (the “2017 Plan”). Stock options granted under both the 2007 and 2017 Plans may be either incentive stock options (“ISOs”) or nonqualified stock options (“NSOs”). As of January 31, 2021, 4.5 million shares of common stock remained available for issuance under the 2017 Plan. Stock-based awards forfeited, cancelled, or repurchased generally are returned to the pool of shares of common stock available for issuance under the 2017 Plan.
The 2007 Plan and 2017 Plan allow for the early exercise of stock options for certain individuals as determined by the Company’s board of directors. Stock options that are early exercised are subject to a
 
F-67

repurchase option that allows the Company to repurchase any unvested shares. Early exercises of stock options are not deemed to be outstanding shares for accounting purposes until those shares vest according to their respective vesting schedules. Accordingly, the consideration received for early exercises of stock options are initially recorded as a liability and reclassified to common stock and additional
paid-in
capital as the underlying awards vest. As of January 31, 2021 and 2020, liabilities for unvested shares related to early exercises of stock options were not material. The related number of unvested shares subject to repurchase was also not material for any period presented.
Stock options under the 2017 Plan generally expire 10 years from the date of grant, or earlier if services are terminated. The exercise price of an ISO and NSO shall not be less than 100% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Company’s board of directors. Stock options granted generally vest over four years and at a rate of 25% upon the first anniversary of the issuance date and 1/48th per month thereafter.
Activity under the Company’s stock option plans is set forth below:
 
    
Number of
Stock Option
Awards
   
Weighted
Average
Exercise

Price
    
Weighted
Average
Remaining
Contractual
term

(in years)
    
Aggregate
Intrinsic Value
 
Outstanding as of January 31, 2018
  
 
28,955,341
 
  $ 0.59        7.7      $ 8,905,754  
  
 
 
         
Granted
     8,811,605     $ 0.57        
Exercised
     (3,853,935   $ 0.35         $ (1,364,006
Cancelled
     (2,250,990   $ 0.75        
  
 
 
         
Outstanding as of January 31, 2019
  
 
31,662,021
 
  $ 0.6        7.4      $ 7,456,493  
Granted
     10,780,372     $ 0.75        
Exercised
     (4,830,469   $ 0.47         $ (3,464,262
Cancelled
     (2,728,460   $ 0.83        
  
 
 
         
Outstanding as of January 31, 2020
  
 
34,883,464
 
  $ 0.65        7.3      $ 19,314,017  
Granted
     8,912,180     $ 0.75        
Exercised
     (11,042,592   $ 0.55         $ (110,643,446 )
Cancelled
     (2,585,875   $ 0.84        
  
 
 
         
Outstanding as of January 31, 2021
  
 
30,167,177
 
  $ 0.7        7.3      $ 1,064,538,557  
  
 
 
         
Options vested and expected to vest as of January 31, 2021
     27,483,800     $ 0.69        7.2      $ 969,997,293  
  
 
 
         
Exercisable as of January 31, 2021
     16,591,050     $ 0.68        6.4      $ 586,047,442  
  
 
 
         
Activity for exercised awards includes early exercises of stock options such that these awards are not considered outstanding stock options upon exercise.
The activity above also includes a grant of a total of 1.5 million stock option awards subject to both service and performance-based vesting conditions to the Chief Executive Officer under the 2017 Plan (“CEO awards”). These stock options have a weighted-average exercise price of $0.75 per share. Upon initial grant in June 2020, these stock option awards had a grant date fair value of $1.1 million and were to vest on the fourth anniversary from the date of grant provided that positive operating income was achieved at the end of fiscal year 2024.
In September 2020, the CEO awards were modified to vest in a single installment on January 31, 2024 contingent upon the closing of the Merger and the Chief Executive Officer’s continuous employment by the
 
F-68

Company through January 31, 2024. No stock-based compensation expense has been recorded as the CEO awards were improbable of vesting before and after the modification in September 2020, because the performance-based vesting condition is contingent upon the closing of the Merger which is not deemed probable until consummated.
In December 2020, the CEO awards were modified again to accelerate vesting of 12.5% of stock options at any time through January 31, 2024 contingent upon certain additional service-based trigger events. For the year ended January 31, 2021, no stock-based compensation expense has been recorded as the CEO awards remained to be improbable of vesting before and after the modification in December 2020. As of January 31, 2021, the total compensation cost related to these unvested CEO awards not yet recognized was $44.3 million after the impact of the modifications.
Total stock-based compensation expense for stock awards recognized during the years ended January 31, 2021, 2020, and 2019 was $4.9 million, $2.9 million, and $1.7 million, respectively. As of January 31, 2021, total unrecognized compensation cost related to stock awards was $9.8 million and is expected to be recognized over a weighted-average period of 2.5 years.
The weighted-average grant date fair value of options granted in the years ended January 31, 2021, 2020, and 2019 was $0.94, $0.31, and $0.24 per share, respectively. The total grant date fair value of options vested during the years ended January 31, 2021, 2020, and 2019 was $5.4 million, $2.5 million, and $1.8 million, respectively.
Stock-based Compensation Associated with Awards
The Company records stock-based compensation expense for stock options based on the estimated fair value of the options on the date of the grant using the Black-Scholes option-pricing model.
The absence of a public market for the Company’s common stock requires the Company’s board of directors to estimate the fair value of its common stock for purposes of granting options and for determining stock-based compensation expense by considering several objective and subjective factors, including contemporaneous third-party valuations, actual and forecasted operating and financial results, market conditions and performance of comparable publicly traded companies, developments and milestones in the Company, the rights and preferences of common and redeemable convertible preferred stock, and transactions involving the Company’s stock. The fair value of the Company’s common stock was determined in accordance with applicable elements of the American Institute of Certified Public Accountants guide, Valuation of Privately Held Company Equity Securities Issued as Compensation.
The weighted-average assumptions in the Black-Scholes option-pricing models used to determine the fair value of stock options granted during the years ended January 31, 2021, 2020, and 2019 were as follows:
 
    
Year Ended January 31,
 
    
2021
   
2020
   
2019
 
Expected volatility
     49.1% – 51.6     40.3% – 40.9 %     40.9% – 41.6
Risk-free interest rate
     0.3% – 1.6     1.4% – 2.4     2.7% – 2.9
Dividend rate
     0.0     0.0     0.0
Expected term (in years)
     5.65.8       5.05.9       6.16.4  
Expected volatility: As the Company is not publicly traded, the expected volatility for the Company’s stock options was determined by using an average of historical volatilities of selected industry peers deemed to be comparable to the Company’s business corresponding to the expected term of the awards.
Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for
zero-coupon
U.S. Treasury notes with maturities corresponding to the expected term of the awards.
 
F-69

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.
Expected term: The expected term represents the period these stock awards are expected to remain outstanding and is based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules, and expectations of future employee behavior.
Stock-based Compensation Expense
The following sets forth the total stock-based compensation expense for the Company’s stock options and restricted common stock included in the Company’s consolidated statements of operations:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Cost of revenue
   $ 115      $ 39      $ 28  
Research and development
     1,807        871        419  
Sales and marketing
     1,501        1,164        541  
General and administrative
     1,524        863        718  
  
 
 
    
 
 
    
 
 
 
Total stock-based compensation expense
  
$
4,947
 
  
$
2,937
 
  
$
1,706
 
  
 
 
    
 
 
    
 
 
 
 
13.
Income Taxes
The components of net loss before income taxes were as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Domestic
   $ (197,908    $ (134,578    $ (108,663
Foreign
     1,082        475        695  
  
 
 
    
 
 
    
 
 
 
Net loss before income taxes
  
$
(196,826
  
$
(134,103
  
$
(107,968
  
 
 
    
 
 
    
 
 
 
The components of the provision for (benefit from) income taxes were as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Current
        
Federal
   $ —        $ —        $ —    
State
     47        35        —    
Foreign
     151        189        119  
  
 
 
    
 
 
    
 
 
 
Total current
  
$
198
 
  
$
224
 
  
$
119
 
  
 
 
    
 
 
    
 
 
 
Deferred
        
Federal
   $ —        $ —        $ —    
State
     —          —          —    
Foreign
     —          —          —    
Total deferred
     —          —          —    
  
 
 
    
 
 
    
 
 
 
Total provision for income taxes
  
$
198
 
  
$
224
 
  
$
119
 
  
 
 
    
 
 
    
 
 
 
 
F-70

A reconciliation of the U.S. federal statutory rate to the Company’s effective tax rate was as follows:
 
    
Year Ended January 31,
 
    
2021
   
2020
   
2019
 
Tax at federal statutory rate
     21.0     21.0     21.0
Permanent differences
     (0.6 )%      (1.5 )%      (0.8 )% 
Warrant Mark to Market
     (7.8 )%      (0.1 )%      (0.1 )% 
Stock-based compensation
     (0.2 )%      (0.2 )%      (0.2 )% 
Change in valuation allowance
     (13.6 )%      (21.1 )%      (21.9 )% 
Research and development tax credits
     1.1     1.8     1.9
  
 
 
   
 
 
   
 
 
 
Effective tax rate
  
 
(0.1
)% 
 
 
(0.1
)% 
 
 
(0.1
)% 
  
 
 
   
 
 
   
 
 
 
The significant components of the Company’s deferred tax assets and liabilities as of January 31, 2021 and 2020 were as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Deferred tax assets:
     
Net operating losses
   $ 114,154      $ 105,663  
Research & development credits
     12,054        14,320  
Deferred revenue
     15,270        6,968  
Accruals and reserves
   $ 8,102      $ 6,692  
Stock-based compensation
     980        653  
Operating lease liabilities
     6,999        3,370  
  
 
 
    
 
 
 
Total deferred tax assets
  
 
157,559
 
  
 
137,666
 
  
 
 
    
 
 
 
Less: valuation allowance
     (150,991      (134,337
Deferred tax liabilities:
     
Depreciation and amortization
     (375      (489
Operating lease
right-of-use
assets
     (6,186      (2,834
  
 
 
    
 
 
 
Total deferred tax liabilities
  
 
(6,561
  
 
(3,323
  
 
 
    
 
 
 
Net deferred tax assets
  
$
7
 
  
$
6
 
  
 
 
    
 
 
 
The Company determines its valuation allowance on deferred tax assets by considering both positive and negative evidence in order to ascertain whether it is more likely than not that deferred tax assets will be realized. Realization of deferred tax assets is dependent upon the generation of future taxable income, if any, the timing and amount of which are uncertain. Due to the Company’s historical operating losses, the Company believes that it is more likely than not that all of the deferred tax will not be realized; accordingly, the Company has recorded a full valuation allowance on its net domestic deferred tax assets as of January 31, 2021 and 2020. The valuation allowance increased by $16.7 million, $36.2 million, and $29.8 million during the years ended January 31, 2021, 2020, and 2019, respectively. The increases were primarily driven by losses and tax credits generated in the United States. As of January 31, 2021, the Company believes it is not more likely than not that the US deferred tax assets will be fully realizable and continues to maintain a full valuation allowance against its net US deferred tax assets.
As of January 31, 2021, the Company had federal and California state net operating loss (“NOL”) carryforwards of $434.7 million and $229.7 million, respectively, of which $281.9 million of the federal NOL carryforwards can be carried forward indefinitely. The federal and California state net operating loss carryforwards begin to expire in 2028 and 2029, respectively. In addition, the Company had NOLs for other states of $134.7 million, which expire beginning in the year 2022.
 
F-71

As of January 31, 2021, the Company had federal and California state research credit carryforwards of $5.1 million and $8.8 million, respectively. The federal credit carryforwards will begin to expire in 2039. The California research credit carryforwards can be carried forward indefinitely. The Company had alternative refueling property tax credits that are permanently limited by Section 382.
Under Internal Revenue Code Section 382, the Company’s ability to utilize NOL carryforwards or other tax attributes such as research tax credits, in any taxable year may be limited if the Company experiences, or has experienced, an “ownership change.” A Section 382 “ownership change” generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company’s stock, increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Similar rules may apply under state tax laws. The Company performed a Section 382 analysis through January 31, 2021. The Company has experienced ownership changes in the prior periods. As a result of the ownership changes, it was estimated that approximately $53.1 million of Federal NOLs, $40.3 million of California NOLs, and $9.7 million of federal tax credits are expected to expire for income tax purposes, and such amounts are excluded from the carryforwards balance as of January 31, 2021. The Company expects to complete the Section 382 analysis during the year ending January 31, 2022. Subsequent ownership changes may affect the limitation in future years.
The following table summarizes the activity related to unrecognized tax benefits as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Unrecognized tax benefits — beginning
   $ 10,153      $ 6,884      $ 4,445  
Gross decreases — prior period tax position
     (3,620      —          —    
Gross increases — current period tax position
     2,869        3,269        2,439  
  
 
 
    
 
 
    
 
 
 
Unrecognized tax benefits — ending
  
$
9,402
 
  
$
10,153
 
  
$
6,884
 
  
 
 
    
 
 
    
 
 
 
As of January 31, 2021, the Company had unrecognized tax benefits of $9.4 million, which would not impact the effective tax rate, if recognized, due to the valuation allowance. The Company does not expect its unrecognized tax benefits will significantly change over the next twelve months.
The Company is subject to income taxes in United States federal and various state, local, and foreign jurisdictions. The tax years from 2007 to 2020 remain open to examination due to the carryover of unused net operating losses or tax credits. As of January 31, 2021, the Company is not subject to income tax examinations by any tax authority.
On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was enacted and signed into law in the United States. The CARES Act includes measures to assist companies, including temporary changes to income and
non-income-based
tax laws. The CARES Act contains several corporate income tax provisions, including making remaining alternative minimum tax (AMT) credits immediately refundable; providing a
5-year
carryback of net operating losses (NOLs) generated in tax years 2019, 2020, and 2021, and removing the 80% taxable income limitation on utilization of those NOLs if carried back to prior tax years or utilized in tax years beginning before 2022; temporarily liberalizing the interest deductibility rules under Section 163(j) of the CARES Act, by raising the adjusted taxable income limitation from 30% to 50% for tax years 2020 and 2021 and giving taxpayers the election of using 2020 adjusted taxable income for purposes of computing 2021 interest deductibility. The CARES Act did not have a material impact on the Company’s tax provision for the year ended January 31, 2021.
The Consolidated Appropriations Act, 2021, which was enacted on December 27, 2020, has expanded, extended, and clarified selected CARES Act provisions, specifically on Paycheck Protection Program (PPP) loan
 
F-72

and Employee Retention Tax Credit, 100% deductibility of business meals as well as other tax extenders. The Consolidated Appropriations Act did not have a material impact on the Company’s tax provision for the year ended January 31, 2021.
On June 29, 2020, California Assembly Bill 85 was signed into law. The legislation suspends the California net operating loss deductions for 2020, 2021, and 2022 for certain taxpayers and imposes a limitation of certain California tax credits for 2020, 2021, and 2022. The legislation disallows the use of California net operating loss deductions if the taxpayer recognizes business income and its adjusted gross income is greater than $1 million. Additionally, any business credit will only offset a maximum of $5 million of California tax. Given the Company’s loss position in the current year, the new legislation did not impact the tax provision for the year ended January 31, 2021. The Company will continue to monitor possible California net operating loss and credit limitations in future periods.
The Company intends to indefinitely reinvest the undistributed earnings of its foreign subsidiaries in those operations. Therefore, the Company has not accrued any provision for taxes associated with the repatriation of undistributed earnings from its foreign subsidiaries as of January 31, 2021. The amount of unrecognized deferred tax liability on these undistributed earnings was not material as of January 31, 2021.
 
14.
Related Party Transactions
Daimler AG and its affiliated entities (“Daimler”) is an investor in the Company and one of its employees is a member of the Company’s board of directors. The following revenue transactions took place between the Company and Daimler during the respective fiscal years:
 
    
Year ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Daimler
   $ 3,457      $ 3,112      $ 1,082  
  
 
 
    
 
 
    
 
 
 
Revenue from related parties
  
$
3,457
 
  
$
3,112
 
  
$
1,082
 
  
 
 
    
 
 
    
 
 
 
Related party accounts receivable as of January 31, 2021 and 2020 from Daimler were $1.2 million and $0.9 million, respectively.
 
15.
Geographic Information
Revenue by geographic area based on the shipping address of the customers was as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
United States
   $ 131,571      $ 130,184      $ 81,408  
Rest of World
     14,919        14,331        10,622  
  
 
 
    
 
 
    
 
 
 
Total revenue
  
$
146,490
 
  
$
144,515
 
  
$
92,030
 
  
 
 
    
 
 
    
 
 
 
Long-lived assets by geographic area were as follows:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
United States
   $ 46,759      $ 36,836  
Rest of World
     5,046        1,374  
  
 
 
    
 
 
 
Total long-lived assets
  
$
51,805
 
  
$
38,210
 
  
 
 
    
 
 
 
 
F-73

16.
Basic and Diluted Net Loss per Share
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended January 31, 2021, 2020, and 2019:
 
(in thousands, except share and per share data)   
Year Ended January 31,
 
    
2021
   
2020
   
2019
 
Numerator:
                        
Net loss attributable to common stockholders
   $ (274,200   $ (134,327   $ (108,087
Denominator:
                        
Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted
     15,116,763       8,893,787       4,342,517  
    
 
 
   
 
 
   
 
 
 
Net loss per share attributable to common stockholders, basic and diluted
  
$
(18.14
 
$
(15.10
 
$
(24.89
    
 
 
   
 
 
   
 
 
 
The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
Redeemable convertible preferred stock (on an
as-converted
basis)
     193,037,715        170,686,661        168,052,012  
Options to purchase common stock
     30,167,178        34,883,465        31,662,022  
Unvested restricted common stock
     —          166,100        564,740  
Unvested early exercised common stock options
     371,193        58,830        58,971  
Redeemable convertible preferred stock warrants
(on an as-converted
basis)
     2,358,546        2,358,546        2,358,546  
Common stock warrants
     36,402,515        14,051,462        13,173,245  
    
 
 
    
 
 
    
 
 
 
Total potentially dilutive common share equivalents
  
 
262,337,147
 
  
 
222,205,064
 
  
 
215,869,536
 
    
 
 
    
 
 
    
 
 
 
 
17.
Employee Benefit Plans
The Company has a defined-contribution plan intended to qualify under Section 401 of the Internal Revenue Code (the “401(k) Plan”). The Company contracted with a third-party provider to act as a custodian and trustee, and to process and maintain the records of participant data. Substantially all of the expenses incurred for administering the 401(k) Plan are paid by the Company. The Company has not made any matching contributions to date.
 
18.
Subsequent Events
On February 26, 2021 (the “Closing Date”), the Company consummated the Merger (the “Closing”) with Switchback Energy Acquisition Corporation (“Switchback”), where a subsidiary of Switchback merged with the Company, with the Company surviving the Merger as a wholly-owned subsidiary of Switchback. As a result of the proposed Merger, Switchback will be renamed to ChargePoint Holdings, Inc. (“New ChargePoint”).
Pursuant to the terms of the Merger Agreement, each stockholder of the Company shall receive 0.9966 shares of New ChargePoint’s common stock and the contingent right to receive certain Earnout Shares (as defined below), for each share of the Company’s common stock, par value $0.0001 per share, owned by such the Company’s stockholder that was outstanding immediately prior to the Closing (other than any shares of the
 
F-74

Company’s restricted stock). In addition, certain investors purchased an aggregate of 22,500,000 shares of New ChargePoint’s common stock (such investors, the “PIPE Investors”) concurrently with the Closing for an aggregate purchase price of $225 million.
Pursuant to a letter agreement (the “Founders Stock Letter”) entered into in connection with the execution of the Merger, immediately prior to the Closing, the initial stockholders (i) surrendered to New ChargePoint, for no consideration and as a capital contribution to New ChargePoint, 984,706 Class B common stock, par value $0.0001 per share (“Founder Shares”), held by them (on a pro rata basis), whereupon such shares were immediately canceled, and (ii) subjected 900,000 Founder Shares (including New ChargePoint’s common stock issued in exchange therefor in the Merger) held by them to potential forfeiture in accordance with the terms of the Founders Stock Letter. Upon the Closing, all outstanding Founder Shares converted into Common Stock on a
one-for-one
basis and the Founder Shares ceased to exist.
Also at the Closing, the NGP Switchback, LLC (the “Sponsor”) exercised its right to convert a portion of the working capital loans made by the Sponsor to Switchback into an additional 1,000,000 Private Warrants at a price of $1.50 per warrant in satisfaction of $1.5 million principal amount of such loans.
In addition, pursuant to the terms of the Merger Agreement, (1) warrants to purchase shares of capital stock of the Company were converted into warrants to purchase an aggregate of 38,761,031 shares of New ChargePoint’s common stock and the contingent right to receive certain Earnout Shares, (2) options to purchase shares of common stock of the Company were converted into options to purchase an aggregate of 30,135,695 shares of New ChargePoint’s common stock and, with respect to vested options, the contingent right to receive certain Earnout Shares and (3) unvested restricted shares of common stock of the Company that were outstanding pursuant to the “early exercise” of New ChargePoint options were converted into an aggregate of 345,689 restricted shares of New ChargePoint.
During the time period between the Closing Date and the five-year anniversary of the Closing Date, eligible former equity holders of the Company may receive up to 27 million additional shares of New ChargePoint’s common stock (the “Earnout Shares”) in the aggregate in three equal tranches of 9,000,000 shares if the volume-weighted average closing sale price of our Common Stock is greater than or equal to $15.00, $20.00 and $30.00 for any 10 trading days within any 20 consecutive trading day period (each a “Trigger Event”). At close of the Merger on February 26, 2021, the Company recorded a liability (“Earnout Liability”) of $828.1 million, based on the estimated fair value of the 27 million Earnout Shares with a corresponding reduction of additional
paid-in
capital in the equity section of the Company’s consolidated balance sheet. On March 19, 2021, as a result of the first two Trigger Events having been met, two of the three tranches for a total of 18 million Earnout Shares were issued with the related Earnout Liability being remeasured and partially settled by issuing the Earnout Shares at a closing market price of $27.84 per share as of that date. The remaining Earnout Liability related to the 9 million Earnout Shares of the third tranche was remeasured and reclassified to equity because the contingency of issuing a variable number of shares under the three tranches of the Earnout Liability was resolved such that the remaining third tranche provides for the issuance of a fixed number of shares of 9,000,000 if the last Earnout Triggering Event is achieved. The combined impact from the remeasurement of the Earnout Liability resulted in a $84.4 million gain recognized as change of fair value in Earnout Liability in the consolidated statement of operations and an increase in additional
paid-in
capital of $743.7 million in the equity section of the Company’s consolidated balance sheet for the period ending April 30, 2021.
On March 15, 2021, the Company repaid the entire loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million of its term loan facility (“2018 Loan”).
Events Subsequent to Original Issuance of Consolidated Financial Statements (unaudited)
On June 4, 2021, the Company issued a notice of the redemption of all of its outstanding Public Warrants
that remain outstanding on July 6, 2021 for a redemption price of $0.01 per warrant. The Private Placement
 
F-75

Warrants that are still held by the initial holders thereof or their permitted transferees are not subject to the
redemption.
On June 29, 2021 the third Earnout Triggering Event occurred and the third and final tranche of 9,000,000 Earnout Shares became issuable.
 
F-76


 
 
 
 

5,695,176 Shares
ChargePoint Holdings, Inc.
Common Stock
 
 
PROSPECTUS
 
 
The date of this prospectus is                     , 2021
 
 
 

PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 13. Other Expenses of Issuance and Distribution.
The following table sets forth the estimated expenses to be borne by the registrant in connection with the shares of Common Stock being registered hereby.
 
Estimated Amount
  
Expense
 
SEC registration fee
   $ 9,706.23  
Accounting fees and expenses
   $ 150,000  
Legal fees and expenses
   $ 100,000  
Financial printing and miscellaneous expenses
   $ 150,000  
  
 
 
 
Total
  
$
409,706.23
 
  
 
 
 
Item 14. Indemnification of Officers and Directors
The Second A&R Charter contains provisions limiting the liability of directors, and our Second A&R Bylaws provide that we will indemnify each of our directors to the fullest extent permitted under Delaware law. The Second A&R Charter and our Second A&R Bylaws also provide us with discretion to indemnify officers and employees when determined appropriate by the Board.
We entered into indemnification agreements with each of our directors and executive officers and certain other key employees. The indemnification agreements provide that we indemnify each of our directors, executive officers and such other key employees against any and all expenses incurred by that director, executive officer or other key employee because of his or her status as one of our directors, executive officers or other key employees, to the fullest extent permitted by Delaware law, the Second A&R Charter and our Second A&R Bylaws. In addition, the indemnification agreements provide that, to the fullest extent permitted by Delaware law, we will advance all expenses incurred by our directors, executive officers, and other key employees in connection with a legal proceeding involving his or her status as a director, executive officer or key employee.
Item 15. Recent Sales of Unregistered Securities.
Acquisition of has-to-be gmbh
On July 20, 2021, ChargePoint and its wholly owned subsidiary ChargePoint European Holdings B.V. (“ChargePoint Europe”) entered into a Share Purchase and Transfer Agreement (the “Share Purchase Agreement”) pursuant to which ChargePoint Europe agreed to acquire has-to-be gmbh for aggregate consideration of Euro 250.0 million payable in cash and ChargePoint common stock, subject to adjustments. On October 6, 2021, ChargePoint Europe completed its acquisition of has-to-be gmbh (the “Closing”) and paid to the former stockholders of has-to-be gmbh an aggregate of 5,695,176 shares of ChargePoint’s common stock (the “Shares”) pursuant to the terms of the Share Purchase Agreement, of which 885,692 Shares are subject to escrow to secure potential future indemnification claims. The Shares were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act because such issuance did not involve a public offering.
Subscription Agreements
In connection with the execution of the Merger Agreement, on September 23, 2020, Switchback entered into separate subscription agreements (collectively, the “Subscription Agreements”) with a number of investors (collectively, the “Subscribers”), pursuant to which the Subscribers agreed to purchase, and Switchback agreed to sell to the Subscribers, an aggregate of 22,500,000 PIPE Shares for a purchase price of $10.00 per share and an aggregate purchase price of $225 million, in a private placement (the “PIPE”). The PIPE was consummated concurrently with the closing of the Merger. The shares of Common Stock issued in the PIPE have not been registered under the Securities Act, in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.
 
II-1

Founder Shares
On May 16, 2019, the Sponsor, purchased an aggregate of 8,625,000 Founder Shares for an aggregate offering price of $25,000, or approximately $0.003 per share. Such securities were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. On July 25, 2019, the Sponsor transferred an aggregate of 80,000 Founder Shares to two of Switchback’s independent directors at their original purchase price. In September 2019, the Sponsor forfeited an aggregate of 772,059 Founder Shares. On July 31, 2020, the Sponsor transferred an aggregate of 40,000 Founder Shares to Switchback’s third independent director at their original purchase price. Prior to the closing of the Merger, the Initial Stockholders forfeited an aggregate of 984,706 Founder Shares. At the closing, each of the remaining 6,868,235 Founder Shares converted into one share of Common Stock. The issuance of Common Stock upon automatic conversion of the Founder Shares at the closing has not been registered under the Securities Act in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act.
Private Warrants
Simultaneously with the consummation of the IPO, the Sponsor purchased from Switchback an aggregate of 5,333,333 Private Warrants at a price of $1.50 per Private Warrant (for a purchase price of approximately $8.0 million). In addition, simultaneously with the closing of the sale of certain over-allotment units in connection with the IPO, Switchback consummated the sale of an additional 188,235 Private Warrants in a private placement to the Sponsor, generating gross proceeds of approximately $282,000. Each Private Warrant entitles the holder thereof to purchase one share of our Common Stock at an exercise price of $11.50 per share. The sales of the Private Warrants were made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
Working Capital Warrants
At the closing of the Merger, the Sponsor exercised its right to convert a portion of the working capital loans made by the Sponsor to ChargePoint into an additional 1,000,000 Private Warrants at a price of $1.50 per warrant in satisfaction of $1.5 million principal amount of such loans. The issuance of these Private Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
Item 16. Exhibits and Financial Statements.
 
(a)
Exhibits.
 
Exhibit No.
  
Description
    3.1    Second Amended and Restated Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to ChargePoint Holdings, Inc.’s Current Report on Form 8-K (File No. 0139004), filed with the SEC on March 1, 2021).
    3.2    Second Amended and Restated Bylaws of ChargePoint Holdings, Inc., effective as of February 26, 2021 (incorporated by reference to Exhibit 3.2 to ChargePoint Holdings, Inc.’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on March 1, 2021).
    5.1    Opinion of Weil, Gotshal & Manges LLP.
  10.1    Letter Agreement (incorporated by reference to Exhibit 10.1 to Switchback Energy Acquisition Corporation’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on July 30, 2019).
  10.2    Founders Stock Letter, Dated September 23, 2020, by and between Switchback and the Initial Stockholders (incorporated by reference to Exhibit 10.2 to Switchback Energy Acquisition Corporation’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on September 24, 2020).
 
II-2

Exhibit No.
  
Description
  10.3    Form of Subscription Agreement (incorporated by reference to Exhibit 10.3 to Switchback Energy Acquisition Corporation’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on September 24, 2020).
  10.4†+    Offer Letter between ChargePoint and Pasquale Romano, dated January 28, 2011 (incorporated by reference to Exhibit 10.14 to Switchback Energy Acquisition Corporation’s Registration Statement on Form S-4/A (File No. 333-249549), filed with the SEC on December 4, 2020).
  10.5+    Amendment to Employment Letter between ChargePoint and Pasquale Romano, dated December 21, 2012 (incorporated by reference to Exhibit 10.15 to Switchback Energy Acquisition Corporation’s Current Report on Form S-4/A (File No. 333-249549), filed with the SEC on December 4, 2020).
  10.6    Private Placement Warrants Purchase Agreement (incorporated by reference to Exhibit 10.5 to Switchback Energy Acquisition Corporation’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on July 30, 2019).
  10.7+    ChargePoint Holdings, Inc. 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to ChargePoint Holdings, Inc.’s Quarterly Report on Form 10-Q (File No. 001-39004), filed with the SEC on September 10, 2021).
  10.8+    ChargePoint Holdings, Inc. 2021 Employee Stock Purchase Plan (incorporated by reference to Annex D to Switchback Energy Acquisition Corporation’s proxy statement/prospectus/consent solicitation statement filed pursuant to Form 424(b)(3) (File No. 333-249549), filed with the SEC on January 8, 2021).
  10.9    Form of Indemnification Agreement (incorporated by reference to Exhibit 10.9 to ChargePoint Holdings, Inc.’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on March 1, 2021).
  10.10+    ChargePoint Holdings Incentive Bonus Plan (incorporated by reference to Exhibit 10.10 to ChargePoint Holdings, Inc.’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on March 1, 2021).
  10.11+    ChargePoint Holdings, Inc. Compensation Program for Non-Employee Directors (incorporated by reference to Exhibit 10.11 to ChargePoint Holdings, Inc.’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on March 1, 2021).
  10.12    Form of Lock-up Agreement (incorporated by reference to Exhibit 10.1 to Switchback Energy Acquisition Corporation’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on September 24, 2020).
  10.13    Amended and Restated Registration Rights Agreement, dated February 26, 2021, by and among ChargePoint, and certain stockholders and equityholders of Chargepoint (incorporated by reference to Exhibit 10.13 to ChargePoint Holdings, Inc.’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on March 1, 2021).
  10.14†+    Employment Agreement between ChargePoint Europe Holdings B.V. and Christopher Burghardt, dated November 6, 2017 (incorporated by reference to Exhibit 10.14 to ChargePoint Holdings, Inc.’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on March 1, 2021).
  10.15†+    Offer Letter between ChargePoint and Michael Hughes, dated May 21, 2018 (incorporated by reference to Exhibit 10.15 to ChargePoint Holdings, Inc.’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on March 1, 2021).
  10.16+    ChargePoint, Inc. 2017 Stock Plan, as amended (incorporated by reference to Exhibit 10.18 to Switchback Energy Acquisition Corporation’s Registration Statement on Form S-4/A (File No. 333249549), filed with the SEC on December 4, 2020).
 
II-3

Exhibit No.
  
Description
  10.17+    Coulomb Technologies, Inc. 2007 Stock Incentive Plan, as amended (incorporated by reference to Exhibit 10.19 to Switchback Energy Acquisition Corporation’s Registration Statement on Form S4/A (File No. 333-249549), filed with the SEC on December 4, 2020).
  10.18+    Form of Change in Control Vesting Acceleration Agreement for ChargePoint (Europe) (incorporated by reference to Exhibit 10.18 to ChargePoint’s Post-Effective Amendment No. 2 to the Registration Statement on Form S-1 (File no. 333-253759), filed with the SEC on May 28, 2021).
  10.19+    Form of Severance and Change in Control Agreement for ChargePoint (US) (incorporated by reference to Exhibit 10.19 to ChargePoint’s Post-Effective Amendment No. 2 to the Registration Statement on Form S-1 (File no. 333-253759), filed with the SEC on May 28, 2021).
  10.20+    Form of Severance and Change in Control Agreement for ChargePoint Europe Holdings B.V. (Europe) (incorporated by reference to Exhibit 10.20 to ChargePoint’s Post-Effective Amendment No. 2 to the Registration Statement on Form S-1 (File no. 333-253759), filed with the SEC on May 28, 2021).
  16.1    Letter from WithumSmith+Brown, PC to the U.S. Securities and Exchange Commission dated February 26, 2021 (incorporated by reference to Exhibit 16.1 to ChargePoint Holdings, Inc.’s Current Report on Form 8-K (File No. 001-39004), filed with the SEC on March 1, 2021).
  23.1    Consent of PricewaterhouseCoopers LLP.
101.INS   
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because iXBRL tags are embedded within the Inline XBRL document).
101.SCH    Inline XBRL Taxonomy Extension Schema Document
101.CAL    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB    Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104    The Cover Page Interactive Data File, formatted in Inline XBRL (included within the Exhibit 101 attachments).
 
The schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation
S-K.
A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.
+
Denotes management compensatory plan, contract or arrangement.
 
(b)
Financial Statements
.
The financial statements filed as part of this registration statement are listed in the index to the financial statements immediately preceding such financial statements, which index to the financial statements is incorporated herein by reference.
Item 17. Undertakings.
(a)
Rule 415 Offering
The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(i) to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
(ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the
 
II-4

estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and
(iii) to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;
provided, however
, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the registration statement is on Form
S-3
and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.
(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:
(i) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and
(ii) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which the prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof;
Provided, however
, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.
(5) That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;
 
II-5

(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
(b)
Filings Incorporating Subsequent Exchange Act Documents by Reference
The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934, as amended), that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c) SEC Position on Indemnification for Securities Act Liabilities
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described in Item 15 above, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933, and will be governed by the final adjudication of such issue.
 
II-6

SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Campbell, State of California, on October 14, 2021.
 
CHARGEPOINT HOLDINGS, INC.
By:   /s/ Rex Jackson
 
Rex Jackson
Chief Financial Officer
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS that each person whose signature appears below constitutes and appoints Pasquale Romano and Rex Jackson and each of them, his or her true and lawful
attorneys-in-fact
and agents, each with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments, including post- effective amendments, to this registration statement, and any registration statement relating to the offering covered by this registration statement and filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said
attorneys-in
fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each of said
attorneys-in-fact
and agents or their substitute or substitutes may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons on behalf of the registrant and in the capacities indicated on October 14, 2021.
 
Signature
  
Title
/s/    Rex Jackson        
Rex Jackson
  
Chief Financial Officer
(Principal Financial Officer)
/s/    Henrik Gerdes        
Henrik Gerdes
  
Chief Accounting Officer
(Principal Accounting Officer)
/s/    Pasquale Romano        
Pasquale Romano
  
Chief Executive Officer and Director
(Principal Executive Officer)
/s/    Roxanne Bowman        
Roxanne Bowman
  
Director
/s/    Bruce Chizen        
Bruce Chizen
  
Director
/s/    Axel Harries        
Axel Harries
  
Director
 
II-7

Signature
  
Title
/s/    Jeffrey Harris         
Jeffrey Harris
  
Director
/s/    Susan Heystee        
Susan Heystee
  
Director
/s/    Mark Leschly        
Mark Leschly
  
Director
/s/    Michael Linse         
Michael Linse
  
Director
/s/    G. Richard Wagoner, Jr.         
G. Richard Wagoner, Jr.
  
Director
 
II-8
EX-5.1 2 d233594dex51.htm EX-5.1 EX-5.1

Exhibit 5.1

 

LOGO

 

   767 Fifth Avenue
New York, NY 10153-0119
+1 212 310 8000 tel
+1 212 310 8007 fax

October 14, 2021

ChargePoint Holdings, Inc.

240 East Hacienda Avenue

Campbell, California 95008

Ladies and Gentlemen:

We have acted as counsel to ChargePoint Holdings, Inc. (the “Company”) in connection with the preparation and filing with the Securities and Exchange Commission of the Company’s Registration Statement on Form S-1 (as amended, the “Registration Statement”), pursuant to the Securities Act of 1933, as amended (the “Securities Act”), relating to the registration by the Company of the number of shares of the Company’s common stock, par value $0.0001 per share of the Company (the “Registered Shares”), for resale by the selling stockholders as defined and listed in the Registration Statement under “Selling Securityholders” (the “Selling Securityholders”). The Registered Shares may be sold by the Selling Securityholders, as set forth in the Registration Statement.

In so acting, we have examined originals or copies (certified or otherwise identified to our satisfaction) of (i) the Registration Statement and (ii) the preliminary prospectus included therein. We also have examined such corporate records, agreements, documents and other instruments, and such certificates or comparable documents of public officials and representatives of the Company, and have made such inquiries of such officers and representatives, as we have deemed relevant and necessary as a basis for the opinions hereinafter set forth.

In such examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed or photostatic copies, and the authenticity of the originals of such latter documents. As to all questions of fact material to these opinions that have not been independently established, we have relied upon certificates or comparable documents of officers and representatives of the Company.

Based on the foregoing, and subject to the qualifications stated herein, we are of the opinion that the Registered Shares are validly issued, fully paid and nonassessable.

The opinions expressed herein are limited to the laws of the State of Delaware and we express no opinion as to the effect on the matters covered by this letter of the laws of any other jurisdiction.


October 14, 2021

Page 2

 

We hereby consent to the filing of this letter as an exhibit to the Registration Statement and to the reference to our firm under the caption “Legal Matters” in the prospectus which is a part of the Registration Statement. In giving such consent we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Securities and Exchange Commission promulgated thereunder.

Very truly yours,

/s/ Weil, Gotshal & Manges LLP

EX-23.1 3 d233594dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1 of ChargePoint Holdings, Inc. of our report dated March 31, 2021, except for the effects of the reverse recapitalization described in Note 1 to the consolidated financial statements, as to which the date is July 2, 2021, relating to the financial statements of ChargePoint, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

San Jose, California

October 14, 2021

EX-101.SCH 4 chpt-20210731.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Description of Business and Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Reverse Recapitalization link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Acquisitions link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Composition of Certain Financial Statement Items link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Leases link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Redeemable Convertible Preferred Stock link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Common Stock link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Stock Warrants and Earnouts link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Equity Plans and Stock-based Compensation link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Geographic Information link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Basic and Diluted Net Loss Per Share link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Employee Benefit Plans link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Acquisitions and Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Reverse Recapitalization (Tables) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Composition of Certain Financial Statement Items (Tables) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Leases (Tables) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Redeemable Convertible Preferred Stock (Tables) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Income Taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Common Stock (Tables) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Stock Warrants and Earnouts (Tables) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Equity Plans and Stock-based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 1042 - Disclosure - Geographic Information (Tables) link:presentationLink link:definitionLink link:calculationLink 1043 - Disclosure - Basic and Diluted Net Loss Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 1044 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1045 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 1046 - Disclosure - Summary of Significant Accounting Policies - Schedule of Reconciliation of Cash, Cash Equivalents, And Restricted Cash (Detail) link:presentationLink link:definitionLink link:calculationLink 1047 - Disclosure - Summary of Significant Accounting Policies - Schedule of Allowance for Doubtful Accounts (Detail) link:presentationLink link:definitionLink link:calculationLink 1048 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives (Detail) link:presentationLink link:definitionLink link:calculationLink 1049 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Contract Acquisition Costs (Detail) link:presentationLink link:definitionLink link:calculationLink 1050 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Acquisition Costs (Detail) link:presentationLink link:definitionLink link:calculationLink 1051 - Disclosure - Reverse Recapitalization - Summary of Number of Shares of Common Stock Issued Immediately Following the Consummation of the Business Combination (Details) link:presentationLink link:definitionLink link:calculationLink 1052 - Disclosure - Reverse Recapitalization - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1053 - Disclosure - Fair Value Measurements - Summary of Company's Assets and Liabilities that were Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:definitionLink link:calculationLink 1054 - Disclosure - Fair Value Measurements - Summary of Changes in the Fair Value of Level 3 Financial Statements (Details) link:presentationLink link:definitionLink link:calculationLink 1055 - Disclosure - Fair Value Measurements - Assets and liabilities measured at fair value on recurring basis (Detail) link:presentationLink link:definitionLink link:calculationLink 1056 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1057 - Disclosure - Acquisitions - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1058 - Disclosure - Composition of Certain Financial Statement Items - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1059 - Disclosure - Composition of Certain Financial Statement Items - Summary of Inventories (Detail) link:presentationLink link:definitionLink link:calculationLink 1060 - Disclosure - Composition of Certain Financial Statement Items - Summary of Property Plant and Equipment Net (Detail) link:presentationLink link:definitionLink link:calculationLink 1061 - Disclosure - Composition of Certain Financial Statement Items - Summary of Accrued and Other Current Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1062 - Disclosure - Composition of Certain Financial Statement Items - Summary Of Revenue (Detail) link:presentationLink link:definitionLink link:calculationLink 1063 - Disclosure - Leases - Schedule of Lease Balances (Detail) link:presentationLink link:definitionLink link:calculationLink 1064 - Disclosure - Leases - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1065 - Disclosure - Leases - Maturities of Operating Leases (Detail) link:presentationLink link:definitionLink link:calculationLink 1066 - Disclosure - Leases - Schedule of Other Supplemental Information of Lease Term and Discount Rate (Detail) link:presentationLink link:definitionLink link:calculationLink 1067 - Disclosure - Leases - Summary of Other Lease Supplemental Cash Flow Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1068 - Disclosure - Debt - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1069 - Disclosure - Debt - Summary of Future Principal Payments (Detail) link:presentationLink link:definitionLink link:calculationLink 1070 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1071 - Disclosure - Commitments and Contingencies - Summary of Future Payments Under the Non-Cancellable&#160;Operating Lease (Details) link:presentationLink link:definitionLink link:calculationLink 1072 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1073 - Disclosure - Redeemable Convertible Preferred Stock - Schedule Of Redeemable Convertible Preferred Stock (Detail) link:presentationLink link:definitionLink link:calculationLink 1074 - Disclosure - Common Stock - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1075 - Disclosure - Common Stock - Summary Of Common Stock Capital Shares Reserved For Future Issuance (Detail) link:presentationLink link:definitionLink link:calculationLink 1076 - Disclosure - Stock Warrants and Earnouts - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1077 - Disclosure - Stock Warrants and Earnouts - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail) link:presentationLink link:definitionLink link:calculationLink 1078 - Disclosure - Stock Warrants and Earnouts - Summary of Assumed Public Warrants (Detail) link:presentationLink link:definitionLink link:calculationLink 1079 - Disclosure - Stock Warrants and Earnouts - Summary of Assumed Public Warrants (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1080 - Disclosure - Stock Warrants and Earnouts - Summary of Fair Value Private Placement Warrants Basis Valuation Techniques (Detail) link:presentationLink link:definitionLink link:calculationLink 1081 - Disclosure - Stock Warrants and Earnouts - Summary of Fair Value Earnout Liability Basis Valuation Techniques (Detail) link:presentationLink link:definitionLink link:calculationLink 1082 - Disclosure - Stock Warrants and Earnouts - Schedule of Warrants Issued and Outstanding (Detail) link:presentationLink link:definitionLink link:calculationLink 1083 - Disclosure - Stock Warrants and Earnouts - Schedule of Outstanding Redeemable Convertible Preferred Stock Warrants (Detail) link:presentationLink link:definitionLink link:calculationLink 1084 - Disclosure - Stock Warrants and Earnouts - Schedule of Liability of Warrants Subject to Re Measurement (Detail) link:presentationLink link:definitionLink link:calculationLink 1085 - Disclosure - Equity Plans and Stock-based Compensation - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1086 - Disclosure - Equity Plans and Stock-based Compensation - Summary of stock option awards (Detail) link:presentationLink link:definitionLink link:calculationLink 1087 - Disclosure - Equity Plans and Stock-based Compensation - Summary of RSU activity (Detail) link:presentationLink link:definitionLink link:calculationLink 1088 - Disclosure - Equity Plans and Stock-based Compensation - Summary of Stock Based Compensation Expense (Detail) link:presentationLink link:definitionLink link:calculationLink 1089 - Disclosure - Equity Plan and Stock-based Compensation - Summary of Weighted-average Assumptions Used to Determine the Fair Value of Stock Options Granted (Detail) link:presentationLink link:definitionLink link:calculationLink 1090 - Disclosure - Income Taxes - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1091 - Disclosure - Income Taxes (Details) - Schedule of income tax provision link:presentationLink link:definitionLink link:calculationLink 1092 - Disclosure - Income Taxes (Details) - Schedule of net deferred tax assets link:presentationLink link:definitionLink link:calculationLink 1093 - Disclosure - Income Taxes - Schedule of Net Loss Before Income Taxes (Detail) link:presentationLink link:definitionLink link:calculationLink 1094 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Detail) link:presentationLink link:definitionLink link:calculationLink 1095 - Disclosure - Income Taxes (Details) - Schedule of reconciliation of the statutory federal income tax rate to the Company's effective tax rate link:presentationLink link:definitionLink link:calculationLink 1096 - Disclosure - Related Party Transactions - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1097 - Disclosure - Related Party Transactions - Summary of Revenue Transactions (Detail) link:presentationLink link:definitionLink link:calculationLink 1098 - Disclosure - Geographic Information - Summary of Revenue and Long-Lived Assets by Geographic Area (Detail) link:presentationLink link:definitionLink link:calculationLink 1099 - Disclosure - Basic and Diluted Net Loss Per Share - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1100 - Disclosure - Basic and Diluted Net Loss Per Share - Summary of Computation of Basic and Diluted Net Loss Per Share (Detail) link:presentationLink link:definitionLink link:calculationLink 1101 - Disclosure - Basic and Diluted Net Loss Per Share - Summary of Computation of Diluted Net Loss Per Share (Detail) link:presentationLink link:definitionLink link:calculationLink 1102 - Disclosure - Acquisitions and Subsequent Events - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 5 chpt-20210731_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 6 chpt-20210731_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 7 chpt-20210731_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 8 chpt-20210731_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 9 g233594g01c36.jpg GRAPHIC begin 644 g233594g01c36.jpg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end GRAPHIC 11 g233594g03c36.jpg GRAPHIC begin 644 g233594g03c36.jpg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end GRAPHIC 12 g233594g04c36.jpg GRAPHIC begin 644 g233594g04c36.jpg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ⅅ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end GRAPHIC 14 g233594g06c36.jpg GRAPHIC begin 644 g233594g06c36.jpg M_]C_X 02D9)1@ ! 0(!>0%Y #_[1_F4&AO=&]S:&]P(#,N, X0DE-! 0 M '\J^@3@X0DE-! 0 \< 5H QLE1QP" " .$))300E M 0S<_Z?:C'O@D%<':NKP7#3CA"24T$.@ Y0 ! ! + M<')I;G1/=71P=70 % %!S=%-B;V]L 0 !);G1E96YU;0 !) M;G1E $-L#A"24T$&0 ! !XX0DE- _, D $ .$))32<0 M * $ 3A"24T#]0 2 O9F8 0!L9F8 !@ M 0 O9F8 0"AF9H !@ 0 R 0!: !@ 0 U 0 M M !@ 3A"24T#^ < ____________________________ M_P/H /____________________________\#Z #_____________ M________________ ^@ _____________________________P/H X M0DE-! @ ! ! "0 D .$))300> $ #A" M24T$&@ #-0 8 BH -S $ M 0 #

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end GRAPHIC 15 g233594g08c36.jpg GRAPHIC begin 644 g233594g08c36.jpg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end GRAPHIC 16 g233594g14e53.jpg GRAPHIC begin 644 g233594g14e53.jpg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g233594g52c41.jpg GRAPHIC begin 644 g233594g52c41.jpg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�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g233594g69k42.jpg GRAPHIC begin 644 g233594g69k42.jpg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end GRAPHIC 19 g233594g70a70.jpg GRAPHIC begin 644 g233594g70a70.jpg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

IKZA9=S-+4U,R[I S'/\ ;CX#?A0-H Q@ M$@YU.'&2 ZFKW]=KDJ0?4&<9V?\ $7EY;*0"A: ];%:Z#"!4U+5-44I(RP8Q MK3XD)G#R85%@506_N,"^W:2-P ^,3.317F&JAHD02!H!L";%S/MBCG-- DW].K6/>*>VZT[D)/I+06R.HCCJ8VBK]01F52L=OAF5=L,D M>X&HG"8)R1Q@Z63DBHTTD'E)#:VE1!N"9+5KX$JS>2H U.HD,%0P;C57)*'< MP.A/MCVJ[>]G]-T^ENWNF*#3]KIE1'6&%165CQH,UE?61$R5LL[YD8S2NL;$ M)#'$@*]:E&1E98=/,"-^H70$D6FVZ>,_B%4146V6+C50HO!B+,1B09)-Y 8_ M<3P<*,XQ@84 ';\''CSG/5M0%1!N0'#$$Z:^XM@2NLQ: 0.A89V=OV ,;T$, MD@"Y5< 8+ # !_P3P ,@'S@YXZ;X=!C65)+]8U_4@2\5\Y=UT5A.DW3OT>@4 MXI/IT]MD5$!.YU(S^2P.<')Y(' 'DGHBH98#8L"KI(3&UYUV.*Z,YD@Z'JYA M.8?06=E@?^['J M&AHY;/:9*>X:D:)R((Y$=:9FRJ-,P)7/(.PX(.,8QUG<1 MQ5>33S97(:B>4BH @4EGI9=N^-+ALG*SZ^6L5"D"JJ#4R6(,=Y^\G%?5XU/> M]772HNM_K)JZIF,:ID9G5FR5 )SD@8R<_.<$X///YZ$.72 MR74]3%P0-!0*,J HP%X)( _=SC . M!_C/^3+D%(1,*>NRW@)%*]HPJ9K'S+F!30"6EK@,7D[X6H9=X &6.W/)VC)& M>0./P..#\_GI?"I&X$V-I ?W+T0VP5# W9+W&V\?KC.",Y (!QX'!\\ M_P"#TA62-+R(O:X&R5Q_*0L)_N.GJ>BWF<; =&7(RI/Y^3R<#D8SS_\ +SX8 MUD(PK& Q>Z@V]%#T=W=M#["7;4@C^QQJLY&65N"3CP/C))\^00,^,GJR M2&6 %]&#-^\L2#A'^XO!]ON)%QA@7)P"7DXW?P=IS_L?'&#X_/GI$ 9)K+?- M4W-M;B1J8P#FT.LF64(LV=^Q=^UE#&N=6QV>B--1@3UU5.M-3P)NDJ3+*"4, M<,0:28^#M0!@< 9('4,BFO.J (8) @)]@UJ]$]\.1E@5-FH"2U8"(#V8=MI. M!$]5_=Z'T=]M4J3415/J6[I6V[2Z/N,++)J2N]X,\&J:^*22&@I7 MB=J>&I^I+"2(#KHN%X.B@TL520#,+V[DBT!1C(XZJCE)IJ/,'UTZ]8[DG3'/ M/35KW.IDN=155-367">26LJZA/51E4T_#YA54/-919(4LLF'ZV?,3754:B208;(B-=]1JR;EX7+YIN^:)N M5TM^J;-<+#=%@H*J2VW.FDI*Q*6OIH:ZAG]J<*XBJ(9TEC<#:ZMEUWG@EE@,,,U-J^C$MQ::*3,T531((8T$ M31S>9,@$'0*-(&K8(9ND\6U9U(H)J*K%@&B%J-3)]),]/'")!)(X+Y)^T4UY MN;ED@"BRFDE!6NPHZ?;%O"UY.9\Y(6Q#)!G0Q%@66-,&MV8_2&TUZ:]5G6%Y MU=2:Q;55XTGHK0-!76LPUEGGU#J!TO=UJI%>2)98],07):)H3E5+3N5*@=!_ M$K>EQUF0!?1:FR1B-*JCAC_6C<\VXVY=(#4@:G'1/0104%)!24[!8J>&*G2) M5"JJ4V^FC15R0%18CPJC(D#'+'/5E%9D5 (62T2-[])TOI1F964@X5*UVMM25@=9(/K6ID&%V[8B=S)@'[ < M@<#C)^.N&\:S*//33%! 9N5S W@W6AMW7I'@N2T31@*L\513D?&6C+#'/YQC/X.!^,GPRK+^-/-!I_FBZVD]=E-L%>* M5$9%1.@(5]T@PKV%P -#@VZ9E:+<7V%8XV()1-,]B M!>>W_:6ZQ/J6 U%#5ZKHO:K)TE@C9WI+!!NE0R1/CZRY5"+34^&5!(RYZ)HR M,ZI'+#%Q TW\T$^@:TN]/%9=$5BBW27T L"&9@>N.57NQZQ^]G>*]5=RGU!> MJ:2H9Y*FZ7&X5-VN+2R* VV2H>:.-<9VK!#&XYPP''6K1X;PU!! KM+JOT(3 M]S%M\957%YI_IDV Z]]']SJ<#3=JF_WV56O.J[G6AF]R9ZN>KVEFW*5(,B(% M^[A=H!P>.,=&9>51E$F@20020#<@FXO G ]>8:P!4D""$!H(M*#]R[8UJ*"A MMDJ/&4K98V(=IANBR?V[$.6*XY)W'GDGQF9 JN >B"';"IS*Z".4ERE54 M& MK?WM!*5)[I45C2.0K;%V.A*^VJ@8 52"5&W&/\?CJ=-7+3RBF@"WRC=XO_.Y M_P /EYA52.M1-V7(D6TNTT,-ER2'&3X8#G.//(_QXY_'^_3,I D";%7O[ZX& MJJ-;)8*+4&6=+&0B)$:O&G[&_"[G;)/EN,8/\''XSCY^!XAR]:ODFBC0(Q=B""?!&?/X_CI\(TLM_2W;]P<934@Q;0C9)PN#^2 M..#X(QC_ &/.>EA+M"DW@LOU^Y/?U"Y7;EPIR"%P=V<#DD'/D8&/'^PQ"L, M;U 'L6\64%&J(%)+ZOT'4R^AP2?I=N53!ZA^QS451+3U*]TM#,D\;^V(Q%J6 MVRDM+N!4,5".%8%XV="P#$=-7133E\P; )DQ!]-/3U&'R\RJJOE-FC"@@M-H MG>?3'93^HK^E]VH]6EEKM4Z?HK=H7O)1+5)0ZSM-%'317F*(O+'0:HCB"_54 M\[!4BK*56JD3:'E)7;UCGBLX5(<@$!\I@;WL)A:=\&U\-0N8FK4,]D[B:.JHJ!:EUH]26J.HK;-<8F<^W-!5&+>OMKB6H6,"5T&BI#Y24&&7KIZ&PCS$# ZW'3&H['3 MK7U5OJHJ1XE85D1:2'8_RLT1PIY^Y7"L,?YZ-I%!W_4QH?K![PL,LR20$83& MO1_7WMC1I-0W*@"!*AIXF (6H4!EJ8B*69"FGAF"@B-MQP>./+6P:85SJ3J72W _O9=*.)JH:,AP&)>J]=;&.M6O?W]++3 M-WAN&H.P=7#IVY>VTM/HZ]5=1+9)#AI)(Z6Z5"3W"GR4VQK<*VI4.P4*5P5% MXC@LO/RP*0&*N8F&A20Y3"0T[.<64^*9F65*L9J-@"1L9W>MB1BI6'TE>HV? MN1'VUK^W]]AU(U0RHL\7_NH4BL,5D5T0"W/2E,E9(GC<[2&4L#G*S?#S0Q2S M9K7L!K-M8P;E^)FL.H_^KFU)3!1&Y<3)U%VGIB_3J[8]IZ6BU#W'MU#KS7;K M!4F*K6I>Q6:I)]TP0TS/]/55%/E5-08]RR>XBL0 3=D<.::*!4*B0[B\L2HO M);"TG$Z\_G!KI@%P#* () B\,*T:/%EU.8H88XHTCABAB6&&*-55(HTX6.-1 M@*H .T* !\'GK4RQ32K. @>W0(D)J\Q?&=774RF=66^Z28A_\K.)F/ RQ& / MDC)SC!/'_P!?\ =$DVA'N0@H1L+_ /#P+F9DED[$I@])L'T_RHT\,9PTA+$> M!^[ /P/'D\$^/XR.9!#J]A(WD$ESOZ@8&HS.9@U2(_Q*G1;;VQEN%SMMHI9J MVX3Q4=OIXVEGFFPA4+CA2^-N3\'AN<#G'3$@ EJ$ VM(M= LW" Q.3"([='K MZ3J'I@$.\/J1KKO-5Z=[>U3T=(K>Q47J !II-H^^*F]PAE]P'82" 3GG&3UD M9O$U>8/6H(& 8:.M]0KN<:>5X:$R!Y@"R:66 X@J]BQZX$PM5U?<6:9R06:@CFU5W[W(" Y1<2@[^^VAE<+3E><71$ M*7),?-!T M-WUW)WCKIOGCJ'!1)MH5ASL/"Y) ;(/!8\_D9SYZB0!9@NVX*) &H#^[PX,A MK[:J2B7#=]CA63;E2N/](R"%)'QSDXX_QCGC Z5@T9 DJ"]8&J.KPX)-5)T% M07N/0%#H,;45:8F +,WD<$XXQX(.?X\DD>3TFK^IU!)9T1,. $0KX+YP$R#- MQ<=M2MXZ2\*<=1[H#;N?W8W8/^" ?C')!SQC)' AF#Y1" )(#+,).%JBW$;H MD%^:\01'^=Y_N-V(J5R3GGG+ ^/'GR#G'SCC XSU4 =08OH!,Q8B!I,S;"&S M$"-]+DVG1;8R$L<>>#D?D>/R>#YY!'C^1TIN"R8/^+2).D2=\*\D!BR).Q$C MOJ.ML>Q]S8(SQGD@YQC@9R#S_M@?SU/+)YAK)OL@-+E0W&M\(-S* 8GZ'76] MG!OC5K4_M%2 "RL-N/)\$'(/)&?&1@=7>4.4$I( .LI$&-W>[Q*N%HR1 MHPQ,P!Z-63P/W<'5=/9H'I8Y2U<04IXD&^26H=@D5-#$A_OS2,1A&0A2,X'4 M:BZ>6D@R;5-F58^NXU;&!,V :^:GE!@$2M2"U(L".V^&3W&U'IGT;]FIO47W MII*2[=S-1(\'9?M]73++6+>K@ADIKA74*CV$6BAC>MNDU3')_246F2G/OU,B M';\*X45&DFD,$7IWJ *>DBYF]A.)G\4*#4#S5$LOG2)9 2-D;&_<8YA>['=C M6_>S6U^[C=R;Y4Z@U7J6L^IK:F8JZ4T;"=OI:>.,K!14MO44U#200(J2PLTK M(&ZZ@!T ["-F8WQE9N=56"2VB]7WFVMH*V>&':6I*2Z6^ODI$KHZ& MX4==-02R&*"O2EJH*AZ6< [2E0L!A>4Y9(Y'5?MD8%Z2:C\I01U+!!%_UP#R MD5$@?,60/6!*";, I O22?4SWZEUH:>S2ZA_I%/26*W-FCLMIL MEGH+/;[?!(,&=((Z(R+*V6 E$>,(.I$&PI.X@H2[I-S:\K#C2#_=Z1[&?T)' MJC-T23_XZ6JAID*2B1Y()IZB7@_13TJE%7/W(S@9*E,C )!S@AE)'2%/- 3)T$SIU MF\2+C7$:R$1Z+:7W&_\ S*YV^O%:VIDEDHHX(9Z2:*80PNBG*;X"V-RDH&(7 M W+X&/'4S2KJQ0 ;#;8GUW5H>":H#(@B#2;E7D/N)89&CUQ>ZK4N MH=1U^E-%Z;J:?^HW"S5$D5^NUP<&2DM-L,3H\$[,1(:Q&5H.KN"3N(YJ>KJ%%N$R4J23/(J^XS%L6-'ZG?TW^EEC M5'"F9&TFE]=?1]3Z'OZ9_P!3;2G=/4L&A]?VIM*:GKJIDI4=X(HY5GVA&B( M4J9,EF7G &X9'5F6SS:ZG_C]G])T9 H,L@H%$SI)"-D2+">@Q:\E2CHK1RJT M*EM$-PJYIEA9W"A$_8Q]S< &-\-\)SAG.K)S*0Z4300&) MV0"V73&7XIGY)R"\W++$CGI-Q*19OW>!W_4$_5X[.1]C6TKZ5NZ5!J[7>M4K M*6:OME)<*>HT[8I(2LGU NU!12TU75LS1*(F=D #E\,%Z]#X?PP54TUU'E( M0*>^B,6D:GKCS/B>,IRLTY8 JYIY@"I8;'ETU&SQR(7^YU.KJZOO>H+W->[Y M52M+5^]([Q98-N*^Z2GN*"5 M;F%+T)'ZD39F/IAN0UR4M#[%,H"2\2<[2QQR2ODM_D9XSG\6X%4D%EN9ASJP MH'V6^C%,%WJW)DY;.#E>."3G(!VDY& 0 ?CI81[182I%H8ZOT(Z9#,C2 8&< M8P<$8QQX^,$\<#&/XZ6&L!MX85WZN4)\.08@?DXR/]U^,_'.1_!!\=+#EH] $=3)0M?W MDL8UV?V\,"3[Z%LPC&/;3P#!<9+ ^%Y_D MDD$Y.?&1Y/'(Z6)@:))&9W&A%D$3]QC7DGIBN8MP?.2I!(_C P ,_/@//2PB&1T[>NFN,"L=^YCS M@Q7MA_\ ;>\/8M?Z*O<=6E(]HU7IZY1U M,DKQ1P-0W2GJ@[O$V\)B/#8P"?/P>EG?[14E&.K!'WG"RS_%#LP=1HID3 (O MJ-\=X/;/]1'1NJK91Q:HM-'6TYIUI3.0_=)DC M@CKGLVD@U.F5=?>!U3B+)XWZ?A\@==(A@&H"?>[[+?$S774?II[]6J335SJM M.W6.N0^Y8M2TOT%0=\8C8&.JC> D@E,P2+(!^PJ0O0)S?H[:6U;8;I>^PACTG62TM75RVF M*OJ_Z!6S2;FC4;Y'IXDD.%+QQ;U)&T@G/6GE\1F @U/_ ,BP 7$%$C4)CJ,- M\,"0-W$J#=ML7CJ3CEX[P^GKNUV)U-6:6[@Z%O=BKJ2615KI*&62VUL"A DU M#61"2FDA'N!@VY9#O^\<#&GP^>*Q5SU (4W(%S4S*Z0HAWP+Q&6N3E!+-5@= M.6$-IF'KB*?^G[Q/2&N_HMSDID MC_R']\#V/Z<6D^X.E];T255CN5)+,3MEHWF5*F+;P089 M=DF2?!VY/^GY YW,RC( 5NRB0TSTU;>-5N"$=8(%I6EUJO<8?4;;3AOMQ@$- MQC\9SXR,D9QQG@@9Z#IHY35,D&!U(C[6TZE8R3Q?1F"BFD"42.J)-@. MX?3J0,:\"/42,D6-P'^M2%!\#]V,\G'QCR20,]!4@U9U*TK%H U-K.2OH,6' M,II$LG3K=,D#_")-\;-%60)42T593RT%:N[F8@TU4J@;6@JEW4TA*CB;ONQH28<#%>5PA%15*9!# M3:1B.^MR=U6CW4[WZD[E5\RI/)0Z9,Q-/;%D9*BICVI[=15;/M,;D>XL);>( MV4% V1UG9W%T@LU!R4R( :#D!#<, PR -'*X4@6)V@=M+@%H$Q(;&(;BD&]W M') . . ,<#D@' .<>3XY^>LHEU&H%-[ZWL][V?98VA2!32P20/V288"@ [!H M@XWXZZ1!G&XC[2,XQSG))QDD\?SSGG/3\Q2(!@(;PS:$)*$P)$IN42H6DH:" M^\=!).,@JPQW*,$D9XSDX&/CG R/_KU+F T1O,7,S^MNV& 8=YT]-U,K6=V" M,L564+L6R#C"88GC Y^T*>D=,);"VHL02A;VCV M8.%2"H8J'>0[3@[2"""? (QQY(QR,<_/2( I('[ZE;;F+/"!LV@C+_:(Z'IC M8:JV+G*G&>%Y.#D_Y^/'^,\XZ9 W1)LW2"H96I)]7"PF0A"OO>5?Z>MT<>TN M30LAY ;.#R_C .0H; ;< /Y_GPA2K'5AC?JP6$R([:8?F0$+:=KQ-[!ZR\*\ M%QDD0$9.2?G! R>>,^? Z8@M&2;?5C>((3VU.)T$B!J[CU + M<=-5 J Q.XX^&)R0!@C'QCC_ .N,"DIVU*/T*&A9T :;-L$@L"R(#=A[VU;] M3 QN;@?#8.&?)! ./N)&<#C\=2RXJ# %_K;76VX5\/S M^RQ$?<77-%8J&0"J,5,V4K5$LN7/2[Z=JV^5]#WB[H4&V9L5FC=-5@) M%+[HS#?;A3R*\;5:Q[5IX9\#8QE9 P3J_@N$-,J03;4&20.HZC7K@*O.='*^ MPV$W(#/]))%T+8KW_5I]#/J4]0G<&U]S.WE,VJM-:8L!LU-I6CKJCWJ.9I14 MSW"W4>&IA/5$"";?[3RF(;@ XQUW""JBFD;!A2"!UN$/0L],8W$99JJ-01U( M@)61*)^KN=<MNW&O>VMTJ;-K_ $=?M)7&FF>F:*^6VIH0\T;?>\<\L8@E MW!6 ]N5@Q(53G@FG- !)L!<;IB;!A3J4+E8'&262+WLN@OH;OUD8:441/&.KLG.7,H8&K*9T]P_3$:A52F+]>U^LB\IK8 M_F(6!MQ*YW !U(/'VG QG 8'GQ^/C%IX@7,!V1E2T0]OW>(EC8C]ZZ@CHM\1 MK?H'EF'L*%;=EFW2@^0"< $'./ _/&.IBOD(J$ $DA:D$= M81B;B1OG]=!?]WZNT29Q.FD;?'"5>.-%>- N5P"Q;(QG(&1\\'_(\=6#.)N! MO8KH-3UW!T6+3'L3^Q@UNQ5!=+UH&_P!+IVEJI+K8 M:Y+K5P4\K2+<*2H?8KQPQL2:BF.59%7W?D+@Y(7B/&C+Y:6&4'] +:7()E>V MIX7E,$FZJ&^ZT.IW.Q@XG71BU,PGCGIE;:P%0*YG^KC"C<2E-,1.@!P6W1C[ M0>"#R \M \VP 7\S,W<'W!U(P?\*$0?0-61,L!6-E'3"!J#M[65.NM'ZTL= M?-;[CIBZPW">NHV"TJVP2JM33U";T5I9$D]N"%R)))Y%6-2V1T].910S21L3 M,@ 1I:*RV>"2VT' M:+6M4]3+](D;31W."WBRRP3,H*5,EQ10G[R(TSU56/B:/IH-B=-](%IP-G99 MLP8++$FQU8_;6!![\]U_5#JB^7'_ *ET':^VW9)[8*6W6N]U]%<>X=YK978P M5UQAMU;64^G8HH\?^!6JFK(R?O&YF48?CE?Q.'RN'+\E/+ ,2?JCV@$WQL?A M_*.3Q%6<%)%7839,Z)Q>'CG"_46]4VKJK5M-V1TK?KE9]+Z;H(ZO4XMM3)0_ MUR]7"&"5%G:%XY9;;04C0HM),R,U9)-/&C@L_1GX9\%RZ%Q=/*3DGF8 U!I/ M45,^UH"P3X[XYF#,'#5,T9C!!)0 1W1A HEVF<5+3W66K^VMF$H9'5FDFEF5 M&W!QL5E+@D@;CO.3Y4C/7;XXSB^(&: !RN6@6)C2VMPI]-$5\RH6#H9XSF(I MG)0C&PG&/ R,D#+#DCPMNG]R?UQG4T@-.3+T04-?5V.-.6H+J-@]HMRQX\GE MN1\9)(!.3S\]+$D9:(V77&#S@\^?QY'^WY!R#C Y&1TL/C]G)\?'^_D8^<<_ M!SC/(/D!86/V,9/GC/V^>3^0 2#Y^!_' Z6%CX'4';DY!_!X'@ ^?X_'QGG/ M2PL?!,Y.T8/..<8Y_G\\D8/P//GI8;E&WLQJ].LX]!W/#8X/)R!P#QP.<\Y\ M8(XSSTL)#]L_?MCT& RF3SG&WC@@_SSCC'X Z6$026U[[ZSZ8UWQO.%VCC( M\\8' \^ MY-?H^"DN=OU%=K/<5C@J/;M=?/3L9E12!(L4IBF(('_G1 #)!)&"::^&IS*N M<@,H:=M]M%;I.%T4(K8:6OI]C(O,]O\ 7EZ@Q;_Z+9-1"6266):.X5EOI:^Y MHK$*\2S&(! V0 9=R G)RH*FNKA*>4U "*2C&UBOU/37"$%R9&OZ6[H?7!+] MN_6+ZMM'T]NN]-WOUI3W>&(2U5*]P,U@F1W792O:*F$T#1(IQ)%[2HRD@2*> M@LW*)!B])N>^D!1;]%@[)S0P6PP$& V&2V7,]KN#<7Z=_6/9_4EHJK/-] B2O69+SVK[7Z]HH;2LUJMM#/$SBVW2R6VUP1. M"<*4"QNK-L71Q@_'&/\ G''5)XD$D!QUFWZQ?61AJZSO*V;3LM1])'5LH6*GCF9]D33.(N'4AT7[B2RDN/ M \D=2++!N'+.C.I.R^_2ZC.IRY-)("U *'5']_2ACMQZC=2>H^@[SW/65$E- M=NU7>2JTG1-35$L]%/9*XU@ML*Q3%=TM)'2!9Y)E+.6^P@#H+B\HUT\]-7** M000FV19Q.YD!=6=E<51F@++(%KB[ )@:@_L1AQ1W4$J%C90Q.&R-P7.,>, # M!"A< +@?'6&/&>>94E7E:+0V+UPXS 5!3"#L>5C]Z;1C;%66W C W? MN_!7C^3D@Y/^, =/R'> )B=!!ZD_P#.'IJ%1 Y9*3-2DH-'8!D*0(-SGBJM MV2 0 PSR.=IXX''\I 5!2(2#X!R/SGJ7*22'8?:Z/7#&@C424/\_LX_1W!UD2/8#G<1D\*0 M0.,@DC*^#QXXR3U%.-R![E?K?[X7+^'2(!N600;"E;@[ZX?%.Y:-7^3@XQ_J'D MG! \^ ./\XZH%!)J1$$W!%ST/1((=#@H!@'>F7>?O87];2@:QU-)8*&8B(R M-&"@92/. 0=I(S\CENF-)%/,"( )Z@O4LQMUN,4<17R45-DNE+:H@^]A((BV M&MZ:^WE'WCO%^[GZW,-TLNBKBT%KTK*)/8JKM3REH[A<&7;')%3%$:GI@'5W M>0S9"H.C>'I!'-L?KOJCU!C2\8^;FW0D29*W'Z_J\6WVZXK4)&AC(W)&^1M0 M8>- H"( D84854C"HJ@8&>>MS)HI% "N;]P*B^ZG U)JKF!?38$K2)]]GA85 MXXV+>WN) #*S.595R1P'4 Y!YQ\_CCHJG,0( *LGL2]/WTEN*08,N"8<[@@@ MB;=!@?.^/:CM'W+M!M'<+M[I_5=+#;<+=3M+$51JC>M4,5*LI3,;(^Y7V MODXYW$)_>J(4#2K3?GBE8)5VE:N-6B8,R[X: MNF@PXVG(#$'C[L9'5H-13)1B[38&@LIW #P'51R$TZB7N3/^!J\Y@T\NX; M]+ =.CUPM04D2,8PJ@ >57Y;D?((Y."<^,CYZE5E&H$"H!G4'0S8A6]7[CTT MRKDJ3T&M[*/[LX>5F$=.@*@G=QX'P,!"_Y/G9C&.D WM-H>GAJ/JC5/J30UFU,JQ*85I$KKC<*?V-V0SR M*U S,YRK+(H !!)Y;QH9G/S"M2#KNA%ON>NF-[PJ@54FS58MH [^MT/H,%'= M=,:"3\#K/RLW-SIYTW?F_I M>E6W2#W8T?A*6&0VK:+1B/MZ"+?IJ_4_1 M47RCC9GB6,RNH4#^V9=N0#@]$<+FYE6;5EU5,"EB38$ W)1@^^\XKS0,C+%9 M /,80D ,ZP?EVM?'5];Z6&DH8*>*.-8Z:GA@C942.0K#!'"@,\]4EB7M!*W$;!#'$YZ[;8EJ[]ZPF5A)_6HK/=W.#OB,M$L(A M7<6&!]&6)!"G>HV_;ST7X9.8.$K!K=/+0")U,?\ ZF^ZQB_B:F@YU-8H JI\ MH.S )L VIM^N D>ICC4-L+Y.W[\''&.>NCU7;ZO\ MCE9_P"/M/\ MCTQ^2M1E)]LK@\[%=5W-M\')P Q^? M X^&/-HEU;?[]ML*-?5%'WP77;705IM=(EYJ!]34ER#P0HP202 !QQ MYQQ68'S6DPHV$])_:>U]O*4PAC2*0F0E<,08PI/ MV[N2H/'\_P#/5.9534B B9)^GZ?N<-30:2#S-+16N(-M<-:.ZU%/6I44E14T M\RL LT,DE-+]IW0,STTT;EH29-IW8._G/Q'*R,NLU&H,!((0V_2+>^+Q6;D; MV)7[$_L8(O1'K$[\Z!'TU!K2JO%&H2,46H8*6YPB./<%B69XEK4C"C VU6X# ?&&'/1=.5E!.B$$D"B&!;KW'V7-W>J,&TV/M;=PO_V0$! end XML 20 d233594ds1_htm.xml IDEA: XBRL DOCUMENT 0001777393 2021-01-31 0001777393 2021-07-31 0001777393 2020-01-31 0001777393 2018-02-01 2019-01-31 0001777393 2019-02-01 2020-01-31 0001777393 2020-02-01 2021-01-31 0001777393 2020-02-01 2020-07-31 0001777393 2021-02-01 2021-07-31 0001777393 2021-05-01 2021-07-31 0001777393 2020-05-01 2020-07-31 0001777393 2021-02-01 2021-04-30 0001777393 2021-02-26 2021-02-26 0001777393 2020-02-01 2020-04-30 0001777393 2021-02-26 0001777393 2018-01-31 0001777393 2020-07-01 2020-07-31 0001777393 2020-08-01 2020-08-31 0001777393 2019-01-31 0001777393 2019-02-01 0001777393 2020-07-31 0001777393 2021-04-30 0001777393 2020-04-30 0001777393 srt:ChiefExecutiveOfficerMember chpt:CeoAwardsPlanMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:IPOMember 2021-07-31 0001777393 chpt:PublicWarrantsMember us-gaap:IPOMember 2021-07-31 0001777393 us-gaap:CommonClassAMember 2021-07-31 0001777393 chpt:CeoAwardsPlanMember 2021-07-31 0001777393 chpt:PublicWarrantsMember 2021-07-31 0001777393 us-gaap:RestrictedStockUnitsRSUMember 2021-07-31 0001777393 chpt:DaimlerMember 2021-07-31 0001777393 us-gaap:LeaseholdImprovementsMember 2021-07-31 0001777393 chpt:OwnedAndOperatedSystemsMember 2021-07-31 0001777393 us-gaap:ConstructionInProgressMember 2021-07-31 0001777393 us-gaap:ToolsDiesAndMoldsMember 2021-07-31 0001777393 us-gaap:MachineryAndEquipmentMember 2021-07-31 0001777393 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-07-31 0001777393 us-gaap:FurnitureAndFixturesMember 2021-07-31 0001777393 us-gaap:CommonStockMember 2021-07-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualFifteenUsdMember us-gaap:CommonStockMember 2021-07-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualTwentyUsdMember 2021-07-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualThirtyUsdMember us-gaap:CommonStockMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember chpt:MeasurementInputMarketPriceMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-07-31 0001777393 us-gaap:PurchaseCommitmentMember 2021-07-31 0001777393 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001777393 us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001777393 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2021-07-31 0001777393 us-gaap:MoneyMarketFundsMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member chpt:AssumedCommonStockWarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember chpt:AssumedCommonStockWarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001777393 chpt:StockOptionsIssuedAndOutstandingMember 2021-07-31 0001777393 chpt:CommonStockReservedForEarnoutMember 2021-07-31 0001777393 chpt:SharesAvailableForGrantUndertwoThousandTwentyOneEquityIncentivePlanMember 2021-07-31 0001777393 chpt:SharesAvailableForGrantUnderTwoThousandTwentyOneEsppMember 2021-07-31 0001777393 chpt:RestrictedStockUnitsAndOutstandingMember 2021-07-31 0001777393 chpt:EquityStockPurchasePlanTwoThousandTwentyOneMember 2021-07-31 0001777393 chpt:EquityIncentivePlanTwoThousandTwentyOneMember 2021-07-31 0001777393 chpt:EquityIncentivePlanTwoThousandSevenMember 2021-07-31 0001777393 chpt:EquityIncentivePlanTwoThousandSeventeenMember 2021-07-31 0001777393 chpt:LegacyChargepointMember us-gaap:CommonStockMember 2021-07-31 0001777393 chpt:LegacyChargepointMember us-gaap:PreferredStockMember 2021-07-31 0001777393 chpt:SeriesBDEPreferredStockMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2021-07-31 0001777393 us-gaap:IPOMember 2021-07-31 0001777393 chpt:SwitchbackMember 2021-07-31 0001777393 srt:ScenarioPreviouslyReportedMember 2021-01-31 0001777393 srt:ChiefExecutiveOfficerMember chpt:CeoAwardsPlanMember 2021-01-31 0001777393 chpt:CeoAwardsPlanMember 2021-01-31 0001777393 chpt:DaimlerMember 2021-01-31 0001777393 us-gaap:LeaseholdImprovementsMember 2021-01-31 0001777393 chpt:OwnedAndOperatedSystemsMember 2021-01-31 0001777393 us-gaap:ConstructionInProgressMember 2021-01-31 0001777393 us-gaap:FurnitureAndFixturesMember 2021-01-31 0001777393 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-01-31 0001777393 us-gaap:MachineryAndEquipmentMember 2021-01-31 0001777393 us-gaap:ToolsDiesAndMoldsMember 2021-01-31 0001777393 us-gaap:SeriesBPreferredStockMember us-gaap:WarrantMember 2021-01-31 0001777393 us-gaap:SeriesDPreferredStockMember us-gaap:WarrantMember 2021-01-31 0001777393 us-gaap:SeriesEPreferredStockMember us-gaap:WarrantMember 2021-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:WarrantMember 2021-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2021-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2021-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2021-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2021-01-31 0001777393 chpt:TwoThousandEighteenLoanMember 2021-01-31 0001777393 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2021-01-31 0001777393 us-gaap:MoneyMarketFundsMember 2021-01-31 0001777393 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 us-gaap:FairValueInputsLevel3Member chpt:RedeemableConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 chpt:SwitchbackMember 2021-01-31 0001777393 chpt:ConversionOfRedeemableConvertiblePreferredStockMember 2021-01-31 0001777393 chpt:StockOptionsIssuedAndOutstandingMember 2021-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsOutstandingMember 2021-01-31 0001777393 chpt:CommonStockWarrantsOutstandingMember 2021-01-31 0001777393 chpt:SharesAvailableForGrantUnderTwoThousandSeventeenStockOptionPlanMember 2021-01-31 0001777393 chpt:EquityIncentivePlanTwoThousandSeventeenMember 2021-01-31 0001777393 chpt:EarnoutSharesMember 2021-01-31 0001777393 chpt:CommonStockWarrantsOutstandingAtExercisePriceSixPointZeroTwoMember us-gaap:CommonStockMember 2021-01-31 0001777393 chpt:CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember us-gaap:CommonStockMember 2021-01-31 0001777393 us-gaap:CommonStockMember 2021-01-31 0001777393 chpt:SeriesH1RedeemableConvertiblePreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesGPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesFPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesEPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesDPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesCPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesBPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesAPreferredStockMember 2021-01-31 0001777393 us-gaap:SeriesHPreferredStockMember 2021-01-31 0001777393 srt:MaximumMember 2021-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesAPreferredStockMember 2021-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesBPreferredStockMember 2021-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesCPreferredStockMember 2021-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesDPreferredStockMember 2021-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesEPreferredStockMember 2021-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesFPreferredStockMember 2021-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesGPreferredStockMember 2021-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesHPreferredStockMember 2021-01-31 0001777393 srt:ScenarioPreviouslyReportedMember chpt:SeriesH1RedeemableConvertiblePreferredStockMember 2021-01-31 0001777393 country:US 2021-01-31 0001777393 chpt:RestOfWorldMember 2021-01-31 0001777393 chpt:OtherStateMember 2021-01-31 0001777393 stpr:CA 2021-01-31 0001777393 chpt:RestrictedCommonStockMember 2021-01-31 0001777393 us-gaap:LetterOfCreditMember 2021-01-31 0001777393 us-gaap:CashMember us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-01-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualFifteenUsdMember 2021-01-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualTwentyUsdMember 2021-01-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualThirtyUsdMember 2021-01-31 0001777393 us-gaap:StateAndLocalJurisdictionMember 2021-01-31 0001777393 us-gaap:CostOfSalesMember 2021-05-01 2021-07-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2021-05-01 2021-07-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2021-05-01 2021-07-31 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2021-05-01 2021-07-31 0001777393 chpt:DaimlerMember 2021-05-01 2021-07-31 0001777393 country:US 2021-05-01 2021-07-31 0001777393 chpt:RestOfTheWorldMember 2021-05-01 2021-07-31 0001777393 chpt:NetworkedChargingSystemsMember 2021-05-01 2021-07-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2021-05-01 2021-07-31 0001777393 chpt:OtherRevenuesMember 2021-05-01 2021-07-31 0001777393 us-gaap:CommonStockMember 2021-05-01 2021-07-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2021-05-01 2021-07-31 0001777393 us-gaap:RetainedEarningsMember 2021-05-01 2021-07-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-01 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember 2021-05-01 2021-07-31 0001777393 chpt:PublicWarrantsMember 2021-05-01 2021-07-31 0001777393 chpt:LegacyChargepointMember us-gaap:CommonStockMember 2021-05-01 2021-07-31 0001777393 us-gaap:CostOfSalesMember 2020-05-01 2020-07-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2020-05-01 2020-07-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2020-05-01 2020-07-31 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2020-05-01 2020-07-31 0001777393 chpt:DaimlerMember 2020-05-01 2020-07-31 0001777393 country:US 2020-05-01 2020-07-31 0001777393 chpt:RestOfTheWorldMember 2020-05-01 2020-07-31 0001777393 chpt:NetworkedChargingSystemsMember 2020-05-01 2020-07-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2020-05-01 2020-07-31 0001777393 chpt:OtherRevenuesMember 2020-05-01 2020-07-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2020-05-01 2020-07-31 0001777393 us-gaap:RetainedEarningsMember 2020-05-01 2020-07-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-05-01 2020-07-31 0001777393 us-gaap:CommonStockMember 2020-05-01 2020-07-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-05-01 2020-07-31 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2021-02-01 2021-07-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2021-02-01 2021-07-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2021-02-01 2021-07-31 0001777393 us-gaap:CostOfSalesMember 2021-02-01 2021-07-31 0001777393 chpt:CeoAwardsPlanMember 2021-02-01 2021-07-31 0001777393 us-gaap:RestrictedStockUnitsRSUMember 2021-02-01 2021-07-31 0001777393 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SalesRevenueNetMember chpt:CustomerTwoMember 2021-02-01 2021-07-31 0001777393 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:AccountsReceivableMember chpt:CustomerOneMember 2021-02-01 2021-07-31 0001777393 chpt:CommonStockAndPreferredStockWarrantsMember 2021-02-01 2021-07-31 0001777393 us-gaap:RestrictedStockUnitsRSUMember 2021-02-01 2021-07-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2021-02-01 2021-07-31 0001777393 chpt:UnvestedEarlyExercisedCommonStockOptionsMember 2021-02-01 2021-07-31 0001777393 us-gaap:EmployeeStockOptionMember 2021-02-01 2021-07-31 0001777393 chpt:DaimlerMember 2021-02-01 2021-07-31 0001777393 country:US 2021-02-01 2021-07-31 0001777393 chpt:RestOfTheWorldMember 2021-02-01 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember 2021-02-01 2021-07-31 0001777393 chpt:PublicWarrantsMember 2021-02-01 2021-07-31 0001777393 chpt:LegacyCommonAndPreferredStockWarrantsMember 2021-02-01 2021-07-31 0001777393 chpt:TwoThousandEighteenLoanMember 2021-02-01 2021-07-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-02-01 2021-07-31 0001777393 us-gaap:FairValueInputsLevel3Member chpt:EarnOutLiabilityMember 2021-02-01 2021-07-31 0001777393 us-gaap:FairValueInputsLevel3Member chpt:RedeemableConvertiblePreferredStockWarrantLiabilityMember 2021-02-01 2021-07-31 0001777393 us-gaap:MoneyMarketFundsMember 2021-02-01 2021-07-31 0001777393 chpt:SwitchbackMember 2021-02-01 2021-07-31 0001777393 chpt:PipeFinancingMember 2021-02-01 2021-07-31 0001777393 chpt:NetworkedChargingSystemsMember 2021-02-01 2021-07-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2021-02-01 2021-07-31 0001777393 chpt:OtherRevenuesMember 2021-02-01 2021-07-31 0001777393 chpt:EquityStockPurchasePlanTwoThousandTwentyOneMember 2021-02-01 2021-07-31 0001777393 chpt:EquityIncentivePlanTwoThousandTwentyOneMember 2021-02-01 2021-07-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualThirtyUsdMember chpt:TrancheThreeMember 2021-02-01 2021-07-31 0001777393 chpt:SwitchbackPublicStockholdersMember 2021-02-01 2021-07-31 0001777393 chpt:PipeFinancingMember 2021-02-01 2021-07-31 0001777393 chpt:LegacyChargepointMember us-gaap:CommonStockMember 2021-02-01 2021-07-31 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2020-02-01 2020-07-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2020-02-01 2020-07-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2020-02-01 2020-07-31 0001777393 us-gaap:CostOfSalesMember 2020-02-01 2020-07-31 0001777393 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SalesRevenueNetMember chpt:CustomerTwoMember 2020-02-01 2020-07-31 0001777393 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:AccountsReceivableMember chpt:CustomerOneMember 2020-02-01 2020-07-31 0001777393 chpt:CommonStockAndPreferredStockWarrantsMember 2020-02-01 2020-07-31 0001777393 us-gaap:RestrictedStockUnitsRSUMember 2020-02-01 2020-07-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-02-01 2020-07-31 0001777393 chpt:UnvestedEarlyExercisedCommonStockOptionsMember 2020-02-01 2020-07-31 0001777393 us-gaap:EmployeeStockOptionMember 2020-02-01 2020-07-31 0001777393 chpt:DaimlerMember 2020-02-01 2020-07-31 0001777393 country:US 2020-02-01 2020-07-31 0001777393 chpt:RestOfTheWorldMember 2020-02-01 2020-07-31 0001777393 chpt:TwoThousandEighteenLoanMember 2020-02-01 2020-07-31 0001777393 chpt:NetworkedChargingSystemsMember 2020-02-01 2020-07-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2020-02-01 2020-07-31 0001777393 chpt:OtherRevenuesMember 2020-02-01 2020-07-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2021-02-01 2021-04-30 0001777393 us-gaap:CommonStockMember 2021-02-01 2021-04-30 0001777393 us-gaap:AdditionalPaidInCapitalMember 2021-02-01 2021-04-30 0001777393 chpt:GainMember chpt:EarnoutSharesMember 2021-02-01 2021-04-30 0001777393 us-gaap:RetainedEarningsMember 2021-02-01 2021-04-30 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-02-01 2021-04-30 0001777393 us-gaap:SubsequentEventMember 2021-02-01 2021-04-30 0001777393 us-gaap:AdditionalPaidInCapitalMember 2020-02-01 2020-04-30 0001777393 us-gaap:RetainedEarningsMember 2020-02-01 2020-04-30 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-02-01 2020-04-30 0001777393 us-gaap:CommonStockMember 2020-02-01 2020-04-30 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2020-02-01 2021-01-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2020-02-01 2021-01-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2020-02-01 2021-01-31 0001777393 us-gaap:CostOfSalesMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SalesRevenueNetMember chpt:CustomerTwoMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:AccountsReceivableMember chpt:CustomerOneMember 2020-02-01 2021-01-31 0001777393 chpt:CommonStockWarrantsMember 2020-02-01 2021-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantMember 2020-02-01 2021-01-31 0001777393 chpt:UnvestedEarlyExercisedCommonStockOptionsMember 2020-02-01 2021-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:EmployeeStockOptionMember 2020-02-01 2021-01-31 0001777393 chpt:DaimlerMember 2020-02-01 2021-01-31 0001777393 chpt:TwoThousandEighteenLoanMember 2020-02-01 2021-01-31 0001777393 us-gaap:MoneyMarketFundsMember 2020-02-01 2021-01-31 0001777393 chpt:NetworkedChargingSystemsMember 2020-02-01 2021-01-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2020-02-01 2021-01-31 0001777393 chpt:OtherRevenuesMember 2020-02-01 2021-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2020-02-01 2021-01-31 0001777393 us-gaap:RetainedEarningsMember 2020-02-01 2021-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-02-01 2021-01-31 0001777393 us-gaap:CommonStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-02-01 2021-01-31 0001777393 chpt:EquityIncentivePlanTwoThousandSeventeenMember 2020-02-01 2021-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember chpt:CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember us-gaap:CommonStockMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember chpt:CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember us-gaap:CommonStockMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember chpt:CommonStockWarrantsOutstandingAtExercisePriceSixPointZeroTwoMember us-gaap:CommonStockMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember chpt:CommonStockWarrantsOutstandingAtExercisePriceSixPointZeroTwoMember us-gaap:CommonStockMember 2020-02-01 2021-01-31 0001777393 chpt:SeriesH1RedeemableConvertiblePreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesHPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesGPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesFPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesEPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesDPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesCPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesBPreferredStockMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesAPreferredStockMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember us-gaap:ComputerSoftwareIntangibleAssetMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember us-gaap:ComputerSoftwareIntangibleAssetMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember chpt:ToolingMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember chpt:ToolingMember 2020-02-01 2021-01-31 0001777393 srt:ChiefExecutiveOfficerMember chpt:CeoAwardsPlanMember 2020-02-01 2021-01-31 0001777393 country:US 2020-02-01 2021-01-31 0001777393 chpt:RestOfWorldMember 2020-02-01 2021-01-31 0001777393 chpt:RestrictedCommonStockMember 2020-02-01 2021-01-31 0001777393 chpt:CaresActMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember chpt:CaresActMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember chpt:CaresActMember 2020-02-01 2021-01-31 0001777393 us-gaap:LeaseholdImprovementsMember 2020-02-01 2021-01-31 0001777393 us-gaap:SeriesBPreferredStockMember us-gaap:WarrantMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember us-gaap:SeriesDPreferredStockMember us-gaap:WarrantMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember us-gaap:SeriesDPreferredStockMember us-gaap:WarrantMember 2020-02-01 2021-01-31 0001777393 srt:MinimumMember us-gaap:SeriesEPreferredStockMember us-gaap:WarrantMember 2020-02-01 2021-01-31 0001777393 srt:MaximumMember us-gaap:SeriesEPreferredStockMember us-gaap:WarrantMember 2020-02-01 2021-01-31 0001777393 chpt:MergerAgreementMember 2021-02-26 0001777393 chpt:FounderSharesMember chpt:FoundersStockLetterMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember chpt:SponsorMember 2021-02-26 0001777393 chpt:SponsorMember 2021-02-26 0001777393 chpt:SwitchbackMember us-gaap:CommonStockMember 2021-02-26 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2021-02-26 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2021-02-26 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2021-02-26 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember chpt:MeasurementInputMarketPriceMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-02-26 0001777393 chpt:SwitchbackMember chpt:MergerAgreementMember chpt:ChargePointCommonStockMember 2021-02-26 0001777393 chpt:SwitchbackMember chpt:ChargePointCommonStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember 2021-02-26 0001777393 chpt:SubscriptionAgreementMember chpt:SwitchbackMember chpt:PipeFinancingMember 2021-02-26 0001777393 us-gaap:CommonStockMember 2021-02-26 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:EarnoutSharesMember 2021-02-26 0001777393 us-gaap:MeasurementInputSharePriceMember chpt:EarnoutSharesMember 2021-02-26 0001777393 us-gaap:MeasurementInputExpectedTermMember chpt:EarnoutSharesMember 2021-02-26 0001777393 us-gaap:MeasurementInputExpectedDividendRateMember chpt:EarnoutSharesMember 2021-02-26 0001777393 us-gaap:MeasurementInputRiskFreeInterestRateMember chpt:EarnoutSharesMember 2021-02-26 0001777393 us-gaap:MeasurementInputPriceVolatilityMember chpt:EarnoutSharesMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesARedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesBRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesCRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesDRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesERedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesFRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesGRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesHRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesHOneRedeemableConvertiblePreferredStockMember 2021-02-26 0001777393 chpt:PipeFinancingMember us-gaap:SubsequentEventMember 2021-02-26 2021-02-26 0001777393 chpt:ChargePointMember us-gaap:CommonStockMember 2021-02-26 2021-02-26 0001777393 chpt:PipeInvestorMember 2021-02-26 2021-02-26 0001777393 chpt:FounderSharesMember chpt:FoundersStockLetterMember 2021-02-26 2021-02-26 0001777393 chpt:PrivatePlacementWarrantsMember chpt:SponsorMember 2021-02-26 2021-02-26 0001777393 us-gaap:CommonStockMember chpt:BusinessCombinationAgreementMember 2021-02-26 2021-02-26 0001777393 chpt:SwitchbackMember chpt:MergerAgreementMember us-gaap:CommonStockMember 2021-02-26 2021-02-26 0001777393 chpt:SwitchbackMember us-gaap:CommonStockMember 2021-02-26 2021-02-26 0001777393 chpt:SwitchbackMember chpt:ChargePointCommonStockMember 2021-02-26 2021-02-26 0001777393 chpt:SubscriptionAgreementMember chpt:SwitchbackMember chpt:PipeFinancingMember 2021-02-26 2021-02-26 0001777393 chpt:SwitchbackMember chpt:FounderSharesMember 2021-02-26 2021-02-26 0001777393 chpt:SwitchbackMember chpt:FounderEarnBackSharesMember 2021-02-26 2021-02-26 0001777393 chpt:FounderEarnBackTriggeringEventMember chpt:SwitchbackMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargepointSharesMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesARedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesBRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesCRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesDRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesERedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesFRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesGRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesHRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 chpt:LegacyChargePointMember chpt:SeriesHOneRedeemableConvertiblePreferredStockMember 2021-02-26 2021-02-26 0001777393 us-gaap:SubsequentEventMember 2021-04-30 0001777393 chpt:TwoThousandEighteenLoanMember 2018-07-31 0001777393 chpt:TwoThousandEighteenLoanMember 2019-06-01 2019-06-30 0001777393 chpt:TwoThousandEighteenLoanMember 2019-06-30 0001777393 chpt:TwoThousandEighteenLoanMember 2021-03-01 2021-03-31 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualFifteenUsdMember 2021-03-12 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualTwentyUsdMember 2021-03-12 0001777393 chpt:EarnoutTriggeringEventMember chpt:EarnoutSharesMember 2021-03-12 0001777393 chpt:EarnoutTriggeringEventMember us-gaap:CommonStockMember 2021-03-12 0001777393 chpt:EarnoutSharesMember 2021-03-12 0001777393 us-gaap:MeasurementInputSharePriceMember chpt:EarnoutSharesMember 2021-03-12 0001777393 us-gaap:MeasurementInputExpectedTermMember chpt:EarnoutSharesMember 2021-03-12 0001777393 us-gaap:MeasurementInputExpectedDividendRateMember chpt:EarnoutSharesMember 2021-03-12 0001777393 us-gaap:MeasurementInputRiskFreeInterestRateMember chpt:EarnoutSharesMember 2021-03-12 0001777393 us-gaap:MeasurementInputPriceVolatilityMember chpt:EarnoutSharesMember 2021-03-12 0001777393 chpt:EarnoutSharesMember 2021-03-12 2021-03-12 0001777393 chpt:MergerAgreementMember chpt:EarnoutSharesMember 2021-03-12 2021-03-12 0001777393 chpt:TrancheThreeMember 2021-03-12 2021-03-12 0001777393 chpt:EarnoutSharesMember 2021-03-13 2021-03-13 0001777393 chpt:EarnoutSharesMember 2021-03-13 0001777393 chpt:HasToBeMember 2021-07-20 2021-07-20 0001777393 chpt:ViricitiBVMember us-gaap:SubsequentEventMember 2021-08-11 2021-08-11 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualThirtyUsdMember chpt:TrancheThreeMember 2021-07-01 0001777393 chpt:EarnoutTriggeringEventMember chpt:SharePriceGreaterOrEqualThirtyUsdMember chpt:TrancheThreeMember 2021-07-01 2021-07-01 0001777393 chpt:PublicWarrantsMember us-gaap:SubsequentEventMember 2021-07-06 0001777393 chpt:PublicWarrantsMember 2021-07-06 0001777393 chpt:PublicWarrantsMember 2021-06-04 0001777393 chpt:PublicWarrantsMember 2021-07-06 2021-07-06 0001777393 srt:ScenarioPreviouslyReportedMember 2020-01-31 0001777393 chpt:DaimlerMember 2020-01-31 0001777393 us-gaap:FurnitureAndFixturesMember 2020-01-31 0001777393 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-01-31 0001777393 us-gaap:MachineryAndEquipmentMember 2020-01-31 0001777393 us-gaap:ToolsDiesAndMoldsMember 2020-01-31 0001777393 us-gaap:ConstructionInProgressMember 2020-01-31 0001777393 chpt:OwnedAndOperatedSystemsMember 2020-01-31 0001777393 us-gaap:LeaseholdImprovementsMember 2020-01-31 0001777393 us-gaap:SeriesBPreferredStockMember us-gaap:WarrantMember 2020-01-31 0001777393 us-gaap:SeriesDPreferredStockMember us-gaap:WarrantMember 2020-01-31 0001777393 us-gaap:SeriesEPreferredStockMember us-gaap:WarrantMember 2020-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:WarrantMember 2020-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2020-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2020-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2020-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2020-01-31 0001777393 chpt:TwoThousandEighteenLoanMember 2020-01-31 0001777393 chpt:ConversionOfRedeemableConvertiblePreferredStockMember 2020-01-31 0001777393 chpt:StockOptionsIssuedAndOutstandingMember 2020-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantsOutstandingMember 2020-01-31 0001777393 chpt:CommonStockWarrantsOutstandingMember 2020-01-31 0001777393 chpt:SharesAvailableForGrantUnderTwoThousandSeventeenStockOptionPlanMember 2020-01-31 0001777393 chpt:CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember us-gaap:CommonStockMember 2020-01-31 0001777393 us-gaap:CommonStockMember 2020-01-31 0001777393 us-gaap:SeriesHPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesGPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesFPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesEPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesDPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesCPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesBPreferredStockMember 2020-01-31 0001777393 us-gaap:SeriesAPreferredStockMember 2020-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesAPreferredStockMember 2020-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesBPreferredStockMember 2020-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesCPreferredStockMember 2020-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesDPreferredStockMember 2020-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesEPreferredStockMember 2020-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesFPreferredStockMember 2020-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesGPreferredStockMember 2020-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesHPreferredStockMember 2020-01-31 0001777393 country:US 2020-01-31 0001777393 chpt:RestOfWorldMember 2020-01-31 0001777393 chpt:RestrictedCommonStockMember 2020-01-31 0001777393 us-gaap:LetterOfCreditMember 2020-01-31 0001777393 us-gaap:CashMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-31 0001777393 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-31 0001777393 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryBillSecuritiesMember 2020-01-31 0001777393 us-gaap:FairValueMeasurementsRecurringMember 2020-01-31 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2019-02-01 2020-01-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2019-02-01 2020-01-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2019-02-01 2020-01-31 0001777393 us-gaap:CostOfSalesMember 2019-02-01 2020-01-31 0001777393 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SalesRevenueNetMember chpt:CustomerTwoMember 2019-02-01 2020-01-31 0001777393 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:AccountsReceivableMember chpt:CustomerOneMember 2019-02-01 2020-01-31 0001777393 chpt:CommonStockWarrantsMember 2019-02-01 2020-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantMember 2019-02-01 2020-01-31 0001777393 chpt:UnvestedEarlyExercisedCommonStockOptionsMember 2019-02-01 2020-01-31 0001777393 chpt:UnvestedRestrictedCommonStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:EmployeeStockOptionMember 2019-02-01 2020-01-31 0001777393 chpt:DaimlerMember 2019-02-01 2020-01-31 0001777393 chpt:TwoThousandEighteenLoanMember 2019-02-01 2020-01-31 0001777393 us-gaap:MoneyMarketFundsMember 2019-02-01 2020-01-31 0001777393 chpt:NetworkedChargingSystemsMember 2019-02-01 2020-01-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2019-02-01 2020-01-31 0001777393 chpt:OtherRevenuesMember 2019-02-01 2020-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2019-02-01 2020-01-31 0001777393 us-gaap:RetainedEarningsMember 2019-02-01 2020-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-02-01 2020-01-31 0001777393 us-gaap:CommonStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2019-02-01 2020-01-31 0001777393 srt:MaximumMember chpt:CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember us-gaap:CommonStockMember 2019-02-01 2020-01-31 0001777393 srt:MinimumMember chpt:CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember us-gaap:CommonStockMember 2019-02-01 2020-01-31 0001777393 chpt:SeriesHRedeemableConvertiblePreferredStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:SeriesHPreferredStockMember 2019-02-01 2020-01-31 0001777393 srt:MaximumMember 2019-02-01 2020-01-31 0001777393 srt:MinimumMember 2019-02-01 2020-01-31 0001777393 country:US 2019-02-01 2020-01-31 0001777393 chpt:RestOfWorldMember 2019-02-01 2020-01-31 0001777393 chpt:RestrictedCommonStockMember 2019-02-01 2020-01-31 0001777393 us-gaap:SeriesBPreferredStockMember us-gaap:WarrantMember 2019-02-01 2020-01-31 0001777393 srt:MinimumMember us-gaap:SeriesDPreferredStockMember us-gaap:WarrantMember 2019-02-01 2020-01-31 0001777393 srt:MaximumMember us-gaap:SeriesDPreferredStockMember us-gaap:WarrantMember 2019-02-01 2020-01-31 0001777393 srt:MinimumMember us-gaap:SeriesEPreferredStockMember us-gaap:WarrantMember 2019-02-01 2020-01-31 0001777393 srt:MaximumMember us-gaap:SeriesEPreferredStockMember us-gaap:WarrantMember 2019-02-01 2020-01-31 0001777393 us-gaap:GeneralAndAdministrativeExpenseMember 2018-02-01 2019-01-31 0001777393 us-gaap:SellingAndMarketingExpenseMember 2018-02-01 2019-01-31 0001777393 us-gaap:ResearchAndDevelopmentExpenseMember 2018-02-01 2019-01-31 0001777393 us-gaap:CostOfSalesMember 2018-02-01 2019-01-31 0001777393 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SalesRevenueNetMember chpt:CustomerTwoMember 2018-02-01 2019-01-31 0001777393 chpt:CommonStockWarrantsMember 2018-02-01 2019-01-31 0001777393 chpt:RedeemableConvertiblePreferredStockWarrantMember 2018-02-01 2019-01-31 0001777393 chpt:UnvestedEarlyExercisedCommonStockOptionsMember 2018-02-01 2019-01-31 0001777393 chpt:UnvestedRestrictedCommonStockMember 2018-02-01 2019-01-31 0001777393 us-gaap:EmployeeStockOptionMember 2018-02-01 2019-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2018-02-01 2019-01-31 0001777393 chpt:DaimlerMember 2018-02-01 2019-01-31 0001777393 chpt:TwoThousandEighteenLoanMember 2018-02-01 2019-01-31 0001777393 chpt:NetworkedChargingSystemsMember 2018-02-01 2019-01-31 0001777393 us-gaap:SubscriptionAndCirculationMember 2018-02-01 2019-01-31 0001777393 chpt:OtherRevenuesMember 2018-02-01 2019-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2018-02-01 2019-01-31 0001777393 us-gaap:RetainedEarningsMember 2018-02-01 2019-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-02-01 2019-01-31 0001777393 us-gaap:CommonStockMember 2018-02-01 2019-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2018-02-01 2019-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2018-02-01 2019-01-31 0001777393 chpt:ElectricFleetMember 2018-02-01 2019-01-31 0001777393 chpt:SeriesHRedeemableConvertiblePreferredStockMember 2018-02-01 2019-01-31 0001777393 us-gaap:SeriesHPreferredStockMember 2018-02-01 2019-01-31 0001777393 srt:MaximumMember 2018-02-01 2019-01-31 0001777393 srt:MinimumMember 2018-02-01 2019-01-31 0001777393 country:US 2018-02-01 2019-01-31 0001777393 chpt:RestOfWorldMember 2018-02-01 2019-01-31 0001777393 chpt:RestrictedCommonStockMember 2018-02-01 2019-01-31 0001777393 chpt:TwoThousandFourteenLoanMember 2014-12-01 2014-12-31 0001777393 srt:MinimumMember chpt:TwoThousandFourteenLoanMember 2014-12-01 2014-12-31 0001777393 chpt:TrancheThreeAndFinalMember us-gaap:SubsequentEventMember 2021-06-29 2021-06-29 0001777393 us-gaap:SubsequentEventMember 2021-03-15 2021-03-15 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2019-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2019-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2019-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember chpt:RedeemableConvertiblePreferredStockWarrantsMember 2019-01-31 0001777393 chpt:ElectricFleetMember 2019-01-31 0001777393 us-gaap:SeriesHPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesGPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesFPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesEPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesDPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesCPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesBPreferredStockMember 2019-01-31 0001777393 us-gaap:SeriesAPreferredStockMember 2019-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesAPreferredStockMember 2019-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesBPreferredStockMember 2019-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesCPreferredStockMember 2019-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesDPreferredStockMember 2019-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesEPreferredStockMember 2019-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesFPreferredStockMember 2019-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesGPreferredStockMember 2019-01-31 0001777393 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesHPreferredStockMember 2019-01-31 0001777393 srt:ScenarioPreviouslyReportedMember 2019-01-31 0001777393 us-gaap:LetterOfCreditMember 2019-01-31 0001777393 chpt:EarnoutSharesMember 2021-03-19 0001777393 chpt:TrancheThreeMember 2021-03-19 2021-03-19 0001777393 chpt:EarnoutSharesMember 2021-03-19 2021-03-19 0001777393 stpr:CA 2020-06-29 2020-06-29 0001777393 chpt:TwoThousandFourteenLoanMember 2014-12-31 0001777393 us-gaap:RetainedEarningsMember 2021-07-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2021-07-31 0001777393 us-gaap:CommonStockMember 2021-07-31 0001777393 us-gaap:CommonStockMember 2020-07-31 0001777393 us-gaap:RetainedEarningsMember 2020-07-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2020-07-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-07-31 0001777393 chpt:LegacyCommonAndPreferredStockWarrantsMember 2021-01-31 0001777393 us-gaap:FairValueInputsLevel3Member chpt:RedeemableConvertiblePreferredStockWarrantLiabilityMember 2021-01-31 0001777393 chpt:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-07-31 0001777393 chpt:LegacyCommonAndPreferredStockWarrantsMember 2021-07-31 0001777393 us-gaap:RestrictedStockUnitsRSUMember 2021-01-31 0001777393 us-gaap:RetainedEarningsMember 2021-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2021-01-31 0001777393 us-gaap:CommonStockMember 2021-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2021-04-30 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-30 0001777393 us-gaap:RetainedEarningsMember 2021-04-30 0001777393 us-gaap:CommonStockMember 2021-04-30 0001777393 us-gaap:RetainedEarningsMember 2020-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2020-01-31 0001777393 us-gaap:CommonStockMember 2020-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-01-31 0001777393 us-gaap:RetainedEarningsMember 2020-04-30 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-30 0001777393 us-gaap:AdditionalPaidInCapitalMember 2020-04-30 0001777393 us-gaap:CommonStockMember 2020-04-30 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2020-04-30 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2020-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2021-01-31 0001777393 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2020-01-31 0001777393 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2019-01-31 0001777393 us-gaap:RetainedEarningsMember 2018-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2018-01-31 0001777393 us-gaap:CommonStockMember 2018-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2018-01-31 0001777393 us-gaap:RedeemableConvertiblePreferredStockMember 2019-01-31 0001777393 us-gaap:CommonStockMember 2019-01-31 0001777393 us-gaap:AdditionalPaidInCapitalMember 2019-01-31 0001777393 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-31 0001777393 us-gaap:RetainedEarningsMember 2019-01-31 0001777393 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2018-01-31 iso4217:USD pure shares utr:Year utr:Day iso4217:EUR iso4217:USD shares chpt:Segment utr:Y false 0001777393 ChargePoint Holdings, Inc. P10D P10D P20D S-1 Non-accelerated Filer true true false 618089000 145491000 400000 400000 2000000 2000000 42708000 35075000 27916000 33592000 22138000 12074000 711251000 226632000 32265000 29988000 20834000 21817000 1215000 1215000 5023000 10468000 770588000 290120000 28416000 19784000 51980000 47162000 47769000 40934000 10208000 128165000 118088000 58000000 48896000 24686000 21582000 22459000 26868000 75843000 961000 972000 235576000 290944000 0.0001 0.0001 0 185180248 0 0 182934257 182934257 0 17492964000 615697000 0.0001 0.0001 1000000000 299771284 322170484 322170484 22961032 22961032 32000 2000 0.0001 0.0001 10000000 0 0 0 0 0 1216893000 62736000 150000 155000 -682063000 -679414000 535012000 -616521000 770588000 290120000 40874000 21368000 67674000 41025000 12082000 9811000 22906000 18815000 3165000 3778000 6051000 7893000 56121000 34957000 96631000 67733000 35384000 20408000 59126000 39024000 7830000 4452000 13470000 9225000 2130000 1069000 4041000 2692000 45344000 25929000 76637000 50941000 10777000 9028000 19994000 16792000 40410000 17126000 65784000 35152000 21923000 10966000 37897000 25167000 22732000 4466000 37199000 9555000 85065000 32558000 140880000 69874000 -74288000 -23530000 -120886000 -53082000 25000 37000 47000 280000 793000 1499000 1628000 11516000 -9237000 10981000 10421000 -33340000 -84420000 7031000 -189000 563000 -174000 131000 -84873000 -35239000 -2546000 -65280000 65000 48000 103000 105000 -84938000 -35287000 -2649000 -65385000 58625000 58625000 0 4292000 0 51855000 0 -110635000 -84938000 -93912000 -169431000 -124010000 0 -84420000 -7427000 -53540000 -92365000 -93912000 -307391000 -124010000 312227526 13468677 266197482 12822481 313602100 13468677 275577000 12822481 -0.27 -6.97 -0.64 -9.67 -0.29 -6.97 -1.12 -9.67 -84938000 -35287000 -2649000 -65385000 -12000 92000 -5000 36000 -23000 -23000 -12000 69000 -5000 13000 -84950000 -35218000 -2654000 -65372000 182934257 615697000 22961032 2000 62736000 155000 -679414000 -616521000 -182934257 -615697000 194060336 20000 615677000 615697000 66606000 66606000 60746989 6000 200460000 200466000 9766774 1000 225375000 225376000 -828180000 -828180000 17539657 2000 488303000 488305000 242640000 242640000 78000 78000 1588 7577000 7577000 82289000 82289000 7000 7000 305073200 31000 1081272000 162000 -597125000 484340000 652901 4378568 0 113608000 113608000 3292219 1761000 1761000 8773596 1000 -8081000 -8080000 40000 40000 28293000 28293000 -84938000 -84938000 -12000 -12000 322170484 32000 1216893000 150000 -682063000 535012000 160583203 520241000 11918418 1000 20331000 37000 -482390000 -462021000 1071203 436000 436000 10000 10000 910000 910000 -30098000 -30098000 -56000 -56000 160583203 520241000 12989621 1000 21687000 -19000 -512488000 -490819000 21783334 92433000 31390000 31390000 -58625000 58625000 58625000 -58625000 58625000 58625000 1523641 1095000 1095000 66440 1000 1000 1190000 1190000 -35287000 -35287000 69000 69000 182366537 612674000 14579702 1000 55363000 50000 -547775000 -492361000 -2649000 -65385000 5576000 4684000 1963000 1749000 35870000 2100000 829000 538000 -9237000 -33340000 10981000 -84420000 7031000 -1236000 -683000 7657000 -16188000 -5620000 7427000 9325000 3335000 -953000 -2031000 9293000 -9324000 3027000 -4054000 15938000 4564000 -61198000 -50069000 7788000 5962000 47014000 -7788000 41052000 92433000 117598000 31390000 511646000 32468000 20894000 36051000 1759000 1542000 541590000 125365000 -6000 36000 472598000 116384000 145891000 73153000 618489000 189537000 344000 1402000 115000 105000 58625000 615697000 66606000 -828180000 242640000 <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1.</div></div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Description of Business<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>and Basis of Presentation </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">ChargePoint Holdings, Inc. (“ChargePoint” or the “Company,” “it,” “its”) designs, develops, and markets networked electric vehicle (“EV”) charging system infrastructure (“Networked Charging Systems”) and cloud-based services which enable consumers the ability to locate, reserve, authenticate and transact EV charging sessions (“Cloud” or “Cloud Services”). As part of ChargePoint’s Networked Charging Systems, subscriptions and other offerings, it provides an open platform that integrates with system hardware from ChargePoint and other manufacturers, connecting systems over an intelligent network that provides real-time information about charging sessions and full control, support and m<div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>nagement of the Networked Charging Systems. This network provides multiple <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">web-based portals</div> for charging system owners, fleet managers, drivers, and utilities. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, the Company offers extended parts and labor warranty (“Assure”) that includes proactive monitoring, fast response times, expert advice and robust reporting. The ChargePoint as a Service (“CPaaS”) program combines the customer’s use of ChargePoint’s owned and operated systems with Cloud Services, Assure and other benefits available to subscribers into one subscription. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s fiscal year ends on January 31. References to fiscal year 2021 relate to the fiscal year ended January 31, 2021 and to fiscal year 2022 refer to the fiscal year ending January 31, 2022. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting. The Company’s condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended January 31, 2021 and the related notes included in the Company’s Registration Statement on Form S-1 filed with the SEC on July 12, 2021, which provides a more complete discussion of the Company’s accounting policies and certain other information. The information as of January 31, 2021 included on the condensed consolidated balance sheets was derived from the Company’s audited consolidated financial statements. The condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company’s financial position as of July 31, 2021 and the results of operations for the three and six months ended July 31, 2021 and 2020, and cash flows for the six months ended July 31, 2021 and 2020. The results of operations for the three and six months ended July 31, 2021 are not necessarily indicative of the results that may be expected for the year ending January 31, 2022. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its product offerings, raising capital, and recruiting personnel. The Company’s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">efforts, or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company’s stockholders. The Company has incurred net operating losses and negative cash flows from operations in every year since inception and expects this to continue for the foreseeable future. As of July 31, 2021, the Company had an accumulated deficit of $682.1 million. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock, borrowings under its loan facilities, customer payments and proceeds from the Reverse Recapitalization (as defined below). The Company had cash, cash equivalents, and restricted cash of $618.5 million as of July 31, 2021. As of September 10, 2021, the date on which these condensed consolidated financial statements were available to be issued, the Company believes that its cash on hand, together with cash generated from sales to customers, will satisfy its working capital and capital requirements for at least the next twelve months. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties. The Company’s actual results could vary as a result of, and its near- and long-term future capital requirements will depend on, many factors, including its growth rate, subscription renewal activity, the timing and extent of spending to support its acquisitions, infrastructure and research and development efforts, the expansion of sales and marketing activities, the timing of new introductions of products or features, the continuing market adoption of its Networked Charging Systems platform, and the overall market acceptance of EVs. The Company has and may in the future enter into arrangements to acquire or invest in complementary businesses, services, and technologies, including intellectual property rights. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may be required to seek additional equity or debt financing. Future liquidity and cash requirements will depend on numerous factors, including market penetration, the introduction of new products, and potential acquisitions of related businesses or technology. In the event that additional financing is required from outside sources, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 26, 2021 (“Closing Date”), Switchback Energy Acquisition Corporation (“Switchback”) consummated the previously announced transactions pursuant to which Lightning Merger Sub Inc., a wholly owned subsidiary of Switchback incorporated in the State of Delaware (“Lightning Merger Sub”), merged with ChargePoint, Inc., a Delaware corporation (“Legacy ChargePoint”); Legacy ChargePoint survived as a wholly-owned subsidiary of Switchback (such transactions, the “Merger,” and, collectively with the other transactions described in the Merger Agreement (as defined below), the “Reverse Recapitalization”). Further, as a result of the Merger, Switchback was renamed “ChargePoint Holdings,<div style="letter-spacing: 0px; top: 0px;;display:inline;"> Inc.</div>” </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Please refer to Note 3 “Reverse Recapitalization” for further details of the Merger. </div></div> 618500000 <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2.</div></div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Summary of Significant Accounting Policies </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other than policies noted below, there have been no significant changes to the significant accounting policies disclosed in Note 2 of the <div style="letter-spacing: 0px; top: 0px;;display:inline;">audited</div> consolidated financial statements as of January 31, 2021 and 2020 and for the years ended January 31, 2021, 2020, and 2019. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock Warrants Liabilities </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company assumed 10,470,562 publicly-traded warrants (“Public Warrants”) and 6,521,568 private placement warrants issued to NGP Switchback, LLC (“Private Placement Warrants” and, together with the</div> <div style="text-indent: 0in; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Public Warrants, the “Common Stock Warrants”) upon the Merger, all of which were issued in <div style="letter-spacing: 0px; top: 0px;;display:inline;">connection</div> with<div style="letter-spacing: 0px; top: 0px;;display:inline;"> Switch</div>back’s initial public offering and subsequent overallotment (other than 1,000,000 Private Placement Warrants <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">which</div> were issued in connection with the closing of the Merger) and entitle the holder to purchase one share of the Company’s Common stock, par value $0.0001 (“Common Stock”) at an exercise price of $11.50 per share. During the six months ended July 31, 2021, 10,226,081 Public Warrants and 4,347,712<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Private Placement Warrants were exercised and the remaining 244,481 Public Warrants outstanding as of the July 6, 2021 redemption date were redeemed for cash. The Public Warrants, prior to their redemption, were publicly traded and were exercisable for cash unless certain conditions occurred, such as the failure to have an effective registration statement related to the shares issuable upon exercise or redemption by the Company under certain conditions, at which time the warrants could be cashlessly exercised. The Private Placement Warrants are not redeemable for cash so long as they are held by the initial purchasers or their permitted transferees but may be redeemable for common stock if certain other conditions are met. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated the Common Stock Warrants and concluded<div style="letter-spacing: 0px; top: 0px;;display:inline;"> that t</div>hey do not meet the criteria to be classified within stockholders’ equity. The agreement governing the Common Stock Warrants includes a provision (“Replacement of Securities Upon Reorganization”), the application of which could result in a different settlement value for the Common Stock Warrants depending on their holder. Because the holder of an instrument is not an input into the pricing of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">fixed-for-fixed</div></div> option on the Company’s ordinary shares, the Private Placement Warrants are not considered to be “indexed to the Company’s own stock.” In addition, the provision provides that in the event of a tender or exchange offer accepted by holders of more than 50% of the outstanding shares of the Company’s ordinary shares, all holders of the Common Stock Warrants (both the Public Warrants and the Private Placement Warrants) would be entitled to receive cash for all of their Common Stock Warrants. Specifically, in the event of a qualifying cash tender offer (which could be outside of the Company’s control), all Common Stock Warrant holders would be entitled to cash, while only certain of the holders of the Company’s ordinary shares may be entitled to cash. These provisions preclude the Company from classifying the Common Stock Warrants in stockholders’ equity. As the Common Stock Warrants meet the definition of a derivative, the Company recorded these warrants as liabilities on the consolidated balance sheet at fair value, with subsequent changes in their respective fair values recognized in the condensed consolidated statements of operations and comprehensive loss at each reporting date. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contingent Earnout<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Liability </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In connection with the Reverse Recapitalization and pursuant to the Merger Agreement and Plan of Merger dated as of September 23, 2020 by and among the Company, Lightning Merger Sub Inc., and Switchback (“Merger Agreement”), eligible ChargePoint equity holders were entitled to receive as additional merger consideration shares of the Comp<div style="display:inline;">a</div>ny’s Common Stock upon the Company achieving certain Earnout Triggering Events (as described in the Merger Agreement and Note 9). In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40,</div> the earnout shares were not indexed to the Common Stock and therefore were accounted for as a liability at the Reverse Recapitalization date and subsequently remeasured at each reporting date with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statements of operations. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The estimated fair value of the contingent consideration was determined using a Monte Carlo simulation using a distribution of potential outcomes on a monthly basis over the Earnout Period (as defined in Note 9) prioritizing the most reliable information available. The assumptions utilized in the calculation were based on the achievement of certain stock price milestones, including the current Company Common Stock price, expected volatility, risk-free rate, expected term and dividend rate. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Impact of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In March 2020, the World Health Organization characterized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> as a pandemic. The impact of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19,</div> including changes in consumer and business behavior, pandemic fears and market downturns, and restrictions on business and individual activities, has created significant volatility in the global economy and led to reduced economic activity. The spread of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> has disrupted ChargePoint’s supply chain and heightened its freight and logistic costs, and has similarly disrupted manufacturing, delivery and overall supply chain of vehicle manufacturers and suppliers, which has led to fluctuations in EV sales around the world. </div><a href="#toc" style="text-indent: 0px;"/></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Until its settlement the contingent earnout liability was categorized as a Level 3 fair val<div style="letter-spacing: 0px; top: 0px;;display:inline;">ue measurem</div>ent (see Fair Value of Financial Instruments accounting policy as described above) because the Company estimated projections during the Earnout Period utilizing unobservable inputs. Contingent earnout payments involve certain assumptions requiring significant judgment and actual results can differ from assumed and estimated amounts. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for doubtful accounts, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of redeemable convertible preferred stock warrants and common stock warrants, including Common Stock Warrants as a result of the Merger, contingent earnout liability, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk and Other Risks and Uncertainties </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts with large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of July 31, 2021 and January 31, 2021, one customer individually accounted for 9% and 16% of accounts receivable, net, respectively. For the six months ended July 31, 2021 and 2020, there were no customers that represented 10% or more of total revenue. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s operating results.</div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As a result of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic, ChargePoint initially modified its business practices (including reducing employee travel, recommending that all <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-essential</div> personnel work from home and cancelling or reducing physical participation in sales activities, meetings, events and conferences), implemented additional safety protocols for essential workers, and implemented temporary cost cutting measures in order to reduce its operating costs. The Company may take further actions as may be required by government authorities or that it determines are in the best interests of its employees, customers, suppliers, vendors and business partners. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">While the ultimate duration and extent of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic depends on current and future developments that cannot be accurately predicted, such as the extent and effectiveness of containment actions and vaccinations, it has already had an adverse effect on the global economy, the ultimate societal and economic impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic remains unknown. The effect of the COVID-19 pandemic can also vary over time and across the geographies in which ChargePoint operates. For example, variations in work-from-home policies can cause fluctuations in ChargePoint’s revenues, and the Company believes that since people are not yet fully back to work it has not yet seen the full return of commercial customer demand for its products. The conditions caused by the COVID-19 pandemic, such as more permanent work-from-home policies, are likely to continue affecting the rate of global infrastructure spending, and thus to continue to adversely impact ChargePoint’s gross margins as the Company’s commercial business contributes higher margins than its residential and fleet businesses. Further, the COVID-19 pandemic could continue to heighten supply chain pricing and logistics expenses, and could, for example, adversely impact ChargePoint’s gross margins through heightened supply chain expenses, and could adversely affect demand for ChargePoint’s platforms, lengthen its sales cycles, reduce the value, renewal rate or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from new customers, cause some of its paying customers to go out of business and limit the ability of its direct sales force to travel to customers and potential customers, all of which could adversely affect its business, results of operations and financial condition<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="background: none; letter-spacing: 0px; top: 0px; text-decoration: none;;display:inline;"> </div></div> <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="/* background-color: rgb(255, 255, 255); */letter-spacing: 0px;top: 0px;;display:inline;">Segment Reporting </div></div></div></div> <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="/* background-color: rgb(255, 255, 255); */letter-spacing: 0px;top: 0px;;display:inline;">The Company operates as one operating segment because its</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="/* background-color: rgb(255, 255, 255); */letter-spacing: 0px;top: 0px;;display:inline;">Chief Executive Officer, as the Company’s chief operating decision maker reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance.</div></div> <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div></div> <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; </div></div></div> </td> </tr> </table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Level 3) — Inputs that are unobservable for the asset or liability. </div></div></div> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-financial assets</div> valued on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring basis</div> that resulted in an impairment in any period presented. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">The carrying values of the Company’s cash eq<div style="letter-spacing: 0px; top: 0px;;display:inline;">uivalents, account</div>s receivable, <div style="letter-spacing: 0px; top: 0px;;display:inline;">net</div>, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining Performance Obligations </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">non-cancellable contracted</div> amounts that will be invoiced and recognized as revenue in future periods. The Company’s Assure, Cloud, and CPaaS subscription terms typically range from one to five years<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">and are paid up-front</div>. Revenue expected to be recognized from remaining performance obligations was $118.2 million as of July 31, 2021, of which 42 % is expected to be recognized over the next twelve months<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue represents billings or payments received in advance of revenue recognition and is recognized in revenue upon transfer of control. Balances consist primarily of Cloud Services and Assure services not yet provided as of the balance sheet date. Contract assets, which represent services provided or products transferred to customers in advance of the date the Company has a right to invoice, are netted against deferred revenue on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">customer-by-customer basis.</div></div> Deferred revenue that will be recognized during the succeeding <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">twelve-month</div> period is recorded as current deferred revenue with the remainder recorded as deferred revenue, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> on the condensed consolidated balance sheets. </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">Total current and non-current deferred revenue was </div> $105.8 million and $89.8 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">million as of July 31, 2021 and January 31, 2021, respectively. The Company recognized $7.7 million and $4.6 million of revenue during the three months ended July 31, 2021 and July 31, 2020, and </div></div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"> </div>$22.9 million and $21.0 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">million of revenue during the six months ended July 31, 2021 and July 31, 2020, respectively, that was included in the deferred revenue balance </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at the beginning of the period. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounting Pronouncements </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company can adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public business</div> entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">when permissible, the Company has elected to adopt new or revised accounting guidance within t<div style="letter-spacing: 0px; top: 0px;;display:inline;">he</div> same time period as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public business</div> entities, as indicated below. Based on the Company’s public float as of July 31, 2021, it will become a large accelerated filer, and lose emerging growth company status, as of January 31, 2022. As of January 31, 2022, the Company will be required to adopt new or revised accounting standards when they are applicable to public companies that are not emerging growth companies. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Issued Accounting Standards Not Yet Adopted </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In June 2016, the FASB issued <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU 2016-13,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financial Instruments</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,</div></div> and has since released various amendments including ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2019-04.</div> The guidance modifies the measurement of expected credit losses on certain financial instruments. The Company will become a large accelerated filer effective January 31, 2022, at which point the Company will follow the timeline for adoption of new accounting pronouncements for public companies. As a result, the Company will adopt ASU 2016-13 for the January 31, 2022 annual period, with a modified retrospective application to all outstanding instruments and a cumulative effect adjustment recorded to opening retained earnings as of February 1, 2021 and is currently assessing the impact the guidance will have on its condensed consolidated financial statements. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,</div></div> which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">step-up in</div> goodwill obtained in a transaction that is not a business combination. The guidance will be effective for annual reporting periods beginning after December 15, 2020, including interim periods therein. As a result, the Company will adopt ASU 2019-12 for the January 31, 2022 annual <div style="letter-spacing: 0px; top: 0px;;display:inline;">period </div>and <div style="letter-spacing: 0px; top: 0px;;display:inline;">is</div> currently assessing the impact the guidance will have on its condensed consolidated financial statements. </div></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In August 2020, the FASB issued ASU<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Debt — Debt with Conversion and Other Options (Subtopic<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40),</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>which modifies and simplifies accounting for convertible instruments. The new guidance eliminates certain separation models that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance will be effective for annual reporting periods beginning after December 15, 2020. As a result, the Company will adopt ASU 2020-06 for the January 31, 2022 annual period and is currently assessing the impact the guidance will have on its condensed consolidated financial statements.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock Warrants Liabilities </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company assumed 10,470,562 publicly-traded warrants (“Public Warrants”) and 6,521,568 private placement warrants issued to NGP Switchback, LLC (“Private Placement Warrants” and, together with the</div> <div style="text-indent: 0in; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Public Warrants, the “Common Stock Warrants”) upon the Merger, all of which were issued in <div style="letter-spacing: 0px; top: 0px;;display:inline;">connection</div> with<div style="letter-spacing: 0px; top: 0px;;display:inline;"> Switch</div>back’s initial public offering and subsequent overallotment (other than 1,000,000 Private Placement Warrants <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">which</div> were issued in connection with the closing of the Merger) and entitle the holder to purchase one share of the Company’s Common stock, par value $0.0001 (“Common Stock”) at an exercise price of $11.50 per share. During the six months ended July 31, 2021, 10,226,081 Public Warrants and 4,347,712<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Private Placement Warrants were exercised and the remaining 244,481 Public Warrants outstanding as of the July 6, 2021 redemption date were redeemed for cash. The Public Warrants, prior to their redemption, were publicly traded and were exercisable for cash unless certain conditions occurred, such as the failure to have an effective registration statement related to the shares issuable upon exercise or redemption by the Company under certain conditions, at which time the warrants could be cashlessly exercised. The Private Placement Warrants are not redeemable for cash so long as they are held by the initial purchasers or their permitted transferees but may be redeemable for common stock if certain other conditions are met. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated the Common Stock Warrants and concluded<div style="letter-spacing: 0px; top: 0px;;display:inline;"> that t</div>hey do not meet the criteria to be classified within stockholders’ equity. The agreement governing the Common Stock Warrants includes a provision (“Replacement of Securities Upon Reorganization”), the application of which could result in a different settlement value for the Common Stock Warrants depending on their holder. Because the holder of an instrument is not an input into the pricing of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">fixed-for-fixed</div></div> option on the Company’s ordinary shares, the Private Placement Warrants are not considered to be “indexed to the Company’s own stock.” In addition, the provision provides that in the event of a tender or exchange offer accepted by holders of more than 50% of the outstanding shares of the Company’s ordinary shares, all holders of the Common Stock Warrants (both the Public Warrants and the Private Placement Warrants) would be entitled to receive cash for all of their Common Stock Warrants. Specifically, in the event of a qualifying cash tender offer (which could be outside of the Company’s control), all Common Stock Warrant holders would be entitled to cash, while only certain of the holders of the Company’s ordinary shares may be entitled to cash. These provisions preclude the Company from classifying the Common Stock Warrants in stockholders’ equity. As the Common Stock Warrants meet the definition of a derivative, the Company recorded these warrants as liabilities on the consolidated balance sheet at fair value, with subsequent changes in their respective fair values recognized in the condensed consolidated statements of operations and comprehensive loss at each reporting date. </div></div> 10470562 6521568 1000000 1 0.0001 11.50 10226081 4347712 244481 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contingent Earnout<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Liability </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In connection with the Reverse Recapitalization and pursuant to the Merger Agreement and Plan of Merger dated as of September 23, 2020 by and among the Company, Lightning Merger Sub Inc., and Switchback (“Merger Agreement”), eligible ChargePoint equity holders were entitled to receive as additional merger consideration shares of the Comp<div style="display:inline;">a</div>ny’s Common Stock upon the Company achieving certain Earnout Triggering Events (as described in the Merger Agreement and Note 9). In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40,</div> the earnout shares were not indexed to the Common Stock and therefore were accounted for as a liability at the Reverse Recapitalization date and subsequently remeasured at each reporting date with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statements of operations. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The estimated fair value of the contingent consideration was determined using a Monte Carlo simulation using a distribution of potential outcomes on a monthly basis over the Earnout Period (as defined in Note 9) prioritizing the most reliable information available. The assumptions utilized in the calculation were based on the achievement of certain stock price milestones, including the current Company Common Stock price, expected volatility, risk-free rate, expected term and dividend rate. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Until its settlement the contingent earnout liability was categorized as a Level 3 fair val<div style="letter-spacing: 0px; top: 0px;;display:inline;">ue measurem</div>ent (see Fair Value of Financial Instruments accounting policy as described above) because the Company estimated projections during the Earnout Period utilizing unobservable inputs. Contingent earnout payments involve certain assumptions requiring significant judgment and actual results can differ from assumed and estimated amounts. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for doubtful accounts, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of redeemable convertible preferred stock warrants and common stock warrants, including Common Stock Warrants as a result of the Merger, contingent earnout liability, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk and Other Risks and Uncertainties </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts with large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of July 31, 2021 and January 31, 2021, one customer individually accounted for 9% and 16% of accounts receivable, net, respectively. For the six months ended July 31, 2021 and 2020, there were no customers that represented 10% or more of total revenue. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s operating results.</div></div> 0.09 0.16 0.10 0.10 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Impact of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In March 2020, the World Health Organization characterized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> as a pandemic. The impact of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19,</div> including changes in consumer and business behavior, pandemic fears and market downturns, and restrictions on business and individual activities, has created significant volatility in the global economy and led to reduced economic activity. The spread of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> has disrupted ChargePoint’s supply chain and heightened its freight and logistic costs, and has similarly disrupted manufacturing, delivery and overall supply chain of vehicle manufacturers and suppliers, which has led to fluctuations in EV sales around the world. </div><a href="#toc" style="text-indent: 0px;"/></div>As a result of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic, ChargePoint initially modified its business practices (including reducing employee travel, recommending that all <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-essential</div> personnel work from home and cancelling or reducing physical participation in sales activities, meetings, events and conferences), implemented additional safety protocols for essential workers, and implemented temporary cost cutting measures in order to reduce its operating costs. The Company may take further actions as may be required by government authorities or that it determines are in the best interests of its employees, customers, suppliers, vendors and business partners.While the ultimate duration and extent of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic depends on current and future developments that cannot be accurately predicted, such as the extent and effectiveness of containment actions and vaccinations, it has already had an adverse effect on the global economy, the ultimate societal and economic impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic remains unknown. The effect of the COVID-19 pandemic can also vary over time and across the geographies in which ChargePoint operates. For example, variations in work-from-home policies can cause fluctuations in ChargePoint’s revenues, and the Company believes that since people are not yet fully back to work it has not yet seen the full return of commercial customer demand for its products. The conditions caused by the COVID-19 pandemic, such as more permanent work-from-home policies, are likely to continue affecting the rate of global infrastructure spending, and thus to continue to adversely impact ChargePoint’s gross margins as the Company’s commercial business contributes higher margins than its residential and fleet businesses. Further, the COVID-19 pandemic could continue to heighten supply chain pricing and logistics expenses, and could, for example, adversely impact ChargePoint’s gross margins through heightened supply chain expenses, and could adversely affect demand for ChargePoint’s platforms, lengthen its sales cycles, reduce the value, renewal rate or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from new customers, cause some of its paying customers to go out of business and limit the ability of its direct sales force to travel to customers and potential customers, all of which could adversely affect its business, results of operations and financial condition<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="/* background-color: rgb(255, 255, 255); */letter-spacing: 0px;top: 0px;;display:inline;">Segment Reporting </div></div></div></div> <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="/* background-color: rgb(255, 255, 255); */letter-spacing: 0px;top: 0px;;display:inline;">The Company operates as one operating segment because its</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="/* background-color: rgb(255, 255, 255); */letter-spacing: 0px;top: 0px;;display:inline;">Chief Executive Officer, as the Company’s chief operating decision maker reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance.</div></div> 1 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div></div> <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; </div></div></div> </td> </tr> </table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Level 3) — Inputs that are unobservable for the asset or liability. </div></div></div> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-financial assets</div> valued on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring basis</div> that resulted in an impairment in any period presented. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">The carrying values of the Company’s cash eq<div style="letter-spacing: 0px; top: 0px;;display:inline;">uivalents, account</div>s receivable, <div style="letter-spacing: 0px; top: 0px;;display:inline;">net</div>, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining Performance Obligations </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">non-cancellable contracted</div> amounts that will be invoiced and recognized as revenue in future periods. The Company’s Assure, Cloud, and CPaaS subscription terms typically range from one to five years<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">and are paid up-front</div>. Revenue expected to be recognized from remaining performance obligations was $118.2 million as of July 31, 2021, of which 42 % is expected to be recognized over the next twelve months<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div> 118200000 0.42 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue represents billings or payments received in advance of revenue recognition and is recognized in revenue upon transfer of control. Balances consist primarily of Cloud Services and Assure services not yet provided as of the balance sheet date. Contract assets, which represent services provided or products transferred to customers in advance of the date the Company has a right to invoice, are netted against deferred revenue on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">customer-by-customer basis.</div></div> Deferred revenue that will be recognized during the succeeding <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">twelve-month</div> period is recorded as current deferred revenue with the remainder recorded as deferred revenue, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> on the condensed consolidated balance sheets. </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">Total current and non-current deferred revenue was </div> $105.8 million and $89.8 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">million as of July 31, 2021 and January 31, 2021, respectively. The Company recognized $7.7 million and $4.6 million of revenue during the three months ended July 31, 2021 and July 31, 2020, and </div></div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"> </div>$22.9 million and $21.0 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">million of revenue during the six months ended July 31, 2021 and July 31, 2020, respectively, that was included in the deferred revenue balance </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at the beginning of the period. </div></div></div> 105800000 89800000 7700000 4600000 22900000 21000000.0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounting Pronouncements </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company can adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public business</div> entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">when permissible, the Company has elected to adopt new or revised accounting guidance within t<div style="letter-spacing: 0px; top: 0px;;display:inline;">he</div> same time period as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public business</div> entities, as indicated below. Based on the Company’s public float as of July 31, 2021, it will become a large accelerated filer, and lose emerging growth company status, as of January 31, 2022. As of January 31, 2022, the Company will be required to adopt new or revised accounting standards when they are applicable to public companies that are not emerging growth companies. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Issued Accounting Standards Not Yet Adopted </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In June 2016, the FASB issued <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU 2016-13,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financial Instruments</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,</div></div> and has since released various amendments including ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2019-04.</div> The guidance modifies the measurement of expected credit losses on certain financial instruments. The Company will become a large accelerated filer effective January 31, 2022, at which point the Company will follow the timeline for adoption of new accounting pronouncements for public companies. As a result, the Company will adopt ASU 2016-13 for the January 31, 2022 annual period, with a modified retrospective application to all outstanding instruments and a cumulative effect adjustment recorded to opening retained earnings as of February 1, 2021 and is currently assessing the impact the guidance will have on its condensed consolidated financial statements. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,</div></div> which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">step-up in</div> goodwill obtained in a transaction that is not a business combination. The guidance will be effective for annual reporting periods beginning after December 15, 2020, including interim periods therein. As a result, the Company will adopt ASU 2019-12 for the January 31, 2022 annual <div style="letter-spacing: 0px; top: 0px;;display:inline;">period </div>and <div style="letter-spacing: 0px; top: 0px;;display:inline;">is</div> currently assessing the impact the guidance will have on its condensed consolidated financial statements. </div></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In August 2020, the FASB issued ASU<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Debt — Debt with Conversion and Other Options (Subtopic<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40),</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>which modifies and simplifies accounting for convertible instruments. The new guidance eliminates certain separation models that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance will be effective for annual reporting periods beginning after December 15, 2020. As a result, the Company will adopt ASU 2020-06 for the January 31, 2022 annual period and is currently assessing the impact the guidance will have on its condensed consolidated financial statements.</div></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3.</div></div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reverse Recapitalization </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 26, 2021, Lightning Merger Sub, a wholly-owned subsidiary of Switchback, merged with Legacy ChargePoint, with Legacy ChargePoint surviving as a wholly-owned subsidiary of Switchback. As a result of the Merger, Switchback was renamed “ChargePoint Holdings, Inc.” Immediately prior to the closing of the Merger: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">all 22,427,306 shares of Legacy ChargePoint’s outstanding Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">were</div> converted into an equivalent number of shares of Legacy ChargePoint common stock on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-to-one</div></div> basis and an additional 1,026,084 shares of Common Stock were issued to settle the accumulated dividend to the Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">H-1</div> redeemable convertible preferred stockholders of $21.1 million; </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">all 160,925,957 shares of Legacy ChargePoint’s outstanding Series H, Series G, Series F, Series E, and Series D redeemable convertible preferred stock <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">were</div> converted into an equivalent number of shares of Legacy ChargePoint common stock on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-to-one</div></div> basis; </div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">all 45,376 shares of Legacy ChargePoint’s outstanding Series C redeemable convertible preferred stock <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">were</div> converted into an equivalent number of shares of Legacy ChargePoint common stock on a 1:73.4403 basis; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">all 130,590 shares of Legacy ChargePoint’s outstanding Series B redeemable convertible preferred stock <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">were</div> converted into an equivalent number of shares of Legacy ChargePoint common stock on a 1:42.9220 basis; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">all 29,126 shares of Legacy ChargePoint’s outstanding Series A redeemable convertible preferred stock <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">were</div> converted into an equivalent number of shares of Legacy ChargePoint common stock on a 1:48.2529 basis. </div></div></td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At the Merger, eligible ChargePoint equity holders received or <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">had</div> the right to receive shares of Common Stock at a deemed value of $10.00 per share after giving effect to the exchange ratio of 0.9966 as defined in the Merger Agreement (“Exchange Ratio”). Accordingly, immediately following the consummation of the Merger, Legacy ChargePoint common stock exchanged into 217,021,368 shares of Common Stock<div style="letter-spacing: 0px; top: 0px;;display:inline;">,</div> 68,896,516 shares were reserved for the issuance of Common Stock upon the potential future exercise of Legacy ChargePoint stock options and warrants that were exchanged into ChargePoint stock options and warrants, and 27,000,000 shares of Common Stock were reserved for the potential future issuance of the earnout shares. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connection with the execution of the Merger Agreement, Switchback entered into separate subscription agreements (each a “Subscription Agreement”) with a number of investors (each a “New PIPE Investor”), pursuant to which the New PIPE Investors agreed to purchase, and Switchback agreed to sell to the New PIPE Investors, an aggregate of 22,500,000 shares of Common Stock (“PIPE Shares”), for a purchase price of $10.00 per share and an aggregate purchase price of $225.0 million, in a private placement pursuant to the subscription agreements (“PIPE Financing”). The PIPE Financing closed simultaneously with the consummation of the Merger. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">Pursuant to the terms of a letter agreement the initial Switchback stockholders entered into in connection with the execution of the Merger Agreement (“Founders Stock Letter”), the initial stockholders surrendered 984,706 of Switchback Class B common stock shares purchased by NGP Switchback, LLC, a Delaware limited liability company (“Sponsor”) prior to Switchback Public Offering on May 16, 2019 ( “Founder Shares”) for no consideration, whereupon such Founder Shares were immediately cancelled. Additionally, 900,000 Founder Earn Back Shares, which were previously subjected to potential forfeiture until the closing volume weighted average price per share of Common Stock <div style="letter-spacing: 0px; top: 0px;;display:inline;">achieved</div> $12.00 for any <span style="-sec-ix-hidden:hidden27288793">ten trading days</span> within any <span style="-sec-ix-hidden:hidden27288795">twenty consecutive trading day</span> period during the five-year period following the Closing (“Founder Earn Back Triggering Event”), met the Earn Back Triggering Event on March 12, 2021. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At the Closing, the Sponsor exercised its right to convert a portion of the working capital loans made by the Sponsor to Switchback into an additional 1,000,000 Private Placement Warrants at a price of $1.50 per warrant in satisfaction of $1.5 million principal amount of such loans. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The number of shares of Common Stock issued immediately following the consummation of the Merger was<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">as follows:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:68%;"> <tr style="font-size: 0px;"> <td style="width: 78%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock of Switchback, outstanding prior to Merger</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,264,704</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less redemption of Switchback shares</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(33,009</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less surrender of Switchback Founder Shares</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(984,706</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 78%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock of Switchback</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">38,246,989</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares issued in PIPE</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,500,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 78%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Merger and PIPE financing shares (1)</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">60,746,989</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Legacy ChargePoint shares (2)</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">217,021,368</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 78%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total shares of common stock immediately after Merger</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">277,768,357</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 78%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Merger is accounted for as a reverse recapitalization under U.S. GAAP. This determination is primarily based on Legacy ChargePoint stockholders comprising a relative majority of the voting power of ChargePoint and having the ability to nominate the members of the Board, Legacy ChargePoint’s operations prior to the acquisition comprising the only ongoing operations of ChargePoint, and Legacy ChargePoint’s senior management comprising a majority of the senior management of ChargePoint. Under this method of accounting, Switchback is treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of ChargePoint represent a continuation of the financial statements of Legacy ChargePoint with the Merger being treated as the equivalent of ChargePoint issuing stock for the net assets of Switchback, accompanied by a recapitalization. The net assets of Switchback are stated at historical costs, with no goodwill or other intangible assets recorded. Operations prior to the Merger are presented as those of ChargePoint. All periods prior to the Merger have been retrospectively adjusted using the Exchange Ratio for the equivalent number of shares outstanding immediately after the Merger to effect the reverse recapitalization. Additionally, upon the consummation of the Merger, the Company gave effect to the issuance of 60,746,989 shares of Common Stock for the previously issued Switchback common stock and PIPE Shares that were outstanding at the Closing Date. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In connection with the Merger, the Company raised $511.6 million of proceeds including the contribution of $286.6 million of cash held in Switchback’s trust account from its initial public offering, net of redemptions of Switchback public stockholders of $0.3 million, and $225.0 million of cash in connection with the PIPE financing. The Company incurred $36.5 million of transaction costs, consisting of banking, legal, and other professional fees, of which $29.5 million was recorded as a reduction to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital of proceeds and the remaining $7.0 million was expensed in the condensed consolidated statements of operations. </div> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This includes 900,000 contingently forfeitable Founder Earn Back Shares pending the occurrence of the Founder Earn Back Triggering Event, which was met on March 12, 2021 </div></div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(2)</div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The number of Legacy ChargePoint shares was determined from the 217,761,738 shares of Legacy ChargePoint common stock outstanding immediately prior to the closing of the Merger converted at the exchange ratio of 0.9966. All fractional shares were rounded down. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="break-inside: avoid; font-size: 0px;"> <td style="width: 4%; vertical-align: top;;text-align:left;"/> <td style="vertical-align: top;;text-align:left;"/> </tr> </table> 22427306 one-to-one basis 1026084 21100000 160925957 160925957 160925957 160925957 160925957 one-to-one basis one-to-one basis one-to-one basis one-to-one basis one-to-one basis 45376 1:73.4403 130590 1:42.9220 29126 1:48.2529 10.00 217021368 217021368 68896516 68896516 22500000 10.00 225000000.0 984706 900000 12.00 P5Y 1000000 1.50 1500000 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The number of shares of Common Stock issued immediately following the consummation of the Merger was<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">as follows:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:68%;"> <tr style="font-size: 0px;"> <td style="width: 78%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock of Switchback, outstanding prior to Merger</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,264,704</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less redemption of Switchback shares</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(33,009</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less surrender of Switchback Founder Shares</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(984,706</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 78%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock of Switchback</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">38,246,989</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares issued in PIPE</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,500,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 78%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Merger and PIPE financing shares (1)</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">60,746,989</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Legacy ChargePoint shares (2)</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">217,021,368</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 78%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total shares of common stock immediately after Merger</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">277,768,357</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 78%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 39264704 33009 -984706 38246989 22500000 60746989 217021368 277768357 60746989 511600000 286600000 300000 225000000.0 36500000 29500000 7000000.0 217761738 0.9966 <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4.</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 59%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Measured as of July 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 59%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 59%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market funds</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">454,713</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">454,713</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 59%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 59%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total financial assets</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">454,713</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">454,713</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 59%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 59%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 59%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock warrant liabilities (Private Placement)</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;;text-align:right;">26,868</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;;text-align:right;">26,868</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; background-color: rgb(255, 255, 255); width: 59%;"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; break-inside: avoid;"> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 59%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total financial liabilities</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;;text-align:right;">—<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;;text-align:right;">26,868</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;;text-align:right;">26,868</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(255, 255, 255);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; background-color: rgb(255, 255, 255); width: 59%;"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Measured as of January 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market funds</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 55%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total financial assets</div></div> </td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 55%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redeemable convertible preferred stock warrant liability</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;">75,843</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;">75,843</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 55%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total financial liabilities</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">75,843</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">75,843</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 55%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The money market funds were classified as cash and cash equivalents on the condensed consolidated balance sheets. The aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains or losses on money market funds as of July 31, 2021 and January 31, 2021. Realized gains and losses, net of tax, were not material for any of the periods presented. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of July 31, 2021 and January 31, 2021, the Company had no investments with a contractual maturity of greater than one year. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redeemable<br/> convertible<br/> preferred stock<br/> warrant liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private<br/> placement<br/> warrant<br/> liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Earnout<br/> liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of January 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(75,843</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Private placement warrant liability acquired as part of the merger</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(127,888</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contingent earnout liability recognized upon the closing of the reverse recapitalization</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(828,180</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value included in other income (expense), net</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,237</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49,264</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">84,420</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reclassification of warrants to stockholders’ equity (deficit) due to exercise</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">51,756</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">66,606</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of earnout shares upon triggering events</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">501,120</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reclassification of remaining contingent earnout liability upon triggering event</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">242,640</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 55%;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of July 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(26,868</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 55%;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">values</div> of the private placement warrant liability, redeemable convertible preferred stock warrant liability and earnout liability are based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy. The significant unobservable inputs used in the fair value measurements of the private placement warrant liability, the redeemable convertible preferred stock warrant liability and the earnout liability include the expected volatility and dividend yield. In determining the fair value of the private placement warrant liability, the Company used the Binomial Lattice Model (“BLM”) that assumes optimal exercise of the Company’s redemption option at the earliest possible date (Note 9). In determining the fair value of the redeemable convertible preferred stock warrant liability, the Company used <div style="letter-spacing: 0px; top: 0px;;display:inline;">the </div>Black-Scholes Option Pricing Model (“Black-Scholes”) to estimate the fair value using unobservable inputs including the expected term, expected volatility, risk-free interest rate and dividend yield (see Note 9). In determining the fair value of the earnout liability, the Company used the Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the Earnout Period using the most reliable information available (see Note 9). </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 59%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Measured as of July 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 59%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 59%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market funds</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">454,713</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">454,713</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 59%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 59%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total financial assets</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">454,713</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">454,713</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 59%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 59%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 59%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock warrant liabilities (Private Placement)</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;;text-align:right;">26,868</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); line-height: 10pt; font-size: 10pt;;text-align:right;">26,868</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; background-color: rgb(255, 255, 255); width: 59%;"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; break-inside: avoid;"> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 59%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total financial liabilities</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;;text-align:right;">—<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;;text-align:right;">26,868</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); line-height: 10pt; font-size: 10pt;;text-align:right;">26,868</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(255, 255, 255);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; background-color: rgb(255, 255, 255); width: 59%;"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 4%;">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Measured as of January 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market funds</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 55%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total financial assets</div></div> </td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 55%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redeemable convertible preferred stock warrant liability</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;">75,843</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;">75,843</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 55%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total financial liabilities</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 10pt; font-size: 10pt;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">75,843</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; width: 5%; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">75,843</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 55%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 454713000 454713000 454713000 454713000 26868000 26868000 0 26868000 26868000 109703000 109703000 109703000 109703000 75843000 75843000 75843000 75843000 0 0 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redeemable<br/> convertible<br/> preferred stock<br/> warrant liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private<br/> placement<br/> warrant<br/> liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Earnout<br/> liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of January 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(75,843</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Private placement warrant liability acquired as part of the merger</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(127,888</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contingent earnout liability recognized upon the closing of the reverse recapitalization</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(828,180</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value included in other income (expense), net</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,237</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49,264</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">84,420</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reclassification of warrants to stockholders’ equity (deficit) due to exercise</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">51,756</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">66,606</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of earnout shares upon triggering events</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">501,120</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reclassification of remaining contingent earnout liability upon triggering event</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">242,640</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 55%;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 55%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of July 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(26,868</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 55%;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> -75843000 127888000 -828180000 9237000 49264000 84420000 51756000 66606000 501120000 242640000 -26868000 <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5.</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Composition of<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Certain Financial Statement Items </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventories </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventories consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Raw materials</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">8,421</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">13,029</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Work</div>-in-progress</div></div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">68</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finished <div style="letter-spacing: 0px; top: 0px;;display:inline;">goods</div></div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,495</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,495</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 72%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Inventories</div></div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">27,916</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">33,592</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 72%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net</div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">899</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,594</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computers and software</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,843</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,384</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,140</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,605</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tooling</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,666</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,705</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,680</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,398</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Owned and operated systems</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,582</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,703</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Construction in progress</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,760</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,462</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 70%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; width: 70%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">61,570</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,851</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 70%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Accumulated depreciation</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(29,305</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(24,863</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 70%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Property and Equipment, Net</div></div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,265</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,988</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 70%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation expense for the three months ended July 31, 2021 and 2020 was $2.9 million and $2.4 million, respectively. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation expense for the six months ended July 31, 2021 and 2020 was $5.6 million and $4.7 million, respectively. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued and other current liabilities </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued and other current liabilities consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,113</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,404</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Refundable customer deposits</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,488</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,482</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Taxes payable</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,495</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,213</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Payroll and related expenses</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,372</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,547</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warranty accruals</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,100</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, current</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,130</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,393</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other liabilities</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,282</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,123</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 72%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Accrued and Other Current Liabilities</div></div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">51,980</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47,162</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 72%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">Revenue</div></div></div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue consisted of the following: </div></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 52%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended July 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended July 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 52%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United States</div></div></td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">51,109</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,347</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86,219</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">62,638</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 52%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rest of World</div></div></td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,012</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,610</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,412</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,095</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 52%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 52%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,121</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,957</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">96,631</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">67,733</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 52%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventories consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Raw materials</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">8,421</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">13,029</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Work</div>-in-progress</div></div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">68</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finished <div style="letter-spacing: 0px; top: 0px;;display:inline;">goods</div></div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,495</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,495</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 72%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Inventories</div></div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">27,916</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">33,592</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 72%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 8421000 13029000 0 68000 19495000 20495000 27916000 33592000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">899</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,594</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computers and software</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,843</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,384</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,140</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,605</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tooling</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,666</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,705</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,680</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,398</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Owned and operated systems</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,582</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,703</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Construction in progress</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,760</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,462</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 70%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; width: 70%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">61,570</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,851</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 70%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Accumulated depreciation</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(29,305</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(24,863</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 70%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 70%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Property and Equipment, Net</div></div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,265</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,988</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 70%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 899000 1594000 5843000 5384000 12140000 10605000 9666000 7705000 9680000 9398000 20582000 17703000 2760000 2462000 61570000 54851000 29305000 24863000 32265000 29988000 2900000 2400000 5600000 4700000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued and other current liabilities consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,113</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,404</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Refundable customer deposits</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,488</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,482</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Taxes payable</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,495</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,213</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Payroll and related expenses</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,372</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,547</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warranty accruals</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,100</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, current</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,130</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,393</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other liabilities</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,282</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,123</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 72%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 72%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Accrued and Other Current Liabilities</div></div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">51,980</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47,162</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 72%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 19113000 18404000 7488000 6482000 6495000 5213000 7372000 7547000 3100000 3000000 3130000 2393000 5282000 4123000 51980000 47162000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue consisted of the following: </div></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 52%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended July 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended July 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 52%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United States</div></div></td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">51,109</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,347</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86,219</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">62,638</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 52%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rest of World</div></div></td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,012</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,610</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,412</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,095</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 52%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 52%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,121</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,957</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">96,631</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">67,733</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 52%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 51109000 32347000 86219000 62638000 5012000 2610000 10412000 5095000 56121000 34957000 96631000 67733000 <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6.</div></div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Debt </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In July 2018, the Company entered into a term loan facility with certain lenders (“2018 Loan”) with a borrowing capacity of $45.0 million to finance working capital and repay all outstanding amounts owed under<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>previous loans. The Company borrowed $35.0 million, with issuance costs of $1.1 million and net proceeds of $33.9 million. The 2018 Loan was secured by substantially all of the Company’s assets, contained customary affirmative and negative covenants, and required the Company to maintain minimum cash balances and attain certain customer billing targets. The 2018 Loan had a <div style="letter-spacing: 0px; top: 0px;;display:inline;">five</div>-year maturity and interest was calculated at LIBOR plus 6.55%. The 2018 Loan agreement was amended on March 20, 2019 to extend the interest only monthly payments through June 30, 2021 to be followed by equal monthly payments of principal and interest. As of January 31, 2021, the Company was in compliance with all financial and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-financial</div> debt covenants. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction costs upon entering into the 2018 Loan were recorded as debt discount and were amortized over the term of the 2018 Loan. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">There was no interest expense incurred during the three months ending July 31, 2021; the interest expense incurred during the three months ended July 31, 2020 was $0.8 million. </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total interest expense incurred during the six months ended </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> July 31, 2021 and 2020 was $1.5 million and $1.6 million, respectively. There was no accrued interest as of July 31, 2021 and January 31, 2021. </div></div><div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In March 2021, the Company repaid the <div style="display:inline;">entire </div>loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million. </div></div> 45000000.0 35000000.0 1100000 33900000 P5Y LIBOR plus 6.55% 0.0655 0 800000 1500000 1600000 0 0 35000000.0 1200000 <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7.</div></div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Commitments<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>and Contingencies </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Purchase Commitments </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Open purchase <div style="display:inline;">commitments </div>are for the purchase of <div style="display:inline;">goods </div>and services related to, but not limited to, manufacturing, facilities, and professional services under <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancellable</div> contracts. As of July 31, 2021, the Company had open purchase commitments for goods and services of $133.7 million, all of which are <div style="display:inline;">expected </div>to be received by June 30, 2024. <br/></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Legal Proceedings</div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company may be involved in various lawsuits, claims, and proceedings, including intellectual property, commercial, securities, and employment matters that arise in the normal course of business. The Company accrues a liability when management believes information available prior to the issuance of the condensed consolidated financial statements indicates it is probable a loss has been incurred as of the date of the condensed consolidated financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred. </div><br/></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company believes it has recorded adequate provisions for any such <div style="letter-spacing: 0px; top: 0px;;display:inline;">lawsuits</div>, claims, and proceedings and, as of July 31, 2021, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in the condensed consolidated financial statements. Based on its experience, the Company believes that damage amounts claimed in these matters are not meaningful indicators of potential liability. Given the inherent uncertainties of litigation, the ultimate outcome of the ongoing matters described herein cannot be predicted with certainty. While litigation is inherently unpredictable, the Company believes it has valid defenses with respect to the legal matters pending against it. Nevertheless, the condensed consolidated financial statements could be materially adversely affected in a particular period by the resolution of one or more of these contingencies. Liabilities established to provide for contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved; and such changes are recorded in the accompanying condensed consolidated statements of operations during the period of the change and reflected in accrued and other current liabilities on the accompanying condensed consolidated balance sheets. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Guarantees<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>and Indemnifications </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has service level commitments to its customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits if the Company fails to meet those levels. To date, the Company has not incurred any material costs as a <div style="letter-spacing: 0px; top: 0px;;display:inline;">result </div>of such commitments. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s arrangements generally include certain provisions for indemnifying customers against liabilities if its products or services infringe a third-party’s intellectual property rights. Additionally, the Company may be required to indemnify for claims caused by its negligence or willful misconduct. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. To date, the Company has not incurred any material costs as a result of such obligations and has not accrued any liabilities related to such obligations in the condensed consolidated financial statements. </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company also may be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leases </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company leases its office facilities under <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable</div> operating leases with various lease terms. The Company also leases certain office equipment under operating lease agreements. </div><br/></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The following table presents future payments of lease liabilities under the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable</div> operating leases as of July 31, 2021 (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:68%;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 80%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;"><div style="letter-spacing: 0px; top: 0px; line-height: 10pt;;display:inline;">2022 (remaining six months)</div></div></td> <td style="vertical-align: bottom; width: 12%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">2,759</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; width: 80%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">2023</div></td> <td style="vertical-align: bottom; width: 12%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;"> </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">5,111</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 80%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">2024</div></td> <td style="vertical-align: bottom; width: 12%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;"> </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">4,329</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; width: 80%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">2025</div></td> <td style="vertical-align: bottom; width: 12%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;"> </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">4,153</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 80%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">2026</div></td> <td style="vertical-align: bottom; width: 12%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;"> </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">3,837</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; width: 80%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">Thereafter</div></td> <td style="vertical-align: bottom; width: 12%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;"> </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">13,871</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 80%;"> </td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 80%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total undiscounted operating lease payments</div></div></td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,060</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 80%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: imputed interest</div></div></td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(9,348</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 80%;"> </td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 80%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease liabilities</div></div></td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,712</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 80%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: current portion of operating lease liabilities</div></div></td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,130</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 80%;"> </td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 80%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, noncurrent</div></div></td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,582</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 80%;"> </td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 133700000 <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The following table presents future payments of lease liabilities under the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable</div> operating leases as of July 31, 2021 (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:68%;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 80%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;"><div style="letter-spacing: 0px; top: 0px; line-height: 10pt;;display:inline;">2022 (remaining six months)</div></div></td> <td style="vertical-align: bottom; width: 12%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">$</div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">2,759</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; width: 80%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">2023</div></td> <td style="vertical-align: bottom; width: 12%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;"> </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">5,111</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 80%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">2024</div></td> <td style="vertical-align: bottom; width: 12%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;"> </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">4,329</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; width: 80%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">2025</div></td> <td style="vertical-align: bottom; width: 12%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;"> </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">4,153</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 80%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">2026</div></td> <td style="vertical-align: bottom; width: 12%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;"> </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">3,837</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; width: 80%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">Thereafter</div></td> <td style="vertical-align: bottom; width: 12%; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;">  </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;"><div style="font-size:10pt;;display:inline;"> </div></td> <td style="vertical-align: bottom; line-height: 10pt; font-size: 10pt;;text-align:right;">13,871</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 80%;"> </td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 80%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total undiscounted operating lease payments</div></div></td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,060</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 80%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: imputed interest</div></div></td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(9,348</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 80%;"> </td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 80%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease liabilities</div></div></td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,712</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 80%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: current portion of operating lease liabilities</div></div></td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,130</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 80%;"> </td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 80%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, noncurrent</div></div></td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,582</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 80%;"> </td> <td style="vertical-align: bottom; width: 12%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 2759000 5111000 4329000 4153000 3837000 13871000 34060000 9348000 24712000 3130000 21582000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">8. Common Stock </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 26, 2021, the Merger was consummated and the Company issued 60,746,989 shares for an aggregate purchase price of $200.5 million, net of issuance costs of $29.4 million. Immediately following the Merger, there were 277,768,357 shares of Common Stock outstanding with a par value of $0.0001. The holder of each share of Common Stock is entitled to one vote. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">The Company has retroactively adjusted the shares issued and outstanding prior to February 26, 2021 to give effect to the <div style="letter-spacing: 0px; top: 0px;;display:inline;">Exchange<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Ratio<br/></div>established in the Merger Agreement to determine the number of shares of Common Stock into which they were converted. Immediately prior to the Merger, 484,951,532 shares were authorized to issue at $0.0001 par value, with 299,771,284 shares designated as Common Stock and 185,180,248 shares of redeemable convertible preferred stock. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock Reserved for Future Issuance </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Shares of Common Stock reserved for future issuance, on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-if converted</div> basis, were as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:68%;"> <tr style="font-size: 0px;"> <td style="width: 78%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock options issued and outstanding</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,401,717</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted stock units outstanding</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,017,149</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock warrants outstanding</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,249,702</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares available for grant under 2021 Equity Incentive Plan</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">40,878,653</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares available for grant under 2021 ESPP</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,177,683</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 78%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total shares of common stock reserved</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">118,724,904</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 78%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">On February 26, 2021, upon the closing of the Merger (Note 3), all of the outstanding redeemable convertible preferred stock was converted to Common Stock pursuant to the conversion rate effective immediately prior to the Merger and the remaining amount was reclassified to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. <br/></div> 60746989 200500000 29400000 277768357 0.0001 one 484951532 0.0001 299771284 185180248 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Shares of Common Stock reserved for future issuance, on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-if converted</div> basis, were as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:68%;"> <tr style="font-size: 0px;"> <td style="width: 78%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock options issued and outstanding</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,401,717</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted stock units outstanding</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,017,149</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock warrants outstanding</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,249,702</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares available for grant under 2021 Equity Incentive Plan</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">40,878,653</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 78%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares available for grant under 2021 ESPP</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,177,683</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 78%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 78%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total shares of common stock reserved</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">118,724,904</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 78%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 26401717 4017149 39249702 40878653 8177683 118724904 <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">9.</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock Warrants and<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Earnout </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redeemable Convertible Preferred Stock Warrants </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Warrants to purchase a total of 2,358,528 <div style="display:inline;">shares of Series B, D and E redeemable convertible preferred stock were initially recognized as a liability recorded at fair value upon issuance and were subject to remeasurement to fair value at each balance sheet date. As part of the Merger, Legacy ChargePoint redeemable convertible preferred stock was converted into Legacy ChargePoint common stock pursuant to the conversion rate effective immediately prior to the Merger while all related Legacy ChargePoint preferred stock warrants were converted into warrants exercisable for shares of Common Stock with terms consistent with the Legacy ChargePoint preferred stock warrants except for the number of shares exercisable therefor and the exercise price, each of which was adjusted using the Exchange Ratio. At that time, the redeemable convertible preferred stock warrant liability was remeasured and reclassified to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">additional paid-in capital.</div> </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The liability associated with these warrants was subject to remeasurement at each balance sheet date using the Level 3 fair value inputs. See Note 4 for further details. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 67%;"/> <td style="width: 13%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">February 26,<br/> 2021</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Merger Date)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 67%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">84.3</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">80.5</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 67%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.1</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 67%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend rate</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 67%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (years)</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Common Stock Warrants </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition to the warrants to purchase 2,358,528 shares of Legacy ChargePoint preferred stock described above, Legacy ChargePoint had outstanding warrants to purchase 36,402,503 shares of Legacy ChargePoint</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">common stock (collectively, “Legacy Warrants”), which now represent warrants to purchase Common Stock. During the three months ended July 31, 2021, 587,880 Legacy Warrants were net exercised resulting in the issuance of 558,100 shares of Common Stock. During the six months ended July 31, 2021, 1,685,185 Legacy Warrants were net exercised resulting in the issuance of 1,480,080 shares of Common Stock. As of July 31, 2021, there were 37,075,846 Legacy Warrants outstanding which are classified as equity. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Private Placement Warrants </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants were initially recognized as a liability on February 26, 2021, at a fair value of $127.9 million and the Private Placement Warrant liability was remeasured to fair value as of any respective exercise dates and as of July 31, 2021. The Company recorded a gain of $3.8 million and $49.2 million for the three and six months ended July 31, 2021, respectively, classified within change in fair value of warrant liabilities in the condensed consolidated statements of operations. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants were valued using the following assumptions under <div style="letter-spacing: 0px; top: 0px;;display:inline;">the </div>BLM that assumes optimal exercise of the Company’s redemption option at the earliest possible date: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 73%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">February 26,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 73%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market price of public stock</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23.65</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">$30.83</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 73%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">$11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 73%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (years)</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.6</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.0</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 73%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">70.2</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 7%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">73.5</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 73%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.6</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 7%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.8</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 73%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend rate</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 7%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> </table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Public Warrants </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Public Warrants may only be exercised for a whole number of shares. The Public Warrants became exercisable 30 days after the completion of the Merger. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Public Warrants were initially recognized as a liability on February 26, 2021 at a fair value of $153.7 million and the public warrant liability was remeasured to fair value based upon the market price as warrants were exercised. <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On June 4, 2021 the Company issued a redemption notice pursuant to which all but 244,481 Public Warrants were exercised by the Public Warrant holders. At the conclusion of the redemption notice period on </div></div>July 6, 2021, the Company redeemed the remaining<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">244,481</div> Public Warrants<div style="letter-spacing: 0px; top: 0px;;display:inline;"> outstanding</div> for $0.01 per warrant. The Company recognized a loss of $14.3 million for the three months ended July 31, 2021 and a loss of $15.9 million for the six months ended July 31, 2021, classified within change in fair value of warrant liabilities in the condensed consolidated statements of operations. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the six months ended July 31, 2021, proceeds received for the exercise of Public Warrants were $117.6 million. As of July 31, 2021, no Public Warrants remained outstanding. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Activity of warrants is set forth below: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 38%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Legacy Common<br/> and Preferred Stock<br/> Warrants <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:7.5px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private<br/> Placement<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Stock<br/> Warrants <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:7.5px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 38%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2021</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">38,761,031</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">38,761,031</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 38%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock Warrants as Part of the Merger</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,521,568</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,470,562</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,992,130</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 38%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants Exercised</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,685,185</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,347,712</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,226,081</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(16,258,978</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 38%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants Redeemed</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(244,481</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(244,481</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 38%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 38%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of July 31, 2021</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">37,075,846</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,173,856</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,249,702</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 38%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The shares (and the warrants’ exercise prices) subject to the Company’s Legacy common and preferred stock warrants were restated to reflect the exchange ratio of approximately 0.9966 established in the Merger Agreement as discussed in Note 3. </div></div> </td> </tr> </table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Contingent Earnout Liability </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the five year period starting at the closing of the Merger (“Earnout Period”), eligible former equity holders of Legacy ChargePoint<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">could</div><br/> receive up to 27,000,000 additional shares of Common Stock (“Earnout Shares”) in the aggregate in three equal tranches if certain Earnout Triggering Events (as described in the Merger Agreement) are fully satisfied. An “Earnout Triggering Event” means the date on which the closing volume weighted-average price (“VWAP”) per share of common stock quoted on the NYSE (or the exchange on which the shares of common stock are then listed) is greater or equal to $15.00, $20.00 and $30.00 for any<span style="-sec-ix-hidden:hidden27288504"> ten</span> trading days within any 20 consecutive trading day period within the Earnout Period. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upon the closing of the Merger, the contingent obligation to issue Earnout Shares was accounted for as a liability because the Earnout Triggering Events that determine the number of Earnout Shares required to be issued include events that are not solely indexed to the common stock of ChargePoint. The estimated fair value of the total Earnout Shares at the closing of the Merger on February 26, 2021, was $828.2 million based on a Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the Earnout Period using the most reliable information available. Assumptions used in the valuation are described below.</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:68%;"> <tr style="font-size: 0px;"> <td style="width: 65%;"/> <td style="width: 13%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 12,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">February 26,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current stock price</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27.84</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30.83</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">72.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">71.60</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.85</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.75</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend rate</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (years)</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.96</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.00</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">The first two Earnout Triggering Events for up to 18,000,000 of the Earnout Shares occurred on March 12, 2021, and, after withholding some of these Earnout Shares<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"> to cover </div>tax <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">withholding obligations,</div> 17,539,657 Earnout Shares were issued on March 19, 2021, and the estimated fair value of the earnout liability was remeasured to $743.7 million, including (i) $501.1 million related to the Earnout Shares issuable upon the occurrence of the Earnout Triggering Event associated with the $15.00 and $20.00 VWAP per share thresholds</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">based on the Common Stock price as of March 12, 2021, and (ii) $242.6 million related to the estimated fair value of earnout liability related to the remaining 9,000,000 Earnout Shares issuable upon the occurrence of the Earnout Triggering Event associated with the $30.00 VWAP per share threshold based on a Monte Carlo simulation valuation model as of March 12, 2021, as described above. The change in fair value resulted in a gain of $84.4 million recognized in the condensed consolidated statement of operations for the three months ended April 30, 2021. Upon settlement of the first two tranches, the classification of the remaining 9,000,000 Earnout Shares of the third tranche was changed to equity on March 12, 2021, because the Earnout Shares became an instrument contingently issuable upon the occurrence of the Earnout Triggering Event into a fixed number of Common Shares that is not based on an observable market price or index other than the Company’s own stock price. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The third and final<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Earnout Triggering Event for up to 9,000,000 of the Earnout Shares associated with the $30.00 VWAP per share threshold occurred on June 29, 2021, and, after the withholding of some of these Earnout Shares <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">to cover</div> tax <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">withholding obligations,</div> 8,773,596 Earnout Shares were issued on July 1, 2021<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">.</div> <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">No</div> further Earnout Shares remained contingently issuable as of July 31, 2021. </div></div> 2358528 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 67%;"/> <td style="width: 13%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">February 26,<br/> 2021</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Merger Date)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 67%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">84.3</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">80.5</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 67%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.1</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 67%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend rate</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 67%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (years)</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> 0.843 0.805 0.000 0.001 0.000 0.000 0.0 1.4 2358528 36402503 587880 558100 1685185 1480080 37075846 127900000 3800000 49200000 The Private Placement Warrants were valued using the following assumptions under <div style="letter-spacing: 0px; top: 0px;;display:inline;">the </div>BLM that assumes optimal exercise of the Company’s redemption option at the earliest possible date: <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 73%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">February 26,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 73%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market price of public stock</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23.65</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">$30.83</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 73%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">$11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 73%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (years)</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.6</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.0</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 73%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">70.2</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 7%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">73.5</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 73%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.6</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 7%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.8</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 73%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend rate</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 7%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> </table> 23.65 30.83 11.50 11.50 4.6 5.0 0.702 0.735 0.006 0.008 0.000 0.000 P30Y 153700000 244481 244481 0.01 14300000 15900000 117600000 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Activity of warrants is set forth below: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 38%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Legacy Common<br/> and Preferred Stock<br/> Warrants <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:7.5px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private<br/> Placement<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Stock<br/> Warrants <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:7.5px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 38%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2021</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">38,761,031</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">38,761,031</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 38%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock Warrants as Part of the Merger</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,521,568</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,470,562</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,992,130</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 38%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants Exercised</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,685,185</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,347,712</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,226,081</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(16,258,978</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 38%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants Redeemed</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(244,481</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(244,481</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 38%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 38%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of July 31, 2021</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">37,075,846</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,173,856</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,249,702</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 38%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The shares (and the warrants’ exercise prices) subject to the Company’s Legacy common and preferred stock warrants were restated to reflect the exchange ratio of approximately 0.9966 established in the Merger Agreement as discussed in Note 3. </div></div> </td> </tr> </table> 38761031 38761031 6521568 10470562 16992130 -1685185 -4347712 -10226081 -16258978 -244481 -244481 37075846 2173856 0 39249702 0.9966 27000000 15.00 20.00 30.00 P20D 828200000 Assumptions used in the valuation are described below. <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:68%;"> <tr style="font-size: 0px;"> <td style="width: 65%;"/> <td style="width: 13%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 12,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">February 26,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current stock price</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27.84</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30.83</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">72.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">71.60</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.85</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.75</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend rate</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (years)</div></div> </td> <td style="vertical-align: bottom; width: 13%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.96</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 12%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.00</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> 27.84 30.83 0.7200 0.7160 0.0085 0.0075 0.0000 0.0000 4.96 5.00 18000000 17539657 743700000 501100000 15.00 20.00 242.6 9000000 30.00 84400000 9000000 9000000 30.00 8773596 <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10.</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Equity Plans and Stock-based Compensation </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 25, 2021, the stockholders of the Company approved the 2021 Equity Incentive Plan (“2021 EIP”) and the 2021 Employee Stock Purchase Plan (“2021 ESPP”). As of July 31, 2021, 40,878,653 and 8,177,683 shares of Common Stock were available under the 2021 EIP and 2021 ESPP, respectively. On the first day of each March, beginning on March 1, 2021 and continuing through March 1, 2030, the 2021 EIP reserve will automatically increase by a number of shares equal to the lesser of (a) 5% of the total number of shares actually issued and outstanding on the last day of the preceding month and (b) a number determined by the Company’s Board of Directors. Further, on the first day of each March during the term of the 2021 ESPP, commencing on March 1, 2021 and ending on (and including) March 1, 2040, the aggregate number of shares of stock that may be issued under the 2021 ESPP shall automatically increase by a number equal to the lesser of (i) one percent (1%) of the total number of shares of stock issued and outstanding on the last day of the preceding month, (ii) 5,400,000 shares of stock (subject to standard anti-dilution adjustments), or (iii) a number of shares of stock determined by the Company’s Board of Directors. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under the 2021 EIP, the Company can grant stock options, stock appreciation rights, restricted stock, restricted stock units (“RSU”) and certain other awards which are <div style="letter-spacing: 0px; top: 0px;;display:inline;">s</div>ettled in the form of common shares issued under this 2021 EIP. Under the 2021 ESPP, eligible employees are permitted to purchase shares of the Company’s Common Stock at 85% of the lower of fair market value the Company’s Common Stock on the first trading day of an offering period or on the purchase date. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">No further awards will be granted under Legacy ChargePoint’s 2017 Stock Plan (“2017 Plan”) and 24,259,238 shares of Common Stock remain reserved for outstanding awards issued under the 2017 Plan at the time of adoption of the 2021 EIP and the 2021 ESPP. Additionally, no other awards can be granted under Legacy ChargePoint’s 2007 Stock Incentive Plan (“2007 Plan”) and 5,143,849 shares of Common Stock remained reserved for outstanding awards issued under the 2007 Plan at the time of the adoption of the 2021 EIP and the 2021 ESPP. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s stock option awards activity is set forth below: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/> Stock Option<br/> Awards</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Exercise Price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> term (in years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/> Intrinsic Value<br/> (in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,166,792</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.71</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.3</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,064,539</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options exercised</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,292,219</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.53</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options forfeited</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(452,893</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.73</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options expired</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(19,963</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">53.22</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 44%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of July 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,401,717</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.69</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.0</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">606,280</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 44%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options vested and expected to vest as of July 31, 2021</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,667,621</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.69</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.0</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">589,470</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 44%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercisable as of July 31, 2021</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,457,228</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.66</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.3</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">378,402</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 44%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The options outstanding as of July 31, 2021, include the June 2020 grant of a stock option to purchase a total of 1.5 million shares of Common Stock subject to both service and performance-based vesting conditions to the Chief Executive Officer under the 2017 Plan (“CEO Award”). No stock-based compensation expense had been recorded as the CEO awards were improbable of vesting before and after two modifications in each of September 2020 and December 2020, because the performance-based vesting condition was contingent upon the closing of the Merger. Accordingly, the Company commenced recognition of stock-based compensation expense for such CEO Award following the Merger in February 2021. As of July 31, 2021, the total unrecognized compensation expense related to these unvested CEO Award was $35.3 million, which is expected to be recognized over a period of 2.5 years<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s RSU activity is set forth below: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 64%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average Grant<br/> Date Fair Value<br/> per Share</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RSU granted</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,680,439</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27.38</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">RSU vested</div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(652,901</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27.30</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RSU forfeited</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,389</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27.30</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 64%;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of July 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,017,149</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27.40</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 64%;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> </table> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of July 31, 2021, total unrecognized stock-based compensation expense related to stock options was $41.0 million, including the CEO Award, and is expected to be recognized over a weighted-average period of 1.9 years. As of July 31, 2021, total unrecognized stock-based compensation expense related to RSU was $86.3 million and is expected to be recognized over a weighted-average period of 3.1 years.</div></div><div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following sets forth the total stock-based compensation expense for the Company’s stock options (including the CEO Award) and RSU included in the Company’s condensed consolidated statements of operations: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cost of revenue</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,164</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">41</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,188</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">64</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,682</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">454</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,357</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">757</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales and marketing</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,169</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">356</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,767</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">655</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,278</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">339</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,558</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">624</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;width:100%;">Total stock-based compensation expense</div></div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,293 </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,190</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,870</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,100</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 40878653 8177683 On the first day of each March, beginning on March 1, 2021 and continuing through March 1, 2030, the 2021 EIP reserve will automatically increase by a number of shares equal to the lesser of (a) 5% of the total number of shares actually issued and outstanding on the last day of the preceding month and (b) a number determined by the Company’s Board of Directors. on the first day of each March during the term of the 2021 ESPP, commencing on March 1, 2021 and ending on (and including) March 1, 2040, the aggregate number of shares of stock that may be issued under the 2021 ESPP shall automatically increase by a number equal to the lesser of (i) one percent (1%) of the total number of shares of stock issued and outstanding on the last day of the preceding month, (ii) 5,400,000 shares of stock (subject to standard anti-dilution adjustments), or (iii) a number of shares of stock determined by the Company’s Board of Directors. Under the 2021 ESPP, eligible employees are permitted to purchase shares of the Company’s Common Stock at 85% of the lower of fair market value the Company’s Common Stock on the first trading day of an offering period or on the purchase date. 24259238 5143849 <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s stock option awards activity is set forth below: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/> Stock Option<br/> Awards</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Exercise Price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> term (in years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/> Intrinsic Value<br/> (in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,166,792</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.71</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.3</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,064,539</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options exercised</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,292,219</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.53</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options forfeited</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(452,893</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.73</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options expired</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(19,963</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">53.22</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 44%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of July 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,401,717</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.69</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.0</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">606,280</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 44%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options vested and expected to vest as of July 31, 2021</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,667,621</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.69</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.0</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">589,470</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 44%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 44%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercisable as of July 31, 2021</div></div> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,457,228</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.66</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.3</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">378,402</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 44%;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 7%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> </table> 30166792 0.71 P7Y3M18D 1064539000 3292219 0.53 452893 0.73 19963 53.22 26401717 0.69 P7Y 606280000 25667621 0.69 P7Y 589470000 16457228 0.66 P6Y3M18D 378402000 1500000 0 35300000 P2Y6M <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s RSU activity is set forth below: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 64%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average Grant<br/> Date Fair Value<br/> per Share</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RSU granted</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,680,439</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27.38</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">RSU vested</div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(652,901</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27.30</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RSU forfeited</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,389</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27.30</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 64%;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of July 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,017,149</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27.40</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 64%;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> </table> 0 0 4680439 27.38 652901 27.30 10389 27.30 4017149 27.40 41000000.0 P1Y10M24D 86300000 P3Y1M6D <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following sets forth the total stock-based compensation expense for the Company’s stock options (including the CEO Award) and RSU included in the Company’s condensed consolidated statements of operations: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cost of revenue</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,164</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">41</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,188</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">64</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,682</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">454</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,357</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">757</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales and marketing</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,169</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">356</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,767</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">655</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,278</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">339</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,558</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">624</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;width:100%;">Total stock-based compensation expense</div></div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,293 </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,190</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,870</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,100</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 2164000 41000 2188000 64000 13682000 454000 14357000 757000 4169000 356000 4767000 655000 8278000 339000 14558000 624000 28293000 1190000 35870000 2100000 <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11.</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Taxes </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The income tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate as adjusted for discrete items arising in that quarter. The effective income tax rate was nil for the three and six months ended July 31, 2021 and 2020. The effective tax rate differs from the U.S. statutory rate primarily due to the full valuation allowances on the Company’s net domestic deferred tax assets as it is more likely than not that all of the deferred tax assets will not be realized. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) was enacted and signed into law in the United States. The CARES Act includes measures to assist companies, including temporary changes to income and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-income-based tax</div> laws. The Company did not receive a stimulus payment related to the CARES Act. </div> 0 0 <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12.</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Related Party Transactions </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Daimler AG and its affiliated entities (“Daimler”) are investors in the Company and one of its employees is a member of the Company’s Board of Directors. The following revenue transactions took place between the Company and Daimler during the periods presented: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 66%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 66%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Daimler</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,071</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">850</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,406</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,576</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 66%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 66%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue from related parties</div></div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,071</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">850</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,406</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,576</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 66%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Related party accounts receivable as of July 31, 2021 and January 31, 2021 from Daimler was $2.5 million and $1.2 million, respectively. </div></div> The following revenue transactions took place between the Company and Daimler during the periods presented: <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 66%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 66%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Daimler</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,071</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">850</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,406</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,576</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 66%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 66%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue from related parties</div></div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,071</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">850</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,406</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,576</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 66%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 2071000 850000 3406000 1576000 2071000 850000 3406000 1576000 2500000 1200000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">13. Basic and Diluted Net Loss per Share </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and six months ended July 31, 2021 and 2020: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="font-size: 0px;"> <td style="width: 52%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands, except share and<br/> per share data)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands, except share and<br/> per share data)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss)</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(84,938</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(35,287</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(2,649</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(65,385</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Adjust:</div></div> Accretion of beneficial conversion feature of redeemable convertible preferred stock</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(58,625</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(58,625</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Adjust:</div></div> Cumulative dividends on redeemable convertible preferred stock</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(4,292</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Adjust:</div></div> Deemed dividends attributable to vested option holders</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(51,855</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Adjust:</div></div> Deemed dividends attributable to common stock warrant holders</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(110,635</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss attributable to common stockholders - Basic</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(84,938</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(93,912</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(169,431</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(124,010</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Less:</div></div> Gain attributable to earnout shares issued</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(84,420</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Less:</div></div> Change in fair value of dilutive warrants</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(7,427</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(53,540</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss attributable to common stockholders - Diluted</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(92,365</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(93,912</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(307,391</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(124,010</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average common shares outstanding</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">312,465,016</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">13,537,501</div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">266,473,703</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">12,822,481</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Less:</div></div> Weighted-average unvested restricted shares and shares subject to repurchase</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(237,490</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(68,824</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(276,221</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average shares outstanding - Basic</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">312,227,526</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">13,468,677</div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">266,197,482</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">12,822,481</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Add:</div></div> Earnout Shares under the treasury stock method</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">7,464,203</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—   </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Add:</div></div> Public and Private Placement Warrants under the treasury stock method</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,374,574</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,915,315</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—   </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average shares outstanding - Diluted</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">313,602,100</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">13,468,677</div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">275,577,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">12,822,481</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share - Basic</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(0.27</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(6.97</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(0.64</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(9.67</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share - Diluted</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(0.29</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(6.97</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1.12</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(9.67</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">As a result of the Merger, the Company has retroactively adjusted the weighted-average number of shares of Common Stock outstanding prior to <div style="letter-spacing: 0px; top: 0px;;display:inline;">the </div>Closing Date by multiplying them by the <div style="letter-spacing: 0px; top: 0px;;display:inline;">Exchange Ratio</div> of 0.9966 used to determine the number of shares of Common Stock into which they converted. The Common Stock issued as a result of the redeemable convertible preferred stock conversion on the Closing Date was included in the basic net loss per share calculation on a prospective basis.</div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Redeemable convertible preferred stock and preferred stock warrants outstanding prior to the Merger Closing Date were excluded from the diluted net loss per share calculation for the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">six-months</div> period ended July 31, 2021, because including them would have had an antidilutive effect<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 64%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0); text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">July 31,<br/> 2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="font-weight:bold;display:inline;width:100%;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="font-weight:bold;display:inline;width:100%;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0); text-indent: 0px; text-align: center;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">July 31,<br/> 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Redeemable convertible preferred stock (on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis)</div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">192,469,995</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options to purchase common stock</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">26,401,717</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">39,463,877</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted stock units</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; text-align: right;">4,017,149</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested early exercised common stock options</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">211,464</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">102,781</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock and preferred stock warrants</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">37,075,846</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">38,193,342</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 64%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total potentially dilutive common share equivalents</div></div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">67,706,176</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">270,229,995</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 64%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and six months ended July 31, 2021 and 2020: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="font-size: 0px;"> <td style="width: 52%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">July 31,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands, except share and<br/> per share data)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands, except share and<br/> per share data)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss)</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(84,938</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(35,287</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(2,649</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(65,385</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Adjust:</div></div> Accretion of beneficial conversion feature of redeemable convertible preferred stock</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(58,625</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(58,625</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Adjust:</div></div> Cumulative dividends on redeemable convertible preferred stock</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(4,292</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Adjust:</div></div> Deemed dividends attributable to vested option holders</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(51,855</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Adjust:</div></div> Deemed dividends attributable to common stock warrant holders</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(110,635</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss attributable to common stockholders - Basic</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(84,938</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(93,912</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(169,431</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(124,010</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Less:</div></div> Gain attributable to earnout shares issued</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(84,420</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Less:</div></div> Change in fair value of dilutive warrants</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(7,427</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(53,540</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss attributable to common stockholders - Diluted</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(92,365</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(93,912</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(307,391</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(124,010</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average common shares outstanding</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">312,465,016</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">13,537,501</div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">266,473,703</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">12,822,481</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Less:</div></div> Weighted-average unvested restricted shares and shares subject to repurchase</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(237,490</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(68,824</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(276,221</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average shares outstanding - Basic</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">312,227,526</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">13,468,677</div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">266,197,482</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">12,822,481</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Add:</div></div> Earnout Shares under the treasury stock method</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">7,464,203</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—   </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Add:</div></div> Public and Private Placement Warrants under the treasury stock method</div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,374,574</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,915,315</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—   </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average shares outstanding - Diluted</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">313,602,100</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">13,468,677</div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">275,577,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">12,822,481</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share - Basic</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(0.27</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(6.97</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(0.64</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(9.67</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share - Diluted</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(0.29</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(6.97</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1.12</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(9.67</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> -84938000 -35287000 -2649000 -65385000 0 58625000 0 58625000 0 -4292000 0 -51855000 0 -110635000 -84938000 -93912000 -169431000 -124010000 0 -84420000 -7427000 -53540000 -92365000 -93912000 -307391000 -124010000 312465016 13537501 266473703 12822481 -237490 -68824 -276221 0 312227526 13468677 266197482 12822481 0 0 7464203 0 1374574 0 1915315 0 313602100 13468677 275577000 12822481 -0.27 -6.97 -0.64 -9.67 -0.29 -6.97 -1.12 -9.67 0.9966 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 64%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0); text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">July 31,<br/> 2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="font-weight:bold;display:inline;width:100%;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="font-weight:bold;display:inline;width:100%;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0); text-indent: 0px; text-align: center;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">July 31,<br/> 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Redeemable convertible preferred stock (on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis)</div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">192,469,995</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options to purchase common stock</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">26,401,717</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">39,463,877</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted stock units</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; text-align: right;">4,017,149</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested early exercised common stock options</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">211,464</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">102,781</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock and preferred stock warrants</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">37,075,846</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">38,193,342</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 64%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 64%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total potentially dilutive common share equivalents</div></div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">67,706,176</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">270,229,995</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 64%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 0 192469995 26401717 39463877 4017149 0 211464 102781 37075846 38193342 67706176 270229995 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">14. Acquisitions<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>and Subsequent Events </div></div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July 20, 2021, the Company entered into a definitive agreement to acquire all of the outstanding shares of has•to•be gmbh (“has•to•be” or “HTB”) for approximately<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro 250.0 million <div style="letter-spacing: 0px; top: 0px;;display:inline;">in cash and Company common stock subject to adjustments. </div></div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 4%; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;">has•to•be<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">is an Austria-based </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">e-mobility</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> provider with a European charging software platform. The acquisition is intended to expand the Company’s access to the European market. The Company currently expects the transaction to close as early as October 2021.</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">On August 11, 2021, the Company acquired all of the outstanding shares of ViriCiti B.V. (“ViriCiti”) for approximately</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">Euro </div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">75.0</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> million in cash,</div></div><br/> <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">subject to adjustments. ViriCiti is a Netherlands-based provider of electrification solutions for eBus and commercial fleets with offices in the Netherlands and the United States. The acquisition is expected to enhance ChargePoint’s fleet solutions portfolio of hardware, software and services by integrating information sources to optimize electric fleet operations.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">As permitted by ASU </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">805-10-50,</div></div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> the Company is not able to include certain required disclosures in its quarterly report on Form </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> for the three and six months ended July 31, 2021, because the information necessary to complete the preliminary purchase price allocation related to the acquisition was not yet available. </div></div></div> 250000000.0 75000000.0 145491000 72753000 400000 400000 0 47037000 2000000 2000000 35075000 38488000 33592000 25419000 12074000 7221000 226632000 191318000 29988000 27941000 21817000 10269000 1215000 1215000 10468000 3448000 290120000 234191000 19784000 19631000 47162000 37659000 40934000 39408000 10208000 0 118088000 96698000 48896000 33266000 24686000 34261000 22459000 8230000 75843000 2718000 972000 798000 290944000 175971000 0.0001 0.0001 185180248 162829195 182934257 182934257 160583203 160583203 693548000 563753000 615697000 520241000 0.0001 0.0001 299771284 240180600 22961032 22961032 11918418 11918418 2000 1000 62736000 20331000 155000 37000 -679414000 -482390000 -616521000 -462021000 290120000 234191000 91893000 101012000 61338000 40563000 28930000 22504000 14034000 14573000 8188000 146490000 144515000 92030000 87083000 105940000 59928000 20385000 16244000 10441000 6073000 4289000 2157000 113541000 126473000 72526000 32949000 18042000 19504000 75017000 69464000 50510000 53002000 56997000 56411000 25922000 23945000 17870000 153941000 150406000 124791000 -120992000 -132364000 -105287000 315000 3245000 1402000 3253000 3544000 3690000 73125000 875000 388000 229000 -565000 -5000 -196826000 -134103000 -107968000 198000 224000 119000 -197024000 -134327000 -108087000 60377000 0 0 16799000 0 0 -274200000 -134327000 -108087000 -18.14 -15.10 -24.89 15116763 8893787 4342517 -197024000 -134327000 -108087000 141000 131000 -106000 0 23000 0 23000 0 0 118000 154000 -106000 -196906000 -134173000 -108193000 118428814 290316000 2436734 0 10463000 -11000 -242165000 -231713000 8400000 39519739 215169000 1454000 1454000 3794964 1000 1366000 1367000 58971 797280 4000 4000 1706000 1706000 -108087000 -108087000 -106000 -106000 157948553 505485000 7087949 1000 14993000 -117000 -350252000 -335375000 2189000 2189000 100000 2634650 14756000 185000 185000 4795588 2201000 2201000 34881 15000 15000 2937000 2937000 -134327000 -134327000 154000 154000 160583203 520241000 11918418 1000 20331000 37000 -482390000 -462021000 200000 22351054 95456000 31547000 31547000 -60377000 60377000 60377000 -60377000 60377000 60377000 10363603 1000 5643000 5644000 679011 268000 268000 4947000 4947000 -197024000 -197024000 118000 118000 182934257 615697000 22961032 2000 62736000 155000 -679414000 -616521000 -197024000 -134327000 -108087000 10083000 7698000 4086000 3762000 3121000 0 4947000 2937000 1706000 1206000 675000 0 73125000 875000 388000 1412000 1425000 1089000 -446000 -589000 -1822000 -3292000 8702000 2735000 9585000 1472000 19457000 8914000 2961000 1760000 -2815000 -1181000 0 -493000 15704000 -1120000 11556000 93000 10802000 17156000 27590000 12720000 -91846000 -87936000 -100546000 11484000 14885000 14822000 0 179514000 0 47014000 132500000 0 0 0 1475000 35530000 -61899000 -16297000 95456000 14756000 215168000 31547000 185000 1454000 0 0 33988000 4003000 0 0 0 0 18182000 5913000 2217000 1370000 128913000 17158000 233798000 141000 132000 -101000 72738000 -132545000 116854000 73153000 205698000 88844000 145891000 73153000 205698000 2801000 3414000 2583000 172000 153000 117000 60377000 0 0 1685000 0 0 2118000 2906000 0 12867000 0 0 647000 1287000 0 268000 15000 4000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1.    Description of Business and Basis of Presentation </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">ChargePoint, Inc. (“ChargePoint” or the “Company,” “it,” “its”) designs, develops, and markets networked electric vehicle (“EV”) charging system infrastructure and cloud-based services which enable consumers the ability to locate, reserve, authenticate, and transact charging sessions for EVs. As part of its networked charging systems, subscriptions, and other offerings, the Company provides an open platform that integrates with system hardware from multiple manufacturers, connecting systems over an intelligent network that provides real-time information about charging systems. This network provides multiple <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">web-based</div> portals for charging system owners, fleet managers, drivers, and utilities. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On September 23, 2020, the Company entered into a merger agreement (the “Merger Agreement”) with Switchback Energy Acquisition Corporation (“Switchback”), where a subsidiary of Switchback was to merge with the Company (collectively with the other transactions described in the Merger Agreement, the “Merger”). As a result of the proposed Merger, Switchback was to be renamed to ChargePoint Holdings, Inc. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 26, 2021 (the “Closing Date”), ChargePoint Holdings, Inc. consummated the Merger by and among Switchback, Lightning Merger Sub Inc., a subsidiary of the Company (“Merger Sub”), and ChargePoint. At the Closing, Merger Sub merged with and into ChargePoint, with ChargePoint surviving the Merger as a wholly owned subsidiary of ChargePoint Holdings, Inc. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, as part of the Merger, certain investors purchased an aggregate of 22,500,000 shares of Common Stock (“PIPE Investors”) concurrently with the Closing for an aggregate purchase price of $225,000,000. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 26, 2021, upon consummation of the Merger, eligible ChargePoint equity holders, including holders of ChargePoint’s redeemable convertible preferred stock which converted into shares of common stock immediately prior to the closing of the Merger, received or have the right to receive shares of common stock at a deemed value of $10.00 per share after giving effect to the exchange ratio of 0.9966 as defined in the Merger Agreement (“Exchange Ratio”). The Merger is accounted for as a reverse recapitalization under U.S. GAAP. For accounting purposes, the financial statements of the Company will represent a continuation of the financial statements of ChargePoint with the Merger treated as the equivalent of ChargePoint issuing stock for the net assets of Switchback, accompanied by a recapitalization. Accordingly, all periods prior to the Merger for the reported share and per share amounts have been retrospectively adjusted using the Exchange Ratio to effect the reverse recapitalization. See Note 18 for more information. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s fiscal year ends on January 31. References to fiscal years 2021, 2020, and 2019 relate to the fiscal years ended January 31, 2021, January 31, 2020, and January 31, 2019, respectively. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Company’s consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its product offerings, raising capital, and recruiting personnel. The Company’s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial efforts, or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company’s stockholders. The Company has incurred net operating losses and negative cash flows from </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">operations in every year since inception and expects this to continue for the foreseeable future. As of January 31, 2021, the Company had an accumulated deficit of $679.4 million. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company has funded its operations primarily with proceeds from the issuance of redeemable cash proceeds of $127.0 million, net of issuance costs of $0.2 million in July and August 2020 through the issuance of 22.4 million shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock and 22.4 million common stock warrants. The Company had cash, cash equivalents, and restricted cash of $145.9 million as of January 31, </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2021. In February 2021, the Company received cash proceeds of $484.1 million from the Merger. As of March 31, 2021, the date on which these consolidated financial statements were available to be issued, the Company believes that its cash on hand as of January 31, 2021 and the proceeds from the Merger, together with cash generated from sales to customers will satisfy its working capital and capital requirements for at least the next twelve months following the issuance of the consolidated financial statements. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties. The Company’s actual results could vary as a result of, and its near- and long-term future capital requirements will depend on, many factors, including its growth rate, subscription renewal activity, the timing and extent of spending to support its infrastructure and research and development efforts, the expansion of sales and marketing activities, the timing of new introductions of products or features, the continuing market adoption of its networked charging systems platform, and the overall market acceptance of EVs. The Company may in the future enter into arrangements to acquire or invest in complementary businesses, services, and technologies, including intellectual property rights, although it has no agreements or commitments to complete any material transactions as of March 31, 2021, the date on which these consolidated financial statements were available to be issued. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may seek additional equity or debt financing. Future liquidity and cash requirements will depend on numerous factors, including market penetration, the introduction of new products, and potential acquisitions of related businesses or technology. In the event that additional financing is required from outside sources, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected. </div></div> 22500000 225000000 10.00 0.9966 -679400000 127000000.0 200000 200000 22400000 22400000 145900000 484100000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2.    Summary of Significant Accounting Policies </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for doubtful accounts, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of redeemable convertible preferred stock warrants and common stock warrants, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk and Other Risks and <div style="letter-spacing: 0px; top: 0px;;display:inline;">Uncertainties</div> </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts with large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. Short-term investments consist of U.S. treasury bills that carry high-credit ratings and accordingly, minimal credit risk exists with respect to these balances. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of January 31, 2021, one customer individually accounted for 16% of accounts receivable, net. As of January 31, 2020, there were no customers that accounted for 10% or more of accounts receivable, net. For the years ended January 31, 2021, 2020, and 2019 there were no customers that represented 10% or more of total revenue. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s operating results. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In December 2019, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> was first reported to the World Health Organization (“WHO”), and in January 2020, the WHO declared the outbreak to be a public health emergency. In March 2020, the WHO characterized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> as a pandemic. Since then, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and efforts to control its spread have significantly curtailed the movement of people, goods, and services worldwide. As a result, the Company has temporarily closed its headquarters and most of its other offices, enabled its employees and contractors to work remotely, implemented travel restrictions, implemented cost cutting measures, and shifted Company events and meetings to virtual-only experiences, all of which may continue for an indefinite amount of time and represent a significant disruption in how it operates its business. The operations of the Company’s partners, vendors, and customers have likewise been disrupted. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">While the duration and extent of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment and mitigation actions, it has already had an adverse effect on the global economy, and the ultimate societal and economic impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic remains unknown. In particular, the conditions caused by this pandemic may affect the rate of global infrastructure spending, which could adversely affect demand for the Company’s platform. Further, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic has caused the Company to experience, in some cases, longer sales cycles and an increase in certain prospective and current customers seeking lower prices or other more favorable contract terms, and has limited the ability of its direct sales force to travel to customers and potential customers. In addition, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic could reduce the value or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from the Company’s paying customers, cause some of its paying customers to go out of business, and affect contraction or attrition rates of its paying customers, all of which could adversely affect the Company’s business, results of operations, and financial condition. Additionally, concerns over the economic impact of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> have caused extreme volatility in financial and other capital markets, which may adversely affect the Company’s ability to access capital markets in the future. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">While the Company has developed and continues to develop plans to help mitigate the potential negative impact of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19,</div> these efforts may not be effective, and any protracted economic downturn will likely limit the </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">effectiveness of its efforts. Accordingly, it is not possible for the Company to predict the duration and ultimate extent to which this will affect its business, future results of operations, and financial condition at this time. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Segment Reporting </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company operates as one operating segment because its CODM, who is its Chief Executive Officer, reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance. The Company has no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels of components below the consolidated unit level. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash, Cash Equivalents, and Restricted Cash </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. Cash equivalents may be invested in money market funds. Cash and cash equivalents are carried at cost, which approximates their fair value. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash of $0.4 million as of January 31, 2021 and 2020 and $0.5 million as of January 31, 2019 relates to cash deposits restricted under letters of credit issued in support of customer agreements. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated statements of cash flows were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">145,491</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">72,753</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">205,238</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">460</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total cash, cash equivalents, and restricted cash</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">145,891</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">73,153</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">205,698</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term Investments </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers investments with original maturities greater than three months and remaining maturities less than one year to be short-term investments. The Company’s short-term investments consist of U.S. treasury bills and are classified as available for sale and reported at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For short-term investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of short-term investments are recorded in other income (expense), net in the consolidated statements of operations. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other-than-temporary Impairment </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluates its short-term investments with unrealized losses for other-than-temporary impairment. When assessing short-term investments for other-than-temporary declines in value, the Company considers factors such as, among other things, the extent and length of time the investment’s fair value has been lower than its cost basis, the financial condition and near-term prospects of the investee, the Company’s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value, and the expected cash flows from the security. If any adjustment to fair value reflects a decline in the value of the investment that the Company considers to be “other than temporary,” the Company reduces the investment to fair value through a charge to the consolidated statements of operations and consolidated statements of comprehensive loss. No such adjustments were necessary during the periods presented. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts Receivable, net </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Accounts receivable are recorded at the invoiced amount and are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing. The Company performs ongoing credit evaluations of its customers and maintains an allowance for doubtful accounts to ensure trade receivables are not overstated due to uncollectibility. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results, or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables are further adjusted. The Company also considers broader factors in evaluating the sufficiency of its allowances for doubtful accounts, including the length of time receivables are past due, macroeconomic conditions, significant <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-time</div> events, and historical experience. When the Company determines that there are accounts receivable that are uncollectible, they are written off against the allowance for doubtful accounts. The change in the allowance for doubtful accounts for the years ended January 31, 2021, 2020, and 2019 was as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 59%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Beginning<br/>Balance</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additions<br/>Charged To<br/>Expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Write-offs</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ending<br/>Balance</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="14" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ended January 31, 2021</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allowance for doubtful accounts</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">121</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(121</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ended January 31, 2020</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allowance for doubtful accounts</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,124</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">339</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,463</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ended January 31, 2019</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allowance for doubtful accounts</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,316</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,812</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,124</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventories </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost, on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">first-in,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">first-out</div> basis. Inventory levels are analyzed periodically and written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value or are in excess of expected demand. The Company analyzes current and future product demand relative to the remaining product life to identify potential excess inventories. The write-down is measured as the difference between the cost of the inventories and net realizable value and charged to inventory reserves, which is a component of cost of revenue. At the point of the loss recognition, a new, lower cost basis for those inventories is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and Equipment, net </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets, as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 63%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Lives</div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 to 5 years</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computers and software</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 to 5 years</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 to 5 years</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tooling</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 to 5 years</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Shorter of the estimated<br/>lease term or useful life</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Owned and operated systems</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">5 to 7 years</td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements are amortized over the shorter of estimated useful lives of the assets or the lease term. Expenditures for repairs and maintenance are charged to expense as incurred. Upon disposition, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is reflected in the consolidated statements of operations. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ChargePoint-as-a-Service</div></div> (“CPaaS”) combines the customer’s use of the Company’s owned and operated systems with Cloud subscription software (“Cloud”) and the Company’s Assure program (“Assure”) into a single subscription. When CPaaS contracts contain a lease, the underlying asset is carried at its carrying value within property and equipment, net on the consolidated balance sheets. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software Development Costs </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company capitalizes qualifying <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software development costs incurred during the application development stage for internal tools and cloud-based applications used to deliver its services, provided that management with the relevant authority authorizes and commits to the funding of the project, it is probable the project will be completed, and the software will be used to perform the function intended. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Capitalized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software development costs are included in property and equipment and are amortized on a straight- line basis over their estimated useful lives once it is ready for its intended use. Amortization of capitalized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software development costs is included within cost of revenue for networked charging systems and subscriptions, research and development expense, sales and marketing expense, and general and administrative expense based on the use of the software. Costs incurred for enhancements that are expected to result in additional material functionality are capitalized. As of January 31, 2021 and 2020, capitalized costs have not been material. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leases </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On February 1, 2019, the Company early adopted the requirements of Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02,</div> Leases (Topic 842) (“ASC 842”), using the modified retrospective approach with no adjustment to comparative periods. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Lessee </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company determines if a contract is a lease or contains a lease at the inception of the contract and reassesses that conclusion if the contract is modified. All leases are assessed for classification as an operating lease or a finance lease. Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (“ROU”) assets are presented separately on the Company’s consolidated balance sheets. Operating lease liabilities are separated into a current portion, included within accrued and other current liabilities on the Company’s consolidated balance sheets, and a noncurrent portion included within operating lease liabilities on the Company’s consolidated balance sheets. The Company does not have material finance leases. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. The Company does not obtain and control its right to use the asset until the lease commencement date. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s ROU assets are also recognized at the applicable lease commencement date. The ROU asset equals the carrying amount of the related lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable ROU asset or lease liability. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The term of the Company’s leases equals the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancellable</div> period of the lease, including any rent-free periods provided by the lessor, and also includes options to renew or extend the lease (including by not terminating the lease) that the Company is reasonably certain to exercise. The Company establishes the term of each lease at lease commencement and reassesses that term in subsequent periods when one of the triggering events outlined in ASC 842 occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The Company’s lease contracts often include lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components. The Company has elected the practical expedient offered by the standard to not separate the lease from <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components and accounts for them as a single lease component. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company elected the package of practical expedients permitted under the transition guidance, which allows the Company to carry forward its historical lease classification, its assessment on whether a contract is or contains a lease, and its initial direct costs for any leases that existed prior to adoption of the new standard. The Company has elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Lessor </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company leases networked charging systems to customers within certain CPaaS contracts. The leasing arrangements the Company enters into with lessees are operating leases, and as a result, the underlying asset is carried at its carrying value as owned and operated systems within property and equipment, net on the consolidated balance sheets. Adoption of ASC 842 did not have a material impact on the Company’s accounting as a lessor. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Impairment of Long-Lived Assets </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluates long-lived assets or asset groups for impairment whenever events indicate that the carrying amount of an asset or asset group may not be recoverable based on expected future cash flows attributable to that asset or asset group. Recoverability of assets held and used is measured by comparison of the carrying amounts of an asset or an asset group to the estimated future undiscounted cash flows which the asset or asset group is expected to generate. If the carrying amount of an asset or asset group exceeds estimated undiscounted future cash flows, then an impairment charge would be recognized based on the excess of the carrying amount of the asset or asset group over its fair value. Assets to be disposed of are reported at the lower of their carrying amount or fair value less costs to sell. There were no impairments of long-lived assets for the years ended January 31, 2021, 2020, and 2019. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Business Combinations </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The total purchase consideration for an acquisition is measured as the fair value of the assets transferred, equity instruments issued, and liabilities assumed at the acquisition date. Costs that are directly attributable to the acquisition are expensed as incurred and included in general and administrative expense in the Company’s consolidated statements of operations. Identifiable assets (including intangible assets), liabilities assumed (including contingent liabilities), and noncontrolling interests in an acquisition are measured initially at their fair values at the acquisition date. The Company recognizes goodwill if the fair value of the total purchase consideration and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, cost of capital, future cash flows, and discount rates. The Company’s estimates of fair value are based on assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. The Company includes the results of operations of the acquired business in the consolidated financial statements beginning on the acquisition date. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill represents the excess of the purchase price of an acquired busines<div style="letter-spacing: 0px; top: 0px;;display:inline;">s over </div>the fair value of the net tangible and identifiable intangible assets acquired. The carrying amount of goodwill is reviewed for impairment </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at least annually, in the second quarter, or whenever events or changes in circumstances <div style="letter-spacing: 0px; top: 0px;;display:inline;">indicate</div> that the carrying value may not be recoverable. As of January 31, 2021 and 2020, the Company had a single operating segment and reporting unit structure. As part of the annual goodwill impairment test performed in the second quarter, the Company first performs a qualitative assessment to determine whether further impairment testing is necessary. If, as a result of the qualitative assessment, it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the quantitative impairment test will be required. If the Company has determined it necessary to perform a quantitative impairment assessment, the Company will compare the fair value of the reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the total amount of goodwill of the reporting unit. The carrying value of goodwill was $1.2 million as of January 31, 2021 and 2020, and no goodwill impairment has been recognized to date. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Level 3) — Inputs that are unobservable for the asset or liability. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-financial</div> assets valued on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> basis that resulted in an impairment in any period presented. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The carrying values of the Company’s cash equivalents, short-term investments, accounts receivable, net, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redeemable Convertible Preferred Stock Warrants </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Warrants to purchase shares of the Company’s Series B, D, and E redeemable convertible preferred stock are classified as liabilities as the underlying redeemable convertible preferred stock is considered redeemable and may require the Company to transfer assets upon exercise. Redeemable convertible preferred stock warrants are recorded within noncurrent liabilities on the consolidated balance sheets. The warrants were recorded at fair value upon issuance and are subject to remeasurement to fair value at each balance sheet date. Changes in fair value of the redeemable convertible preferred stock warrant liability are recorded in the consolidated statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the warrants, conversion of redeemable convertible preferred stock into common stock, or until the redeemable convertible preferred stock is otherwise no longer redeemable. At that time, the redeemable convertible preferred stock warrant liability will be reclassified to redeemable convertible preferred stock or additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital, as applicable. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock Warrants </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Warrants to purchase shares of the Company’s common stock are equity classified and recognized within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital with no subsequent remeasurement. The amount recognized within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital is determined by allocating proceeds received and issuance costs incurred between the instruments issued based on their relative fair value. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue Recognition </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On February 1, 2019, the Company early adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2014-09.</div> Revenue from Contracts with Customers (Topic 606), as amended (“ASC 606”), using the modified retrospective method applied to contracts which were not completed as of that date. During the fiscal years ended January 31, 2021 and January 31, 2020, the Company recognized revenue using the following five-step model as prescribed by ASC 606: </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Identification of the contract, or contracts, with a customer; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Identification of the performance obligations in the contract; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Determination of the transaction price; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of the transaction price to the performance obligations in the contract; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recognition of revenue when, or as, the Company satisfies a performance obligation. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant judgment and estimates are necessary for the allocation of the proceeds received from an arrangement to the multiple performance obligations and the appropriate timing of revenue recognition. The Company enters into contracts with customers that regularly include promises to transfer multiple products and services, such as charging systems, software subscriptions, extended maintenance, and professional services. For arrangements with multiple products or services, the Company evaluates whether the individual products or services qualify as distinct performance obligations. In its assessment of whether products or services are a distinct performance obligation, the Company determines whether the customer can benefit from the product or service on its own or with other readily available resources and whether the service is separately identifiable from other products or services in the contract. This evaluation requires the Company to assess the nature of each of its networked charging systems, subscriptions, and other offerings and how each is provided in the context of the contract, including whether they are significantly integrated which may require judgment based on the facts and circumstances of the contract. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The transaction price for each contract is determined based on the amount the Company expects to be entitled to receive in exchange for transferring the promised products or services to the customer. Collectability of revenue is reasonably assured based on historical evidence of collectability of fees the Company charges its customers. The transaction price in the contract is allocated to each distinct performance obligation in an amount that represents the relative amount of consideration expected to be received in exchange for satisfying each performance obligation. Revenue is recognized when performance obligations are satisfied. Revenue is recorded based on the transaction price excluding amounts collected on behalf of third-parties such as sales taxes, which are collected on behalf of and remitted to governmental authorities, or driver fees, collected on behalf of customers who offer public charging for a fee. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">When agreements involve multiple distinct performance obligations, the Company accounts for individual performance obligations separately if they are distinct. The Company applies significant judgment in identifying and accounting for each performance obligation, as a result of evaluating terms and conditions in contracts. The transaction price is allocated to the separate performance obligations on a relative standalone selling price (“SSP”) basis. The Company determines SSP based on observable standalone selling price when it is available, as well as other factors, including the price charged to its customers, its discounting practices, and its overall pricing objectives, while maximizing observable inputs. In situations where pricing is highly variable, or a product is never sold on a stand-alone basis, the Company estimates the SSP using the residual approach. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company usually bills its customers at the onset of the arrangement for both the products and a predetermined period of time for services. Contracts for services typically range from annual to multi-year agreements with typical payment terms of 30 to 90 days. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Networked charging systems revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Networked charging systems revenue includes revenue related to the deliveries of EV charging system infrastructure. The Company recognizes revenue from sales of networked charging systems upon shipment to the customer, which is when the performance obligation has been satisfied. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Subscriptions revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Subscriptions revenue consists of services related to Cloud, as well as extended maintenance service plans under Assure. Subscriptions revenue also consists of CPaaS revenue, which combines the customer’s use of the Company’s owned and operated systems with Cloud and Assure programs into a single subscription. CPaaS subscriptions contain a lease for the customer’s use of the Company’s owned and operated systems unless the location allows the Company to receive incremental economic benefit from regulatory credits earned on that owned and operated system. Lessor revenue relates to operating leases and historically has not been material. Subscriptions revenue is recognized over time on a straight-line basis as the Company has a stand-ready obligation to deliver such services to the customer. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other revenue consists of fees received for transferring regulatory credits earned for participating in low carbon fuel programs in approved states, charging related fees received from drivers using charging sites owned and operated by the Company, net transaction fees earned for processing payments collected on driver charging sessions at charging sites owned by ChargePoint customers, and other professional services. Revenue from regulatory credits is recognized at the point in time the regulatory credits are transferred. Revenue from fees for owned and operated sites is recognized over time on a straight-line basis over the performance period of the service contract as the Company has a stand-ready obligation to deliver such services. Revenue from driver charging sessions and charging transaction fees is recognized at the point in time the charging session or transaction is completed. Revenue from professional services is recognized as the services are rendered. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revenue Recognition (ASC 605) </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the fiscal year ended January 31, 2019, the Company recognized revenue under ASC Topic 605, Revenue Recognition (“ASC 605”) when persuasive evidence of an arrangement existed, delivery had occurred, the fee was fixed or determinable, and collectability was probable. Revenue for this period was generally recognized net of allowances for returns and any taxes collected from customers and subsequently remitted to governmental authorities. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">When a sales arrangement contained multiple elements, the Company first determined whether the delivered items qualify as separate units of accounting. A delivered item qualified as a separate unit of accounting when it had value to the customer on a standalone basis and when an arrangement included a general right of return relative to the delivered item, delivery, or performance of any undelivered items was considered probable or substantially in control of the Company. The Company then allocated revenue to each separate unit of accounting based on the relative selling price method and using the established selling price hierarchy. The selling price for a unit of accounting was based on its vendor specific objective evidence (“VSOE”), if available, third-party evidence (“TPE”) if VSOE was not available, or best estimate of selling price (“ESP”) if neither VSOE nor TPE was available. The Company generally utilized ESP. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The objective of ESP was to determine the price at which the Company would transact a sale if the product or service were sold on a standalone basis. ESP was generally used for new or highly customized offerings and solutions or offerings not priced within a narrow range, and it applied to a large proportion of the Company’s arrangements with multiple deliverables. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The process for determining ESP requires judgment and considers multiple factors that may vary over time depending upon the unique facts and circumstances related to each deliverable. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Lessor Revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The leasing arrangements the Company enters into with lessees are operating leases. The Company recognizes operating lease revenue on a straight-line basis over the lease term and expenses deferred initial direct costs on the same basis. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease revenue is classified as subscriptions revenue in the Company’s consolidated statements of operations. Operating lease revenue and the future maturities of lease payments from lessees was not material to the consolidated financial statements for all periods presented. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining Performance Obligations </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable</div> contracted amounts that will be invoiced and recognized as revenue in future periods. The Company’s Assure, Cloud, and CPaaS subscription terms typically range from one to five years. Revenue expected to be recognized from remaining performance obligations was $101.8 million as of January 31, 2021, of which 43% is expected to be recognized over the next twelve months and the remainder thereafter. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Deferred revenue represents billings or payments received in advance of revenue recognition and is recognized in revenue upon transfer of control. Balances consist primarily of software subscription services and extended Assure maintenance services not yet provided as of the balance sheet date. Contract assets, which represent services provided or products transferred to customers in advance of the date the Company has a right to invoice, are netted against deferred revenue on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">customer-by-customer</div></div> basis. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as deferred revenue with the remainder recorded as deferred revenue, noncurrent on the consolidated balance sheets. Total deferred revenue was $89.8 million and $72.7 million as of January 31, 2021 and 2020, respectively. The Company recognized $39.4 million, $25.5 million, and $16.0 million of revenue during the years ended January 31, 2021, 2020, and 2019, respectively, that was included in the deferred revenue balance at the beginning of the respective period. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cost of Revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Cost of networked charging systems revenue includes the material costs for parts and manufacturing costs for the hardware products, compensation, including salaries and related personnel expenses, including stock-based compensation, warranty provisions, depreciation of manufacturing related equipment and facilities, amortization of capitalized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software development costs, and allocated overhead costs. Costs for shipping and handling are recorded in cost of revenue as incurred. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Cost of subscriptions revenue includes network and wireless connectivity costs for subscription services, field maintenance costs for Assure to support the Company’s network of systems, depreciation of owned and operated systems used in CPaaS arrangements, amortization of capitalized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software development costs, allocated overhead costs, and support costs to manage the systems and helpdesk services for drivers and site hosts. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cost of other revenue includes costs for the Company’s owned and operated charging sites, as well as costs of environmental and professional services. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Costs to Obtain a Customer Contract </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales commissions are considered incremental and recoverable costs of acquiring customer contracts. Beginning at the Company’s adoption of ASC 606 on February 1, 2019, incremental and recoverable costs for the sale of cloud enabled software and extended maintenance service plans are capitalized as deferred contract acquisition costs within prepaid expenses and other current assets and other assets on the consolidated balance sheets and amortized on a straight-line basis over the anticipated benefit period of five years. The benefit period was estimated by taking into consideration the length of customer contracts, renewals, technology lifecycle, and other factors. This amortization is recorded within sales and marketing expense in the Company’s consolidated statements of operations. The sales commissions paid related to the sale of networked charging systems are expensed as incurred. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company elected the practical expedient that permits the Company to apply ASC Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-40,</div> “Other Assets and Deferred Costs- Contracts with Customers,” (“ASC 340”) to a portfolio containing multiple contracts, as they are similar in their characteristics, and the financial statement effects of applying ASC Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-40</div> to that portfolio would not differ materially from applying it to the individual contracts within that portfolio. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in the deferred contract acquisition costs during the years ended January 31, 2021 and 2020 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance upon adoption of ASC 340 on February 1, 2019</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,189</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Capitalization of deferred contract acquisition costs</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,318</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization of deferred contract acquisition costs</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(675</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance as of January 31, 2020</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,832</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Capitalization of deferred contract acquisition costs</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,908</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization of deferred contract acquisition costs</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,206</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance as of January 31, 2021</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,534</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred acquisition costs capitalized on the consolidated balance sheets were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 78%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred contract acquisition costs, current</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,550</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,013</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred contract acquisition costs, noncurrent</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,984</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,819</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred contract acquisition costs</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,534</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,832</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and Development </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Research and development expenses consist primarily of salary and related expenses, including stock-based compensation, for personnel related to the development of improvements and expanded features for the Company’s products and services, as well as quality assurance, testing, product management, amortization of capitalized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software, and allocated overhead. Research and development costs are expensed as incurred. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based Compensation </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company measures and recognizes compensation expense for all stock-based awards, including stock options and restricted common stock, granted to employees and directors based on the estimated fair value of the awards on the date of grant. The fair value of each stock option award is estimated on the grant date using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock, the expected term of the option, the expected volatility of the price of the Company’s common stock, risk-free interest rates, and the expected dividend yield of the Company’s common stock. The assumptions used to determine the fair value of the awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company amortizes the fair value of each stock award on a straight-line basis over the requisite service period of the awards. Stock-based compensation expense is based on the value of the portion of stock-based awards that is ultimately expected to vest. As such, the Company’s stock-based compensation is reduced for the estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Advertising </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company expenses the costs of advertising, including promotional expenses, as incurred. Advertising expenses for the years ended January 31, 2021, 2020, and 2019 were not material. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warranty </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company provides standard warranty coverage on its products for twelve months, providing parts necessary to repair the systems during the warranty period. The Company accounts for the estimated warranty cost as a charge to networked charging systems cost of revenue when revenue is recognized. The estimated warranty cost is based on historical and predicted product failure rates and repair expenses. Warranty expense for the years ended January 31, 2021, 2020, and 2019 was $3.4 million, $2.8 million, and $2.0 million, respectively. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In addition, the Company offers <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-for</div> subscriptions to extended maintenance service plans under Assure. Assure provides both the labor and parts to maintain the products over the subscription terms of typically one to five years. The costs related to the Assure program are expensed as incurred and charged to subscriptions cost of revenue. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign Currency </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The functional currency of the Company’s foreign subsidiaries is generally the local currency. The translation of foreign currencies into U.S. dollars is performed for monetary assets and liabilities at the end of each reporting period based on the then current exchange rates. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-monetary</div> items are translated using historical exchange rates. For revenue and expense accounts, an average foreign currency rate during the period is applied. Adjustments resulting from translating foreign functional currency financial statements into U.S. dollars are recorded as part of a separate component of stockholders’ deficit and reported in the consolidated statements of comprehensive loss. Foreign currency transaction gains and losses are included in other income (expense), net for the period. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company uses the asset and liability method in accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax asset and liability. Valuation allowances are established when necessary to reduce deferred tax assets where it is more likely than not that the deferred tax assets will not be realized. In evaluating the Company’s ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including historical operating results, ongoing tax planning, and forecasts of future taxable income on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">jurisdiction-by-jurisdiction</div></div> basis. Based on the level of historical losses, the Company has established a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination by the taxing authorities, including resolutions of any related appeals or litigation processes, based on the technical merits of the position. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Loss per Share Attributable to Common Stockholders </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method required for participating securities. The Company considers all series of its redeemable convertible preferred stock to be participating securities. The Company also considers any shares issued on the early exercise of stock options subject to repurchase to be participating securities because holders of such shares have nonforfeitable dividend rights in the event a dividend is paid on common stock. Under the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method, net income is attributed to common stockholders and participating securities based on their participation rights. The holders of the redeemable convertible preferred stock, as well as the holders of early exercised shares subject to repurchase, do not have a contractual obligation to share in the losses of the Company. As such, the Company’s net losses for the years ended January 31, 2021, 2020, and 2019 were not allocated to these participating securities. Under the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. Diluted net loss per share attributable to common stockholders adjusts basic net loss per share for the effect of dilutive securities, including stock options. As the Company has reported losses for all periods presented, all potentially dilutive securities are antidilutive and accordingly, basic net loss per share equals diluted net loss per share. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounting Pronouncements </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company is provided the option to adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public</div> business entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt, when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public</div> business entities, as indicated below. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Adopted Accounting Standards </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In June 2018, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2018-13,</div> “Fair Value Measurement (Topic 820): Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurements,” which expands the disclosure requirements for Level 3 fair value measurements and expands disclosures for measurement uncertainty. This guidance became effective for annual reporting periods beginning after December 15, 2019. The Company adopted the guidance at the beginning of fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In August 2018, the FASB issued <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2018-15,</div> “Intangibles-Goodwill and Other-Internal Use Software (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">350-40):</div> Customer’s Accounting for Implementation Costs Incurred In a Cloud Computing </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Arrangement That Is a Service Contract,” which reduces complexity of the accounting for costs of implementing a cloud computing service arrangement. The guidance is effective for annual reporting periods beginning after December 15, 2020. The Company early adopted this guidance at the beginning of fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In March 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04,</div> “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which provides optional expedients and exceptions for applying U.S. GAAP to contract modifications, hedging relationships, and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The guidance is effective for the Company beginning on March 12, 2020 and it will apply the amendments prospectively through December 31, 2022. The Company adopted this guidance during fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In May 2014, the FASB issued ASC 606 with several subsequent amendments. ASC 606 amends the existing accounting standards for revenue recognition. The new guidance provides a new model to determine when and over what period revenue is recognized. Revenue is recognized for the transfer of promised goods or services to customers in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company early adopted the new revenue standard as of February 1, 2019 using the modified retrospective approach. The impact of the adoption was not material to the Company’s consolidated financial statements and disclosures. Comparative information prior to the date of adoption has not been restated and continues to be reported under the accounting standards in effect for those periods. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">With the adoption of ASC 606 the Company also early adopted ASC 340 which requires the deferral of incremental costs of obtaining a customer contract which, under the old guidance, were expensed as incurred. The guidance requires the deferral of incremental contract acquisition costs and subsequent amortization over the expected period of benefit. The benefit period was estimated by taking into consideration the length of customer contracts, renewals, technology lifecycle, and other factors. The amortization of these costs is charged to sales and marketing expenses in the consolidated statements of operations. The cumulative impact of ASC 340 adoption on February 1, 2019 resulted in an increase of $2.2 million in total assets related to costs to obtain customer contracts that were previously expensed as incurred but would have been capitalized under ASC 340. Upon adoption, the Company recorded the cumulative impact of adoption as an adjustment to the Company’s accumulated deficit on February 1, 2019. Prior periods were not retroactively adjusted. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The adoption of ASC 340 resulted in a net decrease in sales and marketing expenses due to the capitalization and related amortization of deferred contract acquisition costs that would have been expensed as incurred prior to adoption. During the year ended January 31, 2020, the adoption of ASC 340 resulted in offsetting changes within operating assets and liabilities and had no net impact on the consolidated statements of cash flows. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In February 2016, the FASB issued ASC 842. The guidance is effective for annual reporting periods for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public</div> business entities beginning after December 15, 2021 and early adoption is permitted. The new standard requires lessees to recognize operating and finance lease liabilities on the balance sheet, as well as corresponding ROU assets. This standard also made some changes to lessor accounting and aligns key aspects of the lessor accounting model with the revenue recognition standard. In addition, disclosures are required to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. ASC 842 requires adoption using the modified retrospective approach, with the option of applying the requirements of the standard either (a) retrospectively to each prior comparative reporting period presented, or (b) retrospectively at the beginning of the period of adoption. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has early adopted ASC 842 as of February 1, 2019 on a modified retrospective basis. Prior period amounts were not adjusted and continue to be reported in accordance with our historic accounting under </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">previous lease guidance, ASC 840, Leases. Upon adopting ASC 842 at the beginning of the fiscal year ended January 31, 2020, as a lessee, the Company recognized operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets of $11.3 million and operating lease liabilities of $12.5 million and corresponding reductions of $1.6 million to deferred rent and $0.4 million to prepaid rent. The adoption of the standard did not result in any adjustments to accumulated deficit. See Note 6, Leases, for more information. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For lessor accounting, the impact was not material to the Company’s consolidated financial statements and disclosures. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In January 2017, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2017-04,</div> “Intangibles — Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” The new standard simplifies the measurement of goodwill by eliminating step two of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-step</div> impairment test. Step two measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. The new guidance requires an entity to compare the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">tax-deductible</div> goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. The guidance is effective for annual reporting periods beginning after December 15, 2021. The Company early adopted this guidance at the beginning of fiscal year 2020. The impact of the adoption had no impact on the Company’s consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In July 2017, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2017-11,</div> “Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception.” The new guidance reduces the complexity associated with an issuer’s accounting for certain financial instruments with characteristics of liability and equity. Specifically, the FASB determined that a down round feature would no longer cause a freestanding equity-linked financial instrument (or an embedded conversion option) to be accounted for as a derivative liability at fair value with changes in fair value recognized in current earnings. This guidance is effective for annual reporting periods beginning after December 15, 2019. The Company early adopted this guidance at the beginning of fiscal year 2020. The adoption of this guidance did not have a material impact to the Company’s consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In February 2018, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2018-02,</div> “Income Statement- Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” The new guidance permits, but does not require, companies to reclassify the stranded tax effects of the Tax Cuts and Jobs Act (the “Act”) on items within accumulated other comprehensive income to retained earnings. This guidance became effective for annual reporting periods beginning after December 15, 2018. The Company did not elect to reclassify the stranded tax effects of the Act on items within accumulated other comprehensive income to retained earnings. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In June 2018, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2018-07,</div> “Compensation — Stock Compensation (Topic 718): Improvements to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Employee</div> Share-Based Payment Accounting.” The new guidance expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees</div> and to account for awards to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees</div> using the grant date fair value without subsequent periodic measurement. The guidance is effective for annual reporting periods beginning after December 15, 2019. The Company early adopted this guidance in fiscal year 2020 using a modified retrospective transition method. Adoption of this guidance did not have a material impact to the Company’s consolidated financial statements and disclosures. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Issued Accounting Standards Not Yet Adopted </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2016-13,</div> “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” and has since released various amendments including ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2019-04.</div> The guidance modifies the measurement of expected credit losses on certain financial instruments. This guidance is effective for the Company’s annual reporting periods beginning after December 15, 2022. Early adoption is permitted. The Company is currently assessing the impact of the guidance on its consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In November 2018, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2018-18,</div> “Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606”, which clarifies when certain transactions between collaborative arrangement participants should be accounted for under ASC 606 and incorporates <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">unit-of-account</div></div> guidance consistent with ASC 606 to aid in this determination. The guidance is effective for the Company’s annual reporting periods beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">step-up</div> in goodwill obtained in a transaction that is not a business combination. The guidance will be effective for the Company’s annual reporting periods beginning after December 15, 2021. Early adoption is permitted. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> “Debt — Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40),”</div> which modifies and simplifies accounting for convertible instruments. The new guidance eliminates certain separation models that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance will be effective for annual reporting periods beginning after December 15, 2023. Early adoption is permitted, but no earlier than for fiscal years beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In October 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-08,</div> “Codification Improvements to Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">310-20</div> — Receivables-Nonrefundable Fees and Other Costs,” which clarifies the accounting for the amortization period for certain purchased callable debt securities held at a premium by giving consideration to securities which have multiple call dates. The guidance will be effective for annual reporting periods beginning after December 15, 2021. Early adoption is permitted for annual reporting periods beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for doubtful accounts, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of redeemable convertible preferred stock warrants and common stock warrants, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk and Other Risks and <div style="letter-spacing: 0px; top: 0px;;display:inline;">Uncertainties</div> </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts with large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. Short-term investments consist of U.S. treasury bills that carry high-credit ratings and accordingly, minimal credit risk exists with respect to these balances. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of January 31, 2021, one customer individually accounted for 16% of accounts receivable, net. As of January 31, 2020, there were no customers that accounted for 10% or more of accounts receivable, net. For the years ended January 31, 2021, 2020, and 2019 there were no customers that represented 10% or more of total revenue. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s operating results. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In December 2019, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> was first reported to the World Health Organization (“WHO”), and in January 2020, the WHO declared the outbreak to be a public health emergency. In March 2020, the WHO characterized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> as a pandemic. Since then, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and efforts to control its spread have significantly curtailed the movement of people, goods, and services worldwide. As a result, the Company has temporarily closed its headquarters and most of its other offices, enabled its employees and contractors to work remotely, implemented travel restrictions, implemented cost cutting measures, and shifted Company events and meetings to virtual-only experiences, all of which may continue for an indefinite amount of time and represent a significant disruption in how it operates its business. The operations of the Company’s partners, vendors, and customers have likewise been disrupted. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">While the duration and extent of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment and mitigation actions, it has already had an adverse effect on the global economy, and the ultimate societal and economic impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic remains unknown. In particular, the conditions caused by this pandemic may affect the rate of global infrastructure spending, which could adversely affect demand for the Company’s platform. Further, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic has caused the Company to experience, in some cases, longer sales cycles and an increase in certain prospective and current customers seeking lower prices or other more favorable contract terms, and has limited the ability of its direct sales force to travel to customers and potential customers. In addition, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic could reduce the value or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from the Company’s paying customers, cause some of its paying customers to go out of business, and affect contraction or attrition rates of its paying customers, all of which could adversely affect the Company’s business, results of operations, and financial condition. Additionally, concerns over the economic impact of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> have caused extreme volatility in financial and other capital markets, which may adversely affect the Company’s ability to access capital markets in the future. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">While the Company has developed and continues to develop plans to help mitigate the potential negative impact of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19,</div> these efforts may not be effective, and any protracted economic downturn will likely limit the </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">effectiveness of its efforts. Accordingly, it is not possible for the Company to predict the duration and ultimate extent to which this will affect its business, future results of operations, and financial condition at this time. </div></div> 0.16 0.10 0.10 0.10 0.10 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Segment Reporting </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company operates as one operating segment because its CODM, who is its Chief Executive Officer, reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance. The Company has no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels of components below the consolidated unit level. </div></div> 1 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash, Cash Equivalents, and Restricted Cash </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. Cash equivalents may be invested in money market funds. Cash and cash equivalents are carried at cost, which approximates their fair value. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash of $0.4 million as of January 31, 2021 and 2020 and $0.5 million as of January 31, 2019 relates to cash deposits restricted under letters of credit issued in support of customer agreements. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated statements of cash flows were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">145,491</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">72,753</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">205,238</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">460</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total cash, cash equivalents, and restricted cash</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">145,891</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">73,153</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">205,698</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 400000 400000 500000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated statements of cash flows were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">145,491</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">72,753</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">205,238</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">460</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total cash, cash equivalents, and restricted cash</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">145,891</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">73,153</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">205,698</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 145491000 72753000 205238000 400000 400000 460000 145891000 73153000 205698000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term Investments </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers investments with original maturities greater than three months and remaining maturities less than one year to be short-term investments. The Company’s short-term investments consist of U.S. treasury bills and are classified as available for sale and reported at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For short-term investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of short-term investments are recorded in other income (expense), net in the consolidated statements of operations. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other-than-temporary Impairment </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluates its short-term investments with unrealized losses for other-than-temporary impairment. When assessing short-term investments for other-than-temporary declines in value, the Company considers factors such as, among other things, the extent and length of time the investment’s fair value has been lower than its cost basis, the financial condition and near-term prospects of the investee, the Company’s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value, and the expected cash flows from the security. If any adjustment to fair value reflects a decline in the value of the investment that the Company considers to be “other than temporary,” the Company reduces the investment to fair value through a charge to the consolidated statements of operations and consolidated statements of comprehensive loss. No such adjustments were necessary during the periods presented. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts Receivable, net </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Accounts receivable are recorded at the invoiced amount and are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing. The Company performs ongoing credit evaluations of its customers and maintains an allowance for doubtful accounts to ensure trade receivables are not overstated due to uncollectibility. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results, or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables are further adjusted. The Company also considers broader factors in evaluating the sufficiency of its allowances for doubtful accounts, including the length of time receivables are past due, macroeconomic conditions, significant <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-time</div> events, and historical experience. When the Company determines that there are accounts receivable that are uncollectible, they are written off against the allowance for doubtful accounts. The change in the allowance for doubtful accounts for the years ended January 31, 2021, 2020, and 2019 was as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 59%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Beginning<br/>Balance</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additions<br/>Charged To<br/>Expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Write-offs</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ending<br/>Balance</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="14" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ended January 31, 2021</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allowance for doubtful accounts</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">121</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(121</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ended January 31, 2020</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allowance for doubtful accounts</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,124</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">339</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,463</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ended January 31, 2019</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allowance for doubtful accounts</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,316</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,812</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,124</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> The change in the allowance for doubtful accounts for the years ended January 31, 2021, 2020, and 2019 was as follows: <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 59%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Beginning<br/>Balance</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additions<br/>Charged To<br/>Expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Write-offs</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ending<br/>Balance</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="14" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ended January 31, 2021</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allowance for doubtful accounts</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">121</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(121</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ended January 31, 2020</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allowance for doubtful accounts</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,124</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">339</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,463</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ended January 31, 2019</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allowance for doubtful accounts</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,316</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,812</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,124</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> 2000000 121000 121000 2000000 3124000 339000 1463000 2000000 1316000 1812000 4000 3124000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventories </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost, on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">first-in,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">first-out</div> basis. Inventory levels are analyzed periodically and written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value or are in excess of expected demand. The Company analyzes current and future product demand relative to the remaining product life to identify potential excess inventories. The write-down is measured as the difference between the cost of the inventories and net realizable value and charged to inventory reserves, which is a component of cost of revenue. At the point of the loss recognition, a new, lower cost basis for those inventories is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and Equipment, net </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets, as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 63%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Lives</div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 to 5 years</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computers and software</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 to 5 years</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 to 5 years</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tooling</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 to 5 years</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Shorter of the estimated<br/>lease term or useful life</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Owned and operated systems</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">5 to 7 years</td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements are amortized over the shorter of estimated useful lives of the assets or the lease term. Expenditures for repairs and maintenance are charged to expense as incurred. Upon disposition, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is reflected in the consolidated statements of operations. </div></div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ChargePoint-as-a-Service</div></div> (“CPaaS”) combines the customer’s use of the Company’s owned and operated systems with Cloud subscription software (“Cloud”) and the Company’s Assure program (“Assure”) into a single subscription. When CPaaS contracts contain a lease, the underlying asset is carried at its carrying value within property and equipment, net on the consolidated balance sheets. <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets, as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 63%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Lives</div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 to 5 years</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computers and software</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 to 5 years</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 to 5 years</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tooling</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 to 5 years</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Shorter of the estimated<br/>lease term or useful life</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Owned and operated systems</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">5 to 7 years</td></tr></table> P3Y P5Y P3Y P5Y P3Y P5Y P3Y P5Y Shorter of the estimatedlease term or useful life P5Y P7Y <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software Development Costs </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company capitalizes qualifying <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software development costs incurred during the application development stage for internal tools and cloud-based applications used to deliver its services, provided that management with the relevant authority authorizes and commits to the funding of the project, it is probable the project will be completed, and the software will be used to perform the function intended. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Capitalized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software development costs are included in property and equipment and are amortized on a straight- line basis over their estimated useful lives once it is ready for its intended use. Amortization of capitalized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software development costs is included within cost of revenue for networked charging systems and subscriptions, research and development expense, sales and marketing expense, and general and administrative expense based on the use of the software. Costs incurred for enhancements that are expected to result in additional material functionality are capitalized. As of January 31, 2021 and 2020, capitalized costs have not been material. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leases </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On February 1, 2019, the Company early adopted the requirements of Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02,</div> Leases (Topic 842) (“ASC 842”), using the modified retrospective approach with no adjustment to comparative periods. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Lessee </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company determines if a contract is a lease or contains a lease at the inception of the contract and reassesses that conclusion if the contract is modified. All leases are assessed for classification as an operating lease or a finance lease. Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (“ROU”) assets are presented separately on the Company’s consolidated balance sheets. Operating lease liabilities are separated into a current portion, included within accrued and other current liabilities on the Company’s consolidated balance sheets, and a noncurrent portion included within operating lease liabilities on the Company’s consolidated balance sheets. The Company does not have material finance leases. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. The Company does not obtain and control its right to use the asset until the lease commencement date. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s ROU assets are also recognized at the applicable lease commencement date. The ROU asset equals the carrying amount of the related lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable ROU asset or lease liability. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The term of the Company’s leases equals the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancellable</div> period of the lease, including any rent-free periods provided by the lessor, and also includes options to renew or extend the lease (including by not terminating the lease) that the Company is reasonably certain to exercise. The Company establishes the term of each lease at lease commencement and reassesses that term in subsequent periods when one of the triggering events outlined in ASC 842 occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The Company’s lease contracts often include lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components. The Company has elected the practical expedient offered by the standard to not separate the lease from <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components and accounts for them as a single lease component. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company elected the package of practical expedients permitted under the transition guidance, which allows the Company to carry forward its historical lease classification, its assessment on whether a contract is or contains a lease, and its initial direct costs for any leases that existed prior to adoption of the new standard. The Company has elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Lessor </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company leases networked charging systems to customers within certain CPaaS contracts. The leasing arrangements the Company enters into with lessees are operating leases, and as a result, the underlying asset is carried at its carrying value as owned and operated systems within property and equipment, net on the consolidated balance sheets. Adoption of ASC 842 did not have a material impact on the Company’s accounting as a lessor. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Impairment of Long-Lived Assets </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluates long-lived assets or asset groups for impairment whenever events indicate that the carrying amount of an asset or asset group may not be recoverable based on expected future cash flows attributable to that asset or asset group. Recoverability of assets held and used is measured by comparison of the carrying amounts of an asset or an asset group to the estimated future undiscounted cash flows which the asset or asset group is expected to generate. If the carrying amount of an asset or asset group exceeds estimated undiscounted future cash flows, then an impairment charge would be recognized based on the excess of the carrying amount of the asset or asset group over its fair value. Assets to be disposed of are reported at the lower of their carrying amount or fair value less costs to sell. There were no impairments of long-lived assets for the years ended January 31, 2021, 2020, and 2019. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Business Combinations </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The total purchase consideration for an acquisition is measured as the fair value of the assets transferred, equity instruments issued, and liabilities assumed at the acquisition date. Costs that are directly attributable to the acquisition are expensed as incurred and included in general and administrative expense in the Company’s consolidated statements of operations. Identifiable assets (including intangible assets), liabilities assumed (including contingent liabilities), and noncontrolling interests in an acquisition are measured initially at their fair values at the acquisition date. The Company recognizes goodwill if the fair value of the total purchase consideration and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, cost of capital, future cash flows, and discount rates. The Company’s estimates of fair value are based on assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. The Company includes the results of operations of the acquired business in the consolidated financial statements beginning on the acquisition date. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill represents the excess of the purchase price of an acquired busines<div style="letter-spacing: 0px; top: 0px;;display:inline;">s over </div>the fair value of the net tangible and identifiable intangible assets acquired. The carrying amount of goodwill is reviewed for impairment </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at least annually, in the second quarter, or whenever events or changes in circumstances <div style="letter-spacing: 0px; top: 0px;;display:inline;">indicate</div> that the carrying value may not be recoverable. As of January 31, 2021 and 2020, the Company had a single operating segment and reporting unit structure. As part of the annual goodwill impairment test performed in the second quarter, the Company first performs a qualitative assessment to determine whether further impairment testing is necessary. If, as a result of the qualitative assessment, it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the quantitative impairment test will be required. If the Company has determined it necessary to perform a quantitative impairment assessment, the Company will compare the fair value of the reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the total amount of goodwill of the reporting unit. The carrying value of goodwill was $1.2 million as of January 31, 2021 and 2020, and no goodwill impairment has been recognized to date. </div></div> 1200000 1200000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Level 3) — Inputs that are unobservable for the asset or liability. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-financial</div> assets valued on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> basis that resulted in an impairment in any period presented. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The carrying values of the Company’s cash equivalents, short-term investments, accounts receivable, net, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redeemable Convertible Preferred Stock Warrants </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Warrants to purchase shares of the Company’s Series B, D, and E redeemable convertible preferred stock are classified as liabilities as the underlying redeemable convertible preferred stock is considered redeemable and may require the Company to transfer assets upon exercise. Redeemable convertible preferred stock warrants are recorded within noncurrent liabilities on the consolidated balance sheets. The warrants were recorded at fair value upon issuance and are subject to remeasurement to fair value at each balance sheet date. Changes in fair value of the redeemable convertible preferred stock warrant liability are recorded in the consolidated statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the warrants, conversion of redeemable convertible preferred stock into common stock, or until the redeemable convertible preferred stock is otherwise no longer redeemable. At that time, the redeemable convertible preferred stock warrant liability will be reclassified to redeemable convertible preferred stock or additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital, as applicable. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock Warrants </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Warrants to purchase shares of the Company’s common stock are equity classified and recognized within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital with no subsequent remeasurement. The amount recognized within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital is determined by allocating proceeds received and issuance costs incurred between the instruments issued based on their relative fair value. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue Recognition </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On February 1, 2019, the Company early adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2014-09.</div> Revenue from Contracts with Customers (Topic 606), as amended (“ASC 606”), using the modified retrospective method applied to contracts which were not completed as of that date. During the fiscal years ended January 31, 2021 and January 31, 2020, the Company recognized revenue using the following five-step model as prescribed by ASC 606: </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Identification of the contract, or contracts, with a customer; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Identification of the performance obligations in the contract; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Determination of the transaction price; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of the transaction price to the performance obligations in the contract; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recognition of revenue when, or as, the Company satisfies a performance obligation. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant judgment and estimates are necessary for the allocation of the proceeds received from an arrangement to the multiple performance obligations and the appropriate timing of revenue recognition. The Company enters into contracts with customers that regularly include promises to transfer multiple products and services, such as charging systems, software subscriptions, extended maintenance, and professional services. For arrangements with multiple products or services, the Company evaluates whether the individual products or services qualify as distinct performance obligations. In its assessment of whether products or services are a distinct performance obligation, the Company determines whether the customer can benefit from the product or service on its own or with other readily available resources and whether the service is separately identifiable from other products or services in the contract. This evaluation requires the Company to assess the nature of each of its networked charging systems, subscriptions, and other offerings and how each is provided in the context of the contract, including whether they are significantly integrated which may require judgment based on the facts and circumstances of the contract. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The transaction price for each contract is determined based on the amount the Company expects to be entitled to receive in exchange for transferring the promised products or services to the customer. Collectability of revenue is reasonably assured based on historical evidence of collectability of fees the Company charges its customers. The transaction price in the contract is allocated to each distinct performance obligation in an amount that represents the relative amount of consideration expected to be received in exchange for satisfying each performance obligation. Revenue is recognized when performance obligations are satisfied. Revenue is recorded based on the transaction price excluding amounts collected on behalf of third-parties such as sales taxes, which are collected on behalf of and remitted to governmental authorities, or driver fees, collected on behalf of customers who offer public charging for a fee. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">When agreements involve multiple distinct performance obligations, the Company accounts for individual performance obligations separately if they are distinct. The Company applies significant judgment in identifying and accounting for each performance obligation, as a result of evaluating terms and conditions in contracts. The transaction price is allocated to the separate performance obligations on a relative standalone selling price (“SSP”) basis. The Company determines SSP based on observable standalone selling price when it is available, as well as other factors, including the price charged to its customers, its discounting practices, and its overall pricing objectives, while maximizing observable inputs. In situations where pricing is highly variable, or a product is never sold on a stand-alone basis, the Company estimates the SSP using the residual approach. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company usually bills its customers at the onset of the arrangement for both the products and a predetermined period of time for services. Contracts for services typically range from annual to multi-year agreements with typical payment terms of 30 to 90 days. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Networked charging systems revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Networked charging systems revenue includes revenue related to the deliveries of EV charging system infrastructure. The Company recognizes revenue from sales of networked charging systems upon shipment to the customer, which is when the performance obligation has been satisfied. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Subscriptions revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Subscriptions revenue consists of services related to Cloud, as well as extended maintenance service plans under Assure. Subscriptions revenue also consists of CPaaS revenue, which combines the customer’s use of the Company’s owned and operated systems with Cloud and Assure programs into a single subscription. CPaaS subscriptions contain a lease for the customer’s use of the Company’s owned and operated systems unless the location allows the Company to receive incremental economic benefit from regulatory credits earned on that owned and operated system. Lessor revenue relates to operating leases and historically has not been material. Subscriptions revenue is recognized over time on a straight-line basis as the Company has a stand-ready obligation to deliver such services to the customer. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other revenue consists of fees received for transferring regulatory credits earned for participating in low carbon fuel programs in approved states, charging related fees received from drivers using charging sites owned and operated by the Company, net transaction fees earned for processing payments collected on driver charging sessions at charging sites owned by ChargePoint customers, and other professional services. Revenue from regulatory credits is recognized at the point in time the regulatory credits are transferred. Revenue from fees for owned and operated sites is recognized over time on a straight-line basis over the performance period of the service contract as the Company has a stand-ready obligation to deliver such services. Revenue from driver charging sessions and charging transaction fees is recognized at the point in time the charging session or transaction is completed. Revenue from professional services is recognized as the services are rendered. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revenue Recognition (ASC 605) </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the fiscal year ended January 31, 2019, the Company recognized revenue under ASC Topic 605, Revenue Recognition (“ASC 605”) when persuasive evidence of an arrangement existed, delivery had occurred, the fee was fixed or determinable, and collectability was probable. Revenue for this period was generally recognized net of allowances for returns and any taxes collected from customers and subsequently remitted to governmental authorities. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">When a sales arrangement contained multiple elements, the Company first determined whether the delivered items qualify as separate units of accounting. A delivered item qualified as a separate unit of accounting when it had value to the customer on a standalone basis and when an arrangement included a general right of return relative to the delivered item, delivery, or performance of any undelivered items was considered probable or substantially in control of the Company. The Company then allocated revenue to each separate unit of accounting based on the relative selling price method and using the established selling price hierarchy. The selling price for a unit of accounting was based on its vendor specific objective evidence (“VSOE”), if available, third-party evidence (“TPE”) if VSOE was not available, or best estimate of selling price (“ESP”) if neither VSOE nor TPE was available. The Company generally utilized ESP. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The objective of ESP was to determine the price at which the Company would transact a sale if the product or service were sold on a standalone basis. ESP was generally used for new or highly customized offerings and solutions or offerings not priced within a narrow range, and it applied to a large proportion of the Company’s arrangements with multiple deliverables. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The process for determining ESP requires judgment and considers multiple factors that may vary over time depending upon the unique facts and circumstances related to each deliverable. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Lessor Revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The leasing arrangements the Company enters into with lessees are operating leases. The Company recognizes operating lease revenue on a straight-line basis over the lease term and expenses deferred initial direct costs on the same basis. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease revenue is classified as subscriptions revenue in the Company’s consolidated statements of operations. Operating lease revenue and the future maturities of lease payments from lessees was not material to the consolidated financial statements for all periods presented. </div></div> Contracts for services typically range from annual to multi-year agreements with typical payment terms of 30 to 90 days. <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining Performance Obligations </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable</div> contracted amounts that will be invoiced and recognized as revenue in future periods. The Company’s Assure, Cloud, and CPaaS subscription terms typically range from one to five years. Revenue expected to be recognized from remaining performance obligations was $101.8 million as of January 31, 2021, of which 43% is expected to be recognized over the next twelve months and the remainder thereafter. </div> 101800000 0.43 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Deferred revenue represents billings or payments received in advance of revenue recognition and is recognized in revenue upon transfer of control. Balances consist primarily of software subscription services and extended Assure maintenance services not yet provided as of the balance sheet date. Contract assets, which represent services provided or products transferred to customers in advance of the date the Company has a right to invoice, are netted against deferred revenue on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">customer-by-customer</div></div> basis. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as deferred revenue with the remainder recorded as deferred revenue, noncurrent on the consolidated balance sheets. Total deferred revenue was $89.8 million and $72.7 million as of January 31, 2021 and 2020, respectively. The Company recognized $39.4 million, $25.5 million, and $16.0 million of revenue during the years ended January 31, 2021, 2020, and 2019, respectively, that was included in the deferred revenue balance at the beginning of the respective period. </div> 89800000 72700000 39400000 25500000 16000000.0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cost of Revenue </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Cost of networked charging systems revenue includes the material costs for parts and manufacturing costs for the hardware products, compensation, including salaries and related personnel expenses, including stock-based compensation, warranty provisions, depreciation of manufacturing related equipment and facilities, amortization of capitalized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software development costs, and allocated overhead costs. Costs for shipping and handling are recorded in cost of revenue as incurred. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Cost of subscriptions revenue includes network and wireless connectivity costs for subscription services, field maintenance costs for Assure to support the Company’s network of systems, depreciation of owned and operated systems used in CPaaS arrangements, amortization of capitalized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software development costs, allocated overhead costs, and support costs to manage the systems and helpdesk services for drivers and site hosts. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Costs to Obtain a Customer Contract </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales commissions are considered incremental and recoverable costs of acquiring customer contracts. Beginning at the Company’s adoption of ASC 606 on February 1, 2019, incremental and recoverable costs for the sale of cloud enabled software and extended maintenance service plans are capitalized as deferred contract acquisition costs within prepaid expenses and other current assets and other assets on the consolidated balance sheets and amortized on a straight-line basis over the anticipated benefit period of five years. The benefit period was estimated by taking into consideration the length of customer contracts, renewals, technology lifecycle, and other factors. This amortization is recorded within sales and marketing expense in the Company’s consolidated statements of operations. The sales commissions paid related to the sale of networked charging systems are expensed as incurred. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company elected the practical expedient that permits the Company to apply ASC Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-40,</div> “Other Assets and Deferred Costs- Contracts with Customers,” (“ASC 340”) to a portfolio containing multiple contracts, as they are similar in their characteristics, and the financial statement effects of applying ASC Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-40</div> to that portfolio would not differ materially from applying it to the individual contracts within that portfolio. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in the deferred contract acquisition costs during the years ended January 31, 2021 and 2020 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance upon adoption of ASC 340 on February 1, 2019</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,189</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Capitalization of deferred contract acquisition costs</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,318</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization of deferred contract acquisition costs</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(675</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance as of January 31, 2020</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,832</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Capitalization of deferred contract acquisition costs</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,908</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization of deferred contract acquisition costs</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,206</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance as of January 31, 2021</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,534</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred acquisition costs capitalized on the consolidated balance sheets were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 78%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred contract acquisition costs, current</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,550</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,013</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred contract acquisition costs, noncurrent</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,984</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,819</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred contract acquisition costs</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,534</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,832</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in the deferred contract acquisition costs during the years ended January 31, 2021 and 2020 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance upon adoption of ASC 340 on February 1, 2019</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,189</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Capitalization of deferred contract acquisition costs</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,318</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization of deferred contract acquisition costs</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(675</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance as of January 31, 2020</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,832</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Capitalization of deferred contract acquisition costs</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,908</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization of deferred contract acquisition costs</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,206</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance as of January 31, 2021</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,534</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred acquisition costs capitalized on the consolidated balance sheets were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 78%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred contract acquisition costs, current</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,550</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,013</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred contract acquisition costs, noncurrent</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,984</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,819</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred contract acquisition costs</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,534</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,832</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 2189000 2318000 675000 3832000 2908000 1206000 5534000 1550000 1013000 3984000 2819000 5534000 3832000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and Development </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Research and development expenses consist primarily of salary and related expenses, including stock-based compensation, for personnel related to the development of improvements and expanded features for the Company’s products and services, as well as quality assurance, testing, product management, amortization of capitalized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software, and allocated overhead. Research and development costs are expensed as incurred. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based Compensation </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company measures and recognizes compensation expense for all stock-based awards, including stock options and restricted common stock, granted to employees and directors based on the estimated fair value of the awards on the date of grant. The fair value of each stock option award is estimated on the grant date using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock, the expected term of the option, the expected volatility of the price of the Company’s common stock, risk-free interest rates, and the expected dividend yield of the Company’s common stock. The assumptions used to determine the fair value of the awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company amortizes the fair value of each stock award on a straight-line basis over the requisite service period of the awards. Stock-based compensation expense is based on the value of the portion of stock-based awards that is ultimately expected to vest. As such, the Company’s stock-based compensation is reduced for the estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Advertising </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company expenses the costs of advertising, including promotional expenses, as incurred. Advertising expenses for the years ended January 31, 2021, 2020, and 2019 were not material. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warranty </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company provides standard warranty coverage on its products for twelve months, providing parts necessary to repair the systems during the warranty period. The Company accounts for the estimated warranty cost as a charge to networked charging systems cost of revenue when revenue is recognized. The estimated warranty cost is based on historical and predicted product failure rates and repair expenses. Warranty expense for the years ended January 31, 2021, 2020, and 2019 was $3.4 million, $2.8 million, and $2.0 million, respectively. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In addition, the Company offers <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-for</div> subscriptions to extended maintenance service plans under Assure. Assure provides both the labor and parts to maintain the products over the subscription terms of typically one to five years. The costs related to the Assure program are expensed as incurred and charged to subscriptions cost of revenue. </div> 3400000 2800000 2000000.0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign Currency </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The functional currency of the Company’s foreign subsidiaries is generally the local currency. The translation of foreign currencies into U.S. dollars is performed for monetary assets and liabilities at the end of each reporting period based on the then current exchange rates. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-monetary</div> items are translated using historical exchange rates. For revenue and expense accounts, an average foreign currency rate during the period is applied. Adjustments resulting from translating foreign functional currency financial statements into U.S. dollars are recorded as part of a separate component of stockholders’ deficit and reported in the consolidated statements of comprehensive loss. Foreign currency transaction gains and losses are included in other income (expense), net for the period. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company uses the asset and liability method in accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax asset and liability. Valuation allowances are established when necessary to reduce deferred tax assets where it is more likely than not that the deferred tax assets will not be realized. In evaluating the Company’s ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including historical operating results, ongoing tax planning, and forecasts of future taxable income on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">jurisdiction-by-jurisdiction</div></div> basis. Based on the level of historical losses, the Company has established a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination by the taxing authorities, including resolutions of any related appeals or litigation processes, based on the technical merits of the position. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Loss per Share Attributable to Common Stockholders </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method required for participating securities. The Company considers all series of its redeemable convertible preferred stock to be participating securities. The Company also considers any shares issued on the early exercise of stock options subject to repurchase to be participating securities because holders of such shares have nonforfeitable dividend rights in the event a dividend is paid on common stock. Under the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method, net income is attributed to common stockholders and participating securities based on their participation rights. The holders of the redeemable convertible preferred stock, as well as the holders of early exercised shares subject to repurchase, do not have a contractual obligation to share in the losses of the Company. As such, the Company’s net losses for the years ended January 31, 2021, 2020, and 2019 were not allocated to these participating securities. Under the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. Diluted net loss per share attributable to common stockholders adjusts basic net loss per share for the effect of dilutive securities, including stock options. As the Company has reported losses for all periods presented, all potentially dilutive securities are antidilutive and accordingly, basic net loss per share equals diluted net loss per share. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounting Pronouncements </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company is provided the option to adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public</div> business entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt, when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public</div> business entities, as indicated below. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Adopted Accounting Standards </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In June 2018, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2018-13,</div> “Fair Value Measurement (Topic 820): Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurements,” which expands the disclosure requirements for Level 3 fair value measurements and expands disclosures for measurement uncertainty. This guidance became effective for annual reporting periods beginning after December 15, 2019. The Company adopted the guidance at the beginning of fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In August 2018, the FASB issued <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2018-15,</div> “Intangibles-Goodwill and Other-Internal Use Software (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">350-40):</div> Customer’s Accounting for Implementation Costs Incurred In a Cloud Computing </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Arrangement That Is a Service Contract,” which reduces complexity of the accounting for costs of implementing a cloud computing service arrangement. The guidance is effective for annual reporting periods beginning after December 15, 2020. The Company early adopted this guidance at the beginning of fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In March 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04,</div> “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which provides optional expedients and exceptions for applying U.S. GAAP to contract modifications, hedging relationships, and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The guidance is effective for the Company beginning on March 12, 2020 and it will apply the amendments prospectively through December 31, 2022. The Company adopted this guidance during fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In May 2014, the FASB issued ASC 606 with several subsequent amendments. ASC 606 amends the existing accounting standards for revenue recognition. The new guidance provides a new model to determine when and over what period revenue is recognized. Revenue is recognized for the transfer of promised goods or services to customers in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company early adopted the new revenue standard as of February 1, 2019 using the modified retrospective approach. The impact of the adoption was not material to the Company’s consolidated financial statements and disclosures. Comparative information prior to the date of adoption has not been restated and continues to be reported under the accounting standards in effect for those periods. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">With the adoption of ASC 606 the Company also early adopted ASC 340 which requires the deferral of incremental costs of obtaining a customer contract which, under the old guidance, were expensed as incurred. The guidance requires the deferral of incremental contract acquisition costs and subsequent amortization over the expected period of benefit. The benefit period was estimated by taking into consideration the length of customer contracts, renewals, technology lifecycle, and other factors. The amortization of these costs is charged to sales and marketing expenses in the consolidated statements of operations. The cumulative impact of ASC 340 adoption on February 1, 2019 resulted in an increase of $2.2 million in total assets related to costs to obtain customer contracts that were previously expensed as incurred but would have been capitalized under ASC 340. Upon adoption, the Company recorded the cumulative impact of adoption as an adjustment to the Company’s accumulated deficit on February 1, 2019. Prior periods were not retroactively adjusted. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The adoption of ASC 340 resulted in a net decrease in sales and marketing expenses due to the capitalization and related amortization of deferred contract acquisition costs that would have been expensed as incurred prior to adoption. During the year ended January 31, 2020, the adoption of ASC 340 resulted in offsetting changes within operating assets and liabilities and had no net impact on the consolidated statements of cash flows. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In February 2016, the FASB issued ASC 842. The guidance is effective for annual reporting periods for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public</div> business entities beginning after December 15, 2021 and early adoption is permitted. The new standard requires lessees to recognize operating and finance lease liabilities on the balance sheet, as well as corresponding ROU assets. This standard also made some changes to lessor accounting and aligns key aspects of the lessor accounting model with the revenue recognition standard. In addition, disclosures are required to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. ASC 842 requires adoption using the modified retrospective approach, with the option of applying the requirements of the standard either (a) retrospectively to each prior comparative reporting period presented, or (b) retrospectively at the beginning of the period of adoption. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has early adopted ASC 842 as of February 1, 2019 on a modified retrospective basis. Prior period amounts were not adjusted and continue to be reported in accordance with our historic accounting under </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">previous lease guidance, ASC 840, Leases. Upon adopting ASC 842 at the beginning of the fiscal year ended January 31, 2020, as a lessee, the Company recognized operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets of $11.3 million and operating lease liabilities of $12.5 million and corresponding reductions of $1.6 million to deferred rent and $0.4 million to prepaid rent. The adoption of the standard did not result in any adjustments to accumulated deficit. See Note 6, Leases, for more information. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For lessor accounting, the impact was not material to the Company’s consolidated financial statements and disclosures. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In January 2017, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2017-04,</div> “Intangibles — Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” The new standard simplifies the measurement of goodwill by eliminating step two of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-step</div> impairment test. Step two measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. The new guidance requires an entity to compare the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">tax-deductible</div> goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. The guidance is effective for annual reporting periods beginning after December 15, 2021. The Company early adopted this guidance at the beginning of fiscal year 2020. The impact of the adoption had no impact on the Company’s consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In July 2017, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2017-11,</div> “Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception.” The new guidance reduces the complexity associated with an issuer’s accounting for certain financial instruments with characteristics of liability and equity. Specifically, the FASB determined that a down round feature would no longer cause a freestanding equity-linked financial instrument (or an embedded conversion option) to be accounted for as a derivative liability at fair value with changes in fair value recognized in current earnings. This guidance is effective for annual reporting periods beginning after December 15, 2019. The Company early adopted this guidance at the beginning of fiscal year 2020. The adoption of this guidance did not have a material impact to the Company’s consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In February 2018, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2018-02,</div> “Income Statement- Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” The new guidance permits, but does not require, companies to reclassify the stranded tax effects of the Tax Cuts and Jobs Act (the “Act”) on items within accumulated other comprehensive income to retained earnings. This guidance became effective for annual reporting periods beginning after December 15, 2018. The Company did not elect to reclassify the stranded tax effects of the Act on items within accumulated other comprehensive income to retained earnings. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In June 2018, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2018-07,</div> “Compensation — Stock Compensation (Topic 718): Improvements to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Employee</div> Share-Based Payment Accounting.” The new guidance expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees</div> and to account for awards to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees</div> using the grant date fair value without subsequent periodic measurement. The guidance is effective for annual reporting periods beginning after December 15, 2019. The Company early adopted this guidance in fiscal year 2020 using a modified retrospective transition method. Adoption of this guidance did not have a material impact to the Company’s consolidated financial statements and disclosures. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Issued Accounting Standards Not Yet Adopted </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2016-13,</div> “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” and has since released various amendments including ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2019-04.</div> The guidance modifies the measurement of expected credit losses on certain financial instruments. This guidance is effective for the Company’s annual reporting periods beginning after December 15, 2022. Early adoption is permitted. The Company is currently assessing the impact of the guidance on its consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In November 2018, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2018-18,</div> “Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606”, which clarifies when certain transactions between collaborative arrangement participants should be accounted for under ASC 606 and incorporates <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">unit-of-account</div></div> guidance consistent with ASC 606 to aid in this determination. The guidance is effective for the Company’s annual reporting periods beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">step-up</div> in goodwill obtained in a transaction that is not a business combination. The guidance will be effective for the Company’s annual reporting periods beginning after December 15, 2021. Early adoption is permitted. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> “Debt — Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40),”</div> which modifies and simplifies accounting for convertible instruments. The new guidance eliminates certain separation models that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance will be effective for annual reporting periods beginning after December 15, 2023. Early adoption is permitted, but no earlier than for fiscal years beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In October 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-08,</div> “Codification Improvements to Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">310-20</div> — Receivables-Nonrefundable Fees and Other Costs,” which clarifies the accounting for the amortization period for certain purchased callable debt securities held at a premium by giving consideration to securities which have multiple call dates. The guidance will be effective for annual reporting periods beginning after December 15, 2021. Early adoption is permitted for annual reporting periods beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures. </div> 11300000 12500000 1600000 400000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3. Fair Value Measurements </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 46%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross Unrealized</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported as:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 1pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">January 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized<br/>Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gains</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Losses</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash and cash<br/>equivalents</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Short-term<br/>investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,788</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,788</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,788</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market funds</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total assets measured at fair value on a recurring basis</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">145,491</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—  </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—  </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">145,491</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">145,491</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—  </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross Unrealized</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported as:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 1pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">January 31, 2020</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized<br/>Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gains</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Losses</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash and cash<br/>equivalents</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Short-term<br/>investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,266</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,266</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,266</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market funds</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,487</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,487</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,487</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U.S. treasury bills</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47,014</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47,037</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47,037</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total assets measured at fair value on a recurring basis</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">119,767</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">23</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—  </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">119,790</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">72,753</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">47,037</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The money market funds were classified as cash and cash equivalents on the consolidated balance sheets and were within Level 1 of the fair value hierarchy. The aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains or losses on money market funds as of January 31, 2021 and 2020. Realized gains and losses, net of tax, were not material for any of the periods presented. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">All of the Company’s U.S. treasury bills were classified as short-term investments on the consolidated balance sheets and were within Level 2 of the fair value hierarchy because they were valued using inputs other than quoted prices in active markets that were observable either directly or indirectly that may include benchmark yields, reported trades, broker/dealer quotes, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-sided</div> markets, benchmark securities, bids, offers, and reference data including market research publications. Realized gains and losses, net of tax, were not material for any of the periods presented. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of January 31, 2021 and 2020, the Company had no investments with a contractual maturity of greater than one year. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s only Level 3 financial instruments were its redeemable convertible preferred stock warrants. See Note 11 for information on the valuation of the redeemable convertible preferred stock warrant liability. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 46%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross Unrealized</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported as:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 1pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">January 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized<br/>Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gains</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Losses</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash and cash<br/>equivalents</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Short-term<br/>investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,788</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,788</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,788</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market funds</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">109,703</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total assets measured at fair value on a recurring basis</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">145,491</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—  </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—  </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">145,491</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">145,491</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—  </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 44%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross Unrealized</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported as:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 1pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">January 31, 2020</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized<br/>Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gains</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Losses</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash and cash<br/>equivalents</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Short-term<br/>investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,266</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,266</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,266</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market funds</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,487</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,487</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,487</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U.S. treasury bills</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47,014</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47,037</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47,037</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total assets measured at fair value on a recurring basis</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">119,767</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">23</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—  </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">119,790</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">72,753</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">47,037</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 35788000 0 0 35788000 35788000 109703000 0 0 109703000 109703000 145491000 0 0 145491000 145491000 33266000 0 0 33266000 33266000 39487000 0 0 39487000 39487000 47014000 23000 0 47037000 0 47037000 119767000 23000 0 119790000 72753000 47037000 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4. Acquisitions </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In fiscal year 2019, the Company acquired an electric fleet and energy management business for a total purchase consideration of $1.5 million in cash. The Company recognized intangible assets related to customer relationships of $0.3 million and goodwill of $1.2 million. The goodwill amount represented synergies related to the Company’s existing platform expected to be realized from this business combination and assembled workforce. The associated goodwill and intangible assets are not deductible for tax purposes. Acquisition costs were not material and were charged to general and administrative expenses in the consolidated statements of operations as incurred. The intangible assets were recorded at fair value and were fully amortized as of January 31, 2020. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unaudited pro forma results of operations for fiscal years 2019 was not provided because the historical operating results of the acquired business was not material and pro forma results would not be materially different from reported results for the periods presented. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition to the purchase consideration, the Company provided an additional $1.0 million of cash compensation awards and 797,280 shares of restricted common stock to employees for future services that vest over two years from the date of the acquisition. Total grant date fair value for the restricted common stock was $0.6 million. The Company recognizes expenses related to the cash compensation awards and restricted common stock on a straight-line basis over the requisite service period of two years. See Note 10 for further information on the restricted common stock. </div></div> 1500000 300000 1200000 1000000.0 797280 600000 P2Y <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5. Balance Sheet Components </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventories </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventories consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Raw materials</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,029</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,335</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Work-in-progress</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">68</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finished goods</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,495</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,084</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Inventories</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">33,592</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">25,419</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,594</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,347</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computers and software</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,384</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,350</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,605</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,614</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tooling</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,705</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,299</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,398</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,869</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Owned and operated systems</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,703</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,422</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Construction in progress</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,462</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,796</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,851</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,697</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Accumulated depreciation</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(24,863</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(14,756</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Property and Equipment, Net</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">29,988</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">27,941</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation expense for the years ended January 31, 2021, 2020, and 2019 was $10.1 million, $7.1 million, and $3.9 million, respectively. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization expense for intangible assets for the years ended January 31, 2020 and 2019 was $0.6 million and $0.2 million, respectively. There was no amortization expense for the year ended January 31, 2021. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued and other current liabilities </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued and other current liabilities consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,404</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,335</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Refundable customer deposits</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,482</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,241</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Payroll and related expenses</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,547</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,727</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Taxes payable</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,213</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,348</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, current</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,393</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,979</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warranty accruals</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,123</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,029</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Accrued and Other Current Liabilities</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">47,162</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">37,659</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Inventories consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Raw materials</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,029</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,335</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Work-in-progress</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">68</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finished goods</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,495</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,084</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Inventories</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">33,592</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">25,419</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 13029000 11335000 68000 0 20495000 14084000 33592000 25419000 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,594</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,347</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computers and software</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,384</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,350</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,605</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,614</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tooling</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,705</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,299</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,398</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,869</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Owned and operated systems</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,703</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,422</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Construction in progress</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,462</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,796</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,851</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,697</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Accumulated depreciation</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(24,863</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(14,756</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Property and Equipment, Net</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">29,988</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">27,941</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 1594000 1347000 5384000 4350000 10605000 7614000 7705000 6299000 9398000 8869000 17703000 8422000 2462000 5796000 54851000 42697000 24863000 14756000 29988000 27941000 10100000 7100000 3900000 600000 200000 0 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued and other current liabilities consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,404</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,335</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Refundable customer deposits</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,482</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,241</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Payroll and related expenses</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,547</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,727</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Taxes payable</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,213</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,348</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, current</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,393</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,979</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warranty accruals</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,123</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,029</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Accrued and Other Current Liabilities</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">47,162</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">37,659</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 18404000 11335000 6482000 5241000 7547000 6727000 5213000 5348000 2393000 3979000 3000000 2000000 4123000 3029000 47162000 37659000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">6. Leases </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company leases its office facilities under <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancellable</div> operating leases with various lease terms. The Company also leases certain office equipment under operating lease agreements. As of January 31, 2021, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancellable</div> leases expire on various dates between fiscal years 2022 and 2030. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Generally, the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancellable</div> leases include renewal options to extend the lease term from one to five years. The Company has not included any renewal options in its lease terms as these options are not reasonably certain of being exercised. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of January 31, 2021 and 2020, lease balances were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating leases</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">21,817</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10,269</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, current</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,286</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,979</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, noncurrent</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,459</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,230</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease liabilities</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">24,745</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12,209</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes operating lease costs on a straight-line basis over the lease period. Lease expense for the years ended January 31, 2021, 2020, and 2019 was $5.1 million, $4.5 million, and $3.1 million, respectively. Operating lease costs for short-term leases and variable lease costs were not material during the years ended January 31, 2021 and January 31, 2020. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Maturities of the operating lease liabilities as of January 31, 2021 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 11%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Years Ending January 31,</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,719</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,123</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,334</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,152</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,833</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,855</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total undiscounted operating lease payments</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">36,016</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: imputed interest</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,271</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease liabilities</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">24,745</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Maturities of the operating lease liabilities as of January 31, 2020 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Years Ending January 31,</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2021</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,849</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,809</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,671</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">268</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">292</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,341</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total undiscounted operating lease payments</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">14,230</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: imputed interest</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,021</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease liabilities</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12,209</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other supplemental information as of January 31, 2021 and 2020 was as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 85%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lease Term and Discount Rate</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> </tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;;"/> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;;"/> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average remaining operating lease term (years)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.5</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.7</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average operating lease discount rate</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.9</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8.7</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other supplemental cash flow information for the years ended January 31, 2021 and January 31, 2020 was as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    2021    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    2020    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Supplemental Cash Flow Information</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash paid for amounts in the measurement of operating lease liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,226</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,527</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of January 31, 2021, the Company has additional operating leases of approximately $1.0 million that have not yet commenced and as such, have not yet been recognized on the Company’s Consolidated Balance Sheet. These operating leases are expected to commence on February 1, 2021 with lease terms of up to 4.5 years. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of January 31, 2021 and 2020, lease balances were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating leases</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">21,817</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10,269</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, current</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,286</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,979</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, noncurrent</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,459</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,230</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease liabilities</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">24,745</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12,209</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 21817000 10269000 2286000 3979000 22459000 8230000 24745000 12209000 5100000 4500000 3100000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Maturities of the operating lease liabilities as of January 31, 2021 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 11%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Years Ending January 31,</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,719</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,123</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,334</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,152</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,833</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,855</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total undiscounted operating lease payments</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">36,016</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: imputed interest</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,271</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease liabilities</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">24,745</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Maturities of the operating lease liabilities as of January 31, 2020 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Years Ending January 31,</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2021</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,849</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,809</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,671</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">268</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">292</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,341</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total undiscounted operating lease payments</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">14,230</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: imputed interest</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,021</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease liabilities</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12,209</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 4719000 5123000 4334000 4152000 3833000 13855000 36016000 11271000 24745000 4849000 4809000 2671000 268000 292000 1341000 14230000 2021000 12209000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other supplemental information as of January 31, 2021 and 2020 was as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 85%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lease Term and Discount Rate</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> </tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;;"/> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;;"/> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average remaining operating lease term (years)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.5</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.7</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average operating lease discount rate</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.9</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8.7</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> </table> P7Y6M P3Y8M12D 0.079 0.087 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other supplemental cash flow information for the years ended January 31, 2021 and January 31, 2020 was as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    2021    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    2020    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Supplemental Cash Flow Information</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash paid for amounts in the measurement of operating lease liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,226</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,527</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> 4226000 4527000 1000000.0 P4Y6M <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7. Debt </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In December 2014, the Company entered into a $20.0 million term loan agreement to finance working capital requirements and repay certain indebtedness of the Company’s original credit facility (the “2014 Loan”). The 2014 Loan was to be repaid in forty-eight monthly installments commencing on September 1, 2016; the first fifteen payments were interest only, followed by thirty-three equal monthly payments of principal and interest. Interest was calculated at 8.75% plus LIBOR, provided that the interest rate could not be less than 9.75%. The borrowings were secured by substantially all of the Company’s assets. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In July 2018, the Company entered into a term loan facility with certain lenders (the “2018 Loan”) with a borrowing capacity of $45.0 million to finance working capital and repay all outstanding amounts owed under the 2014 Loan, of which $10.0 million expired unused in June 2019. The Company borrowed $35.0 million, with issuance costs of $1.1 million and net proceeds of $33.9 million. The 2018 Loan is secured by substantially all of the Company’s assets, contains customary affirmative and negative covenants, and requires the Company to maintain minimum cash balances and attain certain customer billing targets. The 2018 Loan has a five-year </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">maturity and interest is calculated at LIBOR plus 6.55%. The 2018 Loan agreement was amended on March 20, 2019 to extend the interest only monthly payments through June 30, 2021 to be followed by equal monthly payments of principal and interest. The Company believes that the fair value of the term loan approximates the recorded amount as of January 31, 2021, as the interest rates on the long-term debt are variable and the rates are based on market interest rates after consideration of default and credit risk (using Level 2 inputs). As of January 31, 2021 and 2020 the Company was in compliance with all financial and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-financial</div> debt covenants. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction costs upon entering into the 2018 Loan were recorded as debt discount and are amortized over the term of the 2018 Loan. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total interest expense incurred during the years ended January 31, 2021, 2020, and 2019 was $3.3 million, $3.5 million, and $3.7 million, respectively. There was no accrued interest as of January 31, 2021 and 2020. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total future principal payments under all borrowings as of January 31, 2021 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 11%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Years Ending January 31,</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,500</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,833</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total payments</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">35,000</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In March 2021, the Company repaid the entire loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million. </div></div> 20000000.0 The 2014 Loan was to be repaid in forty-eight monthly installments commencing on September 1, 2016; the first fifteen payments were interest only, followed by thirty-three equal monthly payments of principal and interest. 8.75% plus LIBOR 0.0875 0.0975 45000000.0 10000000.0 35000000.0 1100000 33900000 P5Y LIBOR plus 6.55% 0.0655 3300000 3500000 3700000 0 0 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total future principal payments under all borrowings as of January 31, 2021 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 11%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Years Ending January 31,</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,500</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,833</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total payments</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">35,000</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 11667000 17500000 5833000 35000000 35000000.0 1200000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">8. Commitments and Contingencies </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Purchase Commitments </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Open purchase commitments are for the purchase of goods and services related to, but not limited to, manufacturing, facilities, and professional services under <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancellable</div> contracts. They were not recorded as liabilities on the consolidated balance sheets as of January 31, 2021 and 2020 as the Company had not yet received the related goods or services. The Company had open purchase commitments for goods and services of $64.1 million as of January 31, 2021. All of them are expected to be received by January 31, 2024. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Legal Proceedings </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company may be involved in various lawsuits, claims, and proceedings, including intellectual property, commercial, securities, and employment matters that arise in the normal course of business. The Company accrues a liability when management believes information available prior to the issuance of the consolidated financial statements indicates it is probable a loss has been incurred as of the date of the consolidated financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company believes it has recorded adequate provisions for any such lawsuits, claims, and proceedings as of January 31, 2021. Based on its experience, the Company believes that damage amounts claimed in these matters are not meaningful indicators of potential liability. Given the inherent uncertainties of litigation, the ultimate outcome of the ongoing matters described herein cannot be predicted with certainty. While litigation is inherently unpredictable, the Company believes it has valid defenses with respect to the legal matters pending against it. Nevertheless, the consolidated financial statements could be materially adversely affected in a particular period by the resolution of one or more of these contingencies. Liabilities established to provide for </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved; and such changes are recorded in the accompanying consolidated statements of operations during the period of the change and reflected in accrued and other current liabilities on the accompanying consolidated balance sheets. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Guarantees and Indemnifications </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has service level commitments to its customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits in the event that the Company fails to meet those levels. To date, the Company has not incurred any material costs as a result of such commitments. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s arrangements generally include certain provisions for indemnifying customers against liabilities if its products or services infringe a third-party’s intellectual property rights. Additionally, the Company may be required to indemnify for claims caused by its negligence or willful misconduct. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. To date, the Company has not incurred any material costs as a result of such obligations and has not accrued any liabilities related to such obligations in the consolidated financial statements. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company also may be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Letters of Credit </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company had $0.4 million of secured letters of credit outstanding as of January 31, 2021 and 2020. These primarily relate to support of customer agreements and are fully collateralized by cash deposits which the Company recorded in restricted cash on its consolidated balance sheets based on the term of the remaining restriction. </div></div> 64100000 400000 400000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">9. Redeemable Convertible Preferred Stock </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In fiscal year 2021, the Company issued 22.4 million shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock and 22.4 million common stock warrants for total cash proceeds of $127.0 million, net of issuance costs of $0.2 million. On issuance, the Company’s redeemable convertible preferred stock and common stock warrants were recorded at fair value of the amount of allocated proceeds, net of issuance costs. The Company performed a valuation of the Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock as well as the common stock warrants. The common stock warrants were valued using a Black-Scholes Option pricing model. Based upon that valuation, the Company allocated the net proceeds between the Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock and common stock warrants of $95.5 million and $31.5 million, respectively, based on their relative fair values. In addition, the Company evaluated the conversion feature of the Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock to assess whether it met the definition of a beneficial conversion feature (“BCF”). As the fair value of a share of common stock exceeded the effective conversion price at the issuance date, the Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock contained a BCF. The intrinsic value of $60.4 million was recorded as a discount to the Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock and a credit to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. As a result of the shares being readily convertible into shares of the Company’s common stock at the option of the holders, the full value of the BCF was immediately recorded as a deemed dividend through additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital to reflect the accretion of the discount resulting from the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">at-issuance</div> BCF embedded within the redeemable convertible preferred stock. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In fiscal year 2020, the Company issued 2.6 million shares of Series H redeemable convertible preferred stock and 0.9 million common stock warrants for total cash proceeds of $14.9 million, net of $0.1 million of issuance costs. Of the total cash proceeds, $14.8 million, net of $0.1 million of issuance costs, was allocated to the Series H redeemable convertible preferred stock, based on the estimated fair value of the redeemable convertible preferred stock relative to the estimated fair value of the common stock warrants. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In fiscal year 2019, the Company issued 39.5 million shares of Series H redeemable convertible preferred stock and 13.2 million common stock warrants for total cash proceeds of $216.6 million, net of $8.4 million of issuance costs. Of the total cash proceeds, $215.2 million, net of $8.4 million of issuance costs was allocated to the Series H redeemable convertible preferred stock, based on the estimated fair value of the redeemable convertible preferred stock relative to the estimated fair value of the common stock warrants. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redeemable convertible preferred stock as of January 31, 2021, 2020, and 2019, respectively, consisted of the following: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 48%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidation</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preference</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Authorized</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series A</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,027</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,027</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,746</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,697</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series B</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">132,831</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,146</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,993</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,947</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series C</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,068</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,039</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series D</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,744,194</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,307,263</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,946</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49,469</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series E</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,578,525</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,772,150</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series F</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,611,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,611,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,624</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series G</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,533,636</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,533,636</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">124,745</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series H</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,154,388</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,154,388</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">240,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">229,925</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series H-1</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,351,053</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,351,053</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">129,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">95,456</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">185,180,248</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">182,934,257</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">693,548</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">615,697</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 48%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31, 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidation</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preference</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Authorized</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series A</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,027</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,027</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,746</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,697</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series B</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">132,831</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,146</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,993</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,947</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series C</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,068</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,039</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series D</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,744,194</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,307,262</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,946</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49,469</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series E</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,578,525</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,772,150</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series F</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,611,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,611,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,624</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series G</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,533,636</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,533,636</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">124,745</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series H</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,154,388</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,154,388</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">240,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">229,925</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">162,829,195</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">160,583,203</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">563,753</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">520,241</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 56%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31, 2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidation</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preference</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Authorized</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series A</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,027</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,027</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,746</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,697</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series B</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">132,831</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,146</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,993</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,947</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series C</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,068</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,039</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series D</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,744,194</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,307,263</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,946</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49,469</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series E</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,578,525</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,772,150</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series F</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,611,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,611,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,624</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series G</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,533,636</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,533,636</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">124,745</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series H</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,154,388</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,519,737</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">225,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">215,169</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">162,829,195</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">157,948,553</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">548,753</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">505,485</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The significant features of the Company’s redeemable convertible preferred stock are as follows: </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Dividend provisions </div></div>— The holders of the outstanding shares of Series A, Series B, Series C, Series D, Series E, Series F, Series G, and Series H redeemable convertible preferred stock are entitled to receive, when and if declared by the Company’s Board of Directors, a noncumulative dividend at the annual rate per share of $10.3251, $8.5792, $23.1286, $0.0992, $0.0992, $0.1999, $0.3505, $0.4554 respectively, per annum, adjustable for certain events, such as stock splits and combinations. The holders of the outstanding shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock are entitled to receive a cumulative dividend accrued at the annual rate of $0.4554 per share, accruing on a daily basis through the second anniversary of the issuance of the Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock. In addition, holders of redeemable convertible preferred stock participate in any distribution in excess of preferred dividends on an as converted basis. The Company has declared no dividends as of January 31, 2021. As of January 31, 2021, total unpaid accumulated dividends due to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series H-1</div> redeemable convertible preferred stockholders were $16.8 million. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Liquidation preference </div></div>— In the event of any liquidation, dissolution, winding up or change of control of the Company, whether voluntary or involuntary, the holders of Series H-1 redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $5.6934 per share for each share of Series H-1 redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">After payments to the holders of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock, the holders of Series H redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $5.6934 per share for each share of Series H redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">After payments to the holders of Series H redeemable convertible preferred stock, holders of Series G redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $4.3808 per share for each share of Series G redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">After payments to the holders of Series G redeemable convertible preferred stock, holders of Series F redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $2.4988 per share for each share of Series F redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">After payments to the holders of Series F redeemable convertible preferred stock, holders of Series E redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $2.4802 per share for each share of Series E redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">After payments to the holders of Series E redeemable convertible preferred stock, holders of Series D redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $1.2401 per share for each share of Series D redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">After payments to the holders of Series D redeemable convertible preferred stock, the holders of the Series C and Series B redeemable convertible preferred stock are entitled to receive the amount of $288.9825 and $107.5156 per share, respectively, for each share of Series C and Series B redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">After payments to the holders of Series C and Series B redeemable convertible preferred stock, the holders of the Series A redeemable convertible preferred stock are entitled to receive the amount of $129.0387 per share, respectively, for each share of Series A redeemable convertible preferred stock share then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">After payments to the holders of Series A redeemable convertible preferred stock, the entire remaining assets and surplus funds of the Company legally available for distribution, if any, shall be distributed pro rata among the holders of the then outstanding common stock and redeemable convertible preferred stock on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis, rounded down to the next whole number of shares on a pari passu basis according to the number of shares of common stock held by such holders, until such time as each holder of then outstanding Series A, Series B, Series C, Series D, Series E, Series F, Series G, Series H, and Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock have received an aggregate amount equal to 2, 4, 4, 4, 2.5, 4, 2, 2, and 2 times the preference amount, respectively, of each share of redeemable convertible preferred stock held by each holder. After these distributions have been paid to all holders of redeemable convertible preferred stock, then the holders of then outstanding common stock will be entitled to receive all remaining assets of the Company legally available for distribution pro rata according to the number of outstanding shares of common stock then held by each holder. The redeemable convertible preferred stock will be deemed to have been automatically converted into common stock if the redemption amount per share on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis would be greater than such holder would otherwise be entitled to. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Conversion rights </div></div>— Each share of Series A, Series B, Series C, Series D, Series E, Series F, Series G, Series H, and Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock are convertible, at the option of the holder thereof, at any time after the date of issuance of such share, into such number of fully paid and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-assessable</div> shares of common stock as is determined by dividing, $91.7319, $81.5974, $139.6147, $1.2401, $1.2401, $2.4988, $4.3808, $5.6934, and $5.6934, respectively, by the conversion price $1.9011, $1.9011, $1.9011, $1.2401, $1.2401, $2.4988, $4.3808, $5.6934, and $5.6934, respectively, in effect on the date the certificate is surrendered for conversion. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The holders of each series of redeemable convertible preferred stock shall benefit from certain anti-dilution adjustments in the event the Company issues shares at a per share price lower than the respective issuance price of each series of redeemable convertible preferred stock. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The redeemable convertible preferred stock will automatically convert into shares of common stock at the then effective conversion price for each such share immediately upon the Company’s sale of its common stock in a firm commitment of an underwritten initial public offering pursuant to a registration statement under the </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Securities Act of 1933, as amended, that has a public offering price of not less than $11.3867 per share, adjusted for any stock dividends, combinations, splits, or recapitalizations, and which results in aggregate gross proceeds to the Company of not less than $100.0 million, net of underwriting discounts, commissions, and expenses. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redemption and Balance Sheet Classification </div></div>— While the redeemable convertible preferred stock does not have mandatory redemption provisions, the deemed liquidation preference provisions of the redeemable convertible preferred stock are considered contingent redemption provisions that are not solely within the Company’s control. These elements primarily relate to deemed liquidation events such as a change of control. Accordingly, the Company’s redeemable convertible preferred stock has been presented outside of permanent equity in the mezzanine section of the consolidated balance sheets. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Voting rights </div></div>— The holders of each share of redeemable convertible preferred stock are entitled to the number of votes equal to the number of shares of common stock into which such shares of redeemable convertible preferred stock could be converted. The holder of each share of common stock shall have the right to one vote for each such share and shall be entitled to notice of any stockholders’ meeting in accordance with the bylaws of the Company. Holders of Series A, Series B, Series D, Series, F, and Series H redeemable convertible preferred stock have the right to appoint one, two, three, two, and two directors to the Company’s board of directors, respectively. </div> 22400000 22400000 127000000.0 200000 95500000 31500000 60400000 2600000 900000 14900000 100000 14800000 100000 39500000 13200000 216600000 8400000 215200000 8400000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redeemable convertible preferred stock as of January 31, 2021, 2020, and 2019, respectively, consisted of the following: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 48%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidation</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preference</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Authorized</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series A</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,027</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,027</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,746</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,697</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series B</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">132,831</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,146</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,993</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,947</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series C</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,068</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,039</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series D</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,744,194</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,307,263</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,946</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49,469</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series E</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,578,525</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,772,150</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series F</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,611,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,611,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,624</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series G</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,533,636</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,533,636</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">124,745</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series H</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,154,388</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,154,388</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">240,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">229,925</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series H-1</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,351,053</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,351,053</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">129,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">95,456</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">185,180,248</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">182,934,257</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">693,548</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">615,697</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 48%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31, 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidation</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preference</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Authorized</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series A</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,027</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,027</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,746</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,697</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series B</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">132,831</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,146</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,993</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,947</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series C</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,068</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,039</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series D</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,744,194</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,307,262</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,946</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49,469</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series E</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,578,525</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,772,150</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series F</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,611,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,611,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,624</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series G</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,533,636</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,533,636</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">124,745</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series H</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,154,388</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,154,388</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">240,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">229,925</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">162,829,195</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">160,583,203</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">563,753</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">520,241</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 56%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31, 2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidation</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preference</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Authorized</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series A</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,027</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,027</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,746</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,697</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series B</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">132,831</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,146</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,993</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,947</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series C</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,068</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,039</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series D</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,744,194</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,307,263</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,946</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49,469</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series E</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,578,525</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,772,150</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series F</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,611,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,611,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,624</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series G</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,533,636</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,533,636</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">124,745</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series H</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,154,388</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,519,737</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">225,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">215,169</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">162,829,195</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">157,948,553</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">548,753</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">505,485</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 29027 29027 3746000 3697000 132831 130146 13993000 13947000 45222 45222 13068000 13039000 45744194 44307263 54946000 49469000 22578525 21772150 54000000 26795000 23611372 23611372 59000000 58624000 28533636 28533636 125000000 124745000 42154388 42154388 240000000 229925000 22351053 22351053 129795000 95456000 185180248 182934257 693548000 615697000 29027 29027 3746000 3697000 132831 130146 13993000 13947000 45222 45222 13068000 13039000 45744194 44307262 54946000 49469000 22578525 21772150 54000000 26795000 23611372 23611372 59000000 58624000 28533636 28533636 125000000 124745000 42154388 42154388 240000000 229925000 162829195 160583203 563753000 520241000 29027 29027 3746000 3697000 132831 130146 13993000 13947000 45222 45222 13068000 13039000 45744194 44307263 54946000 49469000 22578525 21772150 54000000 26795000 23611372 23611372 59000000 58624000 28533636 28533636 125000000 124745000 42154388 39519737 225000000 215169000 162829195 157948553 548753000 505485000 10.3251 8.5792 23.1286 0.0992 0.0992 0.1999 0.3505 0.4554 0.4554 0 16800000 5.6934 5.6934 4.3808 2.4988 2.4802 1.2401 288.9825 107.5156 129.0387 91.7319 81.5974 139.6147 1.2401 1.2401 2.4988 4.3808 5.6934 5.6934 1.9011 1.9011 1.9011 1.2401 1.2401 2.4988 4.3808 5.6934 5.6934 11.3867 100000000.0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">10. Common Stock </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of January 31, 2021 and 2020, the Company was authorized to issue 299,771,284 and 240,180,600 shares of common stock, respectively, with a par value of $0.0001 per share. There were 22,961,032 and 11,918,418 shares issued and outstanding as of January 31, 2021 and 2020, respectively. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The holders of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders. The holders of common stock are not entitled to cumulative voting rights with respect to the election of directors, and as a consequence, minority stockholders are not able to elect directors on the basis of their votes alone. Subject to preferences that may be applicable to any shares of redeemable convertible preferred stock currently outstanding or issued in the future, holders of common stock are entitled to receive ratably such dividends as may be declared by the Company’s board of directors out of funds legally available therefor. In the event of the Company’s liquidation, dissolution, or winding up, holders of the Company’s common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preference of any then outstanding redeemable convertible preferred stock. Holders of common stock have no preemptive rights and no right to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted Common Stock </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connection with a business combination in fiscal year 2019 as referenced in Note 4, the Company granted 797,280 shares of restricted common stock to employees for future services that vest over two years from the date of the acquisition. During the years ended January 31, 2021, 2020 and 2019, 166,100, 398,640 and 232,540 shares of restricted common stock vested, respectively. As of January 31, 2021, no shares of restricted common stock remained unvested. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock Reserved for Future Issuance </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Shares of common stock reserved for future issuance on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-if</div> converted basis, were as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Conversion of redeemable convertible preferred stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">193,037,715</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">170,686,661</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock options issued and outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,167,178</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,883,465</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redeemable convertible preferred stock warrants outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,358,546</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,358,546</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock warrants outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,402,515</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,051,462</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares available for grant under 2017 Stock Option Plan</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,528,391</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,844,909</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total shares of common stock reserved</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">266,494,345</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">227,825,043</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 299771284 240180600 0.0001 22961032 22961032 11918418 11918418 one 797280 P2Y 166100 398640 232540 0 0 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Shares of common stock reserved for future issuance on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-if</div> converted basis, were as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Conversion of redeemable convertible preferred stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">193,037,715</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">170,686,661</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock options issued and outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,167,178</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,883,465</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redeemable convertible preferred stock warrants outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,358,546</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,358,546</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock warrants outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,402,515</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,051,462</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares available for grant under 2017 Stock Option Plan</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,528,391</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,844,909</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total shares of common stock reserved</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">266,494,345</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">227,825,043</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 193037715 170686661 30167178 34883465 2358546 2358546 36402515 14051462 4528391 5844909 266494345 227825043 <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11.</div></div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock Warrants </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In connection with its issuance of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">H-1</div> redeemable convertible preferred stock in the fiscal year 2021, the Company issued 22.4 million common stock warrants which were recorded at fair value within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital in stockholders’ deficit. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In connection with its issuance of Series H redeemable convertible preferred stock in fiscal years 2020 and 2019, the Company issued 0.9 million and 13.2 million common stock warrants, respectively, which were recorded at fair value within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital in stockholders’ deficit. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants issued and outstanding as of January 31, 2021 and 2020 consisted of the following: </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Common Stock Warrants </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exercise<br/>Price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Expiration Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,351,053</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.02</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7/31/2030 – 8/6/2030</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,051,462</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.03</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11/16/2028 – 2/14/2029</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total outstanding common stock warrants</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">36,402,515</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31, 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exercise<br/>Price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Expiration Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,051,462</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.03</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11/16/2028 – 2/14/2029</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total outstanding common stock warrants</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">14,051,462</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr></table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redeemable Convertible Preferred Stock Warrants </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 61%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31, 2021 and 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Expiration Date</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exercise<br/>Price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series B Preferred Stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,685</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">107.52</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4/30/2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series D Preferred Stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,436,932</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.24</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4/20/2022 – 1/24/2024</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series E Preferred Stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">806,375</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.24</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12/24/2024 – 7/15/2025</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total outstanding redeemable convertible preferred stock warrants</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,245,992</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The liability associated with these warrants was subject to remeasurement at each balance sheet date using the Level 3 fair value inputs and was as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 69%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at beginning of period</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,718</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,843</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,455</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">73,125</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">875</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">388</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at end of period</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">75,843</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,718</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,843</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 78%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">80.5</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58.4</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">65.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.1</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.6</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.8</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend rate</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (years)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.0</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.0</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Historically, value was assigned to each class of equity securities using an option pricing model method (“OPM”). In July 2020, the Company began allocating the equity value using a hybrid method that utilizes a combination of the OPM and the probability weighted expected return method (“PWERM”). The PWERM is a scenario-based methodology that estimates the fair value of equity securities based upon an analysis of future values for the Company, assuming various outcomes. As the probability of a transaction with a special purpose acquisition company (“SPAC”) increased, the fair value of the redeemable convertible preferred stock warrant liability increased as of January 31, 2021. </div></div> 22400000 900000 13200000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants issued and outstanding as of January 31, 2021 and 2020 consisted of the following: </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Common Stock Warrants </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exercise<br/>Price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Expiration Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,351,053</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.02</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7/31/2030 – 8/6/2030</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,051,462</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.03</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11/16/2028 – 2/14/2029</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total outstanding common stock warrants</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">36,402,515</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31, 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exercise<br/>Price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Expiration Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,051,462</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.03</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11/16/2028 – 2/14/2029</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total outstanding common stock warrants</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">14,051,462</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr></table> 22351053 6.02 2030-07-31 2030-08-06 14051462 9.03 2028-11-16 2029-02-14 36402515 14051462 9.03 2028-11-16 2029-02-14 14051462 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redeemable Convertible Preferred Stock Warrants </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 61%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31, 2021 and 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Expiration Date</div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exercise<br/>Price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series B Preferred Stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,685</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">107.52</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4/30/2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series D Preferred Stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,436,932</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.24</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4/20/2022 – 1/24/2024</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Series E Preferred Stock</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">806,375</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.24</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12/24/2024 – 7/15/2025</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total outstanding redeemable convertible preferred stock warrants</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,245,992</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr></table> 2685 2685 107.52 107.52 2021-04-30 2021-04-30 1436932 1436932 1.24 1.24 2022-04-20 2022-04-20 2024-01-24 2024-01-24 806375 806375 1.24 1.24 2024-12-24 2024-12-24 2025-07-15 2025-07-15 2245992 2245992 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The liability associated with these warrants was subject to remeasurement at each balance sheet date using the Level 3 fair value inputs and was as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 69%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at beginning of period</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,718</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,843</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,455</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">73,125</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">875</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">388</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at end of period</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">75,843</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,718</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,843</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 2718000 1843000 1455000 73125000 875000 388000 75843000 2718000 1843000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 78%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">80.5</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58.4</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">65.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.1</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.6</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.8</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend rate</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (years)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.0</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.0</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> 0.805 0.584 0.650 0.001 0.016 0.028 0.000 0.000 0.000 1.4 2.0 2.0 <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12.</div></div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock Option Plan and Stock-based Compensation </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In 2007, the Company adopted its 2007 Stock Option Plan (the “2007 Plan”) which provides for the granting of stock options to employees, directors, and consultants of the Company. In 2017, the Company adopted its 2017 Stock Option Plan (the “2017 Plan”). Stock options granted under both the 2007 and 2017 Plans may be either incentive stock options (“ISOs”) or nonqualified stock options (“NSOs”). As of January 31, 2021, 4.5 million shares of common stock remained available for issuance under the 2017 Plan. Stock-based awards forfeited, cancelled, or repurchased generally are returned to the pool of shares of common stock available for issuance under the 2017 Plan. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The 2007 Plan and 2017 Plan allow for the early exercise of stock options for certain individuals as determined by the Company’s board of directors. Stock options that are early exercised are subject to a </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">repurchase option that allows the Company to repurchase any unvested shares. Early exercises of stock options are not deemed to be outstanding shares for accounting purposes until those shares vest according to their respective vesting schedules. Accordingly, the consideration received for early exercises of stock options are initially recorded as a liability and reclassified to common stock and additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital as the underlying awards vest. As of January 31, 2021 and 2020, liabilities for unvested shares related to early exercises of stock options were not material. The related number of unvested shares subject to repurchase was also not material for any period presented. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock options under the 2017 Plan generally expire 10 years from the date of grant, or earlier if services are terminated. The exercise price of an ISO and NSO shall not be less than 100% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Company’s board of directors. Stock options granted generally vest over four years and at a rate of 25% upon the first anniversary of the issuance date and 1/48th per month thereafter. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Activity under the Company’s stock option plans is set forth below: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 57%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/>Stock Option<br/>Awards</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/>Average<br/>Exercise</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>term</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/>Intrinsic Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2018</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,955,341</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.59</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.7</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,905,754</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,811,605</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.57</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,853,935</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.35</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,364,006</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cancelled</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,250,990</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.75</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2019</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">31,662,021</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.6</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,456,493</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,780,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.75</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,830,469</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.47</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,464,262</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cancelled</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,728,460</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.83</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2020</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,883,464</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.65</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.3</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,314,017</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,912,180</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.75</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,042,592</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.55</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(110,643,446</td> <td style="vertical-align: bottom; white-space: nowrap;">)</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cancelled</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,585,875</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.84</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2021</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">30,167,177</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.7</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.3</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,064,538,557</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options vested and expected to vest as of January 31, 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27,483,800</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.69</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.2</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">969,997,293</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercisable as of January 31, 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,591,050</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.68</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">586,047,442</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Activity for exercised awards includes early exercises of stock options such that these awards are not considered outstanding stock options upon exercise. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The activity above also includes a grant of a total of 1.5 million stock option awards subject to both service and performance-based vesting conditions to the Chief Executive Officer under the 2017 Plan (“CEO awards”). These stock options have a weighted-average exercise price of $0.75 per share. Upon initial grant in June 2020, these stock option awards had a grant date fair value of $1.1 million and were to vest on the fourth anniversary from the date of grant provided that positive operating income was achieved at the end of fiscal year 2024. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In September 2020, the CEO awards were modified to vest in a single installment on January 31, 2024 contingent upon the closing of the Merger and the Chief Executive Officer’s continuous employment by the </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Company through January 31, 2024. No stock-based compensation expense has been recorded as the CEO awards were improbable of vesting before and after the modification in September 2020, because the performance-based vesting condition is contingent upon the closing of the Merger which is not deemed probable until consummated. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In December 2020, the CEO awards were modified again to accelerate vesting of 12.5% of stock options at any time through January 31, 2024 contingent upon certain additional service-based trigger events. For the year ended January 31, 2021, no stock-based compensation expense has been recorded as the CEO awards remained to be improbable of vesting before and after the modification in December 2020. As of January 31, 2021, the total compensation cost related to these unvested CEO awards not yet recognized was $44.3 million after the impact of the modifications. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total stock-based compensation expense for stock awards recognized during the years ended January 31, 2021, 2020, and 2019 was $4.9 million, $2.9 million, and $1.7 million, respectively. As of January 31, 2021, total unrecognized compensation cost related to stock awards was $9.8 million and is expected to be recognized over a weighted-average period of 2.5 years. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The weighted-average grant date fair value of options granted in the years ended January 31, 2021, 2020, and 2019 was $0.94, $0.31, and $0.24 per share, respectively. The total grant date fair value of options vested during the years ended January 31, 2021, 2020, and 2019 was $5.4 million, $2.5 million, and $1.8 million, respectively. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based Compensation Associated with Awards </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company records stock-based compensation expense for stock options based on the estimated fair value of the options on the date of the grant using the Black-Scholes option-pricing model. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The absence of a public market for the Company’s common stock requires the Company’s board of directors to estimate the fair value of its common stock for purposes of granting options and for determining stock-based compensation expense by considering several objective and subjective factors, including contemporaneous third-party valuations, actual and forecasted operating and financial results, market conditions and performance of comparable publicly traded companies, developments and milestones in the Company, the rights and preferences of common and redeemable convertible preferred stock, and transactions involving the Company’s stock. The fair value of the Company’s common stock was determined in accordance with applicable elements of the American Institute of Certified Public Accountants guide, Valuation of Privately Held Company Equity Securities Issued as Compensation. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The weighted-average assumptions in the Black-Scholes option-pricing models used to determine the fair value of stock options granted during the years ended January 31, 2021, 2020, and 2019 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 48%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49.1% – 51.6</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">40.3% – 40.9</td> <td style="vertical-align: bottom; white-space: nowrap;">%</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">40.9% – 41.6</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.3% – 1.6</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.4% – 2.4</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.7% – 2.9</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend rate</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (in years)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.6 – 5.8</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.0 – 5.9</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.1 – 6.4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility: As the Company is not publicly traded, the expected volatility for the Company’s stock options was determined by using an average of historical volatilities of selected industry peers deemed to be comparable to the Company’s business corresponding to the expected term of the awards. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">zero-coupon</div> U.S. Treasury notes with maturities corresponding to the expected term of the awards. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term: The expected term represents the period these stock awards are expected to remain outstanding and is based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules, and expectations of future employee behavior. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based Compensation Expense </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following sets forth the total stock-based compensation expense for the Company’s stock options and restricted common stock included in the Company’s consolidated statements of operations: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cost of revenue</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">115</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,807</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">871</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">419</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales and marketing</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,501</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,164</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">541</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,524</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">863</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">718</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total stock-based compensation expense</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4,947</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,937</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,706</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 4500000 Stock options under the 2017 Plan generally expire 10 years from the date of grant, or earlier if services are terminated. The exercise price of an ISO and NSO shall not be less than 100% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Company’s board of directors. Stock options granted generally vest over four years and at a rate of 25% upon the first anniversary of the issuance date and 1/48th per month thereafter. <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Activity under the Company’s stock option plans is set forth below: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 57%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/>Stock Option<br/>Awards</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/>Average<br/>Exercise</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>term</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/>Intrinsic Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2018</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,955,341</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.59</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.7</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,905,754</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,811,605</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.57</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,853,935</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.35</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,364,006</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cancelled</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,250,990</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.75</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2019</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">31,662,021</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.6</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,456,493</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,780,372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.75</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,830,469</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.47</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,464,262</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cancelled</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,728,460</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.83</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2020</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,883,464</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.65</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.3</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,314,017</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,912,180</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.75</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,042,592</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.55</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(110,643,446</td> <td style="vertical-align: bottom; white-space: nowrap;">)</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cancelled</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,585,875</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.84</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 31, 2021</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">30,167,177</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.7</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.3</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,064,538,557</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options vested and expected to vest as of January 31, 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27,483,800</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.69</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.2</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">969,997,293</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercisable as of January 31, 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,591,050</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.68</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">586,047,442</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr></table> 28955341 0.59 P7Y8M12D 8905754000 8811605 0.57 3853935 0.35 1364006000 2250990 0.75 31662021 0.6 P7Y4M24D 7456493000 10780372 0.75 4830469 0.47 3464262000 2728460 0.83 34883464 0.65 P7Y3M18D 19314017000 8912180 0.75 11042592 0.55 110643446000 2585875 0.84 30167177 0.7 P7Y3M18D 1064538557000 27483800 0.69 P7Y2M12D 969997293000 16591050 0.68 P6Y4M24D 586047442000 1500000 0.75 1100000 44300000 4900000 2900000 1700000 9800000 P2Y6M 0.94 0.31 0.24 5400000 2500000 1800000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The weighted-average assumptions in the Black-Scholes option-pricing models used to determine the fair value of stock options granted during the years ended January 31, 2021, 2020, and 2019 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 48%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49.1% – 51.6</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">40.3% – 40.9</td> <td style="vertical-align: bottom; white-space: nowrap;">%</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">40.9% – 41.6</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.3% – 1.6</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.4% – 2.4</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.7% – 2.9</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend rate</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (in years)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.6 – 5.8</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.0 – 5.9</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.1 – 6.4</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> 0.491 0.516 0.403 0.409 0.409 0.416 0.003 0.016 0.014 0.024 0.027 0.029 0.000 0.000 0.000 P5Y7M6D P5Y9M18D P5Y P5Y10M24D P6Y1M6D P6Y4M24D <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following sets forth the total stock-based compensation expense for the Company’s stock options and restricted common stock included in the Company’s consolidated statements of operations: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cost of revenue</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">115</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,807</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">871</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">419</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales and marketing</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,501</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,164</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">541</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,524</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">863</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">718</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total stock-based compensation expense</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4,947</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,937</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,706</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 115000 39000 28000 1807000 871000 419000 1501000 1164000 541000 1524000 863000 718000 4947000 2937000 1706000 <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">13.</div></div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div></td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The components of net loss before income taxes were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 58%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Domestic</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(197,908</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(134,578</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(108,663</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,082</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">475</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">695</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss before income taxes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(196,826</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(134,103</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(107,968</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The components of the provision for (benefit from) income taxes were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 76%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Federal</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">151</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">189</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">119</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total current</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">198</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">224</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">119</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Federal</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total provision for income taxes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">198</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">224</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">119</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A reconciliation of the U.S. federal statutory rate to the Company’s effective tax rate was as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 75%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tax at federal statutory rate</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Permanent differences</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.6</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1.5</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.8</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant Mark to Market</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(7.8</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.1</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.1</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based compensation</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.2</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.2</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.2</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation allowance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(13.6</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(21.1</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(21.9</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development tax credits</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.1</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.8</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.9</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Effective tax rate</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.1</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)% </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.1</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)% </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.1</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)% </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The significant components of the Company’s deferred tax assets and liabilities as of January 31, 2021 and 2020 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax assets:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net operating losses</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">114,154</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">105,663</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research &amp; development credits</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,054</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,320</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,270</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,968</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accruals and reserves</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,102</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,692</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based compensation</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">980</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">653</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,999</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,370</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred tax assets</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">157,559</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">137,666</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: valuation allowance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(150,991</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(134,337</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax liabilities:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation and amortization</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(375</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(489</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,186</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,834</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred tax liabilities</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(6,561</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(3,323</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net deferred tax assets</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company determines its valuation allowance on deferred tax assets by considering both positive and negative evidence in order to ascertain whether it is more likely than not that deferred tax assets will be realized. Realization of deferred tax assets is dependent upon the generation of future taxable income, if any, the timing and amount of which are uncertain. Due to the Company’s historical operating losses, the Company believes that it is more likely than not that all of the deferred tax will not be realized; accordingly, the Company has recorded a full valuation allowance on its net domestic deferred tax assets as of January 31, 2021 and 2020. The valuation allowance increased by $16.7 million, $36.2 million, and $29.8 million during the years ended January 31, 2021, 2020, and 2019, respectively. The increases were primarily driven by losses and tax credits generated in the United States. As of January 31, 2021, the Company believes it is not more likely than not that the US deferred tax assets will be fully realizable and continues to maintain a full valuation allowance against its net US deferred tax assets. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of January 31, 2021, the Company had federal and California state net operating loss (“NOL”) carryforwards of $434.7 million and $229.7 million, respectively, of which $281.9 million of the federal NOL carryforwards can be carried forward indefinitely. The federal and California state net operating loss carryforwards begin to expire in 2028 and 2029, respectively. In addition, the Company had NOLs for other states of $134.7 million, which expire beginning in the year 2022. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of January 31, 2021, the Company had federal and California state research credit carryforwards of $5.1 million and $8.8 million, respectively. The federal credit carryforwards will begin to expire in 2039. The California research credit carryforwards can be carried forward indefinitely. The Company had alternative refueling property tax credits that are permanently limited by Section 382. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under Internal Revenue Code Section 382, the Company’s ability to utilize NOL carryforwards or other tax attributes such as research tax credits, in any taxable year may be limited if the Company experiences, or has experienced, an “ownership change.” A Section 382 “ownership change” generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company’s stock, increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Similar rules may apply under state tax laws. The Company performed a Section 382 analysis through January 31, 2021. The Company has experienced ownership changes in the prior periods. As a result of the ownership changes, it was estimated that approximately $53.1 million of Federal NOLs, $40.3 million of California NOLs, and $9.7 million of federal tax credits are expected to expire for income tax purposes, and such amounts are excluded from the carryforwards balance as of January 31, 2021. The Company expects to complete the Section 382 analysis during the year ending January 31, 2022. Subsequent ownership changes may affect the limitation in future years. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the activity related to unrecognized tax benefits as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 68%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrecognized tax benefits — beginning</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,153</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,884</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,445</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross decreases — prior period tax position</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,620</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross increases — current period tax position</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,869</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,269</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,439</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrecognized tax benefits — ending</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">9,402</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10,153</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6,884</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of January 31, 2021, the Company had unrecognized tax benefits of $9.4 million, which would not impact the effective tax rate, if recognized, due to the valuation allowance. The Company does not expect its unrecognized tax benefits will significantly change over the next twelve months. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is subject to income taxes in United States federal and various state, local, and foreign jurisdictions. The tax years from 2007 to 2020 remain open to examination due to the carryover of unused net operating losses or tax credits. As of January 31, 2021, the Company is not subject to income tax examinations by any tax authority. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was enacted and signed into law in the United States. The CARES Act includes measures to assist companies, including temporary changes to income and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-income-based</div> tax laws. The CARES Act contains several corporate income tax provisions, including making remaining alternative minimum tax (AMT) credits immediately refundable; providing a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5-year</div> carryback of net operating losses (NOLs) generated in tax years 2019, 2020, and 2021, and removing the 80% taxable income limitation on utilization of those NOLs if carried back to prior tax years or utilized in tax years beginning before 2022; temporarily liberalizing the interest deductibility rules under Section 163(j) of the CARES Act, by raising the adjusted taxable income limitation from 30% to 50% for tax years 2020 and 2021 and giving taxpayers the election of using 2020 adjusted taxable income for purposes of computing 2021 interest deductibility. The CARES Act did not have a material impact on the Company’s tax provision for the year ended January 31, 2021. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Consolidated Appropriations Act, 2021, which was enacted on December 27, 2020, has expanded, extended, and clarified selected CARES Act provisions, specifically on Paycheck Protection Program (PPP) loan </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">and Employee Retention Tax Credit, 100% deductibility of business meals as well as other tax extenders. The Consolidated Appropriations Act did not have a material impact on the Company’s tax provision for the year ended January 31, 2021.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The components of net loss before income taxes were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 58%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Domestic</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(197,908</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(134,578</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(108,663</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,082</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">475</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">695</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss before income taxes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(196,826</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(134,103</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(107,968</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> -197908000 -134578000 -108663000 1082000 475000 695000 -196826000 -134103000 -107968000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The components of the provision for (benefit from) income taxes were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 76%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Federal</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">47</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">151</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">189</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">119</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total current</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">198</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">224</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">119</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Federal</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total provision for income taxes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">198</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">224</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">119</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 47000 35000 151000 189000 119000 198000 224000 119000 198000 224000 119000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A reconciliation of the U.S. federal statutory rate to the Company’s effective tax rate was as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 75%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tax at federal statutory rate</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Permanent differences</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.6</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1.5</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.8</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant Mark to Market</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(7.8</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.1</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.1</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based compensation</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.2</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.2</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.2</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation allowance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(13.6</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(21.1</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(21.9</td> <td style="vertical-align: bottom; white-space: nowrap;">)% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development tax credits</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.1</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.8</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.9</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Effective tax rate</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.1</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)% </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.1</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)% </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.1</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)% </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 0.210 0.210 0.210 -0.006 -0.015 -0.008 -0.078 -0.001 -0.001 -0.002 -0.002 -0.002 -0.136 -0.211 -0.219 0.011 0.018 0.019 -0.001 -0.001 -0.001 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The significant components of the Company’s deferred tax assets and liabilities as of January 31, 2021 and 2020 were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax assets:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net operating losses</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">114,154</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">105,663</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research &amp; development credits</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,054</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,320</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,270</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,968</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accruals and reserves</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,102</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,692</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based compensation</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">980</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">653</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,999</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,370</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred tax assets</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">157,559</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">137,666</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: valuation allowance</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(150,991</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(134,337</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax liabilities:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation and amortization</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(375</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(489</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,186</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,834</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred tax liabilities</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(6,561</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(3,323</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net deferred tax assets</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 114154000 105663000 12054000 14320000 15270000 6968000 8102000 6692000 980000 653000 6999000 3370000 157559000 137666000 150991000 134337000 375000 489000 6186000 2834000 6561000 3323000 7000 6000 16700000 36200000 29800000 As of January 31, 2021, the Company had federal and California state net operating loss (“NOL”) carryforwards of $434.7 million and $229.7 million, respectively, of which $281.9 million of the federal NOL carryforwards can be carried forward indefinitely. The federal and California state net operating loss carryforwards begin to expire in 2028 and 2029, respectively. In addition, the Company had NOLs for other states of $134.7 million, which expire beginning in the year 2022. 434700000 229700000 281900000 134700000 5100000 8800000 Under Internal Revenue Code Section 382, the Company’s ability to utilize NOL carryforwards or other tax attributes such as research tax credits, in any taxable year may be limited if the Company experiences, or has experienced, an “ownership change.” A Section 382 “ownership change” generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company’s stock, increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. 53100000 40300000 9700000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the activity related to unrecognized tax benefits as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 68%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrecognized tax benefits — beginning</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,153</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,884</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,445</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross decreases — prior period tax position</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,620</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross increases — current period tax position</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,869</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,269</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,439</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrecognized tax benefits — ending</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">9,402</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10,153</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6,884</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 10153000 6884000 4445000 3620000 2869000 3269000 2439000 9402000 10153000 6884000 9400000 P5Y 0.80 0.30 0.50 The Consolidated Appropriations Act, 2021, which was enacted on December 27, 2020, has expanded, extended, and clarified selected CARES Act provisions, specifically on Paycheck Protection Program (PPP) loan and Employee Retention Tax Credit, 100% deductibility of business meals as well as other tax extenders. The Consolidated Appropriations Act did not have a material impact on the Company’s tax provision for the year ended January 31, 2021. The legislation disallows the use of California net operating loss deductions if the taxpayer recognizes business income and its adjusted gross income is greater than $1 million. Additionally, any business credit will only offset a maximum of $5 million of California tax. <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">14.</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Related Party Transactions </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Daimler AG and its affiliated entities (“Daimler”) is an investor in the Company and one of its employees is a member of the Company’s board of directors. The following revenue transactions took place between the Company and Daimler during the respective fiscal years: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Daimler</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,457</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,112</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,082</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue from related parties</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,457</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,112</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,082</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Related party accounts receivable as of January 31, 2021 and 2020 from Daimler were $1.2 million and $0.9 million, respectively. </div></div> The following revenue transactions took place between the Company and Daimler during the respective fiscal years: <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Daimler</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,457</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,112</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,082</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue from related parties</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,457</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,112</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,082</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 3457000 3112000 1082000 3457000 3112000 1082000 1200000 900000 <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">15.</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Geographic Information </div></div></div> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue by geographic area based on the shipping address of the customers was as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United States</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">131,571</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,184</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">81,408</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rest of World</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,919</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,331</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,622</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">146,490</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">144,515</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">92,030</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-lived assets by geographic area were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United States</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46,759</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,836</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rest of World</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,046</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,374</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total long-lived assets</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">51,805</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">38,210</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue by geographic area based on the shipping address of the customers was as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="10" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United States</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">131,571</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,184</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">81,408</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rest of World</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,919</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,331</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,622</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">146,490</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">144,515</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">92,030</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 131571000 130184000 81408000 14919000 14331000 10622000 146490000 144515000 92030000 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-lived assets by geographic area were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United States</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46,759</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,836</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rest of World</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,046</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,374</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total long-lived assets</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">51,805</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">38,210</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 46759000 36836000 5046000 1374000 51805000 38210000 <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16.</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and Diluted Net Loss per Share </div></div></div> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended January 31, 2021, 2020, and 2019: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 67%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;">(in thousands, except share and per share data)</td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss attributable to common stockholders</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(274,200</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(134,327</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(108,087</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,116,763</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,893,787</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,342,517</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share attributable to common stockholders, basic and diluted</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(18.14</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(15.10</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(24.89</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 64%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Redeemable convertible preferred stock (on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis)</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">193,037,715</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">170,686,661</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">168,052,012</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options to purchase common stock</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,167,178</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,883,465</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">31,662,022</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested restricted common stock</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">166,100</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">564,740</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested early exercised common stock options</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">371,193</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,830</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,971</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Redeemable convertible preferred stock warrants <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(on an as-converted</div> basis)</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,358,546</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,358,546</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,358,546</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,402,515</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,051,462</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,173,245</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total potentially dilutive common share equivalents</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">262,337,147</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">222,205,064</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">215,869,536</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended January 31, 2021, 2020, and 2019: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 67%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;">(in thousands, except share and per share data)</td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss attributable to common stockholders</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(274,200</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(134,327</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(108,087</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,116,763</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,893,787</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,342,517</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share attributable to common stockholders, basic and diluted</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(18.14</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(15.10</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(24.89</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> -274200000 -134327000 -108087000 15116763 8893787 4342517 -18.14 -15.10 -24.89 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 64%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended January 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Redeemable convertible preferred stock (on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis)</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">193,037,715</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">170,686,661</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">168,052,012</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options to purchase common stock</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,167,178</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,883,465</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">31,662,022</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested restricted common stock</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">166,100</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">564,740</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested early exercised common stock options</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">371,193</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,830</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,971</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Redeemable convertible preferred stock warrants <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(on an as-converted</div> basis)</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,358,546</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,358,546</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,358,546</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,402,515</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,051,462</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,173,245</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total potentially dilutive common share equivalents</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">262,337,147</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">222,205,064</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">215,869,536</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 193037715 170686661 168052012 30167178 34883465 31662022 166100 564740 371193 58830 58971 2358546 2358546 2358546 36402515 14051462 13173245 262337147 222205064 215869536 <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">17.</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Employee Benefit Plans </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has a defined-contribution plan intended to qualify under Section 401 of the Internal Revenue Code (the “401(k) Plan”). The Company contracted with a third-party provider to act as a custodian and trustee, and to process and maintain the records of participant data. Substantially all of the expenses incurred for administering the 401(k) Plan are paid by the Company. The Company has not made any matching contributions to date. </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">18.</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Subsequent Events </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 26, 2021 (the “Closing Date”), the Company consummated the Merger (the “Closing”) with Switchback Energy Acquisition Corporation (“Switchback”), where a subsidiary of Switchback merged with the Company, with the Company surviving the Merger as a wholly-owned subsidiary of Switchback. As a result of the proposed Merger, Switchback will be renamed to ChargePoint Holdings, Inc. (“New ChargePoint”). </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Pursuant to the terms of the Merger Agreement, each stockholder of the Company shall receive 0.9966 shares of New ChargePoint’s common stock and the contingent right to receive certain Earnout Shares (as defined below), for each share of the Company’s common stock, par value $0.0001 per share, owned by such the Company’s stockholder that was outstanding immediately prior to the Closing (other than any shares of the </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Company’s restricted stock). In addition, certain investors purchased an aggregate of 22,500,000 shares of New ChargePoint’s common stock (such investors, the “PIPE Investors”) concurrently with the Closing for an aggregate purchase price of $225 million. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Pursuant to a letter agreement (the “Founders Stock Letter”) entered into in connection with the execution of the Merger, immediately prior to the Closing, the initial stockholders (i) surrendered to New ChargePoint, for no consideration and as a capital contribution to New ChargePoint, 984,706 Class B common stock, par value $0.0001 per share (“Founder Shares”), held by them (on a pro rata basis), whereupon such shares were immediately canceled, and (ii) subjected 900,000 Founder Shares (including New ChargePoint’s common stock issued in exchange therefor in the Merger) held by them to potential forfeiture in accordance with the terms of the Founders Stock Letter. Upon the Closing, all outstanding Founder Shares converted into Common Stock on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis and the Founder Shares ceased to exist. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Also at the Closing, the NGP Switchback, LLC (the “Sponsor”) exercised its right to convert a portion of the working capital loans made by the Sponsor to Switchback into an additional 1,000,000 Private Warrants at a price of $1.50 per warrant in satisfaction of $1.5 million principal amount of such loans. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, pursuant to the terms of the Merger Agreement, (1) warrants to purchase shares of capital stock of the Company were converted into warrants to purchase an aggregate of 38,761,031 shares of New ChargePoint’s common stock and the contingent right to receive certain Earnout Shares, (2) options to purchase shares of common stock of the Company were converted into options to purchase an aggregate of 30,135,695 shares of New ChargePoint’s common stock and, with respect to vested options, the contingent right to receive certain Earnout Shares and (3) unvested restricted shares of common stock of the Company that were outstanding pursuant to the “early exercise” of New ChargePoint options were converted into an aggregate of 345,689 restricted shares of New ChargePoint. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">During the time period between the Closing Date and the five-year anniversary of the Closing Date, eligible former equity holders of the Company may receive up to 27 million additional shares of New ChargePoint’s common stock (the “Earnout Shares”) in the aggregate in three equal tranches of 9,000,000 shares if the volume-weighted average closing sale price of our Common Stock is greater than or equal to $15.00, $20.00 and $30.00 for any 10 trading days within any 20 consecutive trading day period (each a “Trigger Event”). At close of the Merger on February 26, 2021, the Company recorded a liability (“Earnout Liability”) of $828.1 million, based on the estimated fair value of the 27 million Earnout Shares with a corresponding reduction of additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital in the equity section of the Company’s consolidated balance sheet. On March 19, 2021, as a result of the first two Trigger Events having been met, two of the three tranches for a total of 18 million Earnout Shares were issued with the related Earnout Liability being remeasured and partially settled by issuing the Earnout Shares at a closing market price of $27.84 per share as of that date. The remaining Earnout Liability related to the 9 million Earnout Shares of the third tranche was remeasured and reclassified to equity because the contingency of issuing a variable number of shares under the three tranches of the Earnout Liability was resolved such that the remaining third tranche provides for the issuance of a fixed number of shares of 9,000,000 if the last Earnout Triggering Event is achieved. The combined impact from the remeasurement of the Earnout Liability resulted in a $84.4 million gain recognized as change of fair value in Earnout Liability in the consolidated statement of operations and an increase in additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital of $743.7 million in the equity section of the Company’s consolidated balance sheet for the period ending April 30, 2021. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March 15, 2021, the Company repaid the entire loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million of its term loan facility (“2018 Loan”). </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Events Subsequent to Original Issuance of Consolidated Financial Statements (unaudited) </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On June 4, 2021, the Company issued a notice of the redemption of all of its outstanding Public Warrants </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">that remain outstanding on July 6, 2021 for a redemption price of $0.01 per warrant. The Private Placement </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants that are still held by the initial holders thereof or their permitted transferees are not subject to the </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">redemption. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On June 29, 2021 the third Earnout Triggering Event occurred and the third and final tranche of 9,000,000 Earnout Shares became issuable. </div></div> 0.9966 22500000 225000000 984706 0.0001 900000 one-for-one 1000000 1.50 1500000 38761031 30135695 345689 27000000 15.00 20.00 30.00 P10D P20D 828100 27000000 18000000 27.84 9000000 84400000 743700000 35000000.0 1200000 0.01 9000000 The shares of the Company’s common and redeemable convertible preferred stock, prior to the Merger (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.9966 established in the Merger as described in Note 3. The number of Legacy ChargePoint shares was determined from the 217,761,738 shares of Legacy ChargePoint common stock outstanding immediately prior to the closing of the Merger converted at the exchange ratio of 0.9966. All fractional shares were rounded down. This includes 900,000 contingently forfeitable Founder Earn Back Shares pending the occurrence of the Founder Earn Back Triggering Event, which was met on March 12, 2021 XML 21 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover Page
6 Months Ended
Jul. 31, 2021
Cover [Abstract]  
Document Type S-1
Amendment Flag false
Entity Central Index Key 0001777393
Entity Registrant Name ChargePoint Holdings, Inc.
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company true
Entity Ex Transition Period false

XML 22 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Current assets:      
Cash and cash equivalents $ 618,089 $ 145,491 $ 72,753
Restricted cash 400 400 400
Short-term investments   0 47,037
Accounts receivable, net of allowance 42,708 35,075 38,488
Inventories 27,916 33,592 25,419
Prepaid expenses and other current assets 22,138 12,074 7,221
Total current assets 711,251 226,632 191,318
Property and equipment, net 32,265 29,988 27,941
Operating lease right-of-use assets 20,834 21,817 10,269
Goodwill 1,215 1,215 1,215
Other assets 5,023 10,468 3,448
Total assets 770,588 290,120 234,191
Current liabilities:      
Accounts payable 28,416 19,784 19,631
Accrued and other current liabilities 51,980 47,162 37,659
Deferred revenue 47,769 40,934 39,408
Debt, current   10,208 0
Total current liabilities 128,165 118,088 96,698
Deferred revenue, noncurrent 58,000 48,896 33,266
Debt, noncurrent   24,686 34,261
Operating lease liabilities 21,582 22,459 8,230
Common stock warrant liabilities 26,868    
Redeemable convertible preferred stock warrant liability   75,843 2,718
Other long-term liabilities 961 972 798
Total liabilities 235,576 290,944 175,971
Commitments and contingencies (Note 7)
Redeemable convertible preferred stock   615,697 520,241
Stockholders' equity (deficit):      
Common stock 32 2 1
Preferred stock  
Additional paid-in capital 1,216,893 62,736 20,331
Accumulated other comprehensive income 150 155 37
Accumulated deficit (682,063) (679,414) (482,390)
Total stockholders' equity (deficit) 535,012 (616,521) (462,021)
Total liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit) $ 770,588 $ 290,120 $ 234,191
XML 23 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Accounts receivable $ 2,000 $ 2,000 $ 2,000
Temporary Equity, Par or Stated Value Per Share $ 0.0001 $ 0.0001 $ 0.0001
Temporary Equity, shares authorized 0 185,180,248 162,829,195
Temporary Equity, shares issued 0 182,934,257 160,583,203
Temporary Equity, shares outstanding 0 182,934,257 160,583,203
Temporary Equity liquidation value $ 0 $ 17,492,964  
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001 $ 0.0001
Common stock, shares authorized 1,000,000,000 299,771,284 240,180,600
Common stock, shares issued 322,170,484 22,961,032 11,918,418
Common stock, shares outstanding 322,170,484 22,961,032 11,918,418
Preferred stock par value (in Dollars per share) $ 0.0001 $ 0.0001  
Preferred stock, shares authorized 10,000,000 0  
Preferred stock, shares outstanding 0 0  
Preferred stock, shares issued 0 0  
Previously Reported [Member]      
Temporary Equity liquidation value   $ 693,548 $ 563,753
XML 24 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Revenue              
Revenue $ 56,121 $ 34,957 $ 96,631 $ 67,733 $ 146,490 $ 144,515 $ 92,030
Cost of revenue              
Cost of revenue 45,344 25,929 76,637 50,941 113,541 126,473 72,526
Gross profit 10,777 9,028 19,994 16,792 32,949 18,042 19,504
Operating expenses              
Research and development 40,410 17,126 65,784 35,152 75,017 69,464 50,510
Sales and marketing 21,923 10,966 37,897 25,167 53,002 56,997 56,411
General and administrative 22,732 4,466 37,199 9,555 25,922 23,945 17,870
Total operating expenses 85,065 32,558 140,880 69,874 153,941 150,406 124,791
Loss from operations (74,288) (23,530) (120,886) (53,082) (120,992) (132,364) (105,287)
Interest income 25 37 47 280 315 3,245 1,402
Interest expense   (793) (1,499) (1,628) (3,253) (3,544) (3,690)
Change in fair value of redeemable convertible preferred stock warrant liability   (11,516) 9,237 (10,981) (73,125) (875) (388)
Change in fair value of common stock warrant liabilities (10,421)   33,340 (10,981)      
Change in fair value of contingent earnout liability     84,420        
Transaction costs expensed     (7,031)        
Other (expense) income, net (189) 563 (174) 131 229 (565) (5)
Net loss before income taxes (84,873) (35,239) (2,546) (65,280) (196,826) (134,103) (107,968)
Provision for income taxes 65 48 103 105 198 224 119
Net loss (84,938) (35,287) (2,649) (65,385) (197,024) (134,327) (108,087)
Accretion of beneficial conversion feature of redeemable convertible preferred stock 0 (58,625) 0 (58,625) (60,377) 0 0
Cumulative dividends on redeemable convertible preferred stock 0   (4,292)   (16,799) 0 0
Deemed dividends attributable to vested option holders 0   (51,855)        
Deemed dividends attributable to common stock warrant holders 0   (110,635)        
Net loss attributable to common stockholders - Basic (84,938) (93,912) (169,431) (124,010) $ (274,200) $ (134,327) $ (108,087)
Gain attributable to earnout shares issued 0   (84,420)        
Change in fair value of dilutive warrants (7,427)   (53,540)        
Net loss attributable to common stockholders - Diluted $ (92,365) $ (93,912) $ (307,391) $ (124,010)      
Net loss per share attributable to common stockholders, basic and diluted         $ (18.14) $ (15.10) $ (24.89)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 312,465,016 13,537,501 266,473,703 12,822,481 15,116,763 8,893,787 4,342,517
Weighted average shares outstanding - Basic 312,227,526 13,468,677 266,197,482 12,822,481      
Weighted average shares outstanding - Diluted 313,602,100 13,468,677 275,577,000 12,822,481      
Net loss per share - Basic $ (0.27) $ (6.97) $ (0.64) $ (9.67)      
Net loss per share - Diluted $ (0.29) $ (6.97) $ (1.12) $ (9.67)      
Networked charging systems [Member]              
Revenue              
Revenue $ 40,874 $ 21,368 $ 67,674 $ 41,025 $ 91,893 $ 101,012 $ 61,338
Cost of revenue              
Cost of revenue 35,384 20,408 59,126 39,024 87,083 105,940 59,928
Subscriptions [Member]              
Revenue              
Revenue 12,082 9,811 22,906 18,815 40,563 28,930 22,504
Cost of revenue              
Cost of revenue 7,830 4,452 13,470 9,225 20,385 16,244 10,441
Other [Member]              
Revenue              
Revenue 3,165 3,778 6,051 7,893 14,034 14,573 8,188
Cost of revenue              
Cost of revenue $ 2,130 $ 1,069 $ 4,041 $ 2,692 $ 6,073 $ 4,289 $ 2,157
XML 25 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Statement of Comprehensive Income [Abstract]              
Net income (loss) $ (84,938) $ (35,287) $ (2,649) $ (65,385) $ (197,024) $ (134,327) $ (108,087)
Other comprehensive income (loss):              
Foreign currency translation adjustment (12) 92 (5) 36 141 131 (106)
Available-for-sale short-term investments:              
Unrealized loss on short-term investments, net of tax   (23)   (23) 0 23 0
Reclassification to net income, net of tax         (23) 0 0
Other comprehensive (loss) income (12) 69 (5) 13 118 154 (106)
Comprehensive loss $ (84,950) $ (35,218) $ (2,654) $ (65,372) $ (196,906) $ (134,173) $ (108,193)
XML 26 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Redeemable Convertible Preferred Stock
Common Stock
Balance at Jan. 31, 2018 $ (231,713) $ 10,463 $ (11) $ (242,165)     $ 290,316 $ 0
Balance (in Shares) at Jan. 31, 2018             118,428,814 2,436,734
Vesting of early exercised stock options 4 4            
Stock-based compensation 1,706 1,706            
Net income (loss) (108,087)     (108,087)        
Other comprehensive income (106)   (106)          
Issuance of common stock upon release of restricted stock units (Shares)               797,280
Issuance of common stock upon exercise of vested stock options $ 1,367 1,366           $ 1
Issuance of common stock upon exercise of vested stock options (Shares) 3,853,935             3,794,964
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs (in shares)             39,519,739  
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs             $ 215,169  
Issuance of common stock warrants in connection with Series H-1 redeemable convertible preferred stock $ 1,454 1,454            
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock 0              
Issuance of common stock related to early exercise of stock options (Shares)               58,971
Balance at Jan. 31, 2019 (335,375) 14,993 (117) (350,252)     $ 505,485 $ 1
Balance (in Shares) at Jan. 31, 2019             157,948,553 7,087,949
Vesting of early exercised stock options 15 15            
Stock-based compensation 2,937 2,937            
Net income (loss) (134,327)     (134,327)        
Other comprehensive income 154   154          
Issuance of common stock upon exercise of vested stock options $ 2,201 2,201            
Issuance of common stock upon exercise of vested stock options (Shares) 4,830,469             4,795,588
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs (in shares)             2,634,650  
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs $ 185 185         $ 14,756  
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock 0              
Issuance of common stock related to early exercise of stock options (Shares)               34,881
Balance at Jan. 31, 2020 (462,021) 20,331 37 (482,390) $ 2,189 $ 2,189 $ 520,241 $ 1
Balance (in Shares) at Jan. 31, 2020 [1]             160,583,203 11,918,418
Vesting of early exercised stock options 10 10            
Stock-based compensation 910 910            
Net income (loss) (30,098)     (30,098)        
Other comprehensive income (56)   (56)          
Issuance of common stock upon exercise of vested stock options 436 436            
Issuance of common stock upon exercise of vested stock options (Shares) [1]               1,071,203
Balance at Apr. 30, 2020 (490,819) 21,687 (19) (512,488)     $ 520,241 $ 1
Balance (in Shares) at Apr. 30, 2020 [1]             160,583,203 12,989,621
Balance at Jan. 31, 2020 (462,021) 20,331 37 (482,390) 2,189 2,189 $ 520,241 $ 1
Balance (in Shares) at Jan. 31, 2020 [1]             160,583,203 11,918,418
Net income (loss) (65,385)              
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock (58,625)              
Balance at Jul. 31, 2020 (492,361) 55,363 50 (547,775)     $ 612,674 $ 1
Balance (in Shares) at Jul. 31, 2020 [1]             182,366,537 14,579,702
Balance at Jan. 31, 2020 (462,021) 20,331 37 (482,390) $ 2,189 $ 2,189 $ 520,241 $ 1
Balance (in Shares) at Jan. 31, 2020 [1]             160,583,203 11,918,418
Vesting of early exercised stock options 268 268            
Stock-based compensation 4,947 4,947            
Net income (loss) (197,024)     (197,024)        
Other comprehensive income 118   118          
Issuance of common stock upon exercise of vested stock options $ 5,644 5,643           $ 1
Issuance of common stock upon exercise of vested stock options (Shares) 11,042,592             10,363,603
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs (in shares)             22,351,054  
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs             $ 95,456  
Issuance of common stock warrants in connection with Series H-1 redeemable convertible preferred stock $ 31,547 31,547            
Beneficial conversion feature in connection with Series H-1 redeemable preferred stock 60,377 60,377         (60,377)  
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock (60,377) (60,377)         60,377  
Issuance of common stock related to early exercise of stock options (Shares)               679,011
Balance at Jan. 31, 2021 (616,521) 62,736 155 (679,414)     $ 615,697 $ 2
Balance (in Shares) at Jan. 31, 2021 [1]             182,934,257 22,961,032
Balance at Apr. 30, 2020 (490,819) 21,687 (19) (512,488)     $ 520,241 $ 1
Balance (in Shares) at Apr. 30, 2020 [1]             160,583,203 12,989,621
Vesting of early exercised stock options 1 1            
Stock-based compensation 1,190 1,190            
Net income (loss) (35,287)     (35,287)        
Other comprehensive income 69   69          
Issuance of common stock upon exercise of vested stock options 1,095 1,095            
Issuance of common stock upon exercise of vested stock options (Shares) [1]               1,523,641
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs (in shares) [1]             21,783,334  
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs             $ 92,433  
Issuance of common stock warrants in connection with Series H-1 redeemable convertible preferred stock 31,390 31,390            
Beneficial conversion feature in connection with Series H-1 redeemable preferred stock 58,625 58,625         (58,625)  
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock (58,625) (58,625)         58,625  
Issuance of common stock related to early exercise of stock options (Shares) [1]               66,440
Balance at Jul. 31, 2020 (492,361) 55,363 50 (547,775)     $ 612,674 $ 1
Balance (in Shares) at Jul. 31, 2020 [1]             182,366,537 14,579,702
Balance at Jan. 31, 2021 (616,521) 62,736 155 (679,414)     $ 615,697 $ 2
Balance (in Shares) at Jan. 31, 2021 [1]             182,934,257 22,961,032
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend (Shares) [1]             (182,934,257) 194,060,336
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend 615,697 615,677         $ (615,697) $ 20
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse recapitalization 66,606 66,606            
Issuance of common stock upon the reverse recapitalization, net of issuance costs (Shares) [1]               60,746,989
Issuance of common stock upon the reverse recapitalization, net of issuance costs 200,466 200,460           $ 6
Issuance of common stock upon exercise of warrants (Shares) [1]               9,766,774
Issuance of common stock upon exercise of warrants 225,376 225,375           $ 1
Contingent earnout liability recognized upon the closing of the reverse recapitalization (828,180) (828,180)            
Issuance of earnout shares upon triggering events, net of tax withholding (Shares) [1]               17,539,657
Issuance of earnout shares upon triggering events, net of tax withholding 488,305 488,303           $ 2
Reclassification of remaining contingent earnout liability upon triggering event 242,640 242,640            
Repurchase of early exercised common stock (Shares) [1]               (1,588)
Vesting of early exercised stock options 78 78            
Stock-based compensation 7,577 7,577            
Net income (loss) 82,289     82,289        
Other comprehensive income 7   7          
Balance at Apr. 30, 2021 484,340 1,081,272 162 (597,125)       $ 31
Balance (in Shares) at Apr. 30, 2021 [1]               305,073,200
Balance at Jan. 31, 2021 (616,521) 62,736 155 (679,414)     $ 615,697 $ 2
Balance (in Shares) at Jan. 31, 2021 [1]             182,934,257 22,961,032
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse recapitalization 66,606              
Contingent earnout liability recognized upon the closing of the reverse recapitalization (828,180)              
Reclassification of remaining contingent earnout liability upon triggering event 242,640              
Net income (loss) $ (2,649)              
Issuance of common stock upon exercise of vested stock options (Shares) 3,292,219              
Balance at Jul. 31, 2021 $ 535,012 1,216,893 150 (682,063)       $ 32
Balance (in Shares) at Jul. 31, 2021 [1]               322,170,484
Balance at Apr. 30, 2021 484,340 1,081,272 162 (597,125)       $ 31
Balance (in Shares) at Apr. 30, 2021 [1]               305,073,200
Issuance of common stock upon exercise of warrants (Shares) [1]               4,378,568
Issuance of common stock upon exercise of warrants 113,608 113,608           $ 0
Issuance of earnout shares upon triggering events, net of tax withholding (Shares) [1]               8,773,596
Issuance of earnout shares upon triggering events, net of tax withholding (8,080) (8,081)           $ 1
Vesting of early exercised stock options 40 40            
Stock-based compensation 28,293 28,293            
Net income (loss) (84,938)     (84,938)        
Other comprehensive income (12)   (12)          
Issuance of common stock upon release of restricted stock units (Shares) [1]               652,901
Issuance of common stock upon exercise of vested stock options 1,761 1,761            
Issuance of common stock upon exercise of vested stock options (Shares) [1]               3,292,219
Balance at Jul. 31, 2021 $ 535,012 $ 1,216,893 $ 150 $ (682,063)       $ 32
Balance (in Shares) at Jul. 31, 2021 [1]               322,170,484
[1] The shares of the Company’s common and redeemable convertible preferred stock, prior to the Merger (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.9966 established in the Merger as described in Note 3.
XML 27 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) - USD ($)
$ in Millions
1 Months Ended 12 Months Ended
Aug. 31, 2020
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Statement of Stockholders' Equity [Abstract]          
Net of issuance costs $ 0.2 $ 0.2 $ 0.2 $ 0.1 $ 8.4
XML 28 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Cash flows from operating activities          
Net income (loss) $ (2,649) $ (65,385) $ (197,024) $ (134,327) $ (108,087)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization 5,576 4,684 10,083 7,698 4,086
Non-cash operating lease cost 1,963 1,749 3,762 3,121 0
Stock-based compensation 35,870 2,100 4,947 2,937 1,706
Amortization of deferred contract acquisition costs 829 538 1,206 675 0
Change in fair value of redeemable convertible preferred stock warrant liability (9,237) 10,981 73,125 875 388
Change in fair value of common stock warrant liabilities (33,340) 10,981      
Change in fair value of contingent earnout liability (84,420)        
Inventory reserves     1,412 1,425 1,089
Transaction costs expensed 7,031        
Other 1,236 683 446 589 1,822
Changes in operating assets and liabilities, net of effect of acquisitions:          
Accounts receivable, net (7,657) 16,188 3,292 (8,702) (2,735)
Inventories 5,620 (7,427) (9,585) (1,472) (19,457)
Prepaid expenses and other assets (9,325) (3,335) (8,914) (2,961) (1,760)
Operating lease liabilities (953) (2,031) (2,815) (1,181) 0
Accounts payable 9,293 (9,324) (493) 15,704 (1,120)
Accrued and other liabilities 3,027 (4,054) 11,556 93 10,802
Deferred revenue 15,938 4,564 17,156 27,590 12,720
Net cash used in operating activities (61,198) (50,069) (91,846) (87,936) (100,546)
Cash flows from investing activities          
Purchases of property and equipment (7,788) (5,962) (11,484) (14,885) (14,822)
Purchases of investments     0 (179,514) 0
Maturities of investments   47,014 47,014 132,500 0
Cash paid for acquisition, net of cash acquired     0 0 (1,475)
Net cash (used in) provided by investing activities (7,788) 41,052 35,530 (61,899) (16,297)
Cash flows from financing activities          
Proceeds from the exercise of public warrants 117,598 31,390      
Proceeds from issuance of redeemable convertible preferred stock   92,433 95,456 14,756 215,168
Merger and PIPE financing 511,646        
Proceeds from issuance of common stock warrants     31,547 185 1,454
Payment of transaction costs related to Merger (32,468)        
Proceeds from issuance of debt, net of issuance costs     0 0 33,988
Payment of tax withholding obligations on settlement of earnout shares (20,894)        
Payments of deferred offering costs     (4,003) 0 0
Repayment of borrowings (36,051)        
Repayment of debt     0 0 (18,182)
Proceeds from exercises of vested and unvested stock options 1,759 1,542 5,913 2,217 1,370
Net cash provided by financing activities 541,590 125,365 128,913 17,158 233,798
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (6) 36 141 132 (101)
Net increase in cash, cash equivalents, and restricted cash 472,598 116,384 72,738 (132,545) 116,854
Cash, cash equivalents, and restricted cash at beginning of period 145,891 73,153 73,153 205,698 88,844
Cash, cash equivalents, and restricted cash at end of period 618,489 189,537 145,891 73,153 205,698
Supplementary cash flow information          
Cash paid for interest 344 1,402 2,801 3,414 2,583
Cash paid for taxes 115 105 172 153 117
Supplementary cash flow information on noncash investing and financing activities          
Accretion of beneficial conversion feature of redeemable convertible preferred stock   $ 58,625 60,377 0 0
Deferred transaction costs not yet paid     1,685 0 0
Right-of-use assets obtained in exchange for lease liabilities     2,118 2,906 0
Right-of-use asset remeasurement subsequent to lease extension     12,867 0 0
Vesting of early exercised stock options     268 15 4
Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities     $ 647 $ 1,287 $ 0
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization 615,697        
Reclassification of Legacy ChargePoint redeemable convertible preferred stock warrant liability upon the reverse capitalization 66,606        
Contingent earnout liability recognized upon the closing of the reverse recapitalization 828,180        
Reclassification of remaining contingent earnout liability upon triggering event $ 242,640        
XML 29 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Description of Business and Basis of Presentation
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Accounting Policies [Abstract]    
Description of Business and Basis of Presentation
1.
Description of Business
 
and Basis of Presentation
ChargePoint Holdings, Inc. (“ChargePoint” or the “Company,” “it,” “its”) designs, develops, and markets networked electric vehicle (“EV”) charging system infrastructure (“Networked Charging Systems”) and cloud-based services which enable consumers the ability to locate, reserve, authenticate and transact EV charging sessions (“Cloud” or “Cloud Services”). As part of ChargePoint’s Networked Charging Systems, subscriptions and other offerings, it provides an open platform that integrates with system hardware from ChargePoint and other manufacturers, connecting systems over an intelligent network that provides real-time information about charging sessions and full control, support and m
a
nagement of the Networked Charging Systems. This network provides multiple
web-based portals
for charging system owners, fleet managers, drivers, and utilities.
In addition, the Company offers extended parts and labor warranty (“Assure”) that includes proactive monitoring, fast response times, expert advice and robust reporting. The ChargePoint as a Service (“CPaaS”) program combines the customer’s use of ChargePoint’s owned and operated systems with Cloud Services, Assure and other benefits available to subscribers into one subscription.
The Company’s fiscal year ends on January 31. References to fiscal year 2021 relate to the fiscal year ended January 31, 2021 and to fiscal year 2022 refer to the fiscal year ending January 31, 2022.
Basis of Presentation
The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting. The Company’s condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended January 31, 2021 and the related notes included in the Company’s Registration Statement on Form S-1 filed with the SEC on July 12, 2021, which provides a more complete discussion of the Company’s accounting policies and certain other information. The information as of January 31, 2021 included on the condensed consolidated balance sheets was derived from the Company’s audited consolidated financial statements. The condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company’s financial position as of July 31, 2021 and the results of operations for the three and six months ended July 31, 2021 and 2020, and cash flows for the six months ended July 31, 2021 and 2020. The results of operations for the three and six months ended July 31, 2021 are not necessarily indicative of the results that may be expected for the year ending January 31, 2022.
The Company’s condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its product offerings, raising capital, and recruiting personnel. The Company’s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial
efforts, or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company’s stockholders. The Company has incurred net operating losses and negative cash flows from operations in every year since inception and expects this to continue for the foreseeable future. As of July 31, 2021, the Company had an accumulated deficit of $682.1 million.
The Company has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock, borrowings under its loan facilities, customer payments and proceeds from the Reverse Recapitalization (as defined below). The Company had cash, cash equivalents, and restricted cash of $618.5 million as of July 31, 2021. As of September 10, 2021, the date on which these condensed consolidated financial statements were available to be issued, the Company believes that its cash on hand, together with cash generated from sales to customers, will satisfy its working capital and capital requirements for at least the next twelve months.
The Company’s assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties. The Company’s actual results could vary as a result of, and its near- and long-term future capital requirements will depend on, many factors, including its growth rate, subscription renewal activity, the timing and extent of spending to support its acquisitions, infrastructure and research and development efforts, the expansion of sales and marketing activities, the timing of new introductions of products or features, the continuing market adoption of its Networked Charging Systems platform, and the overall market acceptance of EVs. The Company has and may in the future enter into arrangements to acquire or invest in complementary businesses, services, and technologies, including intellectual property rights. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may be required to seek additional equity or debt financing. Future liquidity and cash requirements will depend on numerous factors, including market penetration, the introduction of new products, and potential acquisitions of related businesses or technology. In the event that additional financing is required from outside sources, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected.
On February 26, 2021 (“Closing Date”), Switchback Energy Acquisition Corporation (“Switchback”) consummated the previously announced transactions pursuant to which Lightning Merger Sub Inc., a wholly owned subsidiary of Switchback incorporated in the State of Delaware (“Lightning Merger Sub”), merged with ChargePoint, Inc., a Delaware corporation (“Legacy ChargePoint”); Legacy ChargePoint survived as a wholly-owned subsidiary of Switchback (such transactions, the “Merger,” and, collectively with the other transactions described in the Merger Agreement (as defined below), the “Reverse Recapitalization”). Further, as a result of the Merger, Switchback was renamed “ChargePoint Holdings,
Inc.
Please refer to Note 3 “Reverse Recapitalization” for further details of the Merger.
1.    Description of Business and Basis of Presentation
ChargePoint, Inc. (“ChargePoint” or the “Company,” “it,” “its”) designs, develops, and markets networked electric vehicle (“EV”) charging system infrastructure and cloud-based services which enable consumers the ability to locate, reserve, authenticate, and transact charging sessions for EVs. As part of its networked charging systems, subscriptions, and other offerings, the Company provides an open platform that integrates with system hardware from multiple manufacturers, connecting systems over an intelligent network that provides real-time information about charging systems. This network provides multiple
web-based
portals for charging system owners, fleet managers, drivers, and utilities.
On September 23, 2020, the Company entered into a merger agreement (the “Merger Agreement”) with Switchback Energy Acquisition Corporation (“Switchback”), where a subsidiary of Switchback was to merge with the Company (collectively with the other transactions described in the Merger Agreement, the “Merger”). As a result of the proposed Merger, Switchback was to be renamed to ChargePoint Holdings, Inc.
On February 26, 2021 (the “Closing Date”), ChargePoint Holdings, Inc. consummated the Merger by and among Switchback, Lightning Merger Sub Inc., a subsidiary of the Company (“Merger Sub”), and ChargePoint. At the Closing, Merger Sub merged with and into ChargePoint, with ChargePoint surviving the Merger as a wholly owned subsidiary of ChargePoint Holdings, Inc.
In addition, as part of the Merger, certain investors purchased an aggregate of 22,500,000 shares of Common Stock (“PIPE Investors”) concurrently with the Closing for an aggregate purchase price of $225,000,000.
On February 26, 2021, upon consummation of the Merger, eligible ChargePoint equity holders, including holders of ChargePoint’s redeemable convertible preferred stock which converted into shares of common stock immediately prior to the closing of the Merger, received or have the right to receive shares of common stock at a deemed value of $10.00 per share after giving effect to the exchange ratio of 0.9966 as defined in the Merger Agreement (“Exchange Ratio”). The Merger is accounted for as a reverse recapitalization under U.S. GAAP. For accounting purposes, the financial statements of the Company will represent a continuation of the financial statements of ChargePoint with the Merger treated as the equivalent of ChargePoint issuing stock for the net assets of Switchback, accompanied by a recapitalization. Accordingly, all periods prior to the Merger for the reported share and per share amounts have been retrospectively adjusted using the Exchange Ratio to effect the reverse recapitalization. See Note 18 for more information.
The Company’s fiscal year ends on January 31. References to fiscal years 2021, 2020, and 2019 relate to the fiscal years ended January 31, 2021, January 31, 2020, and January 31, 2019, respectively.
Basis of Presentation
The consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Company’s consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
The Company’s consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its product offerings, raising capital, and recruiting personnel. The Company’s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial efforts, or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company’s stockholders. The Company has incurred net operating losses and negative cash flows from
operations in every year since inception and expects this to continue for the foreseeable future. As of January 31, 2021, the Company had an accumulated deficit of $679.4 million.
The Company has funded its operations primarily with proceeds from the issuance of redeemable cash proceeds of $127.0 million, net of issuance costs of $0.2 million in July and August 2020 through the issuance of 22.4 million shares of Series
H-1
redeemable convertible preferred stock and 22.4 million common stock warrants. The Company had cash, cash equivalents, and restricted cash of $145.9 million as of January 31,
2021. In February 2021, the Company received cash proceeds of $484.1 million from the Merger. As of March 31, 2021, the date on which these consolidated financial statements were available to be issued, the Company believes that its cash on hand as of January 31, 2021 and the proceeds from the Merger, together with cash generated from sales to customers will satisfy its working capital and capital requirements for at least the next twelve months following the issuance of the consolidated financial statements.
The Company’s assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties. The Company’s actual results could vary as a result of, and its near- and long-term future capital requirements will depend on, many factors, including its growth rate, subscription renewal activity, the timing and extent of spending to support its infrastructure and research and development efforts, the expansion of sales and marketing activities, the timing of new introductions of products or features, the continuing market adoption of its networked charging systems platform, and the overall market acceptance of EVs. The Company may in the future enter into arrangements to acquire or invest in complementary businesses, services, and technologies, including intellectual property rights, although it has no agreements or commitments to complete any material transactions as of March 31, 2021, the date on which these consolidated financial statements were available to be issued. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may seek additional equity or debt financing. Future liquidity and cash requirements will depend on numerous factors, including market penetration, the introduction of new products, and potential acquisitions of related businesses or technology. In the event that additional financing is required from outside sources, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected.
XML 30 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Accounting Policies [Abstract]    
Summary of Significant Accounting Policies
2.
Summary of Significant Accounting Policies
Other than policies noted below, there have been no significant changes to the significant accounting policies disclosed in Note 2 of the
audited
consolidated financial statements as of January 31, 2021 and 2020 and for the years ended January 31, 2021, 2020, and 2019.
Common Stock Warrants Liabilities
The Company assumed 10,470,562 publicly-traded warrants (“Public Warrants”) and 6,521,568 private placement warrants issued to NGP Switchback, LLC (“Private Placement Warrants” and, together with the
Public Warrants, the “Common Stock Warrants”) upon the Merger, all of which were issued in
connection
with
Switch
back’s initial public offering and subsequent overallotment (other than 1,000,000 Private Placement Warrants
which
were issued in connection with the closing of the Merger) and entitle the holder to purchase one share of the Company’s Common stock, par value $0.0001 (“Common Stock”) at an exercise price of $11.50 per share. During the six months ended July 31, 2021, 10,226,081 Public Warrants and 4,347,712
 
Private Placement Warrants were exercised and the remaining 244,481 Public Warrants outstanding as of the July 6, 2021 redemption date were redeemed for cash. The Public Warrants, prior to their redemption, were publicly traded and were exercisable for cash unless certain conditions occurred, such as the failure to have an effective registration statement related to the shares issuable upon exercise or redemption by the Company under certain conditions, at which time the warrants could be cashlessly exercised. The Private Placement Warrants are not redeemable for cash so long as they are held by the initial purchasers or their permitted transferees but may be redeemable for common stock if certain other conditions are met. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
The Company evaluated the Common Stock Warrants and concluded
that t
hey do not meet the criteria to be classified within stockholders’ equity. The agreement governing the Common Stock Warrants includes a provision (“Replacement of Securities Upon Reorganization”), the application of which could result in a different settlement value for the Common Stock Warrants depending on their holder. Because the holder of an instrument is not an input into the pricing of a
fixed-for-fixed
option on the Company’s ordinary shares, the Private Placement Warrants are not considered to be “indexed to the Company’s own stock.” In addition, the provision provides that in the event of a tender or exchange offer accepted by holders of more than 50% of the outstanding shares of the Company’s ordinary shares, all holders of the Common Stock Warrants (both the Public Warrants and the Private Placement Warrants) would be entitled to receive cash for all of their Common Stock Warrants. Specifically, in the event of a qualifying cash tender offer (which could be outside of the Company’s control), all Common Stock Warrant holders would be entitled to cash, while only certain of the holders of the Company’s ordinary shares may be entitled to cash. These provisions preclude the Company from classifying the Common Stock Warrants in stockholders’ equity. As the Common Stock Warrants meet the definition of a derivative, the Company recorded these warrants as liabilities on the consolidated balance sheet at fair value, with subsequent changes in their respective fair values recognized in the condensed consolidated statements of operations and comprehensive loss at each reporting date.
Contingent Earnout
 
Liability
In connection with the Reverse Recapitalization and pursuant to the Merger Agreement and Plan of Merger dated as of September 23, 2020 by and among the Company, Lightning Merger Sub Inc., and Switchback (“Merger Agreement”), eligible ChargePoint equity holders were entitled to receive as additional merger consideration shares of the Comp
a
ny’s Common Stock upon the Company achieving certain Earnout Triggering Events (as described in the Merger Agreement and Note 9). In accordance with ASC
815-40,
the earnout shares were not indexed to the Common Stock and therefore were accounted for as a liability at the Reverse Recapitalization date and subsequently remeasured at each reporting date with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statements of operations.
The estimated fair value of the contingent consideration was determined using a Monte Carlo simulation using a distribution of potential outcomes on a monthly basis over the Earnout Period (as defined in Note 9) prioritizing the most reliable information available. The assumptions utilized in the calculation were based on the achievement of certain stock price milestones, including the current Company Common Stock price, expected volatility, risk-free rate, expected term and dividend rate.
 
Impact of
COVID-19
In March 2020, the World Health Organization characterized
COVID-19
as a pandemic. The impact of
COVID-19,
including changes in consumer and business behavior, pandemic fears and market downturns, and restrictions on business and individual activities, has created significant volatility in the global economy and led to reduced economic activity. The spread of
COVID-19
has disrupted ChargePoint’s supply chain and heightened its freight and logistic costs, and has similarly disrupted manufacturing, delivery and overall supply chain of vehicle manufacturers and suppliers, which has led to fluctuations in EV sales around the world.
Until its settlement the contingent earnout liability was categorized as a Level 3 fair val
ue measurem
ent (see Fair Value of Financial Instruments accounting policy as described above) because the Company estimated projections during the Earnout Period utilizing unobservable inputs. Contingent earnout payments involve certain assumptions requiring significant judgment and actual results can differ from assumed and estimated amounts.
Use of Estimates
The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for doubtful accounts, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of redeemable convertible preferred stock warrants and common stock warrants, including Common Stock Warrants as a result of the Merger, contingent earnout liability, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Concentration of Credit Risk and Other Risks and Uncertainties
Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts with large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. 
Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.
Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of July 31, 2021 and January 31, 2021, one customer individually accounted for 9% and 16% of accounts receivable, net, respectively. For the six months ended July 31, 2021 and 2020, there were no customers that represented 10% or more of total revenue.
The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s operating results.
 
As a result of the
COVID-19
pandemic, ChargePoint initially modified its business practices (including reducing employee travel, recommending that all
non-essential
personnel work from home and cancelling or reducing physical participation in sales activities, meetings, events and conferences), implemented additional safety protocols for essential workers, and implemented temporary cost cutting measures in order to reduce its operating costs. The Company may take further actions as may be required by government authorities or that it determines are in the best interests of its employees, customers, suppliers, vendors and business partners.
While the ultimate duration and extent of the
COVID-19
pandemic depends on current and future developments that cannot be accurately predicted, such as the extent and effectiveness of containment actions and vaccinations, it has already had an adverse effect on the global economy, the ultimate societal and economic impact of the
COVID-19
pandemic remains unknown. The effect of the COVID-19 pandemic can also vary over time and across the geographies in which ChargePoint operates. For example, variations in work-from-home policies can cause fluctuations in ChargePoint’s revenues, and the Company believes that since people are not yet fully back to work it has not yet seen the full return of commercial customer demand for its products. The conditions caused by the COVID-19 pandemic, such as more permanent work-from-home policies, are likely to continue affecting the rate of global infrastructure spending, and thus to continue to adversely impact ChargePoint’s gross margins as the Company’s commercial business contributes higher margins than its residential and fleet businesses. Further, the COVID-19 pandemic could continue to heighten supply chain pricing and logistics expenses, and could, for example, adversely impact ChargePoint’s gross margins through heightened supply chain expenses, and could adversely affect demand for ChargePoint’s platforms, lengthen its sales cycles, reduce the value, renewal rate or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from new customers, cause some of its paying customers to go out of business and limit the ability of its direct sales force to travel to customers and potential customers, all of which could adversely affect its business, results of operations and financial condition
.
Segment Reporting
The Company operates as one operating segment because its
 
Chief Executive Officer, as the Company’s chief operating decision maker reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance.
Fair Value of Financial Instruments
Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value:
 
 
(Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
 
 
(Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and
 
 
(Level 3) — Inputs that are unobservable for the asset or liability.
The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material
non-financial assets
valued on a
non-recurring basis
that resulted in an impairment in any period presented.
The carrying values of the Company’s cash eq
uivalents, account
s receivable,
net
, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments.
Remaining Performance Obligations
Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and
non-cancellable contracted
amounts that will be invoiced and recognized as revenue in future periods. The Company’s Assure, Cloud, and CPaaS subscription terms typically range from one to five years
 
and are paid up-front
. Revenue expected to be recognized from remaining performance obligations was $118.2 million as of July 31, 2021, of which 42 % is expected to be recognized over the next twelve months
.
Deferred Revenue
Deferred revenue represents billings or payments received in advance of revenue recognition and is recognized in revenue upon transfer of control. Balances consist primarily of Cloud Services and Assure services not yet provided as of the balance sheet date. Contract assets, which represent services provided or products transferred to customers in advance of the date the Company has a right to invoice, are netted against deferred revenue on a
customer-by-customer basis.
Deferred revenue that will be recognized during the succeeding
twelve-month
period is recorded as current deferred revenue with the remainder recorded as deferred revenue,
non-current
on the condensed consolidated balance sheets.
Total current and non-current deferred revenue was
$105.8 million and $89.8 
million as of July 31, 2021 and January 31, 2021, respectively. The Company recognized $7.7 million and $4.6 million of revenue during the three months ended July 31, 2021 and July 31, 2020, and
$22.9 million and $21.0 
million of revenue during the six months ended July 31, 2021 and July 31, 2020, respectively, that was included in the deferred revenue balance
at the beginning of the period.
Accounting Pronouncements
The Company can adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as
non-public business
entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt
when permissible, the Company has elected to adopt new or revised accounting guidance within t
he
same time period as
non-public business
entities, as indicated below. Based on the Company’s public float as of July 31, 2021, it will become a large accelerated filer, and lose emerging growth company status, as of January 31, 2022. As of January 31, 2022, the Company will be required to adopt new or revised accounting standards when they are applicable to public companies that are not emerging growth companies.
Recently Issued Accounting Standards Not Yet Adopted
In June 2016, the FASB issued
ASU 2016-13,
Financial Instruments
 — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,
and has since released various amendments including ASU
No. 2019-04.
The guidance modifies the measurement of expected credit losses on certain financial instruments. The Company will become a large accelerated filer effective January 31, 2022, at which point the Company will follow the timeline for adoption of new accounting pronouncements for public companies. As a result, the Company will adopt ASU 2016-13 for the January 31, 2022 annual period, with a modified retrospective application to all outstanding instruments and a cumulative effect adjustment recorded to opening retained earnings as of February 1, 2021 and is currently assessing the impact the guidance will have on its condensed consolidated financial statements.
In December 2019, the FASB issued ASU
2019-12,
Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,
which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis
step-up in
goodwill obtained in a transaction that is not a business combination. The guidance will be effective for annual reporting periods beginning after December 15, 2020, including interim periods therein. As a result, the Company will adopt ASU 2019-12 for the January 31, 2022 annual
period
and
is
currently assessing the impact the guidance will have on its condensed consolidated financial statements.
In August 2020, the FASB issued ASU
 
2020-06,
 
Debt — Debt with Conversion and Other Options (Subtopic
 
470-20)
 
and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic
 
815-40),
 
which modifies and simplifies accounting for convertible instruments. The new guidance eliminates certain separation models that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance will be effective for annual reporting periods beginning after December 15, 2020. As a result, the Company will adopt ASU 2020-06 for the January 31, 2022 annual period and is currently assessing the impact the guidance will have on its condensed consolidated financial statements.
2.    Summary of Significant Accounting Policies
Use of Estimates
The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for doubtful accounts, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of redeemable convertible preferred stock warrants and common stock warrants, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic
environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Concentration of Credit Risk and Other Risks and
Uncertainties
Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts with large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. Short-term investments consist of U.S. treasury bills that carry high-credit ratings and accordingly, minimal credit risk exists with respect to these balances.
Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.
Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of January 31, 2021, one customer individually accounted for 16% of accounts receivable, net. As of January 31, 2020, there were no customers that accounted for 10% or more of accounts receivable, net. For the years ended January 31, 2021, 2020, and 2019 there were no customers that represented 10% or more of total revenue.
The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s operating results.
In December 2019,
COVID-19
was first reported to the World Health Organization (“WHO”), and in January 2020, the WHO declared the outbreak to be a public health emergency. In March 2020, the WHO characterized
COVID-19
as a pandemic. Since then, the
COVID-19
pandemic and efforts to control its spread have significantly curtailed the movement of people, goods, and services worldwide. As a result, the Company has temporarily closed its headquarters and most of its other offices, enabled its employees and contractors to work remotely, implemented travel restrictions, implemented cost cutting measures, and shifted Company events and meetings to virtual-only experiences, all of which may continue for an indefinite amount of time and represent a significant disruption in how it operates its business. The operations of the Company’s partners, vendors, and customers have likewise been disrupted.
While the duration and extent of the
COVID-19
pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment and mitigation actions, it has already had an adverse effect on the global economy, and the ultimate societal and economic impact of the
COVID-19
pandemic remains unknown. In particular, the conditions caused by this pandemic may affect the rate of global infrastructure spending, which could adversely affect demand for the Company’s platform. Further, the
COVID-19
pandemic has caused the Company to experience, in some cases, longer sales cycles and an increase in certain prospective and current customers seeking lower prices or other more favorable contract terms, and has limited the ability of its direct sales force to travel to customers and potential customers. In addition, the
COVID-19
pandemic could reduce the value or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from the Company’s paying customers, cause some of its paying customers to go out of business, and affect contraction or attrition rates of its paying customers, all of which could adversely affect the Company’s business, results of operations, and financial condition. Additionally, concerns over the economic impact of
COVID-19
have caused extreme volatility in financial and other capital markets, which may adversely affect the Company’s ability to access capital markets in the future.
While the Company has developed and continues to develop plans to help mitigate the potential negative impact of
COVID-19,
these efforts may not be effective, and any protracted economic downturn will likely limit the
effectiveness of its efforts. Accordingly, it is not possible for the Company to predict the duration and ultimate extent to which this will affect its business, future results of operations, and financial condition at this time.
Segment Reporting
Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company operates as one operating segment because its CODM, who is its Chief Executive Officer, reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance. The Company has no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels of components below the consolidated unit level.
Cash, Cash Equivalents, and Restricted Cash
The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. Cash equivalents may be invested in money market funds. Cash and cash equivalents are carried at cost, which approximates their fair value.
Restricted cash of $0.4 million as of January 31, 2021 and 2020 and $0.5 million as of January 31, 2019 relates to cash deposits restricted under letters of credit issued in support of customer agreements.
The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated statements of cash flows were as follows:
 
    
January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Cash and cash equivalents
   $ 145,491      $ 72,753      $ 205,238  
Restricted cash
     400        400        460  
  
 
 
    
 
 
    
 
 
 
Total cash, cash equivalents, and restricted cash
  
$
145,891
 
  
$
73,153
 
  
$
205,698
 
  
 
 
    
 
 
    
 
 
 
Short-term Investments
The Company considers investments with original maturities greater than three months and remaining maturities less than one year to be short-term investments. The Company’s short-term investments consist of U.S. treasury bills and are classified as available for sale and reported at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For short-term investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of short-term investments are recorded in other income (expense), net in the consolidated statements of operations.
Other-than-temporary Impairment
The Company evaluates its short-term investments with unrealized losses for other-than-temporary impairment. When assessing short-term investments for other-than-temporary declines in value, the Company considers factors such as, among other things, the extent and length of time the investment’s fair value has been lower than its cost basis, the financial condition and near-term prospects of the investee, the Company’s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value, and the expected cash flows from the security. If any adjustment to fair value reflects a decline in the value of the investment that the Company considers to be “other than temporary,” the Company reduces the investment to fair value through a charge to the consolidated statements of operations and consolidated statements of comprehensive loss. No such adjustments were necessary during the periods presented.
Accounts Receivable, net
Accounts receivable are recorded at the invoiced amount and are
non-interest
bearing. The Company performs ongoing credit evaluations of its customers and maintains an allowance for doubtful accounts to ensure trade receivables are not overstated due to uncollectibility. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results, or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables are further adjusted. The Company also considers broader factors in evaluating the sufficiency of its allowances for doubtful accounts, including the length of time receivables are past due, macroeconomic conditions, significant
one-time
events, and historical experience. When the Company determines that there are accounts receivable that are uncollectible, they are written off against the allowance for doubtful accounts. The change in the allowance for doubtful accounts for the years ended January 31, 2021, 2020, and 2019 was as follows:
 
    
Beginning
Balance
    
Additions
Charged To
Expense
    
Write-offs
    
Ending
Balance
 
    
(in thousands)
 
Year ended January 31, 2021
           
Allowance for doubtful accounts
   $ 2,000      $ 121      $ (121    $ 2,000  
Year ended January 31, 2020
           
Allowance for doubtful accounts
   $ 3,124      $ 339      $ (1,463    $ 2,000  
Year ended January 31, 2019
           
Allowance for doubtful accounts
   $ 1,316      $ 1,812      $ (4    $ 3,124  
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost, on a
first-in,
first-out
basis. Inventory levels are analyzed periodically and written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value or are in excess of expected demand. The Company analyzes current and future product demand relative to the remaining product life to identify potential excess inventories. The write-down is measured as the difference between the cost of the inventories and net realizable value and charged to inventory reserves, which is a component of cost of revenue. At the point of the loss recognition, a new, lower cost basis for those inventories is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
Property and Equipment, net
Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets, as follows:
 
    
Useful Lives
Furniture and fixtures
   3 to 5 years
Computers and software
   3 to 5 years
Machinery and equipment
   3 to 5 years
Tooling
   3 to 5 years
Leasehold improvements
   Shorter of the estimated
lease term or useful life
Owned and operated systems
   5 to 7 years
Leasehold improvements are amortized over the shorter of estimated useful lives of the assets or the lease term. Expenditures for repairs and maintenance are charged to expense as incurred. Upon disposition, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is reflected in the consolidated statements of operations.
ChargePoint-as-a-Service
(“CPaaS”) combines the customer’s use of the Company’s owned and operated systems with Cloud subscription software (“Cloud”) and the Company’s Assure program (“Assure”) into a single subscription. When CPaaS contracts contain a lease, the underlying asset is carried at its carrying value within property and equipment, net on the consolidated balance sheets.
Internal-Use
Software Development Costs
The Company capitalizes qualifying
internal-use
software development costs incurred during the application development stage for internal tools and cloud-based applications used to deliver its services, provided that management with the relevant authority authorizes and commits to the funding of the project, it is probable the project will be completed, and the software will be used to perform the function intended. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Capitalized
internal-use
software development costs are included in property and equipment and are amortized on a straight- line basis over their estimated useful lives once it is ready for its intended use. Amortization of capitalized
internal-use
software development costs is included within cost of revenue for networked charging systems and subscriptions, research and development expense, sales and marketing expense, and general and administrative expense based on the use of the software. Costs incurred for enhancements that are expected to result in additional material functionality are capitalized. As of January 31, 2021 and 2020, capitalized costs have not been material.
Leases
On February 1, 2019, the Company early adopted the requirements of Accounting Standards Update (“ASU”)
2016-02,
Leases (Topic 842) (“ASC 842”), using the modified retrospective approach with no adjustment to comparative periods.
Lessee
The Company determines if a contract is a lease or contains a lease at the inception of the contract and reassesses that conclusion if the contract is modified. All leases are assessed for classification as an operating lease or a finance lease. Operating lease
right-of-use
(“ROU”) assets are presented separately on the Company’s consolidated balance sheets. Operating lease liabilities are separated into a current portion, included within accrued and other current liabilities on the Company’s consolidated balance sheets, and a noncurrent portion included within operating lease liabilities on the Company’s consolidated balance sheets. The Company does not have material finance leases. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. The Company does not obtain and control its right to use the asset until the lease commencement date.
The Company’s lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s ROU assets are also recognized at the applicable lease commencement date. The ROU asset equals the carrying amount of the related lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable ROU asset or lease liability.
The term of the Company’s leases equals the
non-cancellable
period of the lease, including any rent-free periods provided by the lessor, and also includes options to renew or extend the lease (including by not terminating the lease) that the Company is reasonably certain to exercise. The Company establishes the term of each lease at lease commencement and reassesses that term in subsequent periods when one of the triggering events outlined in ASC 842 occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term.
The Company’s lease contracts often include lease and
non-lease
components. The Company has elected the practical expedient offered by the standard to not separate the lease from
non-lease
components and accounts for them as a single lease component.
The Company elected the package of practical expedients permitted under the transition guidance, which allows the Company to carry forward its historical lease classification, its assessment on whether a contract is or contains a lease, and its initial direct costs for any leases that existed prior to adoption of the new standard. The Company has elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.
Lessor
The Company leases networked charging systems to customers within certain CPaaS contracts. The leasing arrangements the Company enters into with lessees are operating leases, and as a result, the underlying asset is carried at its carrying value as owned and operated systems within property and equipment, net on the consolidated balance sheets. Adoption of ASC 842 did not have a material impact on the Company’s accounting as a lessor.
Impairment of Long-Lived Assets
The Company evaluates long-lived assets or asset groups for impairment whenever events indicate that the carrying amount of an asset or asset group may not be recoverable based on expected future cash flows attributable to that asset or asset group. Recoverability of assets held and used is measured by comparison of the carrying amounts of an asset or an asset group to the estimated future undiscounted cash flows which the asset or asset group is expected to generate. If the carrying amount of an asset or asset group exceeds estimated undiscounted future cash flows, then an impairment charge would be recognized based on the excess of the carrying amount of the asset or asset group over its fair value. Assets to be disposed of are reported at the lower of their carrying amount or fair value less costs to sell. There were no impairments of long-lived assets for the years ended January 31, 2021, 2020, and 2019.
Business Combinations
The total purchase consideration for an acquisition is measured as the fair value of the assets transferred, equity instruments issued, and liabilities assumed at the acquisition date. Costs that are directly attributable to the acquisition are expensed as incurred and included in general and administrative expense in the Company’s consolidated statements of operations. Identifiable assets (including intangible assets), liabilities assumed (including contingent liabilities), and noncontrolling interests in an acquisition are measured initially at their fair values at the acquisition date. The Company recognizes goodwill if the fair value of the total purchase consideration and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, cost of capital, future cash flows, and discount rates. The Company’s estimates of fair value are based on assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. The Company includes the results of operations of the acquired business in the consolidated financial statements beginning on the acquisition date.
Goodwill
Goodwill represents the excess of the purchase price of an acquired busines
s over
the fair value of the net tangible and identifiable intangible assets acquired. The carrying amount of goodwill is reviewed for impairment
at least annually, in the second quarter, or whenever events or changes in circumstances
indicate
that the carrying value may not be recoverable. As of January 31, 2021 and 2020, the Company had a single operating segment and reporting unit structure. As part of the annual goodwill impairment test performed in the second quarter, the Company first performs a qualitative assessment to determine whether further impairment testing is necessary. If, as a result of the qualitative assessment, it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the quantitative impairment test will be required. If the Company has determined it necessary to perform a quantitative impairment assessment, the Company will compare the fair value of the reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the total amount of goodwill of the reporting unit. The carrying value of goodwill was $1.2 million as of January 31, 2021 and 2020, and no goodwill impairment has been recognized to date.
Fair Value of Financial Instruments
Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value:
 
   
(Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
 
   
(Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and
 
   
(Level 3) — Inputs that are unobservable for the asset or liability.
The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material
non-financial
assets valued on a
non-recurring
basis that resulted in an impairment in any period presented.
The carrying values of the Company’s cash equivalents, short-term investments, accounts receivable, net, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments.
Redeemable Convertible Preferred Stock Warrants
Warrants to purchase shares of the Company’s Series B, D, and E redeemable convertible preferred stock are classified as liabilities as the underlying redeemable convertible preferred stock is considered redeemable and may require the Company to transfer assets upon exercise. Redeemable convertible preferred stock warrants are recorded within noncurrent liabilities on the consolidated balance sheets. The warrants were recorded at fair value upon issuance and are subject to remeasurement to fair value at each balance sheet date. Changes in fair value of the redeemable convertible preferred stock warrant liability are recorded in the consolidated statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the warrants, conversion of redeemable convertible preferred stock into common stock, or until the redeemable convertible preferred stock is otherwise no longer redeemable. At that time, the redeemable convertible preferred stock warrant liability will be reclassified to redeemable convertible preferred stock or additional
paid-in
capital, as applicable.
Common Stock Warrants
Warrants to purchase shares of the Company’s common stock are equity classified and recognized within additional
paid-in
capital with no subsequent remeasurement. The amount recognized within additional
paid-in
capital is determined by allocating proceeds received and issuance costs incurred between the instruments issued based on their relative fair value.
Revenue Recognition
On February 1, 2019, the Company early adopted ASU
No. 2014-09.
Revenue from Contracts with Customers (Topic 606), as amended (“ASC 606”), using the modified retrospective method applied to contracts which were not completed as of that date. During the fiscal years ended January 31, 2021 and January 31, 2020, the Company recognized revenue using the following five-step model as prescribed by ASC 606:
 
   
Identification of the contract, or contracts, with a customer;
 
   
Identification of the performance obligations in the contract;
 
   
Determination of the transaction price;
 
   
Allocation of the transaction price to the performance obligations in the contract; and
 
   
Recognition of revenue when, or as, the Company satisfies a performance obligation.
Significant judgment and estimates are necessary for the allocation of the proceeds received from an arrangement to the multiple performance obligations and the appropriate timing of revenue recognition. The Company enters into contracts with customers that regularly include promises to transfer multiple products and services, such as charging systems, software subscriptions, extended maintenance, and professional services. For arrangements with multiple products or services, the Company evaluates whether the individual products or services qualify as distinct performance obligations. In its assessment of whether products or services are a distinct performance obligation, the Company determines whether the customer can benefit from the product or service on its own or with other readily available resources and whether the service is separately identifiable from other products or services in the contract. This evaluation requires the Company to assess the nature of each of its networked charging systems, subscriptions, and other offerings and how each is provided in the context of the contract, including whether they are significantly integrated which may require judgment based on the facts and circumstances of the contract.
The transaction price for each contract is determined based on the amount the Company expects to be entitled to receive in exchange for transferring the promised products or services to the customer. Collectability of revenue is reasonably assured based on historical evidence of collectability of fees the Company charges its customers. The transaction price in the contract is allocated to each distinct performance obligation in an amount that represents the relative amount of consideration expected to be received in exchange for satisfying each performance obligation. Revenue is recognized when performance obligations are satisfied. Revenue is recorded based on the transaction price excluding amounts collected on behalf of third-parties such as sales taxes, which are collected on behalf of and remitted to governmental authorities, or driver fees, collected on behalf of customers who offer public charging for a fee.
When agreements involve multiple distinct performance obligations, the Company accounts for individual performance obligations separately if they are distinct. The Company applies significant judgment in identifying and accounting for each performance obligation, as a result of evaluating terms and conditions in contracts. The transaction price is allocated to the separate performance obligations on a relative standalone selling price (“SSP”) basis. The Company determines SSP based on observable standalone selling price when it is available, as well as other factors, including the price charged to its customers, its discounting practices, and its overall pricing objectives, while maximizing observable inputs. In situations where pricing is highly variable, or a product is never sold on a stand-alone basis, the Company estimates the SSP using the residual approach.
The Company usually bills its customers at the onset of the arrangement for both the products and a predetermined period of time for services. Contracts for services typically range from annual to multi-year agreements with typical payment terms of 30 to 90 days.
Networked charging systems revenue
Networked charging systems revenue includes revenue related to the deliveries of EV charging system infrastructure. The Company recognizes revenue from sales of networked charging systems upon shipment to the customer, which is when the performance obligation has been satisfied.
Subscriptions revenue
Subscriptions revenue consists of services related to Cloud, as well as extended maintenance service plans under Assure. Subscriptions revenue also consists of CPaaS revenue, which combines the customer’s use of the Company’s owned and operated systems with Cloud and Assure programs into a single subscription. CPaaS subscriptions contain a lease for the customer’s use of the Company’s owned and operated systems unless the location allows the Company to receive incremental economic benefit from regulatory credits earned on that owned and operated system. Lessor revenue relates to operating leases and historically has not been material. Subscriptions revenue is recognized over time on a straight-line basis as the Company has a stand-ready obligation to deliver such services to the customer.
Other revenue
Other revenue consists of fees received for transferring regulatory credits earned for participating in low carbon fuel programs in approved states, charging related fees received from drivers using charging sites owned and operated by the Company, net transaction fees earned for processing payments collected on driver charging sessions at charging sites owned by ChargePoint customers, and other professional services. Revenue from regulatory credits is recognized at the point in time the regulatory credits are transferred. Revenue from fees for owned and operated sites is recognized over time on a straight-line basis over the performance period of the service contract as the Company has a stand-ready obligation to deliver such services. Revenue from driver charging sessions and charging transaction fees is recognized at the point in time the charging session or transaction is completed. Revenue from professional services is recognized as the services are rendered.
Revenue Recognition (ASC 605)
During the fiscal year ended January 31, 2019, the Company recognized revenue under ASC Topic 605, Revenue Recognition (“ASC 605”) when persuasive evidence of an arrangement existed, delivery had occurred, the fee was fixed or determinable, and collectability was probable. Revenue for this period was generally recognized net of allowances for returns and any taxes collected from customers and subsequently remitted to governmental authorities.
When a sales arrangement contained multiple elements, the Company first determined whether the delivered items qualify as separate units of accounting. A delivered item qualified as a separate unit of accounting when it had value to the customer on a standalone basis and when an arrangement included a general right of return relative to the delivered item, delivery, or performance of any undelivered items was considered probable or substantially in control of the Company. The Company then allocated revenue to each separate unit of accounting based on the relative selling price method and using the established selling price hierarchy. The selling price for a unit of accounting was based on its vendor specific objective evidence (“VSOE”), if available, third-party evidence (“TPE”) if VSOE was not available, or best estimate of selling price (“ESP”) if neither VSOE nor TPE was available. The Company generally utilized ESP.
The objective of ESP was to determine the price at which the Company would transact a sale if the product or service were sold on a standalone basis. ESP was generally used for new or highly customized offerings and solutions or offerings not priced within a narrow range, and it applied to a large proportion of the Company’s arrangements with multiple deliverables.
The process for determining ESP requires judgment and considers multiple factors that may vary over time depending upon the unique facts and circumstances related to each deliverable.
Lessor Revenue
The leasing arrangements the Company enters into with lessees are operating leases. The Company recognizes operating lease revenue on a straight-line basis over the lease term and expenses deferred initial direct costs on the same basis.
Operating lease revenue is classified as subscriptions revenue in the Company’s consolidated statements of operations. Operating lease revenue and the future maturities of lease payments from lessees was not material to the consolidated financial statements for all periods presented.
Remaining Performance Obligations
Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and
non-cancelable
contracted amounts that will be invoiced and recognized as revenue in future periods. The Company’s Assure, Cloud, and CPaaS subscription terms typically range from one to five years. Revenue expected to be recognized from remaining performance obligations was $101.8 million as of January 31, 2021, of which 43% is expected to be recognized over the next twelve months and the remainder thereafter.
Deferred Revenue
Deferred revenue represents billings or payments received in advance of revenue recognition and is recognized in revenue upon transfer of control. Balances consist primarily of software subscription services and extended Assure maintenance services not yet provided as of the balance sheet date. Contract assets, which represent services provided or products transferred to customers in advance of the date the Company has a right to invoice, are netted against deferred revenue on a
customer-by-customer
basis. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as deferred revenue with the remainder recorded as deferred revenue, noncurrent on the consolidated balance sheets. Total deferred revenue was $89.8 million and $72.7 million as of January 31, 2021 and 2020, respectively. The Company recognized $39.4 million, $25.5 million, and $16.0 million of revenue during the years ended January 31, 2021, 2020, and 2019, respectively, that was included in the deferred revenue balance at the beginning of the respective period.
Cost of Revenue
Cost of networked charging systems revenue includes the material costs for parts and manufacturing costs for the hardware products, compensation, including salaries and related personnel expenses, including stock-based compensation, warranty provisions, depreciation of manufacturing related equipment and facilities, amortization of capitalized
internal-use
software development costs, and allocated overhead costs. Costs for shipping and handling are recorded in cost of revenue as incurred.
Cost of subscriptions revenue includes network and wireless connectivity costs for subscription services, field maintenance costs for Assure to support the Company’s network of systems, depreciation of owned and operated systems used in CPaaS arrangements, amortization of capitalized
internal-use
software development costs, allocated overhead costs, and support costs to manage the systems and helpdesk services for drivers and site hosts.
Cost of other revenue includes costs for the Company’s owned and operated charging sites, as well as costs of environmental and professional services.
Costs to Obtain a Customer Contract
Sales commissions are considered incremental and recoverable costs of acquiring customer contracts. Beginning at the Company’s adoption of ASC 606 on February 1, 2019, incremental and recoverable costs for the sale of cloud enabled software and extended maintenance service plans are capitalized as deferred contract acquisition costs within prepaid expenses and other current assets and other assets on the consolidated balance sheets and amortized on a straight-line basis over the anticipated benefit period of five years. The benefit period was estimated by taking into consideration the length of customer contracts, renewals, technology lifecycle, and other factors. This amortization is recorded within sales and marketing expense in the Company’s consolidated statements of operations. The sales commissions paid related to the sale of networked charging systems are expensed as incurred.
The Company elected the practical expedient that permits the Company to apply ASC Subtopic
340-40,
“Other Assets and Deferred Costs- Contracts with Customers,” (“ASC 340”) to a portfolio containing multiple contracts, as they are similar in their characteristics, and the financial statement effects of applying ASC Subtopic
340-40
to that portfolio would not differ materially from applying it to the individual contracts within that portfolio.
Changes in the deferred contract acquisition costs during the years ended January 31, 2021 and 2020 were as follows:
 
   
(in thousands)
 
Balance upon adoption of ASC 340 on February 1, 2019
  $ 2,189  
Capitalization of deferred contract acquisition costs
    2,318  
Amortization of deferred contract acquisition costs
    (675
 
 
 
 
Balance as of January 31, 2020
 
$
3,832
 
 
 
 
 
Capitalization of deferred contract acquisition costs
    2,908  
Amortization of deferred contract acquisition costs
    (1,206
 
 
 
 
Balance as of January 31, 2021
 
$
5,534
 
 
 
 
 
Deferred acquisition costs capitalized on the consolidated balance sheets were as follows:
 
    
January 31
 
    
2021
    
2020
 
    
(in thousands)
 
Deferred contract acquisition costs, current
   $ 1,550      $ 1,013  
Deferred contract acquisition costs, noncurrent
     3,984        2,819  
  
 
 
    
 
 
 
Total deferred contract acquisition costs
  
$
5,534
 
  
$
3,832
 
  
 
 
    
 
 
 
Research and Development
Research and development expenses consist primarily of salary and related expenses, including stock-based compensation, for personnel related to the development of improvements and expanded features for the Company’s products and services, as well as quality assurance, testing, product management, amortization of capitalized
internal-use
software, and allocated overhead. Research and development costs are expensed as incurred.
Stock-based Compensation
The Company measures and recognizes compensation expense for all stock-based awards, including stock options and restricted common stock, granted to employees and directors based on the estimated fair value of the awards on the date of grant. The fair value of each stock option award is estimated on the grant date using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock, the expected term of the option, the expected volatility of the price of the Company’s common stock, risk-free interest rates, and the expected dividend yield of the Company’s common stock. The assumptions used to determine the fair value of the awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.
The Company amortizes the fair value of each stock award on a straight-line basis over the requisite service period of the awards. Stock-based compensation expense is based on the value of the portion of stock-based awards that is ultimately expected to vest. As such, the Company’s stock-based compensation is reduced for the estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
Advertising
The Company expenses the costs of advertising, including promotional expenses, as incurred. Advertising expenses for the years ended January 31, 2021, 2020, and 2019 were not material.
Warranty
The Company provides standard warranty coverage on its products for twelve months, providing parts necessary to repair the systems during the warranty period. The Company accounts for the estimated warranty cost as a charge to networked charging systems cost of revenue when revenue is recognized. The estimated warranty cost is based on historical and predicted product failure rates and repair expenses. Warranty expense for the years ended January 31, 2021, 2020, and 2019 was $3.4 million, $2.8 million, and $2.0 million, respectively.
In addition, the Company offers
paid-for
subscriptions to extended maintenance service plans under Assure. Assure provides both the labor and parts to maintain the products over the subscription terms of typically one to five years. The costs related to the Assure program are expensed as incurred and charged to subscriptions cost of revenue.
Foreign Currency
The functional currency of the Company’s foreign subsidiaries is generally the local currency. The translation of foreign currencies into U.S. dollars is performed for monetary assets and liabilities at the end of each reporting period based on the then current exchange rates.
Non-monetary
items are translated using historical exchange rates. For revenue and expense accounts, an average foreign currency rate during the period is applied. Adjustments resulting from translating foreign functional currency financial statements into U.S. dollars are recorded as part of a separate component of stockholders’ deficit and reported in the consolidated statements of comprehensive loss. Foreign currency transaction gains and losses are included in other income (expense), net for the period.
Income Taxes
The Company uses the asset and liability method in accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the
financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax asset and liability. Valuation allowances are established when necessary to reduce deferred tax assets where it is more likely than not that the deferred tax assets will not be realized. In evaluating the Company’s ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including historical operating results, ongoing tax planning, and forecasts of future taxable income on a
jurisdiction-by-jurisdiction
basis. Based on the level of historical losses, the Company has established a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized.
A tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination by the taxing authorities, including resolutions of any related appeals or litigation processes, based on the technical merits of the position.
Net Loss per Share Attributable to Common Stockholders
Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the
two-class
method required for participating securities. The Company considers all series of its redeemable convertible preferred stock to be participating securities. The Company also considers any shares issued on the early exercise of stock options subject to repurchase to be participating securities because holders of such shares have nonforfeitable dividend rights in the event a dividend is paid on common stock. Under the
two-class
method, net income is attributed to common stockholders and participating securities based on their participation rights. The holders of the redeemable convertible preferred stock, as well as the holders of early exercised shares subject to repurchase, do not have a contractual obligation to share in the losses of the Company. As such, the Company’s net losses for the years ended January 31, 2021, 2020, and 2019 were not allocated to these participating securities. Under the
two-class
method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. Diluted net loss per share attributable to common stockholders adjusts basic net loss per share for the effect of dilutive securities, including stock options. As the Company has reported losses for all periods presented, all potentially dilutive securities are antidilutive and accordingly, basic net loss per share equals diluted net loss per share.
Accounting Pronouncements
The Company is provided the option to adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as
non-public
business entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt, when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as
non-public
business entities, as indicated below.
Recently Adopted Accounting Standards
In June 2018, the FASB issued ASU
No. 2018-13,
“Fair Value Measurement (Topic 820): Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurements,” which expands the disclosure requirements for Level 3 fair value measurements and expands disclosures for measurement uncertainty. This guidance became effective for annual reporting periods beginning after December 15, 2019. The Company adopted the guidance at the beginning of fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures.
In August 2018, the FASB issued
2018-15,
“Intangibles-Goodwill and Other-Internal Use Software (Subtopic
350-40):
Customer’s Accounting for Implementation Costs Incurred In a Cloud Computing
Arrangement That Is a Service Contract,” which reduces complexity of the accounting for costs of implementing a cloud computing service arrangement. The guidance is effective for annual reporting periods beginning after December 15, 2020. The Company early adopted this guidance at the beginning of fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures.
In March 2020, the FASB issued ASU
2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which provides optional expedients and exceptions for applying U.S. GAAP to contract modifications, hedging relationships, and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The guidance is effective for the Company beginning on March 12, 2020 and it will apply the amendments prospectively through December 31, 2022. The Company adopted this guidance during fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures.
In May 2014, the FASB issued ASC 606 with several subsequent amendments. ASC 606 amends the existing accounting standards for revenue recognition. The new guidance provides a new model to determine when and over what period revenue is recognized. Revenue is recognized for the transfer of promised goods or services to customers in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company early adopted the new revenue standard as of February 1, 2019 using the modified retrospective approach. The impact of the adoption was not material to the Company’s consolidated financial statements and disclosures. Comparative information prior to the date of adoption has not been restated and continues to be reported under the accounting standards in effect for those periods.
With the adoption of ASC 606 the Company also early adopted ASC 340 which requires the deferral of incremental costs of obtaining a customer contract which, under the old guidance, were expensed as incurred. The guidance requires the deferral of incremental contract acquisition costs and subsequent amortization over the expected period of benefit. The benefit period was estimated by taking into consideration the length of customer contracts, renewals, technology lifecycle, and other factors. The amortization of these costs is charged to sales and marketing expenses in the consolidated statements of operations. The cumulative impact of ASC 340 adoption on February 1, 2019 resulted in an increase of $2.2 million in total assets related to costs to obtain customer contracts that were previously expensed as incurred but would have been capitalized under ASC 340. Upon adoption, the Company recorded the cumulative impact of adoption as an adjustment to the Company’s accumulated deficit on February 1, 2019. Prior periods were not retroactively adjusted.
The adoption of ASC 340 resulted in a net decrease in sales and marketing expenses due to the capitalization and related amortization of deferred contract acquisition costs that would have been expensed as incurred prior to adoption. During the year ended January 31, 2020, the adoption of ASC 340 resulted in offsetting changes within operating assets and liabilities and had no net impact on the consolidated statements of cash flows.
In February 2016, the FASB issued ASC 842. The guidance is effective for annual reporting periods for
non-public
business entities beginning after December 15, 2021 and early adoption is permitted. The new standard requires lessees to recognize operating and finance lease liabilities on the balance sheet, as well as corresponding ROU assets. This standard also made some changes to lessor accounting and aligns key aspects of the lessor accounting model with the revenue recognition standard. In addition, disclosures are required to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. ASC 842 requires adoption using the modified retrospective approach, with the option of applying the requirements of the standard either (a) retrospectively to each prior comparative reporting period presented, or (b) retrospectively at the beginning of the period of adoption.
The Company has early adopted ASC 842 as of February 1, 2019 on a modified retrospective basis. Prior period amounts were not adjusted and continue to be reported in accordance with our historic accounting under
previous lease guidance, ASC 840, Leases. Upon adopting ASC 842 at the beginning of the fiscal year ended January 31, 2020, as a lessee, the Company recognized operating lease
right-of-use
assets of $11.3 million and operating lease liabilities of $12.5 million and corresponding reductions of $1.6 million to deferred rent and $0.4 million to prepaid rent. The adoption of the standard did not result in any adjustments to accumulated deficit. See Note 6, Leases, for more information.
For lessor accounting, the impact was not material to the Company’s consolidated financial statements and disclosures.
In January 2017, the FASB issued ASU
No. 2017-04,
“Intangibles — Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” The new standard simplifies the measurement of goodwill by eliminating step two of the
two-step
impairment test. Step two measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. The new guidance requires an entity to compare the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any
tax-deductible
goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. The guidance is effective for annual reporting periods beginning after December 15, 2021. The Company early adopted this guidance at the beginning of fiscal year 2020. The impact of the adoption had no impact on the Company’s consolidated financial statements and disclosures.
In July 2017, the FASB issued ASU
No. 2017-11,
“Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception.” The new guidance reduces the complexity associated with an issuer’s accounting for certain financial instruments with characteristics of liability and equity. Specifically, the FASB determined that a down round feature would no longer cause a freestanding equity-linked financial instrument (or an embedded conversion option) to be accounted for as a derivative liability at fair value with changes in fair value recognized in current earnings. This guidance is effective for annual reporting periods beginning after December 15, 2019. The Company early adopted this guidance at the beginning of fiscal year 2020. The adoption of this guidance did not have a material impact to the Company’s consolidated financial statements and disclosures.
In February 2018, the FASB issued ASU
No. 2018-02,
“Income Statement- Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” The new guidance permits, but does not require, companies to reclassify the stranded tax effects of the Tax Cuts and Jobs Act (the “Act”) on items within accumulated other comprehensive income to retained earnings. This guidance became effective for annual reporting periods beginning after December 15, 2018. The Company did not elect to reclassify the stranded tax effects of the Act on items within accumulated other comprehensive income to retained earnings.
In June 2018, the FASB issued ASU
No. 2018-07,
“Compensation — Stock Compensation (Topic 718): Improvements to
Non-Employee
Share-Based Payment Accounting.” The new guidance expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from
non-employees
and to account for awards to
non-employees
using the grant date fair value without subsequent periodic measurement. The guidance is effective for annual reporting periods beginning after December 15, 2019. The Company early adopted this guidance in fiscal year 2020 using a modified retrospective transition method. Adoption of this guidance did not have a material impact to the Company’s consolidated financial statements and disclosures.
Recently Issued Accounting Standards Not Yet Adopted
In June 2016, the FASB issued ASU
No. 2016-13,
“Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” and has since released various amendments including ASU
No. 2019-04.
The guidance modifies the measurement of expected credit losses on certain financial instruments. This guidance is effective for the Company’s annual reporting periods beginning after December 15, 2022. Early adoption is permitted. The Company is currently assessing the impact of the guidance on its consolidated financial statements and disclosures.
In November 2018, the FASB issued ASU
No. 2018-18,
“Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606”, which clarifies when certain transactions between collaborative arrangement participants should be accounted for under ASC 606 and incorporates
unit-of-account
guidance consistent with ASC 606 to aid in this determination. The guidance is effective for the Company’s annual reporting periods beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures.
In December 2019, the FASB issued ASU
2019-12,
“Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis
step-up
in goodwill obtained in a transaction that is not a business combination. The guidance will be effective for the Company’s annual reporting periods beginning after December 15, 2021. Early adoption is permitted. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures.
In August 2020, the FASB issued ASU
2020-06,
“Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic
815-40),”
which modifies and simplifies accounting for convertible instruments. The new guidance eliminates certain separation models that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance will be effective for annual reporting periods beginning after December 15, 2023. Early adoption is permitted, but no earlier than for fiscal years beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures.
In October 2020, the FASB issued ASU
2020-08,
“Codification Improvements to Subtopic
310-20
— Receivables-Nonrefundable Fees and Other Costs,” which clarifies the accounting for the amortization period for certain purchased callable debt securities held at a premium by giving consideration to securities which have multiple call dates. The guidance will be effective for annual reporting periods beginning after December 15, 2021. Early adoption is permitted for annual reporting periods beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures.
XML 31 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Reverse Recapitalization
6 Months Ended
Jul. 31, 2021
Reverse Recapitalization [Abstract]  
Reverse Recapitalization
3.
Reverse Recapitalization
On February 26, 2021, Lightning Merger Sub, a wholly-owned subsidiary of Switchback, merged with Legacy ChargePoint, with Legacy ChargePoint surviving as a wholly-owned subsidiary of Switchback. As a result of the Merger, Switchback was renamed “ChargePoint Holdings, Inc.” Immediately prior to the closing of the Merger:
 
   
all 22,427,306 shares of Legacy ChargePoint’s outstanding Series
H-1
redeemable convertible preferred stock
were
converted into an equivalent number of shares of Legacy ChargePoint common stock on a
one-to-one
basis and an additional 1,026,084 shares of Common Stock were issued to settle the accumulated dividend to the Series
H-1
redeemable convertible preferred stockholders of $21.1 million;
   
all 160,925,957 shares of Legacy ChargePoint’s outstanding Series H, Series G, Series F, Series E, and Series D redeemable convertible preferred stock
were
converted into an equivalent number of shares of Legacy ChargePoint common stock on a
one-to-one
basis;
 
   
all 45,376 shares of Legacy ChargePoint’s outstanding Series C redeemable convertible preferred stock
were
converted into an equivalent number of shares of Legacy ChargePoint common stock on a 1:73.4403 basis;
 
   
all 130,590 shares of Legacy ChargePoint’s outstanding Series B redeemable convertible preferred stock
were
converted into an equivalent number of shares of Legacy ChargePoint common stock on a 1:42.9220 basis; and
 
   
all 29,126 shares of Legacy ChargePoint’s outstanding Series A redeemable convertible preferred stock
were
converted into an equivalent number of shares of Legacy ChargePoint common stock on a 1:48.2529 basis.
At the Merger, eligible ChargePoint equity holders received or
had
the right to receive shares of Common Stock at a deemed value of $10.00 per share after giving effect to the exchange ratio of 0.9966 as defined in the Merger Agreement (“Exchange Ratio”). Accordingly, immediately following the consummation of the Merger, Legacy ChargePoint common stock exchanged into 217,021,368 shares of Common Stock
,
68,896,516 shares were reserved for the issuance of Common Stock upon the potential future exercise of Legacy ChargePoint stock options and warrants that were exchanged into ChargePoint stock options and warrants, and 27,000,000 shares of Common Stock were reserved for the potential future issuance of the earnout shares.
In connection with the execution of the Merger Agreement, Switchback entered into separate subscription agreements (each a “Subscription Agreement”) with a number of investors (each a “New PIPE Investor”), pursuant to which the New PIPE Investors agreed to purchase, and Switchback agreed to sell to the New PIPE Investors, an aggregate of 22,500,000 shares of Common Stock (“PIPE Shares”), for a purchase price of $10.00 per share and an aggregate purchase price of $225.0 million, in a private placement pursuant to the subscription agreements (“PIPE Financing”). The PIPE Financing closed simultaneously with the consummation of the Merger.
Pursuant to the terms of a letter agreement the initial Switchback stockholders entered into in connection with the execution of the Merger Agreement (“Founders Stock Letter”), the initial stockholders surrendered 984,706 of Switchback Class B common stock shares purchased by NGP Switchback, LLC, a Delaware limited liability company (“Sponsor”) prior to Switchback Public Offering on May 16, 2019 ( “Founder Shares”) for no consideration, whereupon such Founder Shares were immediately cancelled. Additionally, 900,000 Founder Earn Back Shares, which were previously subjected to potential forfeiture until the closing volume weighted average price per share of Common Stock
achieved
 $12.00 for any ten trading days within any twenty consecutive trading day period during the five-year period following the Closing (“Founder Earn Back Triggering Event”), met the Earn Back Triggering Event on March 12, 2021.
At the Closing, the Sponsor exercised its right to convert a portion of the working capital loans made by the Sponsor to Switchback into an additional 1,000,000 Private Placement Warrants at a price of $1.50 per warrant in satisfaction of $1.5 million principal amount of such loans.
The number of shares of Common Stock issued immediately following the consummation of the Merger was
 
as follows:
 
    
Shares
 
Common stock of Switchback, outstanding prior to Merger
     39,264,704  
Less redemption of Switchback shares
     (33,009
Less surrender of Switchback Founder Shares
     (984,706
    
 
 
 
Common stock of Switchback
     38,246,989  
Shares issued in PIPE
     22,500,000  
    
 
 
 
Merger and PIPE financing shares (1)
     60,746,989  
Legacy ChargePoint shares (2)
     217,021,368  
    
 
 
 
Total shares of common stock immediately after Merger
     277,768,357  
    
 
 
 
The
 
Merger is accounted for as a reverse recapitalization under U.S. GAAP. This determination is primarily based on Legacy ChargePoint stockholders comprising a relative majority of the voting power of ChargePoint and having the ability to nominate the members of the Board, Legacy ChargePoint’s operations prior to the acquisition comprising the only ongoing operations of ChargePoint, and Legacy ChargePoint’s senior management comprising a majority of the senior management of ChargePoint. Under this method of accounting, Switchback is treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of ChargePoint represent a continuation of the financial statements of Legacy ChargePoint with the Merger being treated as the equivalent of ChargePoint issuing stock for the net assets of Switchback, accompanied by a recapitalization. The net assets of Switchback are stated at historical costs, with no goodwill or other intangible assets recorded. Operations prior to the Merger are presented as those of ChargePoint. All periods prior to the Merger have been retrospectively adjusted using the Exchange Ratio for the equivalent number of shares outstanding immediately after the Merger to effect the reverse recapitalization. Additionally, upon the consummation of the Merger, the Company gave effect to the issuance of 60,746,989 shares of Common Stock for the previously issued Switchback common stock and PIPE Shares that were outstanding at the Closing Date.
In connection with the Merger, the Company raised $511.6 million of proceeds including the contribution of $286.6 million of cash held in Switchback’s trust account from its initial public offering, net of redemptions of Switchback public stockholders of $0.3 million, and $225.0 million of cash in connection with the PIPE financing. The Company incurred $36.5 million of transaction costs, consisting of banking, legal, and other professional fees, of which $29.5 million was recorded as a reduction to additional
paid-in
capital of proceeds and the remaining $7.0 million was expensed in the condensed consolidated statements of operations.
 
(1)
This includes 900,000 contingently forfeitable Founder Earn Back Shares pending the occurrence of the Founder Earn Back Triggering Event, which was met on March 12, 2021
(2)
The number of Legacy ChargePoint shares was determined from the 217,761,738 shares of Legacy ChargePoint common stock outstanding immediately prior to the closing of the Merger converted at the exchange ratio of 0.9966. All fractional shares were rounded down.
XML 32 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Fair Value Disclosures [Abstract]    
Fair Value Measurements
4.
Fair Value Measurements
The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
 
    
Fair Value Measured as of July 31, 2021
        
    
Level 1
    
Level 2
    
Level 3
    
Total
 
    
(in thousands)
 
Assets
                                   
Money market funds
   $ 454,713      $ —        $ —        $ 454,713  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial assets
  
$
454,713
 
  
$
—  
 
  
$
—  
 
  
$
454,713  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Common stock warrant liabilities (Private Placement)
  
$
—  
 
  
$
—  
 
  
$
26,868
 
  
$
26,868  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial liabilities
  
$
  
 
  
$
—  
 
  
$
26,868
 
  
$
26,868  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
Fair Value Measured as of January 31, 2021
        
    
Level 1
    
Level 2
    
Level 3
    
Total
 
    
(in thousands)
 
Assets
                                   
Money market funds
   $ 109,703      $ —        $ —        $ 109,703  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial assets
  
$
109,703
 
  
$
—  
 
  
$
—  
 
  
$
109,703  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Redeemable convertible preferred stock warrant liability
  
$
—  
 
  
$
—  
 
  
$
75,843
 
  
$
75,843  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial liabilities
  
$
—  
 
  
$
—  
 
  
$
75,843
 
  
$
75,843  
    
 
 
    
 
 
    
 
 
    
 
 
 
The money market funds were classified as cash and cash equivalents on the condensed consolidated balance sheets. The aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains or losses on money market funds as of July 31, 2021 and January 31, 2021. Realized gains and losses, net of tax, were not material for any of the periods presented.
As of July 31, 2021 and January 31, 2021, the Company had no investments with a contractual maturity of greater than one year.
The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments:
 
    
Redeemable
convertible
preferred stock
warrant liability
    
Private
placement
warrant
liability
    
Earnout
liability
 
    
(in thousands)
 
Fair value as of January 31, 2021
   $ (75,843    $      $  
Private placement warrant liability acquired as part of the merger
            (127,888       
Contingent earnout liability recognized upon the closing of the reverse recapitalization
                   (828,180
Change in fair value included in other income (expense), net
     9,237        49,264        84,420  
Reclassification of warrants to stockholders’ equity (deficit) due to exercise
            51,756         
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization
     66,606                
Issuance of earnout shares upon triggering events
                   501,120  
Reclassification of remaining contingent earnout liability upon triggering event
                   242,640  
    
 
 
    
 
 
    
 
 
 
Fair value as of July 31, 2021
  
$
    
$
(26,868
  
$
 
    
 
 
    
 
 
    
 
 
 
The fair
values
of the private placement warrant liability, redeemable convertible preferred stock warrant liability and earnout liability are based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy. The significant unobservable inputs used in the fair value measurements of the private placement warrant liability, the redeemable convertible preferred stock warrant liability and the earnout liability include the expected volatility and dividend yield. In determining the fair value of the private placement warrant liability, the Company used the Binomial Lattice Model (“BLM”) that assumes optimal exercise of the Company’s redemption option at the earliest possible date (Note 9). In determining the fair value of the redeemable convertible preferred stock warrant liability, the Company used
the
Black-Scholes Option Pricing Model (“Black-Scholes”) to estimate the fair value using unobservable inputs including the expected term, expected volatility, risk-free interest rate and dividend yield (see Note 9). In determining the fair value of the earnout liability, the Company used the Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the Earnout Period using the most reliable information available (see Note 9).
3. Fair Value Measurements
The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
 
           
Gross Unrealized
           
Reported as:
 
January 31, 2021
  
Amortized
Cost
    
Gains
    
Losses
    
Fair Value
    
Cash and cash
equivalents
    
Short-term
investments
 
                         
(in thousands)
               
Cash
   $ 35,788      $ —        $ —        $ 35,788      $ 35,788      $ —    
Level 1
                 
Money market funds
     109,703        —          —          109,703        109,703        —    
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total assets measured at fair value on a recurring basis
  
$
145,491
 
  
$
—  
 
  
$
—  
 
  
$
145,491
 
  
$
145,491
 
  
$
—  
 
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
           
Gross Unrealized
           
Reported as:
 
January 31, 2020
  
Amortized
Cost
    
Gains
    
Losses
    
Fair Value
    
Cash and cash
equivalents
    
Short-term
investments
 
                         
(in thousands)
               
Cash
   $ 33,266      $ —        $ —        $ 33,266      $ 33,266      $ —    
Level 1
                 
Money market funds
     39,487        —          —          39,487        39,487        —    
Level 2
                 
U.S. treasury bills
     47,014        23        —          47,037        —          47,037  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total assets measured at fair value on a recurring basis
  
$
119,767
 
  
$
23
 
  
$
—  
 
  
$
119,790
 
  
$
72,753
 
  
$
47,037
 
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
The money market funds were classified as cash and cash equivalents on the consolidated balance sheets and were within Level 1 of the fair value hierarchy. The aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains or losses on money market funds as of January 31, 2021 and 2020. Realized gains and losses, net of tax, were not material for any of the periods presented.
All of the Company’s U.S. treasury bills were classified as short-term investments on the consolidated balance sheets and were within Level 2 of the fair value hierarchy because they were valued using inputs other than quoted prices in active markets that were observable either directly or indirectly that may include benchmark yields, reported trades, broker/dealer quotes,
two-sided
markets, benchmark securities, bids, offers, and reference data including market research publications. Realized gains and losses, net of tax, were not material for any of the periods presented.
As of January 31, 2021 and 2020, the Company had no investments with a contractual maturity of greater than one year.
The Company’s only Level 3 financial instruments were its redeemable convertible preferred stock warrants. See Note 11 for information on the valuation of the redeemable convertible preferred stock warrant liability.
XML 33 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Acquisitions
12 Months Ended
Jan. 31, 2021
Business Combinations [Abstract]  
Acquisitions
4. Acquisitions
In fiscal year 2019, the Company acquired an electric fleet and energy management business for a total purchase consideration of $1.5 million in cash. The Company recognized intangible assets related to customer relationships of $0.3 million and goodwill of $1.2 million. The goodwill amount represented synergies related to the Company’s existing platform expected to be realized from this business combination and assembled workforce. The associated goodwill and intangible assets are not deductible for tax purposes. Acquisition costs were not material and were charged to general and administrative expenses in the consolidated statements of operations as incurred. The intangible assets were recorded at fair value and were fully amortized as of January 31, 2020.
Unaudited pro forma results of operations for fiscal years 2019 was not provided because the historical operating results of the acquired business was not material and pro forma results would not be materially different from reported results for the periods presented.
In addition to the purchase consideration, the Company provided an additional $1.0 million of cash compensation awards and 797,280 shares of restricted common stock to employees for future services that vest over two years from the date of the acquisition. Total grant date fair value for the restricted common stock was $0.6 million. The Company recognizes expenses related to the cash compensation awards and restricted common stock on a straight-line basis over the requisite service period of two years. See Note 10 for further information on the restricted common stock.
XML 34 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Composition of Certain Financial Statement Items
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Composition Of Certain Financial Statement Items [Abstract]    
Composition of Certain Financial Statement Items
5.
Composition of
 
Certain Financial Statement Items
Inventories
Inventories consisted of the following:
 
    
July 31,

2021
    
January 31,

2021
 
    
(in thousands)
 
Raw materials
   $ 8,421      $ 13,029  
Work
-in-progress
            68  
Finished
goods
     19,495        20,495  
    
 
 
    
 
 
 
Total Inventories
  
$
27,916
    
$
33,592
 
    
 
 
    
 
 
 
Property and equipment, net
Property and equipment, net consisted of the following:
 
    
July 31,

2021
    
January 31,

2021
 
    
(in thousands)
 
Furniture and fixtures
   $ 899      $ 1,594  
Computers and software
     5,843        5,384  
Machinery and equipment
     12,140        10,605  
Tooling
     9,666        7,705  
Leasehold improvements
     9,680        9,398  
Owned and operated systems
     20,582        17,703  
Construction in progress
     2,760        2,462  
    
 
 
    
 
 
 
       61,570        54,851  
    
 
 
    
 
 
 
Less: Accumulated depreciation
     (29,305      (24,863
    
 
 
    
 
 
 
Total Property and Equipment, Net
   $ 32,265      $ 29,988  
    
 
 
    
 
 
 
Depreciation expense for the three months ended July 31, 2021 and 2020 was $2.9 million and $2.4 million, respectively.
Depreciation expense for the six months ended July 31, 2021 and 2020 was $5.6 million and $4.7 million, respectively.
Accrued and other current liabilities
Accrued and other current liabilities consisted of the following:
 
    
July 31,

2021
    
January 31,

2021
 
    
(in thousands)
 
Accrued expenses
   $ 19,113      $ 18,404  
Refundable customer deposits
     7,488        6,482  
Taxes payable
     6,495        5,213  
Payroll and related expenses
     7,372        7,547  
Warranty accruals
     3,100        3,000  
Operating lease liabilities, current
     3,130        2,393  
Other liabilities
     5,282        4,123  
    
 
 
    
 
 
 
Total Accrued and Other Current Liabilities
   $ 51,980      $ 47,162  
    
 
 
    
 
 
 
Revenue
Revenue consisted of the following:
 
    
Three Months Ended July 31,
    
Six Months Ended July 31,
 
    
2021
    
2020
    
2021
    
2020
 
    
(in thousands)
    
(in thousands)
 
United States
   $ 51,109      $ 32,347      $ 86,219      $ 62,638  
Rest of World
     5,012        2,610        10,412        5,095  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 56,121      $ 34,957      $ 96,631      $ 67,733  
    
 
 
    
 
 
    
 
 
    
 
 
 
5. Balance Sheet Components
Inventories
Inventories consisted of the following:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Raw materials
   $ 13,029      $ 11,335  
Work-in-progress
     68        —    
Finished goods
     20,495        14,084  
  
 
 
    
 
 
 
Total Inventories
  
$
33,592
 
  
$
25,419
 
  
 
 
    
 
 
 
Property and equipment, net
Property and equipment, net consisted of the following:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Furniture and fixtures
   $ 1,594      $ 1,347  
Computers and software
     5,384        4,350  
Machinery and equipment
     10,605        7,614  
Tooling
     7,705        6,299  
Leasehold improvements
     9,398        8,869  
Owned and operated systems
     17,703        8,422  
Construction in progress
     2,462        5,796  
  
 
 
    
 
 
 
     54,851        42,697  
  
 
 
    
 
 
 
Less: Accumulated depreciation
     (24,863      (14,756
  
 
 
    
 
 
 
Total Property and Equipment, Net
  
$
29,988
 
  
$
27,941
 
  
 
 
    
 
 
 
Depreciation expense for the years ended January 31, 2021, 2020, and 2019 was $10.1 million, $7.1 million, and $3.9 million, respectively.
Amortization expense for intangible assets for the years ended January 31, 2020 and 2019 was $0.6 million and $0.2 million, respectively. There was no amortization expense for the year ended January 31, 2021.
Accrued and other current liabilities
Accrued and other current liabilities consisted of the following:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Accrued expenses
   $ 18,404      $ 11,335  
Refundable customer deposits
     6,482        5,241  
Payroll and related expenses
     7,547        6,727  
Taxes payable
     5,213        5,348  
Operating lease liabilities, current
     2,393        3,979  
Warranty accruals
     3,000        2,000  
Other liabilities
     4,123        3,029  
  
 
 
    
 
 
 
Total Accrued and Other Current Liabilities
  
$
47,162
 
  
$
37,659
 
  
 
 
    
 
 
 
 
XML 35 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Leases
12 Months Ended
Jan. 31, 2021
Leases [Abstract]  
Leases
6. Leases
The Company leases its office facilities under
non-cancellable
operating leases with various lease terms. The Company also leases certain office equipment under operating lease agreements. As of January 31, 2021,
non-cancellable
leases expire on various dates between fiscal years 2022 and 2030.
Generally, the Company’s
non-cancellable
leases include renewal options to extend the lease term from one to five years. The Company has not included any renewal options in its lease terms as these options are not reasonably certain of being exercised. The lease agreements do not contain any material residual value guarantees or material restrictive covenants.
As of January 31, 2021 and 2020, lease balances were as follows:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Operating leases
     
Operating lease
right-of-use
assets
  
$
21,817
 
  
$
10,269
 
  
 
 
    
 
 
 
Operating lease liabilities, current
     2,286        3,979  
Operating lease liabilities, noncurrent
     22,459        8,230  
  
 
 
    
 
 
 
Total operating lease liabilities
  
$
24,745
 
  
$
12,209
 
  
 
 
    
 
 
 
The Company recognizes operating lease costs on a straight-line basis over the lease period. Lease expense for the years ended January 31, 2021, 2020, and 2019 was $5.1 million, $4.5 million, and $3.1 million, respectively. Operating lease costs for short-term leases and variable lease costs were not material during the years ended January 31, 2021 and January 31, 2020.
Maturities of the operating lease liabilities as of January 31, 2021 were as follows:
 
    
(in thousands)
 
Years Ending January 31,
  
2022
   $ 4,719  
2023
     5,123  
2024
     4,334  
2025
     4,152  
2026
     3,833  
Thereafter
     13,855  
  
 
 
 
Total undiscounted operating lease payments
  
$
36,016
 
  
 
 
 
Less: imputed interest
     (11,271
  
 
 
 
Total operating lease liabilities
  
$
24,745
 
  
 
 
 
Maturities of the operating lease liabilities as of January 31, 2020 were as follows:
 
    
(in thousands)
 
Years Ending January 31,
  
2021
   $ 4,849  
2022
     4,809  
2023
     2,671  
2024
     268  
2025
     292  
Thereafter
     1,341  
  
 
 
 
Total undiscounted operating lease payments
  
$
14,230
 
Less: imputed interest
     (2,021
  
 
 
 
Total operating lease liabilities
  
$
12,209
 
  
 
 
 
Other supplemental information as of January 31, 2021 and 2020 was as follows:
 
    
January 31,
 
    
2021
   
2020
 
Lease Term and Discount Rate
    
Weighted-average remaining operating lease term (years)
     7.5       3.7  
Weighted-average operating lease discount rate
     7.9     8.7
Other supplemental cash flow information for the years ended January 31, 2021 and January 31, 2020 was as follows:
 
    
Year ended January 31,
 
    
    2021    
    
    2020    
 
    
(in thousands)
 
Supplemental Cash Flow Information
     
Cash paid for amounts in the measurement of operating lease liabilities
   $ 4,226      $ 4,527  
As of January 31, 2021, the Company has additional operating leases of approximately $1.0 million that have not yet commenced and as such, have not yet been recognized on the Company’s Consolidated Balance Sheet. These operating leases are expected to commence on February 1, 2021 with lease terms of up to 4.5 years.
XML 36 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Debt
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Debt Disclosure [Abstract]    
Debt
6.
Debt
In July 2018, the Company entered into a term loan facility with certain lenders (“2018 Loan”) with a borrowing capacity of $45.0 million to finance working capital and repay all outstanding amounts owed under
 
previous loans. The Company borrowed $35.0 million, with issuance costs of $1.1 million and net proceeds of $33.9 million. The 2018 Loan was secured by substantially all of the Company’s assets, contained customary affirmative and negative covenants, and required the Company to maintain minimum cash balances and attain certain customer billing targets. The 2018 Loan had a
five
-year maturity and interest was calculated at LIBOR plus 6.55%. The 2018 Loan agreement was amended on March 20, 2019 to extend the interest only monthly payments through June 30, 2021 to be followed by equal monthly payments of principal and interest. As of January 31, 2021, the Company was in compliance with all financial and
non-financial
debt covenants.
Transaction costs upon entering into the 2018 Loan were recorded as debt discount and were amortized over the term of the 2018 Loan.
There was no interest expense incurred during the three months ending July 31, 2021; the interest expense incurred during the three months ended July 31, 2020 was $0.8 million. 
Total interest expense incurred during the six months ended
July 31, 2021 and 2020 was $1.5 million and $1.6 million, respectively. There was no accrued interest as of July 31, 2021 and January 31, 2021.
In March 2021, the Company repaid the
entire
loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million.
7. Debt
In December 2014, the Company entered into a $20.0 million term loan agreement to finance working capital requirements and repay certain indebtedness of the Company’s original credit facility (the “2014 Loan”). The 2014 Loan was to be repaid in forty-eight monthly installments commencing on September 1, 2016; the first fifteen payments were interest only, followed by thirty-three equal monthly payments of principal and interest. Interest was calculated at 8.75% plus LIBOR, provided that the interest rate could not be less than 9.75%. The borrowings were secured by substantially all of the Company’s assets.
In July 2018, the Company entered into a term loan facility with certain lenders (the “2018 Loan”) with a borrowing capacity of $45.0 million to finance working capital and repay all outstanding amounts owed under the 2014 Loan, of which $10.0 million expired unused in June 2019. The Company borrowed $35.0 million, with issuance costs of $1.1 million and net proceeds of $33.9 million. The 2018 Loan is secured by substantially all of the Company’s assets, contains customary affirmative and negative covenants, and requires the Company to maintain minimum cash balances and attain certain customer billing targets. The 2018 Loan has a five-year
maturity and interest is calculated at LIBOR plus 6.55%. The 2018 Loan agreement was amended on March 20, 2019 to extend the interest only monthly payments through June 30, 2021 to be followed by equal monthly payments of principal and interest. The Company believes that the fair value of the term loan approximates the recorded amount as of January 31, 2021, as the interest rates on the long-term debt are variable and the rates are based on market interest rates after consideration of default and credit risk (using Level 2 inputs). As of January 31, 2021 and 2020 the Company was in compliance with all financial and
non-financial
debt covenants.
Transaction costs upon entering into the 2018 Loan were recorded as debt discount and are amortized over the term of the 2018 Loan.
Total interest expense incurred during the years ended January 31, 2021, 2020, and 2019 was $3.3 million, $3.5 million, and $3.7 million, respectively. There was no accrued interest as of January 31, 2021 and 2020.
Total future principal payments under all borrowings as of January 31, 2021 were as follows:
 
    
(in thousands)
 
Years Ending January 31,
  
2022
     11,667  
2023
     17,500  
2024
     5,833  
  
 
 
 
Total payments
  
$
35,000
 
  
 
 
 
In March 2021, the Company repaid the entire loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million.
XML 37 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Commitments and Contingencies
7.
Commitments
 
and Contingencies
Purchase Commitments
Open purchase
commitments
are for the purchase of
goods
and services related to, but not limited to, manufacturing, facilities, and professional services under
non-cancellable
contracts. As of July 31, 2021, the Company had open purchase commitments for goods and services of $133.7 million, all of which are
expected
to be received by June 30, 2024.
Legal Proceedings
The Company may be involved in various lawsuits, claims, and proceedings, including intellectual property, commercial, securities, and employment matters that arise in the normal course of business. The Company accrues a liability when management believes information available prior to the issuance of the condensed consolidated financial statements indicates it is probable a loss has been incurred as of the date of the condensed consolidated financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred.

The Company believes it has recorded adequate provisions for any such
lawsuits
, claims, and proceedings and, as of July 31, 2021, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in the condensed consolidated financial statements. Based on its experience, the Company believes that damage amounts claimed in these matters are not meaningful indicators of potential liability. Given the inherent uncertainties of litigation, the ultimate outcome of the ongoing matters described herein cannot be predicted with certainty. While litigation is inherently unpredictable, the Company believes it has valid defenses with respect to the legal matters pending against it. Nevertheless, the condensed consolidated financial statements could be materially adversely affected in a particular period by the resolution of one or more of these contingencies. Liabilities established to provide for contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved; and such changes are recorded in the accompanying condensed consolidated statements of operations during the period of the change and reflected in accrued and other current liabilities on the accompanying condensed consolidated balance sheets.
Guarantees
 
and Indemnifications
The Company has service level commitments to its customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits if the Company fails to meet those levels. To date, the Company has not incurred any material costs as a
result
of such commitments.
The Company’s arrangements generally include certain provisions for indemnifying customers against liabilities if its products or services infringe a third-party’s intellectual property rights. Additionally, the Company may be required to indemnify for claims caused by its negligence or willful misconduct. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. To date, the Company has not incurred any material costs as a result of such obligations and has not accrued any liabilities related to such obligations in the condensed consolidated financial statements.
The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company also may be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions.
Leases
The Company leases its office facilities under
non-cancelable
operating leases with various lease terms. The Company also leases certain office equipment under operating lease agreements.

The following table presents future payments of lease liabilities under the Company’s
non-cancelable
operating leases as of July 31, 2021 (in thousands):
 
    
(in
 
thousands)
 
2022 (remaining six months)
  
$
2,759  
2023
  
 
5,111  
2024
  
 
4,329  
2025
  
 
4,153  
2026
  
 
3,837  
Thereafter
  
 
13,871  
    
 
 
 
Total undiscounted operating lease payments
     34,060  
Less: imputed interest
     (9,348
    
 
 
 
Total operating lease liabilities
     24,712  
Less: current portion of operating lease liabilities
     (3,130
    
 
 
 
Operating lease liabilities, noncurrent
   $ 21,582  
    
 
 
 
8. Commitments and Contingencies
Purchase Commitments
Open purchase commitments are for the purchase of goods and services related to, but not limited to, manufacturing, facilities, and professional services under
non-cancellable
contracts. They were not recorded as liabilities on the consolidated balance sheets as of January 31, 2021 and 2020 as the Company had not yet received the related goods or services. The Company had open purchase commitments for goods and services of $64.1 million as of January 31, 2021. All of them are expected to be received by January 31, 2024.
Legal Proceedings
The Company may be involved in various lawsuits, claims, and proceedings, including intellectual property, commercial, securities, and employment matters that arise in the normal course of business. The Company accrues a liability when management believes information available prior to the issuance of the consolidated financial statements indicates it is probable a loss has been incurred as of the date of the consolidated financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred.
The Company believes it has recorded adequate provisions for any such lawsuits, claims, and proceedings as of January 31, 2021. Based on its experience, the Company believes that damage amounts claimed in these matters are not meaningful indicators of potential liability. Given the inherent uncertainties of litigation, the ultimate outcome of the ongoing matters described herein cannot be predicted with certainty. While litigation is inherently unpredictable, the Company believes it has valid defenses with respect to the legal matters pending against it. Nevertheless, the consolidated financial statements could be materially adversely affected in a particular period by the resolution of one or more of these contingencies. Liabilities established to provide for
contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved; and such changes are recorded in the accompanying consolidated statements of operations during the period of the change and reflected in accrued and other current liabilities on the accompanying consolidated balance sheets.
Guarantees and Indemnifications
The Company has service level commitments to its customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits in the event that the Company fails to meet those levels. To date, the Company has not incurred any material costs as a result of such commitments.
The Company’s arrangements generally include certain provisions for indemnifying customers against liabilities if its products or services infringe a third-party’s intellectual property rights. Additionally, the Company may be required to indemnify for claims caused by its negligence or willful misconduct. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. To date, the Company has not incurred any material costs as a result of such obligations and has not accrued any liabilities related to such obligations in the consolidated financial statements.
The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company also may be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions.
Letters of Credit
The Company had $0.4 million of secured letters of credit outstanding as of January 31, 2021 and 2020. These primarily relate to support of customer agreements and are fully collateralized by cash deposits which the Company recorded in restricted cash on its consolidated balance sheets based on the term of the remaining restriction.
XML 38 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Redeemable Convertible Preferred Stock
12 Months Ended
Jan. 31, 2021
Equity [Abstract]  
Redeemable Convertible Preferred Stock
9. Redeemable Convertible Preferred Stock
In fiscal year 2021, the Company issued 22.4 million shares of Series
H-1
redeemable convertible preferred stock and 22.4 million common stock warrants for total cash proceeds of $127.0 million, net of issuance costs of $0.2 million. On issuance, the Company’s redeemable convertible preferred stock and common stock warrants were recorded at fair value of the amount of allocated proceeds, net of issuance costs. The Company performed a valuation of the Series
H-1
redeemable convertible preferred stock as well as the common stock warrants. The common stock warrants were valued using a Black-Scholes Option pricing model. Based upon that valuation, the Company allocated the net proceeds between the Series
H-1
redeemable convertible preferred stock and common stock warrants of $95.5 million and $31.5 million, respectively, based on their relative fair values. In addition, the Company evaluated the conversion feature of the Series
H-1
redeemable convertible preferred stock to assess whether it met the definition of a beneficial conversion feature (“BCF”). As the fair value of a share of common stock exceeded the effective conversion price at the issuance date, the Series
H-1
redeemable convertible preferred stock contained a BCF. The intrinsic value of $60.4 million was recorded as a discount to the Series
H-1
redeemable convertible preferred stock and a credit to additional
paid-in
capital. As a result of the shares being readily convertible into shares of the Company’s common stock at the option of the holders, the full value of the BCF was immediately recorded as a deemed dividend through additional
paid-in
capital to reflect the accretion of the discount resulting from the
at-issuance
BCF embedded within the redeemable convertible preferred stock.
In fiscal year 2020, the Company issued 2.6 million shares of Series H redeemable convertible preferred stock and 0.9 million common stock warrants for total cash proceeds of $14.9 million, net of $0.1 million of issuance costs. Of the total cash proceeds, $14.8 million, net of $0.1 million of issuance costs, was allocated to the Series H redeemable convertible preferred stock, based on the estimated fair value of the redeemable convertible preferred stock relative to the estimated fair value of the common stock warrants.
In fiscal year 2019, the Company issued 39.5 million shares of Series H redeemable convertible preferred stock and 13.2 million common stock warrants for total cash proceeds of $216.6 million, net of $8.4 million of issuance costs. Of the total cash proceeds, $215.2 million, net of $8.4 million of issuance costs was allocated to the Series H redeemable convertible preferred stock, based on the estimated fair value of the redeemable convertible preferred stock relative to the estimated fair value of the common stock warrants.
Redeemable convertible preferred stock as of January 31, 2021, 2020, and 2019, respectively, consisted of the following:
 
    
January 31, 2021
 
    
Shares
    
Liquidation

Preference
    
Carrying

Value
 
    
Authorized
    
Outstanding
 
Series A
     29,027        29,027      $ 3,746      $ 3,697  
Series B
     132,831        130,146        13,993        13,947  
Series C
     45,222        45,222        13,068        13,039  
Series D
     45,744,194        44,307,263        54,946        49,469  
Series E
     22,578,525        21,772,150        54,000        26,795  
Series F
     23,611,372        23,611,372        59,000        58,624  
Series G
     28,533,636        28,533,636        125,000        124,745  
Series H
     42,154,388        42,154,388        240,000        229,925  
Series H-1
     22,351,053        22,351,053        129,795        95,456  
  
 
 
    
 
 
    
 
 
    
 
 
 
  
 
185,180,248
 
  
 
182,934,257
 
  
$
693,548
 
  
$
615,697
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
January 31, 2020
 
    
Shares
    
Liquidation

Preference
    
Carrying

Value
 
    
Authorized
    
Outstanding
 
Series A
     29,027        29,027      $ 3,746      $ 3,697  
Series B
     132,831        130,146        13,993        13,947  
Series C
     45,222        45,222        13,068        13,039  
Series D
     45,744,194        44,307,262        54,946        49,469  
Series E
     22,578,525        21,772,150        54,000        26,795  
Series F
     23,611,372        23,611,372        59,000        58,624  
Series G
     28,533,636        28,533,636        125,000        124,745  
Series H
     42,154,388        42,154,388        240,000        229,925  
  
 
 
    
 
 
    
 
 
    
 
 
 
  
 
162,829,195
 
  
 
160,583,203
 
  
$
563,753
 
  
$
520,241
 
  
 
 
    
 
 
    
 
 
    
 
 
 
    
January 31, 2019
 
    
Shares
    
Liquidation

Preference
    
Carrying

Value
 
    
Authorized
    
Outstanding
 
Series A
     29,027        29,027      $ 3,746      $ 3,697  
Series B
     132,831        130,146        13,993        13,947  
Series C
     45,222        45,222        13,068        13,039  
Series D
     45,744,194        44,307,263        54,946        49,469  
Series E
     22,578,525        21,772,150        54,000        26,795  
Series F
     23,611,372        23,611,372        59,000        58,624  
Series G
     28,533,636        28,533,636        125,000        124,745  
Series H
     42,154,388        39,519,737        225,000        215,169  
  
 
 
    
 
 
    
 
 
    
 
 
 
    
162,829,195
      
157,948,553
    
$
548,753
    
$
505,485
 
  
 
 
    
 
 
    
 
 
    
 
 
 
The significant features of the Company’s redeemable convertible preferred stock are as follows:
Dividend provisions
— The holders of the outstanding shares of Series A, Series B, Series C, Series D, Series E, Series F, Series G, and Series H redeemable convertible preferred stock are entitled to receive, when and if declared by the Company’s Board of Directors, a noncumulative dividend at the annual rate per share of $10.3251, $8.5792, $23.1286, $0.0992, $0.0992, $0.1999, $0.3505, $0.4554 respectively, per annum, adjustable for certain events, such as stock splits and combinations. The holders of the outstanding shares of Series
H-1
redeemable convertible preferred stock are entitled to receive a cumulative dividend accrued at the annual rate of $0.4554 per share, accruing on a daily basis through the second anniversary of the issuance of the Series
H-1
redeemable convertible preferred stock. In addition, holders of redeemable convertible preferred stock participate in any distribution in excess of preferred dividends on an as converted basis. The Company has declared no dividends as of January 31, 2021. As of January 31, 2021, total unpaid accumulated dividends due to the
Series H-1
redeemable convertible preferred stockholders were $16.8 million.
Liquidation preference
— In the event of any liquidation, dissolution, winding up or change of control of the Company, whether voluntary or involuntary, the holders of Series H-1 redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $5.6934 per share for each share of Series H-1 redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series
H-1
redeemable convertible preferred stock, the holders of Series H redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $5.6934 per share for each share of Series H redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series H redeemable convertible preferred stock, holders of Series G redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $4.3808 per share for each share of Series G redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series G redeemable convertible preferred stock, holders of Series F redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $2.4988 per share for each share of Series F redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series F redeemable convertible preferred stock, holders of Series E redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $2.4802 per share for each share of Series E redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series E redeemable convertible preferred stock, holders of Series D redeemable convertible preferred stock shall be entitled to receive on a pari passu basis, and prior and in preference to any distribution of any of the assets, the amount of $1.2401 per share for each share of Series D redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series D redeemable convertible preferred stock, the holders of the Series C and Series B redeemable convertible preferred stock are entitled to receive the amount of $288.9825 and $107.5156 per share, respectively, for each share of Series C and Series B redeemable convertible preferred stock then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series C and Series B redeemable convertible preferred stock, the holders of the Series A redeemable convertible preferred stock are entitled to receive the amount of $129.0387 per share, respectively, for each share of Series A redeemable convertible preferred stock share then held, as applicable, adjusted for any stock dividends, combinations, splits, or recapitalization, plus all declared but unpaid dividends.
After payments to the holders of Series A redeemable convertible preferred stock, the entire remaining assets and surplus funds of the Company legally available for distribution, if any, shall be distributed pro rata among the holders of the then outstanding common stock and redeemable convertible preferred stock on an
as-converted
basis, rounded down to the next whole number of shares on a pari passu basis according to the number of shares of common stock held by such holders, until such time as each holder of then outstanding Series A, Series B, Series C, Series D, Series E, Series F, Series G, Series H, and Series
H-1
redeemable convertible preferred stock have received an aggregate amount equal to 2, 4, 4, 4, 2.5, 4, 2, 2, and 2 times the preference amount, respectively, of each share of redeemable convertible preferred stock held by each holder. After these distributions have been paid to all holders of redeemable convertible preferred stock, then the holders of then outstanding common stock will be entitled to receive all remaining assets of the Company legally available for distribution pro rata according to the number of outstanding shares of common stock then held by each holder. The redeemable convertible preferred stock will be deemed to have been automatically converted into common stock if the redemption amount per share on an
as-converted
basis would be greater than such holder would otherwise be entitled to.
Conversion rights
— Each share of Series A, Series B, Series C, Series D, Series E, Series F, Series G, Series H, and Series
H-1
redeemable convertible preferred stock are convertible, at the option of the holder thereof, at any time after the date of issuance of such share, into such number of fully paid and
non-assessable
shares of common stock as is determined by dividing, $91.7319, $81.5974, $139.6147, $1.2401, $1.2401, $2.4988, $4.3808, $5.6934, and $5.6934, respectively, by the conversion price $1.9011, $1.9011, $1.9011, $1.2401, $1.2401, $2.4988, $4.3808, $5.6934, and $5.6934, respectively, in effect on the date the certificate is surrendered for conversion.
The holders of each series of redeemable convertible preferred stock shall benefit from certain anti-dilution adjustments in the event the Company issues shares at a per share price lower than the respective issuance price of each series of redeemable convertible preferred stock.
The redeemable convertible preferred stock will automatically convert into shares of common stock at the then effective conversion price for each such share immediately upon the Company’s sale of its common stock in a firm commitment of an underwritten initial public offering pursuant to a registration statement under the
Securities Act of 1933, as amended, that has a public offering price of not less than $11.3867 per share, adjusted for any stock dividends, combinations, splits, or recapitalizations, and which results in aggregate gross proceeds to the Company of not less than $100.0 million, net of underwriting discounts, commissions, and expenses.
Redemption and Balance Sheet Classification
— While the redeemable convertible preferred stock does not have mandatory redemption provisions, the deemed liquidation preference provisions of the redeemable convertible preferred stock are considered contingent redemption provisions that are not solely within the Company’s control. These elements primarily relate to deemed liquidation events such as a change of control. Accordingly, the Company’s redeemable convertible preferred stock has been presented outside of permanent equity in the mezzanine section of the consolidated balance sheets.
Voting rights
— The holders of each share of redeemable convertible preferred stock are entitled to the number of votes equal to the number of shares of common stock into which such shares of redeemable convertible preferred stock could be converted. The holder of each share of common stock shall have the right to one vote for each such share and shall be entitled to notice of any stockholders’ meeting in accordance with the bylaws of the Company. Holders of Series A, Series B, Series D, Series, F, and Series H redeemable convertible preferred stock have the right to appoint one, two, three, two, and two directors to the Company’s board of directors, respectively.
XML 39 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Common Stock
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Stockholders' Equity Note [Abstract]    
Common Stock
8. Common Stock
On February 26, 2021, the Merger was consummated and the Company issued 60,746,989 shares for an aggregate purchase price of $200.5 million, net of issuance costs of $29.4 million. Immediately following the Merger, there were 277,768,357 shares of Common Stock outstanding with a par value of $0.0001. The holder of each share of Common Stock is entitled to one vote.
The Company has retroactively adjusted the shares issued and outstanding prior to February 26, 2021 to give effect to the
Exchange
 
Ratio
established in the Merger Agreement to determine the number of shares of Common Stock into which they were converted. Immediately prior to the Merger, 484,951,532 shares were authorized to issue at $0.0001 par value, with 299,771,284 shares designated as Common Stock and 185,180,248 shares of redeemable convertible preferred stock.
Common Stock Reserved for Future Issuance
Shares of Common Stock reserved for future issuance, on an
as-if converted
basis, were as follows:
 
    
July 31,

2021
 
Stock options issued and outstanding
     26,401,717  
Restricted stock units outstanding
     4,017,149  
Common stock warrants outstanding
     39,249,702  
Shares available for grant under 2021 Equity Incentive Plan
     40,878,653  
Shares available for grant under 2021 ESPP
     8,177,683  
    
 
 
 
Total shares of common stock reserved
     118,724,904  
    
 
 
 
On February 26, 2021, upon the closing of the Merger (Note 3), all of the outstanding redeemable convertible preferred stock was converted to Common Stock pursuant to the conversion rate effective immediately prior to the Merger and the remaining amount was reclassified to additional
paid-in
capital.
10. Common Stock
As of January 31, 2021 and 2020, the Company was authorized to issue 299,771,284 and 240,180,600 shares of common stock, respectively, with a par value of $0.0001 per share. There were 22,961,032 and 11,918,418 shares issued and outstanding as of January 31, 2021 and 2020, respectively.
The holders of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders. The holders of common stock are not entitled to cumulative voting rights with respect to the election of directors, and as a consequence, minority stockholders are not able to elect directors on the basis of their votes alone. Subject to preferences that may be applicable to any shares of redeemable convertible preferred stock currently outstanding or issued in the future, holders of common stock are entitled to receive ratably such dividends as may be declared by the Company’s board of directors out of funds legally available therefor. In the event of the Company’s liquidation, dissolution, or winding up, holders of the Company’s common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preference of any then outstanding redeemable convertible preferred stock. Holders of common stock have no preemptive rights and no right to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock.
Restricted Common Stock
In connection with a business combination in fiscal year 2019 as referenced in Note 4, the Company granted 797,280 shares of restricted common stock to employees for future services that vest over two years from the date of the acquisition. During the years ended January 31, 2021, 2020 and 2019, 166,100, 398,640 and 232,540 shares of restricted common stock vested, respectively. As of January 31, 2021, no shares of restricted common stock remained unvested.
Common Stock Reserved for Future Issuance
Shares of common stock reserved for future issuance on an
as-if
converted basis, were as follows:
 
    
January 31,
 
    
2021
    
2020
 
Conversion of redeemable convertible preferred stock
     193,037,715        170,686,661  
Stock options issued and outstanding
     30,167,178        34,883,465  
Redeemable convertible preferred stock warrants outstanding
     2,358,546        2,358,546  
Common stock warrants outstanding
     36,402,515        14,051,462  
Shares available for grant under 2017 Stock Option Plan
     4,528,391        5,844,909  
  
 
 
    
 
 
 
Total shares of common stock reserved
  
 
266,494,345
 
  
 
227,825,043
 
  
 
 
    
 
 
 
XML 40 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Warrants and Earnouts
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Stock Warrants And Earnouts [Abstract]    
Stock Warrants and Earnouts
 
9.
Stock Warrants and
 
Earnout
Redeemable Convertible Preferred Stock Warrants
Warrants to purchase a total of 2,358,528
shares of Series B, D and E redeemable convertible preferred stock were initially recognized as a liability recorded at fair value upon issuance and were subject to remeasurement to fair value at each balance sheet date. As part of the Merger, Legacy ChargePoint redeemable convertible preferred stock was converted into Legacy ChargePoint common stock pursuant to the conversion rate effective immediately prior to the Merger while all related Legacy ChargePoint preferred stock warrants were converted into warrants exercisable for shares of Common Stock with terms consistent with the Legacy ChargePoint preferred stock warrants except for the number of shares exercisable therefor and the exercise price, each of which was adjusted using the Exchange Ratio. At that time, the redeemable convertible preferred stock warrant liability was remeasured and reclassified to
additional paid-in capital.
The liability associated with these warrants was subject to remeasurement at each balance sheet date using the Level 3 fair value inputs. See Note 4 for further details.
The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows:
 
    
February 26,
2021

(Merger Date)
   
January 31,

2021
 
Expected volatility
     84.3     80.5
Risk-free interest rate
     0.0     0.1
Dividend rate
     0.0     0.0
Expected term (years)
     0.0       1.4  
Common Stock Warrants
In addition to the warrants to purchase 2,358,528 shares of Legacy ChargePoint preferred stock described above, Legacy ChargePoint had outstanding warrants to purchase 36,402,503 shares of Legacy ChargePoint
common stock (collectively, “Legacy Warrants”), which now represent warrants to purchase Common Stock. During the three months ended July 31, 2021, 587,880 Legacy Warrants were net exercised resulting in the issuance of 558,100 shares of Common Stock. During the six months ended July 31, 2021, 1,685,185 Legacy Warrants were net exercised resulting in the issuance of 1,480,080 shares of Common Stock. As of July 31, 2021, there were 37,075,846 Legacy Warrants outstanding which are classified as equity.
Private Placement Warrants
The Private Placement Warrants were initially recognized as a liability on February 26, 2021, at a fair value of $127.9 million and the Private Placement Warrant liability was remeasured to fair value as of any respective exercise dates and as of July 31, 2021. The Company recorded a gain of $3.8 million and $49.2 million for the three and six months ended July 31, 2021, respectively, classified within change in fair value of warrant liabilities in the condensed consolidated statements of operations.
The Private Placement Warrants were valued using the following assumptions under
the
BLM that assumes optimal exercise of the Company’s redemption option at the earliest possible date:
 
    
July 31,

2021
   
February 26,

2021
 
Market price of public stock
   $ 23.65       $30.83  
Exercise price
   $ 11.50       $11.50  
Expected term (years)
     4.6       5.0  
Volatility
     70.2     73.5
Risk-free interest rate
     0.6     0.8
Dividend rate
     0.0     0.0
Public Warrants
The Public Warrants may only be exercised for a whole number of shares. The Public Warrants became exercisable 30 days after the completion of the Merger.
The Public Warrants were initially recognized as a liability on February 26, 2021 at a fair value of $153.7 million and the public warrant liability was remeasured to fair value based upon the market price as warrants were exercised.
On June 4, 2021 the Company issued a redemption notice pursuant to which all but 244,481 Public Warrants were exercised by the Public Warrant holders. At the conclusion of the redemption notice period on
July 6, 2021, the Company redeemed the remaining
 
244,481
Public Warrants
 outstanding
 for $0.01 per warrant. The Company recognized a loss of $14.3 million for the three months ended July 31, 2021 and a loss of $15.9 million for the six months ended July 31, 2021, classified within change in fair value of warrant liabilities in the condensed consolidated statements of operations.
During the six months ended July 31, 2021, proceeds received for the exercise of Public Warrants were $117.6 million. As of July 31, 2021, no Public Warrants remained outstanding.
Activity of warrants is set forth below:
 
    
Legacy Common
and Preferred Stock
Warrants
(1)
    
Private
Placement
Warrants
    
Public
Warrants
    
Total

Common Stock
Warrants
(1)
 
Outstanding as of January 31, 2021
     38,761,031        —          —          38,761,031  
Common Stock Warrants as Part of the Merger
     —          6,521,568        10,470,562        16,992,130  
Warrants Exercised
     (1,685,185      (4,347,712      (10,226,081      (16,258,978
Warrants Redeemed
     —          —          (244,481      (244,481
    
 
 
    
 
 
    
 
 
    
 
 
 
Outstanding as of July 31, 2021
     37,075,846        2,173,856        —          39,249,702  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
(1)
The shares (and the warrants’ exercise prices) subject to the Company’s Legacy common and preferred stock warrants were restated to reflect the exchange ratio of approximately 0.9966 established in the Merger Agreement as discussed in Note 3.
Contingent Earnout Liability
During the five year period starting at the closing of the Merger (“Earnout Period”), eligible former equity holders of Legacy ChargePoint
 
could

receive up to 27,000,000 additional shares of Common Stock (“Earnout Shares”) in the aggregate in three equal tranches if certain Earnout Triggering Events (as described in the Merger Agreement) are fully satisfied. An “Earnout Triggering Event” means the date on which the closing volume weighted-average price (“VWAP”) per share of common stock quoted on the NYSE (or the exchange on which the shares of common stock are then listed) is greater or equal to $15.00, $20.00 and $30.00 for any ten trading days within any 20 consecutive trading day period within the Earnout Period.
Upon the closing of the Merger, the contingent obligation to issue Earnout Shares was accounted for as a liability because the Earnout Triggering Events that determine the number of Earnout Shares required to be issued include events that are not solely indexed to the common stock of ChargePoint. The estimated fair value of the total Earnout Shares at the closing of the Merger on February 26, 2021, was $828.2 million based on a Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the Earnout Period using the most reliable information available. Assumptions used in the valuation are described below.
 
    
March 12,

2021
   
February 26,

2021
 
Current stock price
   $ 27.84     $ 30.83  
Expected volatility
     72.00     71.60
Risk-free interest rate
     0.85     0.75
Dividend rate
     0.00     0.00
Expected term (years)
     4.96       5.00  
The first two Earnout Triggering Events for up to 18,000,000 of the Earnout Shares occurred on March 12, 2021, and, after withholding some of these Earnout Shares
 to cover 
tax
withholding obligations,
 17,539,657 Earnout Shares were issued on March 19, 2021, and the estimated fair value of the earnout liability was remeasured to $743.7 million, including (i) $501.1 million related to the Earnout Shares issuable upon the occurrence of the Earnout Triggering Event associated with the $15.00 and $20.00 VWAP per share thresholds
based on the Common Stock price as of March 12, 2021, and (ii) $242.6 million related to the estimated fair value of earnout liability related to the remaining 9,000,000 Earnout Shares issuable upon the occurrence of the Earnout Triggering Event associated with the $30.00 VWAP per share threshold based on a Monte Carlo simulation valuation model as of March 12, 2021, as described above. The change in fair value resulted in a gain of $84.4 million recognized in the condensed consolidated statement of operations for the three months ended April 30, 2021. Upon settlement of the first two tranches, the classification of the remaining 9,000,000 Earnout Shares of the third tranche was changed to equity on March 12, 2021, because the Earnout Shares became an instrument contingently issuable upon the occurrence of the Earnout Triggering Event into a fixed number of Common Shares that is not based on an observable market price or index other than the Company’s own stock price.
The third and final
 
Earnout Triggering Event for up to 9,000,000 of the Earnout Shares associated with the $30.00 VWAP per share threshold occurred on June 29, 2021, and, after the withholding of some of these Earnout Shares
to cover
 tax
withholding obligations,
8,773,596 Earnout Shares were issued on July 1, 2021
.
 
No
further Earnout Shares remained contingently issuable as of July 31, 2021.
 
11.
Stock Warrants
In connection with its issuance of Series
H-1
redeemable convertible preferred stock in the fiscal year 2021, the Company issued 22.4 million common stock warrants which were recorded at fair value within additional
paid-in
capital in stockholders’ deficit.
In connection with its issuance of Series H redeemable convertible preferred stock in fiscal years 2020 and 2019, the Company issued 0.9 million and 13.2 million common stock warrants, respectively, which were recorded at fair value within additional
paid-in
capital in stockholders’ deficit.
Warrants issued and outstanding as of January 31, 2021 and 2020 consisted of the following:
Common Stock Warrants
 
    
January 31, 2021
 
    
Outstanding Warrants
        
    
Number of
Warrants
    
Exercise
Price
    
Expiration Date
 
Common Stock
     22,351,053      $ 6.02        7/31/2030 – 8/6/2030  
Common Stock
     14,051,462      $ 9.03        11/16/2028 – 2/14/2029  
  
 
 
       
Total outstanding common stock warrants
  
 
36,402,515
 
     
  
 
 
       
 
    
January 31, 2020
 
    
Outstanding Warrants
        
    
Number of
Warrants
    
Exercise
Price
    
Expiration Date
 
Common Stock
     14,051,462      $ 9.03        11/16/2028 – 2/14/2029  
  
 
 
       
Total outstanding common stock warrants
  
 
14,051,462
 
     
  
 
 
       
 
Redeemable Convertible Preferred Stock Warrants
 
    
January 31, 2021 and 2020
 
    
Outstanding Warrants
    
Expiration Date
 
    
Number of
Warrants
    
Exercise
Price
 
Series B Preferred Stock
     2,685      $ 107.52        4/30/2021  
Series D Preferred Stock
     1,436,932      $ 1.24        4/20/2022 – 1/24/2024  
Series E Preferred Stock
     806,375      $ 1.24        12/24/2024 – 7/15/2025  
  
 
 
       
Total outstanding redeemable convertible preferred stock warrants
  
 
2,245,992
 
     
  
 
 
       
The liability associated with these warrants was subject to remeasurement at each balance sheet date using the Level 3 fair value inputs and was as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Fair value at beginning of period
   $ 2,718      $ 1,843      $ 1,455  
Change in fair value
     73,125        875        388  
  
 
 
    
 
 
    
 
 
 
Fair value at end of period
  
$
75,843
 
  
$
2,718
 
  
$
1,843
 
  
 
 
    
 
 
    
 
 
 
The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows:
 
    
January 31,
 
    
2021
   
2020
   
2019
 
Expected volatility
     80.5     58.4     65.0
Risk-free interest rate
     0.1     1.6     2.8
Dividend rate
     0.0     0.0     0.0
Expected term (years)
     1.4       2.0       2.0  
Historically, value was assigned to each class of equity securities using an option pricing model method (“OPM”). In July 2020, the Company began allocating the equity value using a hybrid method that utilizes a combination of the OPM and the probability weighted expected return method (“PWERM”). The PWERM is a scenario-based methodology that estimates the fair value of equity securities based upon an analysis of future values for the Company, assuming various outcomes. As the probability of a transaction with a special purpose acquisition company (“SPAC”) increased, the fair value of the redeemable convertible preferred stock warrant liability increased as of January 31, 2021.
XML 41 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Plans and Stock-based Compensation
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Share-based Payment Arrangement [Abstract]    
Equity Plans and Stock-based Compensation
 
10.
Equity Plans and Stock-based Compensation
On February 25, 2021, the stockholders of the Company approved the 2021 Equity Incentive Plan (“2021 EIP”) and the 2021 Employee Stock Purchase Plan (“2021 ESPP”). As of July 31, 2021, 40,878,653 and 8,177,683 shares of Common Stock were available under the 2021 EIP and 2021 ESPP, respectively. On the first day of each March, beginning on March 1, 2021 and continuing through March 1, 2030, the 2021 EIP reserve will automatically increase by a number of shares equal to the lesser of (a) 5% of the total number of shares actually issued and outstanding on the last day of the preceding month and (b) a number determined by the Company’s Board of Directors. Further, on the first day of each March during the term of the 2021 ESPP, commencing on March 1, 2021 and ending on (and including) March 1, 2040, the aggregate number of shares of stock that may be issued under the 2021 ESPP shall automatically increase by a number equal to the lesser of (i) one percent (1%) of the total number of shares of stock issued and outstanding on the last day of the preceding month, (ii) 5,400,000 shares of stock (subject to standard anti-dilution adjustments), or (iii) a number of shares of stock determined by the Company’s Board of Directors.
Under the 2021 EIP, the Company can grant stock options, stock appreciation rights, restricted stock, restricted stock units (“RSU”) and certain other awards which are
s
ettled in the form of common shares issued under this 2021 EIP. Under the 2021 ESPP, eligible employees are permitted to purchase shares of the Company’s Common Stock at 85% of the lower of fair market value the Company’s Common Stock on the first trading day of an offering period or on the purchase date.
No further awards will be granted under Legacy ChargePoint’s 2017 Stock Plan (“2017 Plan”) and 24,259,238 shares of Common Stock remain reserved for outstanding awards issued under the 2017 Plan at the time of adoption of the 2021 EIP and the 2021 ESPP. Additionally, no other awards can be granted under Legacy ChargePoint’s 2007 Stock Incentive Plan (“2007 Plan”) and 5,143,849 shares of Common Stock remained reserved for outstanding awards issued under the 2007 Plan at the time of the adoption of the 2021 EIP and the 2021 ESPP.
The Company’s stock option awards activity is set forth below:
 
    
Number of
Stock Option
Awards
    
Weighted
Average
Exercise Price
    
Weighted
Average
Remaining
Contractual
term (in years)
    
Aggregate
Intrinsic Value
(in thousands)
 
Outstanding as of January 31, 2021
     30,166,792      $ 0.71        7.3      $ 1,064,539  
Options exercised
     (3,292,219    $ 0.53                    
Options forfeited
     (452,893    $ 0.73                    
Options expired
     (19,963    $ 53.22                    
    
 
 
                            
Outstanding as of July 31, 2021
     26,401,717      $ 0.69        7.0      $ 606,280  
    
 
 
                            
Options vested and expected to vest as of July 31, 2021
     25,667,621      $ 0.69        7.0      $ 589,470  
    
 
 
                            
Exercisable as of July 31, 2021
     16,457,228      $ 0.66        6.3      $ 378,402  
    
 
 
                            
The options outstanding as of July 31, 2021, include the June 2020 grant of a stock option to purchase a total of 1.5 million shares of Common Stock subject to both service and performance-based vesting conditions to the Chief Executive Officer under the 2017 Plan (“CEO Award”). No stock-based compensation expense had been recorded as the CEO awards were improbable of vesting before and after two modifications in each of September 2020 and December 2020, because the performance-based vesting condition was contingent upon the closing of the Merger. Accordingly, the Company commenced recognition of stock-based compensation expense for such CEO Award following the Merger in February 2021. As of July 31, 2021, the total unrecognized compensation expense related to these unvested CEO Award was $35.3 million, which is expected to be recognized over a period of 2.5 years
.
The Company’s RSU activity is set forth below:
 
    
Number of
Shares
    
Weighted
Average Grant
Date Fair Value
per Share
 
Outstanding as of January 31, 2021
     —        $ —    
RSU granted
     4,680,439      $ 27.38  
RSU vested
     (652,901    $ 27.30  
RSU forfeited
     (10,389    $ 27.30  
    
 
 
          
Outstanding as of July 31, 2021
     4,017,149      $ 27.40  
    
 
 
          
As of July 31, 2021, total unrecognized stock-based compensation expense related to stock options was $41.0 million, including the CEO Award, and is expected to be recognized over a weighted-average period of 1.9 years. As of July 31, 2021, total unrecognized stock-based compensation expense related to RSU was $86.3 million and is expected to be recognized over a weighted-average period of 3.1 years.
The following sets forth the total stock-based compensation expense for the Company’s stock options (including the CEO Award) and RSU included in the Company’s condensed consolidated statements of operations:
 
    
Three Months Ended

July 31,
    
Six Months Ended

July 31,
 
    
2021
    
2020
    
2021
    
2020
 
    
(in thousands)
    
(in thousands)
 
Cost of revenue
   $ 2,164      $ 41      $ 2,188      $ 64  
Research and development
     13,682        454        14,357        757  
Sales and marketing
     4,169        356        4,767        655  
General and administrative
     8,278        339        14,558        624  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation expense
   $ 28,293      $ 1,190      $ 35,870      $ 2,100  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
12.
Stock Option Plan and Stock-based Compensation
In 2007, the Company adopted its 2007 Stock Option Plan (the “2007 Plan”) which provides for the granting of stock options to employees, directors, and consultants of the Company. In 2017, the Company adopted its 2017 Stock Option Plan (the “2017 Plan”). Stock options granted under both the 2007 and 2017 Plans may be either incentive stock options (“ISOs”) or nonqualified stock options (“NSOs”). As of January 31, 2021, 4.5 million shares of common stock remained available for issuance under the 2017 Plan. Stock-based awards forfeited, cancelled, or repurchased generally are returned to the pool of shares of common stock available for issuance under the 2017 Plan.
The 2007 Plan and 2017 Plan allow for the early exercise of stock options for certain individuals as determined by the Company’s board of directors. Stock options that are early exercised are subject to a
 
repurchase option that allows the Company to repurchase any unvested shares. Early exercises of stock options are not deemed to be outstanding shares for accounting purposes until those shares vest according to their respective vesting schedules. Accordingly, the consideration received for early exercises of stock options are initially recorded as a liability and reclassified to common stock and additional
paid-in
capital as the underlying awards vest. As of January 31, 2021 and 2020, liabilities for unvested shares related to early exercises of stock options were not material. The related number of unvested shares subject to repurchase was also not material for any period presented.
Stock options under the 2017 Plan generally expire 10 years from the date of grant, or earlier if services are terminated. The exercise price of an ISO and NSO shall not be less than 100% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Company’s board of directors. Stock options granted generally vest over four years and at a rate of 25% upon the first anniversary of the issuance date and 1/48th per month thereafter.
Activity under the Company’s stock option plans is set forth below:
 
    
Number of
Stock Option
Awards
   
Weighted
Average
Exercise

Price
    
Weighted
Average
Remaining
Contractual
term

(in years)
    
Aggregate
Intrinsic Value
 
Outstanding as of January 31, 2018
  
 
28,955,341
 
  $ 0.59        7.7      $ 8,905,754  
  
 
 
         
Granted
     8,811,605     $ 0.57        
Exercised
     (3,853,935   $ 0.35         $ (1,364,006
Cancelled
     (2,250,990   $ 0.75        
  
 
 
         
Outstanding as of January 31, 2019
  
 
31,662,021
 
  $ 0.6        7.4      $ 7,456,493  
Granted
     10,780,372     $ 0.75        
Exercised
     (4,830,469   $ 0.47         $ (3,464,262
Cancelled
     (2,728,460   $ 0.83        
  
 
 
         
Outstanding as of January 31, 2020
  
 
34,883,464
 
  $ 0.65        7.3      $ 19,314,017  
Granted
     8,912,180     $ 0.75        
Exercised
     (11,042,592   $ 0.55         $ (110,643,446 )
Cancelled
     (2,585,875   $ 0.84        
  
 
 
         
Outstanding as of January 31, 2021
  
 
30,167,177
 
  $ 0.7        7.3      $ 1,064,538,557  
  
 
 
         
Options vested and expected to vest as of January 31, 2021
     27,483,800     $ 0.69        7.2      $ 969,997,293  
  
 
 
         
Exercisable as of January 31, 2021
     16,591,050     $ 0.68        6.4      $ 586,047,442  
  
 
 
         
Activity for exercised awards includes early exercises of stock options such that these awards are not considered outstanding stock options upon exercise.
The activity above also includes a grant of a total of 1.5 million stock option awards subject to both service and performance-based vesting conditions to the Chief Executive Officer under the 2017 Plan (“CEO awards”). These stock options have a weighted-average exercise price of $0.75 per share. Upon initial grant in June 2020, these stock option awards had a grant date fair value of $1.1 million and were to vest on the fourth anniversary from the date of grant provided that positive operating income was achieved at the end of fiscal year 2024.
In September 2020, the CEO awards were modified to vest in a single installment on January 31, 2024 contingent upon the closing of the Merger and the Chief Executive Officer’s continuous employment by the
 
Company through January 31, 2024. No stock-based compensation expense has been recorded as the CEO awards were improbable of vesting before and after the modification in September 2020, because the performance-based vesting condition is contingent upon the closing of the Merger which is not deemed probable until consummated.
In December 2020, the CEO awards were modified again to accelerate vesting of 12.5% of stock options at any time through January 31, 2024 contingent upon certain additional service-based trigger events. For the year ended January 31, 2021, no stock-based compensation expense has been recorded as the CEO awards remained to be improbable of vesting before and after the modification in December 2020. As of January 31, 2021, the total compensation cost related to these unvested CEO awards not yet recognized was $44.3 million after the impact of the modifications.
Total stock-based compensation expense for stock awards recognized during the years ended January 31, 2021, 2020, and 2019 was $4.9 million, $2.9 million, and $1.7 million, respectively. As of January 31, 2021, total unrecognized compensation cost related to stock awards was $9.8 million and is expected to be recognized over a weighted-average period of 2.5 years.
The weighted-average grant date fair value of options granted in the years ended January 31, 2021, 2020, and 2019 was $0.94, $0.31, and $0.24 per share, respectively. The total grant date fair value of options vested during the years ended January 31, 2021, 2020, and 2019 was $5.4 million, $2.5 million, and $1.8 million, respectively.
Stock-based Compensation Associated with Awards
The Company records stock-based compensation expense for stock options based on the estimated fair value of the options on the date of the grant using the Black-Scholes option-pricing model.
The absence of a public market for the Company’s common stock requires the Company’s board of directors to estimate the fair value of its common stock for purposes of granting options and for determining stock-based compensation expense by considering several objective and subjective factors, including contemporaneous third-party valuations, actual and forecasted operating and financial results, market conditions and performance of comparable publicly traded companies, developments and milestones in the Company, the rights and preferences of common and redeemable convertible preferred stock, and transactions involving the Company’s stock. The fair value of the Company’s common stock was determined in accordance with applicable elements of the American Institute of Certified Public Accountants guide, Valuation of Privately Held Company Equity Securities Issued as Compensation.
The weighted-average assumptions in the Black-Scholes option-pricing models used to determine the fair value of stock options granted during the years ended January 31, 2021, 2020, and 2019 were as follows:
 
    
Year Ended January 31,
 
    
2021
   
2020
   
2019
 
Expected volatility
     49.1% – 51.6     40.3% – 40.9 %     40.9% – 41.6
Risk-free interest rate
     0.3% – 1.6     1.4% – 2.4     2.7% – 2.9
Dividend rate
     0.0     0.0     0.0
Expected term (in years)
     5.6 – 5.8       5.0 – 5.9       6.1 – 6.4  
Expected volatility: As the Company is not publicly traded, the expected volatility for the Company’s stock options was determined by using an average of historical volatilities of selected industry peers deemed to be comparable to the Company’s business corresponding to the expected term of the awards.
Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for
zero-coupon
U.S. Treasury notes with maturities corresponding to the expected term of the awards.
 
Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its common stock.
Expected term: The expected term represents the period these stock awards are expected to remain outstanding and is based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules, and expectations of future employee behavior.
Stock-based Compensation Expense
The following sets forth the total stock-based compensation expense for the Company’s stock options and restricted common stock included in the Company’s consolidated statements of operations:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Cost of revenue
   $ 115      $ 39      $ 28  
Research and development
     1,807        871        419  
Sales and marketing
     1,501        1,164        541  
General and administrative
     1,524        863        718  
  
 
 
    
 
 
    
 
 
 
Total stock-based compensation expense
  
$
4,947
 
  
$
2,937
 
  
$
1,706
 
  
 
 
    
 
 
    
 
 
 
XML 42 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Income Tax Disclosure [Abstract]    
Income Taxes
11.
Income
 
Taxes
The income tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate as adjusted for discrete items arising in that quarter. The effective income tax rate was nil for the three and six months ended July 31, 2021 and 2020. The effective tax rate differs from the U.S. statutory rate primarily due to the full valuation allowances on the Company’s net domestic deferred tax assets as it is more likely than not that all of the deferred tax assets will not be realized.
On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) was enacted and signed into law in the United States. The CARES Act includes measures to assist companies, including temporary changes to income and
non-income-based tax
laws. The Company did not receive a stimulus payment related to the CARES Act.
 
13.
Income Taxes
The components of net loss before income taxes were as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Domestic
   $ (197,908    $ (134,578    $ (108,663
Foreign
     1,082        475        695  
  
 
 
    
 
 
    
 
 
 
Net loss before income taxes
  
$
(196,826
  
$
(134,103
  
$
(107,968
  
 
 
    
 
 
    
 
 
 
The components of the provision for (benefit from) income taxes were as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Current
        
Federal
   $ —        $ —        $ —    
State
     47        35        —    
Foreign
     151        189        119  
  
 
 
    
 
 
    
 
 
 
Total current
  
$
198
 
  
$
224
 
  
$
119
 
  
 
 
    
 
 
    
 
 
 
Deferred
        
Federal
   $ —        $ —        $ —    
State
     —          —          —    
Foreign
     —          —          —    
Total deferred
     —          —          —    
  
 
 
    
 
 
    
 
 
 
Total provision for income taxes
  
$
198
 
  
$
224
 
  
$
119
 
  
 
 
    
 
 
    
 
 
 
 
A reconciliation of the U.S. federal statutory rate to the Company’s effective tax rate was as follows:
 
    
Year Ended January 31,
 
    
2021
   
2020
   
2019
 
Tax at federal statutory rate
     21.0     21.0     21.0
Permanent differences
     (0.6 )%      (1.5 )%      (0.8 )% 
Warrant Mark to Market
     (7.8 )%      (0.1 )%      (0.1 )% 
Stock-based compensation
     (0.2 )%      (0.2 )%      (0.2 )% 
Change in valuation allowance
     (13.6 )%      (21.1 )%      (21.9 )% 
Research and development tax credits
     1.1     1.8     1.9
  
 
 
   
 
 
   
 
 
 
Effective tax rate
  
 
(0.1
)% 
 
 
(0.1
)% 
 
 
(0.1
)% 
  
 
 
   
 
 
   
 
 
 
The significant components of the Company’s deferred tax assets and liabilities as of January 31, 2021 and 2020 were as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Deferred tax assets:
     
Net operating losses
   $ 114,154      $ 105,663  
Research & development credits
     12,054        14,320  
Deferred revenue
     15,270        6,968  
Accruals and reserves
   $ 8,102      $ 6,692  
Stock-based compensation
     980        653  
Operating lease liabilities
     6,999        3,370  
  
 
 
    
 
 
 
Total deferred tax assets
  
 
157,559
 
  
 
137,666
 
  
 
 
    
 
 
 
Less: valuation allowance
     (150,991      (134,337
Deferred tax liabilities:
     
Depreciation and amortization
     (375      (489
Operating lease
right-of-use
assets
     (6,186      (2,834
  
 
 
    
 
 
 
Total deferred tax liabilities
  
 
(6,561
  
 
(3,323
  
 
 
    
 
 
 
Net deferred tax assets
  
$
7
 
  
$
6
 
  
 
 
    
 
 
 
The Company determines its valuation allowance on deferred tax assets by considering both positive and negative evidence in order to ascertain whether it is more likely than not that deferred tax assets will be realized. Realization of deferred tax assets is dependent upon the generation of future taxable income, if any, the timing and amount of which are uncertain. Due to the Company’s historical operating losses, the Company believes that it is more likely than not that all of the deferred tax will not be realized; accordingly, the Company has recorded a full valuation allowance on its net domestic deferred tax assets as of January 31, 2021 and 2020. The valuation allowance increased by $16.7 million, $36.2 million, and $29.8 million during the years ended January 31, 2021, 2020, and 2019, respectively. The increases were primarily driven by losses and tax credits generated in the United States. As of January 31, 2021, the Company believes it is not more likely than not that the US deferred tax assets will be fully realizable and continues to maintain a full valuation allowance against its net US deferred tax assets.
As of January 31, 2021, the Company had federal and California state net operating loss (“NOL”) carryforwards of $434.7 million and $229.7 million, respectively, of which $281.9 million of the federal NOL carryforwards can be carried forward indefinitely. The federal and California state net operating loss carryforwards begin to expire in 2028 and 2029, respectively. In addition, the Company had NOLs for other states of $134.7 million, which expire beginning in the year 2022.
 
As of January 31, 2021, the Company had federal and California state research credit carryforwards of $5.1 million and $8.8 million, respectively. The federal credit carryforwards will begin to expire in 2039. The California research credit carryforwards can be carried forward indefinitely. The Company had alternative refueling property tax credits that are permanently limited by Section 382.
Under Internal Revenue Code Section 382, the Company’s ability to utilize NOL carryforwards or other tax attributes such as research tax credits, in any taxable year may be limited if the Company experiences, or has experienced, an “ownership change.” A Section 382 “ownership change” generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company’s stock, increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Similar rules may apply under state tax laws. The Company performed a Section 382 analysis through January 31, 2021. The Company has experienced ownership changes in the prior periods. As a result of the ownership changes, it was estimated that approximately $53.1 million of Federal NOLs, $40.3 million of California NOLs, and $9.7 million of federal tax credits are expected to expire for income tax purposes, and such amounts are excluded from the carryforwards balance as of January 31, 2021. The Company expects to complete the Section 382 analysis during the year ending January 31, 2022. Subsequent ownership changes may affect the limitation in future years.
The following table summarizes the activity related to unrecognized tax benefits as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Unrecognized tax benefits — beginning
   $ 10,153      $ 6,884      $ 4,445  
Gross decreases — prior period tax position
     (3,620      —          —    
Gross increases — current period tax position
     2,869        3,269        2,439  
  
 
 
    
 
 
    
 
 
 
Unrecognized tax benefits — ending
  
$
9,402
 
  
$
10,153
 
  
$
6,884
 
  
 
 
    
 
 
    
 
 
 
As of January 31, 2021, the Company had unrecognized tax benefits of $9.4 million, which would not impact the effective tax rate, if recognized, due to the valuation allowance. The Company does not expect its unrecognized tax benefits will significantly change over the next twelve months.
The Company is subject to income taxes in United States federal and various state, local, and foreign jurisdictions. The tax years from 2007 to 2020 remain open to examination due to the carryover of unused net operating losses or tax credits. As of January 31, 2021, the Company is not subject to income tax examinations by any tax authority.
On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was enacted and signed into law in the United States. The CARES Act includes measures to assist companies, including temporary changes to income and
non-income-based
tax laws. The CARES Act contains several corporate income tax provisions, including making remaining alternative minimum tax (AMT) credits immediately refundable; providing a
5-year
carryback of net operating losses (NOLs) generated in tax years 2019, 2020, and 2021, and removing the 80% taxable income limitation on utilization of those NOLs if carried back to prior tax years or utilized in tax years beginning before 2022; temporarily liberalizing the interest deductibility rules under Section 163(j) of the CARES Act, by raising the adjusted taxable income limitation from 30% to 50% for tax years 2020 and 2021 and giving taxpayers the election of using 2020 adjusted taxable income for purposes of computing 2021 interest deductibility. The CARES Act did not have a material impact on the Company’s tax provision for the year ended January 31, 2021.
The Consolidated Appropriations Act, 2021, which was enacted on December 27, 2020, has expanded, extended, and clarified selected CARES Act provisions, specifically on Paycheck Protection Program (PPP) loan
 
and Employee Retention Tax Credit, 100% deductibility of business meals as well as other tax extenders. The Consolidated Appropriations Act did not have a material impact on the Company’s tax provision for the year ended January 31, 2021.
XML 43 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Related Party Transactions [Abstract]    
Related party transactions
12.
Related Party Transactions
Daimler AG and its affiliated entities (“Daimler”) are investors in the Company and one of its employees is a member of the Company’s Board of Directors. The following revenue transactions took place between the Company and Daimler during the periods presented:
 
    
Three Months Ended

July 31,
    
Six Months Ended

July 31,
 
    
2021
    
2020
    
2021
    
2020
 
    
(in thousands)
    
(in thousands)
 
Daimler
   $ 2,071      $ 850      $ 3,406      $ 1,576  
    
 
 
    
 
 
    
 
 
    
 
 
 
Revenue from related parties
   $ 2,071      $ 850      $ 3,406      $ 1,576  
    
 
 
    
 
 
    
 
 
    
 
 
 
Related party accounts receivable as of July 31, 2021 and January 31, 2021 from Daimler was $2.5 million and $1.2 million, respectively.
14.
Related Party Transactions
Daimler AG and its affiliated entities (“Daimler”) is an investor in the Company and one of its employees is a member of the Company’s board of directors. The following revenue transactions took place between the Company and Daimler during the respective fiscal years:
 
    
Year ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Daimler
   $ 3,457      $ 3,112      $ 1,082  
  
 
 
    
 
 
    
 
 
 
Revenue from related parties
  
$
3,457
 
  
$
3,112
 
  
$
1,082
 
  
 
 
    
 
 
    
 
 
 
Related party accounts receivable as of January 31, 2021 and 2020 from Daimler were $1.2 million and $0.9 million, respectively.
XML 44 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Geographic Information
12 Months Ended
Jan. 31, 2021
Segment Reporting [Abstract]  
Geographic Information
15.
Geographic Information
Revenue by geographic area based on the shipping address of the customers was as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
United States
   $ 131,571      $ 130,184      $ 81,408  
Rest of World
     14,919        14,331        10,622  
  
 
 
    
 
 
    
 
 
 
Total revenue
  
$
146,490
 
  
$
144,515
 
  
$
92,030
 
  
 
 
    
 
 
    
 
 
 
Long-lived assets by geographic area were as follows:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
United States
   $ 46,759      $ 36,836  
Rest of World
     5,046        1,374  
  
 
 
    
 
 
 
Total long-lived assets
  
$
51,805
 
  
$
38,210
 
  
 
 
    
 
 
 
XML 45 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Basic and Diluted Net Loss Per Share
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Earnings Per Share [Abstract]    
Basic and Diluted Net Loss per Share
13. Basic and Diluted Net Loss per Share
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and six months ended July 31, 2021 and 2020:
 
 
  
Three Months Ended

July 31,
 
 
Six Months Ended

July 31,
 
 
  
2021
 
 
2020
 
 
2021
 
 
2020
 
 
  
(in thousands, except share and
per share data)
 
 
(in thousands, except share and
per share data)
 
Numerator:
  
     
 
     
 
     
 
     
Net income (loss)
  
$
(84,938
 
$
(35,287
 
$
(2,649
 
$
(65,385
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjust:
Accretion of beneficial conversion feature of redeemable convertible preferred stock
  
 
—  
 
 
 
(58,625
 
 
—  
 
 
 
(58,625
Adjust:
Cumulative dividends on redeemable convertible preferred stock
  
 
—  
 
 
 
—  
 
 
 
(4,292
 
 
—  
 
Adjust:
Deemed dividends attributable to vested option holders
  
 
—  
 
 
 
—  
 
 
 
(51,855
 
 
—  
 
Adjust:
Deemed dividends attributable to common stock warrant holders
  
 
—  
 
 
 
—  
 
 
 
(110,635
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to common stockholders - Basic
  
 
(84,938
 
 
(93,912
 
 
(169,431
 
 
(124,010
Less:
Gain attributable to earnout shares issued
  
 
—  
 
 
 
—  
 
 
 
(84,420
 
 
—  
 
Less:
Change in fair value of dilutive warrants
  
 
(7,427
 
 
—  
 
 
 
(53,540
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to common stockholders - Diluted
  
$
(92,365
 
$
(93,912
 
$
(307,391
 
$
(124,010
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator:
  
     
 
     
 
     
 
     
Weighted average common shares outstanding
  
 
312,465,016
 
 
 
13,537,501
 
 
 
266,473,703
 
 
 
12,822,481
 
Less:
Weighted-average unvested restricted shares and shares subject to repurchase
  
 
(237,490
 
 
(68,824
 
 
(276,221
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares outstanding - Basic
  
 
312,227,526
 
 
 
13,468,677
 
 
 
266,197,482
 
 
 
12,822,481
 
Add:
Earnout Shares under the treasury stock method
  
 
—  
 
 
 
—  
 
 
 
7,464,203
 
 
 
—  
 
Add:
Public and Private Placement Warrants under the treasury stock method
  
 
1,374,574
 
 
 
—  
 
 
 
1,915,315
 
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares outstanding - Diluted
  
 
313,602,100
 
 
 
13,468,677
 
 
 
275,577,000
 
 
 
12,822,481
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss per share - Basic
  
$
(0.27
 
$
(6.97
 
$
(0.64
 
$
(9.67
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss per share - Diluted
  
$
(0.29
 
$
(6.97
 
$
(1.12
 
$
(9.67
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As a result of the Merger, the Company has retroactively adjusted the weighted-average number of shares of Common Stock outstanding prior to
the
Closing Date by multiplying them by the
Exchange Ratio
 of 0.9966 used to determine the number of shares of Common Stock into which they converted. The Common Stock issued as a result of the redeemable convertible preferred stock conversion on the Closing Date was included in the basic net loss per share calculation on a prospective basis.
Redeemable convertible preferred stock and preferred stock warrants outstanding prior to the Merger Closing Date were excluded from the diluted net loss per share calculation for the
six-months
period ended July 31, 2021, because including them would have had an antidilutive effect
.
The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows:
 
    
July 31,
2021
 
  
July 31,
2020
 
Redeemable convertible preferred stock (on an
as-converted
basis)
     —          192,469,995  
Options to purchase common stock
     26,401,717        39,463,877  
Restricted stock units
     4,017,149     
 
—  
 
Unvested early exercised common stock options
     211,464        102,781  
Common stock and preferred stock warrants
     37,075,846        38,193,342  
    
 
 
    
 
 
 
Total potentially dilutive common share equivalents
  
 
67,706,176
    
 
270,229,995
 
    
 
 
    
 
 
 
16.
Basic and Diluted Net Loss per Share
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended January 31, 2021, 2020, and 2019:
 
(in thousands, except share and per share data)   
Year Ended January 31,
 
    
2021
   
2020
   
2019
 
Numerator:
                        
Net loss attributable to common stockholders
   $ (274,200   $ (134,327   $ (108,087
Denominator:
                        
Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted
     15,116,763       8,893,787       4,342,517  
    
 
 
   
 
 
   
 
 
 
Net loss per share attributable to common stockholders, basic and diluted
  
$
(18.14
 
$
(15.10
 
$
(24.89
    
 
 
   
 
 
   
 
 
 
The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
Redeemable convertible preferred stock (on an
as-converted
basis)
     193,037,715        170,686,661        168,052,012  
Options to purchase common stock
     30,167,178        34,883,465        31,662,022  
Unvested restricted common stock
     —          166,100        564,740  
Unvested early exercised common stock options
     371,193        58,830        58,971  
Redeemable convertible preferred stock warrants
(on an as-converted
basis)
     2,358,546        2,358,546        2,358,546  
Common stock warrants
     36,402,515        14,051,462        13,173,245  
    
 
 
    
 
 
    
 
 
 
Total potentially dilutive common share equivalents
  
 
262,337,147
 
  
 
222,205,064
 
  
 
215,869,536
 
    
 
 
    
 
 
    
 
 
 
XML 46 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Employee Benefit Plans
12 Months Ended
Jan. 31, 2021
Retirement Benefits [Abstract]  
Employee Benefit Plans
17.
Employee Benefit Plans
The Company has a defined-contribution plan intended to qualify under Section 401 of the Internal Revenue Code (the “401(k) Plan”). The Company contracted with a third-party provider to act as a custodian and trustee, and to process and maintain the records of participant data. Substantially all of the expenses incurred for administering the 401(k) Plan are paid by the Company. The Company has not made any matching contributions to date.
XML 47 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Acquisitions and Subsequent Events
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Subsequent Events [Abstract]    
Subsequent Events
14. Acquisitions
 
and Subsequent Events
On July 20, 2021, the Company entered into a definitive agreement to acquire all of the outstanding shares of has•to•be gmbh (“has•to•be” or “HTB”) for approximately
 
Euro 250.0 million
in cash and Company common stock subject to adjustments.
has•to•be
 
is an Austria-based
e-mobility
provider with a European charging software platform. The acquisition is intended to expand the Company’s access to the European market. The Company currently expects the transaction to close as early as October 2021.
On August 11, 2021, the Company acquired all of the outstanding shares of ViriCiti B.V. (“ViriCiti”) for approximately
 
Euro
75.0
 million in cash,

subject to adjustments. ViriCiti is a Netherlands-based provider of electrification solutions for eBus and commercial fleets with offices in the Netherlands and the United States. The acquisition is expected to enhance ChargePoint’s fleet solutions portfolio of hardware, software and services by integrating information sources to optimize electric fleet operations.
As permitted by ASU
805-10-50,
the Company is not able to include certain required disclosures in its quarterly report on Form
10-Q
for the three and six months ended July 31, 2021, because the information necessary to complete the preliminary purchase price allocation related to the acquisition was not yet available.
18.
Subsequent Events
On February 26, 2021 (the “Closing Date”), the Company consummated the Merger (the “Closing”) with Switchback Energy Acquisition Corporation (“Switchback”), where a subsidiary of Switchback merged with the Company, with the Company surviving the Merger as a wholly-owned subsidiary of Switchback. As a result of the proposed Merger, Switchback will be renamed to ChargePoint Holdings, Inc. (“New ChargePoint”).
Pursuant to the terms of the Merger Agreement, each stockholder of the Company shall receive 0.9966 shares of New ChargePoint’s common stock and the contingent right to receive certain Earnout Shares (as defined below), for each share of the Company’s common stock, par value $0.0001 per share, owned by such the Company’s stockholder that was outstanding immediately prior to the Closing (other than any shares of the
Company’s restricted stock). In addition, certain investors purchased an aggregate of 22,500,000 shares of New ChargePoint’s common stock (such investors, the “PIPE Investors”) concurrently with the Closing for an aggregate purchase price of $225 million.
Pursuant to a letter agreement (the “Founders Stock Letter”) entered into in connection with the execution of the Merger, immediately prior to the Closing, the initial stockholders (i) surrendered to New ChargePoint, for no consideration and as a capital contribution to New ChargePoint, 984,706 Class B common stock, par value $0.0001 per share (“Founder Shares”), held by them (on a pro rata basis), whereupon such shares were immediately canceled, and (ii) subjected 900,000 Founder Shares (including New ChargePoint’s common stock issued in exchange therefor in the Merger) held by them to potential forfeiture in accordance with the terms of the Founders Stock Letter. Upon the Closing, all outstanding Founder Shares converted into Common Stock on a
one-for-one
basis and the Founder Shares ceased to exist.
Also at the Closing, the NGP Switchback, LLC (the “Sponsor”) exercised its right to convert a portion of the working capital loans made by the Sponsor to Switchback into an additional 1,000,000 Private Warrants at a price of $1.50 per warrant in satisfaction of $1.5 million principal amount of such loans.
In addition, pursuant to the terms of the Merger Agreement, (1) warrants to purchase shares of capital stock of the Company were converted into warrants to purchase an aggregate of 38,761,031 shares of New ChargePoint’s common stock and the contingent right to receive certain Earnout Shares, (2) options to purchase shares of common stock of the Company were converted into options to purchase an aggregate of 30,135,695 shares of New ChargePoint’s common stock and, with respect to vested options, the contingent right to receive certain Earnout Shares and (3) unvested restricted shares of common stock of the Company that were outstanding pursuant to the “early exercise” of New ChargePoint options were converted into an aggregate of 345,689 restricted shares of New ChargePoint.
During the time period between the Closing Date and the five-year anniversary of the Closing Date, eligible former equity holders of the Company may receive up to 27 million additional shares of New ChargePoint’s common stock (the “Earnout Shares”) in the aggregate in three equal tranches of 9,000,000 shares if the volume-weighted average closing sale price of our Common Stock is greater than or equal to $15.00, $20.00 and $30.00 for any 10 trading days within any 20 consecutive trading day period (each a “Trigger Event”). At close of the Merger on February 26, 2021, the Company recorded a liability (“Earnout Liability”) of $828.1 million, based on the estimated fair value of the 27 million Earnout Shares with a corresponding reduction of additional
paid-in
capital in the equity section of the Company’s consolidated balance sheet. On March 19, 2021, as a result of the first two Trigger Events having been met, two of the three tranches for a total of 18 million Earnout Shares were issued with the related Earnout Liability being remeasured and partially settled by issuing the Earnout Shares at a closing market price of $27.84 per share as of that date. The remaining Earnout Liability related to the 9 million Earnout Shares of the third tranche was remeasured and reclassified to equity because the contingency of issuing a variable number of shares under the three tranches of the Earnout Liability was resolved such that the remaining third tranche provides for the issuance of a fixed number of shares of 9,000,000 if the last Earnout Triggering Event is achieved. The combined impact from the remeasurement of the Earnout Liability resulted in a $84.4 million gain recognized as change of fair value in Earnout Liability in the consolidated statement of operations and an increase in additional
paid-in
capital of $743.7 million in the equity section of the Company’s consolidated balance sheet for the period ending April 30, 2021.
On March 15, 2021, the Company repaid the entire loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million of its term loan facility (“2018 Loan”).
Events Subsequent to Original Issuance of Consolidated Financial Statements (unaudited)
On June 4, 2021, the Company issued a notice of the redemption of all of its outstanding Public Warrants
that remain outstanding on July 6, 2021 for a redemption price of $0.01 per warrant. The Private Placement
Warrants that are still held by the initial holders thereof or their permitted transferees are not subject to the
redemption.
On June 29, 2021 the third Earnout Triggering Event occurred and the third and final tranche of 9,000,000 Earnout Shares became issuable.
XML 48 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Accounting Policies [Abstract]    
Common Stock Warrants Liabilities
Common Stock Warrants Liabilities
The Company assumed 10,470,562 publicly-traded warrants (“Public Warrants”) and 6,521,568 private placement warrants issued to NGP Switchback, LLC (“Private Placement Warrants” and, together with the
Public Warrants, the “Common Stock Warrants”) upon the Merger, all of which were issued in
connection
with
Switch
back’s initial public offering and subsequent overallotment (other than 1,000,000 Private Placement Warrants
which
were issued in connection with the closing of the Merger) and entitle the holder to purchase one share of the Company’s Common stock, par value $0.0001 (“Common Stock”) at an exercise price of $11.50 per share. During the six months ended July 31, 2021, 10,226,081 Public Warrants and 4,347,712
 
Private Placement Warrants were exercised and the remaining 244,481 Public Warrants outstanding as of the July 6, 2021 redemption date were redeemed for cash. The Public Warrants, prior to their redemption, were publicly traded and were exercisable for cash unless certain conditions occurred, such as the failure to have an effective registration statement related to the shares issuable upon exercise or redemption by the Company under certain conditions, at which time the warrants could be cashlessly exercised. The Private Placement Warrants are not redeemable for cash so long as they are held by the initial purchasers or their permitted transferees but may be redeemable for common stock if certain other conditions are met. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
The Company evaluated the Common Stock Warrants and concluded
that t
hey do not meet the criteria to be classified within stockholders’ equity. The agreement governing the Common Stock Warrants includes a provision (“Replacement of Securities Upon Reorganization”), the application of which could result in a different settlement value for the Common Stock Warrants depending on their holder. Because the holder of an instrument is not an input into the pricing of a
fixed-for-fixed
option on the Company’s ordinary shares, the Private Placement Warrants are not considered to be “indexed to the Company’s own stock.” In addition, the provision provides that in the event of a tender or exchange offer accepted by holders of more than 50% of the outstanding shares of the Company’s ordinary shares, all holders of the Common Stock Warrants (both the Public Warrants and the Private Placement Warrants) would be entitled to receive cash for all of their Common Stock Warrants. Specifically, in the event of a qualifying cash tender offer (which could be outside of the Company’s control), all Common Stock Warrant holders would be entitled to cash, while only certain of the holders of the Company’s ordinary shares may be entitled to cash. These provisions preclude the Company from classifying the Common Stock Warrants in stockholders’ equity. As the Common Stock Warrants meet the definition of a derivative, the Company recorded these warrants as liabilities on the consolidated balance sheet at fair value, with subsequent changes in their respective fair values recognized in the condensed consolidated statements of operations and comprehensive loss at each reporting date.
 
Contingent Earnout Liability
Contingent Earnout
 
Liability
In connection with the Reverse Recapitalization and pursuant to the Merger Agreement and Plan of Merger dated as of September 23, 2020 by and among the Company, Lightning Merger Sub Inc., and Switchback (“Merger Agreement”), eligible ChargePoint equity holders were entitled to receive as additional merger consideration shares of the Comp
a
ny’s Common Stock upon the Company achieving certain Earnout Triggering Events (as described in the Merger Agreement and Note 9). In accordance with ASC
815-40,
the earnout shares were not indexed to the Common Stock and therefore were accounted for as a liability at the Reverse Recapitalization date and subsequently remeasured at each reporting date with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statements of operations.
The estimated fair value of the contingent consideration was determined using a Monte Carlo simulation using a distribution of potential outcomes on a monthly basis over the Earnout Period (as defined in Note 9) prioritizing the most reliable information available. The assumptions utilized in the calculation were based on the achievement of certain stock price milestones, including the current Company Common Stock price, expected volatility, risk-free rate, expected term and dividend rate.
Until its settlement the contingent earnout liability was categorized as a Level 3 fair val
ue measurem
ent (see Fair Value of Financial Instruments accounting policy as described above) because the Company estimated projections during the Earnout Period utilizing unobservable inputs. Contingent earnout payments involve certain assumptions requiring significant judgment and actual results can differ from assumed and estimated amounts.
 
Use of Estimates
Use of Estimates
The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for doubtful accounts, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of redeemable convertible preferred stock warrants and common stock warrants, including Common Stock Warrants as a result of the Merger, contingent earnout liability, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Use of Estimates
The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for doubtful accounts, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of redeemable convertible preferred stock warrants and common stock warrants, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic
environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Concentration of Credit Risk and Other Risks and Uncertainties
Concentration of Credit Risk and Other Risks and Uncertainties
Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts with large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. 
Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.
Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of July 31, 2021 and January 31, 2021, one customer individually accounted for 9% and 16% of accounts receivable, net, respectively. For the six months ended July 31, 2021 and 2020, there were no customers that represented 10% or more of total revenue.
The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s operating results.
Concentration of Credit Risk and Other Risks and
Uncertainties
Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts with large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. Short-term investments consist of U.S. treasury bills that carry high-credit ratings and accordingly, minimal credit risk exists with respect to these balances.
Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.
Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of January 31, 2021, one customer individually accounted for 16% of accounts receivable, net. As of January 31, 2020, there were no customers that accounted for 10% or more of accounts receivable, net. For the years ended January 31, 2021, 2020, and 2019 there were no customers that represented 10% or more of total revenue.
The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s operating results.
In December 2019,
COVID-19
was first reported to the World Health Organization (“WHO”), and in January 2020, the WHO declared the outbreak to be a public health emergency. In March 2020, the WHO characterized
COVID-19
as a pandemic. Since then, the
COVID-19
pandemic and efforts to control its spread have significantly curtailed the movement of people, goods, and services worldwide. As a result, the Company has temporarily closed its headquarters and most of its other offices, enabled its employees and contractors to work remotely, implemented travel restrictions, implemented cost cutting measures, and shifted Company events and meetings to virtual-only experiences, all of which may continue for an indefinite amount of time and represent a significant disruption in how it operates its business. The operations of the Company’s partners, vendors, and customers have likewise been disrupted.
While the duration and extent of the
COVID-19
pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment and mitigation actions, it has already had an adverse effect on the global economy, and the ultimate societal and economic impact of the
COVID-19
pandemic remains unknown. In particular, the conditions caused by this pandemic may affect the rate of global infrastructure spending, which could adversely affect demand for the Company’s platform. Further, the
COVID-19
pandemic has caused the Company to experience, in some cases, longer sales cycles and an increase in certain prospective and current customers seeking lower prices or other more favorable contract terms, and has limited the ability of its direct sales force to travel to customers and potential customers. In addition, the
COVID-19
pandemic could reduce the value or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from the Company’s paying customers, cause some of its paying customers to go out of business, and affect contraction or attrition rates of its paying customers, all of which could adversely affect the Company’s business, results of operations, and financial condition. Additionally, concerns over the economic impact of
COVID-19
have caused extreme volatility in financial and other capital markets, which may adversely affect the Company’s ability to access capital markets in the future.
While the Company has developed and continues to develop plans to help mitigate the potential negative impact of
COVID-19,
these efforts may not be effective, and any protracted economic downturn will likely limit the
effectiveness of its efforts. Accordingly, it is not possible for the Company to predict the duration and ultimate extent to which this will affect its business, future results of operations, and financial condition at this time.
Impact of COVID-19
Impact of
COVID-19
In March 2020, the World Health Organization characterized
COVID-19
as a pandemic. The impact of
COVID-19,
including changes in consumer and business behavior, pandemic fears and market downturns, and restrictions on business and individual activities, has created significant volatility in the global economy and led to reduced economic activity. The spread of
COVID-19
has disrupted ChargePoint’s supply chain and heightened its freight and logistic costs, and has similarly disrupted manufacturing, delivery and overall supply chain of vehicle manufacturers and suppliers, which has led to fluctuations in EV sales around the world.
As a result of the
COVID-19
pandemic, ChargePoint initially modified its business practices (including reducing employee travel, recommending that all
non-essential
personnel work from home and cancelling or reducing physical participation in sales activities, meetings, events and conferences), implemented additional safety protocols for essential workers, and implemented temporary cost cutting measures in order to reduce its operating costs. The Company may take further actions as may be required by government authorities or that it determines are in the best interests of its employees, customers, suppliers, vendors and business partners.While the ultimate duration and extent of the
COVID-19
pandemic depends on current and future developments that cannot be accurately predicted, such as the extent and effectiveness of containment actions and vaccinations, it has already had an adverse effect on the global economy, the ultimate societal and economic impact of the
COVID-19
pandemic remains unknown. The effect of the COVID-19 pandemic can also vary over time and across the geographies in which ChargePoint operates. For example, variations in work-from-home policies can cause fluctuations in ChargePoint’s revenues, and the Company believes that since people are not yet fully back to work it has not yet seen the full return of commercial customer demand for its products. The conditions caused by the COVID-19 pandemic, such as more permanent work-from-home policies, are likely to continue affecting the rate of global infrastructure spending, and thus to continue to adversely impact ChargePoint’s gross margins as the Company’s commercial business contributes higher margins than its residential and fleet businesses. Further, the COVID-19 pandemic could continue to heighten supply chain pricing and logistics expenses, and could, for example, adversely impact ChargePoint’s gross margins through heightened supply chain expenses, and could adversely affect demand for ChargePoint’s platforms, lengthen its sales cycles, reduce the value, renewal rate or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from new customers, cause some of its paying customers to go out of business and limit the ability of its direct sales force to travel to customers and potential customers, all of which could adversely affect its business, results of operations and financial condition
.
 
Segment Reporting
Segment Reporting
The Company operates as one operating segment because its
 
Chief Executive Officer, as the Company’s chief operating decision maker reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance.
Segment Reporting
Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company operates as one operating segment because its CODM, who is its Chief Executive Officer, reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance. The Company has no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels of components below the consolidated unit level.
Cash, Cash Equivalents, and Restricted Cash  
Cash, Cash Equivalents, and Restricted Cash
The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. Cash equivalents may be invested in money market funds. Cash and cash equivalents are carried at cost, which approximates their fair value.
Restricted cash of $0.4 million as of January 31, 2021 and 2020 and $0.5 million as of January 31, 2019 relates to cash deposits restricted under letters of credit issued in support of customer agreements.
The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated statements of cash flows were as follows:
 
    
January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Cash and cash equivalents
   $ 145,491      $ 72,753      $ 205,238  
Restricted cash
     400        400        460  
  
 
 
    
 
 
    
 
 
 
Total cash, cash equivalents, and restricted cash
  
$
145,891
 
  
$
73,153
 
  
$
205,698
 
  
 
 
    
 
 
    
 
 
 
Short-term Investments  
Short-term Investments
The Company considers investments with original maturities greater than three months and remaining maturities less than one year to be short-term investments. The Company’s short-term investments consist of U.S. treasury bills and are classified as available for sale and reported at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For short-term investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of short-term investments are recorded in other income (expense), net in the consolidated statements of operations.
Other-than-temporary Impairment
The Company evaluates its short-term investments with unrealized losses for other-than-temporary impairment. When assessing short-term investments for other-than-temporary declines in value, the Company considers factors such as, among other things, the extent and length of time the investment’s fair value has been lower than its cost basis, the financial condition and near-term prospects of the investee, the Company’s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value, and the expected cash flows from the security. If any adjustment to fair value reflects a decline in the value of the investment that the Company considers to be “other than temporary,” the Company reduces the investment to fair value through a charge to the consolidated statements of operations and consolidated statements of comprehensive loss. No such adjustments were necessary during the periods presented.
Accounts Receivable, net  
Accounts Receivable, net
Accounts receivable are recorded at the invoiced amount and are
non-interest
bearing. The Company performs ongoing credit evaluations of its customers and maintains an allowance for doubtful accounts to ensure trade receivables are not overstated due to uncollectibility. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results, or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables are further adjusted. The Company also considers broader factors in evaluating the sufficiency of its allowances for doubtful accounts, including the length of time receivables are past due, macroeconomic conditions, significant
one-time
events, and historical experience. When the Company determines that there are accounts receivable that are uncollectible, they are written off against the allowance for doubtful accounts. The change in the allowance for doubtful accounts for the years ended January 31, 2021, 2020, and 2019 was as follows:
 
    
Beginning
Balance
    
Additions
Charged To
Expense
    
Write-offs
    
Ending
Balance
 
    
(in thousands)
 
Year ended January 31, 2021
           
Allowance for doubtful accounts
   $ 2,000      $ 121      $ (121    $ 2,000  
Year ended January 31, 2020
           
Allowance for doubtful accounts
   $ 3,124      $ 339      $ (1,463    $ 2,000  
Year ended January 31, 2019
           
Allowance for doubtful accounts
   $ 1,316      $ 1,812      $ (4    $ 3,124  
Inventories  
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost, on a
first-in,
first-out
basis. Inventory levels are analyzed periodically and written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value or are in excess of expected demand. The Company analyzes current and future product demand relative to the remaining product life to identify potential excess inventories. The write-down is measured as the difference between the cost of the inventories and net realizable value and charged to inventory reserves, which is a component of cost of revenue. At the point of the loss recognition, a new, lower cost basis for those inventories is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
Property and Equipment, net  
Property and Equipment, net
Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets, as follows:
 
    
Useful Lives
Furniture and fixtures
   3 to 5 years
Computers and software
   3 to 5 years
Machinery and equipment
   3 to 5 years
Tooling
   3 to 5 years
Leasehold improvements
   Shorter of the estimated
lease term or useful life
Owned and operated systems
   5 to 7 years
Leasehold improvements are amortized over the shorter of estimated useful lives of the assets or the lease term. Expenditures for repairs and maintenance are charged to expense as incurred. Upon disposition, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is reflected in the consolidated statements of operations.
ChargePoint-as-a-Service
(“CPaaS”) combines the customer’s use of the Company’s owned and operated systems with Cloud subscription software (“Cloud”) and the Company’s Assure program (“Assure”) into a single subscription. When CPaaS contracts contain a lease, the underlying asset is carried at its carrying value within property and equipment, net on the consolidated balance sheets.
Internal-Use Software Development Costs  
Internal-Use
Software Development Costs
The Company capitalizes qualifying
internal-use
software development costs incurred during the application development stage for internal tools and cloud-based applications used to deliver its services, provided that management with the relevant authority authorizes and commits to the funding of the project, it is probable the project will be completed, and the software will be used to perform the function intended. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Capitalized
internal-use
software development costs are included in property and equipment and are amortized on a straight- line basis over their estimated useful lives once it is ready for its intended use. Amortization of capitalized
internal-use
software development costs is included within cost of revenue for networked charging systems and subscriptions, research and development expense, sales and marketing expense, and general and administrative expense based on the use of the software. Costs incurred for enhancements that are expected to result in additional material functionality are capitalized. As of January 31, 2021 and 2020, capitalized costs have not been material.
Leases  
Leases
On February 1, 2019, the Company early adopted the requirements of Accounting Standards Update (“ASU”)
2016-02,
Leases (Topic 842) (“ASC 842”), using the modified retrospective approach with no adjustment to comparative periods.
Lessee
The Company determines if a contract is a lease or contains a lease at the inception of the contract and reassesses that conclusion if the contract is modified. All leases are assessed for classification as an operating lease or a finance lease. Operating lease
right-of-use
(“ROU”) assets are presented separately on the Company’s consolidated balance sheets. Operating lease liabilities are separated into a current portion, included within accrued and other current liabilities on the Company’s consolidated balance sheets, and a noncurrent portion included within operating lease liabilities on the Company’s consolidated balance sheets. The Company does not have material finance leases. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. The Company does not obtain and control its right to use the asset until the lease commencement date.
The Company’s lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s ROU assets are also recognized at the applicable lease commencement date. The ROU asset equals the carrying amount of the related lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable ROU asset or lease liability.
The term of the Company’s leases equals the
non-cancellable
period of the lease, including any rent-free periods provided by the lessor, and also includes options to renew or extend the lease (including by not terminating the lease) that the Company is reasonably certain to exercise. The Company establishes the term of each lease at lease commencement and reassesses that term in subsequent periods when one of the triggering events outlined in ASC 842 occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term.
The Company’s lease contracts often include lease and
non-lease
components. The Company has elected the practical expedient offered by the standard to not separate the lease from
non-lease
components and accounts for them as a single lease component.
The Company elected the package of practical expedients permitted under the transition guidance, which allows the Company to carry forward its historical lease classification, its assessment on whether a contract is or contains a lease, and its initial direct costs for any leases that existed prior to adoption of the new standard. The Company has elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.
Lessor
The Company leases networked charging systems to customers within certain CPaaS contracts. The leasing arrangements the Company enters into with lessees are operating leases, and as a result, the underlying asset is carried at its carrying value as owned and operated systems within property and equipment, net on the consolidated balance sheets. Adoption of ASC 842 did not have a material impact on the Company’s accounting as a lessor.
Impairment of Long-Lived Assets  
Impairment of Long-Lived Assets
The Company evaluates long-lived assets or asset groups for impairment whenever events indicate that the carrying amount of an asset or asset group may not be recoverable based on expected future cash flows attributable to that asset or asset group. Recoverability of assets held and used is measured by comparison of the carrying amounts of an asset or an asset group to the estimated future undiscounted cash flows which the asset or asset group is expected to generate. If the carrying amount of an asset or asset group exceeds estimated undiscounted future cash flows, then an impairment charge would be recognized based on the excess of the carrying amount of the asset or asset group over its fair value. Assets to be disposed of are reported at the lower of their carrying amount or fair value less costs to sell. There were no impairments of long-lived assets for the years ended January 31, 2021, 2020, and 2019.
Business Combinations  
Business Combinations
The total purchase consideration for an acquisition is measured as the fair value of the assets transferred, equity instruments issued, and liabilities assumed at the acquisition date. Costs that are directly attributable to the acquisition are expensed as incurred and included in general and administrative expense in the Company’s consolidated statements of operations. Identifiable assets (including intangible assets), liabilities assumed (including contingent liabilities), and noncontrolling interests in an acquisition are measured initially at their fair values at the acquisition date. The Company recognizes goodwill if the fair value of the total purchase consideration and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, cost of capital, future cash flows, and discount rates. The Company’s estimates of fair value are based on assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. The Company includes the results of operations of the acquired business in the consolidated financial statements beginning on the acquisition date.
Goodwill  
Goodwill
Goodwill represents the excess of the purchase price of an acquired busines
s over
the fair value of the net tangible and identifiable intangible assets acquired. The carrying amount of goodwill is reviewed for impairment
at least annually, in the second quarter, or whenever events or changes in circumstances
indicate
that the carrying value may not be recoverable. As of January 31, 2021 and 2020, the Company had a single operating segment and reporting unit structure. As part of the annual goodwill impairment test performed in the second quarter, the Company first performs a qualitative assessment to determine whether further impairment testing is necessary. If, as a result of the qualitative assessment, it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the quantitative impairment test will be required. If the Company has determined it necessary to perform a quantitative impairment assessment, the Company will compare the fair value of the reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the total amount of goodwill of the reporting unit. The carrying value of goodwill was $1.2 million as of January 31, 2021 and 2020, and no goodwill impairment has been recognized to date.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value:
 
 
(Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
 
 
 
(Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and
 
 
(Level 3) — Inputs that are unobservable for the asset or liability.
The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material
non-financial assets
valued on a
non-recurring basis
that resulted in an impairment in any period presented.
The carrying values of the Company’s cash eq
uivalents, account
s receivable,
net
, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments.
Fair Value of Financial Instruments
Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value:
 
   
(Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
 
   
(Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and
 
   
(Level 3) — Inputs that are unobservable for the asset or liability.
The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material
non-financial
assets valued on a
non-recurring
basis that resulted in an impairment in any period presented.
The carrying values of the Company’s cash equivalents, short-term investments, accounts receivable, net, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments.
Redeemable Convertible Preferred Stock Warrants  
Redeemable Convertible Preferred Stock Warrants
Warrants to purchase shares of the Company’s Series B, D, and E redeemable convertible preferred stock are classified as liabilities as the underlying redeemable convertible preferred stock is considered redeemable and may require the Company to transfer assets upon exercise. Redeemable convertible preferred stock warrants are recorded within noncurrent liabilities on the consolidated balance sheets. The warrants were recorded at fair value upon issuance and are subject to remeasurement to fair value at each balance sheet date. Changes in fair value of the redeemable convertible preferred stock warrant liability are recorded in the consolidated statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the warrants, conversion of redeemable convertible preferred stock into common stock, or until the redeemable convertible preferred stock is otherwise no longer redeemable. At that time, the redeemable convertible preferred stock warrant liability will be reclassified to redeemable convertible preferred stock or additional
paid-in
capital, as applicable.
Common Stock Warrants  
Common Stock Warrants
Warrants to purchase shares of the Company’s common stock are equity classified and recognized within additional
paid-in
capital with no subsequent remeasurement. The amount recognized within additional
paid-in
capital is determined by allocating proceeds received and issuance costs incurred between the instruments issued based on their relative fair value.
Revenue Recognition  
Revenue Recognition
On February 1, 2019, the Company early adopted ASU
No. 2014-09.
Revenue from Contracts with Customers (Topic 606), as amended (“ASC 606”), using the modified retrospective method applied to contracts which were not completed as of that date. During the fiscal years ended January 31, 2021 and January 31, 2020, the Company recognized revenue using the following five-step model as prescribed by ASC 606:
 
   
Identification of the contract, or contracts, with a customer;
 
   
Identification of the performance obligations in the contract;
 
   
Determination of the transaction price;
 
   
Allocation of the transaction price to the performance obligations in the contract; and
 
   
Recognition of revenue when, or as, the Company satisfies a performance obligation.
Significant judgment and estimates are necessary for the allocation of the proceeds received from an arrangement to the multiple performance obligations and the appropriate timing of revenue recognition. The Company enters into contracts with customers that regularly include promises to transfer multiple products and services, such as charging systems, software subscriptions, extended maintenance, and professional services. For arrangements with multiple products or services, the Company evaluates whether the individual products or services qualify as distinct performance obligations. In its assessment of whether products or services are a distinct performance obligation, the Company determines whether the customer can benefit from the product or service on its own or with other readily available resources and whether the service is separately identifiable from other products or services in the contract. This evaluation requires the Company to assess the nature of each of its networked charging systems, subscriptions, and other offerings and how each is provided in the context of the contract, including whether they are significantly integrated which may require judgment based on the facts and circumstances of the contract.
The transaction price for each contract is determined based on the amount the Company expects to be entitled to receive in exchange for transferring the promised products or services to the customer. Collectability of revenue is reasonably assured based on historical evidence of collectability of fees the Company charges its customers. The transaction price in the contract is allocated to each distinct performance obligation in an amount that represents the relative amount of consideration expected to be received in exchange for satisfying each performance obligation. Revenue is recognized when performance obligations are satisfied. Revenue is recorded based on the transaction price excluding amounts collected on behalf of third-parties such as sales taxes, which are collected on behalf of and remitted to governmental authorities, or driver fees, collected on behalf of customers who offer public charging for a fee.
When agreements involve multiple distinct performance obligations, the Company accounts for individual performance obligations separately if they are distinct. The Company applies significant judgment in identifying and accounting for each performance obligation, as a result of evaluating terms and conditions in contracts. The transaction price is allocated to the separate performance obligations on a relative standalone selling price (“SSP”) basis. The Company determines SSP based on observable standalone selling price when it is available, as well as other factors, including the price charged to its customers, its discounting practices, and its overall pricing objectives, while maximizing observable inputs. In situations where pricing is highly variable, or a product is never sold on a stand-alone basis, the Company estimates the SSP using the residual approach.
The Company usually bills its customers at the onset of the arrangement for both the products and a predetermined period of time for services. Contracts for services typically range from annual to multi-year agreements with typical payment terms of 30 to 90 days.
Networked charging systems revenue
Networked charging systems revenue includes revenue related to the deliveries of EV charging system infrastructure. The Company recognizes revenue from sales of networked charging systems upon shipment to the customer, which is when the performance obligation has been satisfied.
Subscriptions revenue
Subscriptions revenue consists of services related to Cloud, as well as extended maintenance service plans under Assure. Subscriptions revenue also consists of CPaaS revenue, which combines the customer’s use of the Company’s owned and operated systems with Cloud and Assure programs into a single subscription. CPaaS subscriptions contain a lease for the customer’s use of the Company’s owned and operated systems unless the location allows the Company to receive incremental economic benefit from regulatory credits earned on that owned and operated system. Lessor revenue relates to operating leases and historically has not been material. Subscriptions revenue is recognized over time on a straight-line basis as the Company has a stand-ready obligation to deliver such services to the customer.
Other revenue
Other revenue consists of fees received for transferring regulatory credits earned for participating in low carbon fuel programs in approved states, charging related fees received from drivers using charging sites owned and operated by the Company, net transaction fees earned for processing payments collected on driver charging sessions at charging sites owned by ChargePoint customers, and other professional services. Revenue from regulatory credits is recognized at the point in time the regulatory credits are transferred. Revenue from fees for owned and operated sites is recognized over time on a straight-line basis over the performance period of the service contract as the Company has a stand-ready obligation to deliver such services. Revenue from driver charging sessions and charging transaction fees is recognized at the point in time the charging session or transaction is completed. Revenue from professional services is recognized as the services are rendered.
Revenue Recognition (ASC 605)
During the fiscal year ended January 31, 2019, the Company recognized revenue under ASC Topic 605, Revenue Recognition (“ASC 605”) when persuasive evidence of an arrangement existed, delivery had occurred, the fee was fixed or determinable, and collectability was probable. Revenue for this period was generally recognized net of allowances for returns and any taxes collected from customers and subsequently remitted to governmental authorities.
When a sales arrangement contained multiple elements, the Company first determined whether the delivered items qualify as separate units of accounting. A delivered item qualified as a separate unit of accounting when it had value to the customer on a standalone basis and when an arrangement included a general right of return relative to the delivered item, delivery, or performance of any undelivered items was considered probable or substantially in control of the Company. The Company then allocated revenue to each separate unit of accounting based on the relative selling price method and using the established selling price hierarchy. The selling price for a unit of accounting was based on its vendor specific objective evidence (“VSOE”), if available, third-party evidence (“TPE”) if VSOE was not available, or best estimate of selling price (“ESP”) if neither VSOE nor TPE was available. The Company generally utilized ESP.
The objective of ESP was to determine the price at which the Company would transact a sale if the product or service were sold on a standalone basis. ESP was generally used for new or highly customized offerings and solutions or offerings not priced within a narrow range, and it applied to a large proportion of the Company’s arrangements with multiple deliverables.
The process for determining ESP requires judgment and considers multiple factors that may vary over time depending upon the unique facts and circumstances related to each deliverable.
Lessor Revenue
The leasing arrangements the Company enters into with lessees are operating leases. The Company recognizes operating lease revenue on a straight-line basis over the lease term and expenses deferred initial direct costs on the same basis.
Operating lease revenue is classified as subscriptions revenue in the Company’s consolidated statements of operations. Operating lease revenue and the future maturities of lease payments from lessees was not material to the consolidated financial statements for all periods presented.
Remaining Performance Obligations
Remaining Performance Obligations
Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and
non-cancellable contracted
amounts that will be invoiced and recognized as revenue in future periods. The Company’s Assure, Cloud, and CPaaS subscription terms typically range from one to five years
 
and are paid up-front
. Revenue expected to be recognized from remaining performance obligations was $118.2 million as of July 31, 2021, of which 42 % is expected to be recognized over the next twelve months
.
Remaining Performance Obligations
Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and
non-cancelable
contracted amounts that will be invoiced and recognized as revenue in future periods. The Company’s Assure, Cloud, and CPaaS subscription terms typically range from one to five years. Revenue expected to be recognized from remaining performance obligations was $101.8 million as of January 31, 2021, of which 43% is expected to be recognized over the next twelve months and the remainder thereafter.
Deferred Revenue
Deferred Revenue
Deferred revenue represents billings or payments received in advance of revenue recognition and is recognized in revenue upon transfer of control. Balances consist primarily of Cloud Services and Assure services not yet provided as of the balance sheet date. Contract assets, which represent services provided or products transferred to customers in advance of the date the Company has a right to invoice, are netted against deferred revenue on a
customer-by-customer basis.
Deferred revenue that will be recognized during the succeeding
twelve-month
period is recorded as current deferred revenue with the remainder recorded as deferred revenue,
non-current
on the condensed consolidated balance sheets.
Total current and non-current deferred revenue was
$105.8 million and $89.8 
million as of July 31, 2021 and January 31, 2021, respectively. The Company recognized $7.7 million and $4.6 million of revenue during the three months ended July 31, 2021 and July 31, 2020, and
$22.9 million and $21.0 
million of revenue during the six months ended July 31, 2021 and July 31, 2020, respectively, that was included in the deferred revenue balance
at the beginning of the period.
Deferred Revenue
Deferred revenue represents billings or payments received in advance of revenue recognition and is recognized in revenue upon transfer of control. Balances consist primarily of software subscription services and extended Assure maintenance services not yet provided as of the balance sheet date. Contract assets, which represent services provided or products transferred to customers in advance of the date the Company has a right to invoice, are netted against deferred revenue on a
customer-by-customer
basis. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as deferred revenue with the remainder recorded as deferred revenue, noncurrent on the consolidated balance sheets. Total deferred revenue was $89.8 million and $72.7 million as of January 31, 2021 and 2020, respectively. The Company recognized $39.4 million, $25.5 million, and $16.0 million of revenue during the years ended January 31, 2021, 2020, and 2019, respectively, that was included in the deferred revenue balance at the beginning of the respective period.
Cost of Revenue  
Cost of Revenue
Cost of networked charging systems revenue includes the material costs for parts and manufacturing costs for the hardware products, compensation, including salaries and related personnel expenses, including stock-based compensation, warranty provisions, depreciation of manufacturing related equipment and facilities, amortization of capitalized
internal-use
software development costs, and allocated overhead costs. Costs for shipping and handling are recorded in cost of revenue as incurred.
Cost of subscriptions revenue includes network and wireless connectivity costs for subscription services, field maintenance costs for Assure to support the Company’s network of systems, depreciation of owned and operated systems used in CPaaS arrangements, amortization of capitalized
internal-use
software development costs, allocated overhead costs, and support costs to manage the systems and helpdesk services for drivers and site hosts.
Costs to Obtain a Customer Contract  
Costs to Obtain a Customer Contract
Sales commissions are considered incremental and recoverable costs of acquiring customer contracts. Beginning at the Company’s adoption of ASC 606 on February 1, 2019, incremental and recoverable costs for the sale of cloud enabled software and extended maintenance service plans are capitalized as deferred contract acquisition costs within prepaid expenses and other current assets and other assets on the consolidated balance sheets and amortized on a straight-line basis over the anticipated benefit period of five years. The benefit period was estimated by taking into consideration the length of customer contracts, renewals, technology lifecycle, and other factors. This amortization is recorded within sales and marketing expense in the Company’s consolidated statements of operations. The sales commissions paid related to the sale of networked charging systems are expensed as incurred.
The Company elected the practical expedient that permits the Company to apply ASC Subtopic
340-40,
“Other Assets and Deferred Costs- Contracts with Customers,” (“ASC 340”) to a portfolio containing multiple contracts, as they are similar in their characteristics, and the financial statement effects of applying ASC Subtopic
340-40
to that portfolio would not differ materially from applying it to the individual contracts within that portfolio.
Changes in the deferred contract acquisition costs during the years ended January 31, 2021 and 2020 were as follows:
 
   
(in thousands)
 
Balance upon adoption of ASC 340 on February 1, 2019
  $ 2,189  
Capitalization of deferred contract acquisition costs
    2,318  
Amortization of deferred contract acquisition costs
    (675
 
 
 
 
Balance as of January 31, 2020
 
$
3,832
 
 
 
 
 
Capitalization of deferred contract acquisition costs
    2,908  
Amortization of deferred contract acquisition costs
    (1,206
 
 
 
 
Balance as of January 31, 2021
 
$
5,534
 
 
 
 
 
Deferred acquisition costs capitalized on the consolidated balance sheets were as follows:
 
    
January 31
 
    
2021
    
2020
 
    
(in thousands)
 
Deferred contract acquisition costs, current
   $ 1,550      $ 1,013  
Deferred contract acquisition costs, noncurrent
     3,984        2,819  
  
 
 
    
 
 
 
Total deferred contract acquisition costs
  
$
5,534
 
  
$
3,832
 
  
 
 
    
 
 
 
Research and Development  
Research and Development
Research and development expenses consist primarily of salary and related expenses, including stock-based compensation, for personnel related to the development of improvements and expanded features for the Company’s products and services, as well as quality assurance, testing, product management, amortization of capitalized
internal-use
software, and allocated overhead. Research and development costs are expensed as incurred.
Stock-based Compensation  
Stock-based Compensation
The Company measures and recognizes compensation expense for all stock-based awards, including stock options and restricted common stock, granted to employees and directors based on the estimated fair value of the awards on the date of grant. The fair value of each stock option award is estimated on the grant date using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock, the expected term of the option, the expected volatility of the price of the Company’s common stock, risk-free interest rates, and the expected dividend yield of the Company’s common stock. The assumptions used to determine the fair value of the awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.
The Company amortizes the fair value of each stock award on a straight-line basis over the requisite service period of the awards. Stock-based compensation expense is based on the value of the portion of stock-based awards that is ultimately expected to vest. As such, the Company’s stock-based compensation is reduced for the estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
Advertising  
Advertising
The Company expenses the costs of advertising, including promotional expenses, as incurred. Advertising expenses for the years ended January 31, 2021, 2020, and 2019 were not material.
Warranty  
Warranty
The Company provides standard warranty coverage on its products for twelve months, providing parts necessary to repair the systems during the warranty period. The Company accounts for the estimated warranty cost as a charge to networked charging systems cost of revenue when revenue is recognized. The estimated warranty cost is based on historical and predicted product failure rates and repair expenses. Warranty expense for the years ended January 31, 2021, 2020, and 2019 was $3.4 million, $2.8 million, and $2.0 million, respectively.
In addition, the Company offers
paid-for
subscriptions to extended maintenance service plans under Assure. Assure provides both the labor and parts to maintain the products over the subscription terms of typically one to five years. The costs related to the Assure program are expensed as incurred and charged to subscriptions cost of revenue.
Foreign Currency  
Foreign Currency
The functional currency of the Company’s foreign subsidiaries is generally the local currency. The translation of foreign currencies into U.S. dollars is performed for monetary assets and liabilities at the end of each reporting period based on the then current exchange rates.
Non-monetary
items are translated using historical exchange rates. For revenue and expense accounts, an average foreign currency rate during the period is applied. Adjustments resulting from translating foreign functional currency financial statements into U.S. dollars are recorded as part of a separate component of stockholders’ deficit and reported in the consolidated statements of comprehensive loss. Foreign currency transaction gains and losses are included in other income (expense), net for the period.
Income Taxes  
Income Taxes
The Company uses the asset and liability method in accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the
financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax asset and liability. Valuation allowances are established when necessary to reduce deferred tax assets where it is more likely than not that the deferred tax assets will not be realized. In evaluating the Company’s ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including historical operating results, ongoing tax planning, and forecasts of future taxable income on a
jurisdiction-by-jurisdiction
basis. Based on the level of historical losses, the Company has established a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized.
A tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination by the taxing authorities, including resolutions of any related appeals or litigation processes, based on the technical merits of the position.
Net Loss per Share Attributable to Common Stockholders  
Net Loss per Share Attributable to Common Stockholders
Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the
two-class
method required for participating securities. The Company considers all series of its redeemable convertible preferred stock to be participating securities. The Company also considers any shares issued on the early exercise of stock options subject to repurchase to be participating securities because holders of such shares have nonforfeitable dividend rights in the event a dividend is paid on common stock. Under the
two-class
method, net income is attributed to common stockholders and participating securities based on their participation rights. The holders of the redeemable convertible preferred stock, as well as the holders of early exercised shares subject to repurchase, do not have a contractual obligation to share in the losses of the Company. As such, the Company’s net losses for the years ended January 31, 2021, 2020, and 2019 were not allocated to these participating securities. Under the
two-class
method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. Diluted net loss per share attributable to common stockholders adjusts basic net loss per share for the effect of dilutive securities, including stock options. As the Company has reported losses for all periods presented, all potentially dilutive securities are antidilutive and accordingly, basic net loss per share equals diluted net loss per share.
Accounting Pronouncements
Accounting Pronouncements
The Company can adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as
non-public business
entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt
when permissible, the Company has elected to adopt new or revised accounting guidance within t
he
same time period as
non-public business
entities, as indicated below. Based on the Company’s public float as of July 31, 2021, it will become a large accelerated filer, and lose emerging growth company status, as of January 31, 2022. As of January 31, 2022, the Company will be required to adopt new or revised accounting standards when they are applicable to public companies that are not emerging growth companies.
Recently Issued Accounting Standards Not Yet Adopted
In June 2016, the FASB issued
ASU 2016-13,
Financial Instruments
 — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,
and has since released various amendments including ASU
No. 2019-04.
The guidance modifies the measurement of expected credit losses on certain financial instruments. The Company will become a large accelerated filer effective January 31, 2022, at which point the Company will follow the timeline for adoption of new accounting pronouncements for public companies. As a result, the Company will adopt ASU 2016-13 for the January 31, 2022 annual period, with a modified retrospective application to all outstanding instruments and a cumulative effect adjustment recorded to opening retained earnings as of February 1, 2021 and is currently assessing the impact the guidance will have on its condensed consolidated financial statements.
In December 2019, the FASB issued ASU
2019-12,
Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,
which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis
step-up in
goodwill obtained in a transaction that is not a business combination. The guidance will be effective for annual reporting periods beginning after December 15, 2020, including interim periods therein. As a result, the Company will adopt ASU 2019-12 for the January 31, 2022 annual
period
and
is
currently assessing the impact the guidance will have on its condensed consolidated financial statements.
In August 2020, the FASB issued ASU
 
2020-06,
 
Debt — Debt with Conversion and Other Options (Subtopic
 
470-20)
 
and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic
 
815-40),
 
which modifies and simplifies accounting for convertible instruments. The new guidance eliminates certain separation models that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance will be effective for annual reporting periods beginning after December 15, 2020. As a result, the Company will adopt ASU 2020-06 for the January 31, 2022 annual period and is currently assessing the impact the guidance will have on its condensed consolidated financial statements.
 
Accounting Pronouncements
The Company is provided the option to adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as
non-public
business entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt, when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as
non-public
business entities, as indicated below.
Recently Adopted Accounting Standards
In June 2018, the FASB issued ASU
No. 2018-13,
“Fair Value Measurement (Topic 820): Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurements,” which expands the disclosure requirements for Level 3 fair value measurements and expands disclosures for measurement uncertainty. This guidance became effective for annual reporting periods beginning after December 15, 2019. The Company adopted the guidance at the beginning of fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures.
In August 2018, the FASB issued
2018-15,
“Intangibles-Goodwill and Other-Internal Use Software (Subtopic
350-40):
Customer’s Accounting for Implementation Costs Incurred In a Cloud Computing
Arrangement That Is a Service Contract,” which reduces complexity of the accounting for costs of implementing a cloud computing service arrangement. The guidance is effective for annual reporting periods beginning after December 15, 2020. The Company early adopted this guidance at the beginning of fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures.
In March 2020, the FASB issued ASU
2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which provides optional expedients and exceptions for applying U.S. GAAP to contract modifications, hedging relationships, and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The guidance is effective for the Company beginning on March 12, 2020 and it will apply the amendments prospectively through December 31, 2022. The Company adopted this guidance during fiscal year 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and disclosures.
In May 2014, the FASB issued ASC 606 with several subsequent amendments. ASC 606 amends the existing accounting standards for revenue recognition. The new guidance provides a new model to determine when and over what period revenue is recognized. Revenue is recognized for the transfer of promised goods or services to customers in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company early adopted the new revenue standard as of February 1, 2019 using the modified retrospective approach. The impact of the adoption was not material to the Company’s consolidated financial statements and disclosures. Comparative information prior to the date of adoption has not been restated and continues to be reported under the accounting standards in effect for those periods.
With the adoption of ASC 606 the Company also early adopted ASC 340 which requires the deferral of incremental costs of obtaining a customer contract which, under the old guidance, were expensed as incurred. The guidance requires the deferral of incremental contract acquisition costs and subsequent amortization over the expected period of benefit. The benefit period was estimated by taking into consideration the length of customer contracts, renewals, technology lifecycle, and other factors. The amortization of these costs is charged to sales and marketing expenses in the consolidated statements of operations. The cumulative impact of ASC 340 adoption on February 1, 2019 resulted in an increase of $2.2 million in total assets related to costs to obtain customer contracts that were previously expensed as incurred but would have been capitalized under ASC 340. Upon adoption, the Company recorded the cumulative impact of adoption as an adjustment to the Company’s accumulated deficit on February 1, 2019. Prior periods were not retroactively adjusted.
The adoption of ASC 340 resulted in a net decrease in sales and marketing expenses due to the capitalization and related amortization of deferred contract acquisition costs that would have been expensed as incurred prior to adoption. During the year ended January 31, 2020, the adoption of ASC 340 resulted in offsetting changes within operating assets and liabilities and had no net impact on the consolidated statements of cash flows.
In February 2016, the FASB issued ASC 842. The guidance is effective for annual reporting periods for
non-public
business entities beginning after December 15, 2021 and early adoption is permitted. The new standard requires lessees to recognize operating and finance lease liabilities on the balance sheet, as well as corresponding ROU assets. This standard also made some changes to lessor accounting and aligns key aspects of the lessor accounting model with the revenue recognition standard. In addition, disclosures are required to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. ASC 842 requires adoption using the modified retrospective approach, with the option of applying the requirements of the standard either (a) retrospectively to each prior comparative reporting period presented, or (b) retrospectively at the beginning of the period of adoption.
The Company has early adopted ASC 842 as of February 1, 2019 on a modified retrospective basis. Prior period amounts were not adjusted and continue to be reported in accordance with our historic accounting under
previous lease guidance, ASC 840, Leases. Upon adopting ASC 842 at the beginning of the fiscal year ended January 31, 2020, as a lessee, the Company recognized operating lease
right-of-use
assets of $11.3 million and operating lease liabilities of $12.5 million and corresponding reductions of $1.6 million to deferred rent and $0.4 million to prepaid rent. The adoption of the standard did not result in any adjustments to accumulated deficit. See Note 6, Leases, for more information.
For lessor accounting, the impact was not material to the Company’s consolidated financial statements and disclosures.
In January 2017, the FASB issued ASU
No. 2017-04,
“Intangibles — Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” The new standard simplifies the measurement of goodwill by eliminating step two of the
two-step
impairment test. Step two measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. The new guidance requires an entity to compare the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any
tax-deductible
goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. The guidance is effective for annual reporting periods beginning after December 15, 2021. The Company early adopted this guidance at the beginning of fiscal year 2020. The impact of the adoption had no impact on the Company’s consolidated financial statements and disclosures.
In July 2017, the FASB issued ASU
No. 2017-11,
“Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception.” The new guidance reduces the complexity associated with an issuer’s accounting for certain financial instruments with characteristics of liability and equity. Specifically, the FASB determined that a down round feature would no longer cause a freestanding equity-linked financial instrument (or an embedded conversion option) to be accounted for as a derivative liability at fair value with changes in fair value recognized in current earnings. This guidance is effective for annual reporting periods beginning after December 15, 2019. The Company early adopted this guidance at the beginning of fiscal year 2020. The adoption of this guidance did not have a material impact to the Company’s consolidated financial statements and disclosures.
In February 2018, the FASB issued ASU
No. 2018-02,
“Income Statement- Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” The new guidance permits, but does not require, companies to reclassify the stranded tax effects of the Tax Cuts and Jobs Act (the “Act”) on items within accumulated other comprehensive income to retained earnings. This guidance became effective for annual reporting periods beginning after December 15, 2018. The Company did not elect to reclassify the stranded tax effects of the Act on items within accumulated other comprehensive income to retained earnings.
In June 2018, the FASB issued ASU
No. 2018-07,
“Compensation — Stock Compensation (Topic 718): Improvements to
Non-Employee
Share-Based Payment Accounting.” The new guidance expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from
non-employees
and to account for awards to
non-employees
using the grant date fair value without subsequent periodic measurement. The guidance is effective for annual reporting periods beginning after December 15, 2019. The Company early adopted this guidance in fiscal year 2020 using a modified retrospective transition method. Adoption of this guidance did not have a material impact to the Company’s consolidated financial statements and disclosures.
Recently Issued Accounting Standards Not Yet Adopted
In June 2016, the FASB issued ASU
No. 2016-13,
“Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” and has since released various amendments including ASU
No. 2019-04.
The guidance modifies the measurement of expected credit losses on certain financial instruments. This guidance is effective for the Company’s annual reporting periods beginning after December 15, 2022. Early adoption is permitted. The Company is currently assessing the impact of the guidance on its consolidated financial statements and disclosures.
In November 2018, the FASB issued ASU
No. 2018-18,
“Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606”, which clarifies when certain transactions between collaborative arrangement participants should be accounted for under ASC 606 and incorporates
unit-of-account
guidance consistent with ASC 606 to aid in this determination. The guidance is effective for the Company’s annual reporting periods beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures.
In December 2019, the FASB issued ASU
2019-12,
“Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis
step-up
in goodwill obtained in a transaction that is not a business combination. The guidance will be effective for the Company’s annual reporting periods beginning after December 15, 2021. Early adoption is permitted. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures.
In August 2020, the FASB issued ASU
2020-06,
“Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic
815-40),”
which modifies and simplifies accounting for convertible instruments. The new guidance eliminates certain separation models that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance will be effective for annual reporting periods beginning after December 15, 2023. Early adoption is permitted, but no earlier than for fiscal years beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures.
In October 2020, the FASB issued ASU
2020-08,
“Codification Improvements to Subtopic
310-20
— Receivables-Nonrefundable Fees and Other Costs,” which clarifies the accounting for the amortization period for certain purchased callable debt securities held at a premium by giving consideration to securities which have multiple call dates. The guidance will be effective for annual reporting periods beginning after December 15, 2021. Early adoption is permitted for annual reporting periods beginning after December 15, 2020. The Company is currently assessing the impact of this guidance on its consolidated financial statements and disclosures.
XML 49 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jan. 31, 2021
Accounting Policies [Abstract]  
Schedule of Reconciliation of Cash, Cash Equivalents, And Restricted Cash
The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated statements of cash flows were as follows:
 
    
January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Cash and cash equivalents
   $ 145,491      $ 72,753      $ 205,238  
Restricted cash
     400        400        460  
  
 
 
    
 
 
    
 
 
 
Total cash, cash equivalents, and restricted cash
  
$
145,891
 
  
$
73,153
 
  
$
205,698
 
  
 
 
    
 
 
    
 
 
 
Schedule of Allowance for Doubtful Accounts The change in the allowance for doubtful accounts for the years ended January 31, 2021, 2020, and 2019 was as follows:
    
Beginning
Balance
    
Additions
Charged To
Expense
    
Write-offs
    
Ending
Balance
 
    
(in thousands)
 
Year ended January 31, 2021
           
Allowance for doubtful accounts
   $ 2,000      $ 121      $ (121    $ 2,000  
Year ended January 31, 2020
           
Allowance for doubtful accounts
   $ 3,124      $ 339      $ (1,463    $ 2,000  
Year ended January 31, 2019
           
Allowance for doubtful accounts
   $ 1,316      $ 1,812      $ (4    $ 3,124  
Schedule of Estimated Useful Lives
Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets, as follows:
 
    
Useful Lives
Furniture and fixtures
   3 to 5 years
Computers and software
   3 to 5 years
Machinery and equipment
   3 to 5 years
Tooling
   3 to 5 years
Leasehold improvements
   Shorter of the estimated
lease term or useful life
Owned and operated systems
   5 to 7 years
Schedule of Deferred Acquisition Costs
Changes in the deferred contract acquisition costs during the years ended January 31, 2021 and 2020 were as follows:
 
   
(in thousands)
 
Balance upon adoption of ASC 340 on February 1, 2019
  $ 2,189  
Capitalization of deferred contract acquisition costs
    2,318  
Amortization of deferred contract acquisition costs
    (675
 
 
 
 
Balance as of January 31, 2020
 
$
3,832
 
 
 
 
 
Capitalization of deferred contract acquisition costs
    2,908  
Amortization of deferred contract acquisition costs
    (1,206
 
 
 
 
Balance as of January 31, 2021
 
$
5,534
 
 
 
 
 
Deferred acquisition costs capitalized on the consolidated balance sheets were as follows:
 
    
January 31
 
    
2021
    
2020
 
    
(in thousands)
 
Deferred contract acquisition costs, current
   $ 1,550      $ 1,013  
Deferred contract acquisition costs, noncurrent
     3,984        2,819  
  
 
 
    
 
 
 
Total deferred contract acquisition costs
  
$
5,534
 
  
$
3,832
 
  
 
 
    
 
 
 
XML 50 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Reverse Recapitalization (Tables)
6 Months Ended
Jul. 31, 2021
Business Combinations [Abstract]  
Summary of number of shares of common stock issued immediately following the consummation of the Business Combination
The number of shares of Common Stock issued immediately following the consummation of the Merger was
 
as follows:
 
    
Shares
 
Common stock of Switchback, outstanding prior to Merger
     39,264,704  
Less redemption of Switchback shares
     (33,009
Less surrender of Switchback Founder Shares
     (984,706
    
 
 
 
Common stock of Switchback
     38,246,989  
Shares issued in PIPE
     22,500,000  
    
 
 
 
Merger and PIPE financing shares (1)
     60,746,989  
Legacy ChargePoint shares (2)
     217,021,368  
    
 
 
 
Total shares of common stock immediately after Merger
     277,768,357  
    
 
 
 
XML 51 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Tables)
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Class of Warrant or Right [Line Items]    
Schedule of company's assets that are measured at fair value on a recurring basis  
The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
 
           
Gross Unrealized
           
Reported as:
 
January 31, 2021
  
Amortized
Cost
    
Gains
    
Losses
    
Fair Value
    
Cash and cash
equivalents
    
Short-term
investments
 
                         
(in thousands)
               
Cash
   $ 35,788      $ —        $ —        $ 35,788      $ 35,788      $ —    
Level 1
                 
Money market funds
     109,703        —          —          109,703        109,703        —    
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total assets measured at fair value on a recurring basis
  
$
145,491
 
  
$
—  
 
  
$
—  
 
  
$
145,491
 
  
$
145,491
 
  
$
—  
 
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
           
Gross Unrealized
           
Reported as:
 
January 31, 2020
  
Amortized
Cost
    
Gains
    
Losses
    
Fair Value
    
Cash and cash
equivalents
    
Short-term
investments
 
                         
(in thousands)
               
Cash
   $ 33,266      $ —        $ —        $ 33,266      $ 33,266      $ —    
Level 1
                 
Money market funds
     39,487        —          —          39,487        39,487        —    
Level 2
                 
U.S. treasury bills
     47,014        23        —          47,037        —          47,037  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total assets measured at fair value on a recurring basis
  
$
119,767
 
  
$
23
 
  
$
—  
 
  
$
119,790
 
  
$
72,753
 
  
$
47,037
 
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Summary Of Company's assets and liabilities that were measured at fair value on a recurring basis
The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
 
    
Fair Value Measured as of July 31, 2021
        
    
Level 1
    
Level 2
    
Level 3
    
Total
 
    
(in thousands)
 
Assets
                                   
Money market funds
   $ 454,713      $ —        $ —        $ 454,713  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial assets
  
$
454,713
 
  
$
—  
 
  
$
—  
 
  
$
454,713  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Common stock warrant liabilities (Private Placement)
  
$
—  
 
  
$
—  
 
  
$
26,868
 
  
$
26,868  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial liabilities
  
$
  
 
  
$
—  
 
  
$
26,868
 
  
$
26,868  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
Fair Value Measured as of January 31, 2021
        
    
Level 1
    
Level 2
    
Level 3
    
Total
 
    
(in thousands)
 
Assets
                                   
Money market funds
   $ 109,703      $ —        $ —        $ 109,703  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial assets
  
$
109,703
 
  
$
—  
 
  
$
—  
 
  
$
109,703  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Redeemable convertible preferred stock warrant liability
  
$
—  
 
  
$
—  
 
  
$
75,843
 
  
$
75,843  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial liabilities
  
$
—  
 
  
$
—  
 
  
$
75,843
 
  
$
75,843  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
Summary of changes in the fair value of Level 3 financial statements
The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments:
 
    
Redeemable
convertible
preferred stock
warrant liability
    
Private
placement
warrant
liability
    
Earnout
liability
 
    
(in thousands)
 
Fair value as of January 31, 2021
   $ (75,843    $      $  
Private placement warrant liability acquired as part of the merger
            (127,888       
Contingent earnout liability recognized upon the closing of the reverse recapitalization
                   (828,180
Change in fair value included in other income (expense), net
     9,237        49,264        84,420  
Reclassification of warrants to stockholders’ equity (deficit) due to exercise
            51,756         
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization
     66,606                
Issuance of earnout shares upon triggering events
                   501,120  
Reclassification of remaining contingent earnout liability upon triggering event
                   242,640  
    
 
 
    
 
 
    
 
 
 
Fair value as of July 31, 2021
  
$
    
$
(26,868
  
$
 
    
 
 
    
 
 
    
 
 
 
 
XML 52 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Composition of Certain Financial Statement Items (Tables)
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Composition Of Certain Financial Statement Items [Abstract]    
Summary of inventories
Inventories consisted of the following:
 
    
July 31,

2021
    
January 31,

2021
 
    
(in thousands)
 
Raw materials
   $ 8,421      $ 13,029  
Work
-in-progress
            68  
Finished
goods
     19,495        20,495  
    
 
 
    
 
 
 
Total Inventories
  
$
27,916
    
$
33,592
 
    
 
 
    
 
 
 
Inventories consisted of the following:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Raw materials
   $ 13,029      $ 11,335  
Work-in-progress
     68        —    
Finished goods
     20,495        14,084  
  
 
 
    
 
 
 
Total Inventories
  
$
33,592
 
  
$
25,419
 
  
 
 
    
 
 
 
Summary of property plant and equipment, net
Property and equipment, net consisted of the following:
 
    
July 31,

2021
    
January 31,

2021
 
    
(in thousands)
 
Furniture and fixtures
   $ 899      $ 1,594  
Computers and software
     5,843        5,384  
Machinery and equipment
     12,140        10,605  
Tooling
     9,666        7,705  
Leasehold improvements
     9,680        9,398  
Owned and operated systems
     20,582        17,703  
Construction in progress
     2,760        2,462  
    
 
 
    
 
 
 
       61,570        54,851  
    
 
 
    
 
 
 
Less: Accumulated depreciation
     (29,305      (24,863
    
 
 
    
 
 
 
Total Property and Equipment, Net
   $ 32,265      $ 29,988  
    
 
 
    
 
 
 
Property and equipment, net consisted of the following:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Furniture and fixtures
   $ 1,594      $ 1,347  
Computers and software
     5,384        4,350  
Machinery and equipment
     10,605        7,614  
Tooling
     7,705        6,299  
Leasehold improvements
     9,398        8,869  
Owned and operated systems
     17,703        8,422  
Construction in progress
     2,462        5,796  
  
 
 
    
 
 
 
     54,851        42,697  
  
 
 
    
 
 
 
Less: Accumulated depreciation
     (24,863      (14,756
  
 
 
    
 
 
 
Total Property and Equipment, Net
  
$
29,988
 
  
$
27,941
 
  
 
 
    
 
 
 
Summary of accrued and other current liabilities
Accrued and other current liabilities consisted of the following:
 
    
July 31,

2021
    
January 31,

2021
 
    
(in thousands)
 
Accrued expenses
   $ 19,113      $ 18,404  
Refundable customer deposits
     7,488        6,482  
Taxes payable
     6,495        5,213  
Payroll and related expenses
     7,372        7,547  
Warranty accruals
     3,100        3,000  
Operating lease liabilities, current
     3,130        2,393  
Other liabilities
     5,282        4,123  
    
 
 
    
 
 
 
Total Accrued and Other Current Liabilities
   $ 51,980      $ 47,162  
    
 
 
    
 
 
 
Accrued and other current liabilities consisted of the following:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Accrued expenses
   $ 18,404      $ 11,335  
Refundable customer deposits
     6,482        5,241  
Payroll and related expenses
     7,547        6,727  
Taxes payable
     5,213        5,348  
Operating lease liabilities, current
     2,393        3,979  
Warranty accruals
     3,000        2,000  
Other liabilities
     4,123        3,029  
  
 
 
    
 
 
 
Total Accrued and Other Current Liabilities
  
$
47,162
 
  
$
37,659
 
  
 
 
    
 
 
 
Summary of revenue
Revenue consisted of the following:
 
    
Three Months Ended July 31,
    
Six Months Ended July 31,
 
    
2021
    
2020
    
2021
    
2020
 
    
(in thousands)
    
(in thousands)
 
United States
   $ 51,109      $ 32,347      $ 86,219      $ 62,638  
Rest of World
     5,012        2,610        10,412        5,095  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 56,121      $ 34,957      $ 96,631      $ 67,733  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
XML 53 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Leases (Tables)
12 Months Ended
Jan. 31, 2021
Leases [Abstract]  
Schedule of Lease Balances
As of January 31, 2021 and 2020, lease balances were as follows:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Operating leases
     
Operating lease
right-of-use
assets
  
$
21,817
 
  
$
10,269
 
  
 
 
    
 
 
 
Operating lease liabilities, current
     2,286        3,979  
Operating lease liabilities, noncurrent
     22,459        8,230  
  
 
 
    
 
 
 
Total operating lease liabilities
  
$
24,745
 
  
$
12,209
 
  
 
 
    
 
 
 
Maturities of Operating Leases
Maturities of the operating lease liabilities as of January 31, 2021 were as follows:
 
    
(in thousands)
 
Years Ending January 31,
  
2022
   $ 4,719  
2023
     5,123  
2024
     4,334  
2025
     4,152  
2026
     3,833  
Thereafter
     13,855  
  
 
 
 
Total undiscounted operating lease payments
  
$
36,016
 
  
 
 
 
Less: imputed interest
     (11,271
  
 
 
 
Total operating lease liabilities
  
$
24,745
 
  
 
 
 
Maturities of the operating lease liabilities as of January 31, 2020 were as follows:
 
    
(in thousands)
 
Years Ending January 31,
  
2021
   $ 4,849  
2022
     4,809  
2023
     2,671  
2024
     268  
2025
     292  
Thereafter
     1,341  
  
 
 
 
Total undiscounted operating lease payments
  
$
14,230
 
Less: imputed interest
     (2,021
  
 
 
 
Total operating lease liabilities
  
$
12,209
 
  
 
 
 
Schedule of Other Supplemental Information of Lease Term and Discount Rate
Other supplemental information as of January 31, 2021 and 2020 was as follows:
 
    
January 31,
 
    
2021
   
2020
 
Lease Term and Discount Rate
    
Weighted-average remaining operating lease term (years)
     7.5       3.7  
Weighted-average operating lease discount rate
     7.9     8.7
Summary of Other Lease Supplemental Cash Flow Information
Other supplemental cash flow information for the years ended January 31, 2021 and January 31, 2020 was as follows:
 
    
Year ended January 31,
 
    
    2021    
    
    2020    
 
    
(in thousands)
 
Supplemental Cash Flow Information
     
Cash paid for amounts in the measurement of operating lease liabilities
   $ 4,226      $ 4,527  
XML 54 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Debt (Tables)
12 Months Ended
Jan. 31, 2021
Debt Disclosure [Abstract]  
Summary of Future Principal Payments
Total future principal payments under all borrowings as of January 31, 2021 were as follows:
 
    
(in thousands)
 
Years Ending January 31,
  
2022
     11,667  
2023
     17,500  
2024
     5,833  
  
 
 
 
Total payments
  
$
35,000
 
  
 
 
 
XML 55 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies (Tables)
6 Months Ended
Jul. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Summary of future payments under the non-cancellable operating lease
The following table presents future payments of lease liabilities under the Company’s
non-cancelable
operating leases as of July 31, 2021 (in thousands):
 
    
(in
 
thousands)
 
2022 (remaining six months)
  
$
2,759  
2023
  
 
5,111  
2024
  
 
4,329  
2025
  
 
4,153  
2026
  
 
3,837  
Thereafter
  
 
13,871  
    
 
 
 
Total undiscounted operating lease payments
     34,060  
Less: imputed interest
     (9,348
    
 
 
 
Total operating lease liabilities
     24,712  
Less: current portion of operating lease liabilities
     (3,130
    
 
 
 
Operating lease liabilities, noncurrent
   $ 21,582  
    
 
 
 
XML 56 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Redeemable Convertible Preferred Stock (Tables)
12 Months Ended
Jan. 31, 2021
Equity [Abstract]  
Schedule Of Redeemable Convertible Preferred Stock
Redeemable convertible preferred stock as of January 31, 2021, 2020, and 2019, respectively, consisted of the following:
 
    
January 31, 2021
 
    
Shares
    
Liquidation

Preference
    
Carrying

Value
 
    
Authorized
    
Outstanding
 
Series A
     29,027        29,027      $ 3,746      $ 3,697  
Series B
     132,831        130,146        13,993        13,947  
Series C
     45,222        45,222        13,068        13,039  
Series D
     45,744,194        44,307,263        54,946        49,469  
Series E
     22,578,525        21,772,150        54,000        26,795  
Series F
     23,611,372        23,611,372        59,000        58,624  
Series G
     28,533,636        28,533,636        125,000        124,745  
Series H
     42,154,388        42,154,388        240,000        229,925  
Series H-1
     22,351,053        22,351,053        129,795        95,456  
  
 
 
    
 
 
    
 
 
    
 
 
 
  
 
185,180,248
 
  
 
182,934,257
 
  
$
693,548
 
  
$
615,697
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
January 31, 2020
 
    
Shares
    
Liquidation

Preference
    
Carrying

Value
 
    
Authorized
    
Outstanding
 
Series A
     29,027        29,027      $ 3,746      $ 3,697  
Series B
     132,831        130,146        13,993        13,947  
Series C
     45,222        45,222        13,068        13,039  
Series D
     45,744,194        44,307,262        54,946        49,469  
Series E
     22,578,525        21,772,150        54,000        26,795  
Series F
     23,611,372        23,611,372        59,000        58,624  
Series G
     28,533,636        28,533,636        125,000        124,745  
Series H
     42,154,388        42,154,388        240,000        229,925  
  
 
 
    
 
 
    
 
 
    
 
 
 
  
 
162,829,195
 
  
 
160,583,203
 
  
$
563,753
 
  
$
520,241
 
  
 
 
    
 
 
    
 
 
    
 
 
 
    
January 31, 2019
 
    
Shares
    
Liquidation

Preference
    
Carrying

Value
 
    
Authorized
    
Outstanding
 
Series A
     29,027        29,027      $ 3,746      $ 3,697  
Series B
     132,831        130,146        13,993        13,947  
Series C
     45,222        45,222        13,068        13,039  
Series D
     45,744,194        44,307,263        54,946        49,469  
Series E
     22,578,525        21,772,150        54,000        26,795  
Series F
     23,611,372        23,611,372        59,000        58,624  
Series G
     28,533,636        28,533,636        125,000        124,745  
Series H
     42,154,388        39,519,737        225,000        215,169  
  
 
 
    
 
 
    
 
 
    
 
 
 
    
162,829,195
      
157,948,553
    
$
548,753
    
$
505,485
 
  
 
 
    
 
 
    
 
 
    
 
 
 
XML 57 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes (Tables)
12 Months Ended
Jan. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of income tax provision
The components of the provision for (benefit from) income taxes were as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Current
        
Federal
   $ —        $ —        $ —    
State
     47        35        —    
Foreign
     151        189        119  
  
 
 
    
 
 
    
 
 
 
Total current
  
$
198
 
  
$
224
 
  
$
119
 
  
 
 
    
 
 
    
 
 
 
Deferred
        
Federal
   $ —        $ —        $ —    
State
     —          —          —    
Foreign
     —          —          —    
Total deferred
     —          —          —    
  
 
 
    
 
 
    
 
 
 
Total provision for income taxes
  
$
198
 
  
$
224
 
  
$
119
 
  
 
 
    
 
 
    
 
 
 
Schedule of net deferred tax assets
The significant components of the Company’s deferred tax assets and liabilities as of January 31, 2021 and 2020 were as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
Deferred tax assets:
     
Net operating losses
   $ 114,154      $ 105,663  
Research & development credits
     12,054        14,320  
Deferred revenue
     15,270        6,968  
Accruals and reserves
   $ 8,102      $ 6,692  
Stock-based compensation
     980        653  
Operating lease liabilities
     6,999        3,370  
  
 
 
    
 
 
 
Total deferred tax assets
  
 
157,559
 
  
 
137,666
 
  
 
 
    
 
 
 
Less: valuation allowance
     (150,991      (134,337
Deferred tax liabilities:
     
Depreciation and amortization
     (375      (489
Operating lease
right-of-use
assets
     (6,186      (2,834
  
 
 
    
 
 
 
Total deferred tax liabilities
  
 
(6,561
  
 
(3,323
  
 
 
    
 
 
 
Net deferred tax assets
  
$
7
 
  
$
6
 
  
 
 
    
 
 
 
Schedule of reconciliation of the statutory federal income tax rate to the Company's effective tax rate
A reconciliation of the U.S. federal statutory rate to the Company’s effective tax rate was as follows:
 
    
Year Ended January 31,
 
    
2021
   
2020
   
2019
 
Tax at federal statutory rate
     21.0     21.0     21.0
Permanent differences
     (0.6 )%      (1.5 )%      (0.8 )% 
Warrant Mark to Market
     (7.8 )%      (0.1 )%      (0.1 )% 
Stock-based compensation
     (0.2 )%      (0.2 )%      (0.2 )% 
Change in valuation allowance
     (13.6 )%      (21.1 )%      (21.9 )% 
Research and development tax credits
     1.1     1.8     1.9
  
 
 
   
 
 
   
 
 
 
Effective tax rate
  
 
(0.1
)% 
 
 
(0.1
)% 
 
 
(0.1
)% 
  
 
 
   
 
 
   
 
 
 
Schedule of Net Loss Before Income Taxes
The components of net loss before income taxes were as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Domestic
   $ (197,908    $ (134,578    $ (108,663
Foreign
     1,082        475        695  
  
 
 
    
 
 
    
 
 
 
Net loss before income taxes
  
$
(196,826
  
$
(134,103
  
$
(107,968
  
 
 
    
 
 
    
 
 
 
Summary of Unrecognized Tax Benefits
The following table summarizes the activity related to unrecognized tax benefits as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Unrecognized tax benefits — beginning
   $ 10,153      $ 6,884      $ 4,445  
Gross decreases — prior period tax position
     (3,620      —          —    
Gross increases — current period tax position
     2,869        3,269        2,439  
  
 
 
    
 
 
    
 
 
 
Unrecognized tax benefits — ending
  
$
9,402
 
  
$
10,153
 
  
$
6,884
 
  
 
 
    
 
 
    
 
 
 
XML 58 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Common Stock (Tables)
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Stockholders' Equity Note [Abstract]    
Summary Of Common Stock Capital Shares Reserved For Future Issuance
Shares of Common Stock reserved for future issuance, on an
as-if converted
basis, were as follows:
 
    
July 31,

2021
 
Stock options issued and outstanding
     26,401,717  
Restricted stock units outstanding
     4,017,149  
Common stock warrants outstanding
     39,249,702  
Shares available for grant under 2021 Equity Incentive Plan
     40,878,653  
Shares available for grant under 2021 ESPP
     8,177,683  
    
 
 
 
Total shares of common stock reserved
     118,724,904  
    
 
 
 
Shares of common stock reserved for future issuance on an
as-if
converted basis, were as follows:
 
    
January 31,
 
    
2021
    
2020
 
Conversion of redeemable convertible preferred stock
     193,037,715        170,686,661  
Stock options issued and outstanding
     30,167,178        34,883,465  
Redeemable convertible preferred stock warrants outstanding
     2,358,546        2,358,546  
Common stock warrants outstanding
     36,402,515        14,051,462  
Shares available for grant under 2017 Stock Option Plan
     4,528,391        5,844,909  
  
 
 
    
 
 
 
Total shares of common stock reserved
  
 
266,494,345
 
  
 
227,825,043
 
  
 
 
    
 
 
 
XML 59 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Warrants and Earnouts (Tables)
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Stock Warrants And Earnouts [Abstract]    
Summary of Fair Value Measurement Inputs and Valuation Techniques
The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows:
 
    
February 26,
2021

(Merger Date)
   
January 31,

2021
 
Expected volatility
     84.3     80.5
Risk-free interest rate
     0.0     0.1
Dividend rate
     0.0     0.0
Expected term (years)
     0.0       1.4  
The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows:
 
    
January 31,
 
    
2021
   
2020
   
2019
 
Expected volatility
     80.5     58.4     65.0
Risk-free interest rate
     0.1     1.6     2.8
Dividend rate
     0.0     0.0     0.0
Expected term (years)
     1.4       2.0       2.0  
Summary of Fair Value Private Placement Warrants Basis Valuation Techniques The Private Placement Warrants were valued using the following assumptions under
the
BLM that assumes optimal exercise of the Company’s redemption option at the earliest possible date:
 
    
July 31,

2021
   
February 26,

2021
 
Market price of public stock
   $ 23.65       $30.83  
Exercise price
   $ 11.50       $11.50  
Expected term (years)
     4.6       5.0  
Volatility
     70.2     73.5
Risk-free interest rate
     0.6     0.8
Dividend rate
     0.0     0.0
 
Summary of Assumed Public Warrants
Activity of warrants is set forth below:
 
    
Legacy Common
and Preferred Stock
Warrants
(1)
    
Private
Placement
Warrants
    
Public
Warrants
    
Total

Common Stock
Warrants
(1)
 
Outstanding as of January 31, 2021
     38,761,031        —          —          38,761,031  
Common Stock Warrants as Part of the Merger
     —          6,521,568        10,470,562        16,992,130  
Warrants Exercised
     (1,685,185      (4,347,712      (10,226,081      (16,258,978
Warrants Redeemed
     —          —          (244,481      (244,481
    
 
 
    
 
 
    
 
 
    
 
 
 
Outstanding as of July 31, 2021
     37,075,846        2,173,856        —          39,249,702  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
(1)
The shares (and the warrants’ exercise prices) subject to the Company’s Legacy common and preferred stock warrants were restated to reflect the exchange ratio of approximately 0.9966 established in the Merger Agreement as discussed in Note 3.
 
Summary of Fair Value Earnout Liability Basis Valuation Techniques Assumptions used in the valuation are described below.
    
March 12,

2021
   
February 26,

2021
 
Current stock price
   $ 27.84     $ 30.83  
Expected volatility
     72.00     71.60
Risk-free interest rate
     0.85     0.75
Dividend rate
     0.00     0.00
Expected term (years)
     4.96       5.00  
 
Schedule of Warrants Issued and Outstanding  
Warrants issued and outstanding as of January 31, 2021 and 2020 consisted of the following:
Common Stock Warrants
 
    
January 31, 2021
 
    
Outstanding Warrants
        
    
Number of
Warrants
    
Exercise
Price
    
Expiration Date
 
Common Stock
     22,351,053      $ 6.02        7/31/2030 – 8/6/2030  
Common Stock
     14,051,462      $ 9.03        11/16/2028 – 2/14/2029  
  
 
 
       
Total outstanding common stock warrants
  
 
36,402,515
 
     
  
 
 
       
 
    
January 31, 2020
 
    
Outstanding Warrants
        
    
Number of
Warrants
    
Exercise
Price
    
Expiration Date
 
Common Stock
     14,051,462      $ 9.03        11/16/2028 – 2/14/2029  
  
 
 
       
Total outstanding common stock warrants
  
 
14,051,462
 
     
  
 
 
       
Schedule of Outstanding Redeemable Convertible Preferred Stock Warrants  
Redeemable Convertible Preferred Stock Warrants
 
    
January 31, 2021 and 2020
 
    
Outstanding Warrants
    
Expiration Date
 
    
Number of
Warrants
    
Exercise
Price
 
Series B Preferred Stock
     2,685      $ 107.52        4/30/2021  
Series D Preferred Stock
     1,436,932      $ 1.24        4/20/2022 – 1/24/2024  
Series E Preferred Stock
     806,375      $ 1.24        12/24/2024 – 7/15/2025  
  
 
 
       
Total outstanding redeemable convertible preferred stock warrants
  
 
2,245,992
 
     
  
 
 
       
Schedule of Liability of Warrants Subject to Re Measurement  
The liability associated with these warrants was subject to remeasurement at each balance sheet date using the Level 3 fair value inputs and was as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Fair value at beginning of period
   $ 2,718      $ 1,843      $ 1,455  
Change in fair value
     73,125        875        388  
  
 
 
    
 
 
    
 
 
 
Fair value at end of period
  
$
75,843
 
  
$
2,718
 
  
$
1,843
 
  
 
 
    
 
 
    
 
 
 
XML 60 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Plans and Stock-based Compensation (Tables)
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Share-based Payment Arrangement [Abstract]    
Summary of stock option awards
The Company’s stock option awards activity is set forth below:
 
    
Number of
Stock Option
Awards
    
Weighted
Average
Exercise Price
    
Weighted
Average
Remaining
Contractual
term (in years)
    
Aggregate
Intrinsic Value
(in thousands)
 
Outstanding as of January 31, 2021
     30,166,792      $ 0.71        7.3      $ 1,064,539  
Options exercised
     (3,292,219    $ 0.53                    
Options forfeited
     (452,893    $ 0.73                    
Options expired
     (19,963    $ 53.22                    
    
 
 
                            
Outstanding as of July 31, 2021
     26,401,717      $ 0.69        7.0      $ 606,280  
    
 
 
                            
Options vested and expected to vest as of July 31, 2021
     25,667,621      $ 0.69        7.0      $ 589,470  
    
 
 
                            
Exercisable as of July 31, 2021
     16,457,228      $ 0.66        6.3      $ 378,402  
    
 
 
                            
Activity under the Company’s stock option plans is set forth below:
 
    
Number of
Stock Option
Awards
   
Weighted
Average
Exercise

Price
    
Weighted
Average
Remaining
Contractual
term

(in years)
    
Aggregate
Intrinsic Value
 
Outstanding as of January 31, 2018
  
 
28,955,341
 
  $ 0.59        7.7      $ 8,905,754  
  
 
 
         
Granted
     8,811,605     $ 0.57        
Exercised
     (3,853,935   $ 0.35         $ (1,364,006
Cancelled
     (2,250,990   $ 0.75        
  
 
 
         
Outstanding as of January 31, 2019
  
 
31,662,021
 
  $ 0.6        7.4      $ 7,456,493  
Granted
     10,780,372     $ 0.75        
Exercised
     (4,830,469   $ 0.47         $ (3,464,262
Cancelled
     (2,728,460   $ 0.83        
  
 
 
         
Outstanding as of January 31, 2020
  
 
34,883,464
 
  $ 0.65        7.3      $ 19,314,017  
Granted
     8,912,180     $ 0.75        
Exercised
     (11,042,592   $ 0.55         $ (110,643,446 )
Cancelled
     (2,585,875   $ 0.84        
  
 
 
         
Outstanding as of January 31, 2021
  
 
30,167,177
 
  $ 0.7        7.3      $ 1,064,538,557  
  
 
 
         
Options vested and expected to vest as of January 31, 2021
     27,483,800     $ 0.69        7.2      $ 969,997,293  
  
 
 
         
Exercisable as of January 31, 2021
     16,591,050     $ 0.68        6.4      $ 586,047,442  
  
 
 
         
Summary of Stock Based Compensation Expense
The following sets forth the total stock-based compensation expense for the Company’s stock options (including the CEO Award) and RSU included in the Company’s condensed consolidated statements of operations:
 
    
Three Months Ended

July 31,
    
Six Months Ended

July 31,
 
    
2021
    
2020
    
2021
    
2020
 
    
(in thousands)
    
(in thousands)
 
Cost of revenue
   $ 2,164      $ 41      $ 2,188      $ 64  
Research and development
     13,682        454        14,357        757  
Sales and marketing
     4,169        356        4,767        655  
General and administrative
     8,278        339        14,558        624  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation expense
   $ 28,293      $ 1,190      $ 35,870      $ 2,100  
    
 
 
    
 
 
    
 
 
    
 
 
 
The following sets forth the total stock-based compensation expense for the Company’s stock options and restricted common stock included in the Company’s consolidated statements of operations:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Cost of revenue
   $ 115      $ 39      $ 28  
Research and development
     1,807        871        419  
Sales and marketing
     1,501        1,164        541  
General and administrative
     1,524        863        718  
  
 
 
    
 
 
    
 
 
 
Total stock-based compensation expense
  
$
4,947
 
  
$
2,937
 
  
$
1,706
 
  
 
 
    
 
 
    
 
 
 
Summary of RSU activity  
The Company’s RSU activity is set forth below:
 
    
Number of
Shares
    
Weighted
Average Grant
Date Fair Value
per Share
 
Outstanding as of January 31, 2021
     —        $ —    
RSU granted
     4,680,439      $ 27.38  
RSU vested
     (652,901    $ 27.30  
RSU forfeited
     (10,389    $ 27.30  
    
 
 
          
Outstanding as of July 31, 2021
     4,017,149      $ 27.40  
    
 
 
          
Summary of fair value measurement inputs and valuation techniques  
The weighted-average assumptions in the Black-Scholes option-pricing models used to determine the fair value of stock options granted during the years ended January 31, 2021, 2020, and 2019 were as follows:
 
    
Year Ended January 31,
 
    
2021
   
2020
   
2019
 
Expected volatility
     49.1% – 51.6     40.3% – 40.9 %     40.9% – 41.6
Risk-free interest rate
     0.3% – 1.6     1.4% – 2.4     2.7% – 2.9
Dividend rate
     0.0     0.0     0.0
Expected term (in years)
     5.6 – 5.8       5.0 – 5.9       6.1 – 6.4  
XML 61 R41.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions (Tables)
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Related Party Transactions [Abstract]    
Summary of revenue transactions The following revenue transactions took place between the Company and Daimler during the periods presented:
    
Three Months Ended

July 31,
    
Six Months Ended

July 31,
 
    
2021
    
2020
    
2021
    
2020
 
    
(in thousands)
    
(in thousands)
 
Daimler
   $ 2,071      $ 850      $ 3,406      $ 1,576  
    
 
 
    
 
 
    
 
 
    
 
 
 
Revenue from related parties
   $ 2,071      $ 850      $ 3,406      $ 1,576  
    
 
 
    
 
 
    
 
 
    
 
 
 
The following revenue transactions took place between the Company and Daimler during the respective fiscal years:
    
Year ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
Daimler
   $ 3,457      $ 3,112      $ 1,082  
  
 
 
    
 
 
    
 
 
 
Revenue from related parties
  
$
3,457
 
  
$
3,112
 
  
$
1,082
 
  
 
 
    
 
 
    
 
 
 
XML 62 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Geographic Information (Tables)
12 Months Ended
Jan. 31, 2021
Segment Reporting [Abstract]  
Summary of Revenue by Geographic Area
Revenue by geographic area based on the shipping address of the customers was as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
    
(in thousands)
 
United States
   $ 131,571      $ 130,184      $ 81,408  
Rest of World
     14,919        14,331        10,622  
  
 
 
    
 
 
    
 
 
 
Total revenue
  
$
146,490
 
  
$
144,515
 
  
$
92,030
 
  
 
 
    
 
 
    
 
 
 
Summary of Long-lived Assets by Geographic Area
Long-lived assets by geographic area were as follows:
 
    
January 31,
 
    
2021
    
2020
 
    
(in thousands)
 
United States
   $ 46,759      $ 36,836  
Rest of World
     5,046        1,374  
  
 
 
    
 
 
 
Total long-lived assets
  
$
51,805
 
  
$
38,210
 
  
 
 
    
 
 
 
XML 63 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Basic and Diluted Net Loss Per Share (Tables)
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Earnings Per Share [Abstract]    
Summary of computation of basic and diluted net loss per share
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and six months ended July 31, 2021 and 2020:
 
 
  
Three Months Ended

July 31,
 
 
Six Months Ended

July 31,
 
 
  
2021
 
 
2020
 
 
2021
 
 
2020
 
 
  
(in thousands, except share and
per share data)
 
 
(in thousands, except share and
per share data)
 
Numerator:
  
     
 
     
 
     
 
     
Net income (loss)
  
$
(84,938
 
$
(35,287
 
$
(2,649
 
$
(65,385
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjust:
Accretion of beneficial conversion feature of redeemable convertible preferred stock
  
 
—  
 
 
 
(58,625
 
 
—  
 
 
 
(58,625
Adjust:
Cumulative dividends on redeemable convertible preferred stock
  
 
—  
 
 
 
—  
 
 
 
(4,292
 
 
—  
 
Adjust:
Deemed dividends attributable to vested option holders
  
 
—  
 
 
 
—  
 
 
 
(51,855
 
 
—  
 
Adjust:
Deemed dividends attributable to common stock warrant holders
  
 
—  
 
 
 
—  
 
 
 
(110,635
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to common stockholders - Basic
  
 
(84,938
 
 
(93,912
 
 
(169,431
 
 
(124,010
Less:
Gain attributable to earnout shares issued
  
 
—  
 
 
 
—  
 
 
 
(84,420
 
 
—  
 
Less:
Change in fair value of dilutive warrants
  
 
(7,427
 
 
—  
 
 
 
(53,540
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to common stockholders - Diluted
  
$
(92,365
 
$
(93,912
 
$
(307,391
 
$
(124,010
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator:
  
     
 
     
 
     
 
     
Weighted average common shares outstanding
  
 
312,465,016
 
 
 
13,537,501
 
 
 
266,473,703
 
 
 
12,822,481
 
Less:
Weighted-average unvested restricted shares and shares subject to repurchase
  
 
(237,490
 
 
(68,824
 
 
(276,221
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares outstanding - Basic
  
 
312,227,526
 
 
 
13,468,677
 
 
 
266,197,482
 
 
 
12,822,481
 
Add:
Earnout Shares under the treasury stock method
  
 
—  
 
 
 
—  
 
 
 
7,464,203
 
 
 
—  
 
Add:
Public and Private Placement Warrants under the treasury stock method
  
 
1,374,574
 
 
 
—  
 
 
 
1,915,315
 
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares outstanding - Diluted
  
 
313,602,100
 
 
 
13,468,677
 
 
 
275,577,000
 
 
 
12,822,481
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss per share - Basic
  
$
(0.27
 
$
(6.97
 
$
(0.64
 
$
(9.67
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss per share - Diluted
  
$
(0.29
 
$
(6.97
 
$
(1.12
 
$
(9.67
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended January 31, 2021, 2020, and 2019:
 
(in thousands, except share and per share data)   
Year Ended January 31,
 
    
2021
   
2020
   
2019
 
Numerator:
                        
Net loss attributable to common stockholders
   $ (274,200   $ (134,327   $ (108,087
Denominator:
                        
Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted
     15,116,763       8,893,787       4,342,517  
    
 
 
   
 
 
   
 
 
 
Net loss per share attributable to common stockholders, basic and diluted
  
$
(18.14
 
$
(15.10
 
$
(24.89
    
 
 
   
 
 
   
 
 
 
Summary of computation of diluted net loss per share
The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows:
 
    
July 31,
2021
 
  
July 31,
2020
 
Redeemable convertible preferred stock (on an
as-converted
basis)
     —          192,469,995  
Options to purchase common stock
     26,401,717        39,463,877  
Restricted stock units
     4,017,149     
 
—  
 
Unvested early exercised common stock options
     211,464        102,781  
Common stock and preferred stock warrants
     37,075,846        38,193,342  
    
 
 
    
 
 
 
Total potentially dilutive common share equivalents
  
 
67,706,176
    
 
270,229,995
 
    
 
 
    
 
 
 
 
Summary of Computation of Diluted Net Loss Per Share  
The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:
 
    
Year Ended January 31,
 
    
2021
    
2020
    
2019
 
Redeemable convertible preferred stock (on an
as-converted
basis)
     193,037,715        170,686,661        168,052,012  
Options to purchase common stock
     30,167,178        34,883,465        31,662,022  
Unvested restricted common stock
     —          166,100        564,740  
Unvested early exercised common stock options
     371,193        58,830        58,971  
Redeemable convertible preferred stock warrants
(on an as-converted
basis)
     2,358,546        2,358,546        2,358,546  
Common stock warrants
     36,402,515        14,051,462        13,173,245  
    
 
 
    
 
 
    
 
 
 
Total potentially dilutive common share equivalents
  
 
262,337,147
 
  
 
222,205,064
 
  
 
215,869,536
 
    
 
 
    
 
 
    
 
 
 
XML 64 R44.htm IDEA: XBRL DOCUMENT v3.21.2
Description of Business and Basis of Presentation - Additional Information (Detail)
1 Months Ended 12 Months Ended
Feb. 26, 2021
USD ($)
$ / shares
shares
Aug. 31, 2020
USD ($)
Jul. 31, 2020
USD ($)
shares
Jan. 31, 2021
USD ($)
Jan. 31, 2020
USD ($)
Jan. 31, 2019
USD ($)
Jul. 31, 2021
USD ($)
Jan. 31, 2018
USD ($)
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                
Accumulated deficit       $ 679,414,000 $ 482,390,000   $ 682,063,000  
Cash equivalents and restricted cash     $ 189,537,000 145,891,000 73,153,000 $ 205,698,000 $ 618,489,000 $ 88,844,000
Stockholders equity exchange ratio 0.9966              
Redeemable Cash proceeds     127,000,000.0          
Net of issuance costs   $ 200,000 $ 200,000 $ 200,000 $ 100,000 $ 8,400,000    
Issuance of redeemable convertible preferred stock | shares     22,400,000          
Common stock warrants | shares     22,400,000          
Cash proceeds received from merger $ 484,100,000              
Merger Agreement [Member]                
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                
Business Combination share price | $ / shares $ 10.00              
PIPE Financing [Member] | Subsequent Event [Member]                
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                
Shares issued in PIPE | shares 22,500,000              
Aggregate purchase price $ 225,000,000              
XML 65 R45.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
USD ($)
$ / shares
shares
Jul. 31, 2020
USD ($)
Jul. 31, 2021
USD ($)
Segment
$ / shares
shares
Jul. 31, 2020
USD ($)
Jan. 31, 2021
USD ($)
Segment
$ / shares
Jan. 31, 2020
USD ($)
$ / shares
Jan. 31, 2019
USD ($)
Feb. 01, 2019
USD ($)
Summary of Significant Accounting Policies (Details) [Line Items]                
Number of operating segments | Segment     1   1      
Number of securities called by each warrant or right | shares 1   1          
Revenue expected to be recognised from remaining performance obligations $ 118,200   $ 118,200   $ 101,800      
Percentage of revenue expected to be recognised from remaining performance obligations Over next twelve months 42.00%   42.00%   43.00%      
Total deferred revenue $ 105,800   $ 105,800   $ 89,800 $ 72,700    
Deferred revenue recognised $ 7,700 $ 4,600 $ 22,900 $ 21,000 $ 39,400 $ 25,500 $ 16,000  
Common stock, par value (in Dollars per share) | $ / shares $ 0.0001   $ 0.0001   $ 0.0001 $ 0.0001    
Customer contract payment terms         Contracts for services typically range from annual to multi-year agreements with typical payment terms of 30 to 90 days.      
Restricted cash         $ 400 $ 400 460  
Carrying value of goodwill $ 1,215   $ 1,215   1,215 1,215    
Warranty expense         3,400 2,800 2,000  
Operating lease right-of-use assets 20,834   20,834   21,817 10,269   $ 11,300
Operating lease liabilities $ 24,712   $ 24,712     12,209   $ 12,500
Deferred rent           1,600    
Prepaid rent           400    
Letter of Credit [Member]                
Summary of Significant Accounting Policies (Details) [Line Items]                
Restricted cash         $ 400 $ 400 $ 500  
Customer One [Member] | Accounts Receivable [Member] | Series of Individually Immaterial Business Acquisitions [Member]                
Summary of Significant Accounting Policies (Details) [Line Items]                
Concentration risk percentage     9.00% 16.00% 16.00% 10.00%    
Customer Two [Member] | Sales Revenue Net [Member] | Series of Individually Immaterial Business Acquisitions [Member]                
Summary of Significant Accounting Policies (Details) [Line Items]                
Concentration risk percentage     10.00% 10.00% 10.00% 10.00% 10.00%  
Public Warrants [Member]                
Summary of Significant Accounting Policies (Details) [Line Items]                
Class of warrant or right exercised during period shares | shares 10,226,081   10,226,081          
Class of warrant or right redemed during period shares | shares     244,481          
Private Placement Warrants [Member]                
Summary of Significant Accounting Policies (Details) [Line Items]                
Class of warrant or right issued during period shares | shares 1,000,000   1,000,000          
Class of warrant or right exercised during period shares | shares 4,347,712   4,347,712          
Initial public offering [Member]                
Summary of Significant Accounting Policies (Details) [Line Items]                
Common stock, par value (in Dollars per share) | $ / shares $ 0.0001   $ 0.0001          
Initial public offering [Member] | Public Warrants [Member]                
Summary of Significant Accounting Policies (Details) [Line Items]                
Class of warrant or right issued during period shares | shares 10,470,562   10,470,562          
Initial public offering [Member] | Private Placement Warrants [Member]                
Summary of Significant Accounting Policies (Details) [Line Items]                
Class of warrant or right issued during period shares | shares 6,521,568   6,521,568          
Class A common stock                
Summary of Significant Accounting Policies (Details) [Line Items]                
Number of securities called by each warrant or right, per share (in Dollars per share) | $ / shares $ 11.50   $ 11.50          
XML 66 R46.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Schedule of Reconciliation of Cash, Cash Equivalents, And Restricted Cash (Detail) - USD ($)
$ in Thousands
Jul. 31, 2021
Jan. 31, 2021
Jul. 31, 2020
Jan. 31, 2020
Jan. 31, 2019
Jan. 31, 2018
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]            
Cash and cash equivalents $ 618,089 $ 145,491   $ 72,753 $ 205,238  
Restricted cash   400   400 460  
Total cash, cash equivalents, and restricted cash $ 618,489 $ 145,891 $ 189,537 $ 73,153 $ 205,698 $ 88,844
XML 67 R47.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Schedule of Allowance for Doubtful Accounts (Detail) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Accounts Receivable, after Allowance for Credit Loss [Abstract]      
Beginning Balance $ 2,000 $ 3,124 $ 1,316
Additions Charged To Expense 121 339 1,812
Write-offs (121) (1,463) (4)
Ending Balance $ 2,000 $ 2,000 $ 3,124
XML 68 R48.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives (Detail)
12 Months Ended
Jan. 31, 2021
Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life 5 years
Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life 7 years
Furniture and Fixtures [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life 3 years
Furniture and Fixtures [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life 5 years
Computer Software, Intangible Asset [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life 3 years
Computer Software, Intangible Asset [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life 5 years
Machinery and Equipment [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life 3 years
Machinery and Equipment [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life 5 years
Tooling [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life 3 years
Tooling [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life 5 years
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment useful life Shorter of the estimatedlease term or useful life
XML 69 R49.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Schedule of Deferred Contract Acquisition Costs (Detail) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Deferred Costs [Abstract]          
Balance $ 5,534 $ 3,832 $ 3,832 $ 2,189  
Capitalization of deferred contract acquisition costs     2,908 2,318  
Amortization of deferred contract acquisition costs $ (829) $ (538) (1,206) (675) $ 0
Balance     $ 5,534 $ 3,832 $ 2,189
XML 70 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Schedule of Deferred Acquisition Costs (Detail) - USD ($)
$ in Thousands
Jan. 31, 2021
Jan. 31, 2020
Deferred Costs [Abstract]    
Deferred contract acquisition costs, current $ 1,550 $ 1,013
Deferred contract acquisition costs, noncurrent 3,984 2,819
Total deferred contract acquisition costs $ 5,534 $ 3,832
XML 71 R51.htm IDEA: XBRL DOCUMENT v3.21.2
Reverse Recapitalization - Summary of Number of Shares of Common Stock Issued Immediately Following the Consummation of the Business Combination (Details) - shares
6 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Business Acquisition [Line Items]    
Common stock of Switchback, outstanding prior to Merger 38,246,989  
Merger and PIPE financing shares [1] 60,746,989  
Legacy ChargePoint shares [2] 217,021,368  
Total shares of common stock immediately after Merger 277,768,357  
Switchback [Member]    
Business Acquisition [Line Items]    
Common stock of Switchback, outstanding prior to Merger   39,264,704
Less redemption of Switchback shares (33,009)  
Less surrender of Switchback Founder Shares (984,706)  
PIPE Financing [Member]    
Business Acquisition [Line Items]    
Shares issued in PIPE 22,500,000  
[1] This includes 900,000 contingently forfeitable Founder Earn Back Shares pending the occurrence of the Founder Earn Back Triggering Event, which was met on March 12, 2021
[2] The number of Legacy ChargePoint shares was determined from the 217,761,738 shares of Legacy ChargePoint common stock outstanding immediately prior to the closing of the Merger converted at the exchange ratio of 0.9966. All fractional shares were rounded down.
XML 72 R52.htm IDEA: XBRL DOCUMENT v3.21.2
Reverse Recapitalization - Additional Information (Details)
6 Months Ended 12 Months Ended
Feb. 26, 2021
USD ($)
$ / shares
shares
Jul. 31, 2021
USD ($)
shares
Jan. 31, 2021
shares
Jan. 31, 2020
shares
Jan. 31, 2019
shares
Common stock, shares issued   322,170,484 22,961,032 11,918,418  
Common stock, shares outstanding   322,170,484 22,961,032 11,918,418  
Number of share options exercised during the current period.   3,292,219 11,042,592 4,830,469 3,853,935
Common stock remain reserved for oustanding   118,724,904 266,494,345 227,825,043  
Stockholders equity exchange ratio 0.9966        
Temporary Equity, shares outstanding   0 182,934,257 160,583,203 157,948,553
Merger and PIPE financing shares [1]   60,746,989      
Merger and PIPE financing | $   $ 511,646,000      
Transaction costs | $   36,500,000      
Adjustments to additional paid in capital, decrease for cost recognition | $   29,500,000      
Offering costs expensed | $   7,000,000.0      
Merger Agreement [Member]          
Business acquisition, share price (in Dollars per share) | $ / shares $ 10.00        
SponsorMember | Private Placement Warrants [Member]          
Debt instrument convertible into warrants | $ $ 1,000,000        
Conversion price per warrants | $ / shares $ 1.50        
Due to related party | $ $ 1,500,000        
Switchback Public Stockholders [Member]          
Stocks redeemed value | $   300,000      
PIPE Financing [Member]          
Proceeds from business Combination | $   $ 225,000,000.0      
Switchback [Member]          
Stock surrended During Period, Shares   (984,706)      
Cash held in trust account | $   $ 286,600,000      
Switchback [Member] | Founder Earn Back Triggering Event [Member]          
Share transfer, trigger price price per share. | $ / shares $ 12.00        
Number of consecutive trading days for determining share price 10 days        
Number of trading days for determining share price. 20 days        
Threshold number of trading days for determining share price from date of business combination 5 years        
Switchback [Member] | Subscription Agreement [Member] | PIPE Financing [Member]          
Initial public offering shares (in Shares) 22,500,000        
Public share price (in Dollars per share) | $ / shares $ 10.00        
Initial public offering gross proceeds | $ $ 225,000,000.0        
Legacy Charge Point [Member]          
Common stock, shares outstanding 217,761,738        
Legacy Charge Point [Member] | Series H-1 [Member]          
Temporary Equity, shares outstanding 22,427,306        
Preferred stock, conversion basis one-to-one basis        
Convertible preferred stock, shares issued upon conversion 1,026,084        
Preferred stock, amount of preferred dividends in arrears | $ $ 21,100,000        
Legacy Charge Point [Member] | Series H [Member]          
Temporary Equity, shares outstanding 160,925,957        
Preferred stock, conversion basis one-to-one basis        
Legacy Charge Point [Member] | Series G [Member]          
Temporary Equity, shares outstanding 160,925,957        
Preferred stock, conversion basis one-to-one basis        
Legacy Charge Point [Member] | Series F [Member]          
Temporary Equity, shares outstanding 160,925,957        
Preferred stock, conversion basis one-to-one basis        
Legacy Charge Point [Member] | Series E [Member]          
Temporary Equity, shares outstanding 160,925,957        
Preferred stock, conversion basis one-to-one basis        
Legacy Charge Point [Member] | Series D [Member]          
Temporary Equity, shares outstanding 160,925,957        
Preferred stock, conversion basis one-to-one basis        
Legacy Charge Point [Member] | Series C [Member]          
Temporary Equity, shares outstanding 45,376        
Preferred stock, conversion basis 1:73.4403        
Legacy Charge Point [Member] | Series B [Member]          
Temporary Equity, shares outstanding 130,590        
Preferred stock, conversion basis 1:42.9220        
Legacy Charge Point [Member] | Series A [Member]          
Temporary Equity, shares outstanding 29,126        
Preferred stock, conversion basis 1:48.2529        
Charge Point Common Stock [Member] | Switchback [Member]          
Common stock, shares issued 217,021,368        
Common stock, shares outstanding 217,021,368        
Number of share options exercised during the current period. 68,896,516        
Common stock remain reserved for oustanding 68,896,516        
Charge Point Common Stock [Member] | Switchback [Member] | Merger Agreement [Member]          
Business acquisition, share price (in Dollars per share) | $ / shares $ 10.00        
Founder Shares [Member] | Switchback [Member]          
Stock surrended During Period, Shares 984,706        
Founder Earn Back Shares [Member] | Switchback [Member]          
Number of founder shares forfeited 900,000        
[1] This includes 900,000 contingently forfeitable Founder Earn Back Shares pending the occurrence of the Founder Earn Back Triggering Event, which was met on March 12, 2021
XML 73 R53.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Summary of Company's Assets and Liabilities that were Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Jul. 31, 2021
Jan. 31, 2021
Fair Value, Recurring [Member]    
Assets    
Financial Assets $ 454,713 $ 109,703
Liabilities    
Financial Liabilities 26,868 75,843
Fair Value, Recurring [Member] | Redeemable Convertible Preferred Stock Warrant Liability [Member]    
Liabilities    
Financial Liabilities   75,843
Private Placement Warrants [Member] | Fair Value, Recurring [Member] | Common Stock Warrant Liabilities [Member]    
Liabilities    
Financial Liabilities 26,868  
Money Market Funds [Member]    
Assets    
Financial Assets 454,713 109,703
Level 1 | Fair Value, Recurring [Member]    
Assets    
Financial Assets 454,713 109,703
Liabilities    
Financial Liabilities 0  
Level 1 | Money Market Funds [Member]    
Assets    
Financial Assets 454,713 109,703
Level 3 | Fair Value, Recurring [Member]    
Liabilities    
Financial Liabilities 26,868 75,843
Level 3 | Fair Value, Recurring [Member] | Redeemable Convertible Preferred Stock Warrant Liability [Member]    
Liabilities    
Financial Liabilities   $ 75,843
Level 3 | Private Placement Warrants [Member] | Fair Value, Recurring [Member] | Common Stock Warrant Liabilities [Member]    
Liabilities    
Financial Liabilities $ 26,868  
XML 74 R54.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Summary of Changes in the Fair Value of Level 3 Financial Statements (Details) - Significant Other Unobservable Inputs (Level 3) [Member]
$ in Thousands
6 Months Ended
Jul. 31, 2021
USD ($)
Earnout Liability [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Contingent earnout liability recognized upon the closing of the reverse recapitalization $ (828,180)
Change in fair value included in other income (expense), net 84,420
Issuance of earnout shares upon triggering events 501,120
Reclassification of remaining contingent earnout liability upon triggering event 242,640
Redeemable Convertible Preferred Stock Warrant Liability [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Beginning balance (75,843)
Change in fair value included in other income (expense), net 9,237
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization 66,606
Private Placement Warrants [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Private placement warrant liability acquired as part of the merger (127,888)
Change in fair value included in other income (expense), net 49,264
Reclassification of option warrants to stockholders' equity (deficit) due to exercise 51,756
Ending balance $ (26,868)
XML 75 R55.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Assets and liabilities measured at fair value on recurring basis (Detail) - USD ($)
$ in Thousands
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Debt Securities, Available-for-sale [Line Items]        
Cash and cash equivalents $ 618,089 $ 145,491 $ 72,753 $ 205,238
Short term Investments   0 47,037  
Fair Value, Recurring [Member]        
Debt Securities, Available-for-sale [Line Items]        
Amortized Cost   145,491 119,767  
Gross Unreal Gains   0 23  
Gross Unreal Losses   0 0  
Fair Value   145,491 119,790  
Cash and cash equivalents   145,491 72,753  
Short term Investments     47,037  
Fair Value, Recurring [Member] | Cash [Member]        
Debt Securities, Available-for-sale [Line Items]        
Amortized Cost   35,788 33,266  
Gross Unreal Gains   0 0  
Gross Unreal Losses   0 0  
Fair Value   35,788 33,266  
Cash and cash equivalents   35,788 33,266  
Level 1 | Fair Value, Recurring [Member] | Money Market Funds [Member]        
Debt Securities, Available-for-sale [Line Items]        
Amortized Cost   109,703 39,487  
Gross Unreal Gains   0 0  
Gross Unreal Losses   0 0  
Fair Value   109,703 39,487  
Cash and cash equivalents   $ 109,703 39,487  
Level 2 | Fair Value, Recurring [Member] | US Treasury Bill Securities [Member]        
Debt Securities, Available-for-sale [Line Items]        
Amortized Cost     47,014  
Gross Unreal Gains     23  
Gross Unreal Losses     0  
Fair Value     47,037  
Cash and cash equivalents     0  
Short term Investments     $ 47,037  
XML 76 R56.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Additional Information (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Money Market Funds [Member]      
Unrealized gains or losses $ 0 $ 0 $ 0
XML 77 R57.htm IDEA: XBRL DOCUMENT v3.21.2
Acquisitions - Additional Information (Detail) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2021
Jan. 31, 2019
Jul. 31, 2021
Jan. 31, 2020
Business Acquisition [Line Items]        
Goodwill $ 1,215   $ 1,215 $ 1,215
Cash compensation awards $ 1,000      
Restricted common stock 797,280      
Vesting period 2 years      
Fair value for the restricted common stock $ 600      
Electric Fleet [Member]        
Business Acquisition [Line Items]        
Purchase consideration   $ 1,500    
Intangible assets   300    
Goodwill   $ 1,200    
XML 78 R58.htm IDEA: XBRL DOCUMENT v3.21.2
Composition of Certain Financial Statement Items - Additional Information (Detail) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Composition Of Certain Financial Statement Items [Abstract]              
Depreciation expenses $ 2.9 $ 2.4 $ 5.6 $ 4.7 $ 10.1 $ 7.1 $ 3.9
Amortization expense for intangible assets         $ 0.0 $ 0.6 $ 0.2
XML 79 R59.htm IDEA: XBRL DOCUMENT v3.21.2
Composition of Certain Financial Statement Items - Summary of Inventories (Detail) - USD ($)
$ in Thousands
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Inventory Disclosure [Abstract]      
Raw materials $ 8,421 $ 13,029 $ 11,335
Work-in-progress 0 68 0
Finished goods 19,495 20,495 14,084
Total Inventories $ 27,916 $ 33,592 $ 25,419
XML 80 R60.htm IDEA: XBRL DOCUMENT v3.21.2
Composition of Certain Financial Statement Items - Summary of Property Plant and Equipment Net (Detail) - USD ($)
$ in Thousands
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross $ 61,570 $ 54,851 $ 42,697
Less: Accumulated depreciation (29,305) (24,863) (14,756)
Total Property and Equipment, Net 32,265 29,988 27,941
Furniture and fixtures [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross 899 1,594 1,347
Computers and software [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross 5,843 5,384 4,350
Machinery and equipment [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross 12,140 10,605 7,614
Tooling [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross 9,666 7,705 6,299
Leasehold improvements [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross 9,680 9,398 8,869
Owned and operated systems [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross 20,582 17,703 8,422
Construction in progress [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross $ 2,760 $ 2,462 $ 5,796
XML 81 R61.htm IDEA: XBRL DOCUMENT v3.21.2
Composition of Certain Financial Statement Items - Summary of Accrued and Other Current Liabilities (Detail) - USD ($)
$ in Thousands
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Payables and Accruals [Abstract]      
Accrued expenses $ 19,113 $ 18,404 $ 11,335
Refundable customer deposits 7,488 6,482 5,241
Taxes payable 6,495 5,213 5,348
Payroll and related expenses 7,372 7,547 6,727
Warranty accruals 3,100 3,000 2,000
Operating lease liabilities, current 3,130 2,393 3,979
Other liabilities 5,282 4,123 3,029
Total Accrued and Other Current Liabilities $ 51,980 $ 47,162 $ 37,659
XML 82 R62.htm IDEA: XBRL DOCUMENT v3.21.2
Composition of Certain Financial Statement Items - Summary Of Revenue (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Disaggregation of Revenue [Line Items]              
Revenue from Contract with Customer, Excluding Assessed Tax $ 56,121 $ 34,957 $ 96,631 $ 67,733 $ 146,490 $ 144,515 $ 92,030
United States [Member]              
Disaggregation of Revenue [Line Items]              
Revenue from Contract with Customer, Excluding Assessed Tax 51,109 32,347 86,219 62,638 $ 131,571 $ 130,184 $ 81,408
Rest of World [Member]              
Disaggregation of Revenue [Line Items]              
Revenue from Contract with Customer, Excluding Assessed Tax $ 5,012 $ 2,610 $ 10,412 $ 5,095      
XML 83 R63.htm IDEA: XBRL DOCUMENT v3.21.2
Leases - Schedule of Lease Balances (Detail) - USD ($)
$ in Thousands
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Feb. 01, 2019
Operating leases        
Operating lease right-of-use assets $ 20,834 $ 21,817 $ 10,269 $ 11,300
Operating lease liabilities, current 3,130 2,393 3,979  
Operating lease liabilities, noncurrent 21,582 22,459 8,230  
Total operating lease liabilities $ 24,712   12,209 $ 12,500
Previously Reported [Member]        
Operating leases        
Operating lease liabilities, current   2,286 3,979  
Total operating lease liabilities   $ 24,745 $ 12,209  
XML 84 R64.htm IDEA: XBRL DOCUMENT v3.21.2
Leases - Additional Information (Detail) - USD ($)
$ in Millions
12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Leases [Abstract]      
Lease expense $ 5.1 $ 4.5 $ 3.1
Operating lease not yet commenced amount $ 1.0    
Lessee operating lease not yet commenced, term of contract 4 years 6 months    
XML 85 R65.htm IDEA: XBRL DOCUMENT v3.21.2
Leases - Maturities of Operating Leases (Detail) - USD ($)
$ in Thousands
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Feb. 01, 2019
2022   $ 4,719 $ 4,849  
2023   5,123 4,809  
2024   4,334 2,671  
2025   4,152 268  
2026   3,833 292  
Thereafter   13,855 1,341  
Total undiscounted operating lease payments   36,016 14,230  
Less: imputed interest $ (9,348)   (2,021)  
Total operating lease liabilities $ 24,712   12,209 $ 12,500
Previously Reported [Member]        
Less: imputed interest   (11,271)    
Total operating lease liabilities   $ 24,745 $ 12,209  
XML 86 R66.htm IDEA: XBRL DOCUMENT v3.21.2
Leases - Schedule of Other Supplemental Information of Lease Term and Discount Rate (Detail)
Jan. 31, 2021
Jan. 31, 2020
Lease, Cost [Abstract]    
Weighted-average remaining operating lease term (years) 7 years 6 months 3 years 8 months 12 days
Weighted-average operating lease discount rate 7.90% 8.70%
XML 87 R67.htm IDEA: XBRL DOCUMENT v3.21.2
Leases - Summary of Other Lease Supplemental Cash Flow Information (Detail) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Supplemental Cash Flow Information    
Cash paid for amounts in the measurement of operating lease liabilities $ 4,226 $ 4,527
XML 88 R68.htm IDEA: XBRL DOCUMENT v3.21.2
Debt - Additional Information (Detail) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2021
Jun. 30, 2019
Dec. 31, 2014
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Jul. 31, 2018
Line of Credit Facility [Line Items]                      
Term loan facility interest expense incurred       $ 0.0 $ 0.8            
Term loan facility accrued interest       $ 0.0   $ 0.0   $ 0.0      
2018 Loan                      
Line of Credit Facility [Line Items]                      
Term loan facility maximum borrowing capacity                     $ 45.0
Term loan facility unused borrowing capacity   $ 10.0                  
Term loan facility borrowings during the period   35.0                  
Payment of issuance costs   1.1                  
Proceeds from term loan facility   $ 33.9                  
Term loan facility term   5 years                  
Term loan facility interest rate description   LIBOR plus 6.55%                  
Term loan facility interest rate   6.55%                  
Term loan facility interest expense incurred           $ 1.5 $ 1.6 3.3 $ 3.5 $ 3.7  
Term loan facility accrued interest               $ 0.0 $ 0.0    
Repayments of term loan facility $ 35.0                    
Payments of accrued interest and prepayment fees $ 1.2                    
2014 Loan                      
Line of Credit Facility [Line Items]                      
Term loan facility maximum borrowing capacity     $ 20.0                
Term loan facility interest rate description     8.75% plus LIBOR                
Term loan facility interest rate     8.75%                
Term loan facility payment terms     The 2014 Loan was to be repaid in forty-eight monthly installments commencing on September 1, 2016; the first fifteen payments were interest only, followed by thirty-three equal monthly payments of principal and interest.                
2014 Loan | Minimum [Member]                      
Line of Credit Facility [Line Items]                      
Term loan facility interest rate     9.75%                
XML 89 R69.htm IDEA: XBRL DOCUMENT v3.21.2
Debt - Summary of Future Principal Payments (Detail)
$ in Thousands
Jan. 31, 2021
USD ($)
Long-term Debt, Fiscal Year Maturity [Abstract]  
2022 $ 11,667
2023 17,500
2024 5,833
Total payments $ 35,000
XML 90 R70.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Additional Information (Detail) - USD ($)
$ in Millions
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Commitments and Contingencies (Details) [Line Items]      
Purchase commitments for goods and services   $ 64.1  
Secured letters of credit outstanding   $ 0.4 $ 0.4
Purchase Commitment [Member]      
Commitments and Contingencies (Details) [Line Items]      
Purchase commitments for goods and services $ 133.7    
XML 91 R71.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Summary of Future Payments Under the Non-Cancellable&#160;Operating Lease (Details) - USD ($)
$ in Thousands
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Feb. 01, 2019
Commitments and Contingencies Disclosure [Abstract]        
2022 (remaining six months) $ 2,759      
2023 5,111      
2024 4,329      
2025 4,153      
2026 3,837      
Thereafter 13,871      
Total undiscounted operating lease payments 34,060      
Less: imputed interest (9,348)   $ (2,021)  
Total operating lease liabilities 24,712   12,209 $ 12,500
Less: current portion of operating lease liabilities (3,130) $ (2,393) (3,979)  
Operating lease liabilities, noncurrent $ 21,582 $ 22,459 $ 8,230  
XML 92 R72.htm IDEA: XBRL DOCUMENT v3.21.2
Redeemable Convertible Preferred Stock - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
6 Months Ended 12 Months Ended
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Funding Arrangement [Line Items]        
Cash Proceeds $ 92,433 $ 95,456 $ 14,756 $ 215,168
Maximum [Member]        
Funding Arrangement [Line Items]        
Public offering price   $ 11.3867    
Gross proceeds   $ 100,000    
Series H-1 Redeemable Convertible Preferred Stock [Member]        
Funding Arrangement [Line Items]        
Preferred Stock, Shares Issued   22.4    
Common stock warrants   22.4    
Cash Proceeds   $ 127,000    
Net of issuance costs   200    
Preferred stock warrant at fair value   95,500    
Common Stock warrant at fair value   31,500    
Intrinsic value   $ 60,400    
Cumulative dividend   $ 0.4554    
Dividend   $ 0    
Unpaid accumulated dividend   $ 16,800    
Preferred stock liquidation per share   $ 5.6934    
Preferred stock conversion to common stock price   5.6934    
Preferred stock, conversion price   5.6934    
Series H Preferred Stock [Member]        
Funding Arrangement [Line Items]        
Preferred Stock, Shares Issued     2.6 39.5
Common stock warrants     0.9 13.2
Cash Proceeds     $ 14,900 $ 216,600
Net of issuance costs     100 8,400
Cash Proceeds     $ 14,800 $ 215,200
Noncumulative dividend   0.4554    
Preferred stock liquidation per share   5.6934    
Preferred stock conversion to common stock price   5.6934    
Preferred stock, conversion price   5.6934    
Series A Preferred Stock [Member]        
Funding Arrangement [Line Items]        
Noncumulative dividend   10.3251    
Preferred stock liquidation per share   129.0387    
Preferred stock conversion to common stock price   91.7319    
Preferred stock, conversion price   1.9011    
Series B Preferred Stock [Member]        
Funding Arrangement [Line Items]        
Noncumulative dividend   8.5792    
Preferred stock liquidation per share   107.5156    
Preferred stock conversion to common stock price   81.5974    
Preferred stock, conversion price   1.9011    
Series C Preferred Stock [Member]        
Funding Arrangement [Line Items]        
Noncumulative dividend   23.1286    
Preferred stock liquidation per share   288.9825    
Preferred stock conversion to common stock price   139.6147    
Preferred stock, conversion price   1.9011    
Series D Preferred Stock [Member]        
Funding Arrangement [Line Items]        
Noncumulative dividend   0.0992    
Preferred stock liquidation per share   1.2401    
Preferred stock conversion to common stock price   1.2401    
Preferred stock, conversion price   1.2401    
Series E Preferred Stock [Member]        
Funding Arrangement [Line Items]        
Noncumulative dividend   0.0992    
Preferred stock liquidation per share   2.4802    
Preferred stock conversion to common stock price   1.2401    
Preferred stock, conversion price   1.2401    
Series F Preferred Stock [Member]        
Funding Arrangement [Line Items]        
Noncumulative dividend   0.1999    
Preferred stock liquidation per share   2.4988    
Preferred stock conversion to common stock price   2.4988    
Preferred stock, conversion price   2.4988    
Series G Preferred Stock [Member]        
Funding Arrangement [Line Items]        
Noncumulative dividend   0.3505    
Preferred stock liquidation per share   4.3808    
Preferred stock conversion to common stock price   4.3808    
Preferred stock, conversion price   $ 4.3808    
XML 93 R73.htm IDEA: XBRL DOCUMENT v3.21.2
Redeemable Convertible Preferred Stock - Schedule Of Redeemable Convertible Preferred Stock (Detail) - USD ($)
$ in Thousands
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Temporary Equity [Line Items]        
Shares Authorized 0 185,180,248 162,829,195 162,829,195
Shares Outstanding 0 182,934,257 160,583,203 157,948,553
Liquidation Preference $ 0 $ 17,492,964    
Carrying Value   615,697 $ 520,241 $ 505,485
Previously Reported [Member]        
Temporary Equity [Line Items]        
Liquidation Preference   $ 693,548 $ 563,753 $ 548,753
Series A Preferred Stock [Member]        
Temporary Equity [Line Items]        
Shares Authorized   29,027 29,027 29,027
Shares Outstanding   29,027 29,027 29,027
Carrying Value   $ 3,697 $ 3,697 $ 3,697
Series A Preferred Stock [Member] | Previously Reported [Member]        
Temporary Equity [Line Items]        
Liquidation Preference   $ 3,746 $ 3,746 $ 3,746
Series B Preferred Stock [Member]        
Temporary Equity [Line Items]        
Shares Authorized   132,831 132,831 132,831
Shares Outstanding   130,146 130,146 130,146
Carrying Value   $ 13,947 $ 13,947 $ 13,947
Series B Preferred Stock [Member] | Previously Reported [Member]        
Temporary Equity [Line Items]        
Liquidation Preference   $ 13,993 $ 13,993 $ 13,993
Series C Preferred Stock [Member]        
Temporary Equity [Line Items]        
Shares Authorized   45,222 45,222 45,222
Shares Outstanding   45,222 45,222 45,222
Carrying Value   $ 13,039 $ 13,039 $ 13,039
Series C Preferred Stock [Member] | Previously Reported [Member]        
Temporary Equity [Line Items]        
Liquidation Preference   $ 13,068 $ 13,068 $ 13,068
Series D Preferred Stock [Member]        
Temporary Equity [Line Items]        
Shares Authorized   45,744,194 45,744,194 45,744,194
Shares Outstanding   44,307,263 44,307,262 44,307,263
Carrying Value   $ 49,469 $ 49,469 $ 49,469
Series D Preferred Stock [Member] | Previously Reported [Member]        
Temporary Equity [Line Items]        
Liquidation Preference   $ 54,946 $ 54,946 $ 54,946
Series E Preferred Stock [Member]        
Temporary Equity [Line Items]        
Shares Authorized   22,578,525 22,578,525 22,578,525
Shares Outstanding   21,772,150 21,772,150 21,772,150
Carrying Value   $ 26,795 $ 26,795 $ 26,795
Series E Preferred Stock [Member] | Previously Reported [Member]        
Temporary Equity [Line Items]        
Liquidation Preference   $ 54,000 $ 54,000 $ 54,000
Series F Preferred Stock [Member]        
Temporary Equity [Line Items]        
Shares Authorized   23,611,372 23,611,372 23,611,372
Shares Outstanding   23,611,372 23,611,372 23,611,372
Carrying Value   $ 58,624 $ 58,624 $ 58,624
Series F Preferred Stock [Member] | Previously Reported [Member]        
Temporary Equity [Line Items]        
Liquidation Preference   $ 59,000 $ 59,000 $ 59,000
Series G Preferred Stock [Member]        
Temporary Equity [Line Items]        
Shares Authorized   28,533,636 28,533,636 28,533,636
Shares Outstanding   28,533,636 28,533,636 28,533,636
Carrying Value   $ 124,745 $ 124,745 $ 124,745
Series G Preferred Stock [Member] | Previously Reported [Member]        
Temporary Equity [Line Items]        
Liquidation Preference   $ 125,000 $ 125,000 $ 125,000
Series H Preferred Stock [Member]        
Temporary Equity [Line Items]        
Shares Authorized   42,154,388 42,154,388 42,154,388
Shares Outstanding   42,154,388 42,154,388 39,519,737
Carrying Value   $ 229,925 $ 229,925 $ 215,169
Series H Preferred Stock [Member] | Previously Reported [Member]        
Temporary Equity [Line Items]        
Liquidation Preference   $ 240,000 $ 240,000 $ 225,000
Series H-1 Redeemable Convertible Preferred Stock [Member]        
Temporary Equity [Line Items]        
Shares Authorized   22,351,053    
Shares Outstanding   22,351,053    
Carrying Value   $ 95,456    
Series H-1 Redeemable Convertible Preferred Stock [Member] | Previously Reported [Member]        
Temporary Equity [Line Items]        
Liquidation Preference   $ 129,795    
XML 94 R74.htm IDEA: XBRL DOCUMENT v3.21.2
Common Stock - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Feb. 26, 2021
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Jul. 31, 2021
Redeemable Convertible Preferred Stock [Line Items]          
Common stock outstanding   22,961,032 11,918,418   322,170,484
Common stock par value   $ 0.0001 $ 0.0001   $ 0.0001
Voting rights   one      
Shares par value $ 0.0001        
Shares authorized to issue prior to merger 484,951,532        
Common stock, shares authorized   299,771,284 240,180,600   1,000,000,000
Common stock, shares issued   22,961,032 11,918,418   322,170,484
Common stock shares granted   8,912,180 10,780,372 8,811,605  
Vesting period   2 years      
Redeemable Convertible Preferred Stock [Member]          
Redeemable Convertible Preferred Stock [Line Items]          
Shares authorized to issue prior to merger 185,180,248        
Restricted Common Stock [Member]          
Redeemable Convertible Preferred Stock [Line Items]          
Common stock shares granted       797,280  
Vesting period       2 years  
Restricted common stock vested   166,100 398,640 232,540  
Restricted common stock unvested   0 0    
Common Stock [Member]          
Redeemable Convertible Preferred Stock [Line Items]          
Shares authorized to issue prior to merger 299,771,284        
Common Stock [Member] | Switchback [Member]          
Redeemable Convertible Preferred Stock [Line Items]          
Business combination, stock issued value $ 200.5        
Business combination, issuance costs $ 29.4        
Common stock outstanding 277,768,357        
Common stock par value $ 0.0001        
Voting rights one        
Common Stock [Member] | Switchback [Member] | Merger Agreement [Member]          
Redeemable Convertible Preferred Stock [Line Items]          
Business combination, stock issued 60,746,989        
XML 95 R75.htm IDEA: XBRL DOCUMENT v3.21.2
Common Stock - Summary Of Common Stock Capital Shares Reserved For Future Issuance (Detail) - shares
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Common Stock Capital Shares Reserved For Future Issuance [Line Items]      
Total shares of common stock reserved 118,724,904 266,494,345 227,825,043
Conversion of redeemable convertible preferred stock [Member]      
Common Stock Capital Shares Reserved For Future Issuance [Line Items]      
Total shares of common stock reserved   193,037,715 170,686,661
Restricted Stock Units and Outstanding [Member]      
Common Stock Capital Shares Reserved For Future Issuance [Line Items]      
Total shares of common stock reserved 4,017,149    
Redeemable convertible preferred stock warrants outstanding [Member]      
Common Stock Capital Shares Reserved For Future Issuance [Line Items]      
Total shares of common stock reserved   2,358,546 2,358,546
Shares available for grant under 2017 Stock Option Plan [Member]      
Common Stock Capital Shares Reserved For Future Issuance [Line Items]      
Total shares of common stock reserved   4,528,391 5,844,909
Common stock reserved for Earnout [Member]      
Common Stock Capital Shares Reserved For Future Issuance [Line Items]      
Total shares of common stock reserved 39,249,702    
Stock options issued and outstanding [Member]      
Common Stock Capital Shares Reserved For Future Issuance [Line Items]      
Total shares of common stock reserved 26,401,717 30,167,178 34,883,465
Common stock warrants outstanding [Member]      
Common Stock Capital Shares Reserved For Future Issuance [Line Items]      
Total shares of common stock reserved   36,402,515 14,051,462
Shares available for grant under 2021 Equity Incentive Plan [Member]      
Common Stock Capital Shares Reserved For Future Issuance [Line Items]      
Total shares of common stock reserved 40,878,653    
Shares available for grant under 2021 ESPP [Member]      
Common Stock Capital Shares Reserved For Future Issuance [Line Items]      
Total shares of common stock reserved 8,177,683    
XML 96 R76.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Warrants and Earnouts - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 06, 2021
Jul. 01, 2021
Mar. 19, 2021
Mar. 13, 2021
Mar. 12, 2021
Jul. 31, 2021
Apr. 30, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Jun. 04, 2021
Feb. 26, 2021
Adjustments in warrants               $ 11,516,000 $ (9,237,000) $ 10,981,000 $ 73,125,000 $ 875,000 $ 388,000    
Number of days determining Earnout Triggering Event                 10 days   10 days        
Number of consecutive days determining Earnout Triggering Event                 20 days   20 days        
Class of warrants outstanding           39,249,702     39,249,702   38,761,031        
Warrants Exercised                 (16,258,978)            
Tranche Three [Member]                              
Earnout Shares     9,000,000   9,000,000                    
Series H1 Redeemable Convertible Preferred Stock [Member]                              
Adjustment of common stock warrants issued                     $ 22,400,000        
Series H Redeemable Convertible Preferred Stock [Member]                              
Adjustment of common stock warrants issued                       $ 900,000 $ 13,200,000    
Common Stock [Member]                              
Stock that may be issued           27,000,000     27,000,000   27,000,000        
Class of warrants outstanding           37,075,846     37,075,846   36,402,515 14,051,462      
Common Stock [Member] | Legacy Chargepoint [Member]                              
Class of warrants outstanding           36,402,503     36,402,503            
Warrants Exercised           587,880     1,685,185            
Issuance of common stock upon exercise of warrants           558,100     1,480,080            
Earnout Shares [Member]                              
Earnout liability       $ 743,700,000                     $ 828,100
Earnout liability fair value                             $ 828,200,000
Issuance Of Earnout Shares         18,000,000                    
Stock issued during period, shares, acquisitions       17,539,657                      
Estimated fair value of earn out liability         $ 242.6                    
Earnout Shares [Member] | Merger Agreement [Member]                              
Business combination, stock issued         9,000,000                    
Redeemable Convertible Preferred Stock Warrants [Member] | Series B D E Preferred Stock [Member]                              
Class of warrants outstanding           2,358,528     2,358,528            
Preferred Stock [Member] | Legacy Chargepoint [Member]                              
Class of warrants outstanding           2,358,528     2,358,528            
Gain [Member] | Earnout Shares [Member]                              
Adjustments in warrants             $ 84,400,000                
Earnout Triggering Event [Member] | Share Price Greater Or Equal 15 USD [Member]                              
Share price triggering Earnout         $ 15.00           $ 15.00        
Earnout Triggering Event [Member] | Share Price Greater Or Equal 20 USD [Member]                              
Share price triggering Earnout           $ 20.00     $ 20.00   20.00        
Triggering Share price         $ 20.00                    
Earnout Triggering Event [Member] | Share Price Greater Or Equal 30 USD [Member]                              
Share price triggering Earnout                     $ 30.00        
Earnout Triggering Event [Member] | Share Price Greater Or Equal 30 USD [Member] | Tranche Three [Member]                              
Share price triggering Earnout   $ 30.00                          
Issuance Of Earnout Shares   8,773,596                          
Earnout Shares                 9,000,000            
Earnout Triggering Event [Member] | Common Stock [Member]                              
Threshold triggering Share price         $ 30.00                    
Earnout Triggering Event [Member] | Common Stock [Member] | Share Price Greater Or Equal 15 USD [Member]                              
Earnout triggering share price           15.00     $ 15.00            
Earnout Triggering Event [Member] | Common Stock [Member] | Share Price Greater Or Equal 30 USD [Member]                              
Triggering Share price           $ 30.00     $ 30.00            
Earnout Triggering Event [Member] | Earnout Shares [Member]                              
Stock issuable value         $ 501,100,000                    
Private Placement Warrants [Member]                              
Days from which Warrants are exercisable                 30 years            
Proceeds from warrants exercised                 $ 117,600,000            
Initial measurements of fair value of warrant liability                 127,900,000            
Fair value adjustment of warrants           $ 3,800,000     $ 49,200,000            
Class of warrants outstanding           2,173,856     2,173,856            
Warrants Exercised                 (4,347,712)            
Public Warrants [Member]                              
Initial measurements of fair value of warrant liability                 $ 153,700,000            
Fair value adjustment of warrants           $ 14,300,000     $ 15,900,000            
Class of warrants outstanding           0     0            
Warrants Exercised                 (10,226,081)            
Class of warrants reedemption price per warrant 0.01                            
Number of warrants called for redemption                           244,481  
Class of warrants redeemed Or called during period 244,481                            
XML 97 R77.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Warrants and Earnouts - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail) - Level 3 [Member] - Redeemable Convertible Preferred Stock Warrants [Member]
Feb. 26, 2021
yr
Jan. 31, 2021
yr
Jan. 31, 2020
yr
Jan. 31, 2019
yr
Expected volatility [Member]        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Fair value measurements inputs 0.843 0.805 0.584 0.650
Risk-free interest rate [Member]        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Fair value measurements inputs 0.000 0.001 0.016 0.028
Dividend rate [Member]        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Fair value measurements inputs 0.000 0.000 0.000 0.000
Expected term (years) [Member]        
Fair Value Measurement Inputs and Valuation Techniques [Line Items]        
Fair value measurements inputs 0.0 1.4 2.0 2.0
XML 98 R78.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Warrants and Earnouts - Summary of Assumed Public Warrants (Detail) - shares
6 Months Ended
Jul. 31, 2021
Assumed Common Stock Warrants Or Right [Line Items]  
Outstanding as of January 31, 2021 38,761,031
Common Stock Warrants as Part of the Merger 16,992,130
Warrants Exercised (16,258,978)
Warrants Redeemed (244,481)
Outstanding as of July 31, 2021 39,249,702
Legacy Common and Preferred Stock Warrants [Member]  
Assumed Common Stock Warrants Or Right [Line Items]  
Outstanding as of January 31, 2021 38,761,031
Warrants Exercised (1,685,185)
Outstanding as of July 31, 2021 37,075,846
Private Placement Warrants [Member]  
Assumed Common Stock Warrants Or Right [Line Items]  
Common Stock Warrants as Part of the Merger 6,521,568
Warrants Exercised (4,347,712)
Outstanding as of July 31, 2021 2,173,856
Public Warrants [Member]  
Assumed Common Stock Warrants Or Right [Line Items]  
Common Stock Warrants as Part of the Merger 10,470,562
Warrants Exercised (10,226,081)
Warrants Redeemed (244,481)
Outstanding as of July 31, 2021 0
XML 99 R79.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Warrants and Earnouts - Summary of Assumed Public Warrants (Parenthetical) (Detail)
Feb. 26, 2021
Assumed Common Stock Warrants Or Right [Line Items]  
Stockholders equity exchange ratio 0.9966
Legacy ChargePoint Shares [Member]  
Assumed Common Stock Warrants Or Right [Line Items]  
Stockholders equity exchange ratio 0.9966
XML 100 R80.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Warrants and Earnouts - Summary of Fair Value Private Placement Warrants Basis Valuation Techniques (Detail) - Private Placement Warrants [Member]
Jul. 31, 2021
yr
Feb. 26, 2021
yr
Market price of public stock [Member]    
Fair Value Private Placement Warrants Basis Valuation Techniques [Line Items]    
Fair value measurements inputs 23.65 30.83
Exercise price [Member]    
Fair Value Private Placement Warrants Basis Valuation Techniques [Line Items]    
Fair value measurements inputs 11.50 11.50
Expected term (years) [Member]    
Fair Value Private Placement Warrants Basis Valuation Techniques [Line Items]    
Fair value measurements inputs 4.6 5.0
Expected volatility [Member]    
Fair Value Private Placement Warrants Basis Valuation Techniques [Line Items]    
Fair value measurements inputs 0.702 0.735
Risk-free interest rate [Member]    
Fair Value Private Placement Warrants Basis Valuation Techniques [Line Items]    
Fair value measurements inputs 0.006 0.008
Dividend rate [Member]    
Fair Value Private Placement Warrants Basis Valuation Techniques [Line Items]    
Fair value measurements inputs 0.000 0.000
XML 101 R81.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Warrants and Earnouts - Summary of Fair Value Earnout Liability Basis Valuation Techniques (Detail) - Earnout Shares [Member]
Mar. 12, 2021
yr
Feb. 26, 2021
yr
Current stock price [Member]    
Fair Value Earnout Liability Basis Valuation Techniques [Line Items]    
Earnout Liability Measurement Input 27.84 30.83
Expected volatility [Member]    
Fair Value Earnout Liability Basis Valuation Techniques [Line Items]    
Earnout Liability Measurement Input 0.7200 0.7160
Risk-free interest rate [Member]    
Fair Value Earnout Liability Basis Valuation Techniques [Line Items]    
Earnout Liability Measurement Input 0.0085 0.0075
Dividend rate [Member]    
Fair Value Earnout Liability Basis Valuation Techniques [Line Items]    
Earnout Liability Measurement Input 0.0000 0.0000
Expected term (years) [Member]    
Fair Value Earnout Liability Basis Valuation Techniques [Line Items]    
Earnout Liability Measurement Input 4.96 5.00
XML 102 R82.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Warrants and Earnouts - Schedule of Warrants Issued and Outstanding (Detail) - $ / shares
12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jul. 31, 2021
Class of Warrant or Right [Line Items]      
Total outstanding common stock warrants 38,761,031   39,249,702
Common Stock [Member]      
Class of Warrant or Right [Line Items]      
Total outstanding common stock warrants 36,402,515 14,051,462 37,075,846
Common Stock [Member] | Common Stock Warrants Outstanding at Exercise Price 6.02 [Member]      
Class of Warrant or Right [Line Items]      
Total outstanding common stock warrants 22,351,053    
Exercise Price $ 6.02    
Common Stock [Member] | Common Stock Warrants Outstanding at Exercise Price 6.02 [Member] | Minimum [Member]      
Class of Warrant or Right [Line Items]      
Expiration Date Jul. 31, 2030    
Common Stock [Member] | Common Stock Warrants Outstanding at Exercise Price 6.02 [Member] | Maximum [Member]      
Class of Warrant or Right [Line Items]      
Expiration Date Aug. 06, 2030    
Common Stock [Member] | Common Stock Warrants Outstanding at Exercise Price 9.03 [Member]      
Class of Warrant or Right [Line Items]      
Total outstanding common stock warrants 14,051,462 14,051,462  
Exercise Price $ 9.03 $ 9.03  
Common Stock [Member] | Common Stock Warrants Outstanding at Exercise Price 9.03 [Member] | Minimum [Member]      
Class of Warrant or Right [Line Items]      
Expiration Date Nov. 16, 2028 Nov. 16, 2028  
Common Stock [Member] | Common Stock Warrants Outstanding at Exercise Price 9.03 [Member] | Maximum [Member]      
Class of Warrant or Right [Line Items]      
Expiration Date Feb. 14, 2029 Feb. 14, 2029  
XML 103 R83.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Warrants and Earnouts - Schedule of Outstanding Redeemable Convertible Preferred Stock Warrants (Detail) - $ / shares
12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jul. 31, 2021
Class of Warrant or Right [Line Items]      
Total outstanding common stock warrants 38,761,031   39,249,702
Series B Preferred Stock [Member] | Warrant [Member]      
Class of Warrant or Right [Line Items]      
Total outstanding common stock warrants 2,685 2,685  
Exercise Price $ 107.52 $ 107.52  
Expiration date Apr. 30, 2021 Apr. 30, 2021  
Series D Preferred Stock [Member] | Warrant [Member]      
Class of Warrant or Right [Line Items]      
Total outstanding common stock warrants 1,436,932 1,436,932  
Exercise Price $ 1.24 $ 1.24  
Series D Preferred Stock [Member] | Warrant [Member] | Maximum [Member]      
Class of Warrant or Right [Line Items]      
Expiration date Jan. 24, 2024 Jan. 24, 2024  
Series D Preferred Stock [Member] | Warrant [Member] | Minimum [Member]      
Class of Warrant or Right [Line Items]      
Expiration date Apr. 20, 2022 Apr. 20, 2022  
Series E Preferred Stock [Member] | Warrant [Member]      
Class of Warrant or Right [Line Items]      
Total outstanding common stock warrants 806,375 806,375  
Exercise Price $ 1.24 $ 1.24  
Series E Preferred Stock [Member] | Warrant [Member] | Maximum [Member]      
Class of Warrant or Right [Line Items]      
Expiration date Jul. 15, 2025 Jul. 15, 2025  
Series E Preferred Stock [Member] | Warrant [Member] | Minimum [Member]      
Class of Warrant or Right [Line Items]      
Expiration date Dec. 24, 2024 Dec. 24, 2024  
Redeemable convertible preferred stock [Member] | Warrant [Member]      
Class of Warrant or Right [Line Items]      
Total outstanding common stock warrants 2,245,992 2,245,992  
XML 104 R84.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Warrants and Earnouts - Schedule of Liability of Warrants Subject to Re Measurement (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Class of Warrant or Right [Line Items]            
Change in fair value $ 11,516 $ (9,237) $ 10,981 $ 73,125 $ 875 $ 388
Warrant [Member] | Level 3 [Member]            
Class of Warrant or Right [Line Items]            
Fair value at beginning of period   $ 75,843 $ 2,718 2,718 1,843 1,455
Change in fair value       73,125 875 388
Fair value at end of period       $ 75,843 $ 2,718 $ 1,843
XML 105 R85.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Plans and Stock-based Compensation - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Jan. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options outstanding         30,166,792     28,955,341
Stock based compensation expense $ 28,293 $ 1,190 $ 35,870 $ 2,100 $ 4,947 $ 2,937 $ 1,706  
Total compensation cost related to unvested awards not yet recognised         $ 9,800      
Total unrecognized stock based compensation cost related to stock awards $ 41,000   $ 41,000          
Weighted average period     1 year 10 months 24 days   2 years 6 months      
Common stock capital shares reserved for future issuance 118,724,904   118,724,904   266,494,345 227,825,043    
Weighted average exercise price     $ 0.53   $ 0.55 $ 0.47 $ 0.35  
Weighted-average grant date fair value of options granted         $ 0.94 $ 0.31 $ 0.24  
Total grant date fair value of options vested         $ 5,400 $ 2,500 $ 1,800  
Restricted Stock Units (RSUs) [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total unrecognized stock based compensation cost related to stock awards $ 86,300   $ 86,300          
Weighted average period     3 years 1 month 6 days          
CEO Awards Plan [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock based compensation expense     $ 0          
Total compensation cost related to unvested awards not yet recognised $ 35,300   $ 35,300   $ 44,300      
Weighted average period     2 years 6 months          
Equity Incentive Plan Two Thousand Twenty One [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share based compensation arrangement, shares available for grant 40,878,653   40,878,653          
Share based compensation, terms of plan     On the first day of each March, beginning on March 1, 2021 and continuing through March 1, 2030, the 2021 EIP reserve will automatically increase by a number of shares equal to the lesser of (a) 5% of the total number of shares actually issued and outstanding on the last day of the preceding month and (b) a number determined by the Company’s Board of Directors.          
Equity Stock Purchase Plan Two Thousand Twenty One [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share based compensation arrangement, shares available for grant 8,177,683   8,177,683          
Share based compensation, terms of plan     on the first day of each March during the term of the 2021 ESPP, commencing on March 1, 2021 and ending on (and including) March 1, 2040, the aggregate number of shares of stock that may be issued under the 2021 ESPP shall automatically increase by a number equal to the lesser of (i) one percent (1%) of the total number of shares of stock issued and outstanding on the last day of the preceding month, (ii) 5,400,000 shares of stock (subject to standard anti-dilution adjustments), or (iii) a number of shares of stock determined by the Company’s Board of Directors.          
Share based compensation arrangement, description of plan     Under the 2021 ESPP, eligible employees are permitted to purchase shares of the Company’s Common Stock at 85% of the lower of fair market value the Company’s Common Stock on the first trading day of an offering period or on the purchase date.          
Equity Incentive Plan Two Thousand Seventeen [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share based compensation arrangement, description of plan         Stock options under the 2017 Plan generally expire 10 years from the date of grant, or earlier if services are terminated. The exercise price of an ISO and NSO shall not be less than 100% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Company’s board of directors. Stock options granted generally vest over four years and at a rate of 25% upon the first anniversary of the issuance date and 1/48th per month thereafter.      
Common stock capital shares reserved for future issuance 24,259,238   24,259,238   4,500,000      
Equity Incentive Plan Two Thousand Seven [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common stock capital shares reserved for future issuance 5,143,849   5,143,849          
Chief Executive Officer [Member] | CEO Awards Plan [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options outstanding 1,500,000   1,500,000   1,500,000      
Weighted average exercise price         $ 0.75      
Grant date fair value of stock option awards         $ 1,100,000      
XML 106 R86.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Plans and Stock-based Compensation - Summary of stock option awards (Detail) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Jan. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of stock option awards outstanding beginning balance 30,166,792     28,955,341  
Number of stock option awards granted   8,912,180 10,780,372 8,811,605  
Number of stock option awards exercised (3,292,219) (11,042,592) (4,830,469) (3,853,935)  
Number of stock option awards forfeited (452,893)        
Number of stock option awards expired (19,963) (2,585,875) (2,728,460) (2,250,990)  
Number of stock option awards outstanding ending balance 26,401,717 30,167,177 34,883,464 31,662,021  
Number of stock option awards options vested and expected to vest 25,667,621 27,483,800      
Number of stock option awards exercisable 16,457,228 16,591,050      
Weighted average exercise price outstanding beginning balance $ 0.71 $ 0.65 $ 0.6 $ 0.59  
Weighted average exercise price granted   0.75 0.75 0.57  
Weighted average exercise price exercised 0.53 0.55 0.47 0.35  
Weighted average exercise price forfeited 0.73        
Weighted average exercise price expired 53.22 0.84 0.83 0.75  
Weighted average exercise price outstanding ending balance 0.69 0.71 $ 0.65 $ 0.6  
Weighted average exercise price options vested and expected to vest 0.69 0.69      
Weighted average exercise price exercisable $ 0.66 $ 0.68      
Weighted average remaining contractual term 7 years 7 years 3 months 18 days 7 years 4 months 24 days 7 years 8 months 12 days  
Weighted average remaining contractual term options vested and expected to vest 7 years 7 years 2 months 12 days      
Weighted average remaining contractual term exercisable 6 years 3 months 18 days 6 years 4 months 24 days      
Aggregate intrinsic value outstanding   $ 1,064,539     $ 8,905,754
Aggregate intrinsic value exercised   (110,643,446) $ (3,464,262) $ (1,364,006)  
Aggregate intrinsic value options vested and expected to vest $ 589,470 969,997,293      
Aggregate intrinsic value exercisable 378,402 586,047,442      
Aggregate intrinsic value outstanding $ 606,280 $ 1,064,538,557 $ 19,314,017 $ 7,456,493  
XML 107 R87.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Plans and Stock-based Compensation - Summary of RSU activity (Detail) - Restricted Stock Units (RSUs) [Member]
6 Months Ended
Jul. 31, 2021
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Shares Outstanding as of January 31, 2021 | shares 0
Number of Shares RSU granted | shares 4,680,439
Number of Shares RSU vested | shares (652,901)
Number of Shares RSU forfeited | shares (10,389)
Number of Shares Outstanding as of July 31, 2021 | shares 4,017,149
Weighted Average Grant Date Fair Value per Share Outstanding as of January 31, 2021 | $ / shares $ 0
Weighted Average Grant Date Fair Value per Share RSU granted | $ / shares 27.38
Weighted Average Grant Date Fair Value per Share RSU vested | $ / shares 27.30
Weighted Average Grant Date Fair Value per Share RSU forfeited | $ / shares 27.30
Weighted Average Grant Date Fair Value per Share Outstanding as of July 31, 2021 | $ / shares $ 27.40
XML 108 R88.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Plans and Stock-based Compensation - Summary of Stock Based Compensation Expense (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total stock-based compensation expense $ 28,293 $ 1,190 $ 35,870 $ 2,100 $ 4,947 $ 2,937 $ 1,706
Cost of revenue [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total stock-based compensation expense 2,164 41 2,188 64 115 39 28
Research and development [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total stock-based compensation expense 13,682 454 14,357 757 1,807 871 419
Sales and marketing [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total stock-based compensation expense 4,169 356 4,767 655 1,501 1,164 541
General and administrative [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total stock-based compensation expense $ 8,278 $ 339 $ 14,558 $ 624 $ 1,524 $ 863 $ 718
XML 109 R89.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Plan and Stock-based Compensation - Summary of Weighted-average Assumptions Used to Determine the Fair Value of Stock Options Granted (Detail)
12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected volatility, Minimum 49.10% 40.30% 40.90%
Expected volatility, Maximum 51.60% 40.90% 41.60%
Risk-free interest rate, Minimum 0.30% 1.40% 2.70%
Risk-free interest rate, Maximum 1.60% 2.40% 2.90%
Dividend rate 0.00% 0.00% 0.00%
Minimum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected term (in years) 5 years 7 months 6 days 5 years 6 years 1 month 6 days
Maximum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected term (in years) 5 years 9 months 18 days 5 years 10 months 24 days 6 years 4 months 24 days
XML 110 R90.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 29, 2020
Jul. 31, 2021
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Jan. 31, 2018
Effective income tax rate   0.00% 0.00% (0.10%) (0.10%) (0.10%)  
Valuation allowance increased amount       $ 16,700 $ 36,200 $ 29,800  
Federal net operating loss carryforwards       434,700      
Federal net operating loss carryforwards not expire       $ 281,900      
Income tax description       As of January 31, 2021, the Company had federal and California state net operating loss (“NOL”) carryforwards of $434.7 million and $229.7 million, respectively, of which $281.9 million of the federal NOL carryforwards can be carried forward indefinitely. The federal and California state net operating loss carryforwards begin to expire in 2028 and 2029, respectively. In addition, the Company had NOLs for other states of $134.7 million, which expire beginning in the year 2022.      
Section 382 Ownership Change description       Under Internal Revenue Code Section 382, the Company’s ability to utilize NOL carryforwards or other tax attributes such as research tax credits, in any taxable year may be limited if the Company experiences, or has experienced, an “ownership change.” A Section 382 “ownership change” generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company’s stock, increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period.      
Federal tax credits expected to expire for income tax purposes       $ 9,700      
Unrecognized tax benefits       $ 9,402 $ 10,153 $ 6,884 $ 4,445
Description of Cares Act tax adjustments       The Consolidated Appropriations Act, 2021, which was enacted on December 27, 2020, has expanded, extended, and clarified selected CARES Act provisions, specifically on Paycheck Protection Program (PPP) loan and Employee Retention Tax Credit, 100% deductibility of business meals as well as other tax extenders. The Consolidated Appropriations Act did not have a material impact on the Company’s tax provision for the year ended January 31, 2021.      
Cares Act [Member]              
Carryback of net operating losses, Period       5 years      
Removing percentage of taxable income limitation on utilization of Net Operating Loss       80.00%      
Minimum [Member] | Cares Act [Member]              
Percentage of taxable income limitation       30.00%      
Maximum [Member] | Cares Act [Member]              
Percentage of taxable income limitation       50.00%      
CALIFORNIA              
State net operating loss carryforwards       $ 229,700      
Research credit carryforwards       5,100      
Net Operating Loss due to ownership changes       53,100      
Description of net operating loss deductions The legislation disallows the use of California net operating loss deductions if the taxpayer recognizes business income and its adjusted gross income is greater than $1 million. Additionally, any business credit will only offset a maximum of $5 million of California tax.            
Other State [Member]              
State net operating loss carryforwards       134,700      
State and Local Jurisdiction [Member]              
Research credit carryforwards       8,800      
Net Operating Loss due to ownership changes       $ 40,300      
XML 111 R91.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes (Details) - Schedule of income tax provision - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Current              
Federal        
State         47 35
Foreign         151 189 119
Total current         198 224 119
Deferred              
Federal            
State            
Foreign            
Total deferred            
Total provision for income taxes $ 65 $ 48 $ 103 $ 105 $ 198 $ 224 $ 119
XML 112 R92.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes (Details) - Schedule of net deferred tax assets - USD ($)
$ in Thousands
Jan. 31, 2021
Jan. 31, 2020
Deferred tax assets:    
Net operating losses $ 114,154 $ 105,663
Research & development credits 12,054 14,320
Deferred revenue 15,270 6,968
Accruals and reserves 8,102 6,692
Stock-based compensation 980 653
Operating lease liabilities 6,999 3,370
Total deferred tax assets 157,559 137,666
Less: valuation allowance (150,991) (134,337)
Deferred tax liabilities:    
Depreciation and amortization (375) (489)
Operating lease right-of-use assets (6,186) (2,834)
Total deferred tax liabilities (6,561) (3,323)
Net deferred tax assets $ 7 $ 6
XML 113 R93.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes - Schedule of Net Loss Before Income Taxes (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Income Tax Disclosure [Abstract]              
Domestic         $ (197,908) $ (134,578) $ (108,663)
Foreign         1,082 475 695
Net loss before income taxes $ (84,873) $ (35,239) $ (2,546) $ (65,280) $ (196,826) $ (134,103) $ (107,968)
XML 114 R94.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes - Summary of Unrecognized Tax Benefits (Detail) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Unrecognized tax benefits — beginning $ 10,153 $ 6,884 $ 4,445
Gross decreases — prior period tax position (3,620)    
Gross increases — current period tax position 2,869 3,269 2,439
Unrecognized tax benefits — ending $ 9,402 $ 10,153 $ 6,884
XML 115 R95.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes (Details) - Schedule of reconciliation of the statutory federal income tax rate to the Company's effective tax rate
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Schedule of reconciliation of the statutory federal income tax rate to the Company's effective tax rate [Abstract]          
Tax at federal statutory rate     21.00% 21.00% 21.00%
Permanent differences     (0.60%) (1.50%) (0.80%)
Warrant Mark to Market     (7.80%) (0.10%) (0.10%)
Stock-based compensation     (0.20%) (0.20%) (0.20%)
Change in Valuation Allowance     (13.60%) (21.10%) (21.90%)
Research and development tax credits     1.10% 1.80% 1.90%
Effective tax rate 0.00% 0.00% (0.10%) (0.10%) (0.10%)
XML 116 R96.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions - Additional Information (Detail) - USD ($)
$ in Millions
Jul. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Daimler [Member]      
Related Party Transaction [Line Items]      
Related party accounts receivable $ 2.5 $ 1.2 $ 0.9
XML 117 R97.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions - Summary of Revenue Transactions (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Related Party Transaction [Line Items]              
Revenue from related parties $ 2,071 $ 850 $ 3,406 $ 1,576 $ 3,457 $ 3,112 $ 1,082
Daimler [Member]              
Related Party Transaction [Line Items]              
Revenue from related parties $ 2,071 $ 850 $ 3,406 $ 1,576 $ 3,457 $ 3,112 $ 1,082
XML 118 R98.htm IDEA: XBRL DOCUMENT v3.21.2
Geographic Information - Summary of Revenue and Long-Lived Assets by Geographic Area (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Revenue and long-lived assets by geographical areas [Abstract]              
Revenue $ 56,121 $ 34,957 $ 96,631 $ 67,733 $ 146,490 $ 144,515 $ 92,030
Total long-lived assets         51,805 38,210  
United States [Member]              
Revenue and long-lived assets by geographical areas [Abstract]              
Revenue $ 51,109 $ 32,347 $ 86,219 $ 62,638 131,571 130,184 81,408
Total long-lived assets         46,759 36,836  
Rest of World [Member]              
Revenue and long-lived assets by geographical areas [Abstract]              
Revenue         14,919 14,331 $ 10,622
Total long-lived assets         $ 5,046 $ 1,374  
XML 119 R99.htm IDEA: XBRL DOCUMENT v3.21.2
Basic and Diluted Net Loss Per Share - Additional Information (Detail)
Jul. 31, 2021
Exchange ratio used to determine the number of shares of common stock into which they converted 0.9966
XML 120 R100.htm IDEA: XBRL DOCUMENT v3.21.2
Basic and Diluted Net Loss Per Share - Summary of Computation of Basic and Diluted Net Loss Per Share (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2021
Apr. 30, 2021
Jul. 31, 2020
Apr. 30, 2020
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Numerator:                  
Net income (loss) $ (84,938) $ 82,289 $ (35,287) $ (30,098) $ (2,649) $ (65,385) $ (197,024) $ (134,327) $ (108,087)
Adjust: Accretion of beneficial conversion feature of redeemable convertible preferred stock 0   58,625   0 58,625 60,377 0 0
Adjust: Cumulative dividends on redeemable convertible preferred stock 0       (4,292)        
Adjust: Deemed dividends attributable to vested option holders 0       (51,855)        
Adjust: Deemed dividends attributable to common stock warrant holders 0       (110,635)        
Net loss attributable to common stockholders - Basic (84,938)   (93,912)   (169,431) (124,010) $ (274,200) $ (134,327) $ (108,087)
Less: Gain attributable to earnout shares issued 0       (84,420)        
Less: Change in fair value of dilutive warrants (7,427)       (53,540)        
Net loss attributable to common stockholders - Diluted $ (92,365)   $ (93,912)   $ (307,391) $ (124,010)      
Denominator:                  
Weighted average common shares outstanding 312,465,016   13,537,501   266,473,703 12,822,481 15,116,763 8,893,787 4,342,517
Less: Weighted-average unvested restricted shares and shares subject to repurchase (237,490)   (68,824)   (276,221) 0      
Weighted average shares outstanding - Basic 312,227,526   13,468,677   266,197,482 12,822,481      
Add: Earnout Shares under the treasury stock method 0   0   7,464,203 0      
Add: Public and Private Placement Warrants under the treasury stock method 1,374,574   0   1,915,315 0      
Weighted average shares outstanding - Diluted 313,602,100   13,468,677   275,577,000 12,822,481      
Net loss per share attributable to common stockholders, basic and diluted             $ (18.14) $ (15.10) $ (24.89)
Net loss per share - Basic $ (0.27)   $ (6.97)   $ (0.64) $ (9.67)      
Net loss per share - Diluted $ (0.29)   $ (6.97)   $ (1.12) $ (9.67)      
XML 121 R101.htm IDEA: XBRL DOCUMENT v3.21.2
Basic and Diluted Net Loss Per Share - Summary of Computation of Diluted Net Loss Per Share (Detail) - shares
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total potentially dilutive common share equivalents 67,706,176 270,229,995 262,337,147 222,205,064 215,869,536
Redeemable Convertible Preferred Stock [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total potentially dilutive common share equivalents 0 192,469,995 193,037,715 170,686,661 168,052,012
Options to purchase common stock [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total potentially dilutive common share equivalents 26,401,717 39,463,877 30,167,178 34,883,465 31,662,022
Unvested restricted common stock [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total potentially dilutive common share equivalents       166,100 564,740
Restricted Stock Units (RSUs) [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total potentially dilutive common share equivalents 4,017,149 0      
Unvested early exercised common stock options [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total potentially dilutive common share equivalents 211,464 102,781 371,193 58,830 58,971
Redeemable convertible preferred stock warrant [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total potentially dilutive common share equivalents     2,358,546 2,358,546 2,358,546
Common stock warrants [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total potentially dilutive common share equivalents     36,402,515 14,051,462 13,173,245
Common Stock and Preferred Stock Warrants [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total potentially dilutive common share equivalents 37,075,846 38,193,342      
XML 122 R102.htm IDEA: XBRL DOCUMENT v3.21.2
Acquisitions and Subsequent Events - Additional Information (Detail)
$ / shares in Units, € in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Aug. 11, 2021
EUR (€)
Jul. 20, 2021
EUR (€)
Jun. 29, 2021
shares
Mar. 19, 2021
$ / shares
shares
Mar. 15, 2021
USD ($)
Mar. 12, 2021
$ / shares
shares
Feb. 26, 2021
USD ($)
$ / shares
shares
Apr. 30, 2021
USD ($)
Jul. 31, 2020
USD ($)
Jul. 31, 2021
USD ($)
$ / shares
shares
Jul. 31, 2020
USD ($)
Jan. 31, 2021
USD ($)
$ / shares
shares
Jan. 31, 2020
USD ($)
shares
Jan. 31, 2019
USD ($)
Jul. 06, 2021
$ / shares
Jul. 01, 2021
$ / shares
Mar. 13, 2021
USD ($)
Subsequent Event [Line Items]                                  
Adjustments in warrants | $                 $ 11,516,000 $ (9,237,000) $ 10,981,000 $ 73,125,000 $ 875,000 $ 388,000      
Additional paid-in capital | $                   $ 1,216,893,000   $ 62,736,000 $ 20,331,000        
Issuance Of Earnout Shares                   118,724,904   266,494,345 227,825,043        
Number of days determining Earnout Triggering Event                   10 days   10 days          
Number of consecutive days determining Earnout Triggering Event                   20 days   20 days          
Earnout Triggering Event [Member] | Share Price Greater Or Equal 15 USD [Member]                                  
Subsequent Event [Line Items]                                  
Share price triggering Earnout | $ / shares           $ 15.00           $ 15.00          
Earnout Triggering Event [Member] | Share Price Greater Or Equal 20 USD [Member]                                  
Subsequent Event [Line Items]                                  
Share price triggering Earnout | $ / shares                   $ 20.00   20.00          
Earnout Triggering Event [Member] | Share Price Greater Or Equal 30 USD [Member]                                  
Subsequent Event [Line Items]                                  
Share price triggering Earnout | $ / shares                       $ 30.00          
Tranche Three [Member]                                  
Subsequent Event [Line Items]                                  
Earnout Shares       9,000,000   9,000,000                      
Tranche Three [Member] | Earnout Triggering Event [Member] | Share Price Greater Or Equal 30 USD [Member]                                  
Subsequent Event [Line Items]                                  
Earnout Shares                   9,000,000              
Share price triggering Earnout | $ / shares                               $ 30.00  
Sponsor [Member]                                  
Subsequent Event [Line Items]                                  
Principal amount of working capital loans | $             $ 1,500,000                    
Sponsor [Member] | Private Placement Warrants [Member]                                  
Subsequent Event [Line Items]                                  
Debt conversion converted instrument warrants issued             1,000,000                    
Conversion price per warrants | $ / shares             $ 1.50                    
PIPE Investor [Member]                                  
Subsequent Event [Line Items]                                  
Stock issued during period shares new issues             22,500,000                    
Aggregate purchase price | $             $ 225,000,000                    
Subsequent Event [Member]                                  
Subsequent Event [Line Items]                                  
Repayments of term loan facility | $         $ 35,000,000.0                        
Payments of accrued interest and prepayment fees | $         $ 1,200,000                        
Adjustments in warrants | $               $ 84,400,000                  
Additional paid-in capital | $               $ 743,700,000                  
Subsequent Event [Member] | Tranche Three And Final [Member]                                  
Subsequent Event [Line Items]                                  
Earnout Shares     9,000,000                            
Subsequent Event [Member] | Public Warrants [Member]                                  
Subsequent Event [Line Items]                                  
Class of warrants redemption price per share | $ / shares                             $ 0.01    
Has To Be [Member]                                  
Subsequent Event [Line Items]                                  
Payments to Acquire Businesses, Gross | €   € 250.0                              
ViriCiti B V [Member] | Subsequent Event [Member]                                  
Subsequent Event [Line Items]                                  
Payments to Acquire Businesses, Gross | € € 75.0                                
Common Stock [Member]                                  
Subsequent Event [Line Items]                                  
Stock that may be issued                   27,000,000   27,000,000          
Common Stock [Member] | Business Combination Agreement [Member]                                  
Subsequent Event [Line Items]                                  
Conversion of warrants,shares issued             38,761,031                    
Conversion of options, shares issued             30,135,695                    
Conversion of unvested restricted shares of common stock, shares issued             345,689                    
Common Stock [Member] | Charge Point [Member]                                  
Subsequent Event [Line Items]                                  
Business Acquisition,Number of Shares received             0.9966                    
Earnout Shares [Member]                                  
Subsequent Event [Line Items]                                  
Issuance Of Earnout Shares       18,000,000               27,000,000          
Earnout share price | $ / shares       $ 27.84                          
Earnout liability | $             $ 828,100                   $ 743,700,000
Founder Shares [Member] | Founders Stock Letter [Member]                                  
Subsequent Event [Line Items]                                  
Number of shares cancelled as a capital contribution             984,706                    
Number of shares cancelled as a capital contribution par value per share | $ / shares             $ 0.0001                    
Number of founder shares forfeited             900,000                    
Stock conversion basis             one-for-one                    
EXCEL 123 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

,"2*S'MPYWT4K-]3P>:_N*/?4$L#!!0 M ( !6$3E.7BKL

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end XML 124 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 125 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 126 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 580 645 1 true 145 0 false 9 false false R1.htm 1001 - Document - Cover Page Sheet http://charge.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Consolidated Balance Sheets Sheet http://charge.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Consolidated Statements of Operations Sheet http://charge.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) Sheet http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss Condensed Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 1006 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) Sheet http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) Statements 6 false false R7.htm 1007 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) Sheet http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) Statements 7 false false R8.htm 1008 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 8 false false R9.htm 1009 - Disclosure - Description of Business and Basis of Presentation Sheet http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentation Description of Business and Basis of Presentation Notes 9 false false R10.htm 1010 - Disclosure - Summary of Significant Accounting Policies Sheet http://charge.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 1011 - Disclosure - Reverse Recapitalization Sheet http://charge.com/role/ReverseRecapitalization Reverse Recapitalization Notes 11 false false R12.htm 1012 - Disclosure - Fair Value Measurements Sheet http://charge.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 1013 - Disclosure - Acquisitions Sheet http://charge.com/role/Acquisitions Acquisitions Notes 13 false false R14.htm 1014 - Disclosure - Composition of Certain Financial Statement Items Sheet http://charge.com/role/CompositionOfCertainFinancialStatementItems Composition of Certain Financial Statement Items Notes 14 false false R15.htm 1015 - Disclosure - Leases Sheet http://charge.com/role/Leases Leases Notes 15 false false R16.htm 1016 - Disclosure - Debt Sheet http://charge.com/role/Debt Debt Notes 16 false false R17.htm 1017 - Disclosure - Commitments and Contingencies Sheet http://charge.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 17 false false R18.htm 1018 - Disclosure - Redeemable Convertible Preferred Stock Sheet http://charge.com/role/RedeemableConvertiblePreferredStock Redeemable Convertible Preferred Stock Notes 18 false false R19.htm 1019 - Disclosure - Common Stock Sheet http://charge.com/role/CommonStock Common Stock Notes 19 false false R20.htm 1020 - Disclosure - Stock Warrants and Earnouts Sheet http://charge.com/role/StockWarrantsAndEarnouts Stock Warrants and Earnouts Notes 20 false false R21.htm 1021 - Disclosure - Equity Plans and Stock-based Compensation Sheet http://charge.com/role/EquityPlansAndStockBasedCompensation Equity Plans and Stock-based Compensation Notes 21 false false R22.htm 1022 - Disclosure - Income Taxes Sheet http://charge.com/role/IncomeTaxes Income Taxes Notes 22 false false R23.htm 1023 - Disclosure - Related Party Transactions Sheet http://charge.com/role/RelatedPartyTransactions Related Party Transactions Notes 23 false false R24.htm 1024 - Disclosure - Geographic Information Sheet http://charge.com/role/GeographicInformation Geographic Information Notes 24 false false R25.htm 1025 - Disclosure - Basic and Diluted Net Loss Per Share Sheet http://charge.com/role/BasicAndDilutedNetLossPerShare Basic and Diluted Net Loss Per Share Notes 25 false false R26.htm 1026 - Disclosure - Employee Benefit Plans Sheet http://charge.com/role/EmployeeBenefitPlans Employee Benefit Plans Notes 26 false false R27.htm 1027 - Disclosure - Acquisitions and Subsequent Events Sheet http://charge.com/role/AcquisitionsAndSubsequentEvents Acquisitions and Subsequent Events Notes 27 false false R28.htm 1028 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://charge.com/role/SummaryOfSignificantAccountingPolicies 28 false false R29.htm 1029 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://charge.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://charge.com/role/SummaryOfSignificantAccountingPolicies 29 false false R30.htm 1030 - Disclosure - Reverse Recapitalization (Tables) Sheet http://charge.com/role/ReverseRecapitalizationTables Reverse Recapitalization (Tables) Tables http://charge.com/role/ReverseRecapitalization 30 false false R31.htm 1031 - Disclosure - Fair Value Measurements (Tables) Sheet http://charge.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://charge.com/role/FairValueMeasurements 31 false false R32.htm 1032 - Disclosure - Composition of Certain Financial Statement Items (Tables) Sheet http://charge.com/role/CompositionOfCertainFinancialStatementItemsTables Composition of Certain Financial Statement Items (Tables) Tables http://charge.com/role/CompositionOfCertainFinancialStatementItems 32 false false R33.htm 1033 - Disclosure - Leases (Tables) Sheet http://charge.com/role/LeasesTables Leases (Tables) Tables http://charge.com/role/Leases 33 false false R34.htm 1034 - Disclosure - Debt (Tables) Sheet http://charge.com/role/DebtTables Debt (Tables) Tables http://charge.com/role/Debt 34 false false R35.htm 1035 - Disclosure - Commitments and Contingencies (Tables) Sheet http://charge.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://charge.com/role/CommitmentsAndContingencies 35 false false R36.htm 1036 - Disclosure - Redeemable Convertible Preferred Stock (Tables) Sheet http://charge.com/role/RedeemableConvertiblePreferredStockTables Redeemable Convertible Preferred Stock (Tables) Tables http://charge.com/role/RedeemableConvertiblePreferredStock 36 false false R37.htm 1037 - Disclosure - Income Taxes (Tables) Sheet http://charge.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://charge.com/role/IncomeTaxes 37 false false R38.htm 1038 - Disclosure - Common Stock (Tables) Sheet http://charge.com/role/CommonStockTables Common Stock (Tables) Tables http://charge.com/role/CommonStock 38 false false R39.htm 1039 - Disclosure - Stock Warrants and Earnouts (Tables) Sheet http://charge.com/role/StockWarrantsAndEarnoutsTables Stock Warrants and Earnouts (Tables) Tables http://charge.com/role/StockWarrantsAndEarnouts 39 false false R40.htm 1040 - Disclosure - Equity Plans and Stock-based Compensation (Tables) Sheet http://charge.com/role/EquityPlansAndStockBasedCompensationTables Equity Plans and Stock-based Compensation (Tables) Tables http://charge.com/role/EquityPlansAndStockBasedCompensation 40 false false R41.htm 1041 - Disclosure - Related Party Transactions (Tables) Sheet http://charge.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://charge.com/role/RelatedPartyTransactions 41 false false R42.htm 1042 - Disclosure - Geographic Information (Tables) Sheet http://charge.com/role/GeographicInformationTables Geographic Information (Tables) Tables http://charge.com/role/GeographicInformation 42 false false R43.htm 1043 - Disclosure - Basic and Diluted Net Loss Per Share (Tables) Sheet http://charge.com/role/BasicAndDilutedNetLossPerShareTables Basic and Diluted Net Loss Per Share (Tables) Tables http://charge.com/role/BasicAndDilutedNetLossPerShare 43 false false R44.htm 1044 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail) Sheet http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail Description of Business and Basis of Presentation - Additional Information (Detail) Details 44 false false R45.htm 1045 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://charge.com/role/SummaryOfSignificantAccountingPoliciesTables 45 false false R46.htm 1046 - Disclosure - Summary of Significant Accounting Policies - Schedule of Reconciliation of Cash, Cash Equivalents, And Restricted Cash (Detail) Sheet http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetail Summary of Significant Accounting Policies - Schedule of Reconciliation of Cash, Cash Equivalents, And Restricted Cash (Detail) Details 46 false false R47.htm 1047 - Disclosure - Summary of Significant Accounting Policies - Schedule of Allowance for Doubtful Accounts (Detail) Sheet http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAllowanceForDoubtfulAccountsDetail Summary of Significant Accounting Policies - Schedule of Allowance for Doubtful Accounts (Detail) Details 47 false false R48.htm 1048 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives (Detail) Sheet http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives (Detail) Details 48 false false R49.htm 1049 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Contract Acquisition Costs (Detail) Sheet http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredContractAcquisitionCostsDetail Summary of Significant Accounting Policies - Schedule of Deferred Contract Acquisition Costs (Detail) Details 49 false false R50.htm 1050 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Acquisition Costs (Detail) Sheet http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredAcquisitionCostsDetail Summary of Significant Accounting Policies - Schedule of Deferred Acquisition Costs (Detail) Details 50 false false R51.htm 1051 - Disclosure - Reverse Recapitalization - Summary of Number of Shares of Common Stock Issued Immediately Following the Consummation of the Business Combination (Details) Sheet http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails Reverse Recapitalization - Summary of Number of Shares of Common Stock Issued Immediately Following the Consummation of the Business Combination (Details) Details 51 false false R52.htm 1052 - Disclosure - Reverse Recapitalization - Additional Information (Details) Sheet http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails Reverse Recapitalization - Additional Information (Details) Details 52 false false R53.htm 1053 - Disclosure - Fair Value Measurements - Summary of Company's Assets and Liabilities that were Measured at Fair Value on a Recurring Basis (Details) Sheet http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails Fair Value Measurements - Summary of Company's Assets and Liabilities that were Measured at Fair Value on a Recurring Basis (Details) Details 53 false false R54.htm 1054 - Disclosure - Fair Value Measurements - Summary of Changes in the Fair Value of Level 3 Financial Statements (Details) Sheet http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails Fair Value Measurements - Summary of Changes in the Fair Value of Level 3 Financial Statements (Details) Details 54 false false R55.htm 1055 - Disclosure - Fair Value Measurements - Assets and liabilities measured at fair value on recurring basis (Detail) Sheet http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail Fair Value Measurements - Assets and liabilities measured at fair value on recurring basis (Detail) Details 55 false false R56.htm 1056 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://charge.com/role/FairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 56 false false R57.htm 1057 - Disclosure - Acquisitions - Additional Information (Detail) Sheet http://charge.com/role/AcquisitionsAdditionalInformationDetail Acquisitions - Additional Information (Detail) Details 57 false false R58.htm 1058 - Disclosure - Composition of Certain Financial Statement Items - Additional Information (Detail) Sheet http://charge.com/role/CompositionOfCertainFinancialStatementItemsAdditionalInformationDetail Composition of Certain Financial Statement Items - Additional Information (Detail) Details 58 false false R59.htm 1059 - Disclosure - Composition of Certain Financial Statement Items - Summary of Inventories (Detail) Sheet http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfInventoriesDetail Composition of Certain Financial Statement Items - Summary of Inventories (Detail) Details 59 false false R60.htm 1060 - Disclosure - Composition of Certain Financial Statement Items - Summary of Property Plant and Equipment Net (Detail) Sheet http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail Composition of Certain Financial Statement Items - Summary of Property Plant and Equipment Net (Detail) Details 60 false false R61.htm 1061 - Disclosure - Composition of Certain Financial Statement Items - Summary of Accrued and Other Current Liabilities (Detail) Sheet http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail Composition of Certain Financial Statement Items - Summary of Accrued and Other Current Liabilities (Detail) Details 61 false false R62.htm 1062 - Disclosure - Composition of Certain Financial Statement Items - Summary Of Revenue (Detail) Sheet http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfRevenueDetail Composition of Certain Financial Statement Items - Summary Of Revenue (Detail) Details 62 false false R63.htm 1063 - Disclosure - Leases - Schedule of Lease Balances (Detail) Sheet http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail Leases - Schedule of Lease Balances (Detail) Details 63 false false R64.htm 1064 - Disclosure - Leases - Additional Information (Detail) Sheet http://charge.com/role/LeasesAdditionalInformationDetail Leases - Additional Information (Detail) Details 64 false false R65.htm 1065 - Disclosure - Leases - Maturities of Operating Leases (Detail) Sheet http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail Leases - Maturities of Operating Leases (Detail) Details 65 false false R66.htm 1066 - Disclosure - Leases - Schedule of Other Supplemental Information of Lease Term and Discount Rate (Detail) Sheet http://charge.com/role/LeasesScheduleOfOtherSupplementalInformationOfLeaseTermAndDiscountRateDetail Leases - Schedule of Other Supplemental Information of Lease Term and Discount Rate (Detail) Details 66 false false R67.htm 1067 - Disclosure - Leases - Summary of Other Lease Supplemental Cash Flow Information (Detail) Sheet http://charge.com/role/LeasesSummaryOfOtherLeaseSupplementalCashFlowInformationDetail Leases - Summary of Other Lease Supplemental Cash Flow Information (Detail) Details 67 false false R68.htm 1068 - Disclosure - Debt - Additional Information (Detail) Sheet http://charge.com/role/DebtAdditionalInformationDetail Debt - Additional Information (Detail) Details 68 false false R69.htm 1069 - Disclosure - Debt - Summary of Future Principal Payments (Detail) Sheet http://charge.com/role/DebtSummaryOfFuturePrincipalPaymentsDetail Debt - Summary of Future Principal Payments (Detail) Details 69 false false R70.htm 1070 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://charge.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 70 false false R71.htm 1071 - Disclosure - Commitments and Contingencies - Summary of Future Payments Under the Non-Cancellable&#160;Operating Lease (Details) Sheet http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails Commitments and Contingencies - Summary of Future Payments Under the Non-Cancellable&#160;Operating Lease (Details) Details 71 false false R72.htm 1072 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Detail) Sheet http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail Redeemable Convertible Preferred Stock - Additional Information (Detail) Details 72 false false R73.htm 1073 - Disclosure - Redeemable Convertible Preferred Stock - Schedule Of Redeemable Convertible Preferred Stock (Detail) Sheet http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail Redeemable Convertible Preferred Stock - Schedule Of Redeemable Convertible Preferred Stock (Detail) Details 73 false false R74.htm 1074 - Disclosure - Common Stock - Additional Information (Detail) Sheet http://charge.com/role/CommonStockAdditionalInformationDetail Common Stock - Additional Information (Detail) Details 74 false false R75.htm 1075 - Disclosure - Common Stock - Summary Of Common Stock Capital Shares Reserved For Future Issuance (Detail) Sheet http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail Common Stock - Summary Of Common Stock Capital Shares Reserved For Future Issuance (Detail) Details 75 false false R76.htm 1076 - Disclosure - Stock Warrants and Earnouts - Additional Information (Detail) Sheet http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail Stock Warrants and Earnouts - Additional Information (Detail) Details 76 false false R77.htm 1077 - Disclosure - Stock Warrants and Earnouts - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail) Sheet http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail Stock Warrants and Earnouts - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail) Details 77 false false R78.htm 1078 - Disclosure - Stock Warrants and Earnouts - Summary of Assumed Public Warrants (Detail) Sheet http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail Stock Warrants and Earnouts - Summary of Assumed Public Warrants (Detail) Details 78 false false R79.htm 1079 - Disclosure - Stock Warrants and Earnouts - Summary of Assumed Public Warrants (Parenthetical) (Detail) Sheet http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsParentheticalDetail Stock Warrants and Earnouts - Summary of Assumed Public Warrants (Parenthetical) (Detail) Details 79 false false R80.htm 1080 - Disclosure - Stock Warrants and Earnouts - Summary of Fair Value Private Placement Warrants Basis Valuation Techniques (Detail) Sheet http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail Stock Warrants and Earnouts - Summary of Fair Value Private Placement Warrants Basis Valuation Techniques (Detail) Details 80 false false R81.htm 1081 - Disclosure - Stock Warrants and Earnouts - Summary of Fair Value Earnout Liability Basis Valuation Techniques (Detail) Sheet http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail Stock Warrants and Earnouts - Summary of Fair Value Earnout Liability Basis Valuation Techniques (Detail) Details 81 false false R82.htm 1082 - Disclosure - Stock Warrants and Earnouts - Schedule of Warrants Issued and Outstanding (Detail) Sheet http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail Stock Warrants and Earnouts - Schedule of Warrants Issued and Outstanding (Detail) Details 82 false false R83.htm 1083 - Disclosure - Stock Warrants and Earnouts - Schedule of Outstanding Redeemable Convertible Preferred Stock Warrants (Detail) Sheet http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail Stock Warrants and Earnouts - Schedule of Outstanding Redeemable Convertible Preferred Stock Warrants (Detail) Details 83 false false R84.htm 1084 - Disclosure - Stock Warrants and Earnouts - Schedule of Liability of Warrants Subject to Re Measurement (Detail) Sheet http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfLiabilityOfWarrantsSubjectToReMeasurementDetail Stock Warrants and Earnouts - Schedule of Liability of Warrants Subject to Re Measurement (Detail) Details 84 false false R85.htm 1085 - Disclosure - Equity Plans and Stock-based Compensation - Additional Information (Detail) Sheet http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail Equity Plans and Stock-based Compensation - Additional Information (Detail) Details 85 false false R86.htm 1086 - Disclosure - Equity Plans and Stock-based Compensation - Summary of stock option awards (Detail) Sheet http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail Equity Plans and Stock-based Compensation - Summary of stock option awards (Detail) Details 86 false false R87.htm 1087 - Disclosure - Equity Plans and Stock-based Compensation - Summary of RSU activity (Detail) Sheet http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail Equity Plans and Stock-based Compensation - Summary of RSU activity (Detail) Details 87 false false R88.htm 1088 - Disclosure - Equity Plans and Stock-based Compensation - Summary of Stock Based Compensation Expense (Detail) Sheet http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail Equity Plans and Stock-based Compensation - Summary of Stock Based Compensation Expense (Detail) Details 88 false false R89.htm 1089 - Disclosure - Equity Plan and Stock-based Compensation - Summary of Weighted-average Assumptions Used to Determine the Fair Value of Stock Options Granted (Detail) Sheet http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail Equity Plan and Stock-based Compensation - Summary of Weighted-average Assumptions Used to Determine the Fair Value of Stock Options Granted (Detail) Details 89 false false R90.htm 1090 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://charge.com/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 90 false false R91.htm 1091 - Disclosure - Income Taxes (Details) - Schedule of income tax provision Sheet http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision Income Taxes (Details) - Schedule of income tax provision Details http://charge.com/role/IncomeTaxesTables 91 false false R92.htm 1092 - Disclosure - Income Taxes (Details) - Schedule of net deferred tax assets Sheet http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets Income Taxes (Details) - Schedule of net deferred tax assets Details http://charge.com/role/IncomeTaxesTables 92 false false R93.htm 1093 - Disclosure - Income Taxes - Schedule of Net Loss Before Income Taxes (Detail) Sheet http://charge.com/role/IncomeTaxesScheduleOfNetLossBeforeIncomeTaxesDetail Income Taxes - Schedule of Net Loss Before Income Taxes (Detail) Details 93 false false R94.htm 1094 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Detail) Sheet http://charge.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail Income Taxes - Summary of Unrecognized Tax Benefits (Detail) Details 94 false false R95.htm 1095 - Disclosure - Income Taxes (Details) - Schedule of reconciliation of the statutory federal income tax rate to the Company's effective tax rate Sheet http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate Income Taxes (Details) - Schedule of reconciliation of the statutory federal income tax rate to the Company's effective tax rate Details http://charge.com/role/IncomeTaxesTables 95 false false R96.htm 1096 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://charge.com/role/RelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 96 false false R97.htm 1097 - Disclosure - Related Party Transactions - Summary of Revenue Transactions (Detail) Sheet http://charge.com/role/RelatedPartyTransactionsSummaryOfRevenueTransactionsDetail Related Party Transactions - Summary of Revenue Transactions (Detail) Details 97 false false R98.htm 1098 - Disclosure - Geographic Information - Summary of Revenue and Long-Lived Assets by Geographic Area (Detail) Sheet http://charge.com/role/GeographicInformationSummaryOfRevenueAndLongLivedAssetsByGeographicAreaDetail Geographic Information - Summary of Revenue and Long-Lived Assets by Geographic Area (Detail) Details 98 false false R99.htm 1099 - Disclosure - Basic and Diluted Net Loss Per Share - Additional Information (Detail) Sheet http://charge.com/role/BasicAndDilutedNetLossPerShareAdditionalInformationDetail Basic and Diluted Net Loss Per Share - Additional Information (Detail) Details 99 false false R100.htm 1100 - Disclosure - Basic and Diluted Net Loss Per Share - Summary of Computation of Basic and Diluted Net Loss Per Share (Detail) Sheet http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail Basic and Diluted Net Loss Per Share - Summary of Computation of Basic and Diluted Net Loss Per Share (Detail) Details 100 false false R101.htm 1101 - Disclosure - Basic and Diluted Net Loss Per Share - Summary of Computation of Diluted Net Loss Per Share (Detail) Sheet http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail Basic and Diluted Net Loss Per Share - Summary of Computation of Diluted Net Loss Per Share (Detail) Details 101 false false R102.htm 1102 - Disclosure - Acquisitions and Subsequent Events - Additional Information (Detail) Sheet http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail Acquisitions and Subsequent Events - Additional Information (Detail) Details 102 false false All Reports Book All Reports d233594ds1.htm chpt-20210731.xsd chpt-20210731_cal.xml chpt-20210731_def.xml chpt-20210731_lab.xml chpt-20210731_pre.xml d233594dex231.htm d233594dex51.htm g233594g01c36.jpg g233594g03a03.jpg g233594g03c36.jpg g233594g04c36.jpg g233594g05c36.jpg g233594g06c36.jpg g233594g08c36.jpg g233594g14e53.jpg g233594g52c41.jpg g233594g70a70.jpg http://xbrl.sec.gov/dei/2021 http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/country/2021 http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/stpr/2021 true true JSON 129 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d233594ds1.htm": { "axisCustom": 7, "axisStandard": 36, "contextCount": 580, "dts": { "calculationLink": { "local": [ "chpt-20210731_cal.xml" ] }, "definitionLink": { "local": [ "chpt-20210731_def.xml" ] }, "inline": { "local": [ "d233594ds1.htm" ] }, "labelLink": { "local": [ "chpt-20210731_lab.xml" ] }, "presentationLink": { "local": [ "chpt-20210731_pre.xml" ] }, "schema": { "local": [ "chpt-20210731.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 906, "entityCount": 1, "hidden": { "http://charge.com/20210731": 3, "http://xbrl.sec.gov/dei/2021": 3, "total": 6 }, "keyCustom": 143, "keyStandard": 502, "memberCustom": 82, "memberStandard": 57, "nsprefix": "chpt", "nsuri": "http://charge.com/20210731", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://charge.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Summary of Significant Accounting Policies", "role": "http://charge.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1100 - Disclosure - Basic and Diluted Net Loss Per Share - Summary of Computation of Basic and Diluted Net Loss Per Share (Detail)", "role": "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail", "shortName": "Basic and Diluted Net Loss Per Share - Summary of Computation of Basic and Diluted Net Loss Per Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-3", "lang": null, "name": "chpt:CumulativeUndeclaredDividendsOnRedeemableConvertiblePreferredStock", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1101 - Disclosure - Basic and Diluted Net Loss Per Share - Summary of Computation of Diluted Net Loss Per Share (Detail)", "role": "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail", "shortName": "Basic and Diluted Net Loss Per Share - Summary of Computation of Diluted Net Loss Per Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2020To07_31_2020", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1102 - Disclosure - Acquisitions and Subsequent Events - Additional Information (Detail)", "role": "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "shortName": "Acquisitions and Subsequent Events - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn02_26_2021_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "-5", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:ReverseRecapitalizationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Reverse Recapitalization", "role": "http://charge.com/role/ReverseRecapitalization", "shortName": "Reverse Recapitalization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:ReverseRecapitalizationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Fair Value Measurements", "role": "http://charge.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Acquisitions", "role": "http://charge.com/role/Acquisitions", "shortName": "Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:CompositionOfCertainFinancialStatementItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Composition of Certain Financial Statement Items", "role": "http://charge.com/role/CompositionOfCertainFinancialStatementItems", "shortName": "Composition of Certain Financial Statement Items", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:CompositionOfCertainFinancialStatementItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Leases", "role": "http://charge.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Debt", "role": "http://charge.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Commitments and Contingencies", "role": "http://charge.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Redeemable Convertible Preferred Stock", "role": "http://charge.com/role/RedeemableConvertiblePreferredStock", "shortName": "Redeemable Convertible Preferred Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Common Stock", "role": "http://charge.com/role/CommonStock", "shortName": "Common Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://charge.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "lang": null, "name": "us-gaap:RestrictedCashCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:StockWarrantsAndEarnoutsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Stock Warrants and Earnouts", "role": "http://charge.com/role/StockWarrantsAndEarnouts", "shortName": "Stock Warrants and Earnouts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:StockWarrantsAndEarnoutsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Equity Plans and Stock-based Compensation", "role": "http://charge.com/role/EquityPlansAndStockBasedCompensation", "shortName": "Equity Plans and Stock-based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Income Taxes", "role": "http://charge.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Related Party Transactions", "role": "http://charge.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Geographic Information", "role": "http://charge.com/role/GeographicInformation", "shortName": "Geographic Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Basic and Diluted Net Loss Per Share", "role": "http://charge.com/role/BasicAndDilutedNetLossPerShare", "shortName": "Basic and Diluted Net Loss Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Employee Benefit Plans", "role": "http://charge.com/role/EmployeeBenefitPlans", "shortName": "Employee Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Acquisitions and Subsequent Events", "role": "http://charge.com/role/AcquisitionsAndSubsequentEvents", "shortName": "Acquisitions and Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:CommonStockWarrantLiabilitiesPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:CommonStockWarrantLiabilitiesPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://charge.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Reverse Recapitalization (Tables)", "role": "http://charge.com/role/ReverseRecapitalizationTables", "shortName": "Reverse Recapitalization (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Fair Value Measurements (Tables)", "role": "http://charge.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "chpt:CompositionOfCertainFinancialStatementItemsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Composition of Certain Financial Statement Items (Tables)", "role": "http://charge.com/role/CompositionOfCertainFinancialStatementItemsTables", "shortName": "Composition of Certain Financial Statement Items (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "chpt:CompositionOfCertainFinancialStatementItemsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Leases (Tables)", "role": "http://charge.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Debt (Tables)", "role": "http://charge.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - Commitments and Contingencies (Tables)", "role": "http://charge.com/role/CommitmentsAndContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - Redeemable Convertible Preferred Stock (Tables)", "role": "http://charge.com/role/RedeemableConvertiblePreferredStockTables", "shortName": "Redeemable Convertible Preferred Stock (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - Income Taxes (Tables)", "role": "http://charge.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1038 - Disclosure - Common Stock (Tables)", "role": "http://charge.com/role/CommonStockTables", "shortName": "Common Stock (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "chpt:CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "chpt:StockWarrantsAndEarnoutsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1039 - Disclosure - Stock Warrants and Earnouts (Tables)", "role": "http://charge.com/role/StockWarrantsAndEarnoutsTables", "shortName": "Stock Warrants and Earnouts (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "chpt:StockWarrantsAndEarnoutsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Condensed Consolidated Statements of Operations", "role": "http://charge.com/role/CondensedConsolidatedStatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1040 - Disclosure - Equity Plans and Stock-based Compensation (Tables)", "role": "http://charge.com/role/EquityPlansAndStockBasedCompensationTables", "shortName": "Equity Plans and Stock-based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1041 - Disclosure - Related Party Transactions (Tables)", "role": "http://charge.com/role/RelatedPartyTransactionsTables", "shortName": "Related Party Transactions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1042 - Disclosure - Geographic Information (Tables)", "role": "http://charge.com/role/GeographicInformationTables", "shortName": "Geographic Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1043 - Disclosure - Basic and Diluted Net Loss Per Share (Tables)", "role": "http://charge.com/role/BasicAndDilutedNetLossPerShareTables", "shortName": "Basic and Diluted Net Loss Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1044 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail)", "role": "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "shortName": "Description of Business and Basis of Presentation - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P07_01_2020To07_31_2020", "decimals": "-5", "lang": null, "name": "us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "Unit_Segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1045 - Disclosure - Summary of Significant Accounting Policies (Details)", "role": "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "Unit_Segment", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1046 - Disclosure - Summary of Significant Accounting Policies - Schedule of Reconciliation of Cash, Cash Equivalents, And Restricted Cash (Detail)", "role": "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetail", "shortName": "Summary of Significant Accounting Policies - Schedule of Reconciliation of Cash, Cash Equivalents, And Restricted Cash (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ReceivablesPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2020", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1047 - Disclosure - Summary of Significant Accounting Policies - Schedule of Allowance for Doubtful Accounts (Detail)", "role": "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAllowanceForDoubtfulAccountsDetail", "shortName": "Summary of Significant Accounting Policies - Schedule of Allowance for Doubtful Accounts (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ReceivablesPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2018", "decimals": "-3", "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "chpt:ScheduleOfEstimatedUsefulLivesTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021_MinimumMembersrtRangeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1048 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives (Detail)", "role": "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail", "shortName": "Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "chpt:ScheduleOfEstimatedUsefulLivesTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021_MinimumMembersrtRangeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock", "us-gaap:DeferredChargesPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredPolicyAcquisitionCosts", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1049 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Contract Acquisition Costs (Detail)", "role": "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredContractAcquisitionCostsDetail", "shortName": "Summary of Significant Accounting Policies - Schedule of Deferred Contract Acquisition Costs (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock", "us-gaap:DeferredChargesPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "-3", "lang": null, "name": "us-gaap:DeferredPolicyAcquisitionCostsAdditions", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)", "role": "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss", "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock", "us-gaap:DeferredChargesPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredCostsCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1050 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Acquisition Costs (Detail)", "role": "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredAcquisitionCostsDetail", "shortName": "Summary of Significant Accounting Policies - Schedule of Deferred Acquisition Costs (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock", "us-gaap:DeferredChargesPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredCostsCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "chpt:BusinessCombinationCommonStock", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1051 - Disclosure - Reverse Recapitalization - Summary of Number of Shares of Common Stock Issued Immediately Following the Consummation of the Business Combination (Details)", "role": "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails", "shortName": "Reverse Recapitalization - Summary of Number of Shares of Common Stock Issued Immediately Following the Consummation of the Business Combination (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "chpt:BusinessCombinationCommonStock", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesOutstanding", "div", "div", "div", "div", "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1052 - Disclosure - Reverse Recapitalization - Additional Information (Details)", "role": "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "shortName": "Reverse Recapitalization - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": "-5", "lang": null, "name": "chpt:TransactionCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1053 - Disclosure - Fair Value Measurements - Summary of Company's Assets and Liabilities that were Measured at Fair Value on a Recurring Basis (Details)", "role": "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails", "shortName": "Fair Value Measurements - Summary of Company's Assets and Liabilities that were Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021_EarnOutLiabilityMemberusgaapFairValueByLiabilityClassAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "-3", "first": true, "lang": null, "name": "chpt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentEarnOutLiabilityRecognized", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1054 - Disclosure - Fair Value Measurements - Summary of Changes in the Fair Value of Level 3 Financial Statements (Details)", "role": "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails", "shortName": "Fair Value Measurements - Summary of Changes in the Fair Value of Level 3 Financial Statements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021_EarnOutLiabilityMemberusgaapFairValueByLiabilityClassAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "-3", "first": true, "lang": null, "name": "chpt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentEarnOutLiabilityRecognized", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1055 - Disclosure - Fair Value Measurements - Assets and liabilities measured at fair value on recurring basis (Detail)", "role": "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "shortName": "Fair Value Measurements - Assets and liabilities measured at fair value on recurring basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "-3", "lang": null, "name": "us-gaap:AvailableForSaleEquitySecuritiesAmortizedCostBasis", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021_MoneyMarketFundsMemberusgaapFinancialInstrumentAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MarketableSecuritiesUnrealizedGainLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1056 - Disclosure - Fair Value Measurements - Additional Information (Details)", "role": "http://charge.com/role/FairValueMeasurementsAdditionalInformationDetails", "shortName": "Fair Value Measurements - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021_MoneyMarketFundsMemberusgaapFinancialInstrumentAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MarketableSecuritiesUnrealizedGainLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1057 - Disclosure - Acquisitions - Additional Information (Detail)", "role": "http://charge.com/role/AcquisitionsAdditionalInformationDetail", "shortName": "Acquisitions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "-5", "lang": null, "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1058 - Disclosure - Composition of Certain Financial Statement Items - Additional Information (Detail)", "role": "http://charge.com/role/CompositionOfCertainFinancialStatementItemsAdditionalInformationDetail", "shortName": "Composition of Certain Financial Statement Items - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "chpt:CompositionOfCertainFinancialStatementItemsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1059 - Disclosure - Composition of Certain Financial Statement Items - Summary of Inventories (Detail)", "role": "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfInventoriesDetail", "shortName": "Composition of Certain Financial Statement Items - Summary of Inventories (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "chpt:CompositionOfCertainFinancialStatementItemsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2018", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)", "role": "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "shortName": "Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2018", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1060 - Disclosure - Composition of Certain Financial Statement Items - Summary of Property Plant and Equipment Net (Detail)", "role": "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail", "shortName": "Composition of Certain Financial Statement Items - Summary of Property Plant and Equipment Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1061 - Disclosure - Composition of Certain Financial Statement Items - Summary of Accrued and Other Current Liabilities (Detail)", "role": "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail", "shortName": "Composition of Certain Financial Statement Items - Summary of Accrued and Other Current Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1062 - Disclosure - Composition of Certain Financial Statement Items - Summary Of Revenue (Detail)", "role": "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfRevenueDetail", "shortName": "Composition of Certain Financial Statement Items - Summary Of Revenue (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021_RestOfTheWorldMembersrtStatementGeographicalAxis", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1063 - Disclosure - Leases - Schedule of Lease Balances (Detail)", "role": "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail", "shortName": "Leases - Schedule of Lease Balances (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "chpt:AssetsAndLiabilitiesLesseeTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021_ScenarioPreviouslyReportedMembersrtRestatementAxis", "decimals": "-3", "lang": null, "name": "us-gaap:OperatingLeaseLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1064 - Disclosure - Leases - Additional Information (Detail)", "role": "http://charge.com/role/LeasesAdditionalInformationDetail", "shortName": "Leases - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1065 - Disclosure - Leases - Maturities of Operating Leases (Detail)", "role": "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail", "shortName": "Leases - Maturities of Operating Leases (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1066 - Disclosure - Leases - Schedule of Other Supplemental Information of Lease Term and Discount Rate (Detail)", "role": "http://charge.com/role/LeasesScheduleOfOtherSupplementalInformationOfLeaseTermAndDiscountRateDetail", "shortName": "Leases - Schedule of Other Supplemental Information of Lease Term and Discount Rate (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "chpt:LeaseSupplementalCashFlowInformationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1067 - Disclosure - Leases - Summary of Other Lease Supplemental Cash Flow Information (Detail)", "role": "http://charge.com/role/LeasesSummaryOfOtherLeaseSupplementalCashFlowInformationDetail", "shortName": "Leases - Summary of Other Lease Supplemental Cash Flow Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "chpt:LeaseSupplementalCashFlowInformationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityPeriodicPaymentInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1068 - Disclosure - Debt - Additional Information (Detail)", "role": "http://charge.com/role/DebtAdditionalInformationDetail", "shortName": "Debt - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityPeriodicPaymentInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1069 - Disclosure - Debt - Summary of Future Principal Payments (Detail)", "role": "http://charge.com/role/DebtSummaryOfFuturePrincipalPaymentsDetail", "shortName": "Debt - Summary of Future Principal Payments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P08_01_2020To08_31_2020", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)", "role": "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical", "shortName": "Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R70": { "firstAnchor": { "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PurchaseObligation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1070 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "role": "http://charge.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PurchaseObligation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1071 - Disclosure - Commitments and Contingencies - Summary of Future Payments Under the Non-Cancellable Operating Lease (Details)", "role": "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails", "shortName": "Commitments and Contingencies - Summary of Future Payments Under the Non-Cancellable Operating Lease (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To07_31_2020", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1072 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Detail)", "role": "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "shortName": "Redeemable Convertible Preferred Stock - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021_MaximumMembersrtRangeAxis", "decimals": "4", "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TemporaryEquitySharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1073 - Disclosure - Redeemable Convertible Preferred Stock - Schedule Of Redeemable Convertible Preferred Stock (Detail)", "role": "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail", "shortName": "Redeemable Convertible Preferred Stock - Schedule Of Redeemable Convertible Preferred Stock (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2019", "decimals": "INF", "lang": null, "name": "us-gaap:TemporaryEquitySharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1074 - Disclosure - Common Stock - Additional Information (Detail)", "role": "http://charge.com/role/CommonStockAdditionalInformationDetail", "shortName": "Common Stock - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "lang": "en-US", "name": "us-gaap:CommonStockVotingRights", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "chpt:CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1075 - Disclosure - Common Stock - Summary Of Common Stock Capital Shares Reserved For Future Issuance (Detail)", "role": "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail", "shortName": "Common Stock - Summary Of Common Stock Capital Shares Reserved For Future Issuance (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "chpt:CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021_ConversionOfRedeemableConvertiblePreferredStockMemberCHPTCommonStockCapitalSharesReservedForFutureIssuanceAxis", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2020To07_31_2020", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1076 - Disclosure - Stock Warrants and Earnouts - Additional Information (Detail)", "role": "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "shortName": "Stock Warrants and Earnouts - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "chpt:StockWarrantsAndEarnoutsTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021_SeriesH1RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis", "decimals": "-5", "lang": null, "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "chpt:StockWarrantsAndEarnoutsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn02_26_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_RedeemableConvertiblePreferredStockWarrantsMemberusgaapStatementEquityComponentsAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1077 - Disclosure - Stock Warrants and Earnouts - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail)", "role": "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "shortName": "Stock Warrants and Earnouts - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "chpt:StockWarrantsAndEarnoutsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn02_26_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_RedeemableConvertiblePreferredStockWarrantsMemberusgaapStatementEquityComponentsAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "chpt:ScheduleOfAssumedPublicWarrantsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1078 - Disclosure - Stock Warrants and Earnouts - Summary of Assumed Public Warrants (Detail)", "role": "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail", "shortName": "Stock Warrants and Earnouts - Summary of Assumed Public Warrants (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "chpt:ScheduleOfAssumedPublicWarrantsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "INF", "lang": null, "name": "chpt:ClassOfWarrantOrRightAssumedAsPartOfTheMerger", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_26_2021To02_26_2021", "decimals": "INF", "first": true, "lang": null, "name": "chpt:StockholdersEquityExchangeRatio", "reportCount": 1, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1079 - Disclosure - Stock Warrants and Earnouts - Summary of Assumed Public Warrants (Parenthetical) (Detail)", "role": "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsParentheticalDetail", "shortName": "Stock Warrants and Earnouts - Summary of Assumed Public Warrants (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "chpt:ScheduleOfAssumedPublicWarrantsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_26_2021To02_26_2021_LegacyChargepointSharesMemberusgaapStatementEquityComponentsAxis", "decimals": "4", "lang": null, "name": "chpt:StockholdersEquityExchangeRatio", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1008 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021_MeasurementInputMarketPriceMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1080 - Disclosure - Stock Warrants and Earnouts - Summary of Fair Value Private Placement Warrants Basis Valuation Techniques (Detail)", "role": "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail", "shortName": "Stock Warrants and Earnouts - Summary of Fair Value Private Placement Warrants Basis Valuation Techniques (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021_MeasurementInputMarketPriceMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn03_12_2021_EarnoutSharesMemberusgaapStatementEquityComponentsAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1081 - Disclosure - Stock Warrants and Earnouts - Summary of Fair Value Earnout Liability Basis Valuation Techniques (Detail)", "role": "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail", "shortName": "Stock Warrants and Earnouts - Summary of Fair Value Earnout Liability Basis Valuation Techniques (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn03_12_2021_EarnoutSharesMemberusgaapStatementEquityComponentsAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "chpt:ScheduleOfAssumedPublicWarrantsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1082 - Disclosure - Stock Warrants and Earnouts - Schedule of Warrants Issued and Outstanding (Detail)", "role": "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail", "shortName": "Stock Warrants and Earnouts - Schedule of Warrants Issued and Outstanding (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "chpt:StockWarrantsAndEarnoutsTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis_CommonStockWarrantsOutstandingAtExercisePriceSixPointZeroTwoMemberusgaapClassOfWarrantOrRightAxis", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "chpt:ScheduleOfAssumedPublicWarrantsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1083 - Disclosure - Stock Warrants and Earnouts - Schedule of Outstanding Redeemable Convertible Preferred Stock Warrants (Detail)", "role": "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "shortName": "Stock Warrants and Earnouts - Schedule of Outstanding Redeemable Convertible Preferred Stock Warrants (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "chpt:ScheduleOfRedeemableConvertiblePreferredStockWarrantsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2020To07_31_2020", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1084 - Disclosure - Stock Warrants and Earnouts - Schedule of Liability of Warrants Subject to Re Measurement (Detail)", "role": "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfLiabilityOfWarrantsSubjectToReMeasurementDetail", "shortName": "Stock Warrants and Earnouts - Schedule of Liability of Warrants Subject to Re Measurement (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "chpt:ScheduleOfChangesInFairValueOfWarrantLiabilityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2018_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_WarrantMemberusgaapStatementEquityComponentsAxis", "decimals": "-3", "lang": null, "name": "chpt:FairValueOfWarrantLiability", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1085 - Disclosure - Equity Plans and Stock-based Compensation - Additional Information (Detail)", "role": "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail", "shortName": "Equity Plans and Stock-based Compensation - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-5", "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1086 - Disclosure - Equity Plans and Stock-based Compensation - Summary of stock option awards (Detail)", "role": "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail", "shortName": "Equity Plans and Stock-based Compensation - Summary of stock option awards (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1087 - Disclosure - Equity Plans and Stock-based Compensation - Summary of RSU activity (Detail)", "role": "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail", "shortName": "Equity Plans and Stock-based Compensation - Summary of RSU activity (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1088 - Disclosure - Equity Plans and Stock-based Compensation - Summary of Stock Based Compensation Expense (Detail)", "role": "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail", "shortName": "Equity Plans and Stock-based Compensation - Summary of Stock Based Compensation Expense (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021_CostOfSalesMemberusgaapIncomeStatementLocationAxis", "decimals": "-3", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1089 - Disclosure - Equity Plan and Stock-based Compensation - Summary of Weighted-average Assumptions Used to Determine the Fair Value of Stock Options Granted (Detail)", "role": "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail", "shortName": "Equity Plan and Stock-based Compensation - Summary of Weighted-average Assumptions Used to Determine the Fair Value of Stock Options Granted (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Description of Business and Basis of Presentation", "role": "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentation", "shortName": "Description of Business and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2021To07_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1090 - Disclosure - Income Taxes - Additional Information (Detail)", "role": "http://charge.com/role/IncomeTaxesAdditionalInformationDetail", "shortName": "Income Taxes - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "-5", "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "true" }, "groupType": "disclosure", "isDefault": "false", "longName": "1091 - Disclosure - Income Taxes (Details) - Schedule of income tax provision", "role": "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision", "shortName": "Income Taxes (Details) - Schedule of income tax provision", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": null, "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "true" } }, "R92": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1092 - Disclosure - Income Taxes (Details) - Schedule of net deferred tax assets", "role": "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets", "shortName": "Income Taxes (Details) - Schedule of net deferred tax assets", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1093 - Disclosure - Income Taxes - Schedule of Net Loss Before Income Taxes (Detail)", "role": "http://charge.com/role/IncomeTaxesScheduleOfNetLossBeforeIncomeTaxesDetail", "shortName": "Income Taxes - Schedule of Net Loss Before Income Taxes (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2020", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1094 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Detail)", "role": "http://charge.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail", "shortName": "Income Taxes - Summary of Unrecognized Tax Benefits (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "-3", "lang": null, "name": "us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1095 - Disclosure - Income Taxes (Details) - Schedule of reconciliation of the statutory federal income tax rate to the Company's effective tax rate", "role": "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate", "shortName": "Income Taxes (Details) - Schedule of reconciliation of the statutory federal income tax rate to the Company's effective tax rate", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P02_01_2020To01_31_2021", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021_DaimlerMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1096 - Disclosure - Related Party Transactions - Additional Information (Detail)", "role": "http://charge.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Related Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021_DaimlerMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1097 - Disclosure - Related Party Transactions - Summary of Revenue Transactions (Detail)", "role": "http://charge.com/role/RelatedPartyTransactionsSummaryOfRevenueTransactionsDetail", "shortName": "Related Party Transactions - Summary of Revenue Transactions (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "P05_01_2021To07_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1098 - Disclosure - Geographic Information - Summary of Revenue and Long-Lived Assets by Geographic Area (Detail)", "role": "http://charge.com/role/GeographicInformationSummaryOfRevenueAndLongLivedAssetsByGeographicAreaDetail", "shortName": "Geographic Information - Summary of Revenue and Long-Lived Assets by Geographic Area (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn01_31_2021", "decimals": "-3", "lang": null, "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "4", "first": true, "lang": null, "name": "chpt:ExchangeRatioUsedToDetermineTheNumberOfSharesOfCommonStockIntoWhichTheyConverted", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1099 - Disclosure - Basic and Diluted Net Loss Per Share - Additional Information (Detail)", "role": "http://charge.com/role/BasicAndDilutedNetLossPerShareAdditionalInformationDetail", "shortName": "Basic and Diluted Net Loss Per Share - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d233594ds1.htm", "contextRef": "PAsOn07_31_2021", "decimals": "4", "first": true, "lang": null, "name": "chpt:ExchangeRatioUsedToDetermineTheNumberOfSharesOfCommonStockIntoWhichTheyConverted", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } } }, "segmentCount": 145, "tag": { "chpt_AccretionOfPreferredStockBeneficialConversionFeature": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accretion Of Preferred Stock Beneficial Conversion Feature", "label": "Accretion Of Preferred Stock Beneficial Conversion Feature", "negatedLabel": "Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock", "verboseLabel": "Accretion of beneficial conversion feature of redeemable convertible preferred stock" } } }, "localname": "AccretionOfPreferredStockBeneficialConversionFeature", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "chpt_AccruedAndOtherLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued and other liabilities current.", "label": "Accrued And Other Liabilities Current", "terseLabel": "Accrued and other current liabilities", "totalLabel": "Total Accrued and Other Current Liabilities" } } }, "localname": "AccruedAndOtherLiabilitiesCurrent", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "chpt_AcquisitionsOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedAndOtherCurrentLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities", "label": "Acquisitions Of Property And Equipment Included In Accounts Payable And Accrued And Other Current Liabilities", "terseLabel": "Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities" } } }, "localname": "AcquisitionsOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedAndOtherCurrentLiabilities", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chpt_AdjustmentToAdditionalPaidInCapitalVestingOfEarlyExcercisedStockOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustment to additional paid in capital vesting of early excercised stock options.", "label": "Adjustment To Additional Paid In Capital Vesting Of Early Excercised Stock Options", "terseLabel": "Vesting of early exercised stock options" } } }, "localname": "AdjustmentToAdditionalPaidInCapitalVestingOfEarlyExcercisedStockOptions", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "chpt_AdjustmentsToAdditionalPaidInCapitalContingentEarnoutLiabilityRecognizedUponTheClosingOfTheReverseRecapitalization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital contingent earnout liability recognized upon the closing of the reverse recapitalization.", "label": "Adjustments To Additional Paid In Capital Contingent Earnout Liability Recognized upon the Closing of the Reverse Recapitalization", "negatedTerseLabel": "Contingent earnout liability recognized upon the closing of the reverse recapitalization", "terseLabel": "Contingent earnout liability recognized upon the closing of the reverse recapitalization" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalContingentEarnoutLiabilityRecognizedUponTheClosingOfTheReverseRecapitalization", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "chpt_AdjustmentsToAdditionalPaidInCapitalDecreaseOrCostRecognition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital, decrease for cost recognition.", "label": "Adjustments To Additional Paid In Capital Decrease or Cost Recognition", "terseLabel": "Adjustments to additional paid in capital, decrease for cost recognition" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalDecreaseOrCostRecognition", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "chpt_AdjustmentsToAdditionalPaidInCapitalReclassificationOfLegacyChargepointPreferredStockWarrantLiabilityUponTheReverseCapitalization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital reclassification of legacy chargepoint preferred stock warrant liability upon the reverse capitalization.", "label": "Adjustments To Additional Paid In Capital Reclassification of Legacy ChargePoint Preferred Stock Warrant Liability upon the Reverse Capitalization", "terseLabel": "Reclassification of Legacy ChargePoint redeemable convertible preferred stock warrant liability upon the reverse capitalization", "verboseLabel": "Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse recapitalization" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalReclassificationOfLegacyChargepointPreferredStockWarrantLiabilityUponTheReverseCapitalization", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "chpt_AdjustmentsToAdditionalPaidInCapitalReclassificationOfRemainingContingentEarnoutLiabilityUponTriggeringEventValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments To Additional Paid In Capital Reclassification of Remaining Contingent Earnout Liability Upon Triggering Event Value.", "label": "Adjustments To Additional Paid In Capital Reclassification of Remaining Contingent Earnout Liability Upon Triggering Event Value", "terseLabel": "Reclassification of remaining contingent earnout liability upon triggering event" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalReclassificationOfRemainingContingentEarnoutLiabilityUponTriggeringEventValue", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "chpt_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement.", "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "chpt_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement.", "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_AllowanceForDoubtfulAccountsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Allowance for doubtful accounts.", "label": "Allowance For Doubtful Accounts [Table Text Block]", "terseLabel": "Schedule of Allowance for Doubtful Accounts" } } }, "localname": "AllowanceForDoubtfulAccountsTableTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "chpt_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets and liabilities lessee.", "label": "Assets And Liabilities Lessee [Table Text Block]", "terseLabel": "Schedule of Lease Balances" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "chpt_AssumedCommonStockWarrantLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assumed common stock warrant liabilities.", "label": "Assumed Common Stock Warrant Liabilities [Member]", "verboseLabel": "Common Stock Warrant Liabilities [Member]" } } }, "localname": "AssumedCommonStockWarrantLiabilitiesMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "chpt_AssumedCommonStockWarrantsOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assumed common stock warrants or right.", "label": "Assumed Common Stock Warrants Or Right [Line Items]" } } }, "localname": "AssumedCommonStockWarrantsOrRightLineItems", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsParentheticalDetail" ], "xbrltype": "stringItemType" }, "chpt_AssumedCommonStockWarrantsOrRightTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assumed common stock warrants or right.", "label": "Assumed Common Stock Warrants Or Right [Table]" } } }, "localname": "AssumedCommonStockWarrantsOrRightTable", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsParentheticalDetail" ], "xbrltype": "stringItemType" }, "chpt_BeneficialConversionFeatureInConnectionWithSeriesH1RedeemablePreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Beneficial conversion feature in connection with Series H-1 redeemable preferred stock", "label": "Beneficial Conversion Feature In Connection With Series H1 Redeemable Preferred Stock", "terseLabel": "Beneficial conversion feature in connection with Series H-1 redeemable preferred stock" } } }, "localname": "BeneficialConversionFeatureInConnectionWithSeriesH1RedeemablePreferredStock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "chpt_BusinessCombinationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination agreement", "label": "Business Combination Agreement [Member]" } } }, "localname": "BusinessCombinationAgreementMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_BusinessCombinationAndPipeFinancingShares": { "auth_ref": [], "calculation": { "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails": { "order": 2.0, "parentTag": "chpt_TotalSharesOfCommonStockImmediatelyAfterBusinessCombination", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Business combination and PIPE financing shares.", "label": "Business Combination And PIPE Financing Shares", "verboseLabel": "Merger and PIPE financing shares" } } }, "localname": "BusinessCombinationAndPipeFinancingShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails" ], "xbrltype": "sharesItemType" }, "chpt_BusinessCombinationCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination Common stock.", "label": "Business Combination Common stock", "presentationGuidance": "Common stock of Switchback, outstanding prior to Merger" } } }, "localname": "BusinessCombinationCommonStock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails" ], "xbrltype": "sharesItemType" }, "chpt_CaresActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cares Act [Member]" } } }, "localname": "CaresActMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_CarrybackOfNetOperatingLossesPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carryback of net operating losses, Period.", "label": "Carryback Of Net Operating Losses Period", "terseLabel": "Carryback of net operating losses, Period" } } }, "localname": "CarrybackOfNetOperatingLossesPeriod", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "chpt_CashProceedsReceivedFromMerge": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash proceeds received from merger.", "label": "Cash Proceeds Received From Merge", "terseLabel": "Cash proceeds received from merger" } } }, "localname": "CashProceedsReceivedFromMerge", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_CeoAwardsPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CEO Awards Plan.", "label": "CEO Awards Plan [Member]" } } }, "localname": "CeoAwardsPlanMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_ChangeInFairValueOfContingentEarnoutLiability": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 14.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of contingent earnout liability.", "label": "Change in Fair Value of Contingent Earnout Liability", "negatedLabel": "Change in fair value of contingent earnout liability", "terseLabel": "Change in fair value of contingent earnout liability" } } }, "localname": "ChangeInFairValueOfContingentEarnoutLiability", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "chpt_ChargePointCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Charge point common stock.", "label": "Charge Point Common Stock [Member]", "terseLabel": "Charge Point Common Stock [Member]" } } }, "localname": "ChargePointCommonStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_ChargePointMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Charge Point", "label": "Charge Point [Member]" } } }, "localname": "ChargePointMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_ClassOfWarrantOrRighstDaysFromWhichWarrantsOrRightsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or righst days from which warrants or rights exercisable.", "label": "Class Of Warrant Or Righst Days From Which Warrants Or Rights Exercisable", "verboseLabel": "Days from which Warrants are exercisable" } } }, "localname": "ClassOfWarrantOrRighstDaysFromWhichWarrantsOrRightsExercisable", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "chpt_ClassOfWarrantOrRightAssumedAsPartOfTheMerger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right assumed as part of the merger.", "label": "Class Of Warrant Or Right Assumed As Part Of The Merger", "verboseLabel": "Common Stock Warrants as Part of the Merger" } } }, "localname": "ClassOfWarrantOrRightAssumedAsPartOfTheMerger", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail" ], "xbrltype": "sharesItemType" }, "chpt_ClassOfWarrantOrRightExercisedDuringPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right exercised during period shares.", "label": "Class Of Warrant Or Right Exercised During Period Shares", "terseLabel": "Class of warrant or right exercised during period shares" } } }, "localname": "ClassOfWarrantOrRightExercisedDuringPeriodShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "chpt_ClassOfWarrantOrRightIssuedDuringPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right issued during period shares.", "label": "Class Of Warrant Or Right Issued During Period Shares", "terseLabel": "Class of warrant or right issued during period shares" } } }, "localname": "ClassOfWarrantOrRightIssuedDuringPeriodShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "chpt_ClassOfWarrantOrRightOutstandingIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Outstanding, Intrinsic Value", "label": "Class Of Warrant Or Right Outstanding Intrinsic Value", "terseLabel": "Intrinsic value" } } }, "localname": "ClassOfWarrantOrRightOutstandingIntrinsicValue", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_ClassOfWarrantOrRightRedemedDuringPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right redemed during period shares | shares", "label": "Class Of Warrant Or Right Redemed During Period Shares", "terseLabel": "Class of warrant or right redemed during period shares" } } }, "localname": "ClassOfWarrantOrRightRedemedDuringPeriodShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "chpt_ClassOfWarrantsRedeemedOrCalledDuringPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants redeemed Or called during period.", "label": "Class of Warrants Redeemed Or Called During Period", "terseLabel": "Class of warrants redeemed Or called during period" } } }, "localname": "ClassOfWarrantsRedeemedOrCalledDuringPeriod", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_ClassOfWarrantsRedemptionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants redemption price per share.", "label": "Class Of Warrants Redemption Price Per Share", "terseLabel": "Class of warrants redemption price per share" } } }, "localname": "ClassOfWarrantsRedemptionPricePerShare", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "chpt_ClassOfWarrantsReedemptionPricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants reedemption price per warrant.", "label": "Class of Warrants Reedemption Price per Warrant", "verboseLabel": "Class of warrants reedemption price per warrant" } } }, "localname": "ClassOfWarrantsReedemptionPricePerWarrant", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_CommitmentsandContingenciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Line Items]" } } }, "localname": "CommitmentsandContingenciesDetailsLineItems", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chpt_CommitmentsandContingenciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Table]" } } }, "localname": "CommitmentsandContingenciesDetailsTable", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chpt_CommonStockAndPreferredStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock and preferred stock warrants.", "label": "Common Stock and Preferred Stock Warrants [Member]" } } }, "localname": "CommonStockAndPreferredStockWarrantsMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "domainItemType" }, "chpt_CommonStockCapitalSharesReservedForFutureIssuanceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock capital shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance [Abstract]" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuanceAbstract", "nsuri": "http://charge.com/20210731", "xbrltype": "stringItemType" }, "chpt_CommonStockCapitalSharesReservedForFutureIssuanceAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock capital shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance [Axis]" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuanceAxis", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "stringItemType" }, "chpt_CommonStockCapitalSharesReservedForFutureIssuanceDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock capital shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance [Domain]" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuanceDomain", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "domainItemType" }, "chpt_CommonStockCapitalSharesReservedForFutureIssuanceLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock capital shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance [Line Items]" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuanceLineItems", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "stringItemType" }, "chpt_CommonStockCapitalSharesReservedForFutureIssuanceTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock capital shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance [Table]" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuanceTable", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "stringItemType" }, "chpt_CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock capital shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance [Table Text Block]", "verboseLabel": "Summary Of Common Stock Capital Shares Reserved For Future Issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockTables" ], "xbrltype": "textBlockItemType" }, "chpt_CommonStockReservedForEarnoutMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock Reserved For Earnout [Member]", "terseLabel": "Common stock reserved for Earnout [Member]" } } }, "localname": "CommonStockReservedForEarnoutMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "domainItemType" }, "chpt_CommonStockWarrantLiabilitiesNoncurrent": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 29.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common Stock Warrant Liabilities Noncurrent.", "label": "Common Stock Warrant Liabilities Noncurrent", "terseLabel": "Common stock warrant liabilities" } } }, "localname": "CommonStockWarrantLiabilitiesNoncurrent", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "chpt_CommonStockWarrantLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock warrant liabilities [Policy Text Block].", "label": "Common Stock Warrant Liabilities [Policy Text Block]", "terseLabel": "Common Stock Warrants Liabilities" } } }, "localname": "CommonStockWarrantLiabilitiesPolicyTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chpt_CommonStockWarrantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common Stock Warrant Liability", "label": "Common Stock Warrant Liability", "terseLabel": "Common Stock warrant at fair value" } } }, "localname": "CommonStockWarrantLiability", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_CommonStockWarrantLiabilityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock Warrant Liability [Policy Text Block]", "label": "Common Stock Warrant Liability [Policy Text Block]", "terseLabel": "Common Stock Warrants" } } }, "localname": "CommonStockWarrantLiabilityPolicyTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chpt_CommonStockWarrantsIssuedDuringPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock Warrants Issued During Period.", "label": "Common Stock Warrants Issued During Period", "terseLabel": "Common stock warrants" } } }, "localname": "CommonStockWarrantsIssuedDuringPeriod", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_CommonStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock Warrants [Member]", "terseLabel": "Common stock warrants [Member]" } } }, "localname": "CommonStockWarrantsMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "domainItemType" }, "chpt_CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock warrants outstanding at exercise price nine point zero three.", "label": "Common Stock Warrants Outstanding At Exercise Price Nine Point Zero Three [Member]", "terseLabel": "Common Stock Warrants Outstanding at Exercise Price 9.03 [Member]" } } }, "localname": "CommonStockWarrantsOutstandingAtExercisePriceNinePointZeroThreeMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail" ], "xbrltype": "domainItemType" }, "chpt_CommonStockWarrantsOutstandingAtExercisePriceSixPointZeroTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock warrants outstanding at exercise price six point zero two.", "label": "Common Stock Warrants Outstanding At Exercise Price Six Point Zero Two [Member]", "terseLabel": "Common Stock Warrants Outstanding at Exercise Price 6.02 [Member]" } } }, "localname": "CommonStockWarrantsOutstandingAtExercisePriceSixPointZeroTwoMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail" ], "xbrltype": "domainItemType" }, "chpt_CommonStockWarrantsOutstandingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock warrants outstanding.", "label": "Common Stock Warrants Outstanding [Member]", "terseLabel": "Common stock warrants outstanding [Member]" } } }, "localname": "CommonStockWarrantsOutstandingMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "domainItemType" }, "chpt_CompositionOfCertainFinancialStatementItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Composition of certain financial statement items.", "label": "Composition Of Certain Financial Statement Items [Abstract]" } } }, "localname": "CompositionOfCertainFinancialStatementItemsAbstract", "nsuri": "http://charge.com/20210731", "xbrltype": "stringItemType" }, "chpt_CompositionOfCertainFinancialStatementItemsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Composition of certain financial statement items disclosure.", "label": "Composition Of Certain Financial Statement Items Disclosure [Text Block]", "verboseLabel": "Composition of Certain Financial Statement Items" } } }, "localname": "CompositionOfCertainFinancialStatementItemsDisclosureTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItems" ], "xbrltype": "textBlockItemType" }, "chpt_ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Concentration of credit risk and other risks and uncertainties [Policy Text Block].", "label": "Concentration Of Credit Risk And Other Risks And Uncertainties [Policy Text Block]", "terseLabel": "Concentration of Credit Risk and Other Risks and Uncertainties" } } }, "localname": "ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesPolicyTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chpt_ContingentEarnoutLiabilityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent earnout liability.", "label": "Contingent Earnout Liability [Policy Text Block]", "terseLabel": "Contingent Earnout Liability" } } }, "localname": "ContingentEarnoutLiabilityPolicyTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chpt_ConversionOfOptionssharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of options,shares issued", "label": "Conversion of OptionsShares Issued", "terseLabel": "Conversion of options, shares issued" } } }, "localname": "ConversionOfOptionssharesIssued", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_ConversionOfRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of redeemable convertible preferred stock.", "label": "Conversion of Redeemable Convertible Preferred Stock [Member]", "verboseLabel": "Conversion of redeemable convertible preferred stock [Member]" } } }, "localname": "ConversionOfRedeemableConvertiblePreferredStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "domainItemType" }, "chpt_ConversionOfRedeemablePreferredStockIntoCommonStockOnAccountOfReverseRecapitalization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of redeemable preferred stock into common stock on account of reverse recapitalization.", "label": "Conversion Of Redeemable Preferred Stock Into Common Stock On Account Of Reverse Recapitalization", "terseLabel": "Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization" } } }, "localname": "ConversionOfRedeemablePreferredStockIntoCommonStockOnAccountOfReverseRecapitalization", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chpt_ConversionOfUnvestedRestrictedSharesOfCommonStockSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of unvested restricted shares of common stock, shares issued.", "label": "Conversion of Unvested Restricted Shares Of Common Stock Shares Issued", "terseLabel": "Conversion of unvested restricted shares of common stock, shares issued" } } }, "localname": "ConversionOfUnvestedRestrictedSharesOfCommonStockSharesIssued", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_CreditRiskAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit Risk [Axis]" } } }, "localname": "CreditRiskAxis", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "chpt_CreditRiskDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit Risk [Domain]" } } }, "localname": "CreditRiskDomain", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "chpt_CumulativeUndeclaredDividendsOnRedeemableConvertiblePreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative undeclared dividends on redeemable convertible preferred stock.", "label": "Cumulative Undeclared Dividends On Redeemable Convertible Preferred Stock", "terseLabel": "Adjust: Cumulative dividends on redeemable convertible preferred stock" } } }, "localname": "CumulativeUndeclaredDividendsOnRedeemableConvertiblePreferredStock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "monetaryItemType" }, "chpt_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer one [Member].", "label": "Customer One [Member]", "terseLabel": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "chpt_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer two [Member].", "label": "Customer Two [Member]", "terseLabel": "Customer Two [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "chpt_DaimlerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Daimler.", "label": "Daimler [Member]" } } }, "localname": "DaimlerMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://charge.com/role/RelatedPartyTransactionsSummaryOfRevenueTransactionsDetail" ], "xbrltype": "domainItemType" }, "chpt_DebtNonCurrent": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 27.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt non current.", "label": "Debt Non Current", "terseLabel": "Debt, noncurrent" } } }, "localname": "DebtNonCurrent", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "chpt_DeemedDividendsAttributableToCommonStockWarrantsHolders": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 22.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deemed dividends attributable to common stock warrants holders.", "label": "Deemed Dividends Attributable To Common Stock Warrants Holders", "terseLabel": "Deemed dividends attributable to common stock warrant holders", "verboseLabel": "Adjust: Deemed dividends attributable to common stock warrant holders" } } }, "localname": "DeemedDividendsAttributableToCommonStockWarrantsHolders", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "chpt_DeemedDividendsAttributableToVestedOptionHolders": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deemed dividends attributable to vested option holders.", "label": "Deemed Dividends Attributable To Vested Option Holders", "terseLabel": "Adjust: Deemed dividends attributable to vested option holders" } } }, "localname": "DeemedDividendsAttributableToVestedOptionHolders", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "monetaryItemType" }, "chpt_DeferredRevenuePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred revenue.", "label": "Deferred Revenue [Policy Text Block]", "verboseLabel": "Deferred Revenue" } } }, "localname": "DeferredRevenuePolicyTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chpt_DeferredTaxAssetsOperatingLeaseLiability": { "auth_ref": [], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets operating lease liability.", "label": "Deferred Tax Assets Operating Lease Liability", "verboseLabel": "Operating lease liabilities" } } }, "localname": "DeferredTaxAssetsOperatingLeaseLiability", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "monetaryItemType" }, "chpt_DeferredTaxAssetsOperatingLossCarryforwardsDomesticToFuturePeriod": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets operating loss carryforwards domestic to future period.", "label": "Deferred Tax Assets Operating Loss Carryforwards Domestic To Future Period", "terseLabel": "Federal net operating loss carryforwards not expire" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomesticToFuturePeriod", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_DeferredTaxAssetsResearchAndDevelopmentCredit": { "auth_ref": [], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets research and development credit.", "label": "Deferred Tax Assets Research And Development Credit", "verboseLabel": "Research & development credits" } } }, "localname": "DeferredTaxAssetsResearchAndDevelopmentCredit", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "monetaryItemType" }, "chpt_DeferredTaxLiabilitiesDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets": { "order": 10.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities depreciation and amortization.", "label": "Deferred Tax Liabilities Depreciation And Amortization", "negatedLabel": "Depreciation and amortization" } } }, "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "monetaryItemType" }, "chpt_DeferredTransactionCostsNotYetPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred transaction costs not yet paid.", "label": "Deferred Transaction Costs Not Yet Paid", "terseLabel": "Deferred transaction costs not yet paid" } } }, "localname": "DeferredTransactionCostsNotYetPaid", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chpt_DescriptionOfCaresActTaxAdjustments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of CARES Act Tax Adjustments.", "label": "Description Of Cares Act Tax Adjustments", "terseLabel": "Description of Cares Act tax adjustments" } } }, "localname": "DescriptionOfCaresActTaxAdjustments", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chpt_DescriptionofOrganizationBusinessOperationsandBasisofPresentationDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]" } } }, "localname": "DescriptionofOrganizationBusinessOperationsandBasisofPresentationDetailsLineItems", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chpt_DescriptionofOrganizationBusinessOperationsandBasisofPresentationDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Organization, Business Operations and Basis of Presentation (Details) [Table]" } } }, "localname": "DescriptionofOrganizationBusinessOperationsandBasisofPresentationDetailsTable", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chpt_EarlyRepaymentOfDebt": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 37.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the extinguishment of borrowings before its maturity.", "label": "Early Repayment Of Debt", "negatedLabel": "Repayment of debt" } } }, "localname": "EarlyRepaymentOfDebt", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chpt_EarnOutLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earn out liability", "label": "Earn Out Liability [Member]", "terseLabel": "Earnout Liability [Member]" } } }, "localname": "EarnOutLiabilityMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "chpt_EarnoutLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Earnout liability.", "label": "Earnout Liability", "terseLabel": "Earnout liability", "verboseLabel": "Earnout liability" } } }, "localname": "EarnoutLiability", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_EarnoutSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout share price.", "label": "Earnout Share Price", "terseLabel": "Earnout share price" } } }, "localname": "EarnoutSharePrice", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "chpt_EarnoutShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout shares.", "label": "Earnout Shares", "terseLabel": "Earnout Shares" } } }, "localname": "EarnoutShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_EarnoutSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout Shares", "label": "Earnout Shares [Member]" } } }, "localname": "EarnoutSharesMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "chpt_EarnoutSharesUnderTheTreasuryStockMethod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout shares under the treasury stock method.", "label": "Earnout Shares Under The Treasury Stock Method", "terseLabel": "Add: Earnout Shares under the treasury stock method" } } }, "localname": "EarnoutSharesUnderTheTreasuryStockMethod", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "sharesItemType" }, "chpt_EarnoutTriggeringEventMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout triggering event.", "label": "Earnout Triggering Event [Member]" } } }, "localname": "EarnoutTriggeringEventMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_EarnoutTriggeringSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout triggering share price.", "label": "Earnout Triggering Share Price", "verboseLabel": "Earnout triggering share price" } } }, "localname": "EarnoutTriggeringSharePrice", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "chpt_EffectiveIncomeTaxRateReconciliationWarrantMarkToMarketPercent": { "auth_ref": [], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation warrant mark to market percent.", "label": "Effective Income Tax Rate Reconciliation Warrant Mark To Market Percent", "verboseLabel": "Warrant Mark to Market" } } }, "localname": "EffectiveIncomeTaxRateReconciliationWarrantMarkToMarketPercent", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate" ], "xbrltype": "percentItemType" }, "chpt_ElectricFleetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Electric Fleet [Member]" } } }, "localname": "ElectricFleetMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_EquityIncentivePlanTwoThousandSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Incentive Plan Two Thousand Seven [Member]" } } }, "localname": "EquityIncentivePlanTwoThousandSevenMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_EquityIncentivePlanTwoThousandSeventeenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Incentive Plan Two Thousand Seventeen [Member]" } } }, "localname": "EquityIncentivePlanTwoThousandSeventeenMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_EquityIncentivePlanTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Incentive Plan Two Thousand Twenty One [Member]" } } }, "localname": "EquityIncentivePlanTwoThousandTwentyOneMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_EquityStockPurchasePlanTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Stock Purchase Plan Two Thousand Twenty One [Member]" } } }, "localname": "EquityStockPurchasePlanTwoThousandTwentyOneMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_EstimatedFairValueOfEarnOutLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Estimated fair value of earn out liability.", "label": "Estimated Fair Value Of Earn out Liability", "verboseLabel": "Estimated fair value of earn out liability" } } }, "localname": "EstimatedFairValueOfEarnOutLiability", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_EventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Event [Axis]" } } }, "localname": "EventAxis", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail" ], "xbrltype": "stringItemType" }, "chpt_EventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Event [Domain]" } } }, "localname": "EventDomain", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail" ], "xbrltype": "domainItemType" }, "chpt_ExchangeRatioUsedToDetermineTheNumberOfSharesOfCommonStockIntoWhichTheyConverted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exchange ratio used to determine the number of shares of common stock into which they converted.", "label": "Exchange Ratio Used To Determine The Number Of Shares Of Common Stock Into Which They Converted", "terseLabel": "Exchange ratio used to determine the number of shares of common stock into which they converted" } } }, "localname": "ExchangeRatioUsedToDetermineTheNumberOfSharesOfCommonStockIntoWhichTheyConverted", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "chpt_FairValueAdjustmentOfCommonStockWarrantLiabilities": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 16.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value adjustment of common stock warrant liabilities.", "label": "Fair Value Adjustment Of Common Stock Warrant Liabilities", "negatedLabel": "Change in fair value of common stock warrant liabilities", "terseLabel": "Change in fair value of common stock warrant liabilities" } } }, "localname": "FairValueAdjustmentOfCommonStockWarrantLiabilities", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "chpt_FairValueEarnoutLiabilityBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value earnout liability basis valuation techniques.", "label": "Fair Value Earnout Liability Basis Valuation Techniques [Line Items]" } } }, "localname": "FairValueEarnoutLiabilityBasisValuationTechniquesLineItems", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail" ], "xbrltype": "stringItemType" }, "chpt_FairValueEarnoutLiabilityBasisValuationTechniquesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value earnout liability basis valuation techniques.", "label": "Fair Value Earnout Liability Basis Valuation Techniques [Table]" } } }, "localname": "FairValueEarnoutLiabilityBasisValuationTechniquesTable", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail" ], "xbrltype": "stringItemType" }, "chpt_FairValueEarnoutLiabilityBasisValuationTechniquesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value earnout liability basis valuation techniques.", "label": "Fair Value Earnout Liability Basis Valuation Techniques [Table Text Block]", "verboseLabel": "Summary of Fair Value Earnout Liability Basis Valuation Techniques" } } }, "localname": "FairValueEarnoutLiabilityBasisValuationTechniquesTableTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsTables" ], "xbrltype": "textBlockItemType" }, "chpt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentEarnOutLiabilityRecognized": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability contingent earn out liability recognized.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Contingent Earn Out Liability Recognized", "terseLabel": "Contingent earnout liability recognized upon the closing of the reverse recapitalization" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentEarnOutLiabilityRecognized", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "chpt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationOfOptionWarrantsToStockholdersEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability reclassification of option warrants to stockholders equity.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reclassification Of Option Warrants To Stockholders Equity", "terseLabel": "Reclassification of option warrants to stockholders' equity (deficit) due to exercise" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationOfOptionWarrantsToStockholdersEquity", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "chpt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationOfPreferredStockWarrantLiabilityUponReverseCapitalization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability reclassification of preferred stock warrant liability upon reverse capitalization.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reclassification Of Preferred Stock Warrant Liability Upon Reverse Capitalization", "terseLabel": "Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationOfPreferredStockWarrantLiabilityUponReverseCapitalization", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "chpt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationOfRemainingContingentEarnOutLiabilityUponTriggeringEvent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability reclassification of remaining contingent earn out liability upon triggering event.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reclassification of Remaining Contingent Earn out Liability Upon Triggering Event", "terseLabel": "Reclassification of remaining contingent earnout liability upon triggering event" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationOfRemainingContingentEarnOutLiabilityUponTriggeringEvent", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "chpt_FairValueOfNonvestedSharesOfRestrictedCommonStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value Of Nonvested Shares Of Restricted Common Stock", "label": "Fair Value Of Nonvested Shares Of Restricted Common Stock", "terseLabel": "Fair value for the restricted common stock" } } }, "localname": "FairValueOfNonvestedSharesOfRestrictedCommonStock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_FairValueOfWarrantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of warrant liability.", "label": "Fair Value Of Warrant Liability", "periodEndLabel": "Fair value at end of period", "periodStartLabel": "Fair value at beginning of period" } } }, "localname": "FairValueOfWarrantLiability", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfLiabilityOfWarrantsSubjectToReMeasurementDetail" ], "xbrltype": "monetaryItemType" }, "chpt_FairValuePrivatePlacementWarrantsBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value private placement warrants basis valuation techniques.", "label": "Fair Value Private Placement Warrants Basis Valuation Techniques [Line Items]" } } }, "localname": "FairValuePrivatePlacementWarrantsBasisValuationTechniquesLineItems", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail" ], "xbrltype": "stringItemType" }, "chpt_FairValuePrivatePlacementWarrantsBasisValuationTechniquesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value private placement warrants basis valuation techniques.", "label": "Fair Value Private Placement Warrants Basis Valuation Techniques [Table]" } } }, "localname": "FairValuePrivatePlacementWarrantsBasisValuationTechniquesTable", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail" ], "xbrltype": "stringItemType" }, "chpt_FairValuePrivatePlacementWarrantsBasisValuationTechniquesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value private placement warrants basis valuation techniques.", "label": "Fair Value Private Placement Warrants Basis Valuation Techniques [Table Text Block]", "verboseLabel": "Summary of Fair Value Private Placement Warrants Basis Valuation Techniques" } } }, "localname": "FairValuePrivatePlacementWarrantsBasisValuationTechniquesTableTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsTables" ], "xbrltype": "textBlockItemType" }, "chpt_FounderEarnBackSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founder earn back shares.", "label": "Founder Earn Back Shares [Member]", "terseLabel": "Founder Earn Back Shares [Member]" } } }, "localname": "FounderEarnBackSharesMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_FounderEarnBackTriggeringEventMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founder earn back triggering event.", "label": "Founder Earn Back Triggering Event [Member]", "terseLabel": "Founder Earn Back Triggering Event [Member]" } } }, "localname": "FounderEarnBackTriggeringEventMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founder shares.", "label": "Founder Shares [Member]", "terseLabel": "Founder Shares [Member]" } } }, "localname": "FounderSharesMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_FoundersStockLetterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founders stock letter.", "label": "Founders Stock Letter [Member]" } } }, "localname": "FoundersStockLetterMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_FundingArrangementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Funding Arrangement [Line Items]", "terseLabel": "Funding Arrangement [Line Items]" } } }, "localname": "FundingArrangementLineItems", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chpt_GainAttributableToEarnOutSharesIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain attributable to earn out shares issued.", "label": "Gain Attributable To Earn Out Shares Issued", "terseLabel": "Less: Gain attributable to earnout shares issued" } } }, "localname": "GainAttributableToEarnOutSharesIssued", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "monetaryItemType" }, "chpt_GainAttributableToEarnoutSharesIssued": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 24.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain attributable to earnout shares issued.", "label": "Gain Attributable to Earnout Shares Issued", "terseLabel": "Gain attributable to earnout shares issued" } } }, "localname": "GainAttributableToEarnoutSharesIssued", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "chpt_GainMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gain.", "label": "Gain [Member]" } } }, "localname": "GainMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_GeographicAreaInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographic Area Information [Line Items]" } } }, "localname": "GeographicAreaInformationLineItems", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/GeographicInformationSummaryOfRevenueAndLongLivedAssetsByGeographicAreaDetail" ], "xbrltype": "stringItemType" }, "chpt_GeographicAreaInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographic Area Information [Table]" } } }, "localname": "GeographicAreaInformationTable", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/GeographicInformationSummaryOfRevenueAndLongLivedAssetsByGeographicAreaDetail" ], "xbrltype": "stringItemType" }, "chpt_HasToBeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Has to be.", "label": "Has To Be [Member]" } } }, "localname": "HasToBeMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_ImpactOfCovidNineteenPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Impact of covid nineteen.", "label": "Impact Of Covid Nineteen [Policy Text Block]", "terseLabel": "Impact of COVID-19" } } }, "localname": "ImpactOfCovidNineteenPolicyTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chpt_IncreaseDecreaseInOperatingLeaseLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in operating lease liabilities current.", "label": "Increase Decrease In Operating Lease Liabilities Current", "terseLabel": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiabilitiesCurrent", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chpt_InitialMeasurementsOfFairValueOfWarrantLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial measurements of fair value of warrant liability.", "label": "Initial Measurements of Fair Value of Warrant Liability", "verboseLabel": "Initial measurements of fair value of warrant liability" } } }, "localname": "InitialMeasurementsOfFairValueOfWarrantLiability", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_InventoryReserves": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory reserves.", "label": "Inventory reserves", "verboseLabel": "Inventory reserves" } } }, "localname": "InventoryReserves", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chpt_InvestorAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investor.", "label": "Investor [Axis]" } } }, "localname": "InvestorAxis", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chpt_InvestorDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investor.", "label": "Investor [Domain]" } } }, "localname": "InvestorDomain", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_IssuanceOfCommonStockUponEarlyExerciseOfStockOptionsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock upon early exercise of stock options shares.", "label": "Issuance Of Common Stock Upon Early Exercise Of Stock Options Shares", "terseLabel": "Issuance of common stock related to early exercise of stock options (Shares)" } } }, "localname": "IssuanceOfCommonStockUponEarlyExerciseOfStockOptionsShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "chpt_IssuanceOfCommonStockUponExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock upon exercise of warrants shares.", "label": "Issuance of Common Stock Upon Exercise of Warrants Shares", "terseLabel": "Issuance of common stock upon exercise of warrants (Shares)", "verboseLabel": "Issuance of common stock upon exercise of warrants" } } }, "localname": "IssuanceOfCommonStockUponExerciseOfWarrantsShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_IssuanceOfCommonStockUponExerciseOfWarrantsValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock upon exercise of warrants value.", "label": "Issuance Of Common Stock Upon Exercise Of Warrants Value", "terseLabel": "Issuance of common stock upon exercise of warrants" } } }, "localname": "IssuanceOfCommonStockUponExerciseOfWarrantsValue", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "chpt_IssuanceOfEarnoutSharesUponTriggeringEventsNetOfTaxWithholding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of earnout shares upon triggering events net of tax withholding.", "label": "Issuance Of Earnout Shares Upon Triggering Events Net of Tax Withholding", "terseLabel": "Issuance of earnout shares upon triggering events, net of tax withholding (Shares)", "verboseLabel": "Issuance Of Earnout Shares" } } }, "localname": "IssuanceOfEarnoutSharesUponTriggeringEventsNetOfTaxWithholding", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_IssuanceOfEarnoutSharesValueUponTriggeringEventsNetOfTaxWithholding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of earnout shares value upon triggering events net of tax withholding.", "label": "Issuance Of Earnout Shares Value Upon Triggering Events Net of Tax Withholding", "terseLabel": "Issuance of earnout shares upon triggering events, net of tax withholding" } } }, "localname": "IssuanceOfEarnoutSharesValueUponTriggeringEventsNetOfTaxWithholding", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "chpt_IssuanceOfSeriesRedeemableConvertibleCommonStockWarrantsNetOfIssuanceCostsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of series redeemable convertible common stock warrants net of issuance costs shares.", "label": "Issuance Of Series Redeemable Convertible Common Stock Warrants Net Of Issuance Costs Shares", "terseLabel": "Common stock warrants" } } }, "localname": "IssuanceOfSeriesRedeemableConvertibleCommonStockWarrantsNetOfIssuanceCostsShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_IssuanceOfSeriesRedeemableConvertiblePreferredStockNetOfIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of Series G redeemable convertible preferred stock, net of issuance costs.", "label": "Issuance Of Series Redeemable Convertible Preferred Stock Net Of Issuance Costs", "terseLabel": "Issuance of common stock warrants in connection with Series H-1 redeemable convertible preferred stock" } } }, "localname": "IssuanceOfSeriesRedeemableConvertiblePreferredStockNetOfIssuanceCosts", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "chpt_IssuanceOfSeriesRedeemableConvertiblePreferredStockNetOfIssuanceCostsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of Series G redeemable convertible preferred stock, net of issuance costs, shares.", "label": "Issuance Of Series Redeemable Convertible Preferred Stock Net Of Issuance Costs Shares", "terseLabel": "Issuance of redeemable convertible preferred stock" } } }, "localname": "IssuanceOfSeriesRedeemableConvertiblePreferredStockNetOfIssuanceCostsShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_LeaseSupplementalCashFlowInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Supplemental Cash Flow Information.", "label": "Lease Supplemental Cash Flow Information [Table Text Block]", "terseLabel": "Summary of Other Lease Supplemental Cash Flow Information" } } }, "localname": "LeaseSupplementalCashFlowInformationTableTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "chpt_LegacyChargePointMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legacy Charge Point [Member]", "terseLabel": "Legacy Charge Point [Member]" } } }, "localname": "LegacyChargePointMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_LegacyChargePointShares": { "auth_ref": [], "calculation": { "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails": { "order": 1.0, "parentTag": "chpt_TotalSharesOfCommonStockImmediatelyAfterBusinessCombination", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Legacy charge point shares.", "label": "Legacy Charge Point Shares", "terseLabel": "Legacy ChargePoint shares" } } }, "localname": "LegacyChargePointShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails" ], "xbrltype": "sharesItemType" }, "chpt_LegacyChargepointMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legacy Chargepoint [Member]" } } }, "localname": "LegacyChargepointMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_LegacyChargepointSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legacy ChargePoint Shares [Member]" } } }, "localname": "LegacyChargepointSharesMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsParentheticalDetail" ], "xbrltype": "domainItemType" }, "chpt_LegacyCommonAndPreferredStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legacy Common And Preferred Stock Warrants [Member]", "verboseLabel": "Legacy Common and Preferred Stock Warrants [Member]" } } }, "localname": "LegacyCommonAndPreferredStockWarrantsMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail" ], "xbrltype": "domainItemType" }, "chpt_LesseeOperatingLeaseLeaseNotYetCommencedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lessee Operating Lease Lease Not Yet Commenced Amount.", "label": "Lessee Operating Lease Lease Not Yet Commenced Amount", "terseLabel": "Operating lease not yet commenced amount" } } }, "localname": "LesseeOperatingLeaseLeaseNotYetCommencedAmount", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/LeasesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_MeasurementInputMarketPriceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input market price.", "label": "Measurement Input Market Price [Member]", "verboseLabel": "Market price of public stock [Member]" } } }, "localname": "MeasurementInputMarketPriceMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "chpt_MergerAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Merger Agreement [Member]", "terseLabel": "Merger Agreement [Member]" } } }, "localname": "MergerAgreementMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_NetworkedChargingSystemsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Networked charging systems.", "label": "Networked Charging Systems [Member]", "verboseLabel": "Networked charging systems [Member]" } } }, "localname": "NetworkedChargingSystemsMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "chpt_NonCumulativeDividendsAtAnnualRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non Cumulative Dividends At Annual Rate", "label": "Non Cumulative Dividends At Annual Rate", "terseLabel": "Noncumulative dividend" } } }, "localname": "NonCumulativeDividendsAtAnnualRate", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "chpt_NumberOfConsecutiveDaysDeterminingEarnoutTriggeringEvent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of consecutive days determining earnout triggering event.", "label": "Number Of Consecutive Days Determining Earnout Triggering Event", "terseLabel": "Number of consecutive days determining Earnout Triggering Event", "verboseLabel": "Number of consecutive days determining Earnout Triggering Event" } } }, "localname": "NumberOfConsecutiveDaysDeterminingEarnoutTriggeringEvent", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "chpt_NumberOfConsecutiveTradingDaysForDeterminingSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of consecutive trading days for determining share price.", "label": "Number Of Consecutive Trading Days For Determining Share Price", "terseLabel": "Number of consecutive trading days for determining share price" } } }, "localname": "NumberOfConsecutiveTradingDaysForDeterminingSharePrice", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "chpt_NumberOfDaysDeterminingEarnoutTriggeringEvent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of days determining earnout triggering event.", "label": "Number Of Days Determining Earnout Triggering Event", "terseLabel": "Number of days determining Earnout Triggering Event", "verboseLabel": "Number of days determining Earnout Triggering Event" } } }, "localname": "NumberOfDaysDeterminingEarnoutTriggeringEvent", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "chpt_NumberOfSharesCancelledAsACapitalContributionParValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares cancelled as a capital contribution par value per share.", "label": "Number of shares cancelled as a capital contribution par value per share", "terseLabel": "Number of shares cancelled as a capital contribution par value per share" } } }, "localname": "NumberOfSharesCancelledAsACapitalContributionParValuePerShare", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "chpt_NumberOfTradingDaysForDeterminingSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of trading days for determining share price.", "label": "Number Of Trading Days For Determining Share Price", "terseLabel": "Number of trading days for determining share price." } } }, "localname": "NumberOfTradingDaysForDeterminingSharePrice", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "chpt_NumberOfWarrantsCalledForRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants called for redemption.", "label": "Number of Warrants Called For Redemption", "terseLabel": "Number of warrants called for redemption" } } }, "localname": "NumberOfWarrantsCalledForRedemption", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_OfferingCostsExpensed": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offering costs expensed.", "label": "Offering Costs Expensed", "verboseLabel": "Offering costs expensed" } } }, "localname": "OfferingCostsExpensed", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "chpt_OperatingLossCarryforwardsExpiredAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating loss carryforwards expired amount.", "label": "Operating Loss Carryforwards Expired Amount", "terseLabel": "Net Operating Loss due to ownership changes" } } }, "localname": "OperatingLossCarryforwardsExpiredAmount", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_OtherRevenuesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other revenues.", "label": "Other Revenues [Member]", "terseLabel": "Other [Member]" } } }, "localname": "OtherRevenuesMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "chpt_OtherStateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other State [Member]" } } }, "localname": "OtherStateMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_OwnedAndOperatedSystemsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Owned and operated systems.", "label": "Owned And Operated Systems [Member]", "verboseLabel": "Owned and operated systems [Member]" } } }, "localname": "OwnedAndOperatedSystemsMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "chpt_PaymentsOfTaxesPaidRelatedToNetShareSettlementOfEarnoutShares": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 29.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments of taxes paid related to net share settlement of earnout shares.", "label": "Payments of Taxes Paid Related to Net Share Settlement of Earnout Shares", "negatedLabel": "Payment of tax withholding obligations on settlement of earnout shares" } } }, "localname": "PaymentsOfTaxesPaidRelatedToNetShareSettlementOfEarnoutShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chpt_PercentageOfTaxableIncomeLimitation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Taxable Income Limitation.", "label": "Percentage Of Taxable Income Limitation", "terseLabel": "Percentage of taxable income limitation" } } }, "localname": "PercentageOfTaxableIncomeLimitation", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "chpt_PipeFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PIPE financing.", "label": "PIPE Financing [Member]", "terseLabel": "PIPE Financing [Member]" } } }, "localname": "PipeFinancingMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "chpt_PipeInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PIPE Investor", "label": "PIPE Investor [Member]" } } }, "localname": "PipeInvestorMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_PreferredStockConversionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Stock Conversion Price Per Share", "label": "Preferred Stock Conversion Price Per Share", "terseLabel": "Preferred stock, conversion price" } } }, "localname": "PreferredStockConversionPricePerShare", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "chpt_PreferredStockWarrantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Preferred Stock Warrant Liability", "label": "Preferred Stock Warrant Liability", "terseLabel": "Preferred stock warrant at fair value" } } }, "localname": "PreferredStockWarrantLiability", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants [Member]" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "chpt_ProceedsFromBusinessCombination": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from business combination.", "label": "Proceeds From Business Combination", "terseLabel": "Proceeds from business Combination" } } }, "localname": "ProceedsFromBusinessCombination", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "chpt_ProceedsFromBusinessCombinationAndPipeFinancingNetOfIssuanceCosts": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 28.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from business combination and pipe financing, net of issuance costs.", "label": "Proceeds from Business Combination and PIPE Financing Net of Issuance Costs", "terseLabel": "Merger and PIPE financing" } } }, "localname": "ProceedsFromBusinessCombinationAndPipeFinancingNetOfIssuanceCosts", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "chpt_ProceedsFromIssuanceOfCommonStockAndWarrants": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 34.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From Issuance Of Common Stock And Warrants", "label": "Proceeds From Issuance Of Common Stock And Warrants", "terseLabel": "Proceeds from issuance of common stock warrants" } } }, "localname": "ProceedsFromIssuanceOfCommonStockAndWarrants", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chpt_PublicAndPrivatePlacementsWarrantsUnderTheTreasuryStockMethod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public and private placements warrants under the treasury stock method.", "label": "Public And Private Placements Warrants Under The Treasury Stock Method", "terseLabel": "Add: Public and Private Placement Warrants under the treasury stock method" } } }, "localname": "PublicAndPrivatePlacementsWarrantsUnderTheTreasuryStockMethod", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "sharesItemType" }, "chpt_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Public Warrants [Member]", "terseLabel": "Public Warrants [Member]" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "chpt_ReclassificationOfTemporaryEquityToPermanentEquityShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reclassification Of Temporary Equity To Permanent Equity Shares.", "label": "Reclassification Of Temporary Equity To Permanent Equity Shares", "terseLabel": "Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend (Shares)" } } }, "localname": "ReclassificationOfTemporaryEquityToPermanentEquityShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "chpt_RedeemableConvertiblePreferredStockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable convertible preferred stock.", "label": "Redeemable Convertible Preferred Stock [Abstract]" } } }, "localname": "RedeemableConvertiblePreferredStockAbstract", "nsuri": "http://charge.com/20210731", "xbrltype": "stringItemType" }, "chpt_RedeemableConvertiblePreferredStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable convertible preferred stock.", "label": "Redeemable Convertible Preferred Stock [Line Items]" } } }, "localname": "RedeemableConvertiblePreferredStockLineItems", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chpt_RedeemableConvertiblePreferredStockTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable convertible preferred stock.", "label": "Redeemable Convertible Preferred Stock [Table]" } } }, "localname": "RedeemableConvertiblePreferredStockTable", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chpt_RedeemableConvertiblePreferredStockWarrantLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable convertible preferred stock warrant liability.", "label": "Redeemable Convertible Preferred Stock Warrant Liability [Member]", "terseLabel": "Redeemable Convertible Preferred Stock Warrant Liability [Member]" } } }, "localname": "RedeemableConvertiblePreferredStockWarrantLiabilityMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "chpt_RedeemableConvertiblePreferredStockWarrantLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Redeemable convertible preferred stock warrant liability.", "label": "Redeemable Convertible Preferred Stock Warrant Liability Noncurrent", "terseLabel": "Redeemable convertible preferred stock warrant liability" } } }, "localname": "RedeemableConvertiblePreferredStockWarrantLiabilityNoncurrent", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "chpt_RedeemableConvertiblePreferredStockWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable Convertible Preferred Stock Warrant [Member]", "terseLabel": "Redeemable convertible preferred stock warrant [Member]" } } }, "localname": "RedeemableConvertiblePreferredStockWarrantMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "domainItemType" }, "chpt_RedeemableConvertiblePreferredStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable convertible preferred stock warrants.", "label": "Redeemable Convertible Preferred Stock Warrants [Member]" } } }, "localname": "RedeemableConvertiblePreferredStockWarrantsMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "chpt_RedeemableConvertiblePreferredStockWarrantsOutstandingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable convertible preferred stock warrants outstanding.", "label": "Redeemable Convertible Preferred Stock Warrants Outstanding [Member]", "verboseLabel": "Redeemable convertible preferred stock warrants outstanding [Member]" } } }, "localname": "RedeemableConvertiblePreferredStockWarrantsOutstandingMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "domainItemType" }, "chpt_RefundableCustomerDeposits": { "auth_ref": [], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail": { "order": 7.0, "parentTag": "chpt_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Refundable customer deposits.", "label": "Refundable Customer Deposits", "verboseLabel": "Refundable customer deposits" } } }, "localname": "RefundableCustomerDeposits", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "chpt_RemovingPercentageOfTaxableIncomeLimitationOnUtilizationOfNetOperatingLoss": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Removing percentage of taxable income limitation on utilization of Net Operating Loss.", "label": "Removing Percentage Of Taxable Income Limitation On Utilization Of Net Operating Loss", "terseLabel": "Removing percentage of taxable income limitation on utilization of Net Operating Loss" } } }, "localname": "RemovingPercentageOfTaxableIncomeLimitationOnUtilizationOfNetOperatingLoss", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "chpt_RepaymentOfAccruedInterestAndPrepaymentFees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments of accrued interest and prepayment fees.", "label": "Repayment Of Accrued Interest And Prepayment Fees", "terseLabel": "Payments of accrued interest and prepayment fees" } } }, "localname": "RepaymentOfAccruedInterestAndPrepaymentFees", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_RepaymentOfAcrruedInterestAndPrepaymentFees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments of accrued interest and prepayment fees.", "label": "Repayment of Acrrued Interest and Prepayment Fees", "terseLabel": "Payments of accrued interest and prepayment fees" } } }, "localname": "RepaymentOfAcrruedInterestAndPrepaymentFees", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_RepaymentOfBorrowings": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 31.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repayment of borrowings.", "label": "Repayment of Borrowings", "negatedLabel": "Repayment of borrowings" } } }, "localname": "RepaymentOfBorrowings", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chpt_RestOfTheWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rest of the world.", "label": "Rest Of The World [Member]", "terseLabel": "Rest of World [Member]" } } }, "localname": "RestOfTheWorldMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfRevenueDetail" ], "xbrltype": "domainItemType" }, "chpt_RestOfWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Rest Of World [Member]", "terseLabel": "Rest of World [Member]" } } }, "localname": "RestOfWorldMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/GeographicInformationSummaryOfRevenueAndLongLivedAssetsByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "chpt_RestrictedCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Common Stock", "label": "Restricted Common Stock", "terseLabel": "Restricted common stock" } } }, "localname": "RestrictedCommonStock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_RestrictedCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Common Stock [Member]", "terseLabel": "Restricted Common Stock [Member]" } } }, "localname": "RestrictedCommonStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_RestrictedStockUnitsAndOutstandingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Units and Outstanding [Member]", "label": "Restricted Stock Units and Outstanding [Member]", "terseLabel": "Restricted Stock Units and Outstanding [Member]" } } }, "localname": "RestrictedStockUnitsAndOutstandingMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "domainItemType" }, "chpt_RevenueRemainingPerformanceObligationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue remaining performance obligation [Policy Text Block].", "label": "Revenue Remaining Performance Obligation [Policy Text Block]", "terseLabel": "Remaining Performance Obligations" } } }, "localname": "RevenueRemainingPerformanceObligationPolicyTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chpt_ReverseRecapitalizationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization [Abstract]" } } }, "localname": "ReverseRecapitalizationAbstract", "nsuri": "http://charge.com/20210731", "xbrltype": "stringItemType" }, "chpt_ReverseRecapitalizationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization [Text Block]", "label": "Reverse Recapitalization [Text Block]", "terseLabel": "Reverse Recapitalization" } } }, "localname": "ReverseRecapitalizationTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalization" ], "xbrltype": "textBlockItemType" }, "chpt_RightOfUseAssetRemeasurementSubsequentToLeaseExtension": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Right of use asset remeasurement subsequent to lease extension.", "label": "Right Of Use Asset Remeasurement Subsequent To Lease Extension", "verboseLabel": "Right-of-use asset remeasurement subsequent to lease extension" } } }, "localname": "RightOfUseAssetRemeasurementSubsequentToLeaseExtension", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chpt_ScheduleOfAssumedPublicWarrantsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of assumed public warrants.", "label": "Schedule Of Assumed Public Warrants [Table Text Block]", "verboseLabel": "Summary of Assumed Public Warrants" } } }, "localname": "ScheduleOfAssumedPublicWarrantsTableTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsTables" ], "xbrltype": "textBlockItemType" }, "chpt_ScheduleOfChangesInFairValueOfWarrantLiabilityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of changes in fair value of warrant liability.", "label": "Schedule Of Changes In Fair Value Of Warrant Liability [Table Text Block]", "verboseLabel": "Schedule of Liability of Warrants Subject to Re Measurement" } } }, "localname": "ScheduleOfChangesInFairValueOfWarrantLiabilityTableTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsTables" ], "xbrltype": "textBlockItemType" }, "chpt_ScheduleOfEstimatedUsefulLivesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of estimated useful lives.", "label": "Schedule Of Estimated Useful Lives [Table Text Block]", "terseLabel": "Schedule of Estimated Useful Lives" } } }, "localname": "ScheduleOfEstimatedUsefulLivesTableTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "chpt_ScheduleOfIncomeTaxProvisionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of income tax provision [Abstract]" } } }, "localname": "ScheduleOfIncomeTaxProvisionAbstract", "nsuri": "http://charge.com/20210731", "xbrltype": "stringItemType" }, "chpt_ScheduleOfNetDeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of net deferred tax assets [Abstract]" } } }, "localname": "ScheduleOfNetDeferredTaxAssetsAbstract", "nsuri": "http://charge.com/20210731", "xbrltype": "stringItemType" }, "chpt_ScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of reconciliation of the statutory federal income tax rate to the Company's effective tax rate [Abstract]" } } }, "localname": "ScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRateAbstract", "nsuri": "http://charge.com/20210731", "xbrltype": "stringItemType" }, "chpt_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Redeemable Convertible Preferred Stock Table [Text Block]", "label": "Schedule Of Redeemable Convertible Preferred Stock [Table Text Block]", "terseLabel": "Schedule Of Redeemable Convertible Preferred Stock" } } }, "localname": "ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockTables" ], "xbrltype": "textBlockItemType" }, "chpt_ScheduleOfRedeemableConvertiblePreferredStockWarrantsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of redeemable convertible preferred stock warrants.", "label": "Schedule Of Redeemable Convertible Preferred Stock Warrants [Table Text Block]", "verboseLabel": "Schedule of Outstanding Redeemable Convertible Preferred Stock Warrants" } } }, "localname": "ScheduleOfRedeemableConvertiblePreferredStockWarrantsTableTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsTables" ], "xbrltype": "textBlockItemType" }, "chpt_SectionThreeHundredEightyTwoOwnershipChangeDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Section three hundred eighty two ownership change description.", "label": "Section Three Hundred Eighty Two Ownership Change Description", "verboseLabel": "Section 382 Ownership Change description" } } }, "localname": "SectionThreeHundredEightyTwoOwnershipChangeDescription", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chpt_SeriesARedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A redeemable convertible preferred stock.", "label": "Series A Redeemable Convertible Preferred Stock [Member]", "verboseLabel": "Series A [Member]" } } }, "localname": "SeriesARedeemableConvertiblePreferredStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_SeriesBDEPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series B D E Preferred Stock [Member]" } } }, "localname": "SeriesBDEPreferredStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_SeriesBRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series B redeemable convertible preferred stock.", "label": "Series B Redeemable Convertible Preferred Stock [Member]", "verboseLabel": "Series B [Member]" } } }, "localname": "SeriesBRedeemableConvertiblePreferredStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_SeriesCRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series C redeemable convertible preferred stock.", "label": "Series C Redeemable Convertible Preferred Stock [Member]", "verboseLabel": "Series C [Member]" } } }, "localname": "SeriesCRedeemableConvertiblePreferredStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_SeriesDRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series D redeemable convertible preferred stock.", "label": "Series D Redeemable Convertible Preferred Stock [Member]", "verboseLabel": "Series D [Member]" } } }, "localname": "SeriesDRedeemableConvertiblePreferredStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_SeriesERedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series E redeemable convertible preferred stock.", "label": "Series E Redeemable Convertible Preferred Stock [Member]", "verboseLabel": "Series E [Member]" } } }, "localname": "SeriesERedeemableConvertiblePreferredStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_SeriesFRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series F redeemable convertible preferred stock.", "label": "Series F Redeemable Convertible Preferred Stock [Member]", "verboseLabel": "Series F [Member]" } } }, "localname": "SeriesFRedeemableConvertiblePreferredStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_SeriesGRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series G redeemable convertible preferred stock.", "label": "Series G Redeemable Convertible Preferred Stock [Member]", "verboseLabel": "Series G [Member]" } } }, "localname": "SeriesGRedeemableConvertiblePreferredStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_SeriesH1RedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H1 redeemable convertible preferred stock.", "label": "Series H1 Redeemable Convertible Preferred Stock [Member]", "terseLabel": "Series H-1 Redeemable Convertible Preferred Stock [Member]" } } }, "localname": "SeriesH1RedeemableConvertiblePreferredStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_SeriesHOneRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H one redeemable convertible preferred stock.", "label": "Series H One Redeemable Convertible Preferred Stock [Member]", "verboseLabel": "Series\u00a0H-1 [Member]" } } }, "localname": "SeriesHOneRedeemableConvertiblePreferredStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_SeriesHRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H redeemable convertible preferred stock.", "label": "Series H Redeemable Convertible Preferred Stock [Member]", "verboseLabel": "Series H [Member]" } } }, "localname": "SeriesHRedeemableConvertiblePreferredStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_SharePriceGreaterOrEqualFifteenUsdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price greater or equal fifteen usd.", "label": "Share Price Greater Or Equal Fifteen Usd [Member]", "terseLabel": "Share Price Greater Or Equal 15 USD [Member]", "verboseLabel": "Share Price Greater Or Equal 15 USD [Member]" } } }, "localname": "SharePriceGreaterOrEqualFifteenUsdMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_SharePriceGreaterOrEqualThirtyUsdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price greater or equal thirty usd.", "label": "Share Price Greater Or Equal Thirty Usd [Member]", "terseLabel": "Share Price Greater Or Equal 30 USD [Member]", "verboseLabel": "Share Price Greater Or Equal 30 USD [Member]" } } }, "localname": "SharePriceGreaterOrEqualThirtyUsdMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_SharePriceGreaterOrEqualTwentyUsdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price greater or equal twenty usd.", "label": "Share Price Greater Or Equal Twenty Usd [Member]", "terseLabel": "Share Price Greater Or Equal 20 USD [Member]", "verboseLabel": "Share Price Greater Or Equal 20 USD [Member]" } } }, "localname": "SharePriceGreaterOrEqualTwentyUsdMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_SharePriceRangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price range.", "label": "Share Price Range [Axis]" } } }, "localname": "SharePriceRangeAxis", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail" ], "xbrltype": "stringItemType" }, "chpt_SharePriceRangeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price range.", "label": "Share Price Range [Domain]" } } }, "localname": "SharePriceRangeDomain", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail" ], "xbrltype": "domainItemType" }, "chpt_SharePriceTriggeringEarnout": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price triggering earnout.", "label": "Share Price Triggering Earnout", "terseLabel": "Share price triggering Earnout", "verboseLabel": "Share price triggering Earnout" } } }, "localname": "SharePriceTriggeringEarnout", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "chpt_ShareTransferTriggerPricePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share transfer, trigger price, per share.", "label": "Share Transfer Trigger Price Price Per Share", "terseLabel": "Share transfer, trigger price price per share." } } }, "localname": "ShareTransferTriggerPricePricePerShare", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "chpt_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionOutstandingIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Outstanding, Intrinsic Value", "label": "Sharebased Compensation Arrangement by Sharebased Payment Award, Option, Outstanding, Intrinsic Value", "periodEndLabel": "Aggregate intrinsic value outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionOutstandingIntrinsicValue", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "monetaryItemType" }, "chpt_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionOutstandingNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Outstanding, Number", "label": "Sharebased Compensation Arrangement by Sharebased Payment Award, Option, Outstanding, Number", "periodEndLabel": "Number of stock option awards outstanding ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionOutstandingNumber", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "sharesItemType" }, "chpt_SharesAuthorizedToIssuePriorToMerger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares Authorized To Issue Prior To Merger.", "label": "Shares Authorized To Issue Prior To Merger", "verboseLabel": "Shares authorized to issue prior to merger" } } }, "localname": "SharesAuthorizedToIssuePriorToMerger", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_SharesAvailableForGrantUnderTwoThousandSeventeenStockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares available for grant under\u00a0Two Thousand Seventeen Stock Option Plan.", "label": "Shares Available for Grant Under Two Thousand Seventeen Stock Option Plan [Member]", "verboseLabel": "Shares available for grant under\u00a02017 Stock Option Plan [Member]" } } }, "localname": "SharesAvailableForGrantUnderTwoThousandSeventeenStockOptionPlanMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "domainItemType" }, "chpt_SharesAvailableForGrantUnderTwoThousandTwentyOneEsppMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares Available For Grant Under Two Thousand Twenty One ESPP [Member]", "terseLabel": "Shares available for grant under 2021 ESPP [Member]" } } }, "localname": "SharesAvailableForGrantUnderTwoThousandTwentyOneEsppMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "domainItemType" }, "chpt_SharesAvailableForGrantUndertwoThousandTwentyOneEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares Available For Grant UnderTwo Thousand Twenty One Equity Incentive Plan [Member]", "terseLabel": "Shares available for grant under 2021 Equity Incentive Plan [Member]" } } }, "localname": "SharesAvailableForGrantUndertwoThousandTwentyOneEquityIncentivePlanMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "domainItemType" }, "chpt_SharesParValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares par value.", "label": "Shares Par Value", "verboseLabel": "Shares par value" } } }, "localname": "SharesParValue", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "chpt_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SponsorMember", "terseLabel": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_StockIssuableDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issuable during period value new issues.", "label": "Stock Issuable During Period Value New Issues", "verboseLabel": "Stock issuable value" } } }, "localname": "StockIssuableDuringPeriodValueNewIssues", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_StockIssuedDuringThePeriodUponTheExerciseOfRecapitalizationValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during the period upon the exercise of recapitalization value.", "label": "Stock Issued During The Period Upon The Exercise Of Recapitalization Value", "terseLabel": "Issuance of common stock upon the reverse recapitalization, net of issuance costs" } } }, "localname": "StockIssuedDuringThePeriodUponTheExerciseOfRecapitalizationValue", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "chpt_StockOptionsIssuedAndOutstandingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock options issued and outstanding.", "label": "Stock Options Issued and Outstanding [Member]", "verboseLabel": "Stock options issued and outstanding [Member]" } } }, "localname": "StockOptionsIssuedAndOutstandingMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail" ], "xbrltype": "domainItemType" }, "chpt_StockSharesIssuedDuringThePeriodUponRecapitalizationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock shares issued during the period upon recapitalization shares.", "label": "Stock Shares Issued During The Period Upon Recapitalization Shares", "terseLabel": "Issuance of common stock upon the reverse recapitalization, net of issuance costs (Shares)" } } }, "localname": "StockSharesIssuedDuringThePeriodUponRecapitalizationShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "chpt_StockSurrendedDuringPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock surrounded during period shares.", "label": "Stock Surrended During Period Shares", "terseLabel": "Less surrender of Switchback Founder Shares", "verboseLabel": "Stock surrended During Period, Shares" } } }, "localname": "StockSurrendedDuringPeriodShares", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails" ], "xbrltype": "sharesItemType" }, "chpt_StockWarrantsAndEarnoutsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock warrants and earnouts.", "label": "Stock Warrants And Earnouts [Abstract]" } } }, "localname": "StockWarrantsAndEarnoutsAbstract", "nsuri": "http://charge.com/20210731", "xbrltype": "stringItemType" }, "chpt_StockWarrantsAndEarnoutsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock warrants and earnouts.", "label": "Stock Warrants And Earnouts [Text Block]", "verboseLabel": "Stock Warrants and Earnouts" } } }, "localname": "StockWarrantsAndEarnoutsTextBlock", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnouts" ], "xbrltype": "textBlockItemType" }, "chpt_StockholdersEquityExchangeRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stockholders equity exchange ratio.", "label": "Stockholders Equity Exchange Ratio", "terseLabel": "Stockholders equity exchange ratio" } } }, "localname": "StockholdersEquityExchangeRatio", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsParentheticalDetail" ], "xbrltype": "pureItemType" }, "chpt_SubscriptionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subscription agreement.", "label": "Subscription Agreement [Member]", "terseLabel": "Subscription Agreement [Member]" } } }, "localname": "SubscriptionAgreementMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_SummaryofSignificantAccountingPoliciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "chpt_SummaryofSignificantAccountingPoliciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "chpt_SwitchbackMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Switchback.", "label": "Switchback [Member]", "terseLabel": "Switchback [Member]" } } }, "localname": "SwitchbackMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "chpt_SwitchbackPublicStockholdersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Switchback Public Stockholders [Member]" } } }, "localname": "SwitchbackPublicStockholdersMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_TaxCreditCarryforwardsExpiredAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tax credit carryforwards expired amount.", "label": "Tax Credit Carryforwards Expired Amount", "terseLabel": "Federal tax credits expected to expire for income tax purposes" } } }, "localname": "TaxCreditCarryforwardsExpiredAmount", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_TemporaryEquityPerShareConversionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity Per Share Conversion Price", "label": "Temporary Equity Per Share Conversion Price", "terseLabel": "Preferred stock conversion to common stock price" } } }, "localname": "TemporaryEquityPerShareConversionPrice", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "chpt_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Preferred Stock, Shares Issued", "documentation": "Temporary Equity Stock Issued During Period Shares New Issues", "label": "Temporary Equity Stock Issued During Period Shares New Issues", "verboseLabel": "Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs (in shares)" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chpt_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of trading days for determining share price from date of business combination.", "label": "Threshold Number Of Trading Days For Determining Share Price From Date Of Business Combination", "terseLabel": "Threshold number of trading days for determining share price from date of business combination" } } }, "localname": "ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "chpt_ThresholdTriggeringSharePrice": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Threshold triggering share price.", "label": "Threshold Triggering Share Price", "verboseLabel": "Threshold triggering Share price" } } }, "localname": "ThresholdTriggeringSharePrice", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chpt_ToolingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tooling.", "label": "Tooling [Member]", "terseLabel": "Tooling [Member]" } } }, "localname": "ToolingMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "chpt_TotalSharesOfCommonStockImmediatelyAfterBusinessCombination": { "auth_ref": [], "calculation": { "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Total shares of common stock immediately after business combination.", "label": "Total shares Of Common Stock Immediately After Business Combination", "totalLabel": "Total shares of common stock immediately after Merger" } } }, "localname": "TotalSharesOfCommonStockImmediatelyAfterBusinessCombination", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails" ], "xbrltype": "sharesItemType" }, "chpt_TrancheNameAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche name.", "label": "Tranche Name [Axis]" } } }, "localname": "TrancheNameAxis", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail" ], "xbrltype": "stringItemType" }, "chpt_TrancheNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche name.", "label": "Tranche Name [Domain]" } } }, "localname": "TrancheNameDomain", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail" ], "xbrltype": "domainItemType" }, "chpt_TrancheThreeAndFinalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tranche Three And Final [Member]" } } }, "localname": "TrancheThreeAndFinalMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_TrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche three.", "label": "Tranche Three [Member]", "terseLabel": "Tranche Three [Member]" } } }, "localname": "TrancheThreeMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_TransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction costs.", "label": "Transaction Costs", "terseLabel": "Transaction costs" } } }, "localname": "TransactionCosts", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "chpt_TransactionCostsExpensed": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 17.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction costs expensed.", "label": "Transaction Costs Expensed", "negatedLabel": "Transaction costs expensed", "verboseLabel": "Transaction costs expensed" } } }, "localname": "TransactionCostsExpensed", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "chpt_TriggeringEventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Triggering event.", "label": "Triggering Event [Axis]" } } }, "localname": "TriggeringEventAxis", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "chpt_TriggeringEventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Triggering event.", "label": "Triggering Event [Domain]" } } }, "localname": "TriggeringEventDomain", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "chpt_TriggeringSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Triggering share price.", "label": "Triggering Share Price", "verboseLabel": "Triggering Share price" } } }, "localname": "TriggeringSharePrice", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "chpt_TwoThousandEighteenLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand Eighteen Loan [Member]", "terseLabel": "2018 Loan" } } }, "localname": "TwoThousandEighteenLoanMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_TwoThousandFourteenLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand Fourteen Loan [Member]", "terseLabel": "2014 Loan" } } }, "localname": "TwoThousandFourteenLoanMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_UnvestedEarlyExercisedCommonStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unvested Early Exercised Common Stock Options [Member]", "terseLabel": "Unvested early exercised common stock options [Member]" } } }, "localname": "UnvestedEarlyExercisedCommonStockOptionsMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "domainItemType" }, "chpt_UnvestedRestrictedCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unvested Restricted Common Stock [Member]", "terseLabel": "Unvested restricted common stock [Member]" } } }, "localname": "UnvestedRestrictedCommonStockMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "domainItemType" }, "chpt_VestingOfRestrictedStockAndEarlyExercisedStockOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Vesting Of Restricted Stock And Early Exercised Stock Options", "label": "Vesting Of Restricted Stock And Early Exercised Stock Options", "terseLabel": "Vesting of early exercised stock options" } } }, "localname": "VestingOfRestrictedStockAndEarlyExercisedStockOptions", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chpt_ViricitiBVMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ViriCiti B V.", "label": "ViriCiti B V [Member]" } } }, "localname": "ViricitiBVMember", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chpt_WarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants exercised.", "label": "Warrants Exercised", "verboseLabel": "Warrants Exercised" } } }, "localname": "WarrantsExercised", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail" ], "xbrltype": "sharesItemType" }, "chpt_WarrantsRedeemed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants redeemed.", "label": "Warrants Redeemed", "verboseLabel": "Warrants Redeemed" } } }, "localname": "WarrantsRedeemed", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail" ], "xbrltype": "sharesItemType" }, "chpt_WarrantyAccrualsCurrent": { "auth_ref": [], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail": { "order": 4.0, "parentTag": "chpt_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warranty accruals current.", "label": "Warranty Accruals Current", "verboseLabel": "Warranty accruals" } } }, "localname": "WarrantyAccrualsCurrent", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "chpt_WeightedAverageUnvestedRestrictedSharesAndSharesSubjectToRepurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average unvested restricted shares and shares subject to repurchase.", "label": "Weighted Average Unvested Restricted Shares And Shares Subject To Repurchase", "terseLabel": "Less: Weighted-average unvested restricted shares and shares subject to repurchase" } } }, "localname": "WeightedAverageUnvestedRestrictedSharesAndSharesSubjectToRepurchase", "nsuri": "http://charge.com/20210731", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "sharesItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States [Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfRevenueDetail", "http://charge.com/role/GeographicInformationSummaryOfRevenueAndLongLivedAssetsByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://charge.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://charge.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://charge.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://charge.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r741" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://charge.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://charge.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://charge.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://charge.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r0", "r147", "r153", "r160", "r254", "r439", "r440", "r441", "r475", "r476", "r517", "r519", "r520", "r521", "r742" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r0", "r147", "r153", "r160", "r254", "r439", "r440", "r441", "r475", "r476", "r517", "r519", "r520", "r521", "r742" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r0", "r147", "r153", "r160", "r254", "r439", "r440", "r441", "r475", "r476", "r517", "r519", "r520", "r521", "r742" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r314", "r350", "r402", "r404", "r595", "r596", "r597", "r598", "r599", "r600", "r619", "r684", "r687", "r730", "r731" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail", "http://charge.com/role/IncomeTaxesAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r314", "r350", "r402", "r404", "r595", "r596", "r597", "r598", "r599", "r600", "r619", "r684", "r687", "r730", "r731" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail", "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail", "http://charge.com/role/IncomeTaxesAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r227", "r381", "r382", "r621", "r683", "r685" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r227", "r381", "r382", "r621", "r683", "r685" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r314", "r350", "r391", "r402", "r404", "r595", "r596", "r597", "r598", "r599", "r600", "r619", "r684", "r687", "r730", "r731" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail", "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail", "http://charge.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://charge.com/role/IncomeTaxesAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r314", "r350", "r391", "r402", "r404", "r595", "r596", "r597", "r598", "r599", "r600", "r619", "r684", "r687", "r730", "r731" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail", "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail", "http://charge.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://charge.com/role/IncomeTaxesAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r1", "r144", "r145", "r146", "r148", "r149", "r150", "r151", "r152", "r153", "r155", "r156", "r157", "r158", "r159", "r160", "r180", "r255", "r256", "r442", "r476", "r518", "r520", "r521", "r522", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r743", "r744" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail", "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r1", "r144", "r145", "r146", "r148", "r149", "r150", "r151", "r152", "r153", "r155", "r156", "r157", "r158", "r159", "r160", "r180", "r255", "r256", "r442", "r476", "r518", "r520", "r521", "r522", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r743", "r744" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail", "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r1", "r144", "r146", "r148", "r149", "r150", "r151", "r152", "r153", "r155", "r156", "r158", "r159", "r180", "r255", "r256", "r442", "r476", "r518", "r520", "r521", "r522", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r743", "r744" ], "lang": { "en-us": { "role": { "label": "Previously Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail", "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r228", "r229", "r381", "r383", "r686", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfRevenueDetail", "http://charge.com/role/GeographicInformationSummaryOfRevenueAndLongLivedAssetsByGeographicAreaDetail", "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r228", "r229", "r381", "r383", "r686", "r716", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfRevenueDetail", "http://charge.com/role/GeographicInformationSummaryOfRevenueAndLongLivedAssetsByGeographicAreaDetail", "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r235", "r579" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CALIFORNIA" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Pronouncements" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r50", "r585" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r717" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Receivable, after Allowance for Credit Loss [Abstract]" } } }, "localname": "AccountsReceivableNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r6", "r30", "r236", "r237" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowance" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableRelatedParties": { "auth_ref": [ "r29", "r141", "r577", "r580", "r666" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.", "label": "Accounts Receivable, Related Parties", "verboseLabel": "Related party accounts receivable" } } }, "localname": "AccountsReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r55" ], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail": { "order": 1.0, "parentTag": "chpt_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "verboseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r48", "r284" ], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r33", "r72", "r73", "r74", "r663", "r693", "r697" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r71", "r74", "r84", "r85", "r86", "r144", "r145", "r146", "r510", "r688", "r689", "r744" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r31", "r442", "r585" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r144", "r145", "r146", "r439", "r440", "r441", "r520" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Recognition and Exercise", "terseLabel": "Cash compensation awards" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r311", "r365", "r374" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "verboseLabel": "Adjustment of common stock warrants issued" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Cost [Policy Text Block]", "terseLabel": "Advertising" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r407", "r435", "r444" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Stock based compensation expense", "verboseLabel": "Total stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r239", "r257", "r259", "r261" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAllowanceForDoubtfulAccountsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r37", "r239", "r257" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)", "terseLabel": "Additions Charged To Expense" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAllowanceForDoubtfulAccountsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r260" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "negatedLabel": "Write-offs" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAllowanceForDoubtfulAccountsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfAcquisitionCosts": { "auth_ref": [ "r119", "r275" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Acquisition Costs", "negatedLabel": "Amortization of deferred contract acquisition costs", "terseLabel": "Amortization of deferred contract acquisition costs" } } }, "localname": "AmortizationOfAcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredContractAcquisitionCostsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r119", "r275", "r279" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense for intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Total potentially dilutive common share equivalents" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareAdditionalInformationDetail", "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareAdditionalInformationDetail", "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r136", "r207", "r217", "r223", "r253", "r298", "r299", "r300", "r302", "r303", "r304", "r305", "r306", "r307", "r309", "r310", "r505", "r511", "r540", "r583", "r585", "r638", "r659" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r8", "r10", "r68", "r136", "r253", "r298", "r299", "r300", "r302", "r303", "r304", "r305", "r306", "r307", "r309", "r310", "r505", "r511", "r540", "r583", "r585" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r523" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Financial Assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrust": { "auth_ref": [ "r131" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.", "label": "Assets Held-in-trust", "terseLabel": "Cash held in trust account" } } }, "localname": "AssetsHeldInTrust", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleEquitySecuritiesAmortizedCostBasis": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the cost of equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments for other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.", "label": "Available-for-sale Equity Securities, Amortized Cost Basis", "terseLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleEquitySecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.", "label": "Available-for-sale Securities", "terseLabel": "Fair Value" } } }, "localname": "AvailableForSaleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r244" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.", "label": "Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax", "terseLabel": "Gross Unreal Gains" } } }, "localname": "AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.", "label": "Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax", "terseLabel": "Gross Unreal Losses" } } }, "localname": "AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r408", "r437" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r401", "r403" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAdditionalInformationDetail", "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r401", "r403", "r491", "r492" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAdditionalInformationDetail", "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Business Acquisition,Number of Shares received", "verboseLabel": "Business combination, stock issued" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition, Share Price", "terseLabel": "Business acquisition, share price (in Dollars per share)", "verboseLabel": "Business Combination share price" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r490" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "verboseLabel": "Business combination, issuance costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r496", "r497", "r498" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Purchase consideration", "verboseLabel": "Business combination, stock issued value" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAdditionalInformationDetail", "http://charge.com/role/CommonStockAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure contingent consideration liability from business combination.", "label": "Business Combination, Contingent Consideration, Liability, Measurement Input", "verboseLabel": "Earnout Liability Measurement Input" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail" ], "xbrltype": "decimalItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r501" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": { "auth_ref": [ "r493", "r494" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability", "verboseLabel": "Earnout liability fair value" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r494" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r3", "r143", "r196" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Description of Business and Basis of Presentation" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r4", "r45", "r121" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetail": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets", "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r15", "r122", "r635" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash, Cash Equivalents, and Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r114", "r121", "r127" ], "calculation": { "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period", "terseLabel": "Cash equivalents and restricted cash", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]", "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r114", "r541" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplementary cash flow information on noncash investing and financing activities" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashMember": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.", "label": "Cash [Member]" } } }, "localname": "CashMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CatastrophicEventDomain": { "auth_ref": [ "r292", "r293" ], "lang": { "en-us": { "role": { "documentation": "Catastrophic event, for example, but not limited to, earthquake, windstorm, fire or explosion.", "label": "Catastrophic Event [Domain]" } } }, "localname": "CatastrophicEventDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r133", "r136", "r165", "r166", "r171", "r174", "r176", "r184", "r185", "r186", "r253", "r298", "r303", "r304", "r305", "r309", "r310", "r348", "r349", "r353", "r357", "r540", "r734" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheets", "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Date the warrants or rights are exercisable, in YYYY-MM-DD format.", "label": "Class of Warrant or Right, Date from which Warrants or Rights Exercisable", "terseLabel": "Expiration date", "verboseLabel": "Expiration Date" } } }, "localname": "ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail" ], "xbrltype": "dateItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r375", "r406" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails", "http://charge.com/role/FairValueMeasurementsTables", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails", "http://charge.com/role/FairValueMeasurementsTables", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Number of securities called by each warrant or right, per share (in Dollars per share)", "verboseLabel": "Exercise Price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsTables", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfLiabilityOfWarrantsSubjectToReMeasurementDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Number of securities called by each warrant or right" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Class of warrants outstanding", "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Outstanding as of July 31, 2021", "periodStartLabel": "Outstanding as of January\u00a031, 2021", "terseLabel": "Total outstanding common stock warrants" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r375", "r406" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsTables", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfLiabilityOfWarrantsSubjectToReMeasurementDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r59", "r292", "r646", "r669" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 7)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r289", "r290", "r291", "r294", "r718" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Class A common stock" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r61" ], "lang": { "en-us": { "role": { "definitionGuidance": "Common stock capital shares reserved for future issuance", "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "presentationGuidance": "Issuance Of Earnout Shares", "terseLabel": "Common stock remain reserved for oustanding", "verboseLabel": "Total shares of common stock reserved" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/CommonStockSummaryOfCommonStockCapitalSharesReservedForFutureIssuanceDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockConversionBasis": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Description of basis for conversion of convertible common stock.", "label": "Common Stock, Conversion Basis", "terseLabel": "Stock conversion basis" } } }, "localname": "CommonStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r144", "r145", "r520" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)", "verboseLabel": "Common stock par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r28", "r365" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding", "verboseLabel": "Common stock outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscribedButUnissued": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common Stock, Shares Subscribed but Unissued", "terseLabel": "Stock that may be issued", "verboseLabel": "Stock that may be issued" } } }, "localname": "CommonStockSharesSubscribedButUnissued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r28", "r585" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "presentationGuidance": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock, Voting Rights", "verboseLabel": "Voting rights" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r389", "r390", "r405", "r446" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation and Employee Benefit Plans [Text Block]", "terseLabel": "Employee Benefit Plans" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EmployeeBenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Compensation Related Costs, Policy [Policy Text Block]", "terseLabel": "Stock-based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r79", "r81", "r82", "r91", "r649", "r673" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "auth_ref": [ "r276", "r278", "r495" ], "lang": { "en-us": { "role": { "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.", "label": "Computer Software, Intangible Asset [Member]", "terseLabel": "Computer Software, Intangible Asset [Member]", "verboseLabel": "Computers and software [Member]" } } }, "localname": "ComputerSoftwareIntangibleAssetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r191", "r192", "r233", "r538", "r539", "r717" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r191", "r192", "r233", "r538", "r539", "r699", "r717" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r191", "r192", "r233", "r538", "r539", "r699", "r717" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r191", "r192", "r233", "r538", "r539" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r191", "r192", "r233", "r538", "r539", "r717" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "verboseLabel": "Construction in progress [Member]" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r124", "r125", "r126" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Issued", "terseLabel": "Conversion of warrants,shares issued" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r26", "r27", "r360", "r366", "r370" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Convertible Preferred Stock, Shares Issued upon Conversion", "terseLabel": "Convertible preferred stock, shares issued upon conversion" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r97", "r136", "r253", "r298", "r299", "r300", "r303", "r304", "r305", "r306", "r307", "r309", "r310", "r540" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Revenue [Abstract]", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "verboseLabel": "Cost of revenue [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CumulativeDividends": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative cash dividends distributed to shareholders.", "label": "Cumulative Dividends", "terseLabel": "Unpaid accumulated dividend" } } }, "localname": "CumulativeDividends", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "Current" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r137", "r472", "r479" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r137", "r472" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision": { "order": 4.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "verboseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r137", "r472", "r479", "r481" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Total current" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r137", "r472", "r479" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision": { "order": 3.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1": { "auth_ref": [ "r124", "r126" ], "lang": { "en-us": { "role": { "documentation": "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Warrants or Options Issued", "terseLabel": "Debt conversion converted instrument warrants issued" } } }, "localname": "DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r132", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r325", "r327", "r328", "r330", "r336" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r331" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "terseLabel": "Debt instrument convertible into warrants" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r313", "r333" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price per warrants" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r312", "r334", "r335", "r552", "r554", "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Principal amount of working capital loans" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentPaymentTerms": { "auth_ref": [ "r57", "r655" ], "lang": { "en-us": { "role": { "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.", "label": "Debt Instrument, Payment Terms", "terseLabel": "Term loan facility payment terms" } } }, "localname": "DebtInstrumentPaymentTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Term loan facility term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale [Table]" } } }, "localname": "DebtSecuritiesAvailableForSaleTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredChargesPolicyTextBlock": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.", "label": "Deferred Charges, Policy [Policy Text Block]", "terseLabel": "Costs to Obtain a Customer Contract" } } }, "localname": "DeferredChargesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredCosts": { "auth_ref": [ "r18", "r637", "r658" ], "calculation": { "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredAcquisitionCostsDetail": { "order": 2.0, "parentTag": "us-gaap_DeferredCostsCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.", "label": "Deferred Costs, Noncurrent", "terseLabel": "Deferred contract acquisition costs, noncurrent" } } }, "localname": "DeferredCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredAcquisitionCostsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs [Abstract]" } } }, "localname": "DeferredCostsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DeferredCostsCurrent": { "auth_ref": [ "r67" ], "calculation": { "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredAcquisitionCostsDetail": { "order": 1.0, "parentTag": "us-gaap_DeferredCostsCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.", "label": "Deferred Costs, Current", "terseLabel": "Deferred contract acquisition costs, current" } } }, "localname": "DeferredCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredAcquisitionCostsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsCurrentAndNoncurrent": { "auth_ref": [], "calculation": { "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredAcquisitionCostsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of deferred costs.", "label": "Deferred Costs", "totalLabel": "Total deferred contract acquisition costs" } } }, "localname": "DeferredCostsCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredAcquisitionCostsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r137", "r473", "r479" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision": { "order": 6.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "negatedLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "Deferred" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r49", "r322", "r553" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Net of issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r137", "r473", "r479" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision": { "order": 8.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "verboseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r119", "r137", "r473", "r479", "r480", "r481" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "totalLabel": "Total deferred" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r22", "r23", "r463", "r639", "r656" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredPolicyAcquisitionCosts": { "auth_ref": [ "r667", "r678", "r679", "r681", "r691", "r698" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force.", "label": "Deferred Policy Acquisition Cost", "periodEndLabel": "Balance", "periodStartLabel": "Balance" } } }, "localname": "DeferredPolicyAcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredContractAcquisitionCostsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredPolicyAcquisitionCostsAdditions": { "auth_ref": [ "r678", "r681", "r691" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred policy acquisition cost capitalized.", "label": "Deferred Policy Acquisition Cost, Capitalization", "terseLabel": "Capitalization of deferred contract acquisition costs" } } }, "localname": "DeferredPolicyAcquisitionCostsAdditions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfDeferredContractAcquisitionCostsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock": { "auth_ref": [ "r677", "r680", "r681", "r691" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the movement in deferred policy acquisition costs.", "label": "Deferred Policy Acquisition Costs [Table Text Block]", "terseLabel": "Schedule of Deferred Acquisition Costs" } } }, "localname": "DeferredPolicyAcquisitionCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredRentAssetNetCurrent": { "auth_ref": [ "r44", "r557" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of rental income recognized over rental payment required by lease, classified as current.", "label": "Deferred Rent Asset, Net, Current", "terseLabel": "Deferred rent" } } }, "localname": "DeferredRentAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r38" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "terseLabel": "Total deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueNoncurrent": { "auth_ref": [ "r38" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 30.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred Revenue, Noncurrent", "terseLabel": "Deferred revenue, noncurrent" } } }, "localname": "DeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueRevenueRecognized1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.", "label": "Deferred Revenue, Revenue Recognized", "terseLabel": "Deferred revenue recognised" } } }, "localname": "DeferredRevenueRevenueRecognized1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r137", "r473", "r479" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision": { "order": 7.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "auth_ref": [ "r470", "r471" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.", "label": "Deferred Tax Assets, Deferred Income", "verboseLabel": "Deferred revenue" } } }, "localname": "DeferredTaxAssetsDeferredIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r464" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGrossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Gross [Abstract]", "verboseLabel": "Deferred tax assets:" } } }, "localname": "DeferredTaxAssetsGrossAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r466" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r470", "r471" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "verboseLabel": "Net operating losses" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "auth_ref": [ "r470", "r471" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic", "verboseLabel": "Federal net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "auth_ref": [ "r470", "r471" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local", "terseLabel": "State net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": { "auth_ref": [ "r469", "r470", "r471" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research", "terseLabel": "Research credit carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r470", "r471" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost", "verboseLabel": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [ "r470", "r471" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals", "verboseLabel": "Accruals and reserves" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r465" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedTerseLabel": "Less: valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross [Abstract]", "verboseLabel": "Deferred tax liabilities:" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "auth_ref": [ "r470", "r471" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets": { "order": 11.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.", "label": "Deferred Tax Liabilities, Leasing Arrangements", "negatedLabel": "Operating lease right-of-use assets" } } }, "localname": "DeferredTaxLiabilitiesLeasingArrangements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfNetDeferredTaxAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r119", "r282" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expenses" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r119", "r205" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 25.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units.", "label": "Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities", "terseLabel": "Change in fair value of dilutive warrants", "verboseLabel": "Less: Change in fair value of dilutive warrants" } } }, "localname": "DilutiveSecuritiesEffectOnBasicEarningsPerShareOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Abstract]" } } }, "localname": "DisaggregationOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfRevenueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfRevenueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "verboseLabel": "Summary of revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "verboseLabel": "Equity Plans and Stock-based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DividendsShareBasedCompensation": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 21.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind dividends declared for award under share-based payment arrangement.", "label": "Dividend, Share-based Payment Arrangement", "negatedLabel": "Deemed dividends attributable to vested option holders" } } }, "localname": "DividendsShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r50", "r141", "r301", "r303", "r304", "r308", "r309", "r310", "r577" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Due to related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r92", "r150", "r151", "r153", "r154", "r155", "r161", "r165", "r174", "r175", "r176", "r180", "r181", "r521", "r522", "r650", "r674" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net loss per share - Basic", "verboseLabel": "Net loss per share - Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "definitionGuidance": "Net loss per share attributable to common stockholders, basic and diluted", "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Net loss per share attributable to common stockholders, basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r92", "r150", "r151", "r153", "r154", "r155", "r165", "r174", "r175", "r176", "r180", "r181", "r521", "r522", "r650", "r674" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net loss per share - Diluted", "verboseLabel": "Net loss per share - Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r177", "r178" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss per Share Attributable to Common Stockholders" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r177", "r178", "r179", "r182" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Basic and Diluted Net Loss per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r541" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r453" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective tax rate", "verboseLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail", "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r139", "r453", "r483" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Tax at federal statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r453", "r483" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in Valuation Allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r453", "r483" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "verboseLabel": "Permanent differences" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment": { "auth_ref": [ "r453", "r483" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent", "verboseLabel": "Research and development tax credits" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "auth_ref": [ "r445", "r453" ], "calculation": { "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent", "verboseLabel": "Stock-based compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfTheStatutoryFederalIncomeTaxRateToTheCompanysEffectiveTaxRate" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r55" ], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail": { "order": 3.0, "parentTag": "chpt_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "verboseLabel": "Payroll and related expenses" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Additional Disclosure [Abstract]" } } }, "localname": "EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r436" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "verboseLabel": "Total compensation cost related to unvested awards not yet recognised" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "verboseLabel": "Weighted average period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r436" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "verboseLabel": "Total unrecognized stock based compensation cost related to stock awards" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Options to purchase common stock [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r84", "r85", "r86", "r144", "r145", "r146", "r149", "r156", "r159", "r183", "r254", "r365", "r374", "r439", "r440", "r441", "r475", "r476", "r520", "r542", "r543", "r544", "r545", "r546", "r548", "r688", "r689", "r690", "r744" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfLiabilityOfWarrantsSubjectToReMeasurementDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsParentheticalDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesByInvestmentObjectiveAxis": { "auth_ref": [ "r391", "r400" ], "lang": { "en-us": { "role": { "documentation": "Information by investment objective.", "label": "Investment Objective [Axis]" } } }, "localname": "EquitySecuritiesByInvestmentObjectiveAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquitySecuritiesInvestmentObjectiveMember": { "auth_ref": [ "r391", "r400" ], "lang": { "en-us": { "role": { "documentation": "Objective of investment.", "label": "Investment Objective [Domain]" } } }, "localname": "EquitySecuritiesInvestmentObjectiveMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r119", "r337" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 13.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "disclosureGuidance": "Adjustments in warrants", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "exampleGuidance": "Change in fair value", "label": "Fair Value Adjustment of Warrants", "negatedTerseLabel": "Change in fair value of redeemable convertible preferred stock warrant liability", "presentationGuidance": "Adjustments in warrants", "terseLabel": "Change in fair value of redeemable convertible preferred stock warrant liability" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfLiabilityOfWarrantsSubjectToReMeasurementDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r523", "r524", "r525", "r534" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "verboseLabel": "Summary of Fair Value Measurement Inputs and Valuation Techniques" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r523", "r524" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of company's assets that are measured at fair value on a recurring basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r523", "r534" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r324", "r334", "r335", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r400", "r524", "r592", "r593", "r594" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfLiabilityOfWarrantsSubjectToReMeasurementDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r533", "r534" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r523", "r524", "r527", "r528", "r535" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r324", "r392", "r393", "r398", "r400", "r524", "r592" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "presentationGuidance": "Level\u00a01" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r324", "r334", "r335", "r392", "r393", "r398", "r400", "r524", "r593" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "verboseLabel": "Level\u00a02" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r324", "r334", "r335", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r400", "r524", "r594" ], "lang": { "en-us": { "role": { "definitionGuidance": "Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "presentationGuidance": "Level\u00a03", "terseLabel": "Significant Other Unobservable Inputs (Level 3) [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfLiabilityOfWarrantsSubjectToReMeasurementDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsQuantitativeInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Abstract]" } } }, "localname": "FairValueInputsQuantitativeInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r529", "r534" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r529", "r534" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of changes in the fair value of Level 3 financial statements" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r530" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Change in fair value included in other income (expense), net" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "auth_ref": [ "r531" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "verboseLabel": "Issuance of earnout shares upon triggering events" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "auth_ref": [ "r531" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "negatedLabel": "Private placement warrant liability acquired as part of the merger" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r529" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r324", "r334", "r335", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r400", "r592", "r593", "r594" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "http://charge.com/role/FairValueMeasurementsSummaryOfChangesInTheFairValueOfLevel3FinancialStatementsDetails", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfLiabilityOfWarrantsSubjectToReMeasurementDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r533", "r535" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "auth_ref": [ "r532" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in income for derivative asset (liability) after deduction of derivative liability (asset), measured at fair value using unobservable input (level 3) and still held.", "label": "Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss)", "verboseLabel": "Fair value adjustment of warrants" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r536", "r537" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FeaturesOfConvertiblePreferredStockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Features of Convertible Preferred Stock [Abstract]", "terseLabel": "Features of Convertible Preferred Stock [Abstract]" } } }, "localname": "FeaturesOfConvertiblePreferredStockAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r245", "r246", "r249", "r250", "r251", "r258", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r329", "r363", "r516", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r734", "r735", "r736", "r737", "r738", "r739", "r740" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.", "label": "Financial Liabilities Fair Value Disclosure", "terseLabel": "Financial Liabilities" } } }, "localname": "FinancialLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FullCostMethodUsingGrossRevenueMethodPolicy": { "auth_ref": [ "r634" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for use of the gross revenue method in place of the full cost method of accounting. The policy may describe when the entity believes it is more appropriate due to economic circumstances to compute amortization of capitalized costs based on the gross revenue method (rather than the units of production method that would result in improper matching of costs to the related revenue).", "label": "Full Cost Method Using Gross Revenue Method, Policy [Policy Text Block]", "terseLabel": "Cost of Revenue" } } }, "localname": "FullCostMethodUsingGrossRevenueMethodPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and Fixtures [Member]", "verboseLabel": "Furniture and fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r98" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "verboseLabel": "General and administrative [Member]" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographic Areas, Revenues from External Customers [Abstract]" } } }, "localname": "GeographicAreasRevenuesFromExternalCustomersAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r272", "r273", "r585", "r636" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill", "verboseLabel": "Carrying value of goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheets", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r274", "r277" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r96", "r136", "r207", "r216", "r219", "r222", "r225", "r253", "r298", "r299", "r300", "r303", "r304", "r305", "r306", "r307", "r309", "r310", "r540" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "verboseLabel": "Initial public offering [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r280", "r287" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r138", "r482" ], "calculation": { "http://charge.com/role/IncomeTaxesScheduleOfNetLossBeforeIncomeTaxesDetail": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "verboseLabel": "Domestic" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesScheduleOfNetLossBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r138", "r482" ], "calculation": { "http://charge.com/role/IncomeTaxesScheduleOfNetLossBeforeIncomeTaxesDetail": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "verboseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesScheduleOfNetLossBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r207", "r216", "r219", "r222", "r225" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 }, "http://charge.com/role/IncomeTaxesScheduleOfNetLossBeforeIncomeTaxesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "Net loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations", "http://charge.com/role/IncomeTaxesScheduleOfNetLossBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r286", "r288" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r288" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r139", "r454", "r461", "r468", "r477", "r484", "r486", "r487", "r488" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationDescription": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.", "label": "Income Tax Examination, Description", "verboseLabel": "Income tax description" } } }, "localname": "IncomeTaxExaminationDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r140", "r158", "r159", "r206", "r452", "r478", "r485", "r676" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 19.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 }, "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for income taxes", "totalLabel": "Total provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations", "http://charge.com/role/IncomeTaxesDetailsScheduleOfIncomeTaxProvision" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r83", "r450", "r451", "r461", "r462", "r467", "r474" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r116", "r123" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r118" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r118" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r118" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued and other liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r118" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r118" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of effect of acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r118" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r88", "r204", "r551", "r553", "r651" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r111", "r115", "r123" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r645", "r670" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Interest Payable", "verboseLabel": "Term loan facility accrued interest" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryCostsForContractsOrProgramsPolicy": { "auth_ref": [ "r40", "r42" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory for costs relating to long-term contracts or programs. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average). Elements of costs in inventory may include retained costs representing the excess of manufacturing or production costs over the amounts charged to cost of sales or delivered or in-process units, initial tooling or other deferred startup costs.", "label": "Inventory Costs for Contracts or Programs, Policy [Policy Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryCostsForContractsOrProgramsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r63" ], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfInventoriesDetail": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "verboseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r5", "r66", "r585" ], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfInventoriesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Total Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfInventoriesDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r65" ], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfInventoriesDetail": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Raw Materials, Gross", "verboseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r64" ], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfInventoriesDetail": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "verboseLabel": "Work-in-progress" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r99", "r203" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 18.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r252", "r675" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Short-term Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r119" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Issuance of Stock and Warrants for Services or Claims", "terseLabel": "Net of issuance costs", "verboseLabel": "Net of issuance costs" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease, Cost [Abstract]" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of Other Supplemental Information of Lease Term and Discount Rate" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold Improvements [Member]", "verboseLabel": "Leasehold improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r560" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.", "label": "Leases of Lessee Disclosure [Text Block]", "terseLabel": "Leases" } } }, "localname": "LeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesOperatingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases, Operating [Abstract]", "terseLabel": "Operating leases" } } }, "localname": "LeasesOperatingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": { "auth_ref": [ "r566" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract", "terseLabel": "Lessee operating lease not yet commenced, term of contract" } } }, "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r572" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Maturities of Operating Leases" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r572" ], "calculation": { "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total undiscounted operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r572" ], "calculation": { "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r572" ], "calculation": { "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r572" ], "calculation": { "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r572" ], "calculation": { "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r572" ], "calculation": { "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r572" ], "calculation": { "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r572" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails", "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit [Member]" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Secured letters of credit outstanding" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r54", "r136", "r218", "r253", "r298", "r299", "r300", "r303", "r304", "r305", "r306", "r307", "r309", "r310", "r506", "r511", "r512", "r540", "r583", "r584" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r36", "r136", "r253", "r540", "r585", "r642", "r665" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities, Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r56", "r136", "r253", "r298", "r299", "r300", "r303", "r304", "r305", "r306", "r307", "r309", "r310", "r506", "r511", "r512", "r540", "r583", "r584", "r585" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis": { "auth_ref": [ "r682" ], "lang": { "en-us": { "role": { "documentation": "Information by type of catastrophic event, for example, but not limited to, earthquake, windstorm, fire or explosion.", "label": "Catastrophic Event [Axis]" } } }, "localname": "LiabilityForCatastropheClaimsByCatastrophicEventAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAverageOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Average amount borrowed under the credit facility during the period.", "label": "Line of Credit Facility, Average Outstanding Amount", "terseLabel": "Term loan facility borrowings during the period" } } }, "localname": "LineOfCreditFacilityAverageOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDescription": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate.", "label": "Line of Credit Facility, Interest Rate Description", "terseLabel": "Term loan facility interest rate description" } } }, "localname": "LineOfCreditFacilityInterestRateDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate during the reporting period.", "label": "Line of Credit Facility, Interest Rate During Period", "terseLabel": "Term loan facility interest rate" } } }, "localname": "LineOfCreditFacilityInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Term loan facility maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityPeriodicPaymentInterest": { "auth_ref": [ "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payment applied to interest.", "label": "Line of Credit Facility, Periodic Payment, Interest", "terseLabel": "Term loan facility interest expense incurred" } } }, "localname": "LineOfCreditFacilityPeriodicPaymentInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Term loan facility unused borrowing capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r51", "r135" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.", "label": "Long-lived Assets by Geographic Areas [Table Text Block]", "terseLabel": "Summary of Long-lived Assets by Geographic Area" } } }, "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/GeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r20", "r323", "r332", "r334", "r335", "r640", "r660" ], "calculation": { "http://charge.com/role/DebtSummaryOfFuturePrincipalPaymentsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Total payments" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtSummaryOfFuturePrincipalPaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtByMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term Debt, Fiscal Year Maturity [Abstract]" } } }, "localname": "LongTermDebtByMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r53" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 23.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "terseLabel": "Debt, current" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r142", "r297", "r326" ], "calculation": { "http://charge.com/role/DebtSummaryOfFuturePrincipalPaymentsDetail": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtSummaryOfFuturePrincipalPaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r142", "r297", "r326" ], "calculation": { "http://charge.com/role/DebtSummaryOfFuturePrincipalPaymentsDetail": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtSummaryOfFuturePrincipalPaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r142", "r297", "r326" ], "calculation": { "http://charge.com/role/DebtSummaryOfFuturePrincipalPaymentsDetail": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtSummaryOfFuturePrincipalPaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and Equipment [Member]", "verboseLabel": "Machinery and equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r94" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "Marketable Securities, Unrealized Gain (Loss)", "terseLabel": "Unrealized gains or losses" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Measurement Input, Exercise Price [Member]", "verboseLabel": "Exercise price [Member]" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]", "verboseLabel": "Dividend rate [Member]" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "verboseLabel": "Expected term (years) [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "verboseLabel": "Expected volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "verboseLabel": "Risk-free interest rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input, Share Price [Member]", "terseLabel": "Current stock price [Member]" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail", "http://charge.com/role/FairValueMeasurementsSummaryOfCompanySAssetsAndLiabilitiesThatWereMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r114" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r114" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash (used in) provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r114", "r117", "r120" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r77", "r80", "r86", "r89", "r120", "r136", "r148", "r150", "r151", "r153", "r154", "r158", "r159", "r172", "r207", "r216", "r219", "r222", "r225", "r253", "r298", "r299", "r300", "r303", "r304", "r305", "r306", "r307", "r309", "r310", "r522", "r540", "r647", "r671" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r150", "r151", "r153", "r154", "r161", "r162", "r173", "r176", "r207", "r216", "r219", "r222", "r225" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net loss attributable to common stockholders - Basic" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r164", "r167", "r168", "r169", "r170", "r173", "r176" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Net loss attributable to common stockholders - Diluted" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "verboseLabel": "Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r229" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets", "terseLabel": "Total long-lived assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/GeographicInformationSummaryOfRevenueAndLongLivedAssetsByGeographicAreaDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r198" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r207", "r216", "r219", "r222", "r225" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r563" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r562" ], "calculation": { "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Operating lease liabilities", "totalLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails", "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail", "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r562" ], "calculation": { "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails": { "order": 7.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail": { "order": 5.0, "parentTag": "chpt_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "negatedLabel": "Less: current portion of operating lease liabilities", "terseLabel": "Operating lease liabilities, current", "verboseLabel": "Operating lease liabilities, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails", "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail", "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r562" ], "calculation": { "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails": { "order": 8.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 28.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Operating lease liabilities, noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities", "verboseLabel": "Operating lease liabilities, noncurrent" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails", "http://charge.com/role/CondensedConsolidatedBalanceSheets", "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r564", "r567" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Cash paid for amounts in the measurement of operating lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesSummaryOfOtherLeaseSupplementalCashFlowInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r561" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease\u00a0right-of-use\u00a0assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets", "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r119" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Non-cash\u00a0operating lease cost" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r570", "r573" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average operating lease discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesScheduleOfOtherSupplementalInformationOfLeaseTermAndDiscountRateDetail" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r569", "r573" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted-average remaining operating lease term (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/LeasesScheduleOfOtherSupplementalInformationOfLeaseTermAndDiscountRateDetail" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r556", "r558" ], "calculation": { "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Operating Leases, Future Minimum Payments Due", "totalLabel": "Total undiscounted operating lease payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r556", "r558" ], "calculation": { "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months", "terseLabel": "2022 (remaining six months)" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r556", "r558" ], "calculation": { "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails": { "order": 5.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Five Years", "terseLabel": "2026" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r556", "r558" ], "calculation": { "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails": { "order": 4.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Four Years", "terseLabel": "2025" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r556", "r558" ], "calculation": { "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Three Years", "terseLabel": "2024" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r556", "r558" ], "calculation": { "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Two Years", "terseLabel": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r556", "r558" ], "calculation": { "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails": { "order": 6.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due Thereafter", "terseLabel": "Thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesSummaryOfFuturePaymentsUnderTheNonCancellableOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.", "label": "Operating Loss Carryforwards, Limitations on Use", "terseLabel": "Description of net operating loss deductions" } } }, "localname": "OperatingLossCarryforwardsLimitationsOnUse", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r49" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax [Abstract]", "terseLabel": "Available-for-sale short-term investments:" } } }, "localname": "OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r69" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r78", "r81", "r84", "r85", "r87", "r90", "r365", "r542", "r547", "r548", "r648", "r672" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Other comprehensive (loss) income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r78", "r81", "r503", "r504", "r509" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Other comprehensive income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": { "auth_ref": [ "r72", "r75", "r76", "r247" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax", "negatedLabel": "Reclassification to net income, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r70", "r72" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "terseLabel": "Unrealized loss on short-term investments, net of tax" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r11", "r12", "r55", "r585" ], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail": { "order": 6.0, "parentTag": "chpt_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "verboseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebtNoncurrent": { "auth_ref": [ "r58" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 26.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.", "label": "Other Long-term Debt, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r100" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedLabel": "Other" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 15.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "terseLabel": "Other (expense) income, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "terseLabel": "Payment of issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": { "auth_ref": [ "r110" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 32.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for financing costs associated with business combinations.", "label": "Payments of Merger Related Costs, Financing Activities", "negatedLabel": "Payment of transaction costs related to Merger" } } }, "localname": "PaymentsOfMergerRelatedCostsFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r110" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 36.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payments of deferred offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r102", "r499" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "verboseLabel": "Payments to Acquire Businesses, Gross" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r102" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Cash paid for acquisition, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r104" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Purchases of investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r103" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r408", "r437" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockAccretionOfRedemptionDiscount": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 23.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of accretion of the preferred stock redemption discount during the period.", "label": "Preferred Stock, Accretion of Redemption Discount", "negatedLabel": "Accretion of beneficial conversion feature of redeemable convertible preferred stock", "verboseLabel": "Adjust:\u00a0Accretion of beneficial conversion feature of redeemable convertible preferred stock" } } }, "localname": "PreferredStockAccretionOfRedemptionDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockAmountOfPreferredDividendsInArrears": { "auth_ref": [ "r368" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of cumulative preferred dividends in arrears.", "label": "Preferred Stock, Amount of Preferred Dividends in Arrears", "terseLabel": "Preferred stock, amount of preferred dividends in arrears" } } }, "localname": "PreferredStockAmountOfPreferredDividendsInArrears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockConversionBasis": { "auth_ref": [ "r27", "r366" ], "lang": { "en-us": { "role": { "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.", "label": "Preferred Stock, Conversion Basis", "terseLabel": "Preferred stock, conversion basis" } } }, "localname": "PreferredStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockDividendsPerShareDeclared": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding.", "label": "Preferred Stock, Dividends Per Share, Declared", "terseLabel": "Dividend" } } }, "localname": "PreferredStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r27", "r348" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of cumulative preferred dividends in arrears.", "label": "Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears", "terseLabel": "Cumulative dividend" } } }, "localname": "PreferredStockPerShareAmountsOfPreferredDividendsInArrears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r27", "r348" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockTextBlock": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.", "label": "Preferred Stock [Text Block]", "terseLabel": "Redeemable Convertible Preferred Stock" } } }, "localname": "PreferredStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r27", "r585" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r8", "r43", "r44" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidRent": { "auth_ref": [ "r7", "r9", "r270", "r271" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Rent", "terseLabel": "Prepaid rent" } } }, "localname": "PrepaidRent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "auth_ref": [ "r106" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 35.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.", "label": "Proceeds from Debt, Net of Issuance Costs", "verboseLabel": "Proceeds from issuance of debt, net of issuance costs" } } }, "localname": "ProceedsFromDebtNetOfIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities": { "auth_ref": [ "r107", "r113" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.", "label": "Proceeds from Derivative Instrument, Financing Activities", "terseLabel": "Proceeds from the exercise of public warrants" } } }, "localname": "ProceedsFromDerivativeInstrumentFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r105" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "verboseLabel": "Aggregate purchase price" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants": { "auth_ref": [ "r105" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholder, which takes precedence over common stockholders in the event of liquidation and from issuance of rights to purchase common shares at a predetermined price.", "label": "Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants", "terseLabel": "Cash Proceeds" } } }, "localname": "ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": { "auth_ref": [ "r105" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 33.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.", "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock", "terseLabel": "Proceeds from issuance of redeemable convertible preferred stock", "verboseLabel": "Cash Proceeds" } } }, "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r105" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from Issuance or Sale of Equity", "terseLabel": "Gross proceeds" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r106", "r135" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Proceeds from term loan facility" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash inflows (outflows) from issuing and redeeming redeemable preferred stock; includes convertible and nonconvertible redeemable preferred stock.", "label": "Proceeds from (Repurchase of) Redeemable Preferred Stock", "terseLabel": "Redeemable Cash proceeds" } } }, "localname": "ProceedsFromRepurchaseOfRedeemablePreferredStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "auth_ref": [ "r101" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.", "label": "Proceeds from Sale, Maturity and Collection of Investments", "terseLabel": "Maturities of investments" } } }, "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r105", "r438" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 30.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercises of vested and unvested stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r105" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Warrant Exercises", "verboseLabel": "Proceeds from warrants exercised" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyExpense": { "auth_ref": [ "r118", "r295" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers.", "label": "Product Warranty Expense", "terseLabel": "Warranty expense" } } }, "localname": "ProductWarrantyExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r2", "r77", "r80", "r86", "r112", "r136", "r148", "r158", "r159", "r207", "r216", "r219", "r222", "r225", "r253", "r298", "r299", "r300", "r303", "r304", "r305", "r306", "r307", "r309", "r310", "r503", "r507", "r508", "r513", "r514", "r522", "r540", "r652" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r48", "r285" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Property, Plant and Equipment, Estimated Useful Lives", "terseLabel": "Property plant and equipment useful life" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r47", "r283" ], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, Plant and Equipment, Gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r16", "r17", "r285", "r585", "r654", "r668" ], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Total Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r46", "r285", "r719", "r720" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r16", "r285" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "verboseLabel": "Summary of property plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r16", "r283" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property plant and equipment useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "durationItemType" }, "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis": { "auth_ref": [ "r21", "r641", "r661" ], "lang": { "en-us": { "role": { "documentation": "Information by arrangement, in which the entity has agreed to expend funds to procure goods or services from one or more suppliers.", "label": "Purchase Commitment, Excluding Long-term Commitment [Axis]" } } }, "localname": "PurchaseCommitmentExcludingLongtermCommitmentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain": { "auth_ref": [ "r21", "r641", "r661" ], "lang": { "en-us": { "role": { "documentation": "This item is intended to be populated, by the entity, with Members identifying each purchase commitment about which information required or determined to be disclosed is being provided. If only one such commitment exists, this item may be used to capture such information; if multiple commitments exist, this item is the dimensional default, which will aggregate such information, as appropriate.", "label": "Purchase Commitment, Excluding Long-term Commitment [Domain]" } } }, "localname": "PurchaseCommitmentExcludingLongtermCommitmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PurchaseCommitmentMember": { "auth_ref": [ "r21", "r641", "r661" ], "lang": { "en-us": { "role": { "documentation": "Purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier. Excludes long-term commitments.", "label": "Purchase Commitment [Member]" } } }, "localname": "PurchaseCommitmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PurchaseObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.", "label": "Purchase Obligation", "terseLabel": "Purchase commitments for goods and services" } } }, "localname": "PurchaseObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r238", "r241", "r242", "r243" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable, net" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationsOfTemporaryToPermanentEquity": { "auth_ref": [ "r344", "r515" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.", "label": "Reclassifications of Temporary to Permanent Equity", "terseLabel": "Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend" } } }, "localname": "ReclassificationsOfTemporaryToPermanentEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.", "label": "Redeemable Convertible Preferred Stock [Member]", "terseLabel": "Redeemable Convertible Preferred Stock", "verboseLabel": "Redeemable convertible preferred stock [Member]" } } }, "localname": "RedeemableConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail", "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount": { "auth_ref": [ "r340", "r341", "r342", "r343" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of preferred shares (regardless of class), preferred partnership units (regardless of class), preferential membership interests, or any other form of preferred equity regardless of investee entity legal form.", "label": "Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount", "terseLabel": "Redeemable convertible preferred stock" } } }, "localname": "RedeemableNoncontrollingInterestEquityPreferredCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r399", "r576", "r577" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://charge.com/role/RelatedPartyTransactionsSummaryOfRevenueTransactionsDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://charge.com/role/RelatedPartyTransactionsSummaryOfRevenueTransactionsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r399", "r576", "r580", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://charge.com/role/RelatedPartyTransactionsSummaryOfRevenueTransactionsDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r574", "r575", "r577", "r581", "r582" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related party transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r108", "r135" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "terseLabel": "Repayments of term loan facility" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r448", "r620", "r732" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "verboseLabel": "Research and development [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r127", "r635", "r662" ], "calculation": { "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetail": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r4", "r15", "r127" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r32", "r374", "r442", "r585", "r664", "r692", "r697" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "negatedLabel": "Accumulated deficit", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r144", "r145", "r146", "r149", "r156", "r159", "r254", "r439", "r440", "r441", "r475", "r476", "r520", "r688", "r690" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r201", "r202", "r215", "r220", "r221", "r227", "r228", "r233", "r380", "r381", "r621" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfRevenueDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations", "http://charge.com/role/GeographicInformationSummaryOfRevenueAndLongLivedAssetsByGeographicAreaDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Summary of Revenue by Geographic Area" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/GeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r95", "r301", "r303", "r304", "r308", "r309", "r310", "r700" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenue from Related Parties", "verboseLabel": "Revenue from related parties" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RelatedPartyTransactionsSummaryOfRevenueTransactionsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Description of payment terms in contract with customer. Includes, but is not limited to, timing of payment, existence of financing component, variability of consideration and constraint on variable consideration.", "label": "Revenue, Performance Obligation, Description of Payment Terms", "terseLabel": "Customer contract payment terms" } } }, "localname": "RevenuePerformanceObligationDescriptionOfPaymentTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r129", "r130" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r378" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue expected to be recognised from remaining performance obligations" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Percentage", "terseLabel": "Percentage of revenue expected to be recognised from remaining performance obligations Over next twelve months" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenue" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r568", "r573" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r191", "r233" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Sales Revenue Net [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "verboseLabel": "Summary of accrued and other current liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Summary of computation of diluted net loss per share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-sale [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r491", "r492" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r491", "r492" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Summary of number of shares of common stock issued immediately following the consummation of the Business Combination" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Reconciliation of Cash, Cash Equivalents, And Restricted Cash" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of income tax provision" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of net deferred tax assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r176" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of computation of basic and diluted net loss per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliation of the statutory federal income tax rate to the Company's effective tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r523", "r524" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Summary Of Company's assets and liabilities that were measured at fair value on a recurring basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]", "terseLabel": "Summary of future payments under the\u00a0non-cancellable\u00a0operating lease" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "verboseLabel": "Schedule of Net Loss Before Income Taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r13", "r39", "r40", "r41" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "verboseLabel": "Summary of inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]", "terseLabel": "Summary of Future Principal Payments" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r48", "r285" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r578", "r580" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://charge.com/role/RelatedPartyTransactionsSummaryOfRevenueTransactionsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "Schedule of Related Party Transactions [Table Text Block]", "verboseLabel": "Summary of revenue transactions" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r421", "r426", "r429" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Activity [Table Text Block]", "terseLabel": "Summary of Stock Based Compensation Expense" } } }, "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r408", "r437" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Summary of RSU activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r414", "r426", "r429" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "verboseLabel": "Summary of stock option awards" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "verboseLabel": "Summary of fair value measurement inputs and valuation techniques" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r60", "r133", "r184", "r185", "r338", "r346", "r347", "r348", "r349", "r350", "r351", "r353", "r357", "r363", "r366", "r367", "r369", "r371", "r372", "r373", "r374" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r375", "r406" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Schedule of Warrants Issued and Outstanding" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r197", "r199", "r200", "r207", "r208", "r219", "r223", "r224", "r225", "r226", "r227", "r232", "r233", "r234" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Geographic Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/GeographicInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r209", "r210", "r211", "r212", "r213", "r214", "r228" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentsGeographicalAreasAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segments, Geographical Areas [Abstract]", "terseLabel": "Revenue and long-lived assets by geographical areas [Abstract]" } } }, "localname": "SegmentsGeographicalAreasAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/GeographicInformationSummaryOfRevenueAndLongLivedAssetsByGeographicAreaDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "verboseLabel": "Sales and marketing [Member]" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series B Preferred Stock [Member]", "terseLabel": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesCPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series C preferred stock or outstanding series C preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series C Preferred Stock [Member]", "terseLabel": "Series C Preferred Stock [Member]" } } }, "localname": "SeriesCPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesDPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series D preferred stock or outstanding series D preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series D Preferred Stock [Member]", "terseLabel": "Series D Preferred Stock [Member]" } } }, "localname": "SeriesDPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesEPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series E preferred stock or outstanding series E preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series E Preferred Stock [Member]", "terseLabel": "Series E Preferred Stock [Member]" } } }, "localname": "SeriesEPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesFPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series F preferred stock or outstanding series F preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series F Preferred Stock [Member]", "terseLabel": "Series F Preferred Stock [Member]" } } }, "localname": "SeriesFPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesGPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series G preferred stock or outstanding series G preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series G Preferred Stock [Member]", "terseLabel": "Series G Preferred Stock [Member]" } } }, "localname": "SeriesGPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesHPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series H preferred stock or outstanding series H preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series H Preferred Stock [Member]", "terseLabel": "Series H Preferred Stock [Member]" } } }, "localname": "SeriesHPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Series of Individually Immaterial Business Acquisitions [Member]" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Disclosure [Abstract]" } } }, "localname": "ShareBasedArrangementsToObtainGoodsAndServicesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r118" ], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAdditionalInformationDetail", "http://charge.com/role/CommonStockAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": { "auth_ref": [ "r406", "r409" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Description", "terseLabel": "Share based compensation arrangement, description of plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Number of Shares RSU forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value per Share RSU forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r423" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Number of Shares RSU granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r423" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value per Share RSU granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Number of Shares Outstanding as of July 31, 2021", "periodStartLabel": "Number of Shares Outstanding as of January 31, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted Average Grant Date Fair Value per Share Outstanding as of July 31, 2021", "periodStartLabel": "Weighted Average Grant Date Fair Value per Share Outstanding as of January 31, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Number of Shares RSU vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value per Share RSU vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "verboseLabel": "Dividend rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "verboseLabel": "Expected volatility, Maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "verboseLabel": "Expected volatility, Minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "verboseLabel": "Risk-free interest rate, Maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "verboseLabel": "Risk-free interest rate, Minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "verboseLabel": "Share based compensation arrangement, shares available for grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "verboseLabel": "Number of stock option awards exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Weighted average exercise price exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r428" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value", "negatedLabel": "Aggregate intrinsic value exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period", "negatedLabel": "Number of stock option awards expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Number of stock option awards forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "disclosureGuidance": "Common stock shares granted", "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "verboseLabel": "Number of stock option awards granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "verboseLabel": "Grant date fair value of stock option awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r437" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate intrinsic value outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r416", "r437" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodStartLabel": "Number of stock option awards outstanding beginning balance", "verboseLabel": "Number of options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price outstanding ending balance", "periodStartLabel": "Weighted average exercise price outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r429" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "verboseLabel": "Aggregate intrinsic value options vested and expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "verboseLabel": "Number of stock option awards options vested and expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "verboseLabel": "Weighted average exercise price options vested and expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award", "terseLabel": "Share based compensation, terms of plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r406", "r411" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price exercised", "verboseLabel": "Weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "verboseLabel": "Weighted average exercise price expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "verboseLabel": "Weighted average exercise price forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "verboseLabel": "Weighted average exercise price granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares.", "label": "Share-based Payment Arrangement, Performance Shares, Outstanding Activity [Table Text Block]", "terseLabel": "Summary of Computation of Diluted Net Loss Per Share" } } }, "localname": "ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Public share price (in Dollars per share)", "verboseLabel": "Public offering price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r432", "r443" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "verboseLabel": "Expected term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlanAndStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfStockOptionsGrantedDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r437" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "verboseLabel": "Aggregate intrinsic value exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "verboseLabel": "Weighted average remaining contractual term exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares", "terseLabel": "Restricted common stock unvested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Weighted average remaining contractual term options vested and expected to vest" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r413" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value", "verboseLabel": "Total grant date fair value of options vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares", "terseLabel": "Restricted common stock vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-average grant date fair value of options granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/EquityPlansAndStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]", "terseLabel": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]", "terseLabel": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r19", "r643", "r644", "r657" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term Investments", "terseLabel": "Short term Investments", "verboseLabel": "Short-term investments" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets", "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r128", "r143" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy": { "auth_ref": [ "r732" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs incurred to (1) establish the technological feasibility of a computer software product to be sold, leased, or otherwise marketed; and (2) produce product masters after establishing technological feasibility. This accounting policy also may apply to purchased computer software. This policy also may address the entity's amortization policy for its capitalized computer software costs and how it evaluates such capitalized costs for impairment.", "label": "Software to be Sold, Leased, or Otherwise Marketed, Policy [Policy Text Block]", "terseLabel": "Internal-Use Software Development Costs" } } }, "localname": "SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Standard Product Warranty, Policy [Policy Text Block]", "terseLabel": "Warranty" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r26", "r27", "r28", "r133", "r136", "r165", "r166", "r171", "r174", "r176", "r184", "r185", "r186", "r253", "r298", "r303", "r304", "r305", "r309", "r310", "r348", "r349", "r353", "r357", "r365", "r540", "r734" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheets", "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r62", "r84", "r85", "r86", "r144", "r145", "r146", "r149", "r156", "r159", "r183", "r254", "r365", "r374", "r439", "r440", "r441", "r475", "r476", "r520", "r542", "r543", "r544", "r545", "r546", "r548", "r688", "r689", "r690", "r744" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://charge.com/role/CommonStockAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfLiabilityOfWarrantsSubjectToReMeasurementDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfWarrantsIssuedAndOutstandingDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfAssumedPublicWarrantsParentheticalDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueEarnoutLiabilityBasisValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheets", "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://charge.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://charge.com/role/IncomeTaxesAdditionalInformationDetail", "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail", "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Consolidated Statements of Changes in Stockholders' Equity (Deficit) [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r144", "r145", "r146", "r183", "r621" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedBalanceSheets", "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://charge.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://charge.com/role/IncomeTaxesAdditionalInformationDetail", "http://charge.com/role/LeasesMaturitiesOfOperatingLeasesDetail", "http://charge.com/role/LeasesScheduleOfLeaseBalancesDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails", "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r27", "r28", "r374" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "verboseLabel": "Stock issued during period, shares, acquisitions" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "verboseLabel": "Shares issued in PIPE" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r27", "r28", "r365", "r374" ], "lang": { "en-us": { "role": { "disclosureGuidance": "Stock issued during period shares new issues", "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "presentationGuidance": "Shares issued in PIPE", "terseLabel": "Initial public offering shares (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r27", "r28", "r365", "r374" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Issuance of common stock upon release of restricted stock units (Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited", "terseLabel": "Number of founder shares forfeited" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r27", "r28", "r365", "r374", "r418" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Number of stock option awards exercised", "terseLabel": "Number of share options exercised during the current period.", "verboseLabel": "Issuance of common stock upon exercise of vested stock options (Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://charge.com/role/EquityPlansAndStockBasedCompensationSummaryOfStockOptionAwardsDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r27", "r28", "r365", "r374" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Initial public offering gross proceeds" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r62", "r365", "r374" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Issuance of common stock upon exercise of vested stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodShares": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Shares", "negatedLabel": "Less redemption of Switchback shares" } } }, "localname": "StockRedeemedOrCalledDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationSummaryOfNumberOfSharesOfCommonStockIssuedImmediatelyFollowingTheConsummationOfTheBusinessCombinationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodValue": { "auth_ref": [ "r365" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Value", "terseLabel": "Stocks redeemed value" } } }, "localname": "StockRedeemedOrCalledDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r27", "r28", "r365", "r374" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Repurchase of early exercised common stock (Shares)", "terseLabel": "Number of shares cancelled as a capital contribution" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r28", "r34", "r35", "r136", "r240", "r253", "r540", "r585" ], "calculation": { "http://charge.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders' equity (deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets", "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' equity (deficit):" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r134", "r349", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r361", "r362", "r364", "r374", "r376" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Common Stock" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CommonStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy": { "auth_ref": [ "r24", "r25", "r345" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value.", "label": "Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]", "terseLabel": "Redeemable Convertible Preferred Stock Warrants" } } }, "localname": "StockholdersEquityNoteRedeemablePreferredStockIssuePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubscriptionAndCirculationMember": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Right to receive or access periodic material for specified period of time.", "label": "Subscription and Circulation [Member]", "terseLabel": "Subscriptions [Member]" } } }, "localname": "SubscriptionAndCirculationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r549", "r587" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r549", "r587" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r549", "r587" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r549", "r587" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail", "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r586", "r588" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://charge.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.", "label": "Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]", "verboseLabel": "Summary of Unrecognized Tax Benefits" } } }, "localname": "SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplementary cash flow information", "verboseLabel": "Supplemental Cash Flow Information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://charge.com/role/LeasesSummaryOfOtherLeaseSupplementalCashFlowInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r53" ], "calculation": { "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail": { "order": 2.0, "parentTag": "chpt_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "verboseLabel": "Taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfAccruedAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityByClassOfStockTable": { "auth_ref": [ "r14", "r339" ], "lang": { "en-us": { "role": { "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.", "label": "Temporary Equity, by Class of Stock [Table]", "terseLabel": "Temporary Equity, by Class of Stock [Table]" } } }, "localname": "TemporaryEquityByClassOfStockTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r298", "r303", "r304", "r305", "r309", "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Carrying Value", "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityDividendsAdjustment": { "auth_ref": [], "calculation": { "http://charge.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 20.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends).", "label": "Temporary Equity, Dividends, Adjustment", "negatedLabel": "Cumulative dividends on redeemable convertible preferred stock" } } }, "localname": "TemporaryEquityDividendsAdjustment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Temporary Equity [Line Items]" } } }, "localname": "TemporaryEquityLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityLiquidationPreference": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Liquidation Preference", "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Liquidation Preference", "terseLabel": "Temporary Equity liquidation value" } } }, "localname": "TemporaryEquityLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityLiquidationPreferencePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Liquidation Preference Per Share", "terseLabel": "Preferred stock liquidation per share" } } }, "localname": "TemporaryEquityLiquidationPreferencePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r14", "r339" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "verboseLabel": "Temporary Equity, Par or Stated Value Per Share" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "definitionGuidance": "Shares Authorized", "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Authorized", "terseLabel": "Temporary Equity, shares authorized" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "terseLabel": "Temporary Equity, shares issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "definitionGuidance": "Shares Outstanding", "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Temporary Equity, shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://charge.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail", "http://charge.com/role/ReverseRecapitalizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of new stock classified as temporary equity issued during the period.", "label": "Temporary Equity, Stock Issued During Period, Value, New Issues", "verboseLabel": "Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_ToolsDiesAndMoldsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used to cut, shape, and form metal and other materials into goods for sale.", "label": "Tools, Dies and Molds [Member]", "verboseLabel": "Tooling [Member]" } } }, "localname": "ToolsDiesAndMoldsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CompositionOfCertainFinancialStatementItemsSummaryOfPropertyPlantAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r245", "r246", "r249", "r250", "r251", "r329", "r363", "r516", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r734", "r735", "r736", "r737", "r738", "r739", "r740" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/AcquisitionsAndSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_USTreasuryBillSecuritiesMember": { "auth_ref": [ "r653" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one year or less, are interest bearing, and are backed by the full faith and credit of the United States government.", "label": "US Treasury Bill Securities [Member]" } } }, "localname": "USTreasuryBillSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r449", "r458" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized tax benefits \u2014 ending", "periodStartLabel": "Unrecognized tax benefits \u2014 beginning", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail", "http://charge.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r459" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedLabel": "Gross decreases \u2014 prior period tax position" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r460" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "verboseLabel": "Gross increases \u2014 current period tax position" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r187", "r188", "r189", "r190", "r193", "r194", "r195" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r466" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "verboseLabel": "Valuation allowance increased amount" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfLiabilityOfWarrantsSubjectToReMeasurementDetail", "http://charge.com/role/StockWarrantsAndEarnoutsScheduleOfOutstandingRedeemableConvertiblePreferredStockWarrantsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants and Rights Note Disclosure [Abstract]" } } }, "localname": "WarrantsAndRightsNoteDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and Rights Outstanding, Measurement Input", "verboseLabel": "Fair value measurements inputs" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://charge.com/role/StockWarrantsAndEarnoutsSummaryOfFairValuePrivatePlacementWarrantsBasisValuationTechniquesDetail" ], "xbrltype": "decimalItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r164", "r176" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares outstanding - Diluted", "verboseLabel": "Weighted average shares outstanding - Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted", "verboseLabel": "Weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail", "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": { "auth_ref": [ "r161", "r163" ], "lang": { "en-us": { "role": { "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).", "label": "Weighted Average Number of Shares Issued, Basic", "terseLabel": "Weighted average shares outstanding - Basic" } } }, "localname": "WeightedAverageNumberOfSharesIssuedBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r161", "r176" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares outstanding - Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "terseLabel": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://charge.com/role/BasicAndDilutedNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "stringItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3505-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r143": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2646-109256" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r182": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r196": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r234": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123364984&loc=d3e1205-110223" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r291": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r294": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3,4))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r336": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467743&loc=d3e20905-112640" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r376": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r389": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "http://asc.fasb.org/topic&trid=2127225" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "http://asc.fasb.org/topic&trid=2197446" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r405": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(d))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "740", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944" }, "r446": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r488": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r501": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90193-114008" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123415192&loc=d3e39927-112707" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "http://asc.fasb.org/topic&trid=2208923" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r582": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r588": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SAB Topic 12.F)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123726384&loc=d3e516689-122869" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(17))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(7))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504731&loc=d3e11522-158419" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506110&loc=d3e32546-158582" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(3)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r733": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r734": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r735": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r736": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r737": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r738": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r739": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r740": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r741": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" } }, "version": "2.1" } ZIP 130 0001193125-21-298813-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-298813-xbrl.zip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

)1@P&F9C 9GJPMP( MP' 4EA?F?M[IK2TPU&*UA*M?I\?N5C,V]QGW4\&X.O)0NA1M]V&R@ZDBQDS\ MG1R(G^I8&%O5AN\B,BO* MF5P?T]42.JK8>5"9(>\1!'3)J(3MR0$GGXRTG/#J1LTQ>KF7["7'6)<+LOTP MFR>#Q.[4.")OHLHL=+5NT'1>#9<8>C_T78^,\%X\:!=^X<-K^/)7D[F&.YF_ MTM<%$GWRJ7<8D/A7N'/Q$=-?O7]=4L;D7N*2Z=#B,BA&!+WHKL[#[+<*4C!W MX:"_;LY"V58OY\K'G3"FK?BX/!_G-1"HEH_WJ(V5GJVZ6-ST_KR8N8R%7>$I M'J]T;6-T+>[@9]A V97F&VS?*0BJ=JN@(:G2MR>K;T^7E[-@\HW1NOUC+LHJ/4<5-9>?_J6+%R_;2QTK/[BC1C1I?V M]I49KO=.Z=O&Z=M[V+[:"*?_C4NF3OFN4]7+):5AFZ!AF\^\G9QVJI7R3;J4 M8FWKJSHW#C]LJ40B>_EX!1&U:R9^8X?UG3+)_#FO,F.?Y1@\6YPGBR\Q63R_ M\^F/$H45>V\#6%Q<$67*E\A^GS)OXIH/F"+^X#RQW$J$N9%L0WKP?=FJ?VW) MS:QR4WH($]W5!^WL[?3*75%M!%4;P9)M!/N';2.H[=Y'L#!CNP:-!/=4AK\) M.ZL69\=J):CVZ0C[5&DO0;6#1]C!,LT$=Z_2:60W0:UD.T$"1EF!GG*U7#)[ M&G[U1^?-7ESJ(N>4O[&+BR]-&?8S(6?.;//0UV!.13HKF5 MP&1:T45=SNJ3* ^>ILL/!WGEAXUQ> ;CD3X>9R.E6FI3>$V?S?RP3AK+D;W M\I'4HI8PK+W'TSP50YF(3][ MYLM^N3FWF+8QI.WHP_% [XRS.;FUYN>F$[T_;NOM/"%2Q-%7]%X>[Q(L ]^< MNL6C*HTSC?3V:*"/^\/UG)H(W)%&-!!U(T*",$ 8T'S3I?I9N+NUUDW6<-G MRNGNQ\HYE8N#.]=\0F2&.\N8$!.,?*FX<,W8V@(((+^ MLDJL\Z?%+@]!WH37D:'HD0@7K^6DNEACN,2\^\5UT+*M;XS/0O6]E66TDR2N I M[G4B44O9Z]&Q0*@&.S9GGPY>O' *-'H#&/SP$#E D\06ZD!#H&.WIC-Y[A#;$)R3: M.*.^)F VP[5,+*5;@L @!")DYI^RUZQK;-_DK=CJN/.>\)TWM[^[F]C?O3)/ MB+'0N09Y%;P3;[+06PWO--X?NM-(@3LI<*==L'CB9M3) O$H *<](X*=*N,T MJGZ5JR%55[.2N;X:[I_,Y]C$:$$O@P<+'!:Z5MVQO";6:JFB H6_-*XV(8HU MI+_-"4_0-:5*"BJ-5:2K\KIE$><&FVK7X9-:'X94W\J[K2K9/@L%Z[ M5=1$M=H2E:.7?2KU5*KL,PZ>KQ32'A62)'7#!$:GTQK4J"!3J:15*DGQV!&4 MDO*L3@:QH'H-UM":[U5J;,-:[4HES%9%V?U6-EM+*; ZH&&< ',-]@U7H=RI MYNBD?U4%TZX4T5I%M TJ]5ZMW0V0,$?MG)RDX^'(*9VT0BCI;3:/K3:"?!:-CF^,9I-Z:P:PX0K354Z"/AQ M4TCD^DB/.N%X*TU5(B:H>&V-IDJ"@J9J*-+OE !,R58I;%#2T#]P2?&Z@H;Z M%QGSQ$!569RL+$Y196%@I;#UJCVP& $UN\9<% 5 M=X1V2G'0[IL3 ^_AC^!OHZ6Q2EEDR!ZR(%TC <'%1_G^]EZ)738;#_R5G#,* M1T<*[BRPAU3!FN5X7MVA/8ZH>?.Z9Z^"HE@#0<'A5^I%]!J:.SF0.9J@=W2J M2Z/T'1/GXXP0/C8$3^1_+EUG B(73=,) ^:>AN9GVUEOF'+KCR6: M]5'HJ'[I/I(-'T'51^)7?I(9&\Z-[@6 M';SY><5%T_?)G$T#B]W.K@B$;YJTB7='**R*XS:WSP[(WE<(R4E70+/HJL'T M-(_YZ #X<^V!6<[S3\7W6UOQ^]XY]+3@[RZ[V\+?]<:KX>_Z^X._.^NA%6C? MNH%/%'^--S;@E.$-&#CHFF%/^9MA5U;^)[5GX%^)TED*HA"#'-[$[-?T+-Y' M/QJU!LL7L&(Z[_*,ESK!^"EF*FRFP-DC#(8FN47M:*-VE(Q4M8/-W<%[QS>L M8X)J*AF@D&*[L:6ABDG@X6AH2'*[1L*.W>WF92$="E&D0PU#3B.[[(T]6D>T\ MR+9'\=1$F5*3>E9E:I2Y#(VUW8S,8# Z[@S73]9IG(^YH<1@A6*PL++)%W=/ M5Q[RVNWL?LXXHZU)WZHRO6T7<3K4!]V./ACN 1Y ,4M5S'+<8H).6^^/VL C M>P#A4CQ2#8]4NM]#_?*RJW=ZS85J5"&?H]AAH>DED[VGYV-NO5UQSB5=0K*4 MRX$_9%"G'1<.'BSL'V\N5DL)?3@>Z)WQ'A#SWIV!5M@#N^S9IMR80_IZKS_2 M1YT]F V*0[;CD'T8DIM+CK;>[0[U=FY]JF*,(S#&/C9YJ'<'8_URM ?'\MV! MK$AE'^[+/I0%]N=C'JIHG");O52$/(-'-!U2,8DR>J48V4)9#H=GBP9O<9'= M(/1;3D)]TK;I\X2EXJ2R^]49&!?4'-P^!K 0">BL;6@#LJ51.7 M>K=_J8_:>\[S4Y&WS3V%'G@*4R= .).3]HAJLT[%)(I)%),H)E%,HICD.!&X MOX<-RF)/G5C,<&GY+RMQ/"HG M*))R$\BW&@&\$LX(?%^*08>W.O2WLH^4!)'D1SHT?L(3I^:.GGO-"]X^#>;4#^C6.\<\75/XV%$ M[#6V$-VEEC*2""O$(M=D4RAL24QHLC >?-&BH0G&7S1;H,8(&/@UEDO7>0%_ MSV?6ZZKN212Q%$V#/OTG,/W73V*P;SA6-CND&W;!B9I3BG H014O$:KX.Q$J M'L,(46_Y0Y 2CHT@N&7:2O9+]VBYO!QF(UL:DNW!,KTYD$ZTFN"U5MK5H\MH M6A@PASV?!)['OX2 OEHO V.?)[?3K>14A\><\8HZ/%X32NPC;L$GP[6=P-?" MOBNJW6.\XB M-SOOW^D: Y%NHC+%@P7?9W1 92,Q'$R(J1@4>1W:?$V.:8!R)7!)^7%9]#QZ\B6L^L.F'P EV"N6/]':[C?_/ M2CRTB?"584FE17T"8O ):;;@9)!L(<6D\0@"\A$6Q-_ [DO 'S"J#VII,L?6 M/3.PNES?@,_E4/>N^0B-A- MJ*5=V5IJJNGQQ:2U!3-LCX9&S'7L9\>;",;/QI-C@9C6N$1DTPL#3"&POD0; M1DF4?_UQ=1>2 GM\$1&1AD)7<^V,AYQ1XSQ\Q&__^_V3]C;LK"-4W=.?],UH&K_P%=VZGW ]G\V9SYC]NS>-?A5]]QO2KJ#%SP_8$#[L-GW< M.H-6SH'15](VFE=LP9P"JVF[.YGNG^$;KP>G4K>=1R4R45<1JC'<=S\WW2.0 MM9=/5NK4;+_^'0$WI3K$3DP7)CC^YA0LFY_X/X28/VAC&W&?V7__&_[@9Y3% ME/-!+8Q%]S7L05@,J2][IF*+"C8)L.,=-F[^R(!""VKDF4_BDLGB.7V786[( M51E;>1+-(+X.:>*(U:#L3-HO:_M+I=K]1&;CVNX:;W(#*SNWS]F\A\)@DQX* MPU7I48?I@]>0;E._RP[,N?:R+CL12J_$ <_QD>\8J& R#+6DT41MGXT)&*2V M+_NN)]MN8V/UP&,)/LY:2?X<#/FI.(/\RU'?]M0C733318_I!R:;*IO8['<* MUD=L0#0N;,?'6!S& I E7OCO1)_SR Y!&S$R\GE#4_"=*8PP3;5QI':/NN)6]K^8-QC"1I M7W$AVK7A6H[FF8O X@R,N\=?+9PIL[2 MLC R(]E]\S/Q$#4P]F"UD4L3 MT1=/7>3Q4&N55EKYJ?Y"Y?L+Q8B_TNFJ M[BFEA\D.IL#UOQKN9,X)T^GJQT393V?%5[3I>QA&<4W&=CQ9QFE4=0[71*HZ M9S5X,;8=BW%0P5><&_V7@Z=%Y_ATD6N&\2G@7+K6MD/K_RLSO, E ME^O&7N;'8'L_.MU=_+8?Z8=$X<'X&.EOW;\N[ M75[U:?/:KC&"FO!:K]T:]QH+!:OT5<7ZZM/+$EQO-L4K4S@3>!CJIZ^.5,O3 M%*5%,N1?X?Y5(4WB^0D7W94"9=3-N^W:><__6@OM=5J<5[D*.S+G=5K#?7.> M\M!.3>-],[T_+V:8XV1B9(/AW04V955:KUE:#_?Q,VSCC=C%;_#C PL@,*7W M )BN-%\#-%\MN&^T;^Y3GEQS]-I'\PG(:T^5-FNB-I-^N-S%H\@3Y<.Z7[&JK[[F$3MY$Z_[O-/4B_=5DC=#2E M[ ZO[ [*;KGU2'NX=4O6*R=J)8Y=.+ WO9#-ALTO[)^9KN=K_K.S(CL?T_I7 ME992QO*-YP6&/6&WLP1+8LE!JI3&^XUAUT_CY0_3GV.Q;18"+I*G]\[.LK72 MSJ'CXLI3D>^?*@IP)I1F2]GIR=0_D?UOV%/XSPPK'I\C@FB>LY#5!EYZT$*F MI9W?+C<9=G>":>WQ3&7?>"D^(%L]*[["J+S$$]ELXMDK)2H5S-U0T0>O$.>I M]YPP5/?@4?VOE\-2O1A+]6K#4B-]T+O4AX-1EJ72U38(A2$*7E+L=!EC)UZ& MNZ)ZA8EAHS(=+$%!,4_2?EJRXG9E^4C5)-ZV?&34[[6RE$V4C^BB>@B9\JWY M;G5!K&0_U"AQ!J1J#9#:Q)IIYJO&1BQ=_%D5[0;M3BO;I299>N,R2P*SY$@_ M4U *]()XS,6ETE!OTY0J+E3/[<3(UW955*U=)HGK5 M/%1,WIKBVJ(ZI5)88WLH'(T]O;J:I-55PKN8Q0>BRF$B+9\O MNL,O_E;<:%=K]4=XZ\3,VX-1SF3EF]G2L+?QVL'-"H>@!48 M&IPN.-#_ [H3O [2!P3*8F.M)9PX8P6LW\[5YYNQ\Q[BA?NN2]P,X^I *?]1 M,;7V*[?W/5V[L2>M#9"MU#[M?9\0Z\U#VPT.(RP<"WHQ*H453V1W?39M<.JQ M'#HT33VU@W7:P;>!;8#K0N!)I39&%5=O@"5RT+ND-BBZ&H4'0U % > 9(:AQ MR##>:*DHI@6>]!I7^I.,4(1@!SQV>+L^LE!I/##E'7?*.A;];BM[6[+2.2Z* MR63C,:D?NFQA$#C1&G _>=T0BX-Q"LB4+(]'SFY=&<*0>$B,W)Q+]W/S1WS_<*(K3DK.Z)_%3GA6^"YK!)& M<01&X\%Y8AS?1\ 4FG;\-,(, LOGN":&]HC@CC#N&G2>4(!=3?\=>#Z2/6QW MDXE#Q[%8^C]Z[9U.TR\PP3T& ,?]5K8&,RWB) R1A(*9A*;D)&Y*>G(A2%!G M*:X]^>T202H1QB;A['@:*&7XR14H&DMT\6OS[6QI!&+E@7:SPM'\Q$66!.@4 M>%;8?,BE.)84HZL]/ 6D:@7];=%&5!^4E1L>/%F 1@(5E>[X;T,9$2&((OK6+. 4O MTH'3.#,1OBL"!I,V"9\#07Z9'B%^1?(#=OS!8^X3/1NLK3^9+\P78#M"!-,< M>#:RH!%:.@FHR=Z?YQ_6\S9!ZV[&3B&5E5@R(4;7^KF>>4Q MS46^.AB,9HWD0?[M])ZO6$:2^C6G^+[@30L-G'A6P#\#FPE8E\NI@7$+^@/G19PN+2344):-(-WMY<68WTTZNF#G)R_-8D'47-E MV5NY4FYH);)!*AWZ-T>PU"QP2>UGP$71+N2F:X[Q4M1;>CTF;Q[2HW0?/IH> M8H8&+D-!\$E!@&L'_'::WPG0A9EF<\T6WIE=3=L7\Y2D#1Q#0(<'#HF$__RZH"2/"^53'TQG MKO_*6!*GOXW!C0>.;[K$_>W\&A?:Y1:]1O;$FQ=:*0NI2Q[X^B&B,Y]>UQ37 MY3,-[.6P\V7:$OF+'_R#!\WVS)9(0MH)@?CB'I[]AXD?AT -66=TXRT=UN+? M.=R .CR>W.V0X6!(^KWU]E&",^J23R D!4B5)!P2?3 @_0T-N+8-\!'6Z+R- M-CR*G;A)Z>80I)_#G/"@+C_> %AQ7[=TW3Z;)?SD1'@S%J\/#$*<"6,N=A:1 M3SXZ0J22K(D,W_& '4A($>1,0WI:LJ\%@1(34'8L#_SXQR3[)1YP7:(I$)$% M3]P7=5U16\/[F0.#16=]"RP6D#./(- R ;J$?_,I/OQZ+@M#^>E;^D[K_;S< M47_MMP"%6-Y#>A_\P?W%Z/@T/>G2!0GXWS,^$DM\002494+R\=WBZ>;#!FS^ MT)OB?I]\X"2_WF<'+A;Y0;C6QES[(KT(HABFSMO;?_=WXDJS%X/9Q!'#A.29 M_<9'*S#/VHH\-N>=&"@YK[Y^E_UN-P'@8A#7&CCX*R$11.QW2E\S R%6I0(\ M&/_98=C=AECG'3PTXQ$=OFFUM_K/[_;@=_Z(9^&7R&QZCW1E>&_MZF\S\S;% MM:F(TT;.>]MQY7 #.L]-A>\(CW[#)9UWF_;K_*KY;))E W/3( #ML/JARL;3 M+%SBP\;2\*]^UX\:2W/&@$SE,@6_KREDLF3S6F",_N!V2@(S7\Z3(,F?W"1F M/"@MTHN<>Z%0X1$ )DKGPZZ_(TR2<&[EWMW_OF0CIZ/Z9+:'&CV M'.@<(DJ9!4"0BW,YVVR MQ$T)!>EG7,9$2;7++'59%K)HD]Q9L@=!]@\7AH3K/TMI)K+Z2E.K7HYNRMKF"0,VV!-)81/QUU% MCDQ&45O*\65[,''&EB3!A78Y']+JOA+-\Y>E,M,@*C M_?S9JG\O(Q#8*#ON84.H)ALM3)T.FO"(5WZ'3%0,1Q,Y=?;#/COPI%U7^#YI MUI#7D7'JD-=N=_>0UT%Q,UY;?6D<3+OOP@T=,?HMS0/*<:(R^B-5H7Q'Y!/" M9:&JTL189.KZM_\4'S([X2"L'G:G_./ZA066$R9G#VY7QW(B;VO,V[OT?*/\ MDX=U EE*(]_@>7U)TK>.)U^L-XI&!*B.@,NT-D9R]2MPF:M<2])*'$F6G\RY M'"4)AP(Y7:N6\M+*K&U+>16C'S?9U) L+*;>HC8ZK2W>6G=^3(_P05/ZTI]< MWY'$*C)$EW;I/Y_ %4_G#G'+&3 MFA2),9&:B%O[D&Q%U-DG:CL7@_76LZT$5-$2:4?!V>-^4#T>#:JY;9JQ2GFE ML[$MLMIY\+- RX#F?;F8;#)P>S< M<)2SX69GD8]7UVLC614R;S#L5ZD1!.)RS'@U$QI!.7E&7R1%XV"A"DNWDKH] M@PQ'N2L[M)'.LY$V0$-%*VF 5E+U*K?R:R-9%;*2T/XI+ @T&*W+=2NH2BN_-I(U+^LGT=(;#@.< M_0#+%D\%/'ZS_?#Q5L,HJ3B4YWUG+[+8<*5><;^IE,-9E/8M$\6 (M=&LB)9 ME;@V)C:PGGFEGGFM43(6,R^/B#F]9=:)/K,BUD:Q(5B6NC447]2NZ>&)AE,S+ M8"]\>H_L#\_?/B@*T\;X2UY^]!^"]I>>?9U0_L'G;U48FNF1?G] ^@8>":YI M:&8_I#!BHQ[.ZAFQ.1IKVP(Y.@9RVB:%YAV5*@CV](8CTAU@L >#/1CLP6!/ MS:Z-9$6R*G%M+-=I6D@H<05%3W0,_11]-F=.ZY)C/'J?='L#8ACK,^Q:Z7O7 MS[O*8$>I8$X? 57?8,YV4!46M>EC'\'\Y4H^$%B.RJQRNIBPC#D8DFY'F1-_ M&):I<;BB+>M$1U>1:R-9D:Q*7%NJ+?B7J_%DBG/&P-H> EF;D'?<=..ER6Y9 MP5GI:#L_J7+Q#SA;1#3'L]S89F(L]K]B3\S&[LCYZ&+RNK8T&2_RM5D<6!.P MIN"CR(^HR[^EP/R!Q33T*^;+:5)\//BVN>??KR8.&X/U9\5\9/K-> S>8R"_ M'0;1@Q/Q.8Y?X:9/C@W&_V&STM_WYG9??W= XJ*W9O-)S@!*7$["+1/3P_CQ MW\R*.", U3.#+BEMZ%GLO[%U1T<39#^2R'8D*^"%GM5B^-E^_ MEA!@:<*Z/EB>=']U?2/G=*63[B_V,/[2=7V+SY7=C ">*/7"PSIM',;5?69Y M?PM[A(\&+'H&>R=D'I^3NV&&/6= 0E@KLPQ10P;KT";4UAX9\[2 6=QPLOFV M$\0&PB4S)9]9P#1G.@O\QW0N=LHD.0I<<)*.(\Z%9U^;^K8#G)%]2V"S:HQ: M$_ZK>S:+!!7DAN6_^LRLQ3L$KF?1.)0[^P!H:,_PM'(8Z@_8@%H\X_L=?FNY M?LB_"3?E?_[&@A\LN- N+;Y(^,!])7*5GPPY-7AU_O)2 \ M(@ B+VD7G#EJ3B]?MJ] :ZG,]=_9>Q>[M+-V^";G]Q XON!/V?V M\RL_C+[YT?\Q ';ZZ#E(P'U[Y5!19O8NUGL=+C4S9'?@HCK&P,],4/[A;8/2SH.'6D<2$&6XWG&-_=_XYS MBQ6?6SSHGSJWN+]G;O&HN G .5WZG PZ3@"N\3C)U0G PKW!B:!U8N'&F;"2 M4/_@\0+Y_F>PGN6;7Z@3R%>9::%@X$GFXXS0A42O;9%.37KJ%#8C=%2[3'K> M,;KK_\1@:G[UP"F(11O6&_":@X<)]9+HW=P+.V!VZ/=-S@68M%EO2MSUX76V MT8D]JDCHORSP;1I..-'!?#8^;G%C*^-L41BK4?G/X?!:J> 0&HGK(JZ%]D\& M/!MY6XN).DK 3\&*UQ:IR7(4'_?]1>+F['[RJ-;VRATA7X[K,5^N=EL=R4/Z MPP[IJC.R%%5@,5 \5@\6A-6SBVN-P86I3+DV^I2%*4NNM:0%UP9U5=3XD[U" M0AY/KH^^ZO<,,NKDWI/CC"DJJ(0.QU>3E)#RA^;1%U/3%\MKMBFJM_WBYTM* MZ_IH.+U#S*%*<^11P1V ,#X\%;5;L\X>]<\Z>W3&MFG*8*.6++.2^)6"YRVP MQ48S3.&:9.^+F8A3(ZNZ\MSJ(<=NJDUN=/0!T;N8W&B?E\M8[N+QG:- MC6UE#L"W99UH;E=^=%K\+0\%QC016)GS1%KF!,D&,SAYQ'FI\M(W$EX-+WH. M6/'9[W-#=@[30,)-'N)8LG3%6YNL[XIN6\(9I15F:([]OV_X2:M[YC*A3RYG MH'SM[\; & Y&_>'W9%P8_ 49[3GRV8M3T'M./6Y?N(SKAM)9_8H./>S9U2_6;9B5PYZRHT!Z6G=^:):(,\J'G %]3BR] M]S1[Q*"^)T-WG/G4+T:;SWSN/,V< ZYY?JJV:,[#F#\)_L/^OK/.K07Y"3S9 MNBO,"WW+KEB._!QLFU1L'JR>83S^3.W9NCAS]_.-],,H>XX15!)5RK%0OKPW MAAO/76_%Z9(]R .ZJZ1@TZ4XMVP= N!SG^EK* [D+EUZ$JS@6^]TP$I-?3F3 M+R 3$==[)M'2?]Y]?//+]C/BYH4QY+]>>N*+_F##0Z=OKVVJC]E@M":BT; " MJDT"+F_^!Z3)F[\_I-U2>$-.'B?ZVR]T$PX;YU7LVE,%Y!*6/!EY$KV\ Z85 M[<\K4)\_V*WO>)'V3W@P^%%(M*^>=;%AUYXB^Y!/N? )C!4F&EB!#+"Y06OS M5R(Q+,S:+XY'/!=<0F/7N,,:T]?G^/:]ZPXN*>V[\E_7]720N2=?!9-SD(&9K6V.MEZ76A/A MU&:.=9!C->,8[K&Z<:RX/=9V7=M:L_*MB$KY<4@].WQ72XF O"N6=_4Z1F;4 M^AA925E:/Q03B0+VQ+R8K>1.CBT1SQQ"J.VAF]/&Z_0V#Z\ ZMZ,[ZG+PFS% MUE?/\J=LGD[]U9>3: ZIJ3MT!*9!]'Y7E7,Q"*%C(-3)0*A3(82ZN;>)0OP4 MB9\M\W.J%$%#95H-(H2.@9 J(D@=%:9*ES"T:0_H$L9"1@-K(NHN;#!L77_& M$:J<<5M1:X,\+=R4UI>>_7E!Z>02)4L+W23]H3)3WQ%:9UJ^*D&KVU-&$R&N MSK2(5<*5WB5F;X#0JBVTU!59 W5PA6'CIIG8PAD4]C4\Z%^,3[=&ZSI_Z_J> MN4#P'R!.?DO)7)']0_1^+=N (:PVJ"EE8&7V^@BJVH%JLUFM#*BZ9-!7QO1! M6)UI4BL#JWZOIPJH,!A='TOY'\QC 76%K4SMJ>,Y8<3/[SVI5VM1*VFQV6!. MJ W2XG*)UM6(C"$Q!I@!K2^VEC616M@RZSESLN7(VFPZJX4LO4MZ/11;]067 MRF*K;RB32-MF19?1K=LXIUOW&3!ORLR8EBP3(8(008@@1! B")'R((+I^E*" MD$6>")3$$?UHW_S]8;75F;:IRUDNX[_:6SJ_,1Z9VU&*(3%&ZSW2CV)08WSR MNB%BR1W/+4A#])$RU7$8#H2PGG,8OY8V <01KM(B^:+/ ?W)" M'K_A(UT",#(F=)(S,G;-+6%>J"3 M78V-QWR$T).\4\!_0.%#^]\QGQ8J;@B/9P5P!\V)V!0^"QQQ#]&[D4;:?V(: MP.TO-/[4B\MEGE]>!U_N' MSHOJ)L,O*)\'!+U+-AM_N8A1!Z+P$">P\*ER>%L.O,#"GBQ@%T_Y \2\<*?9,E(WQ3^/5;\POYX+Z^?G;$%2$BX M#,M-5R51"$"W!3("9C&^ ZC&I6_L MUG])57I6;G;4=9>BP0M.H\G>LF%&[8 M[S;B[^2";T$[O#X$U NEQ G1IF^R36^@35^Q39_L.TUL/"V[\] T/Y^ZGZDS M=5F@7?Y#Z!Z'6Q;CL>,Z@N:P9"<"]377H\G7YUJ4!MPR?@(SQ0>[:'F@HKB@ M[PF+G5\7U)[KOS(F3'P*ZI(?>=AFSG_R:6#S#S\[H(3XU2]VB^?%"-!M@OK\ MX9]:$OMC]F6T,K%4S"H=FJ:^.O R:>FM15G@1K[_EP:,L!@87]$S8^N$2QEC M@S&3S+),/:09&!D\I&=_V!"AW&*]*3H%5C(SLX\C( M*BY]3D$NCF2I\5@/,3)2$D8._).O6S+U#R&%PR,K'EK3!.G9YC%I.-BN;AS# MX9%UXQCNL;IQ#(='HEF9,ZIP>"3RKE'#(_MU/593>NAUA<10L%)05.ND-"H9%E4>)^S4]2JQ*EZ&6+!,A M@A!!B"!$$"((D?(@4F!XK46!,S7KD&4AISC\DYY^F$GG +OVY1*!4SJ&AEVX MRHBV*1PO0P"4$5E3.C:&$"@CBJ9T'*R.S??J&C%3IDM06]:)($&0($@0) @2 M!(D*S?=6>NT5="A[1S>2BL^\S\29=VI9?NQ%8=*.0YR I2$_'+VEB]II)[>]F]]UIRU_&=YX915(].8>0']W(.AB?5ITT@O( M<5W1B0?(50 ==+7HH%\8N^E %OA3/8[(^T]?PXYO5 M.TR"%6B(_C9:JAA-OH!,?;/>,XF6_O/NXYM?MNX0W;PPAOS72T]\T1]L>.CT M[34\?LQF2#21(H$54&T2<#'Q/Y%OO=FH)"4@1!,,KCIX0S=X/_S;+W33MLEK M4ZQS#;=G0=M3Q:39U00(P6Y]QXNT?\*#P8]"HGWUK%45<[CT1CX5P*=O?B3[ MT(%8L/F4%)N_$MEU88A^<3SJ60YUM?ES1V.;-"M\=QIB3 M.@*5U:H[I_Y"A_3UNZ:!Q\72+0O$W*!B.T1U]$%N$%&"82KN!;"SM$\T!%:+ M3EJ.&W,9]HU%VJ]^&/(^6II@]8Z->G9RR_,[CA4!E6T]Z!KB M/RRW7Y/]PD2_6S#ZHXEHI,;;LL:1;#BVI?_$3"OC0* J< MQUC> Y0G7'<*EQ0S/B>P(42OX$W]B+5#6Q%_V.@)M5.**]?][:26J>NTW]5$ M];".<#T#.\)A1[C%>>_\(O9G'CP__T&V/4[3^P64T-&N#@W(%$&AP@^"&Z$% M??@41!_JONIU7T.[9Y7=*TT1=BO\((BX?'N]*9D4W]=S>D$1C+Q:;16D2PK.EI[K(2]@THN^4WXV*/0@B]$R$2L(N8"K_ MEEB5KP4ZY#D&IV2/& M<( H192>AM+SFU(=@E*#]+LC!"F"]#R0%BM*^SUB#MP+V!>P/W!NX-W!NX-Q2DE$*E!:,2*@LV M Z M>9ER4_Z7]K_C,%K*]VN7EA6P]/CZ(_/8V!'-62S? U:%_(,QHU$%SKYI5;RNL Z\AI6B+?' MB;N*I[%+><=M#?X&KGEVJ,$60W>ML>K?FLRB#PN^_P[;S'(I\/1S"H ;[V[. M_JL%]Y<%+;IP-57/RBR^E#V0P ?1@F@YW=0L2&264^;7)<9H??*& CC L(&B MNZ N,A,/OZ)KL]VU^0SBF-D9MV:U4_(3"WE/95^$"+2D5S*Z-$J+IAWZ6?)[ MKI$O,]Q^\/\0O+X1K/ZGY#0Z,&B2U@#Q=5'&B!85T+++@3E70);CKO1T,NS5 M)6R.H%2G=FB/=,@H%Z$#DDM9,^I^O9*L%R$!?^4# _1 M+T%+LS[ KXO21;2H@):3_9+#Y60Y[HFN=TC?1/\$P=\\48GM"TXX0 9DD9US M:W]^# EU(*%:8J$@PY%0N#.0X;@S<&<@PW%GU&-GU*(H3/7NTKW&=9?F7:5W MYEV2=(OV7OM$0\ MF62DX[$$A+TJL"\I?=0?D:ZI(^X1]XKAOEAQKQM=TM$[-<$]%NHUOU#O5Q:& MRV5Z_Z".M^8B,AIX?IS,.0TU)PQC9J-;J+3 W%%KPGF\7&!R#0R^B:-[P=^O M@KU8@5?3Z+,RB\>R$D2+8FC958%WDE0LQV$:=DG7J(O=B$A7 >EUD8NUR%2A M+U*)+W(UH=X/IH%#,J9.H#U1-Q9MM&W'C46WMN24$!X/4EL6[8G=?$[8><^L M.' BAX77XS&SHAM/Q&JX%H;;A+%B-:F2 MD4',/G8(JM(X:0V2\9 .(KG>2"XG*V-V!L03U MMWCZR(*;L3PEM>"T.$5UZ=GG%$Y(_&23&U^_?9EG-SJ[\W.Z0;K]'NGH?143 M&_5QDY59?..POS.K=P[V=9/TS 'I=0I+3]?!Z$'@Y@W<@RHKS@&NT>^3[L D M@XZ)0ANQKR+VBQ/:!AD:8+,,E:PIPM!EG=R^<@.*Z\V&TBWW/G4(8^^)A=Q# MA.T1!8[%7R;>(>R^]&48/_Z;61&OI0_8+ ZL"0T9.HM*R]Y=70!7)._O"0CN MYAB0W0!!Z,H7]Y+_#_[=G/O%^(V'5,498$%W1W6IBD-#I,6;X3R;Y)#-T!^" M<=+%O8![0=6]D(]O>I!B&/2)82AII>-F4'0S5+,7\O-5&]!B'L\-M/K0/Q(* MJS^1X;@S<&<@PW%GX,[ G8$[HWX[ \LJ6]1H:JVL$H?+USX(=$B90KA: MIU!).:5A#$C/P')*C'NJ!/DBJRB[_2'I#PJ;4H-5E"W":RG%D_IH0+I#)1NL MH8AN+>2Q9A)K)K%F7@-R^FA!-!SM6,&" M:&\^V@MW#<$I['>)@:?J$.A* +TJL:XIR?&*DWKH[U7A[]W&C_!% M:,2T6Q=0-@6Z:W_2(*!>A&Y@8R6H9/^E9R?,G_,^3'E?J6^X&F@,E M3P"A_8#H1U\1MT"+MT#A#J1.1GJ/F+J20\@0_8A^]"KQO!L6'B.A*J_05E7U M(,.14+@SD.&X,W!G(,-Q9]1C9]2B8!)/Q:EW*B[IXHKGXFH;)]I3@9XP>*T0 M/:?<6.?@4[!19'UM#F<4W!_)'QD,/A3R>BT.\YHK7$[-7A^+5 M&/1(;S @'131"'G%(%^4B&[(N3C,5;5CJBY2"B./R''<&[@WD..X-W!OX-[ MO5';O7%6SDH_ZSC79MY6G7_22\H_/E<&(7%V\\A98U&SB!H#TL-Y0?:_L4(08N@/1.T!^6'\I2T?27/N2)HZPC: MDB3MZ*)?%TF+R9YVN]M(*0S:(<=Q;^#>0([CWL"]@7L#]T9M]T:!R9Y\#BAA M2J@6*:&MYY4P*:1HU"?A6/5IH5%-XC[JFA$(6TP,(6SK"-N24T/ZA:[D;"V$ M;3UAB\DA3 ZA>XZ!# 4"&>KJ"^0X4@KW!G(<]P;N#>0X[HWZ[ WIS,"_%(C# M7T@7[%L\98%C_7WU[R4V9+R>X<$YEJ6T3DCG2?Z6O(UY9N&/F? MR=Q%?W;L:,(?O?/S1RW=\29_Y$SB4N^91$O_>??QS2]; :^;%\:0_WKIB2_Z M@PT/G;Z=A0[/,7[\F$T :B(#""N@VB3@$9;_B7SKS=\?^,;4_+%VQ<,S7A3^ M[1>ZB7+)^H87/)'V M3W@P'I\CVE?/NMBP85HBE%3DTS<_@NM&/M^,L/"0V?R5:(M+>;_/+XY'/,3\+"\Q,GG]P MO)B*G(5C_^^;!WC4>^8RD0SX;@R,X;"C#V2B K[([,MHY4N7LQGS[/E7O^N[ M:HJZ/Q?.R9)@OL[4==)?AAK5 A;&;L2M"3ZO\S<&2B<@XO65/YU1[U6;T!"^ M%04^3\$\,?=5H_:_XY +-_ZUYZ2GW/NTL[$GNLKQ*Z8]CKFE,IT""\4XI*6> MQ[/ \0,N/L\1,_PQ)&JN7#_DE_W,)Y,^OFI36)LS_"M*7]/?/N,NUV_ M6!/JP4+O."[E?26*8:&[Q@\GOQ,_^QT4Q8/_F<&=IW#9A\F\&5_2A6\L228H M]M6+_#\GCC6!K[V"=N$N\5IZ[C*\\;9GDV?QV!/OL[%:-3OKZ7AM)@K M.F";G:Y D'4OZ\&:\7E*SIKP[[_R%Y<8V_,*17WCDA^(T;[W6 M#6AEQ:X41/ _"C?SPQD3.T+\*KQ8<<]7Q-=Q3@V\MU' '_6[Y?_L5F!OBG$= M]@OQJN3SDG[<+J"/%0YWAT&3#U!>?>\Y'9^\43XNI/,*BAF@D[TD,!X'_E1\ MU98I_'U0'OO!FCSFP\!AR=P[&++;;' M(L2U4BUQ;TV8';OL9GR9>9)[9L6!$SDLO$Z8\05XP75H' E:WXQ7RRSX/OCD M NL/K ]B(+%G?$L$,5M&Z>Y-LG_<1 D;HR+CGFN5F<^C)-P%VZ*5H@F-MFTD M:\%!_KL=^XI&4> \QB)LRG>L)6\A-O<$'!Y01? =C5%0?HO== M49NS1UA,_._D$64]4U8]BXLD2E&F'.0[(" "N(<(+IZEQY(\!ES(I;,0WDY? MS3]:(=^:+R#U^Z#_=%K8;D+&'EO_M?,RZQ<#I V/%F.M_O""90RU]TX[6FC M,5E5NNST@-/:'CE:$G&C1@-[YF^/P2]_%T;-MFC2V=P]9IERVX@DQ\F=ZPMY MBFW/4A!$EWB[%[1'K2-U_@\L4)2YQ-7P$P$*)'0'3I!$A3 M(+IZ:FIDD&Y_1$:CWH93*.>Q\V 54YJR;:X:K2CP=#/C2!&5 ;,XL"8T9$L1 MH1/+'E%0G:%+KZ!8T=Q!Y@ .JU.W)P@HQ631JD.:TE=( M(RX5PKO[WVLHC[JDHP^(WMW4BJ:%>G1;6NZD79CCB-3-VR'/AU5&S]=X;QT; MX,D!&(5#%OWM^JC]W[TG)FI2&0W<5XV]L,!R>)%BUNG6?.F5H_-=OMV0,NB: M\^5E-=U@*.L=@PPV#F"OG8.. MZ645]?155AWO*H-&'5V^CLZ(L$O/7D[A_9GPI89"S1R0SJ!'AMWU@RRHHIN" MY&45W50D#XD^,HG9W=304RD-?73KPR,4XY*^K6!;G=M[!JBRL4XQ_]8SZ]7Q M);;8.6:9>X-\^:X<48.H.1,U&!S,P^E0L2'$@Q]1=W%JS'W5YL>NTF"B./#% M_A,[3Z"T5YP5A5R6\HY2;#J&56S6I^"C(8JX9'D:C_T!&73Z1!]L_JPP_:!##&-;16]!&P#](Z5[VK$CR&8TV!*7S]Q>SJ_UAAYM8L9;N-5&UOF96^[)8W6ZXD,6I)&._H. M>O="N[3 P0H=6;&1$ZQYQFD!-DVB;6O;OVV]DW)JM=)O4J>5&R_3UL?HI&U] MLIWDQ$%KT6PK\C4*-MS8 9N.^]7T1\!$;TQ^7H9ROO.^)JZ;=OS*MD1:-'&9 MT) 7FQG]CY&?O'ADVH_IXT1[*_[N?-SX%?%"_ZCY@99\[9\/GY(WWXF>2'0V M"_P7,!LCYKX6T;\[U\JUZSCPMW2>2P7L+7T5K4>Z*!0^&_8'+0*(9]L>5S4(^K'Z5-IKN= MSCKDTF_ZP6Q"/?BIL:D-W)HP%&]$ ?R"\Y1?!JB\ZB7)*X,%*3H6P86?P=Q9 M81D\W>-?#ER+7S", O\O]CZQ.<7GAVD=\6O DA\((^1]-'&LOSA:/VA"\LQ# MR)GO)%3>^GERN_GG8]>G4;K2%%^:!)CV_SG3F1^ Y(IVHG"CE,I9[.1:,'W. MC@MYNX++F%/E-=HKC]B+BT,SGE,]G[J/SJN$[UNH^*Q5^0M(Y\_ ^]GYOJA:#8F*VSAQ8T5^;S?)]<-&]OH%60W-:M%7?'&] W?;S]@QTFQH.N; MC+/$ZK+WFUU_.(%S!6C4/EW\<3&WM-)W=]A19V^AXDFUU5XK5H@6LQAI%VYY M_F)NF:\5.ORNS[W]^>OO*\&"K#6Z\M'#ZXQQ:_0[!Z<%X/ST1XFVZZ"WP72M M)9"6[>W$9B9+R!(-IXI_DFWF^%PFD< >X&\!+NZD+-AYCH!2%WO;'\$,6IAVC,[?24DW, M40/W% ,?PHTJ7*K91(5[8&%;((@7$S_F.ES<./. W)@<^\ %Z?X&-K<6R,)N MX$\0LN!)/.'CJS 5?G##%02XXTFLRB7'@27G5O C,5- 7TH6*[DI6 O2XEWM M;%U?I5X,)"]%$]BI$W%^ LTO[W\OPZ#-_8+%4&?8Z;W7.^][';);G19S]R4+ M!_:=YT=:VI\WZ?VN60P<--C- 4L,(+@*MW6Y-\UWN0,[_S\Q#>#&8/8&C.]! MW@/^"^RF,AA=4("U\_[_+YD7:;/Q:!*P1%0Y+YKL$GY 8W#^TZP,\QCW;VCP MFC1;GL$#R6_- N:"3//X9_/F.S,0;2*FZ"=B'[Y$$Q$5+A!:Y*3O$L4\UC["D#B0T5X.NF._7!"F76ZC1]= ML&XO+8M7'W&+^(NST."[O/Q"#=I2"UN%IOOD@^/ "?49S!TK\@/IN=QG!Q7P MC7?@!,(2D^UG0W$EA7+^Y )Q/2>"'6EMZ@'H>)GI0T>- LP)A(>EF$O$X)], M#K5(1NXEII# *F$2+W;A/ K $^66$XG/^4UXPG+,YWW(@ 4?*)($ M;*5I_65DT61X[,E^Q)Z9:ON5S)5@Z]6W^L#SV(C,$"8&7Z#.> MHWQ!J93T%\ QS8\#()O8&209L;+GYYQ0(9?F8^J #\8?6D2I>5@YX%^%CT7: M0EYO<8F9GQCT"7GFL>[M"%AYV0&7W9DYG1EV\WE&3PA.#G\EQ?:#4B#E5\Y89+9 M#'C^DGJIM)A/\5NYW/['DS%@7\H>H7G""PTTD0B9:C-I&&:VUY@;AL'"=!3; MC]\ZL2%3.9*Q)6_$J$& O5W:?>^TM[=7ES>?W@E9P6\[CS;!4A]Y8&-A MLXJ[)2(MC4[,8UB>>,[ %FIQ_ER_7]Q?:&/0,@%?^+PB7W/I\R(L36'BA MA8*8BP[^ :PR&087INQ:5/2+;\SG7?(SU4XHYBFFEQ2+.E">U-UZ_E-L!#L6 M)2!9 :J$:PK)9?Y4 M(K#_F(0U:>A[@NLT#.- W)H^^C%<8B*2%P>ZT*[C_G8NL67YVMC+T!6?KR'R,&H M(.TB.2F$:(SGW#C>0,H @E,KDXKS/U*ZK 3;#UJCU!H)D:D;^IFG>:)N+/-= MJ6>Q;C*)X;4R_OS#$WE (# \MJA3X.K)EL.#YVJ*<(OQF8')R/& E(%4>F>NPIV1;9P1+DK,4XV_G>_AQ;I-D[.B6;*U?PE^T6Q[& M?^9;9.(#'Z]\;H>'VJ^_WA9!@XJG>*^3X!XD_K]@6Q+M"FQ6@('GT%8L_#<: M@ !:^*WLA3L[\YR2G(IR19@: MVH/J]9CQ%G O9]V&F'7;3]JLOOR41.OO9;1^MP1!FFZC:1(+7JZ#F:"UFG,#,IG=+IWBY"] ,WUW2&+XV$GJA<\^+W)@^9*"/H-O1TXO M?_/WW?/)-\T('W;FX\DW?6SN'2&>F12^XV7^EQ7'ZHL92I[/P-\\1Y*OC'ON M'S?N^?W&@Y;+7TDAFX%=\DF22!*ZZ^/'C-#,?83Y?GFX*N_7>M'DP[HV8^O( M4>+-P=;Z&/K<\)3G59!1Z[/:5=CX.?70W]O-I)>3"F MM@K4/5 \>(V;C+/:7_1XZ5B;I1U]T>)D3J.E24E!&^G7B>QS%'Y $8$BHE$B MHJ%FB:F>($E;)XG*UZW]L L6*9N;L/YTW@6R[L!ATTTX,2X]F__G>D&)R^B* M!@&O;/^#NC%;Z7!P&=YX'7U;L^??[S\O-1XPYXT'S-U#O+H]TAUM&>*53U_; M8H1=4SBYUK;X5$X.##+HF44R$@TUA>5K9I8YE[ *2-4\KG+\AES0@>_)Q'PM M191V.YM:N-12C-:$=;G)SH)9A^9K[<7K_<0/>(O)8*HY8J3K5!';M9JM*LCQ M -3XNB!&,4+VV&'Q*&\+8V)^XG9 .N:@GA(79>GY.0=YTH(?4K(8N$R/+B.: MQ\3!%=YTYUE4AL$?/^T9+9-^]XL??/;CQV@$Z"[^QJ$PNFCT^LQA]CRJ8F)OH &.].QS64R>B%U*2 MYN2&FA?YO&U):\5M2H-7V*#EB%>3]$9;AFBC>,V7:;F)4Z-'NOJHGN(4!>79 M@O(V8#/JV*)YLAE:(2_S2T$2PR@TE;Q%YF8'I%9>KW,T\LX:^0B+ED7)%4Q\;-<:"Q"&7:=D*2M4:8S(J-@D M0O-%Z:E,S"]T.2"C;A5N-!JM)XC?&]G;V_L!$I3/#E)_D)?8!N_]\?LX9$OS M9Y9-WQ;)[3D/?^4LO.._N1G_'C)A594CN'4RU NMB&J^X#Z9B_G9Q!UB]#'I M5+E,KL@D_H?OV\^.Z[;6_DT)4$[BB!@Z%CT5SJ_\A&/1_$*KMO825.0MVQZ" MS21OO_F>568NOD.Z?0P?E,N]_"I(2;=;13P6L^^8<\7LNQ)4:L,:T1VN55Y= M&6.N]-8@T@@H*>_3(;K1F/8#"K(JO^R.V25ZL0UWT$Y;U5PF:"[;C\4XP\:J M9T46J;JEI@B96K%(#,^5%)Y3L;7PKPX54WH=%A+M;C'6_"HSUOQV/BG\G@\S MER,G[Q=SS<-D-)CV6GK!BY-H2ZDC99-Y38J=A=2![L5HYQHEIQH MJ*6CWOGA>8NB&7WE1DLKXU<)#6XE"4H]%#PB@V%C#@77@',Y'@LA?;.FQ//:6PM8$_,BU4P8JNIR4H)<2?I4&Y3>#(R&V/)UH5] M^EV\)!S>R7H8T12$[:UXO-7W_O!VX1S:I0:!>@0H]C-UWS9>23O3A>< ME?7IQVH7->LTV[!&U6M=U*!2&]:(KG,#:Y1[U27^$SG-[G>?E\".!)_+:[DNOQ+)*/N#;'9+AJ(_"M'0.YA>0-(G1+Y2# M:+TV0/+RL&6+I:W(U'(JP.XLM9=ME_2'*%_+X%E^$K4+$A4KEMHJ*U?[-Z*O MO]I)+_4>7TLV5@V#=(NM<6FN,,V%D[F)V"$Q3!RPCG)XEQS.'!"T,@<$9_,# M@B$_%:@]TR"@F9#L:^N$M+"3%M3*G*:<'Z84!RC_E)2J2GH/>F38-5%ZJ\?B M_%I9D $.@&BMP):]&EW?^_$>?C=%PSEM_IWCJ(NGB\I@6GXGY <],AI@ TA4 M[HU<(YIYB(0RS;S:&7 *MD[SIU,GXB,N0]&X@RM!^"'S+-")VMMO?L2TX;MV M-5/;:3)D"';IV5=9@'-IWY 0U>^9SBZ/66!C?!?40C9O]!W9C=LN!^0@-V++B_ MSUCP/?GEPLGY^NW+W,OI[/1R"G_H3<+TW(?N7'0ZG4V>V4G?L65#UA#VEO70?6;E-!'2$FC]5BORXN("M>P$+; MK0V^WUO,HX'CP_>?'#\.W=<[!I<$E?(;FSZR( S@=R'7,=SXNWQQPKP">OV1 M27K;Y&K!Z^Y4N.Y>WR2#WCK"3H!,NT2!XA8\OI[S!:RE)AK[>(_T1SJ97D\VYI25Z!K<.\1Q,6]W134-7 M;#ET!>< ._6B52=0/-](E4Y&^I!T-YXC*CI0U=J@0X;K0EF54ZR($82R M>)9?K2*& ZHVW"]MV^&4IZZ6?>)-U#W:.I]1QX9E2PFH673F1-1MH3Q\:I"!B2V#RN9??H>@.\2LZ\ S#(.4-Q8MGL8NCPZD8]'\Z2Q@ M$P;\>&*:X\'?[9W/DR&/.(![E27.5T&;7_TP_,:BF_$#?2FG\7!OO<0$A7(U M3,UQ;%H]!36*X%Q%<)+7:K"\?;LO'1U1((M]30,/J!=FB/-9TB8_&1O"<\%[ MNXW@P8AT]?P/,KYKF,0ME*W'2=E#V-H=&L0I_TC/P#;BTS%8]C8P&F8=\@G8+9 MB*:AFLJR#6M$TQ"1@&TP=AA] T6-ODP?,UXM=,@9;2+JB]2V%G^JL*W6I6<7 M:37N:9"F&X6.'BC35JP5$_/+L)M=HH^P85JI]H$)NM/V8R[MFFL@*+)(U6U% M1T7$:##["4R<CGN6(F%]R4CZ\T)8XM+HT^<##0XW?#<3)7"$'!!7'\".6 M5 Z_O[PWS67F;"'$$FRYO[&Z"OY>QJ5Z9&"&<)?*?::OX6(S3>9FP;-C1Q/^ MW)V?/VJI4##Y\V;B\7K/)%KZS[N/;W[9QGO=O#"&_,=+#WK1'VQXUN3MC^+G MS\F='\$8XX])M4G [:S_ 0OMS48/KR.,F ?ARL >X(W/.,C_]@M-%JGM0= R MMQ,Z#"]Z#L G^W7NW/(7W'_Q%L;/-)=L,W?)=T X82T@K)KR*OJ M%.4$'IW=^B#*B/;5LRXX_Q;2:\LF<&QX2,2 MV7E Z6T41H+N(>C_@9T2:M<@@^S-)[-(0OD!GTW1XZ9Q_'.-O$D9_J@M*?8S^):X%'!5E\Y">#M]-?]H MB0!OMD8=.NM1A^09^X.?-\8/DH]-6,!V%VGA:.Q[69O+GA%4'YX34T^#/@D2 M%Y::V O'1OQV767M6@ J@)'WOV_T!=JW73B!G?PS6S:R<'&7OY)NA0R\KP*,HK; MD7E,&SH5O9X[]L2\F&V*!1:<95>B05KE..K(9Y\#/-RN=DODJH?"^)/&_9 M?1OX=FQ%-\$]"YXB-Z=%5 M9U0,%ZC01]6BHJ\3TZQB(CVZ;/6Q&>[CQ] *G)E(E2I@)E35X;\@6R%+7CZR MS@DL?J0?_BI%!'0[I-=OC+50=VRLF P58\,8DI'9F.KZVF-CV7"H&AL&Z74* M'4V/@02%C0+1\@N-@;R- 4'6Y.HE.89=TC$+W<ATY.*'Y,1E<2QV;[JO"Y"77,K?:$X-TBLT88%2X M,=6]5WXH&C9L5,]8Y8M5JXI=%.F%L[L;E,)3NA:X&O.*:Z2;<6)DU:#4=S@@ MG2%F:PKGN5J5O#TRZJ*S7#S3%2K4[8W(R*AIH2ZJ:BS!K4H[5UTDUR'F$$-> M9>OGBKFN]XG1Q9*JLA5TU5SOD&X7!T6C(L>RV1P5>/DE;WW2P0+(TE5V^7SN M$F,X0CZ7K*3+Y[-!]%X58\&QA!7+U;!P40DJM6&-B 1$0IDEK+5S!E4M3K5V M5<&@]FN7%[L&QBD9_3104-CK(EK1+,< MD8!(0"3@&4,\]"!N^X_ #T-M%OCCU;GAK?/X!"EN!25*]?=,@XRZF/HIF'<% M.7M#TNDVIHVMLKPKQ-/31Q6UC$-/#ZTZM.^5H%(;UHA(0"1@*J[!/EPR.=K[ MH;&7&?-"%E;@R2EQ#+AR:ZJ!2T-ZX=EUM>2U>G7T=RQD-+ F8O:YS9Z8Z\^F M0)[6QM)2@EQZ]N<%.:ZE>BHUNC;HD8Y>:,%M\R,TIW"SF'A;?T2Z?3S+5CXW M"XG ]3JDIV-[KK9JS7N 2"A4)CSH7XQ[,*U5F/?,=7FC/,_^+:5%%=JR9Y). M!_,9Y;*R&%79ZY/1" V?DEE9C)[LDZZ.9[E1F^ZLY& >"Z@K]"FUIX[GA!$/ M"SZUMX8_(0ELW\LE@E2A68T>&1FH62O@9S'JU3#)J(N]=*K@9S'5( ,R'%3A MBV(U"&9^L09 "2JU88V(!$0"5H/4\&"VOZ?*HT5^W;S@)3$4PW+/9_>XZ8_G MLTMA84%E^[T.Z78*/>6++"S87S.Z9#"J(BB*#AL:9VBF*T&E-JP1D8!(P(/: MK2_R_Y6?TQX'_C1U!-=&+S30#7Q[H 7ZU;/\*>,DRM\3#.&!X+T]QFB'C$;Y M9_?>-F^Y)5.ZE-OP!,=NE\K%8F*H)C&P_J5< M/A832"7=8BN^T55MCOI,4H\-UI][3-J4$E64D(+$[>7?5[AE/LEA#"Q*9?8* M&,2'#"Q-5YJD/\J_1A2]R)JHP:L)]7XP\"&U,74"[8FZ,9.S$FS&IO3191R, M@K+\]2Q@8Q; A_"HOO67]DR#@'H1K(D^.JX3O;97C7X!^OW!R7=I_SN6)O#- M^$])GW*K>08FT8W\_9B6">53^%F,CAT.D)E5,+,8?3O,?\A\.=H67=,R1]@F M85WM;>*?OB.:Q]K;?4?09"7YDIC+WUBYL5[#P,[69R;13F%FP?G17A^5;"5L M+39-6BQ3L9Q6S;*R-JP1BR@1"8@$1 *>?VQ\H2Q83YK+BV4?&9@Z+'4-(_I2 M25_LS7;13Q6D3=(2O"^!/[T"*CM># 2]F5<3?Q+TDM][X-3ZS0'..]%KFG&Y M].SEJUS_)X:/?V/1Q+<7M0Q5U>".^F18P.3.JOR2-D*D\++>+M$[S4FAMQ(B M15<*#\BH7TG4&1UA-'K1_5&"2FU8(R(!D8#G2AN8$;T-_" 3MR2?MY6 )&4'3 M*+8Q3-LY6'3";D@ZU;3V08\.K3>TXY6@4AO6B$A )&#"KH$)NTO+"I@PK?RQ M]B@"XI9#W:27@,SD,1K%P1'-!A3P!RLZ6'6;$N*>TV%.VYOQ'1!N.N.O/SNA M!; N-__7[Q!ST!Q/HYKTT?G,S2DO^%\6^#8-)YP00T,W/JXQML*MU'H>YY,V MK(S'&*556%M?Q=/8%6-* 5< (Y=RI0O/ F3V[% #/*.*WKW#'V ;^P$-7F7I M]^>4=HM^(^56YO3)8)1_24"[-//)/$6%W%S6-E,/8]P78SP8[5."2FU8(R(! MD8!Q7ZSW2?L:T"@*G,(](F&CE5-X9 QZ!*C4VPGZ6:7G>3#9JPN:@>;L02I>:ZH"2:9 M[<=<"3;7[E1DD:J[((J0J16+1"P@%O!H2>G9GR5-3O4AOP,SOHL+9NU/8VY^ M=@XT/X<7^OH9E'\N-N[T#%04#IW]WF,.7'7Z%X,BZT\0,=1 M4=NI%8M$9P&Q@%A +& FL]'NY9_B.9C]G@+U@!O2Q0RU.&0V'Y<)ON4LYG-N M^%BNQCBBU53CI;2^E*3^%D\?67 S%K;H31R%$1 )*)V'CRJYF#5P.UD#=Z?7 M0G1>5MO/O]EVJTHOCGFB' 90Q,1HF MMB4.K2Y,/ M/#S4N=Y G,P5[.[S)PMA%B"+8]GK*Z"OY<)[,AA;A\T MZC[3UW"QF29S$_'9L:,)?^[.SQ^U5"B8_'DSH1^]9Q(M_>?=QS>_;..];EX8 M0_[CI0>]Z \V/&OR]L=LZ;@F:L?A,:DV";C=_3^1;\%^$$$.0#H?G<2A_+=? MZ&$P669ILMCA1<\!C&2_SD-$\R<,Y+/0./)78DCBK0UAK5W8S#^N59/2^RMP MEWZP6Q_D%=&^>M;%)HCS1W-L>"[',TRS-^I^U[E3A;3=0]NLL+^?BWBY1Z:S M@$V8%_+#]KP">!O=D05SW1FU>=1) MQ(7XW\EU9<0HJ\O%]1-5(ZUW^8X5!P$@1"CACUJBN$;&SVR-I<](TTW/*>\ M,PWF)4!<6%UB*QP;JMUUE;5K :@ 1M[_OLEH\FT73F G_\QF&Q?NZO)74GLU M ^?D$W&G#_*\Z5(<>:,I>.Q^/TZ*KRW8=2%681M4SUN2A2#:F6QT7173E2+IO* MR>4O?@!/XB5Y!>M5BP+JA;PC-Y@1=-Z25@%OIIHR8J&WEE*G"U,JH=U50KH' M3CEYD4O/?EC0<='9%RRQF_$#?2FW(7=75Z64')%P(!)R:N.]YE A$O)PJ,J% M0M&>61^],J6T_R::'JW7<[_@O%W@>P#3^Q @EK4)M'#B!]%[N.(4W+HG)I$= M?D!W#AT312^*5$-W[DR!WE/.G?O= ^J[< %;^T$=CX@3XOPH 'U!%V[%6EO0 MZI^^R_.R_P"*<1/NQKMGX \[D>!7#'9RB&H3,&P@FH1[XP F2RK24&P1GQ MFU7Z+>(T7P)_>GES]?6+']S#?KP9+V1 )7'= F1_M941:@G_HL#0I@F-B(LC M<-%,JZ#%;6;4&'/6AC66))\:0:LVK!'Q@'C !JF-+5K:6TS:8-?V=*.UFN(C M?8@1RDKY6E I42__(S:-Y.L9H:A6%@:AOXCV(/H'"M&J#6M$/" >U:^VY^PT&9''>WF&G\/MD5+ !B8RMZ$R^/FA:YKD6C"W^A+X^*I:QZ/(I MVHR]%8NLAY&O"+%:L4A$!")BC^/W-YQ*@5,I<"K%RE2*'DZEV#J58F.P1C;& MWC&O0L.!%$V<%?W\)68T$@ONY; M?XD9"SA>X33JWV>F HMRX<%'[3,;.Y83(4UQ.(CBE%X:#D(T]F*Q692,P0:! M0G%>R)9Y(=)^.HE3HXSC5N2\$+.WMP. MV%!%@C@O%>=7_G3J>^=P]D!2!_[SH4-)CF4>7/&(JS>4D9= ,YX-IFZ%HB+W MEG:WU+'??_4RB[FB,R=:6621*$/<%HQ;RXJGLU1+D294/=LOR*U[JC.#3-&Q9^2*C:M.CHE M(_F)NM2S> &?J,+8D,+F+1W6J[^.K*%5];S^[F,;4B3>Q%$848_OFI7#&I?A MC3<_I#'\O@CT9Z+M\Y"WL.)_8]-'%L0AO_R\_N6*=Y>[&8LO7+XXX>II#Y'C M#K,'/KY^^S(_\='9UY&#=(TA&>K*='!0\/C.'AAD_*_K_\1.]%H-#DYN'3KJ M$%,_YWA>UF;;J4;E-Q(M*FV[E<^6]*A:P*J%D)%9EFJ$B4&Z9I\,3!0E98F2 M<[FM?B-19'>&W8O,&\]6??62#-5&ULOK\1R#[_$BVCPUAMXAW;XRPP849/N> M\[Y'\WV10=C6(JH8#!QT5CC_,8*GGO]N/A+N6$3!,[.O:>"!+1!6QW:C:Q"] MWT/>E\7[_#D(#OQ QT/^99UJ5:.;41O66+@ET0@JX1J+BUP4;\RV@3V-6",B M 9& 2$ D(!(0"8@$1 (B 9%02L/AW>4V32ZD*:4TYFL8QKPVAM?%W+/ @7O\ M4PL6;4JL3)N2V?Q@8\B#?O/!JTYZ#DC,C!'3"%)5MS8*/W29E"7] :=NMN5A MQ8)QO;/LR\K?+@M4D&HRX9]1MCUN8CZ/?I'M'&1R5-<\Y)AOV$S,X. MD7NE0+VN'&U/D@HBS5ZA4#C96MT@"(H!58L0=%998@-5YKF;0YV D-G/?SA] MPXPJM/B10G64,GD*B4$MXS^8A5M)"*>H-R6B0?\.FAH$#)1=2""F$%&HVA3#C7 =? M E1]%#@6SRMGW0KT&% BH,=0O<=P4%KY;KZ'I5'_3 -;U#-]\8,QYA[&Z&?4E?1( M(:30[NS6I?WO.(RXK_C@;ZG 2G3#S3A)>%F)9L@FO.I5XM68PFC<4D@A52FD MB-"IA!P&=QY2 M"&53[H=H"A8MF)6JM_/UC46:ZX>8=6JG1$1GJYZD1PHAA9!"2*$<*+1G9CH8 M"%\]RY^R7\%*.'3L243!NK"O:>"!$1(6XU ?,G!=[PQ)9YC_*?)WB($<_1=5 M.(DI(E6]E)MHP@*1' K8!+QNYXFAU])>E85>2SU)CQ1""B&%SK?'A#J\RFK# MA7DF3KD]T)=;/^"_O(RBP'F,(][I^\&_I0&8% =FQRPKGL8NF.OVMOM5:=CG M']5NFE&/VZP&VZQV.V.+DR2->QVL]SW.3GJG@YV'-P5:]HT87MZ&-18N>1I! M)5QC<>Y=\QIQ!H1"8@$1 (B 9& 2$ D(!(0"8B$PY& %;.%Y:*?Y3<> M?=?>,(ZHDLSU)^KROI*A1D/>^>5?U(MI\"KA8.K DXX^6L9,HW+9>UKXB=YX M-W$41M2S@9XK(=/+\,9;JBO:.[.T]!9]>F] 1MTAZ?7,IIS@^:ET&'#&3 MLB"4V:-J<'#J(8M>IT>ZP]X9_,>:!&6$3*7]/GF)&XB345-$24OGUOV$ R4K M&BAYA!;!29$-@L99#F9+S"9ECKMWR6B$UO+)92E'\UWI0BZ].:".B=S MS%Z'&#T#>5\6[_/GH-DCYN +S8Z)9)NS%\WVXT>7-3A-J9IL-99J@P@\QU-O MA^MK&,;\: YWL^X!B'"/?VK!_&@!QWYZMD";I8<+-#&JF6@>$ZZ:DU[#\L-( M'/#Y:?+!D)&9]]^ZF2K0#+]RFCF/;,4'Q@8&B"FCP*H6AX!=G'[,_QP$@3 HO>;H MP"D^.HQE2AYD,DC?[))^KX-:]!PM>AAJ_J!NS!0!S1EEO(/>.;W&,$"!KA-2 M""F$%$(*(864D_;DLQ--2O*U MBBB+K\]%FTRO^A8EUXC(",KJ+XKT0GHAO=2Y*-)K<5',$-7;@#\R*]3(! FZ M]UBDUTS2(X600A6F\Y3IQG-6X\)60 0W$5*HIF*F)E("DQBJ^D!;DQ@QZ"*- MO;# P0Y=(43VSLXA1?'@C-^YULK'MPXS9*ILF M=\E@U".]X1#-6)1;%6P>896=L7=4<00- H^&>PCW$%*H>5*F-D)">(+P#T^V M++D\ELMH\ &N,_DXI2^I>\0]J#>I@['J($FW9WBH)[;!Q.'%L:^5L@ MR5FPXF?NX1? ZX@/00K@;4]S8,$_ M NJ"WQZ(*%MHR?RNUI^?WEO]I>9 MLX40V56(8,?J*OA[F7#.(P-IQ,,Y[C-]#1=[?3*/%"4.H-[I_/Q12Z,F)G_> MC/.H]TRBI?^\^_CFEVV\U\T+8\A_O/2@%_W!AF=-WOZ8G3VFB>%C\)A4FP1< MW/X/R&S8#R)Y#$B_XK(:H/RW7^AA,%EF:;+8X47/ 8QDO\[C1_,G#.2ST#CR M5P),XBT9%9/Y;.:Z,VKSN3C"T>)_)UP7?R^Q37 _N:ITM.4[5AP$\+2"WB#C MLPPY/5*5>/)P49?.0G@W?37_: F=;S;$#^75%I_:*V0TNS]O+ !)/C;@^;?: M&(M?[7VYBM1S+GO:M$60?GA-D3VV_1,PL#9$YWLH^\"H@+$ \ M>.+4\V$!1_GGSHAC\I5T[V6D5/+)4L Q:_MO%.9'SS\Z:M[EXKSHDBY^#'XI M\2$R1U4K?(KY*5GM_N1"K:7(*LYE[/DD,9N0B$5B@JEHSM#<&*HSTC'M1]_]7++"8)\&[!:OXH0]P6C-O% M?*T*@2M&>TE\9>=[B7?DD"_M[:]^&+Y#W#40=YS+G]G8L9P(^=L0_C[XJUJB M7(F2;0@GLCJ#CQ4^37GH;J>?W-IM)HM?"O4'WJH0H8<8R%XHI5H8G. MMXLFQ9FZ[M]GOG?-]V]:>):4)FEPR'C2ES56U+(G&0.$@< M)(Y2Q"G,LT"?X4R?X0\61KPX&!R!9=< CY'622(H22'T#A"<2"%%/9)AH[*[Q!VS_!^>N&*]?"J#C,P!NE6X\Y!"*)OR;G53L&C!O)2J M;M4W%FFN'V+>J9VR#MVH>I(>*8040@HAA7*@T-O=]BX8"/),-3]1?9C'?,]Q>V!Z;-&:9]O]*B@_[&*B#/=6W?=63;;#%K, M#C&ZYW15Q+H"981,E=TY=9V,]"'IZL.FR))\E.X^JT$T#E>IZNRGTZ+2^VF8 M'7DKX5^@,:8<6?-5(^?N])-3KQLV=S%H:1$TSO(=6V(W*7-JO4-,$YM0E\9V M!:NQFM.UH #V[SEY<;R[I,K1F^[0(.:HTYBC-\KS/G\.]@W2,?*7W0<]%L/WYT68.C[XHL4O5$C")DPD6VN7ZL'OQIQB(1"X@%Q )B ;& 6$ L M(!80"X@%I6K)L(=)Z;.%@WGM"X_[I<4OVBRM?M'DY##JV>D8XF<:!-2+0J)Y M+.*7<-++67X8B:JTGW8''1<#464NU+/_3*[YQ0^29J7A37#E4F>ZK160T"(V]0A #O&>SRPZ

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�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g233594g05c36.jpg GRAPHIC begin 644 g233594g05c36.jpg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end GRAPHIC 10 g233594g03a03.jpg GRAPHIC begin 644 g233594g03a03.jpg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